Unnamed: 0,Unnamed: 1,Unnamed: 2,Unnamed: 3,April,May,June,July,August,September,October,November,December,January,February,March,Total
District,,,,,,,,,,,,,,,,
Baksa,1.1,Total number of pregnant women Registered for ANC,TOTAL,1663.0,1534.0,1608.0,1613.0,1607.0,1418.0,1330.0,1310.0,1514.0,1526.0,1337.0,1792.0,18252.0
Baksa,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1394.0,1246.0,1304.0,1344.0,1288.0,1158.0,1055.0,1062.0,1305.0,1257.0,1110.0,1507.0,15030.0
Baksa,1.2,Number of Pregnant women registered under JSY,TOTAL,1655.0,1529.0,1603.0,1613.0,1607.0,1412.0,1323.0,1309.0,1514.0,1524.0,1331.0,1762.0,18182.0
Baksa,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1149.0,1286.0,1313.0,1383.0,1379.0,1242.0,1421.0,1439.0,1440.0,1141.0,1080.0,1220.0,15493.0
Baksa,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1321.0,1178.0,1464.0,1351.0,1475.0,1259.0,1392.0,1290.0,1137.0,1097.0,1118.0,1287.0,15369.0
Baksa,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1179.0,1079.0,1324.0,1484.0,1405.0,1232.0,1489.0,1459.0,1488.0,1145.0,1044.0,1273.0,15601.0
Baksa,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1353.0,1292.0,1415.0,1448.0,1484.0,1325.0,1392.0,1309.0,1443.0,1332.0,1178.0,1494.0,16465.0
Baksa,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,12.0,3.0,6.0,6.0,3.0,1.0,4.0,6.0,3.0,21.0,3.0,8.0,76.0
Baksa,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,10.0
Baksa,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,738.0,731.0,687.0,726.0,674.0,773.0,666.0,490.0,462.0,508.0,583.0,564.0,7602.0
Baksa,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,1.8,Number of pregnancy test kits used at SC level,TOTAL,678.0,649.0,612.0,637.0,610.0,455.0,457.0,390.0,379.0,381.0,327.0,310.0,5885.0
Baksa,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,3.0,5.0,2.0,2.0,1.0,2.0,2.0,2.0,3.0,1.0,2.0,26.0
Baksa,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,67.0,83.0,71.0,104.0,80.0,107.0,104.0,91.0,86.0,103.0,75.0,81.0,1052.0
Baksa,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,68.0,86.0,76.0,106.0,82.0,108.0,106.0,93.0,88.0,106.0,76.0,83.0,1078.0
Baksa,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,66.0,78.0,70.0,103.0,75.0,102.0,102.0,81.0,80.0,99.0,73.0,81.0,1010.0
Baksa,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,742.0,689.0,679.0,826.0,887.0,947.0,946.0,957.0,894.0,977.0,830.0,812.0,10186.0
Baksa,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,328.0,288.0,280.0,333.0,342.0,401.0,373.0,507.0,450.0,372.0,325.0,309.0,4308.0
Baksa,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,670.0,699.0,534.0,731.0,658.0,886.0,774.0,1230.0,1264.0,848.0,623.0,1327.0,10244.0
Baksa,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,605.0,846.0,842.0,656.0,896.0,1444.0,843.0,1051.0,1305.0,852.0,415.0,2255.0,12010.0
Baksa,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,0.0,,,0.0
Baksa,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,4.0,5.0,7.0,8.0,7.0,6.0,10.0,6.0,4.0,9.0,34.0,50.0,150.0
Baksa,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Baksa,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,0.0,,,0.0,,,0.0
Baksa,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Baksa,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baksa,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Baksa,4.1.1.a,Number of male live births,TOTAL,394.0,399.0,351.0,479.0,494.0,538.0,535.0,527.0,498.0,566.0,448.0,498.0,5727.0
Baksa,4.1.1.b,Number of female live births,TOTAL,406.0,358.0,312.0,455.0,467.0,504.0,516.0,509.0,466.0,510.0,472.0,437.0,5412.0
Baksa,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,800.0,757.0,663.0,934.0,961.0,1042.0,1051.0,1036.0,964.0,1076.0,920.0,935.0,11139.0
Baksa,4.1.2,Number of still births,TOTAL,17.0,26.0,15.0,9.0,19.0,20.0,17.0,20.0,25.0,16.0,17.0,9.0,210.0
Baksa,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,63.0,49.0,67.0,90.0,65.0,65.0,60.0,92.0,120.0,93.0,97.0,112.0,973.0
Baksa,4.2.1,Number of Newborns weighed at birth,TOTAL,795.0,750.0,658.0,934.0,963.0,1045.0,1021.0,1036.0,967.0,1075.0,910.0,935.0,11089.0
Baksa,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,101.0,94.0,72.0,133.0,125.0,111.0,147.0,116.0,156.0,151.0,115.0,117.0,1438.0
Baksa,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,798.0,749.0,657.0,932.0,953.0,1039.0,1048.0,1025.0,962.0,1065.0,918.0,909.0,11055.0
Baksa,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3.0,0.0,5.0,1.0,0.0,4.0,0.0,5.0,0.0,7.0,0.0,1.0,26.0
Baksa,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,2.0,4.0,6.0,9.0,5.0,5.0,6.0,2.0,2.0,0.0,3.0,6.0,50.0
Baksa,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baksa,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,5.0,4.0,11.0,10.0,5.0,9.0,6.0,7.0,2.0,7.0,3.0,7.0,76.0
Baksa,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,10.0
Baksa,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,56.0,45.0,0.0,10.0,111.0
Baksa,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,24.0,24.0,10.0,11.0,4.0,0.0,18.0,3.0,0.0,0.0,0.0,3.0,97.0
Baksa,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,34.0,25.0,23.0,29.0,38.0,57.0,30.0,26.0,53.0,42.0,42.0,10.0,409.0
Baksa,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,769.0,805.0,663.0,957.0,1064.0,976.0,1152.0,1195.0,1094.0,1187.0,924.0,960.0,11746.0
Baksa,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,834.0,757.0,712.0,838.0,884.0,900.0,943.0,878.0,969.0,945.0,880.0,898.0,10438.0
Baksa,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,4.0,0.0,0.0,17.0,7.0,0.0,18.0,16.0,17.0,18.0,97.0
Baksa,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,41.0,33.0,45.0,58.0,52.0,44.0,46.0,77.0,91.0,68.0,77.0,88.0,720.0
Baksa,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,41.0,33.0,45.0,58.0,52.0,44.0,46.0,77.0,91.0,68.0,77.0,88.0,720.0
Baksa,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,0.0,,,0.0
Baksa,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,1.0,3.0,3.0,3.0,2.0,15.0,7.0,1.0,5.0,9.0,3.0,2.0,54.0
Baksa,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,38.0,21.0,32.0,20.0,40.0,49.0,35.0,9.0,16.0,28.0,12.0,4.0,304.0
Baksa,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,39.0,24.0,35.0,23.0,42.0,64.0,42.0,10.0,21.0,37.0,15.0,6.0,358.0
Baksa,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Baksa,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baksa,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,106.0,0.0,0.0,134.0,0.0,0.0,0.0,240.0
Baksa,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,0.0,,,,,50.0,,,,50.0
Baksa,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baksa,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,106.0,0.0,0.0,184.0,0.0,0.0,0.0,290.0
Baksa,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Baksa,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baksa,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Baksa,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baksa,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,32.0,17.0,22.0,190.0,39.0,28.0,37.0,18.0,19.0,14.0,23.0,13.0,452.0
Baksa,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,68.0,53.0,49.0,224.0,70.0,42.0,37.0,44.0,38.0,34.0,48.0,36.0,743.0
Baksa,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,2.0,4.0,11.0,5.0,9.0,7.0,8.0,5.0,11.0,17.0,12.0,13.0,104.0
Baksa,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baksa,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,102.0,74.0,82.0,419.0,118.0,77.0,82.0,67.0,68.0,65.0,83.0,62.0,1299.0
Baksa,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,3.0
Baksa,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.06,Number of IUCD removals,TOTAL,21.0,11.0,18.0,50.0,18.0,42.0,106.0,20.0,18.0,12.0,56.0,16.0,388.0
Baksa,9.07,Number of Oral Pills cycles distributed,TOTAL,3627.0,3555.0,3774.0,4971.0,4186.0,3764.0,3710.0,3473.0,3399.0,3362.0,2976.0,3416.0,44213.0
Baksa,9.08,Number of Condom pieces distributed,TOTAL,7972.0,7830.0,8619.0,11163.0,9051.0,9568.0,10096.0,9360.0,9390.0,7676.0,7161.0,7771.0,105657.0
Baksa,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,3.0,6.0,0.0,2.0,2.0,0.0,0.0,0.0,10.0,0.0,23.0
Baksa,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,54.0,17.0,27.0,85.0,31.0,5.0,14.0,7.0,8.0,16.0,4.0,0.0,268.0
Baksa,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Baksa,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Baksa,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Baksa,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1054.0,550.0,1345.0,995.0,1237.0,970.0,1195.0,1315.0,1592.0,1456.0,1148.0,1121.0,13978.0
Baksa,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1442.0,1288.0,1259.0,1264.0,1297.0,1021.0,1243.0,1600.0,1437.0,1491.0,1182.0,390.0,14914.0
Baksa,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1352.0,1291.0,1337.0,1321.0,1237.0,981.0,1091.0,1278.0,1581.0,1368.0,1391.0,1413.0,15641.0
Baksa,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1182.0,1194.0,1317.0,1302.0,1305.0,930.0,1006.0,1161.0,1410.0,1446.0,1254.0,1535.0,15042.0
Baksa,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,178.0,1127.0,1305.0
Baksa,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,126.0,126.0
Baksa,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,254.0,238.0,216.0,237.0,198.0,294.0,392.0,399.0,332.0,408.0,366.0,321.0,3655.0
Baksa,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1443.0,1281.0,1263.0,1259.0,1184.0,1052.0,1079.0,1495.0,1250.0,1586.0,1282.0,938.0,15112.0
Baksa,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1353.0,1295.0,1337.0,1321.0,1099.0,1017.0,930.0,1229.0,1353.0,1316.0,1430.0,1470.0,15150.0
Baksa,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1183.0,1195.0,1321.0,1292.0,1126.0,993.0,862.0,1066.0,1263.0,1385.0,1263.0,1554.0,14503.0
Baksa,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,142.0,122.0,115.0,86.0,143.0,174.0,182.0,235.0,258.0,243.0,247.0,150.0,2097.0
Baksa,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1581.0,1341.0,1309.0,1016.0,1360.0,856.0,1085.0,1805.0,1486.0,1270.0,1191.0,365.0,14665.0
Baksa,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1366.0,1282.0,1355.0,1159.0,1266.0,837.0,933.0,1395.0,1729.0,1166.0,1393.0,1350.0,15231.0
Baksa,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1198.0,1126.0,1367.0,1164.0,1346.0,812.0,875.0,1235.0,1474.0,1252.0,1299.0,1496.0,14644.0
Baksa,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,811.0,1108.0,1344.0,1288.0,1458.0,968.0,622.0,1898.0,1532.0,1004.0,1084.0,1031.0,14148.0
Baksa,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,867.0,1035.0,1199.0,1105.0,1349.0,954.0,494.0,1071.0,1032.0,799.0,950.0,927.0,11782.0
Baksa,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,424.0,574.0,690.0,667.0,734.0,514.0,318.0,980.0,808.0,532.0,571.0,547.0,7359.0
Baksa,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,387.0,535.0,654.0,619.0,724.0,451.0,304.0,918.0,724.0,490.0,513.0,484.0,6803.0
Baksa,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,811.0,1109.0,1344.0,1286.0,1458.0,965.0,622.0,1898.0,1532.0,1022.0,1084.0,1031.0,14162.0
Baksa,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,935.0,1091.0,1236.0,1136.0,1372.0,974.0,700.0,1138.0,1066.0,888.0,1025.0,1025.0,12586.0
Baksa,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,935.0,1090.0,1236.0,1133.0,1175.0,1064.0,625.0,1070.0,947.0,878.0,1009.0,1030.0,12192.0
Baksa,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,62.0,137.0,149.0,63.0,119.0,25.0,14.0,46.0,30.0,23.0,20.0,18.0,706.0
Baksa,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,62.0,133.0,166.0,79.0,123.0,18.0,8.0,55.0,19.0,25.0,15.0,23.0,726.0
Baksa,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,124.0,270.0,315.0,142.0,242.0,43.0,22.0,101.0,49.0,48.0,35.0,41.0,1432.0
Baksa,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,471.0,430.0,437.0,488.0,657.0,458.0,399.0,440.0,525.0,547.0,546.0,569.0,5967.0
Baksa,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,271.0,279.0,305.0,332.0,339.0,282.0,267.0,289.0,326.0,309.0,282.0,353.0,3634.0
Baksa,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,214.0,212.0,206.0,260.0,212.0,194.0,239.0,230.0,206.0,196.0,217.0,241.0,2627.0
Baksa,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,4.0,8.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,17.0
Baksa,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,5.0,23.0,29.0,20.0,30.0,12.0,1.0,6.0,12.0,0.0,54.0,32.0,224.0
Baksa,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,844.0,796.0,787.0,837.0,789.0,799.0,846.0,799.0,858.0,804.0,802.0,803.0,9764.0
Baksa,10.4.2,Number of Immunisation sessions held during the month,TOTAL,822.0,776.0,774.0,831.0,776.0,785.0,799.0,782.0,847.0,792.0,771.0,791.0,9546.0
Baksa,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,813.0,773.0,774.0,828.0,776.0,781.0,799.0,782.0,847.0,788.0,769.0,791.0,9521.0
Baksa,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Baksa,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,804.0,1102.0,1314.0,1271.0,1514.0,967.0,676.0,1838.0,1480.0,981.0,1067.0,1017.0,14031.0
Baksa,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,201.0,187.0,217.0,200.0,2875.0,541.0,207.0,235.0,224.0,184.0,416.0,2011.0,7498.0
Baksa,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,308.0,281.0,264.0,329.0,2787.0,695.0,220.0,327.0,346.0,337.0,423.0,2069.0,8386.0
Baksa,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,8.0,9.0,13.0,15.0,9.0,7.0,4.0,1.0,10.0,4.0,7.0,5.0,92.0
Baksa,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,230.0,270.0,199.0,256.0,235.0,237.0,224.0,172.0,126.0,111.0,93.0,110.0,2263.0
Baksa,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,13.0,62.0,2.0,21.0,26.0,56.0,1.0,17.0,0.0,3.0,2.0,1.0,204.0
Baksa,13.1,Number of Patients operated for cataract,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Baksa,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,45.0,30.0,11.0,0.0,0.0,0.0,0.0,2.0,0.0,88.0
Baksa,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Baksa,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Baksa,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Baksa,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,16.0,18.0,17.0,17.0,16.0,17.0,16.0,17.0,15.0,18.0,16.0,17.0,-1.0
Baksa,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,750.0,713.0,716.0,746.0,718.0,727.0,737.0,723.0,775.0,721.0,695.0,728.0,-1.0
Baksa,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,3.0,3.0,3.0,2.0,3.0,3.0,3.0,2.0,3.0,3.0,3.0,-1.0
Baksa,14.05,Number of RKS meetings held during the month,TOTAL,31.0,31.0,31.0,32.0,33.0,29.0,28.0,28.0,27.0,28.0,25.0,25.0,348.0
Baksa,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,27.0,27.0,26.0,27.0,26.0,27.0,26.0,27.0,28.0,28.0,27.0,27.0,-1.0
Baksa,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,248.0,237.0,184.0,190.0,291.0,267.0,322.0,253.0,304.0,264.0,295.0,301.0,3156.0
Baksa,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,1.0,,,,,,,-1.0
Baksa,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Baksa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,15.0,23.0,31.0,46.0,42.0,29.0,24.0,33.0,42.0,18.0,26.0,45.0,374.0
Baksa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,205.0,195.0,166.0,215.0,343.0,170.0,299.0,158.0,198.0,115.0,145.0,264.0,2473.0
Baksa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,14.0,23.0,31.0,61.0,38.0,86.0,36.0,17.0,50.0,21.0,18.0,59.0,454.0
Baksa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,688.0,714.0,668.0,906.0,790.0,845.0,788.0,808.0,935.0,845.0,872.0,964.0,9823.0
Baksa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,29.0,46.0,62.0,107.0,80.0,115.0,60.0,50.0,92.0,39.0,44.0,104.0,828.0
Baksa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,893.0,909.0,834.0,1121.0,1133.0,1015.0,1087.0,966.0,1133.0,960.0,1017.0,1228.0,12296.0
Baksa,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Baksa,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,33.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,34.0
Baksa,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,33.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,35.0
Baksa,14.11,In-Patient Head Count at midnight,TOTAL,0.0,35.0,26.0,0.0,33.0,0.0,0.0,0.0,0.0,80.0,26.0,97.0,297.0
Baksa,14.12.1,OPD attendance (All),TOTAL,61949.0,56741.0,62266.0,73069.0,57058.0,62685.0,52526.0,45656.0,44131.0,40418.0,41004.0,51249.0,648752.0
Baksa,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,0.0,,,0.0
Baksa,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,0.0,,,0.0
Baksa,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,14.14.a,Number of patients given AYUSH treatment,TOTAL,1126.0,1084.0,1540.0,1779.0,1116.0,1370.0,1102.0,1978.0,3293.0,4089.0,3504.0,5110.0,27091.0
Baksa,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,82.0,75.0,111.0,116.0,107.0,120.0,90.0,103.0,99.0,106.0,177.0,135.0,1321.0
Baksa,14.14.c,Number of Adolescents counselled,TOTAL,32.0,47.0,55.0,52.0,57.0,52.0,37.0,60.0,51.0,54.0,36.0,42.0,575.0
Baksa,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3678.0,4218.0,4319.0,3843.0,4166.0,3847.0,3743.0,3423.0,3725.0,3425.0,3502.0,3423.0,45312.0
Baksa,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,26.0,9.0,28.0,15.0,56.0,20.0,14.0,8.0,13.0,4.0,0.0,2.0,195.0
Baksa,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,147.0,50.0,366.0,153.0,264.0,73.0,224.0,51.0,163.0,118.0,155.0,25.0,1789.0
Baksa,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Baksa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,206.0,129.0,176.0,219.0,257.0,95.0,220.0,93.0,152.0,136.0,122.0,95.0,1900.0
Baksa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Baksa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,158.0,78.0,121.0,135.0,130.0,133.0,176.0,120.0,158.0,165.0,237.0,165.0,1776.0
Baksa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,511.0,257.0,663.0,507.0,651.0,301.0,620.0,264.0,473.0,419.0,514.0,285.0,5465.0
Baksa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Baksa,15.2,Number of Widal tests conducted,Number tested,27.0,67.0,327.0,257.0,517.0,241.0,239.0,2.0,241.0,124.0,179.0,12.0,2233.0
Baksa,15.3.a,Number of VDRL tests conducted on males,Number tested,89.0,9.0,168.0,116.0,212.0,8.0,162.0,8.0,86.0,87.0,125.0,10.0,1080.0
Baksa,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,210.0,6.0,214.0,107.0,111.0,0.0,94.0,2.0,102.0,68.0,42.0,12.0,968.0
Baksa,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,48.0,14.0,120.0,36.0,74.0,30.0,97.0,36.0,88.0,87.0,90.0,36.0,756.0
Baksa,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,347.0,29.0,502.0,259.0,397.0,38.0,353.0,46.0,276.0,242.0,257.0,58.0,2804.0
Baksa,15.4.1,Number of blood smears examined for Malaria,TOTAL,5722.0,5728.0,8155.0,13698.0,8988.0,7178.0,5402.0,4001.0,4460.0,2848.0,3631.0,4874.0,74685.0
Baksa,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,13.0,15.0,23.0,36.0,13.0,13.0,18.0,13.0,7.0,8.0,8.0,11.0,178.0
Baksa,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,35.0,19.0,24.0,57.0,24.0,23.0,11.0,4.0,51.0,6.0,3.0,6.0,263.0
Baksa,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,10460.0,5820.0,8250.0,760.0,4530.0,12000.0,4500.0,6500.0,0.0,4500.0,11500.0,1500.0,70320.0
Baksa,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,10000.0,0.0,10000.0,12000.0,0.0,10000.0,0.0,16000.0,7000.0,0.0,5000.0,70000.0
Baksa,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4640.0,7570.0,7490.0,6230.0,4530.0,7500.0,8000.0,6500.0,11500.0,0.0,10000.0,3000.0,76960.0
Baksa,16.1.1,Stock position of DPT vaccines,5. Total Stock,5820.0,8250.0,760.0,4530.0,12000.0,4500.0,6500.0,0.0,4500.0,11500.0,1500.0,3500.0,63360.0
Baksa,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0,0.0,9000.0
Baksa,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,6000.0
Baksa,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0,2500.0,11500.0
Baksa,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3500.0,3500.0
Baksa,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,14440.0,11320.0,13240.0,1540.0,0.0,10000.0,4000.0,5500.0,0.0,1000.0,5000.0,14500.0,80540.0
Baksa,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,15000.0,0.0,0.0,10000.0,4000.0,8000.0,9000.0,8000.0,4000.0,12500.0,0.0,70500.0
Baksa,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,3120.0,13080.0,11700.0,1540.0,0.0,10000.0,6500.0,14500.0,7000.0,0.0,3000.0,8800.0,79240.0
Baksa,16.1.2,Stock position of OPV vaccines,5. Total Stock,11320.0,13240.0,1540.0,0.0,10000.0,4000.0,5500.0,0.0,1000.0,5000.0,14500.0,5700.0,71800.0
Baksa,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,870.0,270.0,10270.0,940.0,2440.0,12000.0,4500.0,16500.0,7500.0,6000.0,12000.0,2000.0,75290.0
Baksa,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,12000.0,0.0,14800.0,16800.0,0.0,24400.0,32000.0,10000.0,6000.0,0.0,0.0,116000.0
Baksa,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.3,Stock position of TT vaccines,4. Stock Distributed,600.0,2000.0,9330.0,13300.0,7240.0,7500.0,12400.0,41000.0,11500.0,0.0,10000.0,1500.0,116370.0
Baksa,16.1.3,Stock position of TT vaccines,5. Total Stock,270.0,10270.0,940.0,2440.0,12000.0,4500.0,16500.0,7500.0,6000.0,12000.0,2000.0,500.0,74920.0
Baksa,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2350.0,880.0,6210.0,500.0,1090.0,10000.0,2500.0,2500.0,0.0,3500.0,9500.0,500.0,39530.0
Baksa,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,7500.0,0.0,8000.0,10000.0,0.0,5000.0,0.0,13500.0,6000.0,0.0,0.0,50000.0
Baksa,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1470.0,2170.0,5710.0,7410.0,1090.0,7500.0,5000.0,2500.0,10000.0,0.0,9000.0,500.0,52350.0
Baksa,16.1.5,Stock position of BCG vaccines,5. Total Stock,880.0,6210.0,500.0,1090.0,10000.0,2500.0,2500.0,0.0,3500.0,9500.0,500.0,0.0,37180.0
Baksa,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,8250.0,5915.0,6340.0,1605.0,840.0,0.0,0.0,3500.0,0.0,0.0,5000.0,250.0,31700.0
Baksa,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,5000.0,0.0,5000.0,0.0,0.0,5000.0,0.0,5000.0,5000.0,0.0,5000.0,30000.0
Baksa,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2335.0,4575.0,4735.0,5765.0,840.0,0.0,1500.0,3500.0,5000.0,0.0,4750.0,2000.0,35000.0
Baksa,16.1.6,Stock position of Measles vaccines,5. Total Stock,5915.0,6340.0,1605.0,840.0,0.0,0.0,3500.0,0.0,0.0,5000.0,250.0,3250.0,26700.0
Baksa,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,8100.0,3620.0,8530.0,460.0,1680.0,0.0,0.0,7000.0,500.0,1500.0,9500.0,0.0,40890.0
Baksa,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,7500.0,0.0,8000.0,0.0,0.0,12000.0,0.0,10000.0,8000.0,0.0,5000.0,50500.0
Baksa,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,4480.0,2590.0,8070.0,6780.0,1680.0,0.0,5000.0,6500.0,9000.0,0.0,9500.0,3500.0,57100.0
Baksa,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3620.0,8530.0,460.0,1680.0,0.0,0.0,7000.0,500.0,1500.0,9500.0,0.0,1500.0,34290.0
Baksa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,,12000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0
Baksa,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,12000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0
Baksa,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,,25000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25000.0
Baksa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,25000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25000.0
Baksa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,,9000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0
Baksa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,9000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0
Baksa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,400.0,0.0,0.0,0.0,0.0,0.0,3600.0,4000.0
Baksa,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,920.0,0.0,3520.0,3200.0,0.0,0.0,3600.0,10000.0,21240.0
Baksa,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,520.0,400.0,3520.0,3200.0,0.0,0.0,0.0,13600.0,21240.0
Baksa,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,400.0,0.0,0.0,0.0,0.0,0.0,3600.0,0.0,4000.0
Baksa,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,1500.0,1500.0,1500.0,1500.0,2500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8500.0
Baksa,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,1000.0,0.0,0.0,5400.0,3800.0,0.0,0.0,0.0,0.0,10200.0
Baksa,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,2500.0,0.0,5400.0,3800.0,0.0,0.0,0.0,0.0,11700.0
Baksa,16.3.02,Stock Position of Gloves,5. Total Stock,1500.0,1500.0,1500.0,2500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7000.0
Baksa,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,368.0,368.0
Baksa,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,368.0,368.0
Baksa,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,653500.0,7458850.0,0.0,0.0,30000.0,0.0,,0.0,0.0,0.0,0.0,0.0,8142350.0
Baksa,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,8435850.0,0.0,0.0,968350.0,0.0,0.0,11000.0,0.0,0.0,0.0,0.0,600000.0,10015200.0
Baksa,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,1630500.0,7458850.0,0.0,938350.0,30000.0,0.0,11000.0,0.0,0.0,0.0,0.0,580000.0,10648700.0
Baksa,16.3.07,Stock Position of IFA Tablets,5. Total Stock,7458850.0,0.0,0.0,30000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0,7508850.0
Baksa,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,15000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4900.0,19900.0
Baksa,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5900.0,5900.0,0.0,11800.0
Baksa,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,15000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,1000.0,4900.0,21900.0
Baksa,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4900.0,4900.0,0.0,9800.0
Baksa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,3275.0,3799.0,2324.0,2324.0,2324.0,2324.0,2324.0,18694.0
Baksa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,3580.0,524.0,0.0,0.0,0.0,0.0,0.0,0.0,4104.0
Baksa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,305.0,0.0,1475.0,0.0,0.0,0.0,0.0,0.0,1780.0
Baksa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,3275.0,3799.0,2324.0,2324.0,2324.0,2324.0,2324.0,2324.0,21018.0
Baksa,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,100.0,100.0,100.0,100.0,0.0,0.0,0.0,400.0
Baksa,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Baksa,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,100.0
Baksa,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,100.0,100.0,100.0,100.0,0.0,0.0,0.0,0.0,400.0
Baksa,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,300.0,300.0,0.0,34450.0,1450.0,1450.0,1450.0,39400.0
Baksa,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,2000.0,760.0,0.0,39450.0,0.0,0.0,0.0,132000.0,174210.0
Baksa,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,1700.0,760.0,300.0,5000.0,33000.0,0.0,0.0,132000.0,172760.0
Baksa,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,300.0,300.0,0.0,34450.0,1450.0,1450.0,1450.0,1450.0,40850.0
Baksa,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1000.0,0.0,0.0,0.0,0.0,3300.0,1000.0,600.0,0.0,600.0,2600.0,600.0,9700.0
Baksa,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,1000.0,3300.0,0.0,500.0,0.0,6600.0,2000.0,0.0,0.0,13400.0
Baksa,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1000.0,0.0,0.0,1000.0,0.0,2300.0,900.0,600.0,6000.0,0.0,2000.0,600.0,14400.0
Baksa,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,3300.0,1000.0,600.0,0.0,600.0,2600.0,600.0,0.0,8700.0
Baksa,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,20800.0,15500.0,29750.0,9850.0,17000.0,24008.0,9608.0,19208.0,5208.0,61508.0,85508.0,71500.0,369448.0
Baksa,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,24000.0,0.0,24000.0,24000.0,0.0,24000.0,0.0,72000.0,24000.0,0.0,0.0,192000.0
Baksa,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,5300.0,9750.0,19900.0,16850.0,16992.0,14400.0,14400.0,14000.0,15700.0,0.0,14008.0,12800.0,154100.0
Baksa,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,15500.0,29750.0,9850.0,17000.0,24008.0,9608.0,19208.0,5208.0,61508.0,85508.0,71500.0,58700.0,407348.0
Baksa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,34656.0,34656.0,20493.0,1725.0,2067.0,3400.0,900.0,2400.0,300.0,800.0,2800.0,600.0,104797.0
Baksa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4000.0,0.0,2080.0,5220.0,0.0,4000.0,0.0,4000.0,2000.0,0.0,68000.0,89300.0
Baksa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baksa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,18163.0,18768.0,1738.0,3887.0,2500.0,2500.0,2100.0,3500.0,0.0,2200.0,68200.0,123556.0
Baksa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,34656.0,20493.0,1725.0,2067.0,3400.0,900.0,2400.0,300.0,800.0,2800.0,600.0,400.0,70541.0
Baksa,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,1.0,2.0,,,,,,,4.0
Baksa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Baksa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Baksa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Baksa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,,,,,2.0,,,,,,,4.0
Baksa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Baksa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,,,,,2.0,,,,,,,4.0
Baksa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,,,,1.0,,1.0,,5.0,,,,9.0
Baksa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Baksa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,,,,1.0,,2.0,,5.0,,,,10.0
Baksa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,1.0,3.0,1.0,4.0,4.0,2.0,4.0,2.0,8.0,1.0,7.0,39.0
Baksa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,1.0,,2.0
Baksa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,1.0,3.0,1.0,4.0,4.0,3.0,4.0,2.0,8.0,2.0,7.0,41.0
Baksa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,3.0,,2.0,,4.0,1.0,2.0,2.0,1.0,1.0,17.0
Baksa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Baksa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,3.0,,2.0,,4.0,1.0,2.0,2.0,1.0,1.0,17.0
Baksa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Baksa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Baksa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,1.0,,,,1.0
Baksa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,2.0,,1.0,,1.0,2.0,3.0,,4.0,1.0,,3.0,17.0
Baksa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,1.0,,,,,,,1.0
Baksa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,2.0,,1.0,,1.0,3.0,3.0,,4.0,1.0,,3.0,18.0
Baksa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Baksa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Baksa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Baksa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,1.0,4.0,1.0,4.0,11.0,4.0,1.0,3.0,2.0,4.0,36.0
Baksa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,4.0,1.0,,,,1.0,,1.0,1.0,,10.0
Baksa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,2.0,5.0,5.0,1.0,4.0,11.0,5.0,1.0,4.0,3.0,4.0,46.0
Baksa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Baksa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Baksa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Baksa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,1.0,,,,,,,,,2.0
Baksa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Baksa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,12.0
Baksa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,12.0,2.0,,,1.0,15.0
Baksa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,1.0,1.0,1.0,2.0,1.0,13.0,3.0,1.0,1.0,2.0,27.0
Baksa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Baksa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,,,1.0,,,2.0,5.0,1.0,1.0,1.0,12.0
Baksa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,4.0,2.0,1.0,1.0,,,,3.0,,11.0
Baksa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,,,4.0,3.0,1.0,1.0,2.0,5.0,1.0,4.0,1.0,23.0
Baksa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Baksa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Baksa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Baksa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Baksa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,4.0,4.0,,,,1.0,1.0,,,,10.0
Baksa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,,3.0,,,1.0,8.0,2.0,1.0,2.0,,1.0,20.0
Baksa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,2.0,,3.0,2.0,,1.0,4.0,1.0,3.0,2.0,2.0,22.0
Baksa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,4.0,2.0,7.0,7.0,2.0,1.0,9.0,7.0,3.0,5.0,2.0,3.0,52.0
Baksa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Baksa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Baksa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Baksa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Baksa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,,,,,1.0,,,,,,,2.0
Baksa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,1.0,3.0,2.0,,8.0,15.0,13.0,2.0,4.0,2.0,13.0,66.0
Baksa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,4.0,7.0,5.0,21.0,3.0,4.0,6.0,2.0,25.0,6.0,3.0,5.0,91.0
Baksa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,8.0,8.0,8.0,23.0,3.0,13.0,21.0,15.0,27.0,10.0,5.0,18.0,159.0
Baksa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Baksa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,5.0,,,,,8.0,,11.0,4.0,,,28.0
Baksa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,1.0,1.0,1.0,,,3.0,,1.0,9.0,1.0,2.0,21.0
Baksa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,6.0,1.0,1.0,,,11.0,,12.0,13.0,1.0,2.0,49.0
Baksa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Baksa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Baksa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Baksa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Baksa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Baksa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Baksa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Baksa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Baksa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Baksa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Baksa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Baksa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Baksa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Baksa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,1.0,,,,,,,,,2.0
Baksa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Baksa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,1.0,,,,,,,,,2.0
Baksa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Baksa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Baksa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Baksa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Baksa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Baksa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,1.0,,1.0,,,,,2.0
Baksa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Baksa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,1.0,,1.0,,,,,2.0
Baksa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Baksa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,2.0,10.0,15.0,27.0,4.0,6.0,2.0,6.0,2.0,1.0,2.0,82.0
Baksa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,1.0,5.0,2.0,,,,,,,,,9.0
Baksa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,6.0,3.0,15.0,17.0,27.0,4.0,6.0,2.0,6.0,3.0,1.0,2.0,92.0
Baksa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,,,,,,1.0,,,,,,2.0
Baksa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,9.0,5.0,5.0,2.0,6.0,4.0,1.0,7.0,1.0,,1.0,,41.0
Baksa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,1.0,,2.0,1.0,,2.0,,,1.0,1.0,9.0
Baksa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,10.0,6.0,6.0,2.0,8.0,5.0,2.0,9.0,1.0,,2.0,1.0,52.0
Baksa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Baksa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,5.0,,,,1.0,,,,6.0
Baksa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,1.0,,,2.0,1.0,,,4.0
Baksa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,5.0,1.0,,,3.0,2.0,,,11.0
Baksa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,2.0,,,,,,,,,,,,2.0
Baksa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,9.0,5.0,2.0,2.0,4.0,9.0,4.0,3.0,6.0,6.0,7.0,3.0,60.0
Baksa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,6.0,21.0,3.0,5.0,1.0,8.0,7.0,1.0,20.0,9.0,7.0,11.0,99.0
Baksa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,17.0,26.0,5.0,7.0,5.0,17.0,11.0,4.0,26.0,15.0,14.0,14.0,161.0
Baksa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Baksa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,7.0,7.0,12.0,10.0,7.0,5.0,2.0,4.0,8.0,,3.0,1.0,66.0
Baksa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,10.0,10.0,9.0,11.0,3.0,14.0,7.0,13.0,15.0,11.0,6.0,7.0,116.0
Baksa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,17.0,17.0,22.0,21.0,10.0,19.0,9.0,17.0,23.0,11.0,9.0,8.0,183.0
Baksa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,,2.0,,1.0,1.0,9.0,,1.0,,1.0,16.0
Baksa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,8.0,18.0,10.0,6.0,15.0,5.0,6.0,7.0,9.0,7.0,22.0,5.0,118.0
Baksa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,19.0,33.0,35.0,25.0,21.0,9.0,30.0,35.0,19.0,17.0,18.0,18.0,279.0
Baksa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,27.0,52.0,45.0,33.0,36.0,15.0,37.0,51.0,28.0,25.0,40.0,24.0,413.0
Barpeta,1.1,Total number of pregnant women Registered for ANC,TOTAL,4151.0,4186.0,3639.0,3306.0,3603.0,3579.0,3254.0,3121.0,2848.0,3102.0,3103.0,3418.0,41310.0
Barpeta,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3364.0,3333.0,2827.0,2556.0,2740.0,2676.0,2428.0,2358.0,2247.0,2507.0,2528.0,2843.0,32407.0
Barpeta,1.2,Number of Pregnant women registered under JSY,TOTAL,3901.0,3901.0,3337.0,3107.0,3361.0,3421.0,3068.0,2961.0,2734.0,2935.0,2909.0,3222.0,38857.0
Barpeta,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2683.0,2862.0,2940.0,2841.0,3006.0,3385.0,3532.0,3415.0,3332.0,2992.0,2736.0,2945.0,36669.0
Barpeta,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2980.0,3600.0,3175.0,2912.0,3146.0,3386.0,3170.0,2974.0,2413.0,2301.0,2406.0,2898.0,35361.0
Barpeta,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2719.0,3243.0,3363.0,3095.0,2991.0,3405.0,3583.0,3483.0,2988.0,2649.0,2399.0,2765.0,36683.0
Barpeta,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2348.0,3259.0,2939.0,2698.0,2761.0,2947.0,3219.0,3141.0,2468.0,2669.0,2885.0,3300.0,34634.0
Barpeta,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,74.0,60.0,69.0,40.0,55.0,61.0,62.0,61.0,64.0,61.0,112.0,198.0,917.0
Barpeta,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6.0,3.0,1.0,3.0,5.0,3.0,2.0,0.0,3.0,0.0,0.0,0.0,26.0
Barpeta,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2209.0,2050.0,2027.0,1934.0,1889.0,1702.0,1813.0,1738.0,1689.0,1614.0,1715.0,1753.0,22133.0
Barpeta,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2.0,10.0,11.0,10.0,10.0,10.0,13.0,12.0,9.0,15.0,2.0,4.0,108.0
Barpeta,1.8,Number of pregnancy test kits used at SC level,TOTAL,687.0,1065.0,789.0,604.0,757.0,576.0,468.0,455.0,487.0,504.0,392.0,436.0,7220.0
Barpeta,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,184.0,202.0,216.0,250.0,242.0,301.0,323.0,354.0,304.0,304.0,253.0,209.0,3142.0
Barpeta,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,590.0,609.0,476.0,582.0,608.0,759.0,862.0,790.0,780.0,835.0,681.0,651.0,8223.0
Barpeta,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,774.0,811.0,692.0,832.0,850.0,1060.0,1185.0,1144.0,1084.0,1139.0,934.0,860.0,11365.0
Barpeta,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,727.0,704.0,613.0,764.0,679.0,834.0,998.0,1002.0,914.0,1008.0,837.0,807.0,9887.0
Barpeta,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1808.0,1800.0,1675.0,1957.0,1994.0,2179.0,2288.0,2388.0,2321.0,2377.0,2045.0,1953.0,24785.0
Barpeta,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,504.0,567.0,645.0,616.0,717.0,631.0,529.0,653.0,684.0,708.0,635.0,543.0,7432.0
Barpeta,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1808.0,1795.0,1421.0,1302.0,2818.0,2196.0,2251.0,2393.0,2167.0,2157.0,1863.0,2712.0,24883.0
Barpeta,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1225.0,977.0,1136.0,1142.0,1745.0,2554.0,1470.0,1334.0,1236.0,1488.0,1362.0,3683.0,19352.0
Barpeta,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,0.0,,,,,,,,0.0
Barpeta,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,53.0,82.0,68.0,76.0,85.0,88.0,88.0,90.0,68.0,68.0,49.0,58.0,873.0
Barpeta,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Barpeta,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Barpeta,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Barpeta,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Barpeta,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,30.0,33.0,32.0,33.0,9.0,17.0,9.0,11.0,37.0,41.0,28.0,28.0,308.0
Barpeta,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,211.0,213.0,202.0,207.0,235.0,271.0,268.0,294.0,315.0,336.0,299.0,283.0,3134.0
Barpeta,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barpeta,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,241.0,246.0,234.0,240.0,244.0,288.0,277.0,305.0,352.0,377.0,327.0,311.0,3442.0
Barpeta,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,47.0,74.0,65.0,69.0,76.0,87.0,73.0,80.0,60.0,64.0,46.0,52.0,793.0
Barpeta,4.1.1.a,Number of male live births,TOTAL,1360.0,1380.0,1213.0,1496.0,1516.0,1678.0,1839.0,1839.0,1729.0,1828.0,1582.0,1495.0,18955.0
Barpeta,4.1.1.b,Number of female live births,TOTAL,1222.0,1262.0,1159.0,1307.0,1325.0,1568.0,1655.0,1719.0,1657.0,1677.0,1370.0,1318.0,17239.0
Barpeta,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2582.0,2642.0,2372.0,2803.0,2841.0,3246.0,3494.0,3558.0,3386.0,3505.0,2952.0,2813.0,36194.0
Barpeta,4.1.2,Number of still births,TOTAL,72.0,70.0,76.0,88.0,114.0,102.0,86.0,90.0,103.0,96.0,97.0,83.0,1077.0
Barpeta,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,211.0,244.0,243.0,181.0,214.0,191.0,163.0,186.0,237.0,209.0,229.0,277.0,2585.0
Barpeta,4.2.1,Number of Newborns weighed at birth,TOTAL,2573.0,2636.0,2355.0,2773.0,2804.0,3197.0,3455.0,3550.0,3366.0,3502.0,2949.0,2809.0,35969.0
Barpeta,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,582.0,644.0,534.0,636.0,702.0,666.0,849.0,788.0,899.0,665.0,530.0,536.0,8031.0
Barpeta,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2498.0,2623.0,2346.0,2739.0,2697.0,3185.0,3430.0,3533.0,3341.0,3488.0,2944.0,2805.0,35629.0
Barpeta,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,4.0,5.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Barpeta,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,105.0,109.0,94.0,217.0,155.0,158.0,44.0,178.0,124.0,74.0,45.0,242.0,1545.0
Barpeta,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,26.0,25.0,21.0,19.0,14.0,42.0,40.0,51.0,61.0,2.0,19.0,27.0,347.0
Barpeta,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barpeta,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,131.0,134.0,119.0,241.0,176.0,200.0,84.0,229.0,185.0,76.0,64.0,269.0,1908.0
Barpeta,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,2.0,,,,,1.0,2.0,1.0,,,6.0
Barpeta,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,107.0,101.0,66.0,192.0,158.0,167.0,40.0,181.0,119.0,71.0,43.0,247.0,1492.0
Barpeta,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,4.0,15.0,9.0,4.0,12.0,4.0,2.0,6.0,3.0,5.0,2.0,6.0,72.0
Barpeta,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,97.0,101.0,52.0,103.0,69.0,74.0,44.0,40.0,81.0,65.0,39.0,210.0,975.0
Barpeta,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1808.0,2098.0,1903.0,2178.0,2202.0,2470.0,2585.0,2714.0,2672.0,2727.0,2323.0,2187.0,27867.0
Barpeta,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1885.0,1997.0,1883.0,1897.0,1976.0,2229.0,2352.0,2421.0,2592.0,2509.0,2133.0,2142.0,26016.0
Barpeta,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,1.0,0.0,8.0,0.0,0.0,0.0,5.0,0.0,10.0,0.0,24.0
Barpeta,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,152.0,154.0,178.0,123.0,146.0,121.0,111.0,124.0,140.0,160.0,156.0,192.0,1757.0
Barpeta,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,4.0,3.0,1.0,1.0,5.0,8.0,4.0,2.0,4.0,5.0,5.0,8.0,50.0
Barpeta,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,156.0,157.0,179.0,124.0,151.0,129.0,115.0,126.0,144.0,165.0,161.0,200.0,1807.0
Barpeta,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0,3.0,1.0,1.0,9.0
Barpeta,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,68.0,43.0,52.0,62.0,61.0,84.0,63.0,50.0,48.0,50.0,48.0,49.0,678.0
Barpeta,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,291.0,265.0,286.0,296.0,262.0,322.0,302.0,288.0,293.0,264.0,274.0,297.0,3440.0
Barpeta,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,359.0,308.0,338.0,358.0,323.0,406.0,365.0,338.0,341.0,314.0,322.0,346.0,4118.0
Barpeta,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,1.0,7.0,6.0,3.0,3.0,7.0,17.0,10.0,4.0,2.0,61.0
Barpeta,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,3.0
Barpeta,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Barpeta,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barpeta,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,1.0,7.0,6.0,3.0,5.0,10.0,17.0,10.0,4.0,2.0,66.0
Barpeta,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Barpeta,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,0.0,22.0,42.0
Barpeta,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,1.0,7.0,3.0,22.0,7.0,63.0,11.0,51.0,43.0,32.0,22.0,69.0,331.0
Barpeta,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,33.0,47.0,0.0,34.0,46.0,38.0,5.0,31.0,0.0,30.0,43.0,307.0
Barpeta,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barpeta,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,1.0,40.0,50.0,22.0,41.0,109.0,49.0,56.0,74.0,52.0,52.0,134.0,680.0
Barpeta,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,1.0,1.0
Barpeta,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Barpeta,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barpeta,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Barpeta,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Barpeta,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,5.0,9.0,7.0,10.0,0.0,6.0,0.0,4.0,9.0,1.0,10.0,6.0,67.0
Barpeta,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,36.0,53.0,45.0,28.0,46.0,60.0,47.0,58.0,1.0,0.0,15.0,3.0,392.0
Barpeta,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barpeta,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,41.0,62.0,52.0,38.0,46.0,66.0,47.0,62.0,10.0,1.0,25.0,9.0,459.0
Barpeta,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Barpeta,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,160.0,152.0,154.0,478.0,158.0,178.0,169.0,173.0,332.0,210.0,184.0,213.0,2561.0
Barpeta,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,26.0,37.0,39.0,158.0,39.0,19.0,33.0,28.0,78.0,34.0,39.0,28.0,558.0
Barpeta,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,40.0,36.0,28.0,52.0,25.0,17.0,18.0,10.0,27.0,27.0,12.0,15.0,307.0
Barpeta,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,40.0,24.0,18.0,26.0,71.0,49.0,37.0,17.0,18.0,22.0,31.0,45.0,398.0
Barpeta,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barpeta,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,266.0,249.0,239.0,714.0,293.0,263.0,257.0,228.0,455.0,293.0,266.0,301.0,3824.0
Barpeta,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,65.0,98.0,84.0,100.0,71.0,109.0,80.0,53.0,62.0,49.0,17.0,46.0,834.0
Barpeta,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,1.0,,,,,,,,,,,,1.0
Barpeta,9.06,Number of IUCD removals,TOTAL,13.0,5.0,11.0,12.0,8.0,8.0,10.0,6.0,2.0,12.0,10.0,4.0,101.0
Barpeta,9.07,Number of Oral Pills cycles distributed,TOTAL,10471.0,11819.0,11452.0,13411.0,11932.0,12835.0,11974.0,11819.0,11871.0,11254.0,11301.0,11413.0,141552.0
Barpeta,9.08,Number of Condom pieces distributed,TOTAL,27115.0,26710.0,23206.0,28803.0,25627.0,21256.0,21166.0,21749.0,15970.0,15739.0,14286.0,13782.0,255409.0
Barpeta,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,122.0,158.0,84.0,144.0,278.0,149.0,125.0,205.0,221.0,214.0,301.0,267.0,2268.0
Barpeta,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Barpeta,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Barpeta,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,3.0,2.0,3.0,3.0,3.0,3.0,2.0,3.0,2.0,3.0,3.0,-1.0
Barpeta,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2003.0,2425.0,2533.0,2123.0,2840.0,3585.0,3535.0,3405.0,3342.0,4161.0,3469.0,3505.0,36926.0
Barpeta,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3165.0,3279.0,2716.0,2502.0,2477.0,3187.0,3096.0,3779.0,3287.0,3678.0,2371.0,528.0,34065.0
Barpeta,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3199.0,3255.0,3049.0,2645.0,2396.0,2766.0,2965.0,3192.0,3488.0,3352.0,3304.0,2772.0,36383.0
Barpeta,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3257.0,3251.0,2986.0,2818.0,2473.0,2725.0,2714.0,3034.0,3111.0,3439.0,3089.0,3625.0,36522.0
Barpeta,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,989.0,2929.0,3918.0
Barpeta,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,756.0,756.0
Barpeta,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,820.0,794.0,654.0,714.0,701.0,900.0,1085.0,999.0,932.0,930.0,812.0,934.0,10275.0
Barpeta,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2927.0,2276.0,2327.0,2388.0,1702.0,3267.0,2404.0,3311.0,2071.0,3277.0,2918.0,3161.0,32029.0
Barpeta,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2960.0,2253.0,2483.0,2509.0,1624.0,2793.0,2393.0,2812.0,2130.0,2958.0,3312.0,3517.0,31744.0
Barpeta,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3031.0,2188.0,2450.0,2538.0,1590.0,2903.0,2111.0,2653.0,1928.0,2876.0,2998.0,3652.0,30918.0
Barpeta,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,770.0,739.0,604.0,620.0,596.0,700.0,938.0,985.0,1287.0,981.0,941.0,967.0,10128.0
Barpeta,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2816.0,3335.0,2840.0,2214.0,2016.0,2024.0,3355.0,3876.0,3253.0,3616.0,2370.0,638.0,32353.0
Barpeta,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2819.0,3228.0,3150.0,2468.0,1939.0,1752.0,2927.0,3432.0,3509.0,3363.0,3232.0,2754.0,34573.0
Barpeta,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2872.0,3208.0,2973.0,2604.0,2059.0,1755.0,2680.0,3001.0,3319.0,3426.0,3004.0,3525.0,34426.0
Barpeta,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2314.0,2716.0,2888.0,2817.0,3110.0,2886.0,2055.0,3775.0,3309.0,2666.0,2534.0,3485.0,34555.0
Barpeta,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2626.0,2674.0,2581.0,2248.0,2201.0,2127.0,1404.0,2191.0,2130.0,2005.0,2161.0,2574.0,26922.0
Barpeta,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,295.0,11898.0,2789.0,597.0,979.0,1696.0,1784.0,1544.0,1706.0,2239.0,25527.0
Barpeta,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1186.0,1390.0,1511.0,1439.0,1615.0,1434.0,1044.0,1930.0,1698.0,1323.0,1315.0,1761.0,17646.0
Barpeta,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1114.0,1283.0,1377.0,1363.0,1454.0,1403.0,974.0,1826.0,1563.0,1300.0,1207.0,1708.0,16572.0
Barpeta,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2300.0,2673.0,2888.0,2802.0,3069.0,2837.0,2018.0,3756.0,3261.0,2623.0,2522.0,3469.0,34218.0
Barpeta,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2765.0,2841.0,2676.0,2350.0,2361.0,2374.0,2026.0,2320.0,2255.0,2156.0,2293.0,2746.0,29163.0
Barpeta,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2594.0,2283.0,2285.0,2193.0,1726.0,2363.0,1634.0,2097.0,1576.0,1783.0,2217.0,2737.0,25488.0
Barpeta,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,267.0,248.0,287.0,248.0,197.0,205.0,155.0,207.0,237.0,187.0,203.0,256.0,2697.0
Barpeta,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,248.0,238.0,258.0,223.0,185.0,201.0,134.0,201.0,226.0,159.0,183.0,230.0,2486.0
Barpeta,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,515.0,486.0,545.0,471.0,382.0,406.0,289.0,408.0,463.0,346.0,386.0,486.0,5183.0
Barpeta,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,919.0,988.0,890.0,990.0,953.0,955.0,890.0,1068.0,1108.0,1082.0,1054.0,1158.0,12055.0
Barpeta,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,786.0,813.0,775.0,880.0,787.0,811.0,809.0,910.0,870.0,861.0,901.0,1012.0,10215.0
Barpeta,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,617.0,665.0,640.0,703.0,611.0,653.0,636.0,713.0,703.0,687.0,758.0,849.0,8235.0
Barpeta,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,6.0,5.0,3.0,3.0,5.0,0.0,5.0,8.0,5.0,5.0,45.0
Barpeta,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1304.0,1308.0,1314.0,1353.0,1312.0,1267.0,1293.0,1313.0,1301.0,1270.0,1322.0,1316.0,15673.0
Barpeta,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1287.0,1300.0,1289.0,1335.0,1207.0,1216.0,1260.0,1282.0,1279.0,1263.0,1287.0,1302.0,15307.0
Barpeta,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1279.0,1295.0,1277.0,1316.0,1188.0,1210.0,1252.0,1281.0,1276.0,1262.0,1286.0,1301.0,15223.0
Barpeta,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,319.0,9635.0,574.0,403.0,608.0,761.0,877.0,758.0,870.0,1242.0,16047.0
Barpeta,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2178.0,2624.0,2750.0,2692.0,2893.0,2793.0,2064.0,3614.0,3165.0,2414.0,2246.0,2858.0,32291.0
Barpeta,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,576.0,644.0,631.0,595.0,1683.0,999.0,627.0,598.0,667.0,661.0,2224.0,802.0,10707.0
Barpeta,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,607.0,712.0,723.0,732.0,1731.0,1094.0,632.0,728.0,782.0,757.0,2181.0,912.0,11591.0
Barpeta,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,10.0,10.0,4.0,2.0,5.0,4.0,2.0,2.0,3.0,2.0,2.0,2.0,48.0
Barpeta,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,200.0,258.0,259.0,321.0,329.0,370.0,223.0,186.0,177.0,147.0,257.0,252.0,2979.0
Barpeta,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,6.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Barpeta,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,55.0,53.0,167.0,78.0,99.0,37.0,21.0,37.0,30.0,51.0,72.0,51.0,751.0
Barpeta,13.1,Number of Patients operated for cataract,TOTAL,0.0,139.0,41.0,22.0,172.0,0.0,0.0,0.0,0.0,17.0,17.0,0.0,408.0
Barpeta,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,139.0,41.0,22.0,31.0,0.0,0.0,0.0,0.0,17.0,17.0,0.0,267.0
Barpeta,13.3,Number of School children detected with Refractive errors,TOTAL,22.0,18.0,21.0,5.0,20.0,373.0,284.0,21.0,4.0,44.0,21.0,37.0,870.0
Barpeta,13.4,Number of children provided free glasses,TOTAL,19.0,12.0,15.0,8.0,11.0,307.0,129.0,1.0,3.0,43.0,14.0,27.0,589.0
Barpeta,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Barpeta,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,13.0,12.0,12.0,11.0,12.0,11.0,8.0,8.0,8.0,10.0,10.0,10.0,-1.0
Barpeta,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,974.0,953.0,962.0,958.0,909.0,962.0,969.0,958.0,972.0,978.0,973.0,972.0,-1.0
Barpeta,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Barpeta,14.05,Number of RKS meetings held during the month,TOTAL,10.0,13.0,16.0,11.0,6.0,7.0,8.0,8.0,13.0,9.0,5.0,5.0,111.0
Barpeta,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,19.0,15.0,17.0,19.0,14.0,10.0,21.0,12.0,15.0,16.0,14.0,-1.0
Barpeta,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,482.0,522.0,325.0,331.0,531.0,589.0,101.0,544.0,97.0,93.0,216.0,60.0,3891.0
Barpeta,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Barpeta,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,2.0,1.0,-1.0
Barpeta,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,443.0,408.0,343.0,443.0,427.0,444.0,383.0,393.0,379.0,314.0,361.0,444.0,4782.0
Barpeta,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,818.0,801.0,845.0,768.0,825.0,811.0,805.0,728.0,626.0,617.0,708.0,935.0,9287.0
Barpeta,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,499.0,582.0,439.0,647.0,473.0,790.0,606.0,628.0,499.0,499.0,499.0,667.0,6828.0
Barpeta,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1188.0,1257.0,1287.0,1062.0,1333.0,1092.0,1240.0,1310.0,1164.0,1224.0,1063.0,1327.0,14547.0
Barpeta,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,942.0,990.0,782.0,1090.0,900.0,1234.0,989.0,1021.0,878.0,813.0,860.0,1111.0,11610.0
Barpeta,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2006.0,2058.0,2132.0,1830.0,2158.0,1903.0,2045.0,2038.0,1790.0,1841.0,1771.0,2262.0,23834.0
Barpeta,14.10.2.a,Number of death cases of Inpatient males,TOTAL,51.0,45.0,41.0,35.0,48.0,46.0,50.0,50.0,42.0,48.0,45.0,9.0,510.0
Barpeta,14.10.2.b,Number of death cases of Inpatient females,TOTAL,22.0,33.0,29.0,28.0,30.0,38.0,33.0,44.0,25.0,42.0,21.0,2.0,347.0
Barpeta,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,73.0,78.0,70.0,63.0,78.0,84.0,83.0,94.0,67.0,90.0,66.0,11.0,857.0
Barpeta,14.11,In-Patient Head Count at midnight,TOTAL,2201.0,2703.0,2263.0,2639.0,2381.0,2475.0,2807.0,3066.0,2588.0,2696.0,2391.0,3209.0,31419.0
Barpeta,14.12.1,OPD attendance (All),TOTAL,121708.0,110494.0,113489.0,126544.0,106320.0,112207.0,105741.0,93362.0,83556.0,72340.0,76950.0,104716.0,1227427.0
Barpeta,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,177.0,81.0,108.0,78.0,261.0,214.0,184.0,569.0,107.0,108.0,59.0,95.0,2041.0
Barpeta,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,30.0,27.0,28.0,15.0,30.0,33.0,15.0,32.0,18.0,23.0,4.0,22.0,277.0
Barpeta,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,220.0,114.0,81.0,65.0,218.0,53.0,70.0,751.0,118.0,113.0,34.0,74.0,1911.0
Barpeta,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,209.0,169.0,199.0,182.0,145.0,139.0,258.0,129.0,92.0,203.0,134.0,131.0,1990.0
Barpeta,14.14.c,Number of Adolescents counselled,TOTAL,80.0,63.0,47.0,85.0,74.0,77.0,91.0,70.0,89.0,65.0,55.0,76.0,872.0
Barpeta,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7891.0,8037.0,7709.0,7498.0,7650.0,8162.0,8184.0,8059.0,7833.0,7163.0,7308.0,7875.0,93369.0
Barpeta,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,14.0,27.0,11.0,8.0,24.0,10.0,10.0,37.0,5.0,7.0,8.0,18.0,179.0
Barpeta,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,176.0,204.0,187.0,146.0,157.0,189.0,175.0,200.0,70.0,260.0,196.0,232.0,2192.0
Barpeta,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,5.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0,1.0,14.0
Barpeta,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,392.0,327.0,352.0,423.0,360.0,374.0,376.0,319.0,28.0,270.0,441.0,464.0,4126.0
Barpeta,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,3.0,0.0,0.0,2.0,0.0,1.0,0.0,1.0,1.0,0.0,2.0,11.0
Barpeta,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1016.0,1606.0,1699.0,1693.0,1865.0,1923.0,1570.0,1761.0,721.0,1294.0,1302.0,1344.0,17794.0
Barpeta,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,2.0,0.0,0.0,0.0,1.0,2.0,1.0,0.0,2.0,0.0,2.0,10.0
Barpeta,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1584.0,2137.0,2238.0,2262.0,2382.0,2486.0,2121.0,2280.0,819.0,1824.0,1939.0,2040.0,24112.0
Barpeta,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,10.0,0.0,1.0,2.0,2.0,4.0,1.0,2.0,4.0,1.0,5.0,35.0
Barpeta,15.2,Number of Widal tests conducted,Number tested,207.0,158.0,210.0,284.0,211.0,227.0,219.0,219.0,102.0,110.0,101.0,191.0,2239.0
Barpeta,15.3.a,Number of VDRL tests conducted on males,Number tested,3.0,3.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,16.0
Barpeta,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,1.0,1.0,3.0,0.0,1.0,9.0,1.0,0.0,1.0,1.0,6.0,2.0,26.0
Barpeta,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,371.0,624.0,665.0,770.0,965.0,990.0,663.0,634.0,594.0,594.0,706.0,819.0,8395.0
Barpeta,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,375.0,628.0,670.0,772.0,967.0,1000.0,665.0,635.0,596.0,595.0,712.0,822.0,8437.0
Barpeta,15.4.1,Number of blood smears examined for Malaria,TOTAL,10776.0,8374.0,11890.0,15684.0,10256.0,8703.0,7566.0,6462.0,5106.0,4817.0,4981.0,5736.0,100351.0
Barpeta,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,5.0,1.0,6.0,6.0,6.0,2.0,4.0,3.0,1.0,3.0,2.0,3.0,42.0
Barpeta,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,5.0,7.0,14.0,4.0,1.0,2.0,4.0,1.0,1.0,0.0,1.0,41.0
Barpeta,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,21130.0,20600.0,21800.0,27500.0,28650.0,26850.0,28130.0,17180.0,24930.0,27630.0,15580.0,16030.0,276010.0
Barpeta,16.1.1,Stock position of DPT vaccines,2. Stocks Received,15000.0,20000.0,25000.0,20000.0,5000.0,20000.0,5000.0,23000.0,15000.0,0.0,10000.0,5000.0,163000.0
Barpeta,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,15530.0,18800.0,19300.0,18850.0,6800.0,18720.0,15950.0,15250.0,12300.0,12050.0,9550.0,8600.0,171700.0
Barpeta,16.1.1,Stock position of DPT vaccines,5. Total Stock,20600.0,21800.0,27500.0,28650.0,26850.0,28130.0,17180.0,24930.0,27630.0,15580.0,16030.0,12430.0,267310.0
Barpeta,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,8090.0,8090.0
Barpeta,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,21000.0,0.0,21000.0
Barpeta,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,12910.0,7400.0,20310.0
Barpeta,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8090.0,690.0,8780.0
Barpeta,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,400.0,0.0,6500.0,8400.0,0.0,24500.0,6020.0,11520.0,20.0,620.0,3720.0,3720.0,65420.0
Barpeta,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,14000.0,28000.0,0.0,32000.0,8000.0,16000.0,2500.0,15000.0,7100.0,20000.0,27000.0,169600.0
Barpeta,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,400.0,7500.0,26100.0,8400.0,7500.0,26480.0,10500.0,14000.0,14400.0,4000.0,20000.0,22000.0,161280.0
Barpeta,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,6500.0,8400.0,0.0,24500.0,6020.0,11520.0,20.0,620.0,3720.0,3720.0,8720.0,73740.0
Barpeta,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,19840.0,21820.0,6040.0,0.0,6100.0,9400.0,11640.0,11640.0,15020.0,3320.0,20.0,5360.0,110200.0
Barpeta,16.1.3,Stock position of TT vaccines,2. Stocks Received,16000.0,0.0,0.0,20000.0,10000.0,20000.0,7000.0,26000.0,0.0,0.0,15000.0,2000.0,116000.0
Barpeta,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.1.3,Stock position of TT vaccines,4. Stock Distributed,14020.0,15780.0,6040.0,13900.0,6700.0,17760.0,7000.0,22620.0,11700.0,3300.0,9660.0,7350.0,135830.0
Barpeta,16.1.3,Stock position of TT vaccines,5. Total Stock,21820.0,6040.0,0.0,6100.0,9400.0,11640.0,11640.0,15020.0,3320.0,20.0,5360.0,10.0,90370.0
Barpeta,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Barpeta,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Barpeta,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Barpeta,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0.0,13980.0,1180.0,380.0,550.0,12270.0,7210.0,10.0,23510.0,23760.0,9260.0,13060.0,105170.0
Barpeta,16.1.5,Stock position of BCG vaccines,2. Stocks Received,14000.0,3000.0,0.0,14000.0,16000.0,10000.0,2500.0,26000.0,12000.0,0.0,13000.0,0.0,110500.0
Barpeta,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,20.0,15800.0,800.0,13830.0,4280.0,15060.0,9700.0,2500.0,11750.0,14500.0,9200.0,10000.0,107440.0
Barpeta,16.1.5,Stock position of BCG vaccines,5. Total Stock,13980.0,1180.0,380.0,550.0,12270.0,7210.0,10.0,23510.0,23760.0,9260.0,13060.0,3060.0,108230.0
Barpeta,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,10135.0,12625.0,13975.0,10025.0,925.0,3175.0,20.0,3640.0,6460.0,10010.0,2760.0,7400.0,81150.0
Barpeta,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,10000.0,5000.0,0.0,4150.0,0.0,5000.0,15000.0,10000.0,0.0,10000.0,2500.0,71650.0
Barpeta,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,7510.0,8650.0,8950.0,9100.0,1900.0,3155.0,1380.0,12180.0,6450.0,7250.0,5360.0,6060.0,77945.0
Barpeta,16.1.6,Stock position of Measles vaccines,5. Total Stock,12625.0,13975.0,10025.0,925.0,3175.0,20.0,3640.0,6460.0,10010.0,2760.0,7400.0,3840.0,74855.0
Barpeta,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,10000.0,0.0,425.0,600.0,8250.0,6000.0,7100.0,6550.0,3200.0,5400.0,47525.0
Barpeta,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,10000.0,0.0,45000.0,28545.0,15000.0,5000.0,7500.0,5000.0,0.0,5000.0,2500.0,123545.0
Barpeta,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,10000.0,44575.0,28370.0,7350.0,7250.0,6400.0,5550.0,3350.0,2800.0,3650.0,119295.0
Barpeta,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,10000.0,0.0,425.0,600.0,8250.0,6000.0,7100.0,6550.0,3200.0,5400.0,4250.0,51775.0
Barpeta,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,30000.0,24500.0,13700.0,100.0,300.0,0.0,18820.0,7820.0,13520.0,18020.0,4220.0,4220.0,135220.0
Barpeta,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,10000.0,7000.0,0.0,14000.0,0.0,30000.0,5000.0,21000.0,17500.0,0.0,10000.0,5000.0,119500.0
Barpeta,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,15500.0,17800.0,13600.0,13800.0,300.0,11180.0,16000.0,15300.0,13000.0,13800.0,10000.0,7550.0,147830.0
Barpeta,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,24500.0,13700.0,100.0,300.0,0.0,18820.0,7820.0,13520.0,18020.0,4220.0,4220.0,1670.0,106890.0
Barpeta,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,631.0,1631.0,1331.0,781.0,2781.0,2631.0,2631.0,2631.0,2631.0,2631.0,1331.0,1231.0,22872.0
Barpeta,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,1200.0,0.0,0.0,2400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3600.0
Barpeta,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,200.0,300.0,550.0,400.0,150.0,0.0,200.0,500.0,600.0,0.0,100.0,350.0,3350.0
Barpeta,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1631.0,1331.0,781.0,2781.0,2631.0,2631.0,2431.0,2131.0,2031.0,2631.0,1231.0,881.0,23122.0
Barpeta,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,3780.0,3360.0,0.0,0.0,0.0,0.0,0.0,20580.0,27720.0
Barpeta,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,15120.0,0.0,0.0,0.0,0.0,0.0,0.0,40320.0,0.0,55440.0
Barpeta,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,11340.0,420.0,3360.0,0.0,0.0,0.0,0.0,19740.0,20580.0,55440.0
Barpeta,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,3780.0,3360.0,0.0,0.0,0.0,0.0,0.0,20580.0,0.0,27720.0
Barpeta,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,31000.0,30500.0,24500.0,24000.0,38800.0,36800.0,35000.0,35000.0,35000.0,35000.0,16500.0,20200.0,362300.0
Barpeta,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,22400.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,0.0,26400.0
Barpeta,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,500.0,6000.0,500.0,7600.0,2000.0,1800.0,0.0,11100.0,5400.0,2000.0,300.0,9000.0,46200.0
Barpeta,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,30500.0,24500.0,24000.0,38800.0,36800.0,35000.0,35000.0,23900.0,29600.0,33000.0,20200.0,11200.0,342500.0
Barpeta,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,100.0,5100.0,3800.0,3700.0,5200.0,5000.0,3200.0,3200.0,3200.0,3200.0,350.0,250.0,36300.0
Barpeta,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,5000.0,0.0,0.0,10500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15500.0
Barpeta,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,1300.0,100.0,9000.0,200.0,1800.0,0.0,1250.0,1100.0,500.0,100.0,250.0,15600.0
Barpeta,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,5100.0,3800.0,3700.0,5200.0,5000.0,3200.0,3200.0,1950.0,2100.0,2700.0,250.0,0.0,36200.0
Barpeta,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1200.0,1200.0,1200.0,1200.0,3200.0,3100.0,2900.0,2900.0,2900.0,2900.0,2700.0,2700.0,28100.0
Barpeta,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Barpeta,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,100.0,200.0,100.0,0.0,100.0,0.0,0.0,100.0,600.0
Barpeta,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1200.0,1200.0,1200.0,3200.0,3100.0,2900.0,2800.0,2900.0,2800.0,2900.0,2700.0,2600.0,29500.0
Barpeta,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2460.0,2460.0
Barpeta,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4320.0,0.0,4320.0
Barpeta,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1860.0,1560.0,3420.0
Barpeta,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2460.0,900.0,3360.0
Barpeta,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Barpeta,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Barpeta,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Barpeta,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Barpeta,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Barpeta,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Barpeta,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Barpeta,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Barpeta,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Barpeta,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Barpeta,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Barpeta,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Barpeta,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Barpeta,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Barpeta,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Barpeta,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Barpeta,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Barpeta,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Barpeta,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,3300.0,0.0,0.0,0.0,0.0,0.0,3200.0,3200.0,3200.0,3200.0,200.0,4000.0,20300.0
Barpeta,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,,0.0,0.0,4000.0,0.0,0.0,0.0,0.0,6000.0,0.0,10000.0
Barpeta,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,3300.0,0.0,,0.0,0.0,800.0,2500.0,500.0,0.0,0.0,2200.0,800.0,10100.0
Barpeta,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,3200.0,700.0,2700.0,3200.0,3200.0,4000.0,3200.0,20200.0
Barpeta,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0
Barpeta,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0
Barpeta,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barpeta,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,71000.0,55150.0,66850.0,4400.0,8300.0,4700.0,1700.0,1700.0,2300.0,2250.0,1450.0,1450.0,221250.0
Barpeta,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,18000.0,0.0,30000.0,0.0,0.0,0.0,4200.0,0.0,0.0,0.0,0.0,52200.0
Barpeta,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,15850.0,6300.0,62450.0,26100.0,3600.0,3000.0,100.0,3500.0,50.0,800.0,0.0,0.0,121750.0
Barpeta,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,55150.0,66850.0,4400.0,8300.0,4700.0,1700.0,1600.0,2400.0,2250.0,1450.0,1450.0,1450.0,151700.0
Barpeta,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,7800.0,700.0,2000.0,2900.0,0.0,5200.0,4600.0,100.0,800.0,24100.0
Barpeta,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,13200.0,0.0,3300.0,6600.0,0.0,13200.0,4000.0,0.0,4000.0,2000.0,46300.0
Barpeta,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,5400.0,7100.0,2000.0,5700.0,2900.0,8000.0,4600.0,4500.0,3300.0,2600.0,46100.0
Barpeta,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,7800.0,700.0,2000.0,2900.0,0.0,5200.0,4600.0,100.0,800.0,200.0,24300.0
Barpeta,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,32700.0,58300.0,93700.0,123900.0,99000.0,68100.0,30700.0,57300.0,81300.0,91700.0,68500.0,99500.0,904700.0
Barpeta,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,33600.0,48000.0,48000.0,72000.0,36000.0,0.0,60000.0,48000.0,48000.0,0.0,48000.0,0.0,441600.0
Barpeta,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,8000.0,12600.0,17800.0,96900.0,66900.0,37400.0,33400.0,24000.0,37600.0,23200.0,17000.0,41200.0,416000.0
Barpeta,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,58300.0,93700.0,123900.0,99000.0,68100.0,30700.0,57300.0,81300.0,91700.0,68500.0,99500.0,58300.0,930300.0
Barpeta,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,10500.0,15000.0,15100.0,14400.0,11775.0,3275.0,1075.0,1675.0,1675.0,4475.0,1075.0,2575.0,82600.0
Barpeta,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,6000.0,4000.0,4000.0,8000.0,6000.0,4000.0,4000.0,4000.0,6000.0,0.0,4000.0,4000.0,54000.0
Barpeta,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Barpeta,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1500.0,3900.0,4700.0,10625.0,14500.0,6200.0,3400.0,4000.0,3200.0,3400.0,2500.0,2700.0,60625.0
Barpeta,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,15000.0,15100.0,14400.0,11775.0,3275.0,1075.0,1675.0,1675.0,4475.0,1075.0,2575.0,3875.0,75975.0
Barpeta,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,,,2.0,,,,1.0,,,1.0,,6.0
Barpeta,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,2.0,5.0,4.0,1.0,1.0,,2.0,1.0,,7.0,,,23.0
Barpeta,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Barpeta,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,2.0,5.0,4.0,1.0,1.0,,2.0,1.0,,7.0,,,23.0
Barpeta,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,6.0,10.0,5.0,5.0,,2.0,,4.0,,11.0,2.0,,45.0
Barpeta,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Barpeta,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,6.0,10.0,5.0,5.0,,2.0,,4.0,,11.0,2.0,,45.0
Barpeta,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,3.0,4.0,1.0,3.0,,2.0,8.0,1.0,4.0,2.0,,30.0
Barpeta,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Barpeta,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,3.0,4.0,1.0,3.0,,2.0,8.0,1.0,4.0,2.0,,30.0
Barpeta,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,5.0,3.0,2.0,6.0,7.0,5.0,11.0,2.0,3.0,3.0,4.0,53.0
Barpeta,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,1.0,,1.0,,2.0,,,,4.0
Barpeta,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,5.0,3.0,2.0,7.0,7.0,6.0,11.0,4.0,3.0,3.0,4.0,57.0
Barpeta,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,1.0,2.0,1.0,,1.0,1.0,2.0,2.0,5.0,,2.0,19.0
Barpeta,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Barpeta,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,2.0,1.0,2.0,1.0,,1.0,1.0,2.0,2.0,5.0,,2.0,19.0
Barpeta,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Barpeta,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Barpeta,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Barpeta,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,1.0,,1.0,1.0,1.0,,,,1.0,,6.0
Barpeta,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,2.0,,,1.0,1.0,,,,,,,4.0
Barpeta,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,2.0,1.0,,2.0,2.0,1.0,,,,1.0,,10.0
Barpeta,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Barpeta,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Barpeta,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Barpeta,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,8.0,7.0,7.0,6.0,4.0,5.0,3.0,,5.0,4.0,1.0,3.0,53.0
Barpeta,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,3.0,2.0,2.0,5.0,2.0,2.0,2.0,2.0,1.0,1.0,,1.0,23.0
Barpeta,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,11.0,9.0,9.0,11.0,6.0,7.0,5.0,2.0,6.0,5.0,1.0,4.0,76.0
Barpeta,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,1.0,,,,,,,,,,,1.0,2.0
Barpeta,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,2.0,2.0
Barpeta,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Barpeta,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,,,,,,,,,3.0,4.0
Barpeta,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,1.0,1.0,,,,,,,,2.0
Barpeta,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,3.0,,2.0,,1.0,1.0,2.0,,,,2.0,12.0
Barpeta,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,2.0,1.0,1.0,4.0,2.0,,2.0,3.0,1.0,,,17.0
Barpeta,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,5.0,1.0,4.0,5.0,3.0,1.0,4.0,3.0,1.0,,2.0,31.0
Barpeta,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Barpeta,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,4.0,2.0,1.0,1.0,,,1.0,1.0,1.0,1.0,,,12.0
Barpeta,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,7.0,4.0,12.0,3.0,5.0,1.0,5.0,1.0,3.0,2.0,2.0,2.0,47.0
Barpeta,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,11.0,6.0,13.0,4.0,5.0,1.0,6.0,2.0,4.0,3.0,2.0,2.0,59.0
Barpeta,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Barpeta,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,2.0,,,,,,,,,2.0
Barpeta,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,1.0,,,,,1.0,,,,2.0
Barpeta,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,4.0,,,,,1.0,,,,5.0
Barpeta,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,1.0,3.0,,,,,,,,,5.0
Barpeta,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,4.0,3.0,9.0,3.0,8.0,2.0,1.0,2.0,2.0,,1.0,35.0
Barpeta,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,4.0,5.0,2.0,5.0,3.0,3.0,3.0,1.0,4.0,4.0,35.0
Barpeta,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,6.0,8.0,17.0,5.0,13.0,5.0,4.0,5.0,3.0,4.0,5.0,75.0
Barpeta,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Barpeta,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Barpeta,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Barpeta,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Barpeta,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Barpeta,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,9.0,4.0,3.0,8.0,2.0,5.0,5.0,6.0,9.0,15.0,7.0,4.0,77.0
Barpeta,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,8.0,11.0,9.0,14.0,7.0,8.0,5.0,16.0,20.0,16.0,5.0,11.0,130.0
Barpeta,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,17.0,15.0,12.0,22.0,9.0,13.0,10.0,22.0,29.0,31.0,12.0,15.0,207.0
Barpeta,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Barpeta,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,7.0,2.0,5.0,3.0,1.0,5.0,1.0,1.0,1.0,,1.0,,27.0
Barpeta,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,9.0,9.0,6.0,5.0,1.0,1.0,4.0,5.0,4.0,5.0,1.0,,50.0
Barpeta,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,16.0,11.0,11.0,8.0,2.0,6.0,5.0,6.0,5.0,5.0,2.0,,77.0
Barpeta,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Barpeta,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Barpeta,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Barpeta,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,1.0,,,,,,,,,,,,1.0
Barpeta,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Barpeta,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Barpeta,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Barpeta,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,1.0,,,,1.0
Barpeta,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Barpeta,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,,,,4.0,,,,,,5.0
Barpeta,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Barpeta,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,,,,4.0,,,,,,5.0
Barpeta,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Barpeta,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,2.0,,1.0,2.0,,1.0,1.0,,,,,8.0
Barpeta,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Barpeta,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,2.0,,1.0,2.0,,1.0,1.0,,,,,8.0
Barpeta,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Barpeta,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,2.0,,,,,,,,,2.0
Barpeta,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Barpeta,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,2.0,,,,,,,,,2.0
Barpeta,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Barpeta,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,4.0,2.0,3.0,2.0,2.0,2.0,6.0,,,1.0,2.0,1.0,25.0
Barpeta,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Barpeta,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,4.0,2.0,3.0,2.0,2.0,2.0,6.0,,,1.0,2.0,1.0,25.0
Barpeta,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,3.0,3.0,3.0,1.0,1.0,,,,2.0,15.0
Barpeta,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,7.0,5.0,9.0,4.0,4.0,5.0,2.0,4.0,3.0,4.0,5.0,3.0,55.0
Barpeta,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,1.0,1.0,1.0,1.0,,,,1.0,2.0,2.0,,12.0
Barpeta,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,10.0,7.0,11.0,8.0,8.0,8.0,3.0,5.0,4.0,6.0,7.0,5.0,82.0
Barpeta,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,1.0,1.0,,,,,,,1.0,3.0
Barpeta,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,7.0,5.0,6.0,4.0,6.0,5.0,3.0,2.0,3.0,3.0,6.0,6.0,56.0
Barpeta,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,1.0,1.0,1.0,,,1.0,2.0,,2.0,1.0,,10.0
Barpeta,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,8.0,6.0,7.0,6.0,7.0,5.0,4.0,4.0,3.0,5.0,7.0,7.0,69.0
Barpeta,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Barpeta,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Barpeta,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,1.0,,,,2.0,3.0,,,6.0
Barpeta,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,1.0,,1.0,,2.0,3.0,,,7.0
Barpeta,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,2.0,2.0,1.0,,,,,,,,1.0,7.0
Barpeta,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,9.0,10.0,7.0,,4.0,2.0,3.0,1.0,2.0,,3.0,44.0
Barpeta,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,10.0,7.0,6.0,12.0,3.0,6.0,6.0,9.0,10.0,7.0,5.0,8.0,89.0
Barpeta,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,14.0,18.0,18.0,20.0,3.0,10.0,8.0,12.0,11.0,9.0,5.0,12.0,140.0
Barpeta,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Barpeta,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,6.0,1.0,5.0,3.0,2.0,10.0,2.0,5.0,7.0,5.0,5.0,54.0
Barpeta,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,10.0,12.0,10.0,20.0,9.0,11.0,14.0,12.0,12.0,16.0,3.0,8.0,137.0
Barpeta,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,13.0,18.0,11.0,25.0,12.0,13.0,24.0,14.0,17.0,23.0,8.0,13.0,191.0
Barpeta,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,2.0,1.0,1.0,2.0,1.0,2.0,2.0,,1.0,3.0,4.0,20.0
Barpeta,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,18.0,18.0,12.0,30.0,10.0,18.0,15.0,27.0,16.0,10.0,23.0,15.0,212.0
Barpeta,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,28.0,37.0,48.0,68.0,39.0,49.0,31.0,40.0,74.0,66.0,56.0,57.0,593.0
Barpeta,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,47.0,57.0,61.0,99.0,51.0,68.0,48.0,69.0,90.0,77.0,82.0,76.0,825.0
Bongaigaon,1.1,Total number of pregnant women Registered for ANC,TOTAL,1610.0,1610.0,1323.0,1331.0,1397.0,1310.0,1160.0,1295.0,1114.0,1167.0,1173.0,1575.0,16065.0
Bongaigaon,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1207.0,1196.0,979.0,942.0,1012.0,936.0,838.0,937.0,852.0,883.0,936.0,1245.0,11963.0
Bongaigaon,1.2,Number of Pregnant women registered under JSY,TOTAL,1610.0,1610.0,1323.0,1331.0,1397.0,1310.0,1160.0,1295.0,1114.0,1167.0,1173.0,1575.0,16065.0
Bongaigaon,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,998.0,1116.0,1148.0,1137.0,1199.0,1191.0,1214.0,1172.0,1053.0,1066.0,832.0,1067.0,13193.0
Bongaigaon,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1252.0,1457.0,1294.0,1179.0,1214.0,1265.0,1124.0,1231.0,969.0,1020.0,902.0,1222.0,14129.0
Bongaigaon,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1154.0,1371.0,1350.0,1294.0,1282.0,1403.0,1323.0,1290.0,1134.0,1027.0,911.0,1127.0,14666.0
Bongaigaon,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1213.0,1495.0,1601.0,1286.0,1293.0,1162.0,1114.0,1284.0,1083.0,1096.0,1034.0,1323.0,14984.0
Bongaigaon,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,17.0,11.0,29.0,24.0,9.0,19.0,18.0,8.0,6.0,15.0,20.0,37.0,213.0
Bongaigaon,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1034.0,1391.0,1228.0,1295.0,1304.0,1204.0,1075.0,1061.0,745.0,741.0,863.0,1154.0,13095.0
Bongaigaon,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,0.0,,,,,0.0,0.0,0.0,0.0,0.0
Bongaigaon,1.8,Number of pregnancy test kits used at SC level,TOTAL,330.0,302.0,303.0,276.0,268.0,274.0,249.0,257.0,176.0,189.0,160.0,225.0,3009.0
Bongaigaon,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,8.0,14.0,13.0,12.0,4.0,3.0,15.0,1.0,7.0,13.0,0.0,5.0,95.0
Bongaigaon,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,231.0,235.0,219.0,263.0,312.0,299.0,386.0,395.0,357.0,320.0,274.0,227.0,3518.0
Bongaigaon,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,239.0,249.0,232.0,275.0,316.0,302.0,401.0,396.0,364.0,333.0,274.0,232.0,3613.0
Bongaigaon,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,181.0,196.0,189.0,213.0,269.0,244.0,306.0,367.0,321.0,301.0,270.0,213.0,3070.0
Bongaigaon,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,542.0,573.0,570.0,753.0,736.0,663.0,821.0,741.0,713.0,744.0,577.0,589.0,8022.0
Bongaigaon,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,263.0,364.0,404.0,623.0,443.0,537.0,539.0,619.0,566.0,597.0,429.0,423.0,5807.0
Bongaigaon,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,540.0,575.0,570.0,753.0,736.0,662.0,809.0,741.0,713.0,741.0,577.0,589.0,8006.0
Bongaigaon,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,435.0,404.0,461.0,475.0,550.0,566.0,713.0,658.0,639.0,575.0,511.0,508.0,6495.0
Bongaigaon,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Bongaigaon,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,260.0,267.0,267.0,309.0,336.0,372.0,420.0,354.0,365.0,327.0,326.0,310.0,3913.0
Bongaigaon,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,5.0,,,,7.0,3.0,5.0,3.0,6.0,1.0,4.0,34.0
Bongaigaon,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,5.0,,,,,,,,6.0,1.0,4.0,16.0
Bongaigaon,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Bongaigaon,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Bongaigaon,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Bongaigaon,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,26.0,35.0,22.0,55.0,35.0,0.0,,,,,,8.0,181.0
Bongaigaon,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bongaigaon,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,26.0,35.0,22.0,55.0,35.0,0.0,,,,,,8.0,181.0
Bongaigaon,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,180.0,196.0,193.0,224.0,245.0,255.0,274.0,242.0,273.0,221.0,228.0,228.0,2759.0
Bongaigaon,4.1.1.a,Number of male live births,TOTAL,494.0,578.0,558.0,670.0,696.0,676.0,852.0,730.0,707.0,726.0,616.0,581.0,7884.0
Bongaigaon,4.1.1.b,Number of female live births,TOTAL,525.0,488.0,493.0,645.0,668.0,641.0,758.0,725.0,715.0,655.0,538.0,536.0,7387.0
Bongaigaon,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1019.0,1066.0,1051.0,1315.0,1364.0,1317.0,1610.0,1455.0,1422.0,1381.0,1154.0,1117.0,15271.0
Bongaigaon,4.1.2,Number of still births,TOTAL,28.0,28.0,21.0,27.0,31.0,31.0,34.0,38.0,26.0,32.0,30.0,25.0,351.0
Bongaigaon,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,156.0,180.0,168.0,148.0,157.0,115.0,109.0,208.0,183.0,226.0,236.0,226.0,2112.0
Bongaigaon,4.2.1,Number of Newborns weighed at birth,TOTAL,966.0,1033.0,1039.0,1314.0,1364.0,1317.0,1610.0,1455.0,1422.0,1381.0,1153.0,1117.0,15171.0
Bongaigaon,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,101.0,135.0,133.0,189.0,210.0,147.0,173.0,166.0,153.0,168.0,100.0,89.0,1764.0
Bongaigaon,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1016.0,1066.0,1051.0,1308.0,1364.0,1317.0,1607.0,1440.0,1422.0,1355.0,1152.0,1116.0,15214.0
Bongaigaon,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0
Bongaigaon,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,6.0,,,,,,,0.0,0.0,0.0,0.0,6.0
Bongaigaon,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,26.0,35.0,22.0,,,,,,,,,8.0,91.0
Bongaigaon,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bongaigaon,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,26.0,44.0,22.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,8.0,101.0
Bongaigaon,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,180.0,196.0,193.0,224.0,245.0,255.0,274.0,242.0,273.0,221.0,228.0,228.0,2759.0
Bongaigaon,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,5.0,14.0,3.0,1.0,1.0,1.0,7.0,6.0,5.0,6.0,0.0,0.0,49.0
Bongaigaon,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Bongaigaon,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,30.0,36.0,37.0,46.0,1.0,1.0,81.0,60.0,52.0,6.0,0.0,0.0,350.0
Bongaigaon,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
Bongaigaon,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,860.0,863.0,910.0,1029.0,1035.0,893.0,1195.0,1276.0,1252.0,927.0,844.0,833.0,11917.0
Bongaigaon,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,826.0,744.0,836.0,1318.0,1053.0,943.0,1314.0,1138.0,1318.0,1359.0,1154.0,1088.0,13091.0
Bongaigaon,6.3,PNC maternal complications attended,TOTAL,2.0,1.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,7.0
Bongaigaon,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,145.0,171.0,154.0,135.0,143.0,101.0,94.0,195.0,175.0,221.0,224.0,217.0,1975.0
Bongaigaon,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,145.0,171.0,154.0,135.0,143.0,101.0,94.0,195.0,175.0,221.0,224.0,217.0,1975.0
Bongaigaon,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,8.0,15.0,8.0,3.0,19.0,26.0,17.0,20.0,30.0,31.0,7.0,19.0,203.0
Bongaigaon,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,7.0,129.0,94.0,2.0,134.0,143.0,110.0,99.0,150.0,113.0,6.0,75.0,1062.0
Bongaigaon,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,15.0,144.0,102.0,5.0,153.0,169.0,127.0,119.0,180.0,144.0,13.0,94.0,1265.0
Bongaigaon,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0
Bongaigaon,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,0.0,,,,,,,,,0.0
Bongaigaon,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bongaigaon,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0
Bongaigaon,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bongaigaon,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,11.0,0.0,0.0,0.0,24.0,25.0,0.0,35.0,0.0,0.0,0.0,29.0,124.0
Bongaigaon,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,15.0,,,,9.0,54.0,,19.0,0.0,0.0,20.0,30.0,147.0
Bongaigaon,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Bongaigaon,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bongaigaon,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,26.0,0.0,0.0,0.0,33.0,79.0,0.0,54.0,0.0,0.0,20.0,59.0,271.0
Bongaigaon,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bongaigaon,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,1.0,,,,,,,,,,,1.0
Bongaigaon,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bongaigaon,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bongaigaon,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bongaigaon,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Bongaigaon,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bongaigaon,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bongaigaon,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,76.0,72.0,63.0,162.0,120.0,144.0,105.0,160.0,217.0,85.0,92.0,241.0,1537.0
Bongaigaon,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,9.0,6.0,21.0,8.0,25.0,31.0,17.0,56.0,13.0,6.0,16.0,11.0,219.0
Bongaigaon,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,1.0,,2.0,3.0,2.0,1.0,1.0,3.0,4.0,1.0,2.0,1.0,21.0
Bongaigaon,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,3.0,9.0,5.0,3.0,12.0,11.0,12.0,22.0,5.0,5.0,9.0,96.0
Bongaigaon,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bongaigaon,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,86.0,81.0,95.0,178.0,150.0,188.0,134.0,231.0,256.0,97.0,115.0,262.0,1873.0
Bongaigaon,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,14.0,,,,14.0
Bongaigaon,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bongaigaon,9.06,Number of IUCD removals,TOTAL,11.0,19.0,7.0,4.0,7.0,14.0,11.0,30.0,14.0,6.0,2.0,12.0,137.0
Bongaigaon,9.07,Number of Oral Pills cycles distributed,TOTAL,3224.0,3269.0,3004.0,3384.0,3278.0,3829.0,3639.0,3913.0,3559.0,3277.0,3261.0,4458.0,42095.0
Bongaigaon,9.08,Number of Condom pieces distributed,TOTAL,9123.0,9806.0,10692.0,9652.0,9216.0,11937.0,11676.0,10740.0,11623.0,10061.0,7952.0,9711.0,122189.0
Bongaigaon,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,8.0,8.0,5.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28.0
Bongaigaon,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,3.0,1.0,1.0,1.0,2.0,2.0,3.0,2.0,1.0,3.0,1.0,-1.0
Bongaigaon,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,525.0,1532.0,1005.0,1191.0,1047.0,1330.0,1395.0,1572.0,2008.0,1381.0,1289.0,1408.0,15683.0
Bongaigaon,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1288.0,1230.0,1077.0,1069.0,1016.0,1193.0,1207.0,1470.0,1219.0,1368.0,1058.0,886.0,14081.0
Bongaigaon,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1259.0,1378.0,1219.0,1065.0,968.0,1035.0,1134.0,1309.0,1360.0,1091.0,1130.0,1329.0,14277.0
Bongaigaon,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1181.0,1277.0,1285.0,1239.0,1063.0,1072.0,1067.0,1153.0,1258.0,1151.0,1045.0,1371.0,14162.0
Bongaigaon,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,62.0,311.0,373.0
Bongaigaon,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,41.0,41.0
Bongaigaon,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,9.0
Bongaigaon,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,170.0,132.0,229.0,253.0,187.0,187.0,127.0,281.0,402.0,460.0,353.0,322.0,3103.0
Bongaigaon,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1276.0,1011.0,1082.0,825.0,977.0,1197.0,1026.0,1425.0,1214.0,1390.0,1052.0,1165.0,13640.0
Bongaigaon,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1245.0,1120.0,1223.0,811.0,930.0,1033.0,939.0,1278.0,1340.0,1093.0,1155.0,1386.0,13553.0
Bongaigaon,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1171.0,1020.0,1291.0,920.0,980.0,1084.0,915.0,1080.0,1261.0,1180.0,1045.0,1406.0,13353.0
Bongaigaon,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,75.0,78.0,86.0,121.0,89.0,110.0,125.0,136.0,202.0,299.0,234.0,232.0,1787.0
Bongaigaon,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1266.0,1233.0,1075.0,1069.0,908.0,991.0,1103.0,1506.0,1237.0,1378.0,953.0,877.0,13596.0
Bongaigaon,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1232.0,1365.0,1207.0,1064.0,882.0,876.0,1015.0,1304.0,1387.0,1103.0,1088.0,1333.0,13856.0
Bongaigaon,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1156.0,1280.0,1274.0,1229.0,950.0,909.0,999.0,1120.0,1268.0,1199.0,1036.0,1370.0,13790.0
Bongaigaon,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,756.0,1209.0,1232.0,1161.0,1215.0,1391.0,1206.0,1083.0,1428.0,996.0,686.0,1367.0,13730.0
Bongaigaon,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,862.0,951.0,936.0,778.0,877.0,903.0,800.0,735.0,792.0,694.0,558.0,1007.0,9893.0
Bongaigaon,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,368.0,605.0,626.0,604.0,613.0,714.0,581.0,541.0,724.0,524.0,355.0,701.0,6956.0
Bongaigaon,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,354.0,561.0,603.0,552.0,596.0,676.0,622.0,538.0,692.0,468.0,330.0,653.0,6645.0
Bongaigaon,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,722.0,1166.0,1229.0,1156.0,1209.0,1390.0,1203.0,1079.0,1416.0,992.0,685.0,1354.0,13601.0
Bongaigaon,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1002.0,1052.0,1030.0,859.0,955.0,1003.0,857.0,959.0,880.0,772.0,738.0,1067.0,11174.0
Bongaigaon,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,979.0,731.0,1030.0,706.0,901.0,1014.0,735.0,938.0,855.0,782.0,715.0,1081.0,10467.0
Bongaigaon,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,166.0,152.0,168.0,179.0,191.0,161.0,96.0,26.0,58.0,12.0,10.0,24.0,1243.0
Bongaigaon,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,167.0,144.0,173.0,144.0,174.0,146.0,77.0,19.0,40.0,9.0,5.0,30.0,1128.0
Bongaigaon,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,333.0,296.0,341.0,323.0,365.0,307.0,173.0,45.0,98.0,21.0,15.0,54.0,2371.0
Bongaigaon,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,317.0,315.0,275.0,341.0,364.0,361.0,329.0,424.0,381.0,315.0,289.0,361.0,4072.0
Bongaigaon,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,196.0,183.0,188.0,211.0,191.0,220.0,186.0,242.0,221.0,195.0,189.0,258.0,2480.0
Bongaigaon,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,127.0,126.0,121.0,131.0,127.0,133.0,133.0,135.0,126.0,104.0,134.0,158.0,1555.0
Bongaigaon,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,8.0,3.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,18.0
Bongaigaon,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,646.0,646.0,629.0,649.0,633.0,633.0,626.0,665.0,631.0,621.0,607.0,643.0,7629.0
Bongaigaon,10.4.2,Number of Immunisation sessions held during the month,TOTAL,625.0,632.0,626.0,624.0,602.0,612.0,613.0,627.0,618.0,594.0,564.0,622.0,7359.0
Bongaigaon,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,581.0,577.0,576.0,577.0,558.0,574.0,556.0,570.0,565.0,537.0,500.0,567.0,6738.0
Bongaigaon,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,692.0,1151.0,1117.0,1117.0,1167.0,1385.0,1158.0,1056.0,1388.0,930.0,593.0,1062.0,12816.0
Bongaigaon,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,127.0,119.0,136.0,118.0,1271.0,1352.0,144.0,175.0,145.0,118.0,210.0,163.0,4078.0
Bongaigaon,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,76.0,116.0,122.0,128.0,1138.0,990.0,142.0,134.0,128.0,124.0,163.0,101.0,3362.0
Bongaigaon,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,4.0,2.0,4.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,14.0
Bongaigaon,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,33.0,30.0,59.0,36.0,46.0,26.0,27.0,16.0,20.0,40.0,44.0,17.0,394.0
Bongaigaon,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,2.0,16.0,10.0,3.0,2.0,2.0,0.0,2.0,2.0,0.0,5.0,5.0,49.0
Bongaigaon,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,13.3,Number of School children detected with Refractive errors,TOTAL,5.0,4.0,0.0,0.0,27.0,98.0,0.0,0.0,0.0,0.0,0.0,0.0,134.0
Bongaigaon,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,27.0,14.0,0.0,0.0,0.0,0.0,0.0,0.0,41.0
Bongaigaon,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Bongaigaon,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Bongaigaon,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,1.0,2.0,3.0,3.0,3.0,3.0,-1.0
Bongaigaon,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,17.0,16.0,17.0,17.0,17.0,17.0,17.0,17.0,16.0,16.0,16.0,15.0,-1.0
Bongaigaon,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,528.0,515.0,515.0,504.0,499.0,497.0,527.0,528.0,524.0,507.0,488.0,519.0,-1.0
Bongaigaon,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,2.0,3.0,4.0,4.0,4.0,4.0,-1.0
Bongaigaon,14.05,Number of RKS meetings held during the month,TOTAL,12.0,12.0,15.0,12.0,13.0,9.0,13.0,11.0,12.0,12.0,12.0,17.0,150.0
Bongaigaon,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,16.0,16.0,16.0,15.0,14.0,15.0,15.0,16.0,15.0,15.0,16.0,16.0,-1.0
Bongaigaon,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,94.0,85.0,97.0,103.0,98.0,100.0,108.0,72.0,46.0,68.0,55.0,62.0,988.0
Bongaigaon,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Bongaigaon,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Bongaigaon,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,77.0,30.0,53.0,62.0,48.0,67.0,43.0,21.0,25.0,22.0,16.0,32.0,496.0
Bongaigaon,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,439.0,367.0,380.0,492.0,388.0,358.0,259.0,286.0,209.0,163.0,158.0,290.0,3789.0
Bongaigaon,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,66.0,46.0,43.0,60.0,68.0,74.0,43.0,38.0,42.0,28.0,17.0,64.0,589.0
Bongaigaon,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,770.0,627.0,787.0,835.0,891.0,665.0,502.0,571.0,360.0,373.0,312.0,506.0,7199.0
Bongaigaon,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,143.0,76.0,96.0,122.0,116.0,141.0,86.0,59.0,67.0,50.0,33.0,96.0,1085.0
Bongaigaon,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1209.0,994.0,1167.0,1327.0,1279.0,1023.0,761.0,857.0,569.0,536.0,470.0,796.0,10988.0
Bongaigaon,14.10.2.a,Number of death cases of Inpatient males,TOTAL,16.0,8.0,11.0,18.0,6.0,8.0,5.0,5.0,8.0,3.0,0.0,0.0,88.0
Bongaigaon,14.10.2.b,Number of death cases of Inpatient females,TOTAL,8.0,6.0,8.0,11.0,7.0,4.0,2.0,3.0,3.0,3.0,0.0,0.0,55.0
Bongaigaon,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,24.0,14.0,19.0,29.0,13.0,12.0,7.0,8.0,11.0,6.0,0.0,0.0,143.0
Bongaigaon,14.11,In-Patient Head Count at midnight,TOTAL,1.0,1.0,0.0,1.0,4.0,2.0,1.0,2.0,2.0,0.0,0.0,0.0,14.0
Bongaigaon,14.12.1,OPD attendance (All),TOTAL,64706.0,59546.0,61812.0,69040.0,57410.0,60172.0,51731.0,44849.0,41841.0,37467.0,39111.0,52752.0,640437.0
Bongaigaon,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,24.0,22.0,32.0,25.0,,32.0,,,,,,135.0
Bongaigaon,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Bongaigaon,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,17.0,41.0,39.0,44.0,37.0,21.0,38.0,18.0,28.0,39.0,38.0,39.0,399.0
Bongaigaon,14.14.a,Number of patients given AYUSH treatment,TOTAL,129.0,85.0,66.0,125.0,133.0,97.0,190.0,75.0,35.0,106.0,70.0,0.0,1111.0
Bongaigaon,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,123.0,131.0,0.0,147.0,125.0,82.0,0.0,0.0,0.0,0.0,0.0,608.0
Bongaigaon,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3117.0,2787.0,3119.0,3324.0,3413.0,2995.0,2929.0,2690.0,2500.0,2231.0,2206.0,2405.0,33716.0
Bongaigaon,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,21.0,32.0,44.0,20.0,19.0,36.0,17.0,29.0,14.0,19.0,19.0,33.0,303.0
Bongaigaon,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,268.0,231.0,237.0,229.0,200.0,203.0,211.0,101.0,0.0,337.0,159.0,222.0,2398.0
Bongaigaon,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,4.0
Bongaigaon,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,102.0,173.0,160.0,140.0,192.0,156.0,136.0,89.0,0.0,189.0,221.0,274.0,1832.0
Bongaigaon,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,2.0,2.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,0.0,9.0
Bongaigaon,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,307.0,852.0,728.0,685.0,653.0,349.0,585.0,413.0,35.0,409.0,480.0,477.0,5973.0
Bongaigaon,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,677.0,1256.0,1125.0,1054.0,1045.0,708.0,932.0,603.0,35.0,935.0,860.0,973.0,10203.0
Bongaigaon,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,2.0,2.0,2.0,0.0,1.0,1.0,0.0,0.0,2.0,2.0,0.0,13.0
Bongaigaon,15.2,Number of Widal tests conducted,Number tested,53.0,18.0,181.0,185.0,47.0,227.0,181.0,169.0,26.0,75.0,20.0,157.0,1339.0
Bongaigaon,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,6.0,6.0,0.0,0.0,1.0,14.0,26.0,14.0,0.0,0.0,7.0,74.0
Bongaigaon,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,4.0
Bongaigaon,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,396.0,63.0,362.0,364.0,371.0,414.0,391.0,394.0,319.0,269.0,284.0,248.0,3875.0
Bongaigaon,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,396.0,69.0,368.0,364.0,372.0,416.0,406.0,421.0,333.0,269.0,284.0,255.0,3953.0
Bongaigaon,15.4.1,Number of blood smears examined for Malaria,TOTAL,10271.0,12048.0,16082.0,22094.0,14882.0,13341.0,8164.0,8401.0,6050.0,6408.0,6801.0,8960.0,133502.0
Bongaigaon,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3.0,4.0,5.0,9.0,2.0,1.0,1.0,0.0,1.0,0.0,3.0,1.0,30.0
Bongaigaon,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,1.0,1.0,2.0,1.0,1.0,1.0,8.0,4.0,3.0,0.0,0.0,22.0
Bongaigaon,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,6000.0,3000.0,12000.0,5500.0,9000.0,9000.0,6500.0,15950.0,9450.0,15150.0,12800.0,17450.0,121800.0
Bongaigaon,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,20000.0,,10000.0,5000.0,,10000.0,,10000.0,,10000.0,,65000.0
Bongaigaon,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3000.0,11000.0,6500.0,6500.0,5000.0,2500.0,550.0,6500.0,4300.0,2350.0,5350.0,9650.0,63200.0
Bongaigaon,16.1.1,Stock position of DPT vaccines,5. Total Stock,3000.0,12000.0,5500.0,9000.0,9000.0,6500.0,15950.0,9450.0,15150.0,12800.0,17450.0,7800.0,123600.0
Bongaigaon,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,3500.0,3500.0
Bongaigaon,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,9000.0,,9000.0
Bongaigaon,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,5500.0,100.0,5600.0
Bongaigaon,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3500.0,3400.0,6900.0
Bongaigaon,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,7500.0,,15000.0,0.0,0.0,0.0,0.0,7000.0,,,,3000.0,32500.0
Bongaigaon,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,15000.0,,,13000.0,,7000.0,1000.0,6000.0,,9000.0,,51000.0
Bongaigaon,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,7500.0,,15000.0,,13000.0,,,8000.0,6000.0,,6000.0,,55500.0
Bongaigaon,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,15000.0,0.0,0.0,0.0,0.0,7000.0,0.0,0.0,0.0,3000.0,3000.0,28000.0
Bongaigaon,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,12000.0,5500.0,16000.0,8500.0,6000.0,9300.0,7300.0,12300.0,9300.0,6800.0,5000.0,11800.0,109800.0
Bongaigaon,16.1.3,Stock position of TT vaccines,2. Stocks Received,,20000.0,,,5000.0,,10000.0,,,,10000.0,,45000.0
Bongaigaon,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6500.0,9500.0,7500.0,2500.0,1700.0,2000.0,5000.0,3000.0,2500.0,1800.0,3200.0,4800.0,50000.0
Bongaigaon,16.1.3,Stock position of TT vaccines,5. Total Stock,5500.0,16000.0,8500.0,6000.0,9300.0,7300.0,12300.0,9300.0,6800.0,5000.0,11800.0,7000.0,104800.0
Bongaigaon,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Bongaigaon,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Bongaigaon,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Bongaigaon,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Bongaigaon,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,1000.0,2500.0,500.0,5000.0,2000.0,,500.0,2200.0,1050.0,6550.0,21300.0
Bongaigaon,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,6000.0,6500.0,1000.0,6000.0,,,5500.0,5000.0,,10000.0,,40000.0
Bongaigaon,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,5000.0,5000.0,3000.0,1500.0,3000.0,2000.0,5000.0,3300.0,1150.0,4500.0,3250.0,36700.0
Bongaigaon,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,1000.0,2500.0,500.0,5000.0,2000.0,0.0,500.0,2200.0,1050.0,6550.0,3300.0,24600.0
Bongaigaon,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,7500.0,2500.0,6500.0,1500.0,3750.0,3500.0,1750.0,1000.0,2500.0,2250.0,1100.0,4175.0,38025.0
Bongaigaon,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,5000.0,,5000.0,2500.0,,,5000.0,2500.0,,5000.0,,25000.0
Bongaigaon,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5000.0,1000.0,5000.0,2750.0,2750.0,1750.0,750.0,3500.0,2750.0,1150.0,1925.0,2175.0,30500.0
Bongaigaon,16.1.6,Stock position of Measles vaccines,5. Total Stock,2500.0,6500.0,1500.0,3750.0,3500.0,1750.0,1000.0,2500.0,2250.0,1100.0,4175.0,2000.0,32525.0
Bongaigaon,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,160000.0,160000.0
Bongaigaon,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,87000.0,87000.0
Bongaigaon,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,73000.0,73000.0
Bongaigaon,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,14500.0,5500.0,2500.0,0.0,1500.0,9600.0,6000.0,11800.0,8100.0,12800.0,10500.0,16800.0,99600.0
Bongaigaon,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,6000.0,,6500.0,10200.0,,10000.0,,10000.0,,10000.0,,52700.0
Bongaigaon,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,9000.0,9000.0,2500.0,5000.0,2100.0,3600.0,4200.0,3700.0,5300.0,2300.0,3700.0,9100.0,59500.0
Bongaigaon,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5500.0,2500.0,0.0,1500.0,9600.0,6000.0,11800.0,8100.0,12800.0,10500.0,16800.0,7700.0,92800.0
Bongaigaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Bongaigaon,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Bongaigaon,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Bongaigaon,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bongaigaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1400.0,1400.0,1400.0,0.0,0.0,1400.0,1300.0,400.0,500.0,1600.0,1300.0,1700.0,12400.0
Bongaigaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,400.0,3300.0,,,3300.0,3300.0,,2000.0,,12300.0
Bongaigaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,1400.0,400.0,1900.0,100.0,900.0,3200.0,2200.0,300.0,1600.0,1500.0,13500.0
Bongaigaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1400.0,1400.0,0.0,0.0,1400.0,1300.0,400.0,500.0,1600.0,1300.0,1700.0,200.0,11200.0
Bongaigaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,41400.0,28400.0,28400.0,4800.0,14400.0,33600.0,31200.0,43200.0,38400.0,52800.0,52800.0,76800.0,446200.0
Bongaigaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,24000.0,,24000.0,24000.0,,24000.0,24000.0,24000.0,,24000.0,268800.0,436800.0
Bongaigaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,13000.0,24000.0,23600.0,14400.0,4800.0,2400.0,12000.0,28800.0,9600.0,,,194400.0,327000.0
Bongaigaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,28400.0,28400.0,4800.0,14400.0,33600.0,31200.0,43200.0,38400.0,52800.0,52800.0,76800.0,151200.0,556000.0
Bongaigaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,28000.0,5800.0,8300.0,5400.0,3500.0,3000.0,3000.0,3500.0,3100.0,4500.0,4200.0,4500.0,76800.0
Bongaigaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,4000.0,,,,,2000.0,2000.0,2000.0,,2000.0,30000.0,42000.0
Bongaigaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Bongaigaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,22200.0,1500.0,2900.0,1900.0,500.0,0.0,1500.0,2400.0,600.0,300.0,1700.0,21300.0,56800.0
Bongaigaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,5800.0,8300.0,5400.0,3500.0,3000.0,3000.0,3500.0,3100.0,4500.0,4200.0,4500.0,13200.0,62000.0
Bongaigaon,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,,,1.0,,,,,1.0,,,3.0
Bongaigaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,,1.0,,,,1.0,3.0,1.0,2.0,,9.0
Bongaigaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bongaigaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,,1.0,,,,1.0,3.0,1.0,2.0,,9.0
Bongaigaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,6.0,2.0,2.0,8.0,7.0,5.0,2.0,4.0,6.0,1.0,3.0,1.0,47.0
Bongaigaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,,,1.0
Bongaigaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,6.0,2.0,2.0,8.0,7.0,6.0,2.0,4.0,6.0,1.0,3.0,1.0,48.0
Bongaigaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,2.0,2.0,4.0,5.0,2.0,5.0,2.0,4.0,3.0,,1.0,31.0
Bongaigaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,2.0,,,,2.0
Bongaigaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,2.0,2.0,4.0,5.0,2.0,5.0,2.0,6.0,3.0,,1.0,33.0
Bongaigaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,8.0,6.0,8.0,12.0,6.0,21.0,29.0,15.0,6.0,7.0,2.0,15.0,135.0
Bongaigaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,1.0,,,2.0
Bongaigaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,8.0,6.0,8.0,12.0,6.0,21.0,29.0,15.0,7.0,8.0,2.0,15.0,137.0
Bongaigaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,1.0,1.0,1.0,1.0,,1.0,2.0,1.0,3.0,3.0,15.0
Bongaigaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bongaigaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,1.0,1.0,1.0,1.0,,1.0,2.0,1.0,3.0,3.0,15.0
Bongaigaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,1.0,,,,,,,,1.0,,,,2.0
Bongaigaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bongaigaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,1.0,,,,,,,,1.0,,,,2.0
Bongaigaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,1.0,,1.0,,,2.0
Bongaigaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bongaigaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,1.0,,1.0,,,2.0
Bongaigaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bongaigaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bongaigaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bongaigaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,3.0,4.0,1.0,1.0,3.0,6.0,6.0,5.0,12.0,14.0,5.0,63.0
Bongaigaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,3.0,4.0,5.0,3.0,2.0,2.0,,,1.0,2.0,3.0,27.0
Bongaigaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,6.0,8.0,6.0,4.0,5.0,8.0,6.0,5.0,13.0,16.0,8.0,90.0
Bongaigaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Bongaigaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Bongaigaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Bongaigaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,,,,,,,,,,1.0,2.0
Bongaigaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Bongaigaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,,,,,,,,,,1.0,2.0
Bongaigaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,1.0,1.0,,,,,1.0,1.0,,5.0
Bongaigaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,1.0,,2.0,2.0,1.0,,6.0
Bongaigaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,1.0,1.0,1.0,,1.0,,2.0,3.0,2.0,,11.0
Bongaigaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,1.0,,,1.0,,,,,,2.0
Bongaigaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Bongaigaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,1.0,,,1.0,1.0,,,,,3.0
Bongaigaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,1.0,,1.0,,,1.0,3.0
Bongaigaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,2.0,2.0,,1.0,1.0,2.0,,1.0,1.0,,,10.0
Bongaigaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,4.0,,1.0,,1.0,2.0,1.0,,,9.0
Bongaigaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,2.0,2.0,4.0,1.0,2.0,3.0,1.0,4.0,2.0,,1.0,22.0
Bongaigaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Bongaigaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Bongaigaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Bongaigaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Bongaigaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,3.0,1.0,3.0,2.0,1.0,1.0,3.0,5.0,2.0,2.0,,24.0
Bongaigaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,2.0,3.0,2.0,1.0,1.0,3.0,4.0,3.0,1.0,1.0,1.0,23.0
Bongaigaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,5.0,5.0,5.0,3.0,2.0,4.0,7.0,8.0,3.0,3.0,1.0,48.0
Bongaigaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,,2.0,1.0,,,,,1.0,,5.0
Bongaigaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,1.0,1.0,,2.0
Bongaigaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,,,2.0,1.0,,,,1.0,2.0,,7.0
Bongaigaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Bongaigaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bongaigaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,1.0,,,,,,,,,,,,1.0
Bongaigaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bongaigaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Bongaigaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Bongaigaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bongaigaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,1.0,,,,,,,,,1.0
Bongaigaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,3.0,,,1.0,,,1.0,5.0
Bongaigaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bongaigaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,3.0,,,1.0,,,1.0,5.0
Bongaigaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bongaigaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Bongaigaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,1.0,3.0,,2.0,5.0,1.0,1.0,,3.0,1.0,18.0
Bongaigaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bongaigaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,1.0,3.0,,2.0,5.0,1.0,1.0,,3.0,1.0,18.0
Bongaigaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,3.0,1.0,1.0,1.0,2.0,1.0,1.0,,1.0,,11.0
Bongaigaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,6.0,2.0,2.0,4.0,,3.0,4.0,3.0,4.0,4.0,6.0,41.0
Bongaigaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,1.0,1.0,,,2.0,1.0,1.0,,1.0,1.0,2.0,11.0
Bongaigaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,7.0,6.0,3.0,5.0,3.0,6.0,6.0,4.0,5.0,6.0,8.0,63.0
Bongaigaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Bongaigaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,2.0,2.0,5.0,2.0,1.0,3.0,,1.0,2.0,2.0,4.0,25.0
Bongaigaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,1.0,,1.0,2.0,1.0,1.0,,,7.0
Bongaigaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,2.0,2.0,6.0,3.0,1.0,4.0,2.0,2.0,3.0,3.0,4.0,33.0
Bongaigaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,,1.0,,,,,,,2.0
Bongaigaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Bongaigaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,,,1.0,,,,,,,2.0
Bongaigaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Bongaigaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,10.0,,3.0,2.0,2.0,2.0,1.0,,4.0,3.0,1.0,1.0,29.0
Bongaigaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,8.0,4.0,1.0,10.0,5.0,1.0,1.0,2.0,5.0,5.0,4.0,,46.0
Bongaigaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,18.0,4.0,4.0,12.0,7.0,3.0,2.0,2.0,9.0,8.0,5.0,1.0,75.0
Bongaigaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,,,1.0,,,,,2.0
Bongaigaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,8.0,4.0,4.0,6.0,4.0,3.0,4.0,4.0,5.0,10.0,3.0,7.0,62.0
Bongaigaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,9.0,8.0,12.0,15.0,14.0,18.0,21.0,15.0,20.0,25.0,19.0,9.0,185.0
Bongaigaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,17.0,13.0,16.0,21.0,18.0,21.0,25.0,20.0,25.0,35.0,22.0,16.0,249.0
Bongaigaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,2.0,,,,,2.0,,3.0,1.0,8.0
Bongaigaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,10.0,9.0,16.0,24.0,18.0,10.0,9.0,7.0,13.0,7.0,10.0,15.0,148.0
Bongaigaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,8.0,18.0,13.0,19.0,8.0,10.0,16.0,18.0,17.0,20.0,17.0,12.0,176.0
Bongaigaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,18.0,27.0,29.0,45.0,26.0,20.0,25.0,25.0,32.0,27.0,30.0,28.0,332.0
Cachar,1.1,Total number of pregnant women Registered for ANC,TOTAL,3708.0,3938.0,3906.0,3628.0,4166.0,3707.0,3065.0,2891.0,3132.0,3073.0,2697.0,3367.0,41278.0
Cachar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2993.0,3192.0,3131.0,3025.0,3356.0,3024.0,2422.0,2272.0,2446.0,2492.0,2183.0,2853.0,33389.0
Cachar,1.2,Number of Pregnant women registered under JSY,TOTAL,3672.0,3938.0,3911.0,3628.0,4166.0,3607.0,3043.0,2875.0,3126.0,3031.0,2561.0,3198.0,40756.0
Cachar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2454.0,2450.0,2459.0,2688.0,2928.0,2939.0,3077.0,3173.0,3200.0,2992.0,2531.0,2546.0,33437.0
Cachar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2530.0,2856.0,2783.0,2764.0,3076.0,2952.0,2216.0,2832.0,2473.0,2196.0,2015.0,2384.0,31077.0
Cachar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2882.0,3134.0,3333.0,3240.0,3416.0,3707.0,2693.0,3438.0,3677.0,2952.0,2416.0,2610.0,37498.0
Cachar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3810.0,4085.0,4213.0,3920.0,4767.0,4507.0,4007.0,4108.0,3170.0,2681.0,3205.0,2886.0,45359.0
Cachar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,194.0,119.0,142.0,116.0,43.0,69.0,72.0,304.0,243.0,349.0,287.0,94.0,2032.0
Cachar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,4.0,0.0,5.0,5.0,0.0,0.0,0.0,2.0,2.0,18.0
Cachar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3131.0,3436.0,3639.0,3311.0,3984.0,3833.0,3216.0,3101.0,3010.0,3276.0,2623.0,3425.0,39985.0
Cachar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,7.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,4.0,20.0
Cachar,1.8,Number of pregnancy test kits used at SC level,TOTAL,749.0,816.0,667.0,692.0,680.0,589.0,481.0,409.0,585.0,494.0,473.0,540.0,7175.0
Cachar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,114.0,148.0,186.0,180.0,190.0,189.0,240.0,217.0,177.0,177.0,141.0,137.0,2096.0
Cachar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,290.0,241.0,194.0,209.0,208.0,220.0,240.0,301.0,277.0,354.0,297.0,243.0,3074.0
Cachar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,404.0,389.0,380.0,389.0,398.0,409.0,480.0,518.0,454.0,531.0,438.0,380.0,5170.0
Cachar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,284.0,283.0,293.0,291.0,351.0,336.0,405.0,425.0,351.0,370.0,328.0,278.0,3995.0
Cachar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,9.0,3.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,5.0,0.0,2.0,22.0
Cachar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2465.0,2229.0,2104.0,2206.0,2371.0,2656.0,2817.0,2753.0,2992.0,3055.0,2525.0,2548.0,30721.0
Cachar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,921.0,628.0,702.0,643.0,789.0,646.0,904.0,855.0,993.0,1230.0,1091.0,1380.0,10782.0
Cachar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2314.0,2083.0,1835.0,2475.0,2322.0,2345.0,2762.0,2674.0,3110.0,2995.0,2508.0,2428.0,29851.0
Cachar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,377.0,1051.0,1094.0,2090.0,1227.0,2060.0,980.0,3350.0,1843.0,2466.0,1975.0,2719.0,21232.0
Cachar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,0.0,0.0,,,,,,,,0.0
Cachar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,411.0,397.0,348.0,357.0,448.0,376.0,580.0,487.0,557.0,445.0,451.0,430.0,5287.0
Cachar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,83.0,97.0,87.0,85.0,107.0,95.0,117.0,109.0,133.0,119.0,92.0,98.0,1222.0
Cachar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,21.0,13.0,20.0,18.0,19.0,20.0,16.0,15.0,19.0,19.0,22.0,19.0,221.0
Cachar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Cachar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Cachar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Cachar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,297.0,303.0,249.0,268.0,344.0,369.0,369.0,368.0,415.0,393.0,307.0,324.0,4006.0
Cachar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Cachar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,297.0,303.0,249.0,268.0,344.0,369.0,369.0,368.0,415.0,393.0,307.0,324.0,4006.0
Cachar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,227.0,286.0,196.0,263.0,306.0,32.0,333.0,307.0,346.0,281.0,266.0,255.0,3098.0
Cachar,4.1.1.a,Number of male live births,TOTAL,1672.0,1495.0,1478.0,1501.0,1602.0,1754.0,1922.0,1884.0,1934.0,2021.0,1762.0,1778.0,20803.0
Cachar,4.1.1.b,Number of female live births,TOTAL,1549.0,1441.0,1280.0,1400.0,1551.0,1599.0,1863.0,1821.0,1960.0,1939.0,1581.0,1493.0,19477.0
Cachar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3221.0,2936.0,2758.0,2901.0,3153.0,3353.0,3785.0,3705.0,3894.0,3960.0,3343.0,3271.0,40280.0
Cachar,4.1.2,Number of still births,TOTAL,86.0,94.0,90.0,78.0,81.0,114.0,138.0,94.0,135.0,130.0,94.0,246.0,1380.0
Cachar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,220.0,267.0,253.0,224.0,273.0,170.0,227.0,143.0,139.0,126.0,160.0,208.0,2410.0
Cachar,4.2.1,Number of Newborns weighed at birth,TOTAL,3221.0,2934.0,2758.0,2901.0,3157.0,3340.0,3786.0,3702.0,3866.0,3952.0,3333.0,3297.0,40247.0
Cachar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,646.0,596.0,776.0,675.0,688.0,775.0,852.0,715.0,714.0,835.0,789.0,677.0,8738.0
Cachar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3117.0,2904.0,2688.0,2826.0,2927.0,3062.0,2514.0,3454.0,3498.0,3494.0,3012.0,3042.0,36538.0
Cachar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6.0,9.0,8.0,25.0,22.0,27.0,4.0,4.0,14.0,20.0,25.0,35.0,199.0
Cachar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Cachar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,26.0,30.0,66.0,35.0,15.0,58.0,45.0,55.0,83.0,12.0,2.0,91.0,518.0
Cachar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Cachar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,32.0,39.0,74.0,60.0,37.0,85.0,49.0,59.0,97.0,32.0,27.0,126.0,717.0
Cachar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Cachar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,184.0,200.0,232.0,161.0,225.0,154.0,231.0,236.0,275.0,285.0,219.0,405.0,2807.0
Cachar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,10.0,12.0,14.0,108.0,9.0,19.0,4.0,9.0,14.0,29.0,3.0,6.0,237.0
Cachar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,308.0,231.0,246.0,292.0,328.0,395.0,358.0,395.0,419.0,397.0,369.0,318.0,4056.0
Cachar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,20.0,8.0,372.0,368.0,13.0,8.0,510.0,530.0,494.0,399.0,344.0,361.0,3427.0
Cachar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2692.0,2304.0,1897.0,2257.0,2470.0,2242.0,2415.0,2403.0,2661.0,2587.0,2031.0,2232.0,28191.0
Cachar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2479.0,2552.0,2275.0,2437.0,2703.0,2482.0,2740.0,2464.0,2457.0,2225.0,1921.0,1821.0,28556.0
Cachar,6.3,PNC maternal complications attended,TOTAL,21.0,0.0,21.0,10.0,18.0,24.0,34.0,0.0,0.0,0.0,0.0,0.0,128.0
Cachar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,133.0,142.0,162.0,105.0,134.0,15.0,74.0,79.0,76.0,98.0,124.0,91.0,1233.0
Cachar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Cachar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,133.0,143.0,162.0,105.0,134.0,15.0,74.0,79.0,76.0,98.0,124.0,91.0,1234.0
Cachar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,95.0,62.0,53.0,123.0,53.0,65.0,64.0,56.0,36.0,52.0,40.0,44.0,743.0
Cachar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,1.0,26.0,15.0,17.0,0.0,2.0,1.0,2.0,0.0,0.0,19.0,0.0,83.0
Cachar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1.0,430.0,377.0,4.0,0.0,2.0,0.0,1.0,0.0,0.0,70.0,84.0,969.0
Cachar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,2.0,456.0,392.0,21.0,0.0,4.0,1.0,3.0,0.0,0.0,89.0,84.0,1052.0
Cachar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,2.0,0.0,8.0,2.0,0.0,1.0,52.0,30.0,17.0,5.0,21.0,139.0
Cachar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,,1.0,1.0,,,,,,,,3.0
Cachar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Cachar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,2.0,0.0,9.0,3.0,0.0,1.0,52.0,30.0,17.0,5.0,21.0,142.0
Cachar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,130.0,179.0,113.0,255.0,200.0,107.0,66.0,44.0,303.0,87.0,126.0,272.0,1882.0
Cachar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,30.0,,,43.0,30.0,19.0,0.0,2.0,,,,,124.0
Cachar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,53.0,67.0,35.0,47.0,47.0,51.0,11.0,14.0,79.0,12.0,9.0,15.0,440.0
Cachar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Cachar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,213.0,246.0,148.0,345.0,277.0,177.0,77.0,60.0,382.0,99.0,135.0,287.0,2446.0
Cachar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,6.0,5.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,15.0
Cachar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Cachar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,41.0,49.0,90.0
Cachar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Cachar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,41.0,49.0,90.0
Cachar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,9.0,2.0,3.0,2.0,2.0,2.0,0.0,2.0,4.0,3.0,29.0
Cachar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,6.0,2.0,2.0,1.0,14.0
Cachar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Cachar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,6.0,23.0,10.0,11.0,16.0,10.0,68.0,39.0,0.0,54.0,41.0,49.0,327.0
Cachar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Cachar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,7.0,23.0,10.0,11.0,16.0,11.0,68.0,40.0,6.0,56.0,43.0,50.0,341.0
Cachar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,6.0,3.0,0.0,6.0,6.0,6.0,0.0,0.0,4.0,1.0,1.0,3.0,36.0
Cachar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,64.0,101.0,106.0,518.0,56.0,61.0,47.0,55.0,88.0,57.0,67.0,90.0,1310.0
Cachar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,43.0,55.0,21.0,93.0,30.0,35.0,44.0,47.0,14.0,25.0,33.0,5.0,445.0
Cachar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,19.0,0.0,,,,,,23.0,10.0,52.0
Cachar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,23.0,22.0,24.0,15.0,21.0,20.0,23.0,21.0,16.0,9.0,9.0,13.0,216.0
Cachar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Cachar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,130.0,178.0,151.0,645.0,107.0,116.0,114.0,123.0,118.0,91.0,132.0,118.0,2023.0
Cachar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,13.0,9.0,10.0,1.0,11.0,13.0,6.0,32.0,41.0,21.0,15.0,19.0,191.0
Cachar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,4.0,2.0,3.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,2.0,13.0
Cachar,9.06,Number of IUCD removals,TOTAL,15.0,22.0,20.0,26.0,27.0,25.0,33.0,31.0,23.0,15.0,9.0,13.0,259.0
Cachar,9.07,Number of Oral Pills cycles distributed,TOTAL,5029.0,5578.0,5475.0,8132.0,5716.0,6083.0,5258.0,5399.0,5510.0,5591.0,5765.0,5166.0,68702.0
Cachar,9.08,Number of Condom pieces distributed,TOTAL,22551.0,20551.0,20794.0,30287.0,16508.0,17201.0,15746.0,17866.0,19149.0,17136.0,16970.0,17459.0,232218.0
Cachar,9.09,Number of Centchroman (weekly) pills given,TOTAL,9.0,230.0,3.0,3.0,100.0,21.0,59.0,58.0,0.0,2.0,57.0,2.0,544.0
Cachar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,45.0,37.0,15.0,41.0,21.0,6.0,32.0,33.0,34.0,38.0,48.0,26.0,376.0
Cachar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,2.0,1.0,2.0,1.0,0.0,5.0,0.0,0.0,0.0,11.0
Cachar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,2.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,7.0
Cachar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,1.0,2.0,2.0,2.0,1.0,1.0,3.0,2.0,4.0,5.0,8.0,-1.0
Cachar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1308.0,4085.0,2343.0,3887.0,2982.0,4206.0,1969.0,1525.0,6326.0,5109.0,3838.0,3888.0,41466.0
Cachar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3050.0,3408.0,3084.0,2889.0,2752.0,2921.0,2235.0,3265.0,3763.0,3402.0,2269.0,1112.0,34150.0
Cachar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3163.0,3308.0,3246.0,3135.0,2716.0,2877.0,2163.0,2873.0,3546.0,3382.0,2820.0,3090.0,36319.0
Cachar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3073.0,3274.0,3141.0,3179.0,2815.0,2942.0,2136.0,2765.0,3166.0,3216.0,2885.0,3538.0,36130.0
Cachar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,801.0,3076.0,3877.0
Cachar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,722.0,722.0
Cachar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0,25.0
Cachar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1441.0,960.0,1088.0,1117.0,1280.0,1436.0,896.0,1116.0,681.0,1474.0,1537.0,1266.0,14292.0
Cachar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2929.0,1486.0,3191.0,3135.0,1543.0,3415.0,1422.0,2664.0,1168.0,4784.0,3337.0,3277.0,32351.0
Cachar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3009.0,1403.0,2998.0,3136.0,1606.0,3248.0,1378.0,2370.0,1020.0,4044.0,3668.0,3768.0,31648.0
Cachar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2960.0,1394.0,2881.0,3045.0,1554.0,3118.0,1435.0,2250.0,986.0,3735.0,3422.0,3883.0,30663.0
Cachar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,322.0,644.0,751.0,652.0,798.0,507.0,241.0,1074.0,1414.0,1397.0,1123.0,1002.0,9925.0
Cachar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2907.0,3391.0,2965.0,2672.0,1560.0,1004.0,554.0,4267.0,4074.0,3540.0,2329.0,1037.0,30300.0
Cachar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2814.0,3311.0,3190.0,2957.0,1547.0,966.0,456.0,2676.0,4211.0,3951.0,3080.0,2889.0,32048.0
Cachar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2754.0,3187.0,2994.0,2962.0,1553.0,937.0,413.0,2599.0,2996.0,3880.0,3263.0,3432.0,30970.0
Cachar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2235.0,2586.0,2629.0,2749.0,3192.0,3447.0,2635.0,2690.0,3518.0,3524.0,2797.0,3417.0,35419.0
Cachar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2159.0,2520.0,2529.0,2680.0,2547.0,2959.0,1783.0,1927.0,2503.0,2658.0,2248.0,2622.0,29135.0
Cachar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,21.0,0.0,24.0,0.0,0.0,0.0,0.0,0.0,11.0,56.0
Cachar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1143.0,1358.0,1378.0,1416.0,1577.0,1742.0,1285.0,1375.0,1678.0,1862.0,1445.0,1784.0,18043.0
Cachar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1053.0,1225.0,1244.0,1318.0,1525.0,1683.0,1280.0,1264.0,1536.0,1683.0,1329.0,1662.0,16802.0
Cachar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2196.0,2583.0,2622.0,2734.0,3102.0,3425.0,2565.0,2639.0,3214.0,3545.0,2774.0,3446.0,34845.0
Cachar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2484.0,2872.0,2723.0,2913.0,2756.0,3083.0,1970.0,2407.0,2764.0,2792.0,2301.0,2844.0,31909.0
Cachar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2411.0,1189.0,2744.0,2838.0,1668.0,3136.0,1286.0,1905.0,836.0,3150.0,2447.0,2843.0,26453.0
Cachar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,2.0,2.0,5.0,4.0,4.0,4.0,3.0,3.0,3.0,3.0,0.0,25.0,58.0
Cachar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,112.0,194.0,130.0,90.0,43.0,57.0,64.0,120.0,137.0,187.0,138.0,190.0,1462.0
Cachar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,101.0,162.0,109.0,98.0,42.0,67.0,83.0,82.0,132.0,168.0,141.0,190.0,1375.0
Cachar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,213.0,356.0,239.0,188.0,85.0,124.0,147.0,202.0,269.0,355.0,279.0,380.0,2837.0
Cachar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1601.0,1595.0,1514.0,1525.0,1651.0,1612.0,1354.0,1476.0,1629.0,1766.0,1480.0,1877.0,19080.0
Cachar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1779.0,1823.0,1831.0,2094.0,1723.0,1673.0,1317.0,1717.0,1848.0,1955.0,1692.0,1945.0,21397.0
Cachar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1350.0,1452.0,1465.0,1410.0,1475.0,1389.0,1081.0,1432.0,1543.0,1552.0,1322.0,1483.0,16954.0
Cachar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Cachar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1619.0,1595.0,1664.0,1638.0,1628.0,1649.0,1642.0,1655.0,1613.0,1641.0,1519.0,1553.0,19416.0
Cachar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1579.0,1569.0,1628.0,1603.0,1576.0,1599.0,1556.0,1612.0,1574.0,1599.0,1400.0,1505.0,18800.0
Cachar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1546.0,1540.0,1602.0,1540.0,1545.0,1572.0,1516.0,1421.0,1505.0,1502.0,1352.0,1471.0,18112.0
Cachar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,4.0,6.0,0.0,0.0,0.0,18.0,10.0,0.0,0.0,13.0,51.0
Cachar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2035.0,2526.0,2501.0,2633.0,2864.0,3367.0,2566.0,2527.0,3380.0,3394.0,2521.0,3207.0,33521.0
Cachar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,836.0,865.0,877.0,857.0,3091.0,1466.0,899.0,891.0,1024.0,1044.0,863.0,1210.0,13923.0
Cachar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,876.0,970.0,929.0,942.0,2600.0,1284.0,856.0,946.0,1022.0,1036.0,899.0,1229.0,13589.0
Cachar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,37.0,29.0,6.0,20.0,18.0,10.0,3.0,1.0,2.0,4.0,8.0,4.0,142.0
Cachar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,465.0,469.0,363.0,487.0,444.0,280.0,193.0,213.0,249.0,219.0,193.0,245.0,3820.0
Cachar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,12.0,2.0,3.0,17.0,10.0,7.0,2.0,0.0,7.0,14.0,0.0,0.0,74.0
Cachar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,4.0,13.0,5.0,44.0,32.0,8.0,14.0,9.0,1.0,0.0,4.0,4.0,138.0
Cachar,13.1,Number of Patients operated for cataract,TOTAL,32.0,11.0,41.0,44.0,45.0,38.0,18.0,49.0,41.0,20.0,13.0,102.0,454.0
Cachar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,32.0,11.0,41.0,44.0,45.0,38.0,18.0,49.0,41.0,19.0,13.0,102.0,453.0
Cachar,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,,,,,,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Cachar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,16.0,16.0,16.0,16.0,16.0,16.0,18.0,16.0,16.0,17.0,19.0,19.0,-1.0
Cachar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1401.0,1411.0,1408.0,1396.0,1369.0,1390.0,1326.0,1399.0,1382.0,1355.0,1323.0,1379.0,-1.0
Cachar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,2.0,2.0,2.0,2.0,1.0,2.0,2.0,2.0,3.0,3.0,3.0,-1.0
Cachar,14.05,Number of RKS meetings held during the month,TOTAL,7.0,4.0,5.0,7.0,5.0,3.0,4.0,6.0,7.0,5.0,7.0,9.0,69.0
Cachar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,29.0,26.0,30.0,30.0,28.0,29.0,29.0,28.0,26.0,28.0,27.0,27.0,-1.0
Cachar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,372.0,394.0,312.0,380.0,354.0,297.0,317.0,371.0,251.0,227.0,225.0,287.0,3787.0
Cachar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,-1.0
Cachar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Cachar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,401.0,525.0,532.0,506.0,498.0,535.0,368.0,699.0,470.0,594.0,70.0,49.0,5247.0
Cachar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1542.0,1566.0,1697.0,1643.0,1655.0,1469.0,1561.0,1429.0,1388.0,1358.0,1578.0,2029.0,18915.0
Cachar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,419.0,592.0,399.0,478.0,464.0,584.0,473.0,537.0,512.0,613.0,124.0,129.0,5324.0
Cachar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3988.0,3940.0,3739.0,3611.0,3929.0,3391.0,4369.0,3845.0,4603.0,4247.0,4353.0,4104.0,48119.0
Cachar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,820.0,1117.0,931.0,984.0,962.0,1119.0,841.0,1236.0,982.0,1207.0,194.0,178.0,10571.0
Cachar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5530.0,5506.0,5436.0,5254.0,5584.0,4860.0,5930.0,5274.0,5991.0,5605.0,5931.0,6133.0,67034.0
Cachar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,199.0,168.0,179.0,546.0
Cachar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,60.0,57.0,66.0,186.0
Cachar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,259.0,225.0,245.0,732.0
Cachar,14.11,In-Patient Head Count at midnight,TOTAL,564.0,4459.0,573.0,3992.0,3918.0,529.0,424.0,528.0,4761.0,793.0,743.0,2278.0,23562.0
Cachar,14.12.1,OPD attendance (All),TOTAL,121836.0,118675.0,127500.0,124402.0,124011.0,112988.0,89334.0,101579.0,90979.0,85215.0,89467.0,91698.0,1277684.0
Cachar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,149.0,158.0,171.0,80.0,87.0,55.0,45.0,119.0,59.0,70.0,91.0,134.0,1218.0
Cachar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,34.0,54.0,31.0,1.0,0.0,29.0,0.0,0.0,0.0,0.0,29.0,65.0,243.0
Cachar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,200.0,159.0,234.0,121.0,132.0,93.0,0.0,7.0,4.0,0.0,0.0,5.0,955.0
Cachar,14.14.a,Number of patients given AYUSH treatment,TOTAL,152.0,163.0,0.0,144.0,110.0,115.0,105.0,75.0,54.0,52.0,48.0,53.0,1071.0
Cachar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,164.0,154.0,111.0,122.0,223.0,182.0,238.0,187.0,126.0,157.0,184.0,189.0,2037.0
Cachar,14.14.c,Number of Adolescents counselled,TOTAL,48.0,79.0,90.0,78.0,77.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,372.0
Cachar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8560.0,12955.0,13013.0,8571.0,13322.0,8687.0,10122.0,12011.0,8510.0,11907.0,7698.0,12965.0,128321.0
Cachar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,113.0,397.0,144.0,107.0,820.0,149.0,114.0,503.0,127.0,446.0,214.0,332.0,3466.0
Cachar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,9.0,63.0,403.0,104.0,106.0,512.0,8.0,18.0,21.0,51.0,72.0,65.0,1432.0
Cachar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,1.0,16.0,3.0,3.0,23.0,0.0,0.0,0.0,2.0,1.0,1.0,50.0
Cachar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1.0,86.0,328.0,125.0,133.0,359.0,7.0,11.0,22.0,15.0,25.0,22.0,1134.0
Cachar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,5.0,1.0,1.0,13.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0
Cachar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,835.0,1285.0,1497.0,1146.0,1201.0,726.0,280.0,1013.0,272.0,591.0,606.0,705.0,10157.0
Cachar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,3.0,2.0,2.0,2.0,1.0,0.0,0.0,0.0,3.0,0.0,2.0,17.0
Cachar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,845.0,1434.0,2228.0,1375.0,1440.0,1597.0,295.0,1042.0,315.0,657.0,703.0,792.0,12723.0
Cachar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,5.0,23.0,6.0,6.0,37.0,0.0,0.0,0.0,5.0,1.0,3.0,88.0
Cachar,15.2,Number of Widal tests conducted,Number tested,70.0,60.0,332.0,99.0,137.0,330.0,54.0,65.0,49.0,38.0,58.0,71.0,1363.0
Cachar,15.3.a,Number of VDRL tests conducted on males,Number tested,10.0,25.0,178.0,8.0,10.0,319.0,3.0,8.0,3.0,4.0,3.0,168.0,739.0
Cachar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,36.0,468.0,210.0,1.0,0.0,234.0,3.0,22.0,3.0,1.0,20.0,207.0,1205.0
Cachar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,165.0,316.0,588.0,452.0,315.0,570.0,403.0,376.0,273.0,195.0,193.0,448.0,4294.0
Cachar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,211.0,809.0,976.0,461.0,325.0,1123.0,409.0,406.0,279.0,200.0,216.0,823.0,6238.0
Cachar,15.4.1,Number of blood smears examined for Malaria,TOTAL,8455.0,10630.0,14844.0,15631.0,11818.0,11800.0,9050.0,9238.0,8910.0,8172.0,7418.0,7549.0,123515.0
Cachar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,1.0,40.0,8.0,3.0,11.0,88.0,99.0,73.0,1.0,0.0,7.0,331.0
Cachar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,9.0,32.0,50.0,30.0,45.0,27.0,2.0,20.0,1.0,1.0,1.0,220.0
Cachar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,28000.0,7000.0,14500.0,20900.0,19400.0,22500.0,12500.0,18300.0,46200.0,50500.0,33900.0,19900.0,293600.0
Cachar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,25000.0,25000.0,20000.0,20000.0,0.0,35000.0,30000.0,25000.0,0.0,0.0,0.0,180000.0
Cachar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,21000.0,17500.0,18600.0,21500.0,16900.0,10000.0,29200.0,2100.0,20700.0,16600.0,14000.0,13400.0,201500.0
Cachar,16.1.1,Stock position of DPT vaccines,5. Total Stock,7000.0,14500.0,20900.0,19400.0,22500.0,12500.0,18300.0,46200.0,50500.0,33900.0,19900.0,6500.0,272100.0
Cachar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Cachar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Cachar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Cachar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,9240.0,0.0,0.0,18000.0,0.0,17500.0,2200.0,800.0,1400.0,20400.0,10400.0,2200.0,82140.0
Cachar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,52000.0,0.0,40000.0,0.0,20000.0,2000.0,20000.0,10000.0,4100.0,600.0,148700.0
Cachar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,9240.0,0.0,34000.0,18000.0,22500.0,15300.0,21400.0,1400.0,1000.0,20000.0,12300.0,2800.0,157940.0
Cachar,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,18000.0,0.0,17500.0,2200.0,800.0,1400.0,20400.0,10400.0,2200.0,0.0,72900.0
Cachar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,36450.0,16000.0,25500.0,15300.0,9800.0,19350.0,8850.0,5700.0,33600.0,12900.0,21300.0,10300.0,215050.0
Cachar,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,25000.0,8000.0,10000.0,20000.0,0.0,25000.0,30000.0,0.0,20000.0,0.0,0.0,138000.0
Cachar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,20450.0,15500.0,18200.0,15500.0,10450.0,10500.0,28150.0,2100.0,20700.0,11600.0,11000.0,7500.0,171650.0
Cachar,16.1.3,Stock position of TT vaccines,5. Total Stock,16000.0,25500.0,15300.0,9800.0,19350.0,8850.0,5700.0,33600.0,12900.0,21300.0,10300.0,2800.0,181400.0
Cachar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1200.0,0.0,2900.0,50.0,2250.0,11050.0,4150.0,300.0,33000.0,44900.0,28300.0,17200.0,145300.0
Cachar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,17000.0,0.0,17000.0,20000.0,0.0,0.0,33500.0,30000.0,0.0,0.0,0.0,117500.0
Cachar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1200.0,14100.0,2850.0,14800.0,11200.0,6900.0,3850.0,800.0,18100.0,16600.0,11100.0,9900.0,111400.0
Cachar,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,2900.0,50.0,2250.0,11050.0,4150.0,300.0,33000.0,44900.0,28300.0,17200.0,7300.0,151400.0
Cachar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,12425.0,2175.0,7925.0,10325.0,8075.0,4825.0,575.0,25.0,9775.0,15025.0,12925.0,4425.0,88500.0
Cachar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,15000.0,10000.0,5000.0,5000.0,0.0,5000.0,10000.0,15000.0,10000.0,0.0,0.0,75000.0
Cachar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,10250.0,9250.0,7600.0,7250.0,8250.0,4250.0,5550.0,250.0,9750.0,12100.0,8500.0,4150.0,87150.0
Cachar,16.1.6,Stock position of Measles vaccines,5. Total Stock,2175.0,7925.0,10325.0,8075.0,4825.0,575.0,25.0,9775.0,15025.0,12925.0,4425.0,275.0,76350.0
Cachar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,30000.0,0.0,8100.0,300.0,2300.0,0.0,0.0,2000.0,30800.0,42150.0,34050.0,21400.0,171100.0
Cachar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,17000.0,0.0,17000.0,0.0,0.0,25000.0,30000.0,32000.0,10000.0,0.0,0.0,131000.0
Cachar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,30000.0,8900.0,7800.0,15000.0,2300.0,0.0,23000.0,1200.0,20650.0,18100.0,12650.0,13200.0,152800.0
Cachar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,8100.0,300.0,2300.0,0.0,0.0,2000.0,30800.0,42150.0,34050.0,21400.0,8200.0,149300.0
Cachar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1690.0,1190.0,1590.0,1290.0,3140.0,2890.0,2840.0,2740.0,2740.0,2240.0,2240.0,1890.0,26480.0
Cachar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,400.0,0.0,2300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2700.0
Cachar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,350.0,,350.0
Cachar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,500.0,0.0,300.0,450.0,250.0,50.0,100.0,0.0,500.0,0.0,,0.0,2150.0
Cachar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1190.0,1590.0,1290.0,3140.0,2890.0,2840.0,2740.0,2740.0,2240.0,2240.0,1890.0,1890.0,26680.0
Cachar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,11820.0,0.0,0.0,0.0,10080.0,3580.0,80.0,3980.0,64460.0,4660.0,4660.0,0.0,103320.0
Cachar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,10080.0,0.0,0.0,45360.0,60480.0,0.0,0.0,0.0,0.0,115920.0
Cachar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,4660.0,,4660.0
Cachar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,11820.0,0.0,0.0,0.0,6500.0,3500.0,41460.0,0.0,59800.0,0.0,,0.0,123080.0
Cachar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,10080.0,3580.0,80.0,3980.0,64460.0,4660.0,4660.0,0.0,0.0,91500.0
Cachar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,316340.0,300740.0,300740.0,282740.0,296940.0,252540.0,232740.0,232740.0,232740.0,222740.0,222740.0,197340.0,3091080.0
Cachar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,25200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25200.0
Cachar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,25400.0,,25400.0
Cachar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,15600.0,0.0,18000.0,11000.0,44400.0,19800.0,0.0,0.0,10000.0,0.0,,11400.0,130200.0
Cachar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,300740.0,300740.0,282740.0,296940.0,252540.0,232740.0,232740.0,232740.0,222740.0,222740.0,197340.0,185940.0,2960680.0
Cachar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,400.0,0.0,0.0,0.0,12000.0,4200.0,600.0,600.0,600.0,600.0,0.0,0.0,19000.0
Cachar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,12000.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,12000.0
Cachar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Cachar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,400.0,0.0,0.0,0.0,7800.0,3600.0,0.0,0.0,0.0,600.0,,0.0,12400.0
Cachar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,12000.0,4200.0,600.0,600.0,600.0,600.0,0.0,0.0,0.0,18600.0
Cachar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,5200.0,4900.0,4600.0,4600.0,4200.0,3900.0,3900.0,3700.0,3700.0,3500.0,3500.0,3300.0,49000.0
Cachar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,200.0,,200.0
Cachar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,300.0,300.0,0.0,400.0,300.0,0.0,200.0,0.0,200.0,0.0,,300.0,2000.0
Cachar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4900.0,4600.0,4600.0,4200.0,3900.0,3900.0,3700.0,3700.0,3500.0,3500.0,3300.0,3000.0,46800.0
Cachar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,8000.0,8000.0
Cachar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8000.0,8000.0
Cachar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,900.0,550.0,1950.0,600.0,850.0,90.0,0.0,0.0,440.0,220.0,117.0,0.0,5717.0
Cachar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,2000.0,0.0,500.0,0.0,0.0,0.0,1440.0,1000.0,0.0,0.0,0.0,4940.0
Cachar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.3.02,Stock Position of Gloves,4. Stock Distributed,350.0,600.0,1350.0,250.0,760.0,90.0,0.0,1000.0,1220.0,103.0,117.0,0.0,5840.0
Cachar,16.3.02,Stock Position of Gloves,5. Total Stock,550.0,1950.0,600.0,850.0,90.0,0.0,0.0,440.0,220.0,117.0,0.0,0.0,4817.0
Cachar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Cachar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Cachar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Cachar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Cachar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Cachar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Cachar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Cachar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Cachar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Cachar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Cachar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Cachar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Cachar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Cachar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Cachar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Cachar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Cachar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Cachar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Cachar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Cachar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Cachar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Cachar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Cachar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,3000.0,0.0,18000.0,12600.0,32300.0,23200.0,7750.0,7050.0,6100.0,4800.0,3250.0,150.0,118200.0
Cachar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,18000.0,0.0,20000.0,5400.0,0.0,0.0,4450.0,5000.0,0.0,0.0,99600.0,152450.0
Cachar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,3000.0,0.0,5400.0,300.0,14500.0,15450.0,700.0,5400.0,6300.0,1550.0,3100.0,12000.0,67700.0
Cachar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,18000.0,12600.0,32300.0,23200.0,7750.0,7050.0,6100.0,4800.0,3250.0,150.0,87750.0,202950.0
Cachar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,3200.0,3100.0,100.0,0.0,13200.0,4300.0,4000.0,200.0,28100.0
Cachar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,13200.0,6600.0,0.0,0.0,13200.0,4000.0,4000.0,0.0,0.0,41000.0
Cachar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,10000.0,6700.0,3000.0,100.0,0.0,12900.0,4300.0,3800.0,200.0,41000.0
Cachar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,3200.0,3100.0,100.0,0.0,13200.0,4300.0,4000.0,200.0,0.0,28100.0
Cachar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,63600.0,19000.0,15800.0,34600.0,40800.0,47000.0,28400.0,5600.0,144800.0,124000.0,110000.0,69200.0,702800.0
Cachar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,48000.0,48000.0,36000.0,48000.0,0.0,24000.0,144000.0,24000.0,24000.0,0.0,0.0,396000.0
Cachar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,44600.0,51200.0,29200.0,29800.0,41800.0,18600.0,46800.0,4800.0,44800.0,38000.0,40800.0,49600.0,440000.0
Cachar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,19000.0,15800.0,34600.0,40800.0,47000.0,28400.0,5600.0,144800.0,124000.0,110000.0,69200.0,19600.0,658800.0
Cachar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,7550.0,2950.0,9950.0,11750.0,12650.0,10150.0,8250.0,10050.0,13650.0,13750.0,11750.0,9750.0,122200.0
Cachar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,10000.0,4000.0,4000.0,0.0,0.0,6000.0,4000.0,4000.0,0.0,0.0,0.0,32000.0
Cachar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Cachar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4600.0,3000.0,2200.0,3100.0,2500.0,1900.0,4200.0,400.0,3900.0,2000.0,2000.0,2600.0,32400.0
Cachar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2950.0,9950.0,11750.0,12650.0,10150.0,8250.0,10050.0,13650.0,13750.0,11750.0,9750.0,7150.0,121800.0
Cachar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,1.0,2.0,3.0,1.0,3.0,,1.0,4.0,,1.0,1.0,19.0
Cachar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,1.0,,,,,,,1.0
Cachar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Cachar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,1.0,,,,,,,1.0
Cachar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,1.0,1.0,5.0,5.0,3.0,2.0,2.0,2.0,3.0,1.0,3.0,30.0
Cachar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Cachar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,1.0,1.0,5.0,5.0,3.0,2.0,2.0,2.0,3.0,1.0,3.0,30.0
Cachar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,5.0,8.0,6.0,8.0,6.0,10.0,10.0,11.0,8.0,6.0,3.0,2.0,83.0
Cachar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Cachar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,5.0,8.0,6.0,9.0,6.0,10.0,10.0,11.0,8.0,6.0,3.0,2.0,84.0
Cachar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,12.0,6.0,10.0,8.0,15.0,17.0,9.0,14.0,9.0,11.0,10.0,124.0
Cachar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,1.0,1.0
Cachar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,12.0,6.0,10.0,8.0,15.0,17.0,9.0,14.0,9.0,11.0,11.0,125.0
Cachar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,,,1.0,2.0,2.0,2.0,1.0,2.0,3.0,2.0,16.0
Cachar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,,,1.0,,,,,,2.0
Cachar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,1.0,,,1.0,2.0,3.0,2.0,1.0,2.0,3.0,2.0,18.0
Cachar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,1.0,,,,,,1.0,1.0,1.0,1.0,5.0
Cachar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Cachar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,1.0,,,,,,1.0,2.0,1.0,1.0,6.0
Cachar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,,,3.0,,2.0,1.0,1.0,1.0,1.0,,10.0
Cachar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,,1.0,,,,,1.0,,,,,3.0
Cachar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,1.0,,3.0,,2.0,2.0,1.0,1.0,1.0,,13.0
Cachar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Cachar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Cachar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,1.0,,,,,,1.0
Cachar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,8.0,3.0,5.0,4.0,8.0,10.0,8.0,19.0,15.0,16.0,9.0,7.0,112.0
Cachar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,,3.0,2.0,,,1.0,1.0,1.0,1.0,,1.0,12.0
Cachar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,10.0,3.0,8.0,6.0,8.0,10.0,9.0,20.0,16.0,17.0,9.0,8.0,124.0
Cachar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Cachar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Cachar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Cachar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,,,,1.0,1.0,,1.0,,2.0,,,7.0
Cachar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,,,,,,,,1.0,,,2.0
Cachar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,3.0,,,,1.0,1.0,,1.0,,3.0,,,9.0
Cachar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,1.0,,,,,,,,1.0,,3.0
Cachar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,3.0,,2.0,,,,,,2.0,,,8.0
Cachar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,4.0,1.0,2.0,,,,,,2.0,1.0,,11.0
Cachar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Cachar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Cachar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,,,,,,,,,,,1.0
Cachar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,2.0,1.0,1.0,1.0,2.0,1.0,,2.0,,,2.0,13.0
Cachar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,,3.0,,1.0,5.0,2.0,2.0,1.0,1.0,4.0,20.0
Cachar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,3.0,1.0,4.0,1.0,3.0,6.0,2.0,4.0,1.0,1.0,6.0,33.0
Cachar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Cachar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Cachar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,,,,,,1.0,,,,,,2.0
Cachar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,3.0,1.0,2.0,5.0,1.0,4.0,2.0,2.0,3.0,1.0,3.0,30.0
Cachar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,11.0,5.0,3.0,3.0,3.0,8.0,2.0,3.0,10.0,10.0,9.0,70.0
Cachar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,6.0,14.0,6.0,5.0,8.0,4.0,12.0,4.0,5.0,13.0,11.0,12.0,100.0
Cachar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,1.0,2.0,1.0,3.0,1.0,,1.0,1.0,1.0,,12.0
Cachar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,3.0,,1.0,2.0,2.0,4.0,1.0,3.0,7.0,6.0,,29.0
Cachar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,3.0,1.0,3.0,3.0,5.0,5.0,1.0,4.0,8.0,7.0,,41.0
Cachar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Cachar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Cachar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Cachar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,2.0,,,1.0,,,,,,,3.0
Cachar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Cachar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,2.0,,,1.0,,,,,,,3.0
Cachar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,,3.0,,2.0,1.0,1.0,,8.0
Cachar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Cachar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,,3.0,,2.0,1.0,1.0,,8.0
Cachar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,,,,,,,1.0,,1.0,3.0
Cachar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Cachar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,,,,,,,1.0,,1.0,3.0
Cachar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,1.0,,,,,,1.0,,,2.0
Cachar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Cachar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,1.0,,,,,,1.0,,,2.0
Cachar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,2.0,2.0,2.0,1.0,5.0,3.0,5.0,4.0,3.0,5.0,33.0
Cachar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Cachar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,2.0,2.0,2.0,1.0,5.0,3.0,5.0,4.0,3.0,5.0,33.0
Cachar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Cachar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,2.0,2.0,,5.0,2.0,,3.0,,3.0,,1.0,19.0
Cachar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,1.0,1.0,,,1.0,,1.0,1.0,5.0
Cachar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,2.0,2.0,,6.0,3.0,,3.0,2.0,3.0,1.0,2.0,25.0
Cachar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,1.0,1.0,2.0,,,,,,1.0,1.0,,6.0
Cachar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,1.0,,1.0,,,2.0
Cachar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,1.0,2.0,,,,1.0,,2.0,1.0,,8.0
Cachar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Cachar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Cachar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Cachar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Cachar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,,1.0,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,10.0
Cachar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,5.0,1.0,2.0,1.0,1.0,5.0,1.0,,3.0,1.0,,23.0
Cachar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,5.0,5.0,2.0,2.0,1.0,2.0,6.0,2.0,1.0,4.0,2.0,1.0,33.0
Cachar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,,,1.0,,,,,,1.0,3.0
Cachar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,4.0,2.0,2.0,1.0,2.0,,1.0,4.0,,7.0,3.0,,26.0
Cachar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,8.0,11.0,6.0,7.0,4.0,1.0,7.0,9.0,4.0,19.0,10.0,4.0,90.0
Cachar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,13.0,13.0,8.0,8.0,6.0,2.0,8.0,13.0,4.0,26.0,13.0,5.0,119.0
Cachar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,2.0,4.0,1.0,,,2.0,1.0,,1.0,1.0,,13.0
Cachar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,14.0,18.0,17.0,18.0,13.0,12.0,18.0,14.0,20.0,27.0,14.0,18.0,203.0
Cachar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,35.0,60.0,35.0,26.0,32.0,28.0,33.0,33.0,45.0,81.0,51.0,39.0,498.0
Cachar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,50.0,80.0,56.0,45.0,45.0,40.0,53.0,48.0,65.0,109.0,66.0,57.0,714.0
Chirang,1.1,Total number of pregnant women Registered for ANC,TOTAL,1059.0,1095.0,1121.0,1013.0,1033.0,923.0,796.0,827.0,844.0,886.0,834.0,950.0,11381.0
Chirang,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,715.0,693.0,737.0,722.0,689.0,690.0,583.0,647.0,679.0,666.0,645.0,702.0,8168.0
Chirang,1.2,Number of Pregnant women registered under JSY,TOTAL,988.0,1058.0,1107.0,1013.0,1033.0,920.0,789.0,827.0,844.0,882.0,829.0,950.0,11240.0
Chirang,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,693.0,756.0,772.0,775.0,736.0,812.0,857.0,913.0,788.0,682.0,606.0,656.0,9046.0
Chirang,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,823.0,885.0,949.0,834.0,895.0,795.0,763.0,766.0,662.0,705.0,670.0,841.0,9588.0
Chirang,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,802.0,864.0,905.0,906.0,819.0,899.0,858.0,895.0,744.0,655.0,692.0,797.0,9836.0
Chirang,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,932.0,828.0,978.0,901.0,944.0,873.0,853.0,767.0,776.0,844.0,736.0,865.0,10297.0
Chirang,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,44.0,21.0,29.0,64.0,31.0,26.0,25.0,20.0,26.0,37.0,15.0,26.0,364.0
Chirang,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,2.0,3.0,1.0,0.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,16.0
Chirang,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,381.0,390.0,452.0,397.0,471.0,397.0,333.0,408.0,411.0,349.0,306.0,331.0,4626.0
Chirang,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,15.0,11.0,50.0,13.0,6.0,8.0,8.0,6.0,5.0,7.0,11.0,10.0,150.0
Chirang,1.8,Number of pregnancy test kits used at SC level,TOTAL,294.0,320.0,259.0,339.0,351.0,347.0,264.0,258.0,285.0,275.0,240.0,331.0,3563.0
Chirang,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,5.0,0.0,0.0,9.0,7.0,10.0,6.0,13.0,12.0,20.0,4.0,3.0,89.0
Chirang,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,147.0,145.0,153.0,156.0,188.0,149.0,194.0,183.0,160.0,224.0,176.0,148.0,2023.0
Chirang,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,152.0,145.0,153.0,165.0,195.0,159.0,200.0,196.0,172.0,244.0,180.0,151.0,2112.0
Chirang,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,36.0,68.0,71.0,66.0,84.0,72.0,85.0,138.0,107.0,140.0,108.0,97.0,1072.0
Chirang,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,438.0,394.0,384.0,451.0,493.0,478.0,553.0,496.0,555.0,523.0,455.0,491.0,5711.0
Chirang,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,430.0,387.0,378.0,84.0,39.0,79.0,71.0,58.0,267.0,286.0,219.0,310.0,2608.0
Chirang,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,437.0,392.0,382.0,450.0,493.0,478.0,543.0,496.0,555.0,523.0,455.0,491.0,5695.0
Chirang,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,275.0,238.0,219.0,341.0,318.0,369.0,315.0,413.0,375.0,405.0,352.0,377.0,3997.0
Chirang,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,0.0,,0.0,,,,,,,,,0.0
Chirang,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chirang,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chirang,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Chirang,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Chirang,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Chirang,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chirang,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Chirang,4.1.1.a,Number of male live births,TOTAL,309.0,294.0,274.0,320.0,363.0,357.0,397.0,358.0,365.0,397.0,332.0,335.0,4101.0
Chirang,4.1.1.b,Number of female live births,TOTAL,286.0,255.0,261.0,292.0,323.0,279.0,369.0,332.0,358.0,366.0,303.0,301.0,3725.0
Chirang,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,595.0,549.0,535.0,612.0,686.0,636.0,766.0,690.0,723.0,763.0,635.0,636.0,7826.0
Chirang,4.1.2,Number of still births,TOTAL,6.0,2.0,8.0,6.0,10.0,5.0,7.0,5.0,13.0,7.0,5.0,8.0,82.0
Chirang,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,26.0,18.0,55.0,10.0,39.0,20.0,17.0,27.0,15.0,11.0,17.0,18.0,273.0
Chirang,4.2.1,Number of Newborns weighed at birth,TOTAL,501.0,525.0,517.0,578.0,650.0,633.0,725.0,694.0,719.0,756.0,632.0,623.0,7553.0
Chirang,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,106.0,112.0,69.0,273.0,363.0,307.0,364.0,328.0,386.0,348.0,372.0,303.0,3331.0
Chirang,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,538.0,520.0,510.0,562.0,662.0,623.0,724.0,688.0,713.0,757.0,631.0,617.0,7545.0
Chirang,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,1.0,0.0,1.0,52.0,78.0,106.0,98.0,83.0,54.0,74.0,547.0
Chirang,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,4.0,6.0,24.0,8.0,3.0,16.0,44.0,67.0,62.0,33.0,40.0,42.0,349.0
Chirang,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chirang,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chirang,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,4.0,6.0,25.0,8.0,4.0,68.0,122.0,173.0,160.0,116.0,94.0,116.0,896.0
Chirang,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,16.0,14.0,19.0,23.0,19.0,52.0,77.0,15.0,36.0,27.0,31.0,29.0,358.0
Chirang,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,9.0,5.0,16.0,1.0,29.0,16.0,23.0,3.0,4.0,2.0,1.0,5.0,114.0
Chirang,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,13.0,24.0,22.0,27.0,15.0,32.0,59.0,15.0,73.0,105.0,74.0,53.0,512.0
Chirang,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,327.0,281.0,247.0,297.0,379.0,445.0,516.0,615.0,710.0,541.0,280.0,283.0,4921.0
Chirang,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,262.0,250.0,228.0,230.0,341.0,452.0,589.0,426.0,511.0,323.0,283.0,257.0,4152.0
Chirang,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,60.0,58.0,52.0,54.0,43.0,56.0,323.0
Chirang,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,23.0,39.0,44.0,23.0,27.0,12.0,19.0,20.0,17.0,11.0,13.0,18.0,266.0
Chirang,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,23.0,39.0,44.0,23.0,27.0,12.0,19.0,20.0,17.0,11.0,13.0,18.0,266.0
Chirang,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Chirang,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,4.0,0.0,5.0,0.0,2.0,1.0,3.0,3.0,1.0,2.0,0.0,0.0,21.0
Chirang,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,16.0,16.0,23.0,20.0,17.0,16.0,12.0,17.0,16.0,10.0,8.0,10.0,181.0
Chirang,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,20.0,16.0,28.0,20.0,19.0,17.0,15.0,20.0,17.0,12.0,8.0,10.0,202.0
Chirang,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,12.0,9.0,0.0,2.0,11.0,12.0,12.0,0.0,0.0,0.0,5.0,0.0,63.0
Chirang,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chirang,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chirang,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,31.0,27.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,58.0
Chirang,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,51.0,22.0,,,,,,,,,73.0
Chirang,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chirang,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,82.0,49.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,131.0
Chirang,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chirang,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chirang,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chirang,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chirang,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,145.0,67.0,51.0,229.0,69.0,72.0,53.0,45.0,23.0,36.0,46.0,37.0,873.0
Chirang,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,74.0,46.0,45.0,79.0,59.0,35.0,36.0,35.0,40.0,37.0,36.0,47.0,569.0
Chirang,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,9.0,2.0,9.0,9.0,0.0,3.0,0.0,0.0,2.0,1.0,9.0,2.0,46.0
Chirang,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,20.0,10.0,26.0,,10.0,,,,,,,,66.0
Chirang,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chirang,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,248.0,125.0,131.0,317.0,138.0,110.0,89.0,80.0,65.0,74.0,91.0,86.0,1554.0
Chirang,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chirang,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chirang,9.06,Number of IUCD removals,TOTAL,87.0,27.0,49.0,43.0,29.0,24.0,25.0,12.0,8.0,12.0,23.0,39.0,378.0
Chirang,9.07,Number of Oral Pills cycles distributed,TOTAL,1658.0,1590.0,1677.0,2833.0,2012.0,2066.0,1781.0,1796.0,1633.0,1794.0,1788.0,1624.0,22252.0
Chirang,9.08,Number of Condom pieces distributed,TOTAL,3067.0,2868.0,3170.0,4658.0,2512.0,3313.0,2722.0,2597.0,2725.0,3400.0,3242.0,3030.0,37304.0
Chirang,9.09,Number of Centchroman (weekly) pills given,TOTAL,4.0,0.0,0.0,0.0,30.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,37.0
Chirang,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,5.0,7.0,7.0,14.0,15.0,53.0
Chirang,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chirang,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,-1.0
Chirang,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,745.0,603.0,766.0,602.0,751.0,819.0,756.0,548.0,981.0,620.0,832.0,836.0,8859.0
Chirang,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,779.0,857.0,756.0,672.0,701.0,716.0,731.0,937.0,680.0,747.0,599.0,149.0,8324.0
Chirang,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,706.0,798.0,803.0,749.0,683.0,701.0,665.0,799.0,696.0,733.0,650.0,712.0,8695.0
Chirang,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,711.0,713.0,696.0,783.0,706.0,623.0,665.0,751.0,706.0,697.0,633.0,721.0,8405.0
Chirang,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,128.0,871.0,999.0
Chirang,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,81.0,81.0
Chirang,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,60.0,56.0,64.0,76.0,49.0,87.0,51.0,47.0,111.0,116.0,110.0,51.0,878.0
Chirang,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,726.0,612.0,697.0,696.0,566.0,725.0,540.0,843.0,618.0,703.0,602.0,567.0,7895.0
Chirang,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,659.0,535.0,738.0,735.0,529.0,715.0,503.0,712.0,640.0,675.0,647.0,658.0,7746.0
Chirang,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,663.0,481.0,614.0,746.0,547.0,634.0,525.0,690.0,659.0,674.0,626.0,668.0,7527.0
Chirang,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,39.0,8.0,22.0,10.0,9.0,3.0,1.0,9.0,33.0,66.0,56.0,12.0,268.0
Chirang,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,789.0,855.0,759.0,673.0,709.0,717.0,712.0,931.0,672.0,720.0,599.0,130.0,8266.0
Chirang,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,737.0,793.0,801.0,766.0,692.0,703.0,671.0,807.0,683.0,712.0,650.0,718.0,8733.0
Chirang,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,749.0,721.0,730.0,792.0,718.0,648.0,671.0,750.0,691.0,676.0,619.0,710.0,8475.0
Chirang,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,530.0,664.0,738.0,597.0,869.0,778.0,648.0,673.0,985.0,753.0,543.0,745.0,8523.0
Chirang,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,481.0,604.0,581.0,474.0,697.0,600.0,359.0,454.0,493.0,519.0,480.0,550.0,6292.0
Chirang,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Chirang,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,270.0,318.0,362.0,310.0,434.0,393.0,342.0,336.0,479.0,391.0,265.0,384.0,4284.0
Chirang,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,253.0,335.0,370.0,285.0,433.0,382.0,305.0,334.0,505.0,363.0,276.0,356.0,4197.0
Chirang,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,523.0,653.0,732.0,595.0,867.0,775.0,647.0,670.0,984.0,754.0,541.0,740.0,8481.0
Chirang,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,526.0,635.0,602.0,525.0,736.0,618.0,386.0,511.0,510.0,543.0,503.0,581.0,6676.0
Chirang,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,489.0,541.0,537.0,519.0,647.0,616.0,310.0,476.0,465.0,523.0,493.0,538.0,6154.0
Chirang,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,92.0,110.0,108.0,98.0,115.0,99.0,82.0,108.0,88.0,82.0,83.0,104.0,1169.0
Chirang,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,87.0,121.0,110.0,92.0,99.0,93.0,74.0,86.0,65.0,89.0,66.0,103.0,1085.0
Chirang,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,179.0,231.0,218.0,190.0,214.0,192.0,156.0,194.0,153.0,171.0,149.0,207.0,2254.0
Chirang,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,209.0,209.0,258.0,287.0,312.0,262.0,229.0,257.0,263.0,267.0,249.0,307.0,3109.0
Chirang,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,161.0,152.0,177.0,182.0,157.0,163.0,148.0,183.0,180.0,164.0,148.0,209.0,2024.0
Chirang,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,102.0,134.0,145.0,142.0,134.0,129.0,122.0,134.0,146.0,122.0,109.0,152.0,1571.0
Chirang,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chirang,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chirang,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,470.0,465.0,455.0,465.0,463.0,467.0,461.0,454.0,456.0,459.0,458.0,475.0,5548.0
Chirang,10.4.2,Number of Immunisation sessions held during the month,TOTAL,446.0,450.0,444.0,454.0,440.0,455.0,444.0,443.0,425.0,429.0,416.0,454.0,5300.0
Chirang,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,444.0,449.0,443.0,450.0,436.0,453.0,440.0,441.0,421.0,427.0,414.0,442.0,5260.0
Chirang,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,6.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Chirang,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,473.0,645.0,717.0,594.0,1199.0,741.0,638.0,630.0,937.0,689.0,560.0,736.0,8559.0
Chirang,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,31.0,66.0,81.0,154.0,990.0,114.0,60.0,92.0,79.0,83.0,205.0,94.0,2049.0
Chirang,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,118.0,132.0,143.0,191.0,968.0,184.0,149.0,141.0,135.0,149.0,242.0,195.0,2747.0
Chirang,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,7.0,5.0,1.0,0.0,12.0,0.0,0.0,0.0,1.0,0.0,0.0,28.0
Chirang,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,276.0,341.0,386.0,377.0,228.0,249.0,181.0,147.0,124.0,126.0,173.0,172.0,2780.0
Chirang,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,147.0,149.0,12.0,33.0,18.0,28.0,5.0,4.0,9.0,0.0,5.0,7.0,417.0
Chirang,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,336.0,382.0,389.0,217.0,266.0,177.0,200.0,179.0,214.0,94.0,128.0,161.0,2743.0
Chirang,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,3.0,1.0,0.0,5.0
Chirang,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,1.0,0.0,4.0
Chirang,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,1.0,,,,1.0,,1.0,-1.0
Chirang,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,8.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,5.0,5.0,4.0,5.0,-1.0
Chirang,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,382.0,411.0,414.0,421.0,414.0,419.0,397.0,405.0,392.0,393.0,389.0,401.0,-1.0
Chirang,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,3.0,3.0,2.0,4.0,2.0,3.0,3.0,3.0,3.0,2.0,-1.0
Chirang,14.05,Number of RKS meetings held during the month,TOTAL,8.0,8.0,9.0,11.0,10.0,11.0,9.0,10.0,11.0,11.0,10.0,12.0,120.0
Chirang,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,11.0,10.0,10.0,11.0,12.0,12.0,9.0,11.0,12.0,13.0,9.0,10.0,-1.0
Chirang,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,276.0,272.0,380.0,199.0,295.0,272.0,220.0,185.0,148.0,195.0,182.0,217.0,2841.0
Chirang,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,1.0,,,,,,,-1.0
Chirang,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Chirang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1.0,6.0,3.0,3.0,2.0,2.0,3.0,3.0,3.0,2.0,2.0,5.0,35.0
Chirang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,29.0,13.0,26.0,32.0,26.0,22.0,17.0,15.0,22.0,15.0,11.0,18.0,246.0
Chirang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,2.0,4.0,2.0,1.0,3.0,1.0,1.0,2.0,1.0,1.0,12.0,1.0,31.0
Chirang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,92.0,84.0,69.0,86.0,95.0,99.0,86.0,73.0,94.0,87.0,68.0,78.0,1011.0
Chirang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,3.0,10.0,5.0,4.0,5.0,3.0,4.0,5.0,4.0,3.0,14.0,6.0,66.0
Chirang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,121.0,97.0,95.0,118.0,121.0,121.0,103.0,88.0,116.0,102.0,79.0,96.0,1257.0
Chirang,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,12.0
Chirang,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Chirang,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,16.0
Chirang,14.11,In-Patient Head Count at midnight,TOTAL,0.0,23.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0
Chirang,14.12.1,OPD attendance (All),TOTAL,28163.0,23484.0,30632.0,42085.0,34736.0,34420.0,31184.0,25809.0,28065.0,35962.0,30741.0,35669.0,380950.0
Chirang,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,1.0,1.0,1.0,1.0,1.0,369.0,1.0,1.0,1.0,1.0,0.0,378.0
Chirang,14.14.a,Number of patients given AYUSH treatment,TOTAL,529.0,942.0,1076.0,828.0,1328.0,1194.0,705.0,679.0,879.0,668.0,817.0,737.0,10382.0
Chirang,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,14.14.c,Number of Adolescents counselled,TOTAL,315.0,210.0,240.0,182.0,256.0,287.0,263.0,106.0,178.0,178.0,0.0,0.0,2215.0
Chirang,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1081.0,1218.0,1139.0,1197.0,1034.0,1036.0,783.0,930.0,881.0,611.0,660.0,772.0,11342.0
Chirang,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,39.0,190.0,67.0,63.0,64.0,41.0,15.0,21.0,15.0,30.0,12.0,17.0,574.0
Chirang,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Chirang,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Chirang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,13.0,0.0,0.0,0.0,0.0,21.0,0.0,0.0,0.0,0.0,0.0,0.0,34.0
Chirang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,13.0,0.0,0.0,0.0,0.0,32.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0
Chirang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,15.2,Number of Widal tests conducted,Number tested,211.0,256.0,194.0,405.0,275.0,222.0,181.0,195.0,109.0,138.0,170.0,465.0,2821.0
Chirang,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0
Chirang,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,7.0,21.0,28.0,17.0,13.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,91.0
Chirang,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,7.0,21.0,28.0,17.0,27.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,105.0
Chirang,15.4.1,Number of blood smears examined for Malaria,TOTAL,3140.0,3326.0,3799.0,5622.0,3382.0,3041.0,2376.0,2399.0,1739.0,1168.0,1577.0,2599.0,34168.0
Chirang,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,22.0,13.0,31.0,20.0,10.0,9.0,18.0,5.0,7.0,1.0,4.0,15.0,155.0
Chirang,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,45.0,62.0,77.0,77.0,50.0,40.0,60.0,45.0,19.0,6.0,18.0,39.0,538.0
Chirang,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,37945.0,30245.0,35625.0,33425.0,29425.0,,20325.0,17825.0,645.0,645.0,645.0,645.0,207395.0
Chirang,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,10000.0,,,,,,0.0,,,,,10000.0
Chirang,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,700.0,,,9000.0,,,,,9700.0
Chirang,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,7700.0,4620.0,2200.0,4000.0,4900.0,,2500.0,8180.0,,,,,34100.0
Chirang,16.1.1,Stock position of DPT vaccines,5. Total Stock,30245.0,35625.0,33425.0,29425.0,23825.0,0.0,17825.0,645.0,645.0,645.0,645.0,645.0,173595.0
Chirang,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,0.0,0.0,,,0.0
Chirang,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Chirang,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Chirang,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,5400.0,400.0,,12000.0,0.0,,,4000.0,0.0,0.0,,,21800.0
Chirang,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,18000.0,,8000.0,,4000.0,1000.0,,,,,31000.0
Chirang,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,5000.0,400.0,6000.0,12000.0,3000.0,,,5000.0,0.0,,,,31400.0
Chirang,16.1.2,Stock position of OPV vaccines,5. Total Stock,400.0,0.0,12000.0,0.0,5000.0,0.0,4000.0,0.0,0.0,0.0,0.0,0.0,21400.0
Chirang,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,7660.0,1960.0,10360.0,8160.0,6160.0,,10360.0,,60.0,60.0,60.0,60.0,44900.0
Chirang,16.1.3,Stock position of TT vaccines,2. Stocks Received,,10000.0,,,,,,,,,,,10000.0
Chirang,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.1.3,Stock position of TT vaccines,4. Stock Distributed,5700.0,1600.0,2200.0,2000.0,2000.0,,2000.0,,,,,,15500.0
Chirang,16.1.3,Stock position of TT vaccines,5. Total Stock,1960.0,10360.0,8160.0,6160.0,4160.0,0.0,8360.0,0.0,60.0,60.0,60.0,60.0,39400.0
Chirang,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,8360.0,0.0,0.0,0.0,,8360.0
Chirang,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Chirang,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,8300.0,,,,,8300.0
Chirang,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60.0,0.0,0.0,0.0,0.0,60.0
Chirang,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2350.0,300.0,1300.0,2350.0,2500.0,,600.0,,2090.0,2090.0,2090.0,2090.0,17760.0
Chirang,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,5500.0,3000.0,5000.0,3000.0,,,,,,,,16500.0
Chirang,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2050.0,4500.0,1950.0,4850.0,2450.0,,,,,,,,15800.0
Chirang,16.1.5,Stock position of BCG vaccines,5. Total Stock,300.0,1300.0,2350.0,2500.0,3050.0,0.0,600.0,0.0,2090.0,2090.0,2090.0,2090.0,18460.0
Chirang,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,9775.0,7425.0,10375.0,9275.0,8525.0,,,0.0,1250.0,1250.0,1250.0,1250.0,50375.0
Chirang,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,5000.0,,,,,,3500.0,,,,,8500.0
Chirang,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2350.0,2050.0,1100.0,750.0,1425.0,,,1410.0,,,,,9085.0
Chirang,16.1.6,Stock position of Measles vaccines,5. Total Stock,7425.0,10375.0,9275.0,8525.0,7100.0,0.0,0.0,2090.0,1250.0,1250.0,1250.0,1250.0,49790.0
Chirang,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,0.0,0.0,0.0,,0.0
Chirang,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Chirang,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chirang,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,12500.0,4800.0,5700.0,3500.0,7200.0,,15480.0,14300.0,5120.0,5120.0,5120.0,5120.0,83960.0
Chirang,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,5500.0,,6000.0,5100.0,,,,,,,,16600.0
Chirang,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,7700.0,4600.0,2200.0,2300.0,3500.0,,1180.0,9180.0,0.0,,,,30660.0
Chirang,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,4800.0,5700.0,3500.0,7200.0,8800.0,0.0,14300.0,5120.0,5120.0,5120.0,5120.0,5120.0,69900.0
Chirang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,0.0,0.0,,,0.0
Chirang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,600.0,,,,,,,,,600.0
Chirang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,600.0,,,,,,,,,600.0
Chirang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,540.0,540.0,540.0,540.0,540.0,540.0,540.0,540.0,4320.0
Chirang,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,5040.0,,,,,,,,,5040.0
Chirang,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,4500.0,,,,,,,,,4500.0
Chirang,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,540.0,540.0,540.0,540.0,540.0,540.0,540.0,540.0,540.0,4860.0
Chirang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,0.0,,,,0.0
Chirang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,27800.0,,,,,,,,,27800.0
Chirang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,27800.0,,,,,,,,,27800.0
Chirang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,0.0,,,,0.0
Chirang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,10500.0,,,,,,,,,10500.0
Chirang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,10500.0,,,,,,,,,10500.0
Chirang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,0.0,,,,0.0
Chirang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,1000.0,,,,,,,,,1000.0
Chirang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,1000.0,,,,,,,,,1000.0
Chirang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,0.0,,,,0.0
Chirang,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,8000.0,8000.0
Chirang,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Chirang,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8000.0,8000.0
Chirang,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,20100.0,18500.0,14100.0,9600.0,5300.0,4200.0,,200.0,1350.0,100.0,,,73450.0
Chirang,16.3.02,Stock Position of Gloves,2. Stocks Received,3000.0,,,,,,3800.0,2200.0,,,,2000.0,11000.0
Chirang,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Chirang,16.3.02,Stock Position of Gloves,4. Stock Distributed,4600.0,4400.0,4500.0,4300.0,1100.0,4200.0,3600.0,1050.0,1250.0,,,200.0,29200.0
Chirang,16.3.02,Stock Position of Gloves,5. Total Stock,18500.0,14100.0,9600.0,5300.0,4200.0,0.0,200.0,1350.0,100.0,100.0,0.0,1800.0,55250.0
Chirang,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,0.0,,,,0.0
Chirang,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Chirang,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Chirang,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,600.0,,,,0.0,,,0.0,600.0
Chirang,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,1500.0,,,,,,,,3000.0,4500.0
Chirang,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,900.0,600.0,,,,,,,600.0,2100.0
Chirang,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2400.0,3000.0
Chirang,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,0.0,,,,0.0
Chirang,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,3000.0,,,,,,,,,3000.0
Chirang,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,3000.0,,,,,,,,,3000.0
Chirang,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,0.0,,,,0.0
Chirang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Chirang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Chirang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chirang,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chirang,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,3486000.0,,,,,,,,,,,304500.0,3790500.0
Chirang,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,3486000.0,,,,,,,,,,,,3486000.0
Chirang,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,304500.0,304500.0
Chirang,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,5500.0,1000.0,6500.0
Chirang,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,13000.0,13000.0
Chirang,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,4500.0,,4500.0
Chirang,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,14000.0,15000.0
Chirang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,100.0,,,,,,,460.0,3300.0,3860.0
Chirang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,1000.0,,,,,,,,4000.0,29780.0,34780.0
Chirang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Chirang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,900.0,,,,,,,,1160.0,3950.0,6010.0
Chirang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,100.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,3300.0,29130.0,32630.0
Chirang,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,100.0,,100.0,0.0,,,,200.0
Chirang,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,100.0,,,,,,,,100.0
Chirang,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,100.0,,,,,100.0
Chirang,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,100.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0
Chirang,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,4500.0,2700.0,1800.0,3000.0,600.0,,0.0,11900.0,0.0,0.0,,24500.0
Chirang,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,10200.0,4800.0,,13000.0,,2300.0,,18000.0,,2000.0,,198000.0,248300.0
Chirang,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Chirang,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,5700.0,6600.0,900.0,11800.0,2400.0,2900.0,,6100.0,11900.0,2000.0,,85200.0,135500.0
Chirang,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,4500.0,2700.0,1800.0,3000.0,600.0,0.0,0.0,11900.0,0.0,0.0,0.0,112800.0,137300.0
Chirang,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4100.0,2100.0,,1800.0,900.0,,1400.0,800.0,2590.0,2590.0,2590.0,2590.0,21460.0
Chirang,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,3000.0,3300.0,3000.0,,,3300.0,,,,,12600.0
Chirang,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2000.0,2100.0,1200.0,4200.0,1300.0,,600.0,1510.0,,,,,12910.0
Chirang,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2100.0,0.0,1800.0,900.0,2600.0,0.0,800.0,2590.0,2590.0,2590.0,2590.0,2590.0,21150.0
Chirang,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,24900.0,16250.0,21400.0,42800.0,57400.0,,49800.0,69000.0,80400.0,80400.0,80400.0,80400.0,603150.0
Chirang,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,12000.0,24000.0,24000.0,,,24000.0,24000.0,,,,,108000.0
Chirang,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,8650.0,6850.0,2600.0,9400.0,3300.0,,4800.0,12600.0,,,,,48200.0
Chirang,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,16250.0,21400.0,42800.0,57400.0,54100.0,0.0,69000.0,80400.0,80400.0,80400.0,80400.0,80400.0,662950.0
Chirang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,200.0,,100.0,2100.0,3600.0,,650.0,4550.0,3850.0,3850.0,3850.0,3850.0,26600.0
Chirang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,2000.0,2000.0,2000.0,,,4000.0,2000.0,,,,,12000.0
Chirang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Chirang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,200.0,1900.0,,500.0,2100.0,,100.0,2700.0,,,,,7500.0
Chirang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,100.0,2100.0,3600.0,1500.0,0.0,4550.0,3850.0,3850.0,3850.0,3850.0,3850.0,31100.0
Chirang,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,1.0,,,,,,,,,,1.0
Chirang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Chirang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chirang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Chirang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,1.0,,,,,,,1.0
Chirang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chirang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,1.0,,,,,,,1.0
Chirang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,1.0,,1.0,,1.0,,,1.0,1.0,1.0,,7.0
Chirang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chirang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,1.0,,1.0,,1.0,,,1.0,1.0,1.0,,7.0
Chirang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,1.0,1.0,1.0,,,1.0,1.0,,1.0,,8.0
Chirang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chirang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,1.0,1.0,1.0,1.0,,,1.0,1.0,,1.0,,8.0
Chirang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,1.0,,1.0,,,,2.0
Chirang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Chirang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,1.0,,2.0,,,,3.0
Chirang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chirang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chirang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Chirang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,2.0,,1.0,,2.0,1.0,5.0,3.0,,,,,14.0
Chirang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chirang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,2.0,,1.0,,2.0,1.0,5.0,3.0,,,,,14.0
Chirang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chirang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chirang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Chirang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,2.0,1.0,1.0,2.0,6.0,3.0,4.0,3.0,5.0,3.0,2.0,34.0
Chirang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,,2.0,,,,,,,,,3.0
Chirang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,2.0,1.0,3.0,2.0,6.0,3.0,4.0,3.0,5.0,3.0,2.0,37.0
Chirang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Chirang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Chirang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Chirang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Chirang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Chirang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,1.0,,,,,,,,1.0
Chirang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Chirang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Chirang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,1.0,,,,,,,,,1.0
Chirang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Chirang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Chirang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Chirang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,1.0,2.0,,,,,,,3.0
Chirang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Chirang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Chirang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,,,2.0,2.0,,,,,,,5.0
Chirang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Chirang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Chirang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Chirang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Chirang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,2.0,,,,,,,2.0
Chirang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,1.0,,,,,,,1.0,2.0
Chirang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,1.0,3.0,,,,,,1.0,5.0
Chirang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,2.0,,1.0,,1.0,,,,,,,5.0
Chirang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,1.0,1.0,,,,,,,,3.0
Chirang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,3.0,,2.0,1.0,1.0,,,,,,,8.0
Chirang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Chirang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Chirang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Chirang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Chirang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Chirang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Chirang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Chirang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Chirang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Chirang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Chirang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Chirang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,,,,,,,,,1.0
Chirang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Chirang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Chirang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Chirang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,,3.0,1.0,1.0,1.0,1.0,1.0,,,,10.0
Chirang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Chirang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,,3.0,1.0,1.0,1.0,1.0,1.0,,,,10.0
Chirang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,1.0,,,1.0,,,,,,,,2.0
Chirang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Chirang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,1.0,,,1.0,,,,,,,,2.0
Chirang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,2.0,,1.0,,1.0,,,1.0,,,,5.0
Chirang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Chirang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,2.0,,1.0,,1.0,,,1.0,,,,5.0
Chirang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,1.0,,1.0,,,,,,,2.0
Chirang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Chirang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,,1.0,,,,,,,2.0
Chirang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Chirang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,2.0,1.0,,1.0,,,,,,,,4.0
Chirang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,2.0,1.0,,1.0,,,,,,,,4.0
Chirang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Chirang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,3.0,2.0,2.0,,,,,,,,8.0
Chirang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,4.0,5.0,5.0,7.0,,1.0,,,,,,23.0
Chirang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,5.0,8.0,7.0,9.0,,1.0,,,,,,31.0
Chirang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,2.0,,,,1.0,,,,3.0
Chirang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,5.0,2.0,2.0,6.0,1.0,6.0,,,4.0,1.0,,,27.0
Chirang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,5.0,4.0,7.0,4.0,2.0,1.0,1.0,,,,,1.0,25.0
Chirang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,10.0,6.0,9.0,10.0,5.0,7.0,1.0,,5.0,1.0,,1.0,55.0
Darrang,1.1,Total number of pregnant women Registered for ANC,TOTAL,2157.0,2187.0,1903.0,1746.0,1941.0,2150.0,1736.0,1841.0,1496.0,1684.0,1740.0,1812.0,22393.0
Darrang,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1460.0,1397.0,1267.0,1182.0,1286.0,1316.0,1119.0,1167.0,1049.0,1144.0,1150.0,1226.0,14763.0
Darrang,1.2,Number of Pregnant women registered under JSY,TOTAL,1869.0,1646.0,1212.0,1130.0,1274.0,1285.0,1118.0,1185.0,988.0,1089.0,1208.0,1100.0,15104.0
Darrang,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1563.0,1675.0,1715.0,1673.0,1799.0,1903.0,1978.0,1907.0,1669.0,1687.0,1460.0,1671.0,20700.0
Darrang,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1733.0,1937.0,1675.0,1581.0,1715.0,1823.0,1648.0,1644.0,1202.0,1534.0,1432.0,1606.0,19530.0
Darrang,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1570.0,1835.0,1833.0,1619.0,1712.0,1822.0,1857.0,1711.0,1474.0,1474.0,1405.0,1504.0,19816.0
Darrang,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1546.0,1613.0,1520.0,1443.0,1482.0,1648.0,1498.0,1555.0,1208.0,1343.0,1197.0,1256.0,17309.0
Darrang,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,55.0,55.0,42.0,62.0,27.0,23.0,23.0,118.0,105.0,119.0,79.0,84.0,792.0
Darrang,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,76.0,72.0,70.0,51.0,64.0,336.0
Darrang,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1179.0,1149.0,1095.0,1145.0,1060.0,1191.0,1034.0,996.0,942.0,890.0,930.0,1004.0,12615.0
Darrang,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,2.0,0.0,165.0,343.0,129.0,34.0,52.0,169.0,104.0,106.0,125.0,1229.0
Darrang,1.8,Number of pregnancy test kits used at SC level,TOTAL,418.0,453.0,382.0,400.0,496.0,472.0,401.0,439.0,481.0,340.0,411.0,327.0,5020.0
Darrang,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,8.0,5.0,6.0,18.0,24.0,42.0,47.0,24.0,33.0,32.0,41.0,31.0,311.0
Darrang,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,186.0,188.0,203.0,210.0,197.0,306.0,245.0,258.0,283.0,236.0,279.0,249.0,2840.0
Darrang,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,194.0,193.0,209.0,228.0,221.0,348.0,292.0,282.0,316.0,268.0,320.0,280.0,3151.0
Darrang,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,119.0,109.0,98.0,133.0,120.0,157.0,145.0,132.0,158.0,127.0,133.0,154.0,1585.0
Darrang,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,28.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28.0
Darrang,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1127.0,1146.0,1025.0,1193.0,1287.0,1425.0,1382.0,1480.0,1426.0,1329.0,1135.0,1161.0,15116.0
Darrang,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,449.0,359.0,280.0,340.0,386.0,354.0,368.0,349.0,335.0,303.0,199.0,465.0,4187.0
Darrang,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1005.0,1079.0,516.0,608.0,1814.0,769.0,814.0,801.0,713.0,41.0,37.0,541.0,8738.0
Darrang,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,624.0,252.0,176.0,228.0,239.0,1968.0,474.0,467.0,474.0,249.0,93.0,2164.0,7408.0
Darrang,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Darrang,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,51.0,40.0,52.0,59.0,61.0,62.0,85.0,73.0,48.0,69.0,62.0,68.0,730.0
Darrang,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Darrang,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Darrang,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Darrang,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Darrang,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,4.0,5.0,9.0,7.0,14.0,16.0,15.0,18.0,21.0,9.0,9.0,13.0,140.0
Darrang,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,16.0,17.0,19.0,31.0,30.0,22.0,27.0,25.0,32.0,21.0,35.0,25.0,300.0
Darrang,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darrang,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,20.0,22.0,28.0,38.0,44.0,38.0,42.0,43.0,53.0,30.0,44.0,38.0,440.0
Darrang,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,37.0,30.0,33.0,35.0,42.0,43.0,61.0,44.0,35.0,45.0,45.0,43.0,493.0
Darrang,4.1.1.a,Number of male live births,TOTAL,752.0,726.0,686.0,764.0,806.0,957.0,863.0,949.0,912.0,866.0,787.0,756.0,9824.0
Darrang,4.1.1.b,Number of female live births,TOTAL,609.0,634.0,578.0,689.0,747.0,847.0,882.0,861.0,844.0,777.0,704.0,722.0,8894.0
Darrang,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1361.0,1360.0,1264.0,1453.0,1553.0,1804.0,1745.0,1810.0,1756.0,1643.0,1491.0,1478.0,18718.0
Darrang,4.1.2,Number of still births,TOTAL,21.0,25.0,29.0,39.0,39.0,40.0,33.0,37.0,48.0,33.0,31.0,30.0,405.0
Darrang,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,777.0,356.0,538.0,617.0,373.0,363.0,495.0,638.0,416.0,435.0,638.0,749.0,6395.0
Darrang,4.2.1,Number of Newborns weighed at birth,TOTAL,1311.0,1292.0,1207.0,1379.0,1492.0,1715.0,1684.0,1739.0,1642.0,1581.0,1413.0,1427.0,17882.0
Darrang,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,329.0,346.0,195.0,195.0,261.0,217.0,218.0,246.0,367.0,238.0,243.0,208.0,3063.0
Darrang,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1343.0,1275.0,1235.0,1404.0,1483.0,1779.0,1638.0,1766.0,1645.0,1427.0,1383.0,1429.0,17807.0
Darrang,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,2.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0,2.0,0.0,2.0,11.0
Darrang,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,5.0,4.0,4.0,5.0,2.0,2.0,10.0,11.0,6.0,4.0,4.0,20.0,77.0
Darrang,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,21.0,180.0,33.0,51.0,73.0,48.0,47.0,47.0,48.0,44.0,58.0,46.0,696.0
Darrang,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darrang,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,27.0,186.0,37.0,56.0,75.0,50.0,58.0,59.0,56.0,50.0,62.0,68.0,784.0
Darrang,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Darrang,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,172.0,392.0,310.0,312.0,366.0,251.0,405.0,912.0,1023.0,989.0,914.0,913.0,6959.0
Darrang,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,14.0,141.0,20.0,31.0,30.0,22.0,14.0,94.0,81.0,83.0,62.0,29.0,621.0
Darrang,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,227.0,267.0,172.0,168.0,142.0,246.0,322.0,873.0,939.0,830.0,737.0,786.0,5709.0
Darrang,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,11.0,23.0,0.0,21.0,32.0,39.0,36.0,40.0,55.0,33.0,25.0,17.0,332.0
Darrang,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1053.0,1004.0,1023.0,1097.0,1106.0,1296.0,1337.0,1476.0,1298.0,1182.0,1089.0,1191.0,14152.0
Darrang,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,989.0,998.0,924.0,997.0,973.0,1177.0,1137.0,1418.0,1208.0,1200.0,1057.0,1005.0,13083.0
Darrang,6.3,PNC maternal complications attended,TOTAL,1.0,0.0,10.0,5.0,3.0,1.0,1.0,5.0,1.0,1.0,22.0,0.0,50.0
Darrang,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,511.0,378.0,263.0,273.0,200.0,293.0,332.0,302.0,251.0,373.0,481.0,590.0,4247.0
Darrang,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,90.0,99.0,58.0,99.0,47.0,28.0,22.0,131.0,38.0,16.0,16.0,131.0,775.0
Darrang,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,601.0,477.0,321.0,372.0,247.0,321.0,354.0,433.0,289.0,389.0,497.0,721.0,5022.0
Darrang,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,70.0,22.0,26.0,126.0,119.0,53.0,103.0,26.0,23.0,33.0,59.0,67.0,727.0
Darrang,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,170.0,204.0,171.0,244.0,228.0,126.0,134.0,99.0,77.0,214.0,263.0,250.0,2180.0
Darrang,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,240.0,226.0,197.0,370.0,347.0,179.0,237.0,125.0,100.0,247.0,322.0,317.0,2907.0
Darrang,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Darrang,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,10.0,0.0,0.0,9.0,0.0,6.0,0.0,2.0,27.0
Darrang,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,1.0,0.0,2.0,5.0,0.0,0.0,3.0,3.0,1.0,0.0,15.0
Darrang,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,3.0,7.0
Darrang,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darrang,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,1.0,12.0,5.0,0.0,11.0,3.0,10.0,1.0,5.0,49.0
Darrang,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Darrang,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,30.0,30.0,34.0,0.0,195.0,60.0,132.0,105.0,49.0,0.0,68.0,124.0,827.0
Darrang,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,32.0,9.0,20.0,11.0,31.0,106.0,0.0,74.0,4.0,48.0,0.0,0.0,335.0
Darrang,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,35.0,42.0,4.0,2.0,10.0,56.0,51.0,45.0,120.0,69.0,67.0,30.0,531.0
Darrang,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darrang,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,97.0,81.0,58.0,13.0,236.0,222.0,183.0,224.0,173.0,117.0,135.0,154.0,1693.0
Darrang,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Darrang,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Darrang,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darrang,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Darrang,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Darrang,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,1.0,1.0,1.0,2.0,1.0,1.0,4.0,1.0,3.0,0.0,1.0,1.0,17.0
Darrang,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1.0,3.0,1.0,5.0,5.0,0.0,7.0,7.0,7.0,5.0,4.0,7.0,52.0
Darrang,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darrang,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,4.0,2.0,7.0,6.0,1.0,11.0,8.0,10.0,5.0,5.0,8.0,69.0
Darrang,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Darrang,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,179.0,148.0,133.0,220.0,478.0,259.0,160.0,244.0,364.0,164.0,260.0,164.0,2773.0
Darrang,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,40.0,60.0,44.0,38.0,83.0,28.0,35.0,79.0,18.0,111.0,12.0,61.0,609.0
Darrang,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,15.0,27.0,25.0,39.0,25.0,56.0,44.0,48.0,43.0,31.0,70.0,46.0,469.0
Darrang,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,158.0,110.0,84.0,163.0,102.0,46.0,49.0,69.0,71.0,47.0,47.0,21.0,967.0
Darrang,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darrang,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,392.0,345.0,286.0,460.0,688.0,389.0,288.0,440.0,496.0,353.0,389.0,292.0,4818.0
Darrang,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,147.0,114.0,92.0,176.0,101.0,43.0,49.0,60.0,68.0,43.0,67.0,30.0,990.0
Darrang,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Darrang,9.06,Number of IUCD removals,TOTAL,42.0,20.0,18.0,32.0,31.0,32.0,93.0,51.0,88.0,18.0,30.0,24.0,479.0
Darrang,9.07,Number of Oral Pills cycles distributed,TOTAL,3854.0,3852.0,4017.0,4303.0,4264.0,3806.0,4001.0,3763.0,3636.0,3559.0,3412.0,3280.0,45747.0
Darrang,9.08,Number of Condom pieces distributed,TOTAL,13998.0,13960.0,12106.0,13358.0,13546.0,13818.0,11418.0,10416.0,9690.0,8518.0,6851.0,6927.0,134606.0
Darrang,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,36.0,0.0,1.0,10.0,0.0,7.0,40.0,0.0,0.0,0.0,94.0
Darrang,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,50.0,38.0,26.0,29.0,51.0,11.0,12.0,9.0,32.0,25.0,19.0,38.0,340.0
Darrang,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,2.0,0.0,0.0,5.0
Darrang,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,4.0
Darrang,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Darrang,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1698.0,1100.0,1252.0,1653.0,1805.0,2123.0,2084.0,2020.0,1534.0,1731.0,1643.0,1554.0,20197.0
Darrang,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1688.0,1648.0,1516.0,1395.0,1367.0,1638.0,1733.0,1906.0,1414.0,1595.0,940.0,93.0,16933.0
Darrang,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1613.0,1699.0,1575.0,1481.0,1368.0,1468.0,1577.0,1719.0,1475.0,1632.0,1571.0,1277.0,18455.0
Darrang,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1505.0,1681.0,1619.0,1591.0,1466.0,1428.0,1557.0,1646.0,1321.0,1560.0,1543.0,1696.0,18613.0
Darrang,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,713.0,1589.0,2302.0
Darrang,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,454.0,454.0
Darrang,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,851.0,595.0,746.0,817.0,908.0,993.0,932.0,1078.0,444.0,277.0,765.0,888.0,9294.0
Darrang,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1684.0,1648.0,1506.0,1357.0,1371.0,1639.0,1200.0,1724.0,457.0,1377.0,1706.0,1615.0,17284.0
Darrang,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1634.0,1700.0,1570.0,1437.0,1380.0,1473.0,1088.0,1506.0,521.0,1200.0,1702.0,1742.0,16953.0
Darrang,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1524.0,1686.0,1616.0,1547.0,1445.0,1450.0,1050.0,1424.0,458.0,1140.0,1563.0,1883.0,16786.0
Darrang,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,787.0,643.0,674.0,827.0,903.0,944.0,892.0,1064.0,861.0,817.0,831.0,823.0,10066.0
Darrang,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1699.0,1609.0,1501.0,1393.0,1347.0,1638.0,1692.0,1899.0,1386.0,1590.0,926.0,196.0,16876.0
Darrang,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1594.0,1652.0,1566.0,1474.0,1385.0,1472.0,1540.0,1706.0,1476.0,1619.0,1548.0,1301.0,18333.0
Darrang,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1517.0,1619.0,1630.0,1600.0,1439.0,1446.0,1527.0,1619.0,1292.0,1563.0,1518.0,1714.0,18484.0
Darrang,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1301.0,1581.0,1560.0,1577.0,1676.0,1830.0,1838.0,980.0,1709.0,1656.0,1747.0,1695.0,19150.0
Darrang,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1129.0,1161.0,1130.0,1141.0,1175.0,2459.0,3368.0,1028.0,1152.0,1117.0,1136.0,1297.0,17293.0
Darrang,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,1029.0,1472.0,826.0,1084.0,1431.0,1122.0,1518.0,1578.0,1385.0,1468.0,12913.0
Darrang,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,706.0,827.0,811.0,842.0,844.0,961.0,951.0,500.0,910.0,845.0,925.0,871.0,9993.0
Darrang,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,603.0,747.0,744.0,714.0,792.0,867.0,877.0,463.0,782.0,787.0,840.0,796.0,9012.0
Darrang,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1309.0,1574.0,1555.0,1556.0,1636.0,1828.0,1828.0,963.0,1692.0,1632.0,1765.0,1667.0,19005.0
Darrang,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1147.0,1203.0,1181.0,1199.0,1238.0,2150.0,2333.0,1507.0,1131.0,1137.0,1154.0,1300.0,16680.0
Darrang,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1147.0,1199.0,1150.0,1154.0,1233.0,2150.0,1736.0,1350.0,512.0,833.0,1194.0,1320.0,14978.0
Darrang,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,65.0,32.0,22.0,32.0,27.0,22.0,85.0,46.0,34.0,41.0,57.0,54.0,517.0
Darrang,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,53.0,30.0,21.0,24.0,30.0,21.0,72.0,33.0,29.0,32.0,60.0,41.0,446.0
Darrang,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,118.0,62.0,43.0,56.0,57.0,43.0,157.0,79.0,63.0,73.0,117.0,95.0,963.0
Darrang,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,534.0,571.0,543.0,580.0,682.0,873.0,880.0,775.0,578.0,623.0,612.0,664.0,7915.0
Darrang,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,535.0,512.0,537.0,605.0,533.0,613.0,691.0,655.0,556.0,565.0,584.0,611.0,6997.0
Darrang,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,442.0,518.0,512.0,536.0,496.0,568.0,567.0,630.0,536.0,461.0,487.0,537.0,6290.0
Darrang,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,5.0,2.0,10.0,2.0,6.0,3.0,3.0,3.0,0.0,4.0,2.0,2.0,42.0
Darrang,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,96.0,90.0,102.0,85.0,95.0,108.0,103.0,118.0,93.0,81.0,91.0,80.0,1142.0
Darrang,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,931.0,938.0,932.0,927.0,922.0,954.0,951.0,940.0,898.0,903.0,895.0,935.0,11126.0
Darrang,10.4.2,Number of Immunisation sessions held during the month,TOTAL,901.0,909.0,889.0,894.0,853.0,936.0,992.0,931.0,834.0,873.0,868.0,889.0,10769.0
Darrang,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,851.0,858.0,852.0,844.0,807.0,861.0,941.0,892.0,782.0,824.0,815.0,841.0,10168.0
Darrang,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,4.0,4.0,174.0,145.0,32.0,3.0,0.0,8.0,24.0,8.0,88.0,342.0,832.0
Darrang,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1287.0,1523.0,1490.0,1480.0,1614.0,1771.0,1661.0,937.0,1581.0,1484.0,1360.0,1262.0,17450.0
Darrang,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,465.0,498.0,506.0,435.0,863.0,825.0,598.0,504.0,375.0,409.0,536.0,478.0,6492.0
Darrang,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,546.0,616.0,502.0,520.0,771.0,814.0,719.0,687.0,461.0,515.0,535.0,518.0,7204.0
Darrang,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Darrang,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,8.0,6.0,25.0,29.0,10.0,3.0,2.0,2.0,1.0,4.0,7.0,10.0,107.0
Darrang,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,667.0,885.0,827.0,720.0,891.0,850.0,719.0,505.0,429.0,381.0,577.0,497.0,7948.0
Darrang,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,76.0,17.0,200.0,59.0,120.0,160.0,223.0,71.0,215.0,148.0,189.0,101.0,1579.0
Darrang,13.1,Number of Patients operated for cataract,TOTAL,8.0,2.0,0.0,30.0,44.0,34.0,28.0,87.0,98.0,77.0,46.0,60.0,514.0
Darrang,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,8.0,2.0,0.0,30.0,44.0,34.0,28.0,89.0,98.0,77.0,0.0,60.0,470.0
Darrang,13.3,Number of School children detected with Refractive errors,TOTAL,70.0,38.0,6.0,17.0,22.0,6.0,2025.0,37.0,5.0,0.0,82.0,51.0,2359.0
Darrang,13.4,Number of children provided free glasses,TOTAL,0.0,4.0,25.0,0.0,46.0,6.0,1799.0,0.0,103.0,4.0,82.0,47.0,2116.0
Darrang,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Darrang,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,11.0,8.0,7.0,7.0,7.0,8.0,7.0,9.0,8.0,7.0,8.0,9.0,-1.0
Darrang,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,721.0,713.0,707.0,708.0,697.0,703.0,735.0,722.0,706.0,711.0,682.0,703.0,-1.0
Darrang,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,3.0,2.0,3.0,3.0,4.0,5.0,4.0,4.0,4.0,4.0,4.0,-1.0
Darrang,14.05,Number of RKS meetings held during the month,TOTAL,13.0,14.0,15.0,14.0,14.0,14.0,14.0,12.0,10.0,12.0,12.0,14.0,158.0
Darrang,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,16.0,15.0,15.0,16.0,14.0,17.0,17.0,18.0,17.0,16.0,18.0,16.0,-1.0
Darrang,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,116.0,97.0,84.0,76.0,72.0,54.0,73.0,74.0,79.0,84.0,75.0,42.0,926.0
Darrang,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Darrang,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,-1.0
Darrang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,238.0,262.0,463.0,403.0,311.0,202.0,341.0,201.0,128.0,167.0,234.0,380.0,3330.0
Darrang,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,904.0,957.0,1066.0,1245.0,1010.0,998.0,920.0,651.0,510.0,852.0,893.0,811.0,10817.0
Darrang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,162.0,177.0,242.0,238.0,458.0,136.0,138.0,134.0,113.0,116.0,194.0,262.0,2370.0
Darrang,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2053.0,1989.0,2156.0,2156.0,1938.0,1941.0,1689.0,1549.0,1630.0,1684.0,1627.0,1655.0,22067.0
Darrang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,400.0,439.0,705.0,641.0,769.0,338.0,479.0,335.0,241.0,283.0,428.0,642.0,5700.0
Darrang,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2957.0,2946.0,3222.0,3401.0,2948.0,2939.0,2609.0,2200.0,2140.0,2536.0,2520.0,2466.0,32884.0
Darrang,14.10.2.a,Number of death cases of Inpatient males,TOTAL,17.0,7.0,10.0,15.0,9.0,14.0,13.0,18.0,12.0,19.0,11.0,10.0,155.0
Darrang,14.10.2.b,Number of death cases of Inpatient females,TOTAL,12.0,9.0,14.0,6.0,9.0,8.0,17.0,10.0,19.0,15.0,13.0,10.0,142.0
Darrang,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,29.0,16.0,24.0,21.0,18.0,22.0,30.0,28.0,31.0,34.0,24.0,20.0,297.0
Darrang,14.11,In-Patient Head Count at midnight,TOTAL,2539.0,2328.0,2350.0,2207.0,2280.0,2316.0,2568.0,2422.0,1918.0,2135.0,2090.0,2224.0,27377.0
Darrang,14.12.1,OPD attendance (All),TOTAL,66609.0,66725.0,78072.0,73321.0,70214.0,66188.0,46508.0,55101.0,46180.0,41382.0,46264.0,59691.0,716255.0
Darrang,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,17.0,9.0,14.0,38.0,44.0,42.0,41.0,30.0,21.0,40.0,55.0,14.0,365.0
Darrang,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,4.0
Darrang,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,30.0,40.0,40.0,60.0,32.0,42.0,31.0,38.0,31.0,31.0,29.0,22.0,426.0
Darrang,14.14.a,Number of patients given AYUSH treatment,TOTAL,1845.0,2384.0,2136.0,2294.0,1152.0,1486.0,1467.0,1731.0,1360.0,1350.0,1318.0,1944.0,20467.0
Darrang,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,713.0,210.0,262.0,186.0,430.0,356.0,346.0,152.0,245.0,272.0,272.0,328.0,3772.0
Darrang,14.14.c,Number of Adolescents counselled,TOTAL,0.0,327.0,20.0,120.0,107.0,75.0,112.0,82.0,108.0,78.0,72.0,116.0,1217.0
Darrang,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2829.0,2770.0,3106.0,2947.0,3101.0,2955.0,2811.0,2942.0,2798.0,2640.0,2627.0,2764.0,34290.0
Darrang,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,206.0,226.0,209.0,223.0,227.0,191.0,182.0,226.0,304.0,168.0,209.0,107.0,2478.0
Darrang,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,67.0,71.0,76.0,48.0,63.0,50.0,9.0,50.0,28.0,57.0,55.0,31.0,605.0
Darrang,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,1.0,6.0
Darrang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,135.0,195.0,158.0,124.0,154.0,92.0,1.0,50.0,106.0,179.0,172.0,231.0,1597.0
Darrang,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,4.0
Darrang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,529.0,563.0,530.0,460.0,364.0,517.0,532.0,479.0,526.0,502.0,587.0,411.0,6000.0
Darrang,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Darrang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,731.0,829.0,764.0,632.0,581.0,659.0,542.0,579.0,660.0,738.0,814.0,673.0,8202.0
Darrang,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,2.0,2.0,2.0,0.0,0.0,1.0,0.0,3.0,1.0,1.0,12.0
Darrang,15.2,Number of Widal tests conducted,Number tested,131.0,152.0,285.0,299.0,331.0,212.0,177.0,155.0,85.0,59.0,71.0,146.0,2103.0
Darrang,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,3.0,0.0,201.0,206.0
Darrang,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,214.0,214.0
Darrang,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,11.0,8.0,335.0,575.0,13.0,11.0,25.0,13.0,9.0,3.0,3.0,356.0,1362.0
Darrang,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,11.0,8.0,335.0,575.0,13.0,11.0,26.0,14.0,9.0,6.0,3.0,771.0,1782.0
Darrang,15.4.1,Number of blood smears examined for Malaria,TOTAL,1849.0,2082.0,3864.0,3725.0,4550.0,5076.0,3010.0,1763.0,2067.0,1474.0,1971.0,2130.0,33561.0
Darrang,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,2.0,0.0,0.0,0.0,2.0,2.0,0.0,1.0,0.0,25.0,123.0,156.0
Darrang,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,1.0,1.0,0.0,0.0,1.0,2.0,4.0,1.0,0.0,0.0,1.0,11.0
Darrang,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,33990.0,22490.0,22990.0,34900.0,25900.0,13900.0,12900.0,18400.0,13900.0,14280.0,6280.0,5910.0,225840.0
Darrang,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,10000.0,20000.0,0.0,0.0,10000.0,10000.0,5000.0,10000.0,0.0,12270.0,5000.0,82270.0
Darrang,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,11500.0,9500.0,8000.0,9000.0,12000.0,11000.0,4500.0,9500.0,9620.0,8000.0,12640.0,6000.0,111260.0
Darrang,16.1.1,Stock position of DPT vaccines,5. Total Stock,22490.0,22990.0,34990.0,25900.0,13900.0,12900.0,18400.0,13900.0,14280.0,6280.0,5910.0,4910.0,196850.0
Darrang,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,0.0,5200.0,5200.0
Darrang,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,15000.0,0.0,15000.0
Darrang,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,9800.0,3500.0,13300.0
Darrang,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5200.0,1700.0,6900.0
Darrang,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,3000.0,0.0,1000.0,29500.0,12500.0,500.0,1000.0,8000.0,0.0,0.0,0.0,7000.0,62500.0
Darrang,16.1.2,Stock position of OPV vaccines,2. Stocks Received,4000.0,12500.0,40000.0,0.0,0.0,16000.0,8000.0,2000.0,0.0,0.0,19800.0,16000.0,118300.0
Darrang,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,7000.0,11500.0,11500.0,17000.0,12000.0,15500.0,1000.0,10000.0,0.0,0.0,12800.0,7500.0,105800.0
Darrang,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,1000.0,29500.0,12500.0,500.0,1000.0,8000.0,0.0,0.0,0.0,7000.0,15500.0,75000.0
Darrang,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,39130.0,28580.0,30770.0,45610.0,38750.0,30490.0,21390.0,25490.0,30390.0,21680.0,24130.0,18120.0,354530.0
Darrang,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,12400.0,20000.0,2400.0,3200.0,3200.0,10000.0,29000.0,0.0,10000.0,0.0,0.0,90200.0
Darrang,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.1.3,Stock position of TT vaccines,4. Stock Distributed,10550.0,10210.0,5160.0,9260.0,11460.0,12300.0,5900.0,24100.0,8710.0,7550.0,6010.0,5090.0,116300.0
Darrang,16.1.3,Stock position of TT vaccines,5. Total Stock,28580.0,30770.0,45610.0,38750.0,30490.0,21390.0,25490.0,30390.0,21680.0,24130.0,18120.0,13030.0,328430.0
Darrang,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,35040.0
Darrang,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Darrang,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Darrang,16.1.4,Stock position of DT vaccines,5. Total Stock,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,2920.0,35040.0
Darrang,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,15970.0,9970.0,18470.0,13470.0,17970.0,12970.0,13970.0,7970.0,11970.0,14970.0,7970.0,17470.0,163140.0
Darrang,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,10000.0,0.0,10000.0,0.0,8000.0,0.0,7000.0,6500.0,0.0,13000.0,0.0,54500.0
Darrang,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6000.0,1500.0,5000.0,5500.0,5000.0,7000.0,6000.0,3000.0,3500.0,7000.0,3500.0,6500.0,59500.0
Darrang,16.1.5,Stock position of BCG vaccines,5. Total Stock,9970.0,18470.0,13470.0,17970.0,12970.0,13970.0,7970.0,11970.0,14970.0,7970.0,17470.0,10970.0,158140.0
Darrang,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,28625.0,24875.0,25375.0,30875.0,27375.0,12125.0,11160.0,11160.0,11760.0,11660.0,17910.0,19160.0,232060.0
Darrang,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,5000.0,10000.0,0.0,0.0,0.0,0.0,5000.0,5000.0,10000.0,5000.0,2000.0,42000.0
Darrang,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3750.0,4500.0,4500.0,3500.0,15250.0,965.0,0.0,4400.0,5100.0,3750.0,3750.0,3500.0,52965.0
Darrang,16.1.6,Stock position of Measles vaccines,5. Total Stock,24875.0,25375.0,30875.0,27375.0,12125.0,11160.0,11160.0,11760.0,11660.0,17910.0,19160.0,17660.0,221095.0
Darrang,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,5000.0,0.0,700.0,0.0,1250.0,5000.0,6600.0,1100.0,3500.0,5400.0,28550.0
Darrang,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,5000.0,0.0,20000.0,10000.0,7500.0,5000.0,5000.0,0.0,5000.0,5000.0,5000.0,67500.0
Darrang,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,5000.0,19300.0,10700.0,6250.0,1250.0,3400.0,5500.0,2600.0,3100.0,3000.0,60100.0
Darrang,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,5000.0,0.0,700.0,0.0,1250.0,5000.0,6600.0,1100.0,3500.0,5400.0,7400.0,35950.0
Darrang,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,20500.0,8000.0,8380.0,380.0,2380.0,3880.0,5000.0,10000.0,12500.0,12310.0,7810.0,6000.0,97140.0
Darrang,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,10000.0,0.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,0.0,5000.0,500.0,75500.0
Darrang,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,12500.0,9620.0,8000.0,8000.0,8500.0,8880.0,5000.0,7500.0,10190.0,4500.0,6810.0,6500.0,96000.0
Darrang,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,8000.0,8380.0,380.0,2380.0,3880.0,5000.0,10000.0,12500.0,12310.0,7810.0,6000.0,0.0,76640.0
Darrang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1100.0,600.0,1150.0,550.0,550.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3950.0
Darrang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,3000.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0
Darrang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,500.0,2450.0,600.0,3000.0,550.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7100.0
Darrang,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,600.0,1150.0,550.0,550.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2850.0
Darrang,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,9000.0,9000.0,9000.0,9000.0,9000.0,21000.0,15000.0,15000.0,15000.0,15000.0,15000.0,9000.0,150000.0
Darrang,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,15120.0,12000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,27120.0
Darrang,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,15120.0,0.0,6000.0,0.0,0.0,0.0,0.0,6000.0,0.0,27120.0
Darrang,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,9000.0,9000.0,9000.0,9000.0,21000.0,15000.0,15000.0,15000.0,15000.0,15000.0,9000.0,9000.0,150000.0
Darrang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
Darrang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,19800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19800.0
Darrang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,18800.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19800.0
Darrang,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
Darrang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,1500.0,900.0,0.0,0.0,0.0,0.0,2400.0
Darrang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,9000.0,0.0,1500.0,0.0,0.0,0.0,0.0,0.0,0.0,10500.0
Darrang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,9000.0,0.0,0.0,600.0,900.0,0.0,0.0,0.0,0.0,10500.0
Darrang,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,1500.0,900.0,0.0,0.0,0.0,0.0,0.0,2400.0
Darrang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,300.0,300.0,300.0,300.0,1100.0,600.0,600.0,500.0,500.0,500.0,500.0,400.0,5900.0
Darrang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0
Darrang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,2200.0,500.0,0.0,100.0,0.0,0.0,0.0,100.0,0.0,2900.0
Darrang,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,300.0,300.0,300.0,1100.0,600.0,600.0,500.0,500.0,500.0,500.0,400.0,400.0,6000.0
Darrang,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,3312.0,3012.0,2352.0,1632.0,1272.0,1792.0,872.0,1872.0,3168.0,2296.0,1216.0,4540.0,27336.0
Darrang,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,0.0,0.0,0.0,1320.0,1680.0,2400.0,3600.0,0.0,0.0,4620.0,13320.0,26940.0
Darrang,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,300.0,660.0,720.0,360.0,800.0,2600.0,1400.0,2304.0,872.0,1080.0,1296.0,982.0,13374.0
Darrang,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,3012.0,2352.0,1632.0,1272.0,1792.0,872.0,1872.0,3168.0,2296.0,1216.0,4540.0,16878.0,40902.0
Darrang,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,6864.0,6514.0,4544.0,4274.0,1934.0,1984.0,3004.0,2284.0,3456.0,2422.0,1342.0,5380.0,44002.0
Darrang,16.3.02,Stock Position of Gloves,2. Stocks Received,,1000.0,1720.0,1000.0,1320.0,3680.0,2400.0,7000.0,0.0,0.0,5390.0,2140.0,25650.0
Darrang,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.3.02,Stock Position of Gloves,4. Stock Distributed,350.0,2970.0,1990.0,3340.0,1270.0,2660.0,3120.0,5828.0,1034.0,1080.0,1352.0,876.0,25870.0
Darrang,16.3.02,Stock Position of Gloves,5. Total Stock,6514.0,4544.0,4274.0,1934.0,1984.0,3004.0,2284.0,3456.0,2422.0,1342.0,5380.0,6644.0,43782.0
Darrang,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Darrang,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Darrang,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Darrang,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Darrang,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Darrang,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Darrang,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Darrang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Darrang,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darrang,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1934500.0,1874500.0,1974500.0,1833000.0,1717000.0,1281500.0,221000.0,200000.0,45500.0,40000.0,0.0,0.0,11121500.0
Darrang,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,110000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,420000.0,530000.0
Darrang,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,60000.0,10000.0,141500.0,116000.0,435500.0,1060500.0,21000.0,154500.0,5500.0,40000.0,,60000.0,2104500.0
Darrang,16.3.07,Stock Position of IFA Tablets,5. Total Stock,1874500.0,1974500.0,1833000.0,1717000.0,1281500.0,221000.0,200000.0,45500.0,40000.0,0.0,0.0,360000.0,9547000.0
Darrang,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,12000.0,12000.0,11300.0,10700.0,8800.0,6800.0,6500.0,5700.0,5700.0,5000.0,7950.0,6650.0,99100.0
Darrang,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3650.0,0.0,0.0,3650.0
Darrang,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,700.0,600.0,1900.0,2000.0,300.0,800.0,0.0,700.0,700.0,1300.0,1500.0,10500.0
Darrang,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,12000.0,11300.0,10700.0,8800.0,6800.0,6500.0,5700.0,5700.0,5000.0,7950.0,6650.0,5150.0,92250.0
Darrang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,9000.0,0.0,0.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,3200.0,24200.0
Darrang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,10500.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,2000.0,11680.0,26180.0
Darrang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,1500.0,9000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,800.0,3500.0,14800.0
Darrang,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,9000.0,0.0,0.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,3200.0,11380.0,35580.0
Darrang,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,100.0,30.0,0.0,0.0,0.0,0.0,0.0,130.0
Darrang,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Darrang,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,,0.0,0.0,0.0,70.0,30.0,0.0,0.0,0.0,0.0,0.0,100.0
Darrang,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,100.0,30.0,0.0,0.0,0.0,0.0,0.0,0.0,130.0
Darrang,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,18000.0,13800.0,30900.0,16400.0,14600.0,7800.0,1600.0,0.0,12400.0,8700.0,1350.0,93900.0,219450.0
Darrang,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,22500.0,0.0,13000.0,5200.0,0.0,0.0,35000.0,0.0,0.0,99600.0,0.0,175300.0
Darrang,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,4200.0,5400.0,14500.0,14800.0,12000.0,6200.0,1600.0,22600.0,3700.0,7350.0,7050.0,50500.0,149900.0
Darrang,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,13800.0,30900.0,16400.0,14600.0,7800.0,1600.0,0.0,12400.0,8700.0,1350.0,93900.0,43400.0,244850.0
Darrang,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1400.0,0.0,530.0,0.0,3000.0,3000.0,2810.0,1910.0,3410.0,3200.0,3100.0,600.0,22960.0
Darrang,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,500.0,880.0,0.0,6600.0,3300.0,3310.0,0.0,3300.0,3300.0,2000.0,0.0,0.0,23190.0
Darrang,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1900.0,350.0,530.0,3600.0,3300.0,3500.0,900.0,1800.0,3510.0,2100.0,2500.0,600.0,24590.0
Darrang,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,530.0,0.0,3000.0,3000.0,2810.0,1910.0,3410.0,3200.0,3100.0,600.0,0.0,21560.0
Darrang,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,37000.0,15400.0,29400.0,25800.0,39600.0,55000.0,89600.0,113000.0,79400.0,88000.0,63000.0,45200.0,680400.0
Darrang,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,24000.0,24000.0,48000.0,60000.0,48000.0,24000.0,0.0,24000.0,0.0,0.0,0.0,252000.0
Darrang,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,21600.0,10000.0,27600.0,34200.0,44600.0,13400.0,600.0,33600.0,15400.0,25000.0,17800.0,14400.0,258200.0
Darrang,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,15400.0,29400.0,25800.0,39600.0,55000.0,89600.0,113000.0,79400.0,88000.0,63000.0,45200.0,30800.0,674200.0
Darrang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,12012.0,10112.0,12902.0,13232.0,12272.0,11852.0,8922.0,14352.0,15608.0,12186.0,10716.0,45520.0,179686.0
Darrang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4780.0,4000.0,2000.0,8000.0,4220.0,8200.0,7400.0,0.0,2000.0,46620.0,57497.0,144717.0
Darrang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Darrang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1900.0,1990.0,3670.0,2960.0,8420.0,7150.0,2770.0,6144.0,3422.0,3470.0,11816.0,21707.0,75419.0
Darrang,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,10112.0,12902.0,13232.0,12272.0,11852.0,8922.0,14352.0,15608.0,12186.0,10716.0,45520.0,81310.0,248984.0
Darrang,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,,,,,,1.0,1.0,2.0,,,,6.0
Darrang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,1.0,,,,,,,,1.0,3.0
Darrang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Darrang,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,1.0,,,,,,,,1.0,3.0
Darrang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,2.0,1.0,,,,,,,3.0
Darrang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Darrang,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,2.0,1.0,,,,,,,3.0
Darrang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,1.0,,1.0,,3.0,2.0,1.0,3.0,2.0,2.0,15.0
Darrang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,,,1.0
Darrang,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,1.0,,1.0,1.0,3.0,2.0,1.0,3.0,2.0,2.0,16.0
Darrang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,8.0,3.0,1.0,2.0,2.0,2.0,2.0,4.0,4.0,2.0,1.0,31.0
Darrang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Darrang,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,8.0,3.0,1.0,2.0,2.0,2.0,2.0,4.0,4.0,2.0,1.0,31.0
Darrang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,2.0,1.0,,1.0,,,,1.0,1.0,2.0,3.0,11.0
Darrang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,,,,,,,,,1.0
Darrang,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,2.0,1.0,,1.0,,,,1.0,1.0,2.0,3.0,12.0
Darrang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Darrang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Darrang,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,1.0,1.0
Darrang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,,,,1.0,,1.0,,,,,3.0
Darrang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,,,1.0,,1.0,1.0,,,,4.0
Darrang,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,2.0,,,,2.0,,2.0,1.0,,,,7.0
Darrang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Darrang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Darrang,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Darrang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,2.0,,1.0,4.0,1.0,6.0,7.0,2.0,,,1.0,24.0
Darrang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,1.0,1.0,2.0,2.0,,,,,1.0,,8.0
Darrang,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,3.0,1.0,2.0,6.0,3.0,6.0,7.0,2.0,,1.0,1.0,32.0
Darrang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Darrang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Darrang,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,1.0,,,,,,,,1.0
Darrang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,1.0,3.0,2.0,1.0,1.0,,,,1.0,1.0,12.0
Darrang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,1.0,,,,,1.0,,2.0
Darrang,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,1.0,1.0,3.0,2.0,2.0,1.0,,,,2.0,1.0,14.0
Darrang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,1.0,,,,2.0,,1.0,,4.0
Darrang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,1.0,2.0,2.0,1.0,2.0,3.0,3.0,1.0,1.0,2.0,3.0,22.0
Darrang,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,1.0,2.0,2.0,2.0,2.0,3.0,3.0,3.0,1.0,3.0,3.0,26.0
Darrang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Darrang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Darrang,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Darrang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,4.0,,,,,,,,4.0
Darrang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,,2.0,1.0,,2.0,,1.0,,,7.0
Darrang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,6.0,1.0,4.0,5.0,2.0,2.0,1.0,1.0,1.0,,,24.0
Darrang,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,6.0,2.0,4.0,11.0,3.0,2.0,3.0,1.0,2.0,,,35.0
Darrang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,1.0,1.0,,,2.0
Darrang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Darrang,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,1.0,1.0,,,2.0
Darrang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,6.0,3.0,2.0,2.0,3.0,1.0,3.0,6.0,2.0,3.0,5.0,2.0,38.0
Darrang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,8.0,7.0,7.0,12.0,5.0,4.0,9.0,7.0,7.0,4.0,4.0,6.0,80.0
Darrang,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,14.0,10.0,9.0,14.0,8.0,5.0,12.0,13.0,9.0,7.0,9.0,8.0,118.0
Darrang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,1.0,,,,,1.0,,,2.0
Darrang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,1.0,1.0,1.0,1.0,3.0,4.0,,1.0,1.0,,1.0,15.0
Darrang,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,1.0,1.0,1.0,2.0,3.0,4.0,,1.0,2.0,,1.0,17.0
Darrang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Darrang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Darrang,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Darrang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Darrang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Darrang,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Darrang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,1.0,,1.0,,,,2.0
Darrang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Darrang,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,1.0,,1.0,,,,2.0
Darrang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,,,1.0,,,,,,,2.0
Darrang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Darrang,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,,,1.0,,,,,,,2.0
Darrang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Darrang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Darrang,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Darrang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,1.0,,,,1.0,,,2.0
Darrang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Darrang,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,1.0,,,,1.0,,,2.0
Darrang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,1.0,1.0,,1.0,,,,1.0,,6.0
Darrang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,3.0,6.0,4.0,4.0,4.0,4.0,2.0,,3.0,2.0,5.0,37.0
Darrang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,,,1.0,,1.0,1.0,2.0,2.0,,,8.0
Darrang,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,4.0,7.0,5.0,6.0,4.0,6.0,3.0,2.0,5.0,3.0,5.0,51.0
Darrang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,2.0,,,,,,,,,,,,2.0
Darrang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,4.0,4.0,4.0,3.0,3.0,4.0,1.0,,1.0,1.0,2.0,28.0
Darrang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,1.0,1.0,1.0,1.0,,,,1.0,1.0,7.0
Darrang,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,3.0,4.0,5.0,5.0,4.0,4.0,5.0,1.0,,1.0,2.0,3.0,37.0
Darrang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Darrang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,1.0,,,,,,,,,,2.0
Darrang,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,1.0,,,,,,,,,,2.0
Darrang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Darrang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,3.0,2.0,4.0,4.0,2.0,3.0,3.0,,3.0,2.0,4.0,32.0
Darrang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,4.0,5.0,14.0,8.0,7.0,5.0,10.0,4.0,3.0,9.0,8.0,10.0,87.0
Darrang,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,6.0,8.0,16.0,12.0,11.0,7.0,13.0,7.0,3.0,12.0,10.0,14.0,119.0
Darrang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Darrang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,5.0,4.0,2.0,3.0,5.0,4.0,5.0,3.0,3.0,,35.0
Darrang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,11.0,10.0,11.0,15.0,16.0,14.0,13.0,12.0,14.0,18.0,6.0,13.0,153.0
Darrang,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,11.0,11.0,16.0,19.0,19.0,17.0,18.0,16.0,19.0,21.0,9.0,13.0,189.0
Darrang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Darrang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,4.0,5.0,3.0,4.0,6.0,3.0,7.0,2.0,9.0,5.0,3.0,6.0,57.0
Darrang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,10.0,20.0,22.0,23.0,19.0,21.0,24.0,31.0,24.0,21.0,31.0,15.0,261.0
Darrang,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,14.0,25.0,25.0,27.0,25.0,24.0,31.0,33.0,33.0,26.0,35.0,21.0,319.0
Dhemaji,1.1,Total number of pregnant women Registered for ANC,TOTAL,1313.0,1550.0,1435.0,1437.0,1378.0,1331.0,986.0,1092.0,1014.0,1366.0,1308.0,1515.0,15725.0
Dhemaji,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1062.0,1240.0,1138.0,1151.0,1122.0,1059.0,790.0,888.0,870.0,1104.0,1063.0,1303.0,12790.0
Dhemaji,1.2,Number of Pregnant women registered under JSY,TOTAL,1313.0,1547.0,1435.0,1437.0,1378.0,1322.0,982.0,1092.0,1004.0,1357.0,1308.0,1515.0,15690.0
Dhemaji,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,910.0,1114.0,1235.0,1328.0,1192.0,1289.0,1272.0,1319.0,1232.0,1145.0,1015.0,1028.0,14079.0
Dhemaji,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,845.0,1287.0,1341.0,1097.0,1282.0,1210.0,985.0,1004.0,780.0,1006.0,952.0,1148.0,12937.0
Dhemaji,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,899.0,1084.0,1469.0,1292.0,1284.0,1435.0,1250.0,1104.0,1088.0,966.0,974.0,1192.0,14037.0
Dhemaji,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1110.0,1282.0,1306.0,1227.0,1242.0,1303.0,1060.0,1088.0,854.0,975.0,956.0,1153.0,13556.0
Dhemaji,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,11.0,28.0,28.0,18.0,34.0,16.0,18.0,40.0,27.0,18.0,13.0,38.0,289.0
Dhemaji,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Dhemaji,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,947.0,854.0,563.0,670.0,717.0,773.0,580.0,505.0,581.0,658.0,648.0,718.0,8214.0
Dhemaji,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,6.0,2.0,0.0,0.0,3.0,2.0,10.0,0.0,6.0,1.0,4.0,7.0,41.0
Dhemaji,1.8,Number of pregnancy test kits used at SC level,TOTAL,264.0,188.0,282.0,496.0,373.0,350.0,313.0,282.0,284.0,264.0,234.0,225.0,3555.0
Dhemaji,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,2.0,2.0,1.0,4.0,15.0
Dhemaji,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,3.0,5.0,7.0,11.0,15.0,7.0,13.0,5.0,11.0,15.0,12.0,6.0,110.0
Dhemaji,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,4.0,6.0,8.0,11.0,16.0,7.0,13.0,7.0,13.0,17.0,13.0,10.0,125.0
Dhemaji,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1.0,4.0,5.0,6.0,11.0,4.0,4.0,3.0,5.0,10.0,7.0,5.0,65.0
Dhemaji,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1041.0,1011.0,1007.0,1276.0,1408.0,1507.0,1528.0,1531.0,1448.0,1562.0,1322.0,1264.0,15905.0
Dhemaji,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,588.0,507.0,562.0,720.0,733.0,616.0,621.0,692.0,657.0,1072.0,949.0,660.0,8377.0
Dhemaji,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,692.0,1152.0,1190.0,1166.0,1258.0,1223.0,2029.0,1486.0,1479.0,1551.0,1327.0,1248.0,15801.0
Dhemaji,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1156.0,383.0,503.0,805.0,259.0,2075.0,424.0,1021.0,644.0,1690.0,1045.0,3461.0,13466.0
Dhemaji,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Dhemaji,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,28.0,14.0,20.0,28.0,46.0,36.0,29.0,34.0,44.0,36.0,33.0,27.0,375.0
Dhemaji,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Dhemaji,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Dhemaji,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Dhemaji,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Dhemaji,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,180.0,145.0,165.0,206.0,194.0,220.0,202.0,198.0,179.0,222.0,188.0,193.0,2292.0
Dhemaji,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhemaji,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,180.0,145.0,165.0,206.0,194.0,220.0,202.0,198.0,179.0,222.0,188.0,193.0,2292.0
Dhemaji,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,26.0,12.0,15.0,22.0,38.0,29.0,20.0,26.0,40.0,24.0,26.0,20.0,298.0
Dhemaji,4.1.1.a,Number of male live births,TOTAL,543.0,508.0,544.0,703.0,791.0,773.0,856.0,790.0,809.0,849.0,714.0,719.0,8599.0
Dhemaji,4.1.1.b,Number of female live births,TOTAL,519.0,502.0,472.0,594.0,666.0,758.0,698.0,743.0,665.0,743.0,634.0,568.0,7562.0
Dhemaji,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1062.0,1010.0,1016.0,1297.0,1457.0,1531.0,1554.0,1533.0,1474.0,1592.0,1348.0,1287.0,16161.0
Dhemaji,4.1.2,Number of still births,TOTAL,18.0,26.0,27.0,26.0,30.0,31.0,27.0,45.0,37.0,28.0,27.0,18.0,340.0
Dhemaji,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,389.0,443.0,352.0,447.0,317.0,320.0,270.0,339.0,408.0,352.0,463.0,446.0,4546.0
Dhemaji,4.2.1,Number of Newborns weighed at birth,TOTAL,1060.0,1006.0,1013.0,1290.0,1429.0,1528.0,1545.0,1528.0,1463.0,1589.0,1339.0,1283.0,16073.0
Dhemaji,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,132.0,103.0,135.0,179.0,213.0,200.0,189.0,214.0,193.0,188.0,166.0,148.0,2060.0
Dhemaji,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1013.0,973.0,938.0,1206.0,1260.0,1459.0,1496.0,1480.0,1389.0,1540.0,1310.0,1190.0,15254.0
Dhemaji,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,21.0,1.0,1.0,5.0,1.0,8.0,0.0,0.0,7.0,12.0,1.0,3.0,60.0
Dhemaji,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,4.0,2.0,0.0,1.0,0.0,3.0,0.0,0.0,0.0,0.0,21.0,1.0,32.0
Dhemaji,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,14.0,0.0,20.0,51.0,43.0,41.0,38.0,17.0,32.0,30.0,1.0,10.0,297.0
Dhemaji,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhemaji,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,39.0,3.0,21.0,57.0,44.0,52.0,38.0,17.0,39.0,42.0,23.0,14.0,389.0
Dhemaji,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Dhemaji,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,5.0,1.0,0.0,4.0,0.0,5.0,0.0,0.0,5.0,0.0,1.0,3.0,24.0
Dhemaji,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Dhemaji,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,19.0,3.0,1.0,4.0,1.0,3.0,0.0,0.0,1.0,0.0,0.0,3.0,35.0
Dhemaji,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,14.0,0.0,20.0,51.0,38.0,41.0,38.0,17.0,32.0,27.0,0.0,10.0,288.0
Dhemaji,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,843.0,698.0,892.0,990.0,1261.0,1382.0,1290.0,1359.0,1293.0,1331.0,1057.0,703.0,13099.0
Dhemaji,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,677.0,539.0,554.0,668.0,782.0,984.0,676.0,885.0,878.0,832.0,765.0,1010.0,9250.0
Dhemaji,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,3.0,1.0,0.0,3.0,0.0,5.0,0.0,0.0,12.0
Dhemaji,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,364.0,422.0,328.0,422.0,298.0,299.0,260.0,322.0,387.0,316.0,436.0,435.0,4289.0
Dhemaji,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,9.0,5.0,5.0,7.0,4.0,1.0,0.0,8.0,6.0,3.0,4.0,1.0,53.0
Dhemaji,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,373.0,427.0,333.0,429.0,302.0,300.0,260.0,330.0,393.0,319.0,440.0,436.0,4342.0
Dhemaji,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,58.0,74.0,73.0,62.0,57.0,67.0,57.0,59.0,44.0,51.0,50.0,88.0,740.0
Dhemaji,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,148.0,138.0,139.0,158.0,172.0,174.0,162.0,158.0,169.0,143.0,130.0,164.0,1855.0
Dhemaji,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,206.0,212.0,212.0,220.0,229.0,241.0,219.0,217.0,213.0,194.0,180.0,252.0,2595.0
Dhemaji,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhemaji,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dhemaji,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,72.0,0.0,0.0,0.0,0.0,72.0,0.0,0.0,85.0,138.0,114.0,481.0
Dhemaji,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,126.0,0.0,70.0,63.0,164.0,0.0,64.0,19.0,0.0,88.0,315.0,909.0
Dhemaji,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Dhemaji,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhemaji,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,198.0,0.0,70.0,63.0,164.0,72.0,64.0,19.0,85.0,226.0,429.0,1390.0
Dhemaji,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dhemaji,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,11.0,17.0,17.0,34.0,19.0,22.0,35.0,23.0,34.0,22.0,33.0,47.0,314.0
Dhemaji,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhemaji,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,11.0,17.0,17.0,34.0,19.0,22.0,35.0,23.0,34.0,22.0,33.0,47.0,314.0
Dhemaji,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dhemaji,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,8.0,16.0,15.0,34.0,18.0,20.0,33.0,23.0,34.0,22.0,33.0,47.0,303.0
Dhemaji,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhemaji,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,8.0,16.0,15.0,34.0,18.0,20.0,33.0,23.0,34.0,22.0,33.0,47.0,303.0
Dhemaji,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dhemaji,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,114.0,123.0,108.0,1313.0,171.0,126.0,119.0,100.0,63.0,67.0,54.0,148.0,2506.0
Dhemaji,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,21.0,95.0,108.0,297.0,109.0,73.0,48.0,55.0,51.0,65.0,47.0,100.0,1069.0
Dhemaji,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,20.0,26.0,47.0,45.0,50.0,55.0,33.0,46.0,20.0,20.0,31.0,53.0,446.0
Dhemaji,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,111.0,137.0,123.0,132.0,76.0,67.0,71.0,44.0,81.0,16.0,78.0,114.0,1050.0
Dhemaji,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhemaji,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,266.0,381.0,386.0,1787.0,406.0,321.0,271.0,245.0,215.0,168.0,210.0,415.0,5071.0
Dhemaji,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,8.0,23.0,31.0,20.0,41.0,37.0,21.0,51.0,8.0,16.0,22.0,38.0,316.0
Dhemaji,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dhemaji,9.06,Number of IUCD removals,TOTAL,25.0,52.0,27.0,60.0,47.0,61.0,54.0,29.0,50.0,43.0,49.0,66.0,563.0
Dhemaji,9.07,Number of Oral Pills cycles distributed,TOTAL,2374.0,2758.0,3034.0,3531.0,3031.0,2908.0,3023.0,2871.0,2742.0,2650.0,2858.0,2785.0,34565.0
Dhemaji,9.08,Number of Condom pieces distributed,TOTAL,2676.0,2943.0,3787.0,3674.0,3176.0,2511.0,2815.0,2894.0,2497.0,2449.0,2521.0,2927.0,34870.0
Dhemaji,9.09,Number of Centchroman (weekly) pills given,TOTAL,2.0,22.0,1.0,17.0,23.0,31.0,2.0,2.0,22.0,3.0,18.0,3.0,146.0
Dhemaji,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,2.0,10.0,17.0,66.0,23.0,7.0,15.0,22.0,24.0,14.0,0.0,30.0,230.0
Dhemaji,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Dhemaji,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,3.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,7.0
Dhemaji,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Dhemaji,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Dhemaji,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1206.0,1059.0,913.0,1034.0,1216.0,1470.0,1426.0,1468.0,1414.0,1478.0,1142.0,1367.0,15193.0
Dhemaji,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1129.0,1114.0,964.0,902.0,910.0,1045.0,1248.0,1449.0,1074.0,1296.0,820.0,50.0,12001.0
Dhemaji,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1213.0,1204.0,1144.0,979.0,942.0,920.0,1070.0,1252.0,1428.0,1138.0,1241.0,1012.0,13543.0
Dhemaji,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1196.0,1206.0,1166.0,1162.0,924.0,926.0,960.0,1089.0,1159.0,1305.0,1059.0,1420.0,13572.0
Dhemaji,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,370.0,1420.0,1790.0
Dhemaji,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,246.0,246.0
Dhemaji,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,393.0,326.0,276.0,411.0,457.0,545.0,569.0,468.0,314.0,561.0,482.0,415.0,5217.0
Dhemaji,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1121.0,724.0,326.0,1294.0,1014.0,918.0,1182.0,1131.0,457.0,1607.0,1089.0,1343.0,12206.0
Dhemaji,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1214.0,806.0,413.0,1273.0,1104.0,821.0,1009.0,1005.0,634.0,1527.0,1361.0,1425.0,12592.0
Dhemaji,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1203.0,812.0,405.0,1461.0,1085.0,815.0,961.0,847.0,497.0,1496.0,1204.0,1704.0,12490.0
Dhemaji,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,412.0,339.0,335.0,436.0,530.0,679.0,611.0,634.0,666.0,726.0,608.0,655.0,6631.0
Dhemaji,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1209.0,1117.0,966.0,918.0,913.0,1037.0,1242.0,1447.0,1075.0,1303.0,829.0,50.0,12106.0
Dhemaji,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1241.0,1224.0,1157.0,957.0,942.0,927.0,1065.0,1246.0,1428.0,1140.0,1219.0,991.0,13537.0
Dhemaji,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1250.0,1234.0,1198.0,1197.0,933.0,932.0,972.0,1089.0,1160.0,1304.0,1040.0,1413.0,13722.0
Dhemaji,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,744.0,1024.0,1123.0,1183.0,1383.0,1294.0,1294.0,1216.0,1213.0,1026.0,937.0,1231.0,13668.0
Dhemaji,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,568.0,622.0,668.0,729.0,848.0,854.0,757.0,752.0,759.0,686.0,780.0,905.0,8928.0
Dhemaji,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,657.0,693.0,703.0,1012.0,1288.0,1011.0,1097.0,1071.0,836.0,994.0,800.0,580.0,10742.0
Dhemaji,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,377.0,497.0,560.0,587.0,711.0,679.0,641.0,629.0,630.0,512.0,471.0,641.0,6935.0
Dhemaji,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,364.0,523.0,563.0,585.0,655.0,614.0,653.0,585.0,583.0,514.0,461.0,590.0,6690.0
Dhemaji,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,741.0,1020.0,1123.0,1172.0,1366.0,1293.0,1294.0,1214.0,1213.0,1026.0,932.0,1231.0,13625.0
Dhemaji,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,840.0,912.0,957.0,991.0,1178.0,1072.0,910.0,856.0,877.0,765.0,792.0,990.0,11140.0
Dhemaji,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,854.0,628.0,419.0,1069.0,1223.0,972.0,845.0,702.0,541.0,840.0,804.0,1030.0,9927.0
Dhemaji,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,6.0,5.0,3.0,5.0,31.0,4.0,12.0,9.0,13.0,16.0,18.0,124.0,246.0
Dhemaji,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3.0,1.0,1.0,9.0,28.0,6.0,7.0,7.0,18.0,8.0,18.0,111.0,217.0
Dhemaji,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,9.0,6.0,4.0,14.0,59.0,10.0,19.0,16.0,31.0,24.0,36.0,235.0,463.0
Dhemaji,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,308.0,354.0,330.0,450.0,535.0,445.0,355.0,358.0,375.0,345.0,333.0,347.0,4535.0
Dhemaji,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,263.0,253.0,245.0,273.0,313.0,341.0,274.0,253.0,228.0,279.0,216.0,251.0,3189.0
Dhemaji,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,171.0,185.0,155.0,204.0,213.0,202.0,175.0,161.0,177.0,146.0,167.0,146.0,2102.0
Dhemaji,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,0.0,0.0,3.0,2.0,0.0,0.0,1.0,0.0,1.0,0.0,8.0
Dhemaji,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,23.0,17.0,11.0,13.0,6.0,14.0,6.0,5.0,4.0,0.0,6.0,7.0,112.0
Dhemaji,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,706.0,703.0,707.0,747.0,730.0,731.0,722.0,726.0,724.0,719.0,698.0,726.0,8639.0
Dhemaji,10.4.2,Number of Immunisation sessions held during the month,TOTAL,704.0,696.0,699.0,723.0,666.0,667.0,684.0,694.0,703.0,679.0,661.0,705.0,8281.0
Dhemaji,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,700.0,692.0,699.0,723.0,666.0,665.0,684.0,690.0,699.0,675.0,654.0,682.0,8229.0
Dhemaji,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,441.0,511.0,493.0,862.0,1202.0,771.0,671.0,670.0,505.0,563.0,672.0,355.0,7716.0
Dhemaji,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,630.0,714.0,980.0,1055.0,1307.0,1144.0,1173.0,1150.0,910.0,716.0,627.0,752.0,11158.0
Dhemaji,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,193.0,111.0,121.0,157.0,544.0,375.0,165.0,193.0,145.0,133.0,101.0,98.0,2336.0
Dhemaji,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,315.0,182.0,168.0,258.0,754.0,409.0,201.0,230.0,201.0,177.0,172.0,162.0,3229.0
Dhemaji,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,33.0,15.0,10.0,11.0,0.0,5.0,2.0,0.0,0.0,0.0,4.0,7.0,87.0
Dhemaji,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,470.0,483.0,495.0,474.0,698.0,401.0,401.0,220.0,204.0,135.0,250.0,416.0,4647.0
Dhemaji,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,2.0,0.0,0.0,10.0
Dhemaji,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,9.0,7.0,12.0,9.0,15.0,14.0,12.0,17.0,8.0,2.0,4.0,4.0,113.0
Dhemaji,13.1,Number of Patients operated for cataract,TOTAL,9.0,9.0,9.0,9.0,7.0,11.0,4.0,0.0,4.0,0.0,6.0,9.0,77.0
Dhemaji,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,5.0,5.0,1.0,6.0,0.0,0.0,0.0,4.0,0.0,5.0,9.0,35.0
Dhemaji,13.3,Number of School children detected with Refractive errors,TOTAL,40.0,33.0,39.0,17.0,258.0,232.0,49.0,38.0,65.0,20.0,76.0,44.0,911.0
Dhemaji,13.4,Number of children provided free glasses,TOTAL,25.0,33.0,24.0,0.0,248.0,201.0,18.0,18.0,43.0,0.0,13.0,21.0,644.0
Dhemaji,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Dhemaji,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,15.0,14.0,15.0,14.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,-1.0
Dhemaji,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,701.0,696.0,688.0,683.0,650.0,653.0,666.0,685.0,680.0,669.0,668.0,672.0,-1.0
Dhemaji,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Dhemaji,14.05,Number of RKS meetings held during the month,TOTAL,4.0,5.0,9.0,8.0,4.0,8.0,6.0,4.0,4.0,5.0,4.0,6.0,67.0
Dhemaji,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,14.0,13.0,12.0,14.0,14.0,13.0,12.0,12.0,12.0,10.0,12.0,12.0,-1.0
Dhemaji,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,61.0,75.0,53.0,38.0,39.0,54.0,32.0,29.0,12.0,39.0,26.0,26.0,484.0
Dhemaji,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Dhemaji,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Dhemaji,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,58.0,46.0,81.0,121.0,55.0,80.0,67.0,29.0,38.0,16.0,76.0,131.0,798.0
Dhemaji,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,300.0,296.0,295.0,344.0,268.0,249.0,303.0,252.0,219.0,241.0,211.0,307.0,3285.0
Dhemaji,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,55.0,42.0,72.0,79.0,33.0,44.0,50.0,22.0,36.0,32.0,58.0,80.0,603.0
Dhemaji,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,783.0,813.0,868.0,991.0,1022.0,1060.0,1028.0,899.0,882.0,965.0,836.0,908.0,11055.0
Dhemaji,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,113.0,88.0,153.0,200.0,88.0,124.0,117.0,51.0,74.0,48.0,134.0,211.0,1401.0
Dhemaji,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1083.0,1109.0,1163.0,1335.0,1290.0,1309.0,1331.0,1151.0,1101.0,1206.0,1047.0,1215.0,14340.0
Dhemaji,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8.0,17.0,12.0,15.0,13.0,24.0,22.0,20.0,19.0,20.0,17.0,17.0,204.0
Dhemaji,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,10.0,10.0,17.0,6.0,21.0,13.0,9.0,10.0,16.0,12.0,4.0,135.0
Dhemaji,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,15.0,27.0,22.0,32.0,19.0,45.0,35.0,29.0,29.0,36.0,29.0,21.0,339.0
Dhemaji,14.11,In-Patient Head Count at midnight,TOTAL,3292.0,3091.0,3316.0,3898.0,3521.0,3731.0,3498.0,3225.0,3198.0,3169.0,3057.0,3618.0,40614.0
Dhemaji,14.12.1,OPD attendance (All),TOTAL,47433.0,49572.0,58325.0,65724.0,50959.0,53928.0,49903.0,44065.0,43671.0,43301.0,44978.0,58967.0,610826.0
Dhemaji,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,6.0,4.0,1.0,3.0,3.0,5.0,0.0,2.0,2.0,4.0,0.0,0.0,30.0
Dhemaji,14.14.a,Number of patients given AYUSH treatment,TOTAL,2600.0,2912.0,2926.0,2986.0,3008.0,1564.0,2341.0,2371.0,1916.0,1833.0,2159.0,3137.0,29753.0
Dhemaji,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,150.0,203.0,256.0,328.0,235.0,211.0,208.0,157.0,160.0,155.0,170.0,214.0,2447.0
Dhemaji,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3147.0,3559.0,3795.0,3794.0,3585.0,3735.0,3163.0,2792.0,3422.0,2807.0,2827.0,3541.0,40167.0
Dhemaji,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,49.0,96.0,45.0,56.0,44.0,62.0,22.0,38.0,36.0,26.0,31.0,33.0,538.0
Dhemaji,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,194.0,203.0,194.0,211.0,204.0,172.0,161.0,159.0,140.0,433.0,262.0,237.0,2570.0
Dhemaji,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,1.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,4.0
Dhemaji,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,105.0,159.0,140.0,128.0,129.0,122.0,127.0,104.0,107.0,267.0,158.0,161.0,1707.0
Dhemaji,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Dhemaji,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,732.0,810.0,819.0,745.0,724.0,834.0,561.0,627.0,91.0,653.0,766.0,681.0,8043.0
Dhemaji,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Dhemaji,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1031.0,1172.0,1153.0,1084.0,1057.0,1128.0,849.0,890.0,338.0,1353.0,1186.0,1079.0,12320.0
Dhemaji,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,2.0,2.0,2.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,8.0
Dhemaji,15.2,Number of Widal tests conducted,Number tested,364.0,478.0,822.0,898.0,534.0,435.0,432.0,301.0,244.0,206.0,228.0,418.0,5360.0
Dhemaji,15.3.a,Number of VDRL tests conducted on males,Number tested,3.0,7.0,1.0,30.0,6.0,5.0,37.0,2.0,5.0,4.0,9.0,2.0,111.0
Dhemaji,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,5.0,5.0,8.0,4.0,4.0,4.0,44.0,3.0,11.0,4.0,7.0,3.0,102.0
Dhemaji,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,324.0,355.0,347.0,317.0,299.0,454.0,270.0,210.0,308.0,233.0,320.0,723.0,4160.0
Dhemaji,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,332.0,367.0,356.0,351.0,309.0,463.0,351.0,215.0,324.0,241.0,336.0,728.0,4373.0
Dhemaji,15.4.1,Number of blood smears examined for Malaria,TOTAL,3965.0,5555.0,6820.0,10065.0,8002.0,5519.0,3981.0,3771.0,3426.0,2659.0,2613.0,3975.0,60351.0
Dhemaji,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,1.0,1.0,4.0,336.0,1.0,1.0,2.0,1.0,0.0,1.0,1.0,349.0
Dhemaji,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,3.0,2.0,8.0,2.0,2.0,3.0,3.0,1.0,1.0,0.0,0.0,26.0
Dhemaji,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,55260.0,50220.0,42220.0,45820.0,32370.0,20870.0,28350.0,25880.0,25030.0,19800.0,13420.0,6580.0,365820.0
Dhemaji,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,20000.0,0.0,0.0,20000.0,0.0,5000.0,0.0,0.0,0.0,10000.0,55000.0
Dhemaji,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,5040.0,8000.0,16400.0,13450.0,11500.0,12520.0,2470.0,5850.0,5230.0,6380.0,6840.0,6090.0,99770.0
Dhemaji,16.1.1,Stock position of DPT vaccines,5. Total Stock,50220.0,42220.0,45820.0,32370.0,20870.0,28350.0,25880.0,25030.0,19800.0,13420.0,6580.0,10490.0,321050.0
Dhemaji,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,4400.0,16400.0
Dhemaji,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,0.0,6000.0,18000.0
Dhemaji,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7600.0,1000.0,8600.0
Dhemaji,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,4400.0,9400.0,25800.0
Dhemaji,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,6000.0,540.0,0.0,19800.0,3740.0,140.0,0.0,0.0,0.0,3500.0,4000.0,600.0,38320.0
Dhemaji,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,29000.0,0.0,0.0,14000.0,0.0,8000.0,7000.0,127000.0,124000.0,20000.0,329000.0
Dhemaji,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,5460.0,540.0,9200.0,16060.0,3600.0,14140.0,0.0,8000.0,3500.0,126500.0,127400.0,11400.0,325800.0
Dhemaji,16.1.2,Stock position of OPV vaccines,5. Total Stock,540.0,0.0,19800.0,3740.0,140.0,0.0,0.0,0.0,3500.0,4000.0,600.0,9200.0,41520.0
Dhemaji,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,0.0,0.0,11500.0,400.0,30000.0,26000.0,25430.0,23030.0,21630.0,13330.0,7830.0,1500.0,160650.0
Dhemaji,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,20000.0,0.0,34000.0,0.0,10000.0,0.0,5000.0,0.0,0.0,0.0,10000.0,79000.0
Dhemaji,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.1.3,Stock position of TT vaccines,4. Stock Distributed,0.0,8500.0,11100.0,4400.0,4000.0,10570.0,2400.0,6400.0,8300.0,5500.0,6330.0,5500.0,73000.0
Dhemaji,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,11500.0,400.0,30000.0,26000.0,25430.0,23030.0,21630.0,13330.0,7830.0,1500.0,6000.0,166650.0
Dhemaji,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,15100.0,9900.0,13400.0,7300.0,12850.0,11050.0,9650.0,8950.0,10450.0,8850.0,14550.0,10950.0,133000.0
Dhemaji,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,9500.0,0.0,9500.0,0.0,7000.0,0.0,6000.0,2000.0,10000.0,0.0,10000.0,54000.0
Dhemaji,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,5200.0,6000.0,6100.0,3950.0,1800.0,8400.0,700.0,4500.0,3600.0,4300.0,3600.0,5300.0,53450.0
Dhemaji,16.1.5,Stock position of BCG vaccines,5. Total Stock,9900.0,13400.0,7300.0,12850.0,11050.0,9650.0,8950.0,10450.0,8850.0,14550.0,10950.0,15650.0,133550.0
Dhemaji,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,11780.0,9250.0,11300.0,11100.0,12085.0,11085.0,5175.0,3975.0,5360.0,7690.0,4520.0,1605.0,94925.0
Dhemaji,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,5000.0,5000.0,5000.0,0.0,0.0,0.0,5000.0,5000.0,0.0,0.0,10000.0,35000.0
Dhemaji,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2530.0,2950.0,5200.0,4015.0,1000.0,5910.0,1200.0,3615.0,2670.0,3170.0,2915.0,3725.0,38900.0
Dhemaji,16.1.6,Stock position of Measles vaccines,5. Total Stock,9250.0,11300.0,11100.0,12085.0,11085.0,5175.0,3975.0,5360.0,7690.0,4520.0,1605.0,7880.0,91025.0
Dhemaji,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,23715.0,23465.0,22465.0,18815.0,10015.0,4415.0,600.0,0.0,1100.0,4500.0,1130.0,0.0,110220.0
Dhemaji,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,35000.0,0.0,5000.0,0.0,5000.0,5000.0,0.0,0.0,5000.0,55000.0
Dhemaji,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,2765.0,0.0,0.0,0.0,0.0,0.0,0.0,2765.0
Dhemaji,16.1.7,Stock position of JE vaccines,4. Stock Distributed,250.0,1000.0,3650.0,43800.0,5600.0,6050.0,600.0,3900.0,1600.0,3370.0,1130.0,2750.0,73700.0
Dhemaji,16.1.7,Stock position of JE vaccines,5. Total Stock,23465.0,22465.0,18815.0,10015.0,4415.0,600.0,0.0,1100.0,4500.0,1130.0,0.0,2250.0,88755.0
Dhemaji,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,18500.0,11250.0,14300.0,4000.0,19850.0,17650.0,24850.0,22950.0,25950.0,20850.0,13750.0,8450.0,202350.0
Dhemaji,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,9500.0,0.0,23500.0,0.0,20000.0,0.0,10000.0,0.0,0.0,0.0,5000.0,68000.0
Dhemaji,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,7250.0,6450.0,10300.0,7650.0,2200.0,12800.0,1900.0,7000.0,5100.0,7100.0,5300.0,6500.0,79550.0
Dhemaji,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,11250.0,14300.0,4000.0,19850.0,17650.0,24850.0,22950.0,25950.0,20850.0,13750.0,8450.0,6950.0,190800.0
Dhemaji,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,4950.0,3400.0,1480.0,3960.0,3925.0,3505.0,3505.0,3505.0,3405.0,2105.0,1705.0,1705.0,37150.0
Dhemaji,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,600.0,3000.0,1600.0,0.0,600.0,0.0,0.0,0.0,0.0,0.0,0.0,5800.0
Dhemaji,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,1550.0,2520.0,520.0,1635.0,420.0,600.0,0.0,100.0,1300.0,400.0,0.0,0.0,9045.0
Dhemaji,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,3400.0,1480.0,3960.0,3925.0,3505.0,3505.0,3505.0,3405.0,2105.0,1705.0,1705.0,1705.0,33905.0
Dhemaji,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,31400.0,26360.0,7360.0,7360.0,11340.0,8220.0,23340.0,23340.0,31420.0,9860.0,3360.0,3360.0,186720.0
Dhemaji,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,5040.0,0.0,50400.0,0.0,15120.0,0.0,0.0,0.0,0.0,70560.0
Dhemaji,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,5040.0,19000.0,0.0,1060.0,3120.0,35280.0,0.0,7040.0,21560.0,6500.0,0.0,0.0,98600.0
Dhemaji,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,26360.0,7360.0,7360.0,11340.0,8220.0,23340.0,23340.0,31420.0,9860.0,3360.0,3360.0,3360.0,158680.0
Dhemaji,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,13200.0,11400.0,400.0,4200.0,18000.0,16399.0,14999.0,14999.0,21599.0,13599.0,7399.0,6399.0,142593.0
Dhemaji,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,4000.0,25800.0,0.0,7000.0,0.0,6600.0,0.0,0.0,0.0,0.0,43400.0
Dhemaji,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,1800.0,11000.0,200.0,12000.0,1601.0,8400.0,0.0,0.0,8000.0,6200.0,1000.0,1000.0,51201.0
Dhemaji,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,11400.0,400.0,4200.0,18000.0,16399.0,14999.0,14999.0,21599.0,13599.0,7399.0,6399.0,5399.0,134792.0
Dhemaji,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1200.0,1200.0,1200.0,8900.0,9500.0,8570.0,8870.0,8870.0,8870.0,2870.0,2570.0,1570.0,64190.0
Dhemaji,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,2000.0,8000.0,9000.0,0.0,6000.0,0.0,8870.0,0.0,0.0,0.0,0.0,33870.0
Dhemaji,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,2000.0,300.0,8400.0,930.0,5700.0,0.0,8870.0,6000.0,300.0,1000.0,0.0,33500.0
Dhemaji,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1200.0,1200.0,8900.0,9500.0,8570.0,8870.0,8870.0,8870.0,2870.0,2570.0,1570.0,1570.0,64560.0
Dhemaji,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4207.0,4207.0,9009.0,13559.0,13489.0,13426.0,13262.0,13190.0,13126.0,13126.0,13126.0,13126.0,136853.0
Dhemaji,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,5000.0,4550.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9550.0
Dhemaji,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,198.0,0.0,70.0,63.0,164.0,72.0,64.0,,,0.0,401.0,1032.0
Dhemaji,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4207.0,9009.0,13559.0,13489.0,13426.0,13262.0,13190.0,13126.0,13126.0,13126.0,13126.0,12725.0,145371.0
Dhemaji,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7000.0,7000.0
Dhemaji,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,1000.0
Dhemaji,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,6000.0
Dhemaji,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,700.0,0.0,0.0,3650.0,1400.0,1500.0,500.0,0.0,7750.0
Dhemaji,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,4000.0,0.0,0.0,5100.0,4200.0,1000.0,0.0,0.0,0.0,14300.0
Dhemaji,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,3300.0,700.0,0.0,1450.0,6450.0,900.0,1000.0,500.0,0.0,14300.0
Dhemaji,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,700.0,0.0,0.0,3650.0,1400.0,1500.0,500.0,0.0,0.0,7750.0
Dhemaji,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,10000.0
Dhemaji,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,2000.0
Dhemaji,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8000.0,8000.0
Dhemaji,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1990000.0,3725500.0,3036500.0,2149000.0,2002000.0,1907500.0,1852000.0,1684000.0,1508500.0,115500.0,1308500.0,1183000.0,22462000.0
Dhemaji,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,1816500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1214500.0,0.0,0.0,3031000.0
Dhemaji,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,81000.0,689000.0,887500.0,147000.0,94500.0,55500.0,168000.0,175500.0,1393000.0,21500.0,125500.0,3000.0,3841000.0
Dhemaji,16.3.07,Stock Position of IFA Tablets,5. Total Stock,3725500.0,3036500.0,2149000.0,2002000.0,1907500.0,1852000.0,1684000.0,1508500.0,115500.0,1308500.0,1183000.0,1180000.0,21652000.0
Dhemaji,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,320.0,10000.0,9300.0,8400.0,6100.0,5250.0,4250.0,3350.0,3350.0,2700.0,2500.0,2500.0,58020.0
Dhemaji,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0
Dhemaji,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,320.0,700.0,900.0,2300.0,850.0,1000.0,900.0,0.0,650.0,200.0,0.0,500.0,8320.0
Dhemaji,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,10000.0,9300.0,8400.0,6100.0,5250.0,4250.0,3350.0,3350.0,2700.0,2500.0,2500.0,2000.0,59700.0
Dhemaji,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,50.0,50.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Dhemaji,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,50.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Dhemaji,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,50.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Dhemaji,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,8300.0,6300.0,4300.0,4300.0,8500.0,0.0,0.0,5000.0,23600.0,16600.0,3050.0,79950.0
Dhemaji,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,12000.0,2500.0,0.0,0.0,11000.0,0.0,1500.0,5000.0,20000.0,0.0,0.0,10000.0,62000.0
Dhemaji,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,3700.0,4500.0,2000.0,0.0,6800.0,8500.0,1500.0,0.0,1400.0,7000.0,13550.0,3000.0,51950.0
Dhemaji,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,8300.0,6300.0,4300.0,4300.0,8500.0,0.0,0.0,5000.0,23600.0,16600.0,3050.0,10050.0,90000.0
Dhemaji,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2100.0,0.0,0.0,5400.0,6500.0,5100.0,3500.0,3300.0,4200.0,700.0,300.0,0.0,31100.0
Dhemaji,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,6600.0,3300.0,0.0,3300.0,0.0,3300.0,0.0,0.0,0.0,3300.0,19800.0
Dhemaji,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2100.0,0.0,1200.0,2200.0,1400.0,4900.0,200.0,2400.0,3500.0,400.0,300.0,2000.0,20600.0
Dhemaji,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,5400.0,6500.0,5100.0,3500.0,3300.0,4200.0,700.0,300.0,0.0,1300.0,30300.0
Dhemaji,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,41200.0,41200.0,58000.0,72400.0,98800.0,86400.0,88800.0,88800.0,110400.0,81600.0,65600.0,58400.0,891600.0
Dhemaji,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,28800.0,24000.0,69600.0,0.0,20000.0,0.0,36000.0,0.0,0.0,0.0,0.0,178400.0
Dhemaji,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,12000.0,9600.0,43200.0,12400.0,17600.0,0.0,14400.0,28800.0,16000.0,7200.0,14400.0,175600.0
Dhemaji,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,41200.0,58000.0,72400.0,98800.0,86400.0,88800.0,88800.0,110400.0,81600.0,65600.0,58400.0,44000.0,894400.0
Dhemaji,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,6300.0,9400.0,9800.0,12400.0,11400.0,8600.0,8600.0,11100.0,8800.0,8000.0,7000.0,101400.0
Dhemaji,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,6900.0,4000.0,2000.0,6000.0,0.0,2000.0,2400.0,4000.0,0.0,0.0,0.0,2000.0,29300.0
Dhemaji,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhemaji,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,600.0,900.0,1600.0,3400.0,1000.0,4800.0,2400.0,1500.0,2300.0,800.0,1000.0,1900.0,22200.0
Dhemaji,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,6300.0,9400.0,9800.0,12400.0,11400.0,8600.0,8600.0,11100.0,8800.0,8000.0,7000.0,7100.0,108500.0
Dhemaji,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,1.0,1.0,1.0,3.0,2.0,1.0,1.0,10.0
Dhemaji,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,,,1.0,,,1.0,1.0,,4.0,8.0
Dhemaji,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dhemaji,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,,,1.0,,,1.0,1.0,,4.0,8.0
Dhemaji,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,4.0,4.0,4.0,3.0,8.0,7.0,2.0,5.0,7.0,3.0,4.0,53.0
Dhemaji,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dhemaji,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,4.0,4.0,4.0,3.0,8.0,7.0,2.0,5.0,7.0,3.0,4.0,53.0
Dhemaji,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,3.0,1.0,1.0,3.0,2.0,3.0,2.0,6.0,3.0,2.0,1.0,1.0,28.0
Dhemaji,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Dhemaji,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,1.0,1.0,3.0,2.0,3.0,2.0,6.0,4.0,2.0,1.0,1.0,29.0
Dhemaji,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,,1.0,4.0,6.0,7.0,6.0,11.0,9.0,3.0,7.0,3.0,59.0
Dhemaji,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dhemaji,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,,1.0,4.0,6.0,7.0,6.0,11.0,9.0,3.0,7.0,3.0,59.0
Dhemaji,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,1.0,,1.0,,1.0,1.0,2.0,3.0,1.0,,,11.0
Dhemaji,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,,1.0,,,,,2.0
Dhemaji,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,2.0,,1.0,,1.0,1.0,3.0,3.0,1.0,,,13.0
Dhemaji,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,1.0,,,,,1.0,,,1.0,,3.0
Dhemaji,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Dhemaji,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,1.0,,,,,1.0,,,1.0,1.0,4.0
Dhemaji,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,2.0,,,1.0,1.0,1.0,2.0,,,,8.0
Dhemaji,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,,,2.0,,1.0,1.0,,,,1.0,,6.0
Dhemaji,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,2.0,2.0,,2.0,2.0,1.0,2.0,,1.0,,14.0
Dhemaji,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,1.0,,,,,,,,,,1.0
Dhemaji,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dhemaji,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,1.0,,,,,,,,,,1.0
Dhemaji,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,4.0,6.0,5.0,5.0,5.0,5.0,12.0,6.0,6.0,9.0,4.0,5.0,72.0
Dhemaji,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,1.0,4.0,3.0,1.0,2.0,,,1.0,2.0,2.0,18.0
Dhemaji,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,7.0,6.0,9.0,8.0,6.0,14.0,6.0,6.0,10.0,6.0,7.0,90.0
Dhemaji,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Dhemaji,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Dhemaji,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Dhemaji,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,1.0,,,,,,,,,2.0
Dhemaji,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Dhemaji,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Dhemaji,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Dhemaji,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,1.0,,,,1.0
Dhemaji,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,2.0,,,1.0,,,,,1.0,,,,4.0
Dhemaji,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,5.0,,,1.0,2.0,2.0,1.0,1.0,1.0,2.0,3.0,4.0,22.0
Dhemaji,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,,,,,9.0
Dhemaji,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,8.0,1.0,1.0,3.0,3.0,4.0,2.0,2.0,2.0,2.0,3.0,4.0,35.0
Dhemaji,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Dhemaji,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Dhemaji,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Dhemaji,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,1.0,1.0,,,,,,,2.0
Dhemaji,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,1.0,,,,,1.0,,,2.0
Dhemaji,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,1.0,,2.0,1.0,1.0,,1.0,2.0,2.0,2.0,1.0,14.0
Dhemaji,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,1.0,1.0,,,,1.0,,1.0,,5.0
Dhemaji,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,1.0,1.0,3.0,3.0,1.0,,1.0,3.0,3.0,3.0,1.0,21.0
Dhemaji,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Dhemaji,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Dhemaji,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Dhemaji,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,1.0,,,,,1.0
Dhemaji,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Dhemaji,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,2.0,1.0,1.0,4.0,2.0,9.0,8.0,4.0,7.0,5.0,2.0,45.0
Dhemaji,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,3.0,3.0,4.0,3.0,,2.0,6.0,1.0,5.0,2.0,3.0,34.0
Dhemaji,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,5.0,4.0,5.0,8.0,2.0,11.0,14.0,5.0,12.0,7.0,5.0,80.0
Dhemaji,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Dhemaji,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,2.0,1.0,,,,,,,,,4.0
Dhemaji,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,1.0,,1.0,1.0,,,3.0
Dhemaji,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,,2.0,1.0,,,1.0,,1.0,1.0,,,7.0
Dhemaji,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dhemaji,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Dhemaji,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dhemaji,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Dhemaji,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dhemaji,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Dhemaji,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dhemaji,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Dhemaji,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dhemaji,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Dhemaji,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dhemaji,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,1.0,,,,,,,,,1.0
Dhemaji,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dhemaji,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,1.0,,,1.0,,,,,3.0
Dhemaji,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dhemaji,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,1.0,,,1.0,,,,,3.0
Dhemaji,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dhemaji,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Dhemaji,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dhemaji,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Dhemaji,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dhemaji,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,2.0,2.0,3.0,3.0,3.0,3.0,2.0,5.0,4.0,,28.0
Dhemaji,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Dhemaji,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,2.0,2.0,3.0,3.0,3.0,3.0,2.0,5.0,4.0,,28.0
Dhemaji,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,3.0,1.0,1.0,,1.0,1.0,1.0,,,10.0
Dhemaji,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,6.0,2.0,3.0,6.0,1.0,6.0,3.0,,6.0,5.0,3.0,3.0,44.0
Dhemaji,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,1.0,,,1.0,1.0,,1.0,,,,4.0
Dhemaji,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,6.0,3.0,5.0,9.0,2.0,8.0,4.0,1.0,8.0,6.0,3.0,3.0,58.0
Dhemaji,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Dhemaji,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,6.0,6.0,4.0,2.0,3.0,2.0,2.0,1.0,2.0,1.0,,33.0
Dhemaji,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Dhemaji,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,6.0,6.0,5.0,3.0,3.0,2.0,2.0,1.0,2.0,1.0,,35.0
Dhemaji,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,,,,1.0,,,,,,,2.0
Dhemaji,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Dhemaji,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Dhemaji,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,,,,1.0,,,1.0,,,,3.0
Dhemaji,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,2.0,,,,,,,,,2.0
Dhemaji,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,1.0,3.0,3.0,2.0,4.0,1.0,3.0,,1.0,,18.0
Dhemaji,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,,,5.0,2.0,2.0,4.0,4.0,7.0,4.0,4.0,3.0,38.0
Dhemaji,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,,1.0,10.0,5.0,4.0,8.0,5.0,10.0,4.0,5.0,3.0,58.0
Dhemaji,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,,,1.0,,1.0,,,,,3.0
Dhemaji,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,2.0,6.0,4.0,4.0,5.0,2.0,6.0,4.0,6.0,3.0,6.0,50.0
Dhemaji,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,1.0,5.0,1.0,4.0,2.0,6.0,5.0,6.0,1.0,1.0,2.0,35.0
Dhemaji,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,4.0,3.0,11.0,5.0,8.0,8.0,8.0,12.0,10.0,7.0,4.0,8.0,88.0
Dhemaji,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,3.0,,6.0,4.0,1.0,3.0,,1.0,1.0,3.0,1.0,23.0
Dhemaji,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,11.0,13.0,10.0,14.0,9.0,13.0,11.0,12.0,13.0,10.0,11.0,6.0,133.0
Dhemaji,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,12.0,17.0,16.0,29.0,32.0,30.0,15.0,21.0,31.0,16.0,21.0,22.0,262.0
Dhemaji,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,23.0,33.0,26.0,49.0,45.0,44.0,29.0,33.0,45.0,27.0,35.0,29.0,418.0
Dhubri,1.1,Total number of pregnant women Registered for ANC,TOTAL,5825.0,5999.0,5405.0,5557.0,5353.0,5490.0,5332.0,4420.0,4042.0,4078.0,3961.0,4852.0,60314.0
Dhubri,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3860.0,3944.0,3553.0,3528.0,3145.0,3222.0,3406.0,3150.0,3003.0,2953.0,2857.0,3654.0,40275.0
Dhubri,1.2,Number of Pregnant women registered under JSY,TOTAL,5644.0,5797.0,5085.0,5397.0,5156.0,5304.0,5128.0,4225.0,3965.0,3857.0,3715.0,4585.0,57858.0
Dhubri,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3887.0,4107.0,4321.0,4503.0,4358.0,4783.0,4795.0,4647.0,4579.0,4141.0,3486.0,3884.0,51491.0
Dhubri,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4711.0,5068.0,4874.0,5002.0,4758.0,5130.0,4794.0,4145.0,3025.0,3282.0,3389.0,4333.0,52511.0
Dhubri,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4381.0,4668.0,4803.0,4964.0,4482.0,5118.0,5494.0,4767.0,3961.0,3172.0,3146.0,4329.0,53285.0
Dhubri,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,5075.0,5241.0,4843.0,5260.0,5300.0,4909.0,5083.0,4798.0,3914.0,4020.0,3783.0,4374.0,56600.0
Dhubri,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,67.0,84.0,68.0,86.0,82.0,51.0,109.0,64.0,51.0,89.0,62.0,64.0,877.0
Dhubri,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,15.0,18.0
Dhubri,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2807.0,3058.0,2432.0,2637.0,2428.0,2801.0,2655.0,2017.0,2140.0,2107.0,1908.0,2125.0,29115.0
Dhubri,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,7.0,11.0,4.0,2.0,9.0,4.0,8.0,10.0,6.0,8.0,7.0,10.0,86.0
Dhubri,1.8,Number of pregnancy test kits used at SC level,TOTAL,532.0,335.0,303.0,555.0,632.0,671.0,597.0,787.0,857.0,775.0,791.0,690.0,7525.0
Dhubri,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,708.0,558.0,387.0,328.0,309.0,317.0,366.0,413.0,523.0,540.0,412.0,346.0,5207.0
Dhubri,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,872.0,1055.0,1040.0,1393.0,1644.0,1781.0,1837.0,1747.0,1750.0,1727.0,1429.0,1352.0,17627.0
Dhubri,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1580.0,1613.0,1427.0,1721.0,1953.0,2098.0,2203.0,2160.0,2273.0,2267.0,1841.0,1698.0,22834.0
Dhubri,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1394.0,1350.0,1002.0,1241.0,1129.0,1378.0,1338.0,1960.0,2181.0,1952.0,1619.0,1488.0,18032.0
Dhubri,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,64.0,6.0,17.0,123.0,276.0,246.0,41.0,172.0,36.0,142.0,124.0,267.0,1514.0
Dhubri,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1793.0,1796.0,1671.0,2241.0,2291.0,2292.0,2408.0,2365.0,2474.0,2536.0,2054.0,2032.0,25953.0
Dhubri,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1005.0,914.0,805.0,1141.0,1131.0,1023.0,798.0,841.0,1108.0,1049.0,942.0,1096.0,11853.0
Dhubri,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1726.0,1730.0,1569.0,1955.0,2170.0,2130.0,2112.0,2197.0,2527.0,2465.0,1974.0,2008.0,24563.0
Dhubri,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,397.0,437.0,721.0,1647.0,928.0,2010.0,370.0,1272.0,1030.0,1031.0,2515.0,4062.0,16420.0
Dhubri,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,,,,,,,,,,0.0,0.0,0.0
Dhubri,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,9.0,9.0,7.0,7.0,9.0,6.0,17.0,10.0,11.0,22.0,23.0,11.0,141.0
Dhubri,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Dhubri,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Dhubri,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,89.0,103.0,94.0,76.0,110.0,112.0,104.0,114.0,118.0,92.0,62.0,70.0,1144.0
Dhubri,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhubri,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,89.0,103.0,94.0,76.0,110.0,112.0,104.0,114.0,118.0,92.0,62.0,70.0,1144.0
Dhubri,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Dhubri,4.1.1.a,Number of male live births,TOTAL,1738.0,1715.0,1633.0,2074.0,2170.0,2278.0,2337.0,2296.0,2418.0,2423.0,1961.0,1921.0,24964.0
Dhubri,4.1.1.b,Number of female live births,TOTAL,1584.0,1635.0,1408.0,1816.0,2000.0,2024.0,2185.0,2161.0,2232.0,2310.0,1860.0,1767.0,22982.0
Dhubri,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3322.0,3350.0,3041.0,3890.0,4170.0,4302.0,4522.0,4457.0,4650.0,4733.0,3821.0,3688.0,47946.0
Dhubri,4.1.2,Number of still births,TOTAL,74.0,96.0,73.0,79.0,96.0,106.0,114.0,92.0,123.0,98.0,80.0,92.0,1123.0
Dhubri,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,686.0,741.0,739.0,696.0,655.0,538.0,445.0,420.0,461.0,469.0,292.0,385.0,6527.0
Dhubri,4.2.1,Number of Newborns weighed at birth,TOTAL,3289.0,3337.0,3045.0,3886.0,4159.0,4281.0,4530.0,4449.0,4624.0,4761.0,3821.0,3672.0,47854.0
Dhubri,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,479.0,531.0,664.0,758.0,936.0,862.0,754.0,723.0,773.0,861.0,686.0,766.0,8793.0
Dhubri,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3226.0,3283.0,3027.0,3818.0,4128.0,4226.0,4506.0,4433.0,4590.0,4694.0,3782.0,3459.0,47172.0
Dhubri,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,21.0,42.0,5.0,3.0,17.0,15.0,15.0,13.0,4.0,2.0,0.0,138.0
Dhubri,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,3.0,10.0,9.0,17.0,23.0,38.0,42.0,22.0,22.0,19.0,5.0,6.0,216.0
Dhubri,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,469.0,540.0,488.0,624.0,638.0,629.0,616.0,649.0,672.0,668.0,480.0,334.0,6807.0
Dhubri,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhubri,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,473.0,571.0,539.0,646.0,664.0,684.0,673.0,686.0,707.0,691.0,487.0,340.0,7161.0
Dhubri,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Dhubri,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,541.0,805.0,694.0,665.0,735.0,874.0,854.0,970.0,916.0,914.0,718.0,810.0,9496.0
Dhubri,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,152.0,153.0,231.0,116.0,100.0,225.0,223.0,185.0,200.0,107.0,18.0,21.0,1731.0
Dhubri,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,614.0,756.0,686.0,728.0,872.0,928.0,900.0,1061.0,912.0,918.0,747.0,826.0,9948.0
Dhubri,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,31.0,55.0,54.0,52.0,75.0,55.0,55.0,58.0,63.0,65.0,67.0,80.0,710.0
Dhubri,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2451.0,2741.0,2591.0,2471.0,3481.0,3312.0,3841.0,3934.0,3762.0,4032.0,3272.0,3186.0,39074.0
Dhubri,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2234.0,2429.0,2002.0,2130.0,2576.0,2590.0,3320.0,3261.0,3716.0,3667.0,2909.0,2796.0,33630.0
Dhubri,6.3,PNC maternal complications attended,TOTAL,11.0,145.0,168.0,136.0,30.0,3.0,2.0,3.0,27.0,12.0,48.0,21.0,606.0
Dhubri,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,428.0,438.0,451.0,373.0,368.0,321.0,255.0,145.0,154.0,152.0,136.0,176.0,3397.0
Dhubri,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,428.0,438.0,451.0,373.0,368.0,321.0,255.0,145.0,154.0,152.0,136.0,176.0,3397.0
Dhubri,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Dhubri,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,42.0,42.0,25.0,31.0,14.0,47.0,46.0,15.0,29.0,60.0,69.0,68.0,488.0
Dhubri,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,340.0,295.0,281.0,315.0,254.0,247.0,250.0,241.0,268.0,285.0,262.0,325.0,3363.0
Dhubri,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,382.0,337.0,306.0,346.0,268.0,294.0,296.0,256.0,297.0,345.0,331.0,393.0,3851.0
Dhubri,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,3.0
Dhubri,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,3.0,0.0,0.0,4.0
Dhubri,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhubri,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,1.0,3.0,0.0,0.0,7.0
Dhubri,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dhubri,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,76.0,0.0,0.0,115.0,0.0,48.0,112.0,0.0,0.0,0.0,351.0
Dhubri,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,47.0,0.0,0.0,82.0,0.0,30.0,35.0,0.0,0.0,0.0,194.0
Dhubri,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,34.0,0.0,0.0,0.0,13.0,47.0
Dhubri,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhubri,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,123.0,0.0,0.0,197.0,0.0,112.0,147.0,0.0,0.0,13.0,592.0
Dhubri,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dhubri,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhubri,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dhubri,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,19.0,17.0,18.0,21.0,23.0,27.0,18.0,25.0,24.0,22.0,12.0,0.0,226.0
Dhubri,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhubri,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,19.0,17.0,18.0,21.0,23.0,27.0,18.0,25.0,24.0,22.0,12.0,0.0,226.0
Dhubri,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dhubri,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,120.0,317.0,246.0,245.0,640.0,596.0,262.0,244.0,416.0,402.0,515.0,404.0,4407.0
Dhubri,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,79.0,117.0,74.0,83.0,168.0,258.0,111.0,61.0,144.0,150.0,137.0,157.0,1539.0
Dhubri,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,21.0,24.0,17.0,38.0,53.0,105.0,45.0,31.0,31.0,43.0,25.0,23.0,456.0
Dhubri,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,7.0,8.0,18.0,50.0,46.0,133.0,114.0,157.0,159.0,149.0,93.0,22.0,956.0
Dhubri,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhubri,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,227.0,466.0,355.0,416.0,907.0,1092.0,532.0,493.0,750.0,744.0,770.0,606.0,7358.0
Dhubri,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,27.0,42.0,57.0,98.0,106.0,202.0,176.0,283.0,235.0,231.0,174.0,99.0,1730.0
Dhubri,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,3.0,17.0,22.0,5.0,3.0,3.0,6.0,23.0,2.0,84.0
Dhubri,9.06,Number of IUCD removals,TOTAL,35.0,24.0,31.0,43.0,76.0,57.0,50.0,39.0,34.0,38.0,50.0,155.0,632.0
Dhubri,9.07,Number of Oral Pills cycles distributed,TOTAL,9671.0,9711.0,11132.0,10946.0,10146.0,10166.0,12026.0,10374.0,10486.0,9487.0,9499.0,10714.0,124358.0
Dhubri,9.08,Number of Condom pieces distributed,TOTAL,28100.0,27797.0,27048.0,28538.0,23480.0,23433.0,24618.0,26178.0,21803.0,16237.0,16068.0,19339.0,282639.0
Dhubri,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,173.0,166.0,185.0,489.0,311.0,246.0,267.0,368.0,362.0,307.0,350.0,422.0,3646.0
Dhubri,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,1.0,3.0,3.0,4.0,2.0,1.0,1.0,3.0,3.0,2.0,1.0,-1.0
Dhubri,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3820.0,3706.0,3329.0,4598.0,3320.0,5171.0,4058.0,3907.0,5962.0,5227.0,4116.0,4928.0,52142.0
Dhubri,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4267.0,3979.0,3666.0,3701.0,3118.0,4197.0,4332.0,4706.0,4485.0,3913.0,2512.0,741.0,43617.0
Dhubri,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3876.0,3919.0,3694.0,3868.0,3246.0,3695.0,4017.0,4009.0,4635.0,3779.0,3459.0,4017.0,46214.0
Dhubri,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3608.0,3631.0,3577.0,3769.0,3314.0,3752.0,3708.0,3679.0,4200.0,3683.0,3320.0,4345.0,44586.0
Dhubri,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1172.0,3748.0,4920.0
Dhubri,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,626.0,626.0
Dhubri,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1176.0,1270.0,985.0,1299.0,1401.0,1683.0,1638.0,1860.0,1901.0,1844.0,1351.0,1626.0,18034.0
Dhubri,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4300.0,3962.0,3603.0,3606.0,2709.0,4180.0,4060.0,4665.0,4417.0,3910.0,3020.0,3377.0,45809.0
Dhubri,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3890.0,3952.0,3649.0,3805.0,2838.0,3701.0,3821.0,3944.0,4545.0,3772.0,3493.0,4234.0,45644.0
Dhubri,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3632.0,3614.0,3549.0,3657.0,2873.0,3745.0,3504.0,3641.0,4067.0,3677.0,3340.0,4399.0,43698.0
Dhubri,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,701.0,785.0,604.0,862.0,950.0,1113.0,1388.0,1664.0,1601.0,1470.0,1137.0,1207.0,13482.0
Dhubri,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4176.0,4173.0,3719.0,3587.0,2597.0,4136.0,4342.0,4712.0,4508.0,3876.0,2574.0,883.0,43283.0
Dhubri,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3561.0,4031.0,3777.0,3798.0,2730.0,3680.0,4016.0,4173.0,4604.0,3784.0,3477.0,3933.0,45564.0
Dhubri,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3289.0,3460.0,3601.0,3691.0,2758.0,3730.0,3654.0,3677.0,4177.0,3693.0,3300.0,4293.0,43323.0
Dhubri,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2808.0,3221.0,3334.0,3661.0,3469.0,4067.0,3757.0,4151.0,4324.0,3481.0,3147.0,3981.0,43401.0
Dhubri,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1996.0,1920.0,1886.0,2042.0,1834.0,2274.0,2032.0,2261.0,2036.0,1819.0,1891.0,2551.0,24542.0
Dhubri,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1492.0,1623.0,1690.0,1941.0,1785.0,2136.0,1935.0,2115.0,2192.0,1734.0,1608.0,2043.0,22294.0
Dhubri,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1271.0,1471.0,1588.0,1691.0,1634.0,1868.0,1762.0,1968.0,2066.0,1680.0,1526.0,1893.0,20418.0
Dhubri,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2763.0,3094.0,3278.0,3632.0,3419.0,4004.0,3697.0,4083.0,4258.0,3414.0,3134.0,3936.0,42712.0
Dhubri,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2206.0,2129.0,2042.0,2321.0,2130.0,2529.0,2222.0,2332.0,2178.0,1983.0,2035.0,2652.0,26759.0
Dhubri,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2195.0,2131.0,2008.0,2212.0,2020.0,2518.0,2061.0,2299.0,2121.0,1946.0,2021.0,2670.0,26202.0
Dhubri,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,370.0,353.0,342.0,396.0,370.0,555.0,422.0,451.0,460.0,386.0,346.0,478.0,4929.0
Dhubri,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,430.0,377.0,336.0,384.0,366.0,527.0,353.0,403.0,415.0,383.0,318.0,438.0,4730.0
Dhubri,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,800.0,730.0,678.0,780.0,736.0,1082.0,775.0,854.0,875.0,769.0,664.0,916.0,9659.0
Dhubri,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,849.0,854.0,761.0,985.0,924.0,943.0,962.0,970.0,931.0,915.0,928.0,872.0,10894.0
Dhubri,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,823.0,735.0,757.0,901.0,877.0,898.0,910.0,940.0,827.0,833.0,837.0,811.0,10149.0
Dhubri,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,657.0,599.0,633.0,704.0,708.0,735.0,776.0,779.0,654.0,605.0,612.0,650.0,8112.0
Dhubri,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1507.0,1468.0,1477.0,1564.0,1506.0,1494.0,1578.0,1508.0,1569.0,1508.0,1477.0,1452.0,18108.0
Dhubri,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1371.0,1412.0,1406.0,1475.0,1353.0,1436.0,1488.0,1467.0,1495.0,1398.0,1379.0,1405.0,17085.0
Dhubri,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1293.0,1360.0,1340.0,1401.0,1290.0,1370.0,1410.0,1395.0,1370.0,1288.0,1287.0,1308.0,16112.0
Dhubri,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2708.0,3140.0,3264.0,3608.0,3829.0,4025.0,3704.0,4063.0,4178.0,3396.0,3377.0,3756.0,43048.0
Dhubri,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,717.0,754.0,621.0,784.0,6373.0,1799.0,972.0,1346.0,1081.0,924.0,3554.0,1266.0,20191.0
Dhubri,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,684.0,719.0,635.0,852.0,6447.0,1873.0,946.0,1207.0,1038.0,925.0,3913.0,1251.0,20490.0
Dhubri,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,8.0,17.0,2.0,8.0,4.0,32.0,5.0,4.0,4.0,7.0,8.0,22.0,121.0
Dhubri,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,742.0,816.0,841.0,788.0,807.0,287.0,402.0,368.0,529.0,523.0,420.0,393.0,6916.0
Dhubri,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,3.0,2.0,0.0,0.0,3.0,0.0,2.0,2.0,7.0,4.0,10.0,4.0,37.0
Dhubri,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,106.0,60.0,80.0,107.0,114.0,144.0,172.0,107.0,87.0,92.0,182.0,166.0,1417.0
Dhubri,13.1,Number of Patients operated for cataract,TOTAL,44.0,33.0,50.0,39.0,50.0,55.0,64.0,75.0,57.0,37.0,56.0,63.0,623.0
Dhubri,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,44.0,33.0,50.0,39.0,50.0,55.0,64.0,69.0,53.0,37.0,41.0,47.0,582.0
Dhubri,13.3,Number of School children detected with Refractive errors,TOTAL,28.0,24.0,6.0,0.0,0.0,77.0,139.0,26.0,18.0,0.0,36.0,38.0,392.0
Dhubri,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,77.0,120.0,0.0,0.0,0.0,0.0,0.0,197.0
Dhubri,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,1.0,1.0,1.0,-1.0
Dhubri,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,13.0,14.0,12.0,14.0,13.0,12.0,11.0,16.0,16.0,16.0,15.0,15.0,-1.0
Dhubri,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1264.0,1258.0,1251.0,1281.0,1162.0,1206.0,1246.0,1187.0,1251.0,1178.0,1172.0,1195.0,-1.0
Dhubri,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,8.0,8.0,8.0,8.0,8.0,8.0,8.0,8.0,8.0,7.0,7.0,-1.0
Dhubri,14.05,Number of RKS meetings held during the month,TOTAL,16.0,18.0,18.0,18.0,17.0,18.0,16.0,8.0,12.0,14.0,12.0,14.0,181.0
Dhubri,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,19.0,20.0,18.0,23.0,18.0,22.0,20.0,25.0,27.0,27.0,27.0,26.0,-1.0
Dhubri,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,456.0,521.0,432.0,642.0,498.0,505.0,463.0,755.0,849.0,868.0,730.0,787.0,7506.0
Dhubri,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Dhubri,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,3.0,1.0,-1.0
Dhubri,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,695.0,571.0,658.0,649.0,499.0,737.0,769.0,839.0,917.0,973.0,456.0,158.0,7921.0
Dhubri,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1453.0,1679.0,1290.0,1531.0,1256.0,1036.0,958.0,769.0,656.0,529.0,782.0,858.0,12797.0
Dhubri,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,702.0,726.0,1245.0,1115.0,1257.0,791.0,718.0,661.0,732.0,905.0,355.0,200.0,9407.0
Dhubri,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2548.0,2286.0,2338.0,2874.0,3057.0,2786.0,2680.0,2343.0,2053.0,2095.0,2153.0,1677.0,28890.0
Dhubri,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1397.0,1297.0,1903.0,1764.0,1756.0,1528.0,1487.0,1500.0,1649.0,1878.0,811.0,358.0,17328.0
Dhubri,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4001.0,3965.0,3628.0,4405.0,4313.0,3822.0,3638.0,3112.0,2709.0,2624.0,2935.0,2535.0,41687.0
Dhubri,14.10.2.a,Number of death cases of Inpatient males,TOTAL,34.0,41.0,31.0,29.0,42.0,50.0,27.0,43.0,46.0,35.0,31.0,57.0,466.0
Dhubri,14.10.2.b,Number of death cases of Inpatient females,TOTAL,36.0,35.0,38.0,35.0,32.0,24.0,33.0,32.0,36.0,24.0,29.0,22.0,376.0
Dhubri,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,70.0,76.0,69.0,64.0,74.0,74.0,60.0,75.0,82.0,59.0,60.0,79.0,842.0
Dhubri,14.11,In-Patient Head Count at midnight,TOTAL,7031.0,6667.0,6349.0,6339.0,7208.0,6746.0,6346.0,5418.0,4957.0,234.0,193.0,213.0,57701.0
Dhubri,14.12.1,OPD attendance (All),TOTAL,148667.0,184970.0,129603.0,160479.0,141321.0,135626.0,123149.0,116840.0,102365.0,96887.0,107443.0,129435.0,1576785.0
Dhubri,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,29.0,37.0,30.0,29.0,22.0,39.0,57.0,36.0,42.0,47.0,46.0,5.0,419.0
Dhubri,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,2.0,2.0,1.0,9.0
Dhubri,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,690.0,643.0,763.0,663.0,733.0,569.0,487.0,472.0,390.0,374.0,407.0,68.0,6259.0
Dhubri,14.14.a,Number of patients given AYUSH treatment,TOTAL,422.0,627.0,1375.0,1565.0,515.0,616.0,456.0,469.0,805.0,541.0,489.0,503.0,8383.0
Dhubri,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,619.0,531.0,495.0,455.0,514.0,563.0,512.0,516.0,478.0,538.0,465.0,473.0,6159.0
Dhubri,14.14.c,Number of Adolescents counselled,TOTAL,68.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,3.0,3.0,2.0,2.0,92.0
Dhubri,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9362.0,10436.0,8907.0,9450.0,9994.0,10304.0,10598.0,9037.0,9372.0,8510.0,8170.0,8792.0,112932.0
Dhubri,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,68.0,126.0,222.0,14.0,49.0,33.0,41.0,38.0,135.0,139.0,73.0,70.0,1008.0
Dhubri,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,86.0,139.0,173.0,111.0,97.0,137.0,92.0,75.0,44.0,113.0,115.0,103.0,1285.0
Dhubri,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,1.0,1.0,1.0,5.0,0.0,1.0,3.0,0.0,0.0,0.0,1.0,14.0
Dhubri,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,335.0,280.0,284.0,306.0,273.0,249.0,258.0,298.0,209.0,311.0,285.0,318.0,3406.0
Dhubri,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,2.0,0.0,0.0,7.0,0.0,4.0,0.0,1.0,14.0
Dhubri,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,380.0,578.0,640.0,445.0,633.0,562.0,557.0,565.0,286.0,228.0,397.0,575.0,5846.0
Dhubri,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,3.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Dhubri,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,801.0,997.0,1097.0,862.0,1003.0,948.0,907.0,938.0,539.0,652.0,797.0,996.0,10537.0
Dhubri,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,2.0,1.0,1.0,10.0,8.0,1.0,10.0,0.0,4.0,0.0,2.0,40.0
Dhubri,15.2,Number of Widal tests conducted,Number tested,242.0,132.0,228.0,206.0,175.0,147.0,147.0,169.0,103.0,68.0,71.0,116.0,1804.0
Dhubri,15.3.a,Number of VDRL tests conducted on males,Number tested,32.0,70.0,37.0,0.0,20.0,44.0,44.0,29.0,26.0,87.0,57.0,103.0,549.0
Dhubri,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,306.0,278.0,265.0,0.0,239.0,240.0,240.0,248.0,265.0,297.0,243.0,320.0,2941.0
Dhubri,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,99.0,563.0,442.0,100.0,92.0,350.0,350.0,414.0,199.0,179.0,42.0,74.0,2904.0
Dhubri,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,437.0,911.0,744.0,100.0,351.0,634.0,634.0,691.0,490.0,563.0,342.0,497.0,6394.0
Dhubri,15.4.1,Number of blood smears examined for Malaria,TOTAL,6532.0,9131.0,13505.0,14317.0,13326.0,9780.0,9981.0,9750.0,6228.0,6291.0,6985.0,7851.0,113677.0
Dhubri,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,1.0,4.0,3.0,5.0,0.0,1.0,4.0,7.0,1.0,26.0
Dhubri,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,5.0,27.0,13.0,10.0,9.0,14.0,13.0,15.0,4.0,4.0,7.0,5.0,126.0
Dhubri,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,36400.0,22900.0,32400.0,37400.0,38400.0,22400.0,17900.0,29900.0,18400.0,23400.0,17400.0,3500.0,300400.0
Dhubri,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,25000.0,20000.0,20000.0,15000.0,0.0,30000.0,0.0,20000.0,10000.0,0.0,20000.0,160000.0
Dhubri,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,13500.0,15500.0,15000.0,19000.0,31000.0,4500.0,18000.0,11500.0,15000.0,16000.0,13900.0,6500.0,179400.0
Dhubri,16.1.1,Stock position of DPT vaccines,5. Total Stock,22900.0,32400.0,37400.0,38400.0,22400.0,17900.0,29900.0,18400.0,23400.0,17400.0,3500.0,17000.0,281000.0
Dhubri,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Dhubri,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Dhubri,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Dhubri,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,21700.0,2700.0,30000.0,7200.0,0.0,20000.0,0.0,9500.0,0.0,0.0,8000.0,500.0,99600.0
Dhubri,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,45000.0,0.0,8000.0,38000.0,0.0,20000.0,2000.0,19000.0,468500.0,460000.0,40000.0,1100500.0
Dhubri,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,19000.0,17700.0,22800.0,15200.0,18000.0,20000.0,10500.0,11500.0,19000.0,460500.0,467500.0,6000.0,1087700.0
Dhubri,16.1.2,Stock position of OPV vaccines,5. Total Stock,2700.0,30000.0,7200.0,0.0,20000.0,0.0,9500.0,0.0,0.0,8000.0,500.0,34500.0,112400.0
Dhubri,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,38250.0,27750.0,34750.0,20750.0,23750.0,16250.0,4250.0,10000.0,1500.0,0.0,12000.0,23750.0,213000.0
Dhubri,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,20000.0,0.0,20000.0,20000.0,0.0,20000.0,0.0,0.0,20000.0,20000.0,10000.0,130000.0
Dhubri,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.1.3,Stock position of TT vaccines,4. Stock Distributed,10500.0,13000.0,14000.0,17000.0,27500.0,12000.0,14250.0,8500.0,1500.0,8000.0,8250.0,11500.0,146000.0
Dhubri,16.1.3,Stock position of TT vaccines,5. Total Stock,27750.0,34750.0,20750.0,23750.0,16250.0,4250.0,10000.0,1500.0,0.0,12000.0,23750.0,22250.0,197000.0
Dhubri,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,8500.0,600.0,2600.0,1400.0,2400.0,9000.0,0.0,0.0,3000.0,5500.0,22500.0,9500.0,65000.0
Dhubri,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,14500.0,4000.0,15000.0,20000.0,0.0,0.0,16000.0,15500.0,30000.0,0.0,0.0,115000.0
Dhubri,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,7900.0,12500.0,5200.0,14000.0,13400.0,9000.0,0.0,13000.0,13000.0,13000.0,13000.0,7000.0,121000.0
Dhubri,16.1.5,Stock position of BCG vaccines,5. Total Stock,600.0,2600.0,1400.0,2400.0,9000.0,0.0,0.0,3000.0,5500.0,22500.0,9500.0,2500.0,59000.0
Dhubri,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,20250.0,15000.0,17000.0,9000.0,11250.0,6000.0,2250.0,5750.0,9000.0,11000.0,3750.0,1000.0,111250.0
Dhubri,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,10000.0,0.0,10000.0,5000.0,0.0,10000.0,10000.0,10000.0,0.0,10000.0,5000.0,70000.0
Dhubri,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5250.0,8000.0,8000.0,7750.0,10250.0,3750.0,6500.0,6750.0,8000.0,7250.0,12750.0,5000.0,89250.0
Dhubri,16.1.6,Stock position of Measles vaccines,5. Total Stock,15000.0,17000.0,9000.0,11250.0,6000.0,2250.0,5750.0,9000.0,11000.0,3750.0,1000.0,1000.0,92000.0
Dhubri,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,30000.0,13000.0,17000.0,3300.0,2300.0,31500.0,8000.0,22000.0,8500.0,13000.0,7500.0,14000.0,170100.0
Dhubri,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,20000.0,0.0,14500.0,32000.0,0.0,30000.0,0.0,20000.0,10000.0,20000.0,10000.0,156500.0
Dhubri,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,17000.0,16000.0,13700.0,15500.0,2800.0,23500.0,16000.0,13500.0,15500.0,15500.0,13500.0,11500.0,174000.0
Dhubri,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,13000.0,17000.0,3300.0,2300.0,31500.0,8000.0,22000.0,8500.0,13000.0,7500.0,14000.0,12500.0,152600.0
Dhubri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,875.0,775.0,775.0,675.0,1825.0,625.0,25.0,0.0,0.0,0.0,0.0,0.0,5575.0
Dhubri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0
Dhubri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,100.0,0.0,100.0,50.0,1200.0,600.0,25.0,0.0,,0.0,0.0,0.0,2075.0
Dhubri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,775.0,775.0,675.0,1825.0,625.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,4700.0
Dhubri,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,5040.0,0.0,10080.0,10080.0,0.0,0.0,0.0,15120.0,0.0,40320.0
Dhubri,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,40320.0,0.0,55440.0,0.0,0.0,0.0,0.0,50400.0,0.0,40320.0,186480.0
Dhubri,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,35280.0,5040.0,45360.0,0.0,10080.0,0.0,,35280.0,15120.0,40320.0,186480.0
Dhubri,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,5040.0,0.0,10080.0,10080.0,0.0,0.0,0.0,15120.0,0.0,0.0,40320.0
Dhubri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,2000.0,0.0,2800.0,2800.0,0.0,0.0,0.0,2400.0,0.0,10000.0
Dhubri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,20000.0,0.0,20000.0,0.0,0.0,0.0,0.0,7200.0,0.0,0.0,47200.0
Dhubri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,18000.0,2000.0,17200.0,0.0,2800.0,0.0,,4800.0,2400.0,0.0,47200.0
Dhubri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,2000.0,0.0,2800.0,2800.0,0.0,0.0,0.0,2400.0,0.0,0.0,10000.0
Dhubri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,1000.0,0.0,1500.0,1500.0,1200.0,0.0,0.0,6000.0,0.0,11200.0
Dhubri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,10000.0,0.0,9000.0,0.0,6000.0,0.0,0.0,20000.0,0.0,0.0,45000.0
Dhubri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,9000.0,1000.0,7500.0,0.0,6300.0,1200.0,,14000.0,6000.0,0.0,45000.0
Dhubri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,1000.0,0.0,1500.0,1500.0,1200.0,0.0,0.0,6000.0,0.0,0.0,11200.0
Dhubri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Dhubri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Dhubri,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Dhubri,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Dhubri,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Dhubri,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Dhubri,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Dhubri,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Dhubri,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Dhubri,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Dhubri,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Dhubri,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Dhubri,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Dhubri,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Dhubri,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Dhubri,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Dhubri,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Dhubri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Dhubri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Dhubri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Dhubri,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Dhubri,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Dhubri,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Dhubri,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Dhubri,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Dhubri,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Dhubri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Dhubri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Dhubri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Dhubri,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Dhubri,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Dhubri,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Dhubri,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Dhubri,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Dhubri,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhubri,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1300.0,0.0,0.0,5100.0,8500.0,5300.0,900.0,0.0,1400.0,900.0,3900.0,400.0,27700.0
Dhubri,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,9900.0,13200.0,9900.0,0.0,0.0,9900.0,6600.0,8000.0,0.0,0.0,57500.0
Dhubri,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1300.0,0.0,4800.0,9800.0,13100.0,4400.0,900.0,8500.0,7100.0,5000.0,3500.0,400.0,58800.0
Dhubri,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,5100.0,8500.0,5300.0,900.0,0.0,1400.0,900.0,3900.0,400.0,0.0,26400.0
Dhubri,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,28800.0,2400.0,67200.0,33600.0,64800.0,62400.0,57800.0,38400.0,52800.0,74400.0,32800.0,387500.0,902900.0
Dhubri,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,96000.0,0.0,144000.0,0.0,0.0,0.0,72000.0,24000.0,24000.0,387500.0,240000.0,987500.0
Dhubri,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,26400.0,31200.0,33600.0,112800.0,2400.0,4600.0,19400.0,57600.0,2400.0,65600.0,32800.0,544800.0,933600.0
Dhubri,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,2400.0,67200.0,33600.0,64800.0,62400.0,57800.0,38400.0,52800.0,74400.0,32800.0,387500.0,82700.0,956800.0
Dhubri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,9200.0,7400.0,13200.0,10700.0,11000.0,15500.0,13200.0,11700.0,13100.0,16100.0,15100.0,13300.0,149500.0
Dhubri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,8000.0,0.0,4000.0,8000.0,0.0,0.0,4000.0,4000.0,2000.0,0.0,80000.0,110000.0
Dhubri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Dhubri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1800.0,2200.0,2500.0,3700.0,3500.0,2300.0,1500.0,2600.0,1000.0,3000.0,1800.0,54000.0,79900.0
Dhubri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,7400.0,13200.0,10700.0,11000.0,15500.0,13200.0,11700.0,13100.0,16100.0,15100.0,13300.0,39300.0,179600.0
Dhubri,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,3.0,1.0,2.0,2.0,,,1.0,1.0,,,11.0
Dhubri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,2.0,,,3.0,4.0,4.0,4.0,8.0,3.0,2.0,,31.0
Dhubri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dhubri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,2.0,,,3.0,4.0,4.0,4.0,8.0,3.0,2.0,,31.0
Dhubri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,15.0,22.0,10.0,11.0,11.0,18.0,16.0,10.0,16.0,8.0,5.0,1.0,143.0
Dhubri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dhubri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,15.0,22.0,10.0,11.0,11.0,18.0,16.0,10.0,16.0,8.0,5.0,1.0,143.0
Dhubri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,10.0,8.0,5.0,9.0,7.0,2.0,4.0,11.0,4.0,4.0,3.0,71.0
Dhubri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,2.0,,,,,2.0,1.0,,5.0
Dhubri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,10.0,8.0,5.0,11.0,7.0,2.0,4.0,11.0,6.0,5.0,3.0,76.0
Dhubri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,5.0,5.0,3.0,6.0,6.0,5.0,3.0,5.0,4.0,4.0,3.0,51.0
Dhubri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,1.0,,1.0
Dhubri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,5.0,5.0,3.0,6.0,6.0,5.0,3.0,5.0,4.0,5.0,3.0,52.0
Dhubri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,,1.0,4.0,4.0,1.0,3.0,1.0,,,15.0
Dhubri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dhubri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,1.0,4.0,4.0,1.0,3.0,1.0,,,15.0
Dhubri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Dhubri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
Dhubri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,,,,,1.0,,,,,,2.0
Dhubri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,3.0,,1.0,1.0,2.0,,,,,,,,7.0
Dhubri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,2.0,,,,,,,,,,,1.0,3.0
Dhubri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,5.0,,1.0,1.0,2.0,,,,,,,1.0,10.0
Dhubri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dhubri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dhubri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Dhubri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,11.0,2.0,8.0,7.0,6.0,6.0,6.0,14.0,17.0,5.0,2.0,3.0,87.0
Dhubri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,3.0,1.0,3.0,1.0,1.0,1.0,2.0,2.0,3.0,2.0,2.0,21.0
Dhubri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,11.0,5.0,9.0,10.0,7.0,7.0,7.0,16.0,19.0,8.0,4.0,5.0,108.0
Dhubri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Dhubri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Dhubri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Dhubri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,,,,,,,,,,1.0
Dhubri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Dhubri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,2.0,,4.0,2.0,3.0,3.0,1.0,3.0,2.0,3.0,2.0,25.0
Dhubri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,2.0,,,,,,,,,2.0
Dhubri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,2.0,,6.0,2.0,3.0,3.0,1.0,3.0,2.0,3.0,2.0,27.0
Dhubri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,3.0,2.0,3.0,1.0,1.0,,1.0,,,,,11.0
Dhubri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,1.0,1.0,1.0,5.0,3.0,2.0,4.0,9.0,1.0,,,28.0
Dhubri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,1.0,3.0,3.0,1.0,2.0,,1.0,3.0,,,1.0,17.0
Dhubri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,3.0,5.0,6.0,7.0,7.0,6.0,2.0,6.0,12.0,1.0,,1.0,56.0
Dhubri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Dhubri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,1.0,,,,,,,,1.0,2.0
Dhubri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,1.0,1.0,,,,,2.0
Dhubri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,1.0,,,1.0,1.0,,,,1.0,4.0
Dhubri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,1.0,1.0,1.0,1.0,,2.0,,,,,6.0
Dhubri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,9.0,5.0,8.0,5.0,10.0,4.0,12.0,8.0,6.0,1.0,2.0,2.0,72.0
Dhubri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,3.0,6.0,5.0,4.0,2.0,2.0,4.0,1.0,2.0,1.0,1.0,,31.0
Dhubri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,12.0,11.0,14.0,10.0,13.0,7.0,16.0,11.0,8.0,2.0,3.0,2.0,109.0
Dhubri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Dhubri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Dhubri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Dhubri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Dhubri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,1.0,,1.0,1.0,,,1.0,,,,,5.0
Dhubri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,10.0,10.0,14.0,9.0,8.0,5.0,15.0,11.0,7.0,4.0,5.0,2.0,100.0
Dhubri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,6.0,6.0,10.0,11.0,10.0,6.0,10.0,18.0,6.0,8.0,6.0,100.0
Dhubri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,14.0,17.0,20.0,20.0,20.0,15.0,21.0,22.0,25.0,10.0,13.0,8.0,205.0
Dhubri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Dhubri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,1.0,1.0,,2.0,,1.0,1.0,1.0,1.0,8.0
Dhubri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,1.0,2.0,3.0,,1.0,,,,1.0,1.0,,11.0
Dhubri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,1.0,2.0,4.0,1.0,1.0,2.0,,1.0,2.0,2.0,1.0,19.0
Dhubri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dhubri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,2.0,2.0,2.0,1.0,,,,,,,,7.0
Dhubri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dhubri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,2.0,2.0,2.0,1.0,,,,,,,,7.0
Dhubri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dhubri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Dhubri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dhubri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Dhubri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dhubri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,2.0,1.0,2.0,,,1.0,3.0,3.0,,,1.0,,13.0
Dhubri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dhubri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,2.0,1.0,2.0,,,1.0,3.0,3.0,,,1.0,,13.0
Dhubri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dhubri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,1.0,2.0,,1.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,14.0
Dhubri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dhubri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,1.0,2.0,,1.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,14.0
Dhubri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dhubri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Dhubri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dhubri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Dhubri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dhubri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,3.0,2.0,4.0,5.0,5.0,5.0,7.0,3.0,4.0,4.0,2.0,44.0
Dhubri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Dhubri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,3.0,2.0,4.0,5.0,5.0,5.0,7.0,3.0,4.0,4.0,2.0,44.0
Dhubri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,1.0,,3.0,2.0,,2.0,2.0,,,1.0,11.0
Dhubri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,8.0,7.0,8.0,16.0,6.0,5.0,10.0,5.0,3.0,6.0,4.0,83.0
Dhubri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,3.0,,1.0,3.0,,,4.0,4.0,3.0,2.0,,21.0
Dhubri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,6.0,11.0,8.0,9.0,22.0,8.0,5.0,16.0,11.0,6.0,8.0,5.0,115.0
Dhubri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,,,,1.0,,,,,,,,2.0
Dhubri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,2.0,6.0,4.0,1.0,2.0,5.0,2.0,3.0,5.0,3.0,3.0,39.0
Dhubri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Dhubri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,2.0,6.0,4.0,2.0,2.0,5.0,2.0,3.0,5.0,3.0,3.0,41.0
Dhubri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,1.0,,,,1.0,,2.0
Dhubri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,,1.0,2.0,,1.0,,,,5.0
Dhubri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,2.0,,,,,,1.0,1.0,4.0
Dhubri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,,2.0,1.0,3.0,,1.0,,2.0,1.0,11.0
Dhubri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,2.0,1.0,,,,,3.0
Dhubri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,6.0,1.0,4.0,2.0,1.0,,2.0,1.0,,1.0,,20.0
Dhubri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,4.0,4.0,5.0,6.0,4.0,4.0,2.0,,1.0,3.0,1.0,34.0
Dhubri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,10.0,5.0,9.0,8.0,5.0,6.0,5.0,1.0,1.0,4.0,1.0,57.0
Dhubri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Dhubri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,2.0,3.0,5.0,3.0,3.0,1.0,4.0,,,1.0,2.0,26.0
Dhubri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,5.0,2.0,7.0,10.0,8.0,8.0,11.0,10.0,6.0,6.0,4.0,6.0,83.0
Dhubri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,7.0,4.0,10.0,15.0,11.0,11.0,12.0,14.0,6.0,6.0,5.0,8.0,109.0
Dhubri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,2.0,2.0,2.0,4.0,3.0,1.0,2.0,1.0,4.0,3.0,2.0,26.0
Dhubri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,13.0,16.0,20.0,23.0,26.0,21.0,18.0,27.0,24.0,11.0,13.0,10.0,222.0
Dhubri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,27.0,27.0,17.0,34.0,33.0,32.0,43.0,47.0,46.0,41.0,40.0,34.0,421.0
Dhubri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,40.0,45.0,39.0,59.0,63.0,56.0,62.0,76.0,71.0,56.0,56.0,46.0,669.0
Dibrugarh,1.1,Total number of pregnant women Registered for ANC,TOTAL,2249.0,2527.0,2389.0,2515.0,2470.0,2231.0,2148.0,2029.0,1845.0,2009.0,2058.0,2556.0,27026.0
Dibrugarh,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1872.0,2129.0,1950.0,1904.0,2003.0,1683.0,1661.0,1616.0,1374.0,1644.0,1818.0,2139.0,21793.0
Dibrugarh,1.2,Number of Pregnant women registered under JSY,TOTAL,1965.0,2311.0,2160.0,2090.0,2113.0,2094.0,1881.0,1885.0,1622.0,1854.0,1804.0,2166.0,23945.0
Dibrugarh,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1540.0,1903.0,1861.0,2096.0,2840.0,2040.0,2139.0,1864.0,1815.0,1747.0,1542.0,1612.0,22999.0
Dibrugarh,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1646.0,1942.0,1721.0,1841.0,1973.0,1741.0,1533.0,1561.0,1358.0,1453.0,1631.0,2009.0,20409.0
Dibrugarh,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1733.0,1890.0,1911.0,2111.0,2111.0,2012.0,1942.0,1725.0,1681.0,1445.0,1539.0,1993.0,22093.0
Dibrugarh,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2032.0,2291.0,2174.0,2340.0,2069.0,2130.0,2107.0,1751.0,1533.0,1729.0,1654.0,2147.0,23957.0
Dibrugarh,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,24.0,181.0,133.0,177.0,187.0,122.0,100.0,132.0,77.0,64.0,62.0,57.0,1316.0
Dibrugarh,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,8.0,1.0,2.0,1.0,2.0,2.0,6.0,0.0,0.0,0.0,0.0,0.0,22.0
Dibrugarh,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1770.0,2308.0,2561.0,2222.0,2233.0,2126.0,2087.0,1831.0,1999.0,1908.0,1640.0,1757.0,24442.0
Dibrugarh,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,3.0,0.0,6.0,0.0,0.0,25.0,2.0,0.0,2.0,1.0,3.0,42.0
Dibrugarh,1.8,Number of pregnancy test kits used at SC level,TOTAL,421.0,484.0,495.0,467.0,452.0,414.0,322.0,306.0,367.0,370.0,343.0,327.0,4768.0
Dibrugarh,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,4.0,2.0,3.0,7.0,4.0,2.0,2.0,4.0,4.0,4.0,2.0,1.0,39.0
Dibrugarh,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,8.0,24.0,9.0,14.0,9.0,13.0,10.0,9.0,6.0,7.0,10.0,10.0,129.0
Dibrugarh,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,12.0,26.0,12.0,21.0,13.0,15.0,12.0,13.0,10.0,11.0,12.0,11.0,168.0
Dibrugarh,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,12.0,18.0,12.0,21.0,12.0,15.0,12.0,11.0,10.0,11.0,10.0,11.0,155.0
Dibrugarh,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1322.0,1371.0,1401.0,1446.0,1731.0,1751.0,1728.0,1677.0,1758.0,1689.0,1600.0,1465.0,18939.0
Dibrugarh,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,392.0,344.0,334.0,512.0,556.0,601.0,646.0,369.0,297.0,498.0,423.0,422.0,5394.0
Dibrugarh,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1360.0,1257.0,1320.0,1597.0,1759.0,1850.0,1829.0,1828.0,2054.0,1790.0,1595.0,2021.0,20260.0
Dibrugarh,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,564.0,347.0,1231.0,851.0,461.0,1108.0,365.0,866.0,1377.0,941.0,549.0,1095.0,9755.0
Dibrugarh,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dibrugarh,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,363.0,333.0,368.0,507.0,465.0,586.0,459.0,430.0,530.0,418.0,435.0,435.0,5329.0
Dibrugarh,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,6.0,24.0,39.0
Dibrugarh,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,0.0,0.0,,,,,,0.0,0.0,0.0,,0.0
Dibrugarh,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,0.0,0.0,0.0,,,,0.0,,0.0
Dibrugarh,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,7.0,128.0,151.0,9.0,0.0,0.0,3.0,6.0,0.0,0.0,0.0,1.0,305.0
Dibrugarh,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,286.0,200.0,203.0,283.0,345.0,304.0,291.0,297.0,382.0,326.0,366.0,288.0,3571.0
Dibrugarh,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibrugarh,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,293.0,328.0,354.0,292.0,345.0,304.0,294.0,303.0,382.0,326.0,366.0,289.0,3876.0
Dibrugarh,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,125.0,124.0,139.0,231.0,140.0,273.0,137.0,88.0,166.0,122.0,155.0,207.0,1907.0
Dibrugarh,4.1.1.a,Number of male live births,TOTAL,908.0,794.0,796.0,1033.0,1040.0,1104.0,1141.0,1083.0,1240.0,1095.0,1005.0,949.0,12188.0
Dibrugarh,4.1.1.b,Number of female live births,TOTAL,787.0,687.0,703.0,920.0,1135.0,1108.0,1004.0,1002.0,1034.0,980.0,1005.0,915.0,11280.0
Dibrugarh,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1695.0,1481.0,1499.0,1953.0,2175.0,2212.0,2145.0,2085.0,2274.0,2075.0,2010.0,1864.0,23468.0
Dibrugarh,4.1.2,Number of still births,TOTAL,33.0,42.0,40.0,48.0,51.0,65.0,63.0,51.0,51.0,59.0,53.0,52.0,608.0
Dibrugarh,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,415.0,387.0,408.0,410.0,268.0,304.0,161.0,157.0,180.0,165.0,134.0,227.0,3216.0
Dibrugarh,4.2.1,Number of Newborns weighed at birth,TOTAL,1608.0,1410.0,1500.0,1947.0,2175.0,2211.0,2143.0,2080.0,2240.0,2074.0,2010.0,1873.0,23271.0
Dibrugarh,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,375.0,379.0,315.0,548.0,511.0,641.0,478.0,468.0,520.0,447.0,366.0,407.0,5455.0
Dibrugarh,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1608.0,1406.0,1485.0,1946.0,2170.0,2206.0,2132.0,2080.0,2233.0,2022.0,2006.0,1853.0,23147.0
Dibrugarh,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,2.0,1.0,0.0,103.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,106.0
Dibrugarh,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,2.0,0.0,1.0,2.0,30.0,2.0,,0.0,0.0,0.0,0.0,0.0,37.0
Dibrugarh,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,286.0,200.0,203.0,291.0,340.0,305.0,291.0,297.0,382.0,326.0,575.0,575.0,4071.0
Dibrugarh,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibrugarh,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,288.0,202.0,205.0,293.0,473.0,307.0,291.0,297.0,382.0,326.0,575.0,575.0,4214.0
Dibrugarh,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1.0,0.0,2.0,10.0,75.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,98.0
Dibrugarh,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Dibrugarh,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,116.0,0.0,115.0,25.0,130.0,30.0,50.0,26.0,68.0,54.0,0.0,36.0,650.0
Dibrugarh,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,258.0,254.0,250.0,0.0,276.0,280.0,280.0,285.0,275.0,290.0,209.0,207.0,2864.0
Dibrugarh,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1467.0,1384.0,1326.0,1592.0,1848.0,2082.0,1816.0,1978.0,1882.0,1897.0,1889.0,1520.0,20681.0
Dibrugarh,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1138.0,1068.0,1026.0,1171.0,1531.0,1464.0,1553.0,1609.0,1678.0,1742.0,1672.0,1477.0,17129.0
Dibrugarh,6.3,PNC maternal complications attended,TOTAL,0.0,2.0,1.0,0.0,4.0,2.0,0.0,0.0,4.0,2.0,0.0,0.0,15.0
Dibrugarh,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,361.0,293.0,319.0,263.0,190.0,240.0,123.0,111.0,116.0,148.0,157.0,217.0,2538.0
Dibrugarh,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,27.0,18.0,24.0,61.0,62.0,16.0,53.0,71.0,57.0,6.0,8.0,8.0,411.0
Dibrugarh,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,388.0,311.0,343.0,324.0,252.0,256.0,176.0,182.0,173.0,154.0,165.0,225.0,2949.0
Dibrugarh,7.2,Number of MTPs conducted at Private Facilities,TOTAL,36.0,0.0,28.0,27.0,17.0,39.0,24.0,10.0,19.0,26.0,33.0,15.0,274.0
Dibrugarh,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Dibrugarh,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,73.0,79.0,86.0,28.0,28.0,7.0,7.0,7.0,9.0,7.0,9.0,9.0,349.0
Dibrugarh,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,73.0,79.0,86.0,28.0,28.0,7.0,7.0,7.0,9.0,7.0,10.0,9.0,350.0
Dibrugarh,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,47.0,0.0,16.0,44.0,20.0,20.0,105.0,252.0
Dibrugarh,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,,,,,,,,0.0,0.0,0.0,0.0
Dibrugarh,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibrugarh,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,47.0,0.0,16.0,44.0,20.0,20.0,105.0,252.0
Dibrugarh,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,33.0,170.0,103.0,100.0,90.0,0.0,428.0,220.0,330.0,975.0,2449.0
Dibrugarh,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,91.0,76.0,0.0,0.0,0.0,60.0,90.0,0.0,350.0,667.0
Dibrugarh,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,21.0,16.0,7.0,7.0,6.0,13.0,9.0,10.0,11.0,8.0,6.0,40.0,154.0
Dibrugarh,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibrugarh,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,21.0,16.0,40.0,268.0,185.0,113.0,99.0,10.0,499.0,318.0,336.0,1365.0,3270.0
Dibrugarh,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,22.0,25.0,18.0,26.0,33.0,22.0,30.0,33.0,38.0,41.0,23.0,28.0,339.0
Dibrugarh,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibrugarh,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,22.0,25.0,18.0,26.0,33.0,22.0,30.0,33.0,38.0,41.0,23.0,28.0,339.0
Dibrugarh,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,24.0,27.0,52.0,25.0,71.0,79.0,0.0,0.0,0.0,278.0
Dibrugarh,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,11.0,21.0,25.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,82.0
Dibrugarh,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,22.0,25.0,,26.0,34.0,22.0,30.0,33.0,38.0,41.0,23.0,28.0,322.0
Dibrugarh,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibrugarh,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,22.0,36.0,21.0,75.0,86.0,74.0,55.0,104.0,117.0,41.0,23.0,28.0,682.0
Dibrugarh,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,25.0,47.0,47.0,64.0,29.0,31.0,26.0,30.0,37.0,26.0,39.0,35.0,436.0
Dibrugarh,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,115.0,129.0,109.0,260.0,155.0,158.0,128.0,132.0,132.0,147.0,145.0,109.0,1719.0
Dibrugarh,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,8.0,5.0,4.0,26.0,13.0,19.0,21.0,23.0,102.0,157.0,43.0,2.0,423.0
Dibrugarh,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,83.0,72.0,61.0,90.0,76.0,103.0,83.0,65.0,99.0,92.0,84.0,191.0,1099.0
Dibrugarh,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dibrugarh,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,231.0,253.0,221.0,440.0,273.0,311.0,258.0,250.0,370.0,422.0,311.0,337.0,3677.0
Dibrugarh,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,98.0,93.0,76.0,102.0,119.0,124.0,128.0,128.0,228.0,317.0,227.0,288.0,1928.0
Dibrugarh,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,7.0,2.0,2.0,1.0,15.0,21.0,1.0,0.0,24.0,54.0,27.0,6.0,160.0
Dibrugarh,9.06,Number of IUCD removals,TOTAL,40.0,59.0,99.0,32.0,35.0,18.0,18.0,38.0,28.0,18.0,23.0,28.0,436.0
Dibrugarh,9.07,Number of Oral Pills cycles distributed,TOTAL,3166.0,3813.0,3748.0,4908.0,4658.0,4695.0,4691.0,4615.0,4574.0,4559.0,4726.0,4819.0,52972.0
Dibrugarh,9.08,Number of Condom pieces distributed,TOTAL,14220.0,16344.0,15661.0,21881.0,20710.0,19575.0,19553.0,19243.0,24631.0,22233.0,23029.0,23561.0,240641.0
Dibrugarh,9.09,Number of Centchroman (weekly) pills given,TOTAL,5.0,95.0,1.0,0.0,29.0,4.0,11.0,2.0,16.0,4.0,41.0,5.0,213.0
Dibrugarh,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,70.0,50.0,105.0,41.0,80.0,38.0,29.0,36.0,6.0,6.0,20.0,15.0,496.0
Dibrugarh,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Dibrugarh,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,4.0,4.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,3.0,3.0,-1.0
Dibrugarh,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2579.0,1883.0,1843.0,1885.0,2007.0,2144.0,2231.0,2342.0,2430.0,2071.0,2056.0,1885.0,25356.0
Dibrugarh,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1813.0,1824.0,1575.0,1788.0,1787.0,1762.0,1941.0,2161.0,1906.0,2006.0,1457.0,228.0,20248.0
Dibrugarh,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1856.0,1830.0,1751.0,1834.0,1786.0,1517.0,1549.0,1992.0,2121.0,1835.0,1828.0,1482.0,21381.0
Dibrugarh,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1667.0,1780.0,1775.0,1922.0,1879.0,1590.0,1482.0,1618.0,1921.0,1923.0,1728.0,1969.0,21254.0
Dibrugarh,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,535.0,1780.0,2319.0
Dibrugarh,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,443.0,443.0
Dibrugarh,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Dibrugarh,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1445.0,1279.0,1256.0,1426.0,917.0,1123.0,998.0,704.0,383.0,1048.0,1283.0,1029.0,12891.0
Dibrugarh,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1833.0,1808.0,1520.0,1773.0,1567.0,1457.0,898.0,1687.0,800.0,2320.0,1754.0,1485.0,18902.0
Dibrugarh,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1851.0,1814.0,1679.0,1822.0,1580.0,1266.0,759.0,1443.0,875.0,1800.0,2133.0,1792.0,18814.0
Dibrugarh,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1668.0,1783.0,1704.0,1882.0,1610.0,1341.0,733.0,1207.0,749.0,1710.0,1800.0,2156.0,18343.0
Dibrugarh,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1146.0,971.0,955.0,809.0,1134.0,964.0,728.0,1247.0,1318.0,1013.0,841.0,533.0,11659.0
Dibrugarh,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2116.0,1980.0,1541.0,1550.0,1668.0,1647.0,1031.0,2341.0,1914.0,1994.0,1386.0,286.0,19454.0
Dibrugarh,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1719.0,2147.0,1897.0,1642.0,1666.0,1511.0,883.0,1956.0,2251.0,1963.0,1749.0,1490.0,20874.0
Dibrugarh,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1550.0,1863.0,1906.0,1796.0,1899.0,1678.0,884.0,1673.0,1874.0,2078.0,1705.0,1971.0,20877.0
Dibrugarh,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1367.0,1697.0,1780.0,1917.0,2330.0,1889.0,1816.0,1950.0,1604.0,1802.0,1730.0,1772.0,21654.0
Dibrugarh,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1349.0,1565.0,1632.0,1485.0,1608.0,1421.0,1207.0,1359.0,1115.0,1388.0,1298.0,1543.0,16970.0
Dibrugarh,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1335.0,1640.0,1707.0,2216.0,2609.0,377.0,216.0,2106.0,1738.0,1776.0,1458.0,1546.0,18724.0
Dibrugarh,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,722.0,863.0,934.0,1000.0,1191.0,967.0,931.0,997.0,813.0,942.0,891.0,892.0,11143.0
Dibrugarh,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,645.0,835.0,846.0,917.0,1130.0,917.0,878.0,937.0,790.0,851.0,830.0,880.0,10456.0
Dibrugarh,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1367.0,1698.0,1780.0,1917.0,2321.0,1884.0,1809.0,1934.0,1603.0,1793.0,1721.0,1772.0,21599.0
Dibrugarh,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1518.0,1751.0,1842.0,1588.0,1790.0,1676.0,1392.0,1550.0,1386.0,1474.0,1446.0,1691.0,19104.0
Dibrugarh,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1522.0,1762.0,1803.0,1531.0,1550.0,1584.0,781.0,1202.0,605.0,1524.0,1449.0,1743.0,17056.0
Dibrugarh,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,17.0,42.0,48.0,42.0,25.0,31.0,18.0,6.0,40.0,26.0,44.0,26.0,365.0
Dibrugarh,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,142.0,42.0,121.0,97.0,129.0,119.0,94.0,79.0,78.0,68.0,71.0,93.0,1133.0
Dibrugarh,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,124.0,49.0,94.0,92.0,113.0,91.0,93.0,90.0,93.0,62.0,76.0,96.0,1073.0
Dibrugarh,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,266.0,91.0,215.0,189.0,242.0,210.0,187.0,169.0,171.0,130.0,147.0,189.0,2206.0
Dibrugarh,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,845.0,886.0,749.0,1052.0,1033.0,877.0,784.0,940.0,1076.0,1186.0,1078.0,939.0,11445.0
Dibrugarh,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,536.0,511.0,492.0,652.0,639.0,513.0,462.0,635.0,589.0,629.0,583.0,649.0,6890.0
Dibrugarh,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,325.0,268.0,287.0,331.0,374.0,288.0,258.0,318.0,322.0,311.0,279.0,313.0,3674.0
Dibrugarh,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,3.0
Dibrugarh,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Dibrugarh,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1025.0,1039.0,1032.0,1030.0,1028.0,1023.0,1014.0,1000.0,1007.0,1006.0,1016.0,1023.0,12243.0
Dibrugarh,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1026.0,1040.0,1019.0,1013.0,1017.0,1006.0,1002.0,998.0,999.0,1002.0,1009.0,1017.0,12148.0
Dibrugarh,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1017.0,1030.0,1007.0,997.0,1002.0,986.0,978.0,983.0,977.0,989.0,990.0,996.0,11952.0
Dibrugarh,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1288.0,1498.0,1587.0,1608.0,1461.0,353.0,182.0,1377.0,1363.0,1344.0,1262.0,1488.0,14811.0
Dibrugarh,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1212.0,1572.0,1496.0,1602.0,2040.0,1827.0,1616.0,1682.0,1402.0,1539.0,1538.0,1249.0,18775.0
Dibrugarh,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,340.0,301.0,285.0,526.0,1673.0,1064.0,385.0,341.0,339.0,381.0,1238.0,469.0,7342.0
Dibrugarh,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,570.0,592.0,492.0,852.0,1738.0,942.0,510.0,631.0,720.0,753.0,1647.0,584.0,10031.0
Dibrugarh,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,5.0,4.0,9.0,0.0,191.0,0.0,6.0,1.0,1.0,5.0,6.0,17.0,245.0
Dibrugarh,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,467.0,506.0,517.0,560.0,782.0,458.0,407.0,274.0,251.0,194.0,219.0,201.0,4836.0
Dibrugarh,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,11.0,0.0,0.0,12.0
Dibrugarh,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,19.0,13.0,7.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,49.0
Dibrugarh,13.1,Number of Patients operated for cataract,TOTAL,52.0,126.0,12.0,14.0,41.0,41.0,6.0,27.0,5.0,4.0,3.0,3.0,334.0
Dibrugarh,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,126.0,12.0,14.0,41.0,41.0,6.0,27.0,5.0,4.0,3.0,3.0,282.0
Dibrugarh,13.3,Number of School children detected with Refractive errors,TOTAL,15.0,26.0,6.0,7.0,21.0,21.0,167.0,12.0,0.0,5.0,0.0,7.0,287.0
Dibrugarh,13.4,Number of children provided free glasses,TOTAL,15.0,26.0,6.0,7.0,21.0,21.0,167.0,12.0,0.0,5.0,0.0,7.0,287.0
Dibrugarh,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,-1.0
Dibrugarh,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,12.0,12.0,12.0,14.0,11.0,13.0,12.0,12.0,11.0,12.0,13.0,12.0,-1.0
Dibrugarh,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,883.0,893.0,896.0,895.0,848.0,888.0,874.0,868.0,885.0,850.0,868.0,876.0,-1.0
Dibrugarh,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,4.0,4.0,3.0,3.0,3.0,2.0,3.0,3.0,2.0,2.0,3.0,-1.0
Dibrugarh,14.05,Number of RKS meetings held during the month,TOTAL,10.0,8.0,8.0,10.0,9.0,7.0,5.0,5.0,5.0,3.0,2.0,3.0,75.0
Dibrugarh,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,24.0,18.0,21.0,18.0,16.0,15.0,15.0,17.0,13.0,15.0,14.0,16.0,-1.0
Dibrugarh,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,79.0,48.0,51.0,72.0,104.0,107.0,102.0,129.0,141.0,120.0,51.0,74.0,1078.0
Dibrugarh,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Dibrugarh,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,,-1.0
Dibrugarh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,501.0,434.0,527.0,640.0,600.0,556.0,713.0,397.0,423.0,440.0,146.0,218.0,5595.0
Dibrugarh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2869.0,3257.0,3642.0,3303.0,3188.0,3173.0,4082.0,2347.0,3052.0,2984.0,531.0,3001.0,35429.0
Dibrugarh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,440.0,525.0,541.0,671.0,654.0,563.0,590.0,482.0,447.0,413.0,242.0,275.0,5843.0
Dibrugarh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3302.0,3930.0,3696.0,3937.0,3555.0,3388.0,3876.0,2919.0,4045.0,2873.0,1103.0,3578.0,40202.0
Dibrugarh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,941.0,959.0,1068.0,1311.0,1254.0,1119.0,1303.0,879.0,870.0,853.0,388.0,493.0,11438.0
Dibrugarh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6171.0,7187.0,7338.0,7240.0,6743.0,6561.0,7958.0,5266.0,7097.0,5857.0,1634.0,6579.0,75631.0
Dibrugarh,14.10.2.a,Number of death cases of Inpatient males,TOTAL,19.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,25.0
Dibrugarh,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,5.0
Dibrugarh,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,22.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,30.0
Dibrugarh,14.11,In-Patient Head Count at midnight,TOTAL,292.0,190.0,391.0,396.0,262.0,211.0,209.0,180.0,158.0,167.0,176.0,185.0,2817.0
Dibrugarh,14.12.1,OPD attendance (All),TOTAL,154979.0,156119.0,182568.0,191621.0,184273.0,178921.0,168717.0,163133.0,146588.0,123039.0,119477.0,146632.0,1916067.0
Dibrugarh,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,55.0,21.0,90.0,80.0,0.0,108.0,114.0,21.0,168.0,24.0,43.0,13.0,737.0
Dibrugarh,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,6.0,5.0,15.0,3.0,,14.0,15.0,8.0,2.0,12.0,2.0,3.0,85.0
Dibrugarh,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,48.0,9.0,20.0,47.0,5.0,45.0,35.0,12.0,15.0,9.0,30.0,9.0,284.0
Dibrugarh,14.14.a,Number of patients given AYUSH treatment,TOTAL,2399.0,2452.0,2507.0,2527.0,2359.0,2289.0,2122.0,1202.0,1470.0,1397.0,1479.0,1678.0,23881.0
Dibrugarh,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,69.0,69.0,0.0,0.0,0.0,0.0,0.0,0.0,138.0
Dibrugarh,14.14.c,Number of Adolescents counselled,TOTAL,123.0,108.0,0.0,126.0,53.0,35.0,0.0,0.0,0.0,0.0,0.0,0.0,445.0
Dibrugarh,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7631.0,8444.0,5902.0,6320.0,6887.0,6310.0,6432.0,5401.0,6007.0,4733.0,4687.0,5053.0,73807.0
Dibrugarh,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,236.0,261.0,210.0,260.0,266.0,246.0,301.0,161.0,148.0,87.0,116.0,112.0,2404.0
Dibrugarh,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,16.0,15.0,386.0,10.0,0.0,5.0,8.0,4.0,8.0,0.0,86.0,56.0,594.0
Dibrugarh,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,45.0,17.0,21.0,15.0,0.0,21.0,20.0,31.0,29.0,0.0,86.0,37.0,322.0
Dibrugarh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,478.0,618.0,248.0,564.0,0.0,600.0,942.0,668.0,193.0,619.0,427.0,713.0,6070.0
Dibrugarh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,1.0,2.0,1.0,0.0,0.0,0.0,1.0,5.0
Dibrugarh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,539.0,650.0,655.0,589.0,0.0,626.0,970.0,703.0,230.0,619.0,599.0,806.0,6986.0
Dibrugarh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,1.0,2.0,1.0,0.0,0.0,0.0,1.0,5.0
Dibrugarh,15.2,Number of Widal tests conducted,Number tested,187.0,106.0,72.0,153.0,87.0,174.0,101.0,47.0,27.0,22.0,18.0,7.0,1001.0
Dibrugarh,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,3.0,0.0,31.0,20.0,5.0,16.0,0.0,0.0,18.0,86.0,0.0,179.0
Dibrugarh,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,26.0,86.0,0.0,112.0
Dibrugarh,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,102.0,96.0,95.0,92.0,0.0,102.0,97.0,116.0,139.0,349.0,128.0,151.0,1467.0
Dibrugarh,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,102.0,99.0,95.0,123.0,20.0,107.0,113.0,116.0,139.0,393.0,300.0,151.0,1758.0
Dibrugarh,15.4.1,Number of blood smears examined for Malaria,TOTAL,6015.0,7115.0,10320.0,13263.0,19494.0,10414.0,7451.0,7138.0,5969.0,6380.0,6284.0,5668.0,105511.0
Dibrugarh,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,15.0,3.0,1594.0,0.0,0.0,0.0,1439.0,3051.0
Dibrugarh,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,2.0,3.0,3.0,5.0,0.0,1.0,0.0,0.0,0.0,15.0,0.0,29.0
Dibrugarh,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3280.0,2337.0,2812.0,4489.0,4813.0,4773.0,3668.0,3509.0,2179.0,3873.0,2598.0,3444.0,41775.0
Dibrugarh,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,2000.0,3000.0,1600.0,1000.0,0.0,1000.0,0.0,3000.0,0.0,2000.0,0.0,13600.0
Dibrugarh,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,943.0,1525.0,1323.0,1276.0,1040.0,1105.0,1159.0,1330.0,1306.0,1275.0,1154.0,1130.0,14566.0
Dibrugarh,16.1.1,Stock position of DPT vaccines,5. Total Stock,2337.0,2812.0,4489.0,4813.0,4773.0,3668.0,3509.0,2179.0,3873.0,2598.0,3444.0,2314.0,40809.0
Dibrugarh,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Dibrugarh,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Dibrugarh,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Dibrugarh,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Dibrugarh,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,265.0,315.0,43.0,425.0,0.0,241.0,30.0,339.0,0.0,500.0,314.0,1648.0,4120.0
Dibrugarh,16.1.2,Stock position of OPV vaccines,2. Stocks Received,600.0,550.0,1150.0,0.0,1100.0,0.0,550.0,0.0,500.0,325.0,1840.0,0.0,6615.0
Dibrugarh,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,550.0,822.0,768.0,425.0,859.0,211.0,241.0,339.0,0.0,511.0,506.0,645.0,5877.0
Dibrugarh,16.1.2,Stock position of OPV vaccines,5. Total Stock,315.0,43.0,425.0,0.0,241.0,30.0,339.0,0.0,500.0,314.0,1648.0,1003.0,4858.0
Dibrugarh,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4070.0,3020.0,2215.0,1530.0,1854.0,2144.0,944.0,2685.0,1295.0,345.0,0.0,896.0,20998.0
Dibrugarh,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,1000.0,500.0,1500.0,1500.0,0.0,2500.0,0.0,0.0,0.0,2000.0,0.0,9000.0
Dibrugarh,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1050.0,1805.0,1185.0,1176.0,1210.0,1200.0,759.0,1390.0,950.0,345.0,1104.0,865.0,13039.0
Dibrugarh,16.1.3,Stock position of TT vaccines,5. Total Stock,3020.0,2215.0,1530.0,1854.0,2144.0,944.0,2685.0,1295.0,345.0,0.0,896.0,31.0,16959.0
Dibrugarh,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Dibrugarh,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Dibrugarh,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Dibrugarh,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Dibrugarh,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,444.0,194.0,455.0,115.0,304.0,784.0,295.0,84.0,559.0,2240.0,1384.0,2366.0,9224.0
Dibrugarh,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,1100.0,0.0,1100.0,1100.0,0.0,0.0,950.0,2750.0,0.0,1800.0,0.0,8800.0
Dibrugarh,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,250.0,839.0,340.0,911.0,620.0,489.0,211.0,475.0,1069.0,856.0,818.0,766.0,7644.0
Dibrugarh,16.1.5,Stock position of BCG vaccines,5. Total Stock,194.0,455.0,115.0,304.0,784.0,295.0,84.0,559.0,2240.0,1384.0,2366.0,1600.0,10380.0
Dibrugarh,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3830.0,2780.0,4245.0,3043.0,3493.0,3627.0,2470.0,1000.0,3.0,2057.0,672.0,1122.0,28342.0
Dibrugarh,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,3000.0,0.0,2000.0,1000.0,0.0,0.0,0.0,3000.0,0.0,2000.0,0.0,11000.0
Dibrugarh,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1050.0,1535.0,1202.0,1550.0,866.0,1157.0,1470.0,997.0,946.0,1385.0,1550.0,478.0,14186.0
Dibrugarh,16.1.6,Stock position of Measles vaccines,5. Total Stock,2780.0,4245.0,3043.0,3493.0,3627.0,2470.0,1000.0,3.0,2057.0,672.0,1122.0,644.0,25156.0
Dibrugarh,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,3572.0,3072.0,5337.0,4303.0,5417.0,10.0,0.0,2000.0,185.0,1789.0,589.0,1627.0,27901.0
Dibrugarh,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,3000.0,0.0,5000.0,0.0,0.0,2000.0,0.0,3000.0,0.0,2000.0,0.0,15000.0
Dibrugarh,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.1.7,Stock position of JE vaccines,4. Stock Distributed,500.0,735.0,1034.0,3886.0,5407.0,10.0,0.0,1815.0,1396.0,1200.0,962.0,1246.0,18191.0
Dibrugarh,16.1.7,Stock position of JE vaccines,5. Total Stock,3072.0,5337.0,4303.0,5417.0,10.0,0.0,2000.0,185.0,1789.0,589.0,1627.0,381.0,24710.0
Dibrugarh,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1730.0,435.0,400.0,17.0,107.0,672.0,66.0,2000.0,295.0,3572.0,2357.0,2354.0,14005.0
Dibrugarh,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,1100.0,0.0,1100.0,1500.0,0.0,2000.0,0.0,4500.0,0.0,1000.0,0.0,11200.0
Dibrugarh,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1295.0,1135.0,383.0,1010.0,935.0,606.0,66.0,1705.0,1223.0,1215.0,1003.0,1063.0,11639.0
Dibrugarh,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,435.0,400.0,17.0,107.0,672.0,66.0,2000.0,295.0,3572.0,2357.0,2354.0,1291.0,13566.0
Dibrugarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,475.0,475.0,475.0,475.0,1200.0,1200.0,1200.0,400.0,350.0,0.0,0.0,0.0,6250.0
Dibrugarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,3600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3600.0
Dibrugarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,2875.0,0.0,0.0,800.0,50.0,350.0,0.0,0.0,0.0,4075.0
Dibrugarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,475.0,475.0,475.0,1200.0,1200.0,1200.0,400.0,350.0,0.0,0.0,0.0,0.0,5775.0
Dibrugarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,25342.0,25342.0,25342.0,25342.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29820.0,131188.0
Dibrugarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29820.0,0.0,29820.0
Dibrugarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,25342.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25342.0
Dibrugarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,25342.0,25342.0,25342.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29820.0,29820.0,135666.0
Dibrugarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,99900.0,99900.0,99900.0,99900.0,7500.0,7500.0,7500.0,6100.0,5100.0,100.0,100.0,0.0,433500.0
Dibrugarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,30000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30000.0
Dibrugarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,122400.0,0.0,0.0,1400.0,1000.0,5000.0,0.0,100.0,0.0,129900.0
Dibrugarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,99900.0,99900.0,99900.0,7500.0,7500.0,7500.0,6100.0,5100.0,100.0,100.0,0.0,0.0,333600.0
Dibrugarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,600.0,600.0,600.0,600.0,8000.0,8000.0,8000.0,7750.0,6250.0,6250.0,6250.0,8250.0,61150.0
Dibrugarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,10500.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,12500.0
Dibrugarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,3100.0,0.0,0.0,250.0,1500.0,0.0,0.0,0.0,0.0,4850.0
Dibrugarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,600.0,600.0,600.0,8000.0,8000.0,8000.0,7750.0,6250.0,6250.0,6250.0,8250.0,8250.0,68800.0
Dibrugarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1478.0,1478.0,1478.0,1478.0,500.0,500.0,500.0,5150.0,4850.0,4850.0,4850.0,7300.0,34412.0
Dibrugarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,5000.0,0.0,0.0,4650.0,0.0,0.0,0.0,2450.0,0.0,12100.0
Dibrugarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,5978.0,0.0,0.0,0.0,300.0,0.0,0.0,0.0,0.0,6278.0
Dibrugarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1478.0,1478.0,1478.0,500.0,500.0,500.0,5150.0,4850.0,4850.0,4850.0,7300.0,7300.0,40234.0
Dibrugarh,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Dibrugarh,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Dibrugarh,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Dibrugarh,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Dibrugarh,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Dibrugarh,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Dibrugarh,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Dibrugarh,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Dibrugarh,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Dibrugarh,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Dibrugarh,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Dibrugarh,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Dibrugarh,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Dibrugarh,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Dibrugarh,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Dibrugarh,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Dibrugarh,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Dibrugarh,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Dibrugarh,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Dibrugarh,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Dibrugarh,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Dibrugarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Dibrugarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Dibrugarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Dibrugarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Dibrugarh,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Dibrugarh,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Dibrugarh,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Dibrugarh,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Dibrugarh,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Dibrugarh,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Dibrugarh,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Dibrugarh,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Dibrugarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Dibrugarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Dibrugarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Dibrugarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Dibrugarh,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Dibrugarh,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Dibrugarh,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Dibrugarh,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Dibrugarh,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Dibrugarh,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Dibrugarh,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Dibrugarh,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,7970.0,5870.0,3060.0,14060.0,9460.0,12460.0,10160.0,7310.0,10410.0,13110.0,9300.0,5100.0,108270.0
Dibrugarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,13200.0,0.0,6600.0,0.0,0.0,6600.0,7300.0,0.0,0.0,0.0,33700.0
Dibrugarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2100.0,2810.0,2200.0,4600.0,3600.0,2300.0,2850.0,3500.0,4600.0,3810.0,4200.0,2900.0,39470.0
Dibrugarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,5870.0,3060.0,14060.0,9460.0,12460.0,10160.0,7310.0,10410.0,13110.0,9300.0,5100.0,2200.0,102500.0
Dibrugarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,52980.0,35780.0,32980.0,35380.0,14930.0,8930.0,16800.0,35400.0,1830.0,73230.0,45830.0,20030.0,374100.0
Dibrugarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,21600.0,19200.0,24000.0,38400.0,38400.0,36000.0,0.0,91200.0,0.0,0.0,0.0,268800.0
Dibrugarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,17200.0,24400.0,16800.0,44450.0,44400.0,30530.0,17400.0,33570.0,19800.0,27400.0,25800.0,17800.0,319550.0
Dibrugarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,35780.0,32980.0,35380.0,14930.0,8930.0,16800.0,35400.0,1830.0,73230.0,45830.0,20030.0,2230.0,323350.0
Dibrugarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,6310.0,4710.0,8760.0,11160.0,10060.0,6860.0,4060.0,6460.0,4960.0,9060.0,5660.0,7060.0,85120.0
Dibrugarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,6000.0,4000.0,2000.0,4000.0,0.0,4000.0,0.0,8000.0,0.0,4000.0,0.0,32000.0
Dibrugarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dibrugarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1600.0,1950.0,1600.0,3100.0,7200.0,2800.0,1600.0,1500.0,3900.0,3400.0,2600.0,2800.0,34050.0
Dibrugarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4710.0,8760.0,11160.0,10060.0,6860.0,4060.0,6460.0,4960.0,9060.0,5660.0,7060.0,4260.0,83070.0
Dibrugarh,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,,,,,,1.0,,,,,2.0
Dibrugarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,2.0,2.0,2.0,6.0
Dibrugarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dibrugarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,2.0,2.0,2.0,6.0
Dibrugarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,1.0,,,,,,,,,1.0
Dibrugarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dibrugarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,1.0,,,,,,,,,1.0
Dibrugarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,3.0,2.0,4.0,,1.0,2.0,5.0,4.0,3.0,2.0,26.0
Dibrugarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dibrugarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,3.0,2.0,4.0,,1.0,2.0,5.0,4.0,3.0,2.0,26.0
Dibrugarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,3.0,2.0,1.0,,4.0,4.0,4.0,3.0,3.0,4.0,3.0,32.0
Dibrugarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dibrugarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,3.0,2.0,1.0,,4.0,4.0,4.0,3.0,3.0,4.0,3.0,32.0
Dibrugarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,1.0,,,,,3.0,2.0,,1.0,1.0,9.0
Dibrugarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dibrugarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,1.0,,,,,3.0,2.0,,1.0,1.0,9.0
Dibrugarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dibrugarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dibrugarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Dibrugarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,9.0
Dibrugarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,,,,1.0,,,,2.0
Dibrugarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,2.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,11.0
Dibrugarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dibrugarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dibrugarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Dibrugarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,1.0,,1.0,2.0,5.0,1.0,4.0,4.0,3.0,3.0,3.0,28.0
Dibrugarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,1.0,,,,1.0,2.0,1.0,1.0,6.0
Dibrugarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,1.0,,1.0,3.0,5.0,1.0,4.0,5.0,5.0,4.0,4.0,34.0
Dibrugarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Dibrugarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Dibrugarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,,,1.0,,,,,,2.0
Dibrugarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,,1.0,,,,,1.0,3.0
Dibrugarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,2.0,1.0,,1.0,2.0,,2.0,2.0,,,11.0
Dibrugarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,1.0,,,,,,,,1.0,,3.0
Dibrugarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,1.0,3.0,1.0,,1.0,2.0,,2.0,2.0,1.0,,14.0
Dibrugarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,2.0,,1.0,3.0,,2.0,,3.0,4.0,15.0
Dibrugarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,2.0,2.0,1.0,1.0,1.0,3.0,3.0,3.0,2.0,2.0,20.0
Dibrugarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,2.0,4.0,1.0,2.0,4.0,3.0,5.0,3.0,5.0,6.0,35.0
Dibrugarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Dibrugarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Dibrugarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Dibrugarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,1.0,1.0,3.0,1.0,2.0,2.0,2.0,3.0,2.0,2.0,2.0,22.0
Dibrugarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,1.0,,1.0,,,2.0
Dibrugarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,1.0,1.0,3.0,1.0,2.0,2.0,3.0,3.0,3.0,2.0,2.0,24.0
Dibrugarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Dibrugarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Dibrugarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Dibrugarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,4.0,2.0,1.0,,3.0,2.0,7.0,4.0,2.0,3.0,,4.0,32.0
Dibrugarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,1.0,2.0,5.0,3.0,4.0,5.0,2.0,2.0,12.0,7.0,10.0,55.0
Dibrugarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,6.0,3.0,3.0,5.0,6.0,6.0,12.0,6.0,4.0,15.0,7.0,14.0,87.0
Dibrugarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,1.0,,,,1.0,1.0,1.0,2.0,2.0,9.0
Dibrugarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,1.0,1.0,,,1.0,,2.0,1.0,1.0,7.0
Dibrugarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,,2.0,1.0,,,2.0,1.0,3.0,3.0,3.0,16.0
Dibrugarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dibrugarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Dibrugarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dibrugarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Dibrugarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,,,,,,,1.0,2.0
Dibrugarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dibrugarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,,,,,,,1.0,2.0
Dibrugarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Dibrugarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dibrugarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,,,,,,,,,1.0
Dibrugarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dibrugarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Dibrugarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,2.0,,,2.0,1.0,1.0,2.0,2.0,1.0,,1.0,12.0
Dibrugarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Dibrugarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,2.0,,,2.0,1.0,1.0,2.0,2.0,1.0,,1.0,12.0
Dibrugarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,,1.0,,,,,,,,,3.0
Dibrugarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,4.0,2.0,3.0,6.0,2.0,1.0,,3.0,1.0,3.0,4.0,2.0,31.0
Dibrugarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,,1.0,,1.0,2.0,1.0,1.0,1.0,,,8.0
Dibrugarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,5.0,3.0,8.0,2.0,2.0,2.0,4.0,2.0,4.0,4.0,2.0,42.0
Dibrugarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,,,,,,,1.0,,,,,2.0
Dibrugarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,,1.0,2.0,,2.0,2.0,1.0,,5.0,4.0,3.0,22.0
Dibrugarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,,,1.0,,,1.0,,,3.0
Dibrugarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,3.0,,1.0,3.0,,2.0,3.0,2.0,,6.0,4.0,3.0,27.0
Dibrugarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Dibrugarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,,,,,,1.0,,2.0,4.0
Dibrugarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Dibrugarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,1.0,,,,,,1.0,,2.0,5.0
Dibrugarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Dibrugarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,2.0,,,,3.0,3.0,2.0,1.0,4.0,1.0,1.0,18.0
Dibrugarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,3.0,,1.0,2.0,1.0,,2.0,2.0,4.0,1.0,2.0,21.0
Dibrugarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,4.0,5.0,,2.0,2.0,4.0,3.0,4.0,3.0,8.0,2.0,3.0,40.0
Dibrugarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,1.0,1.0,,2.0,2.0,1.0,1.0,,,8.0
Dibrugarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,4.0,2.0,3.0,4.0,2.0,6.0,8.0,3.0,6.0,8.0,9.0,56.0
Dibrugarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,4.0,6.0,7.0,8.0,10.0,4.0,11.0,12.0,17.0,14.0,12.0,10.0,115.0
Dibrugarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,5.0,10.0,9.0,12.0,15.0,6.0,19.0,22.0,21.0,21.0,20.0,19.0,179.0
Dibrugarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,8.0
Dibrugarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,11.0,8.0,11.0,18.0,10.0,10.0,21.0,13.0,7.0,14.0,15.0,18.0,156.0
Dibrugarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,16.0,8.0,6.0,12.0,11.0,9.0,17.0,21.0,19.0,25.0,26.0,20.0,190.0
Dibrugarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,28.0,16.0,17.0,30.0,21.0,20.0,39.0,35.0,27.0,40.0,42.0,39.0,354.0
Goalpara,1.1,Total number of pregnant women Registered for ANC,TOTAL,2562.0,2758.0,2596.0,2437.0,2782.0,2170.0,2577.0,2407.0,2148.0,2202.0,2220.0,2373.0,29232.0
Goalpara,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1704.0,1869.0,1806.0,1731.0,1834.0,1470.0,1671.0,1581.0,1540.0,1624.0,1704.0,1884.0,20418.0
Goalpara,1.2,Number of Pregnant women registered under JSY,TOTAL,2552.0,2755.0,2594.0,2436.0,2780.0,2168.0,2575.0,2407.0,2148.0,2202.0,2220.0,2351.0,29188.0
Goalpara,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1822.0,1999.0,1943.0,1995.0,2138.0,1925.0,2429.0,2378.0,2313.0,2154.0,2047.0,1917.0,25060.0
Goalpara,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1888.0,2245.0,1966.0,2141.0,2151.0,1969.0,2359.0,2129.0,1869.0,1787.0,1812.0,2125.0,24441.0
Goalpara,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1942.0,2101.0,2145.0,2151.0,2131.0,2039.0,2548.0,2228.0,2304.0,1974.0,1811.0,1928.0,25302.0
Goalpara,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2101.0,2356.0,2049.0,2117.0,2205.0,2254.0,2284.0,2509.0,2087.0,1941.0,2015.0,1990.0,25908.0
Goalpara,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,54.0,36.0,34.0,23.0,52.0,48.0,63.0,62.0,68.0,89.0,43.0,49.0,621.0
Goalpara,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,2.0,1.0,2.0,1.0,0.0,1.0,3.0,1.0,1.0,0.0,0.0,13.0
Goalpara,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1513.0,1422.0,1682.0,1669.0,1741.0,1530.0,1383.0,1445.0,1382.0,1370.0,1374.0,1455.0,17966.0
Goalpara,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,17.0,10.0,9.0,8.0,9.0,3.0,11.0,23.0,15.0,13.0,6.0,8.0,132.0
Goalpara,1.8,Number of pregnancy test kits used at SC level,TOTAL,619.0,587.0,687.0,818.0,605.0,572.0,562.0,618.0,750.0,788.0,705.0,703.0,8014.0
Goalpara,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,86.0,71.0,74.0,82.0,73.0,62.0,82.0,81.0,101.0,139.0,121.0,104.0,1076.0
Goalpara,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,156.0,140.0,152.0,130.0,182.0,148.0,202.0,180.0,191.0,172.0,142.0,138.0,1933.0
Goalpara,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,242.0,211.0,226.0,212.0,255.0,210.0,284.0,261.0,292.0,311.0,263.0,242.0,3009.0
Goalpara,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,179.0,160.0,159.0,128.0,180.0,148.0,138.0,145.0,208.0,219.0,212.0,171.0,2047.0
Goalpara,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1496.0,1441.0,1251.0,1508.0,1494.0,1579.0,1660.0,1690.0,1853.0,1796.0,1577.0,1599.0,18944.0
Goalpara,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,476.0,494.0,464.0,587.0,432.0,579.0,674.0,1069.0,851.0,580.0,634.0,695.0,7535.0
Goalpara,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1008.0,1337.0,1237.0,1512.0,1409.0,1279.0,1764.0,1774.0,2102.0,1867.0,1402.0,1668.0,18359.0
Goalpara,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,325.0,740.0,1342.0,1788.0,992.0,4146.0,1372.0,2849.0,2293.0,2257.0,3144.0,2400.0,23648.0
Goalpara,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,,0.0,,,,,,,,,,0.0
Goalpara,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,132.0,147.0,161.0,166.0,165.0,150.0,164.0,148.0,194.0,210.0,170.0,173.0,1980.0
Goalpara,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Goalpara,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Goalpara,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Goalpara,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Goalpara,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,118.0,108.0,77.0,98.0,93.0,98.0,85.0,101.0,102.0,103.0,108.0,129.0,1220.0
Goalpara,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Goalpara,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,118.0,108.0,77.0,98.0,93.0,98.0,85.0,101.0,102.0,103.0,108.0,129.0,1220.0
Goalpara,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,102.0,106.0,127.0,124.0,137.0,122.0,125.0,123.0,160.0,156.0,140.0,141.0,1563.0
Goalpara,4.1.1.a,Number of male live births,TOTAL,992.0,968.0,862.0,1001.0,994.0,1006.0,1118.0,1083.0,1236.0,1217.0,1085.0,1067.0,12629.0
Goalpara,4.1.1.b,Number of female live births,TOTAL,860.0,797.0,762.0,872.0,906.0,921.0,979.0,993.0,1081.0,1070.0,902.0,929.0,11072.0
Goalpara,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1852.0,1765.0,1624.0,1873.0,1900.0,1927.0,2097.0,2076.0,2317.0,2287.0,1987.0,1996.0,23701.0
Goalpara,4.1.2,Number of still births,TOTAL,34.0,42.0,28.0,27.0,28.0,29.0,29.0,36.0,43.0,45.0,32.0,28.0,401.0
Goalpara,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,147.0,154.0,279.0,158.0,123.0,302.0,344.0,172.0,97.0,157.0,168.0,245.0,2346.0
Goalpara,4.2.1,Number of Newborns weighed at birth,TOTAL,1852.0,1758.0,1617.0,1860.0,1872.0,1908.0,2082.0,2061.0,2309.0,2253.0,1979.0,1988.0,23539.0
Goalpara,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,268.0,237.0,248.0,270.0,257.0,274.0,315.0,277.0,366.0,341.0,286.0,266.0,3405.0
Goalpara,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1832.0,1738.0,1591.0,1831.0,1852.0,1880.0,2050.0,2045.0,2271.0,2225.0,1946.0,1966.0,23227.0
Goalpara,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,5.0,4.0,10.0,1.0,11.0,10.0,18.0,23.0,24.0,22.0,26.0,18.0,172.0
Goalpara,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,7.0,5.0,1.0,2.0,5.0,11.0,34.0,29.0,67.0,76.0,59.0,34.0,330.0
Goalpara,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,2.0,8.0,11.0,10.0,13.0,18.0,21.0,29.0,19.0,24.0,21.0,13.0,189.0
Goalpara,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Goalpara,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,14.0,17.0,22.0,13.0,29.0,39.0,73.0,81.0,110.0,122.0,106.0,65.0,691.0
Goalpara,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Goalpara,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,66.0,20.0,279.0,64.0,151.0,148.0,98.0,84.0,110.0,104.0,92.0,62.0,1278.0
Goalpara,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,13.0,14.0,12.0,33.0,115.0,114.0,31.0,47.0,44.0,34.0,55.0,27.0,539.0
Goalpara,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,67.0,20.0,270.0,126.0,118.0,118.0,30.0,81.0,49.0,36.0,45.0,28.0,988.0
Goalpara,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,53.0,33.0,36.0,29.0,20.0,31.0,23.0,28.0,33.0,23.0,18.0,13.0,340.0
Goalpara,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1644.0,1589.0,1427.0,1539.0,1530.0,1641.0,1749.0,1903.0,2058.0,2064.0,1800.0,1774.0,20718.0
Goalpara,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1466.0,1366.0,1035.0,1166.0,1214.0,1216.0,1422.0,1464.0,1487.0,1468.0,1341.0,1299.0,15944.0
Goalpara,6.3,PNC maternal complications attended,TOTAL,32.0,53.0,78.0,9.0,65.0,45.0,42.0,18.0,15.0,19.0,15.0,15.0,406.0
Goalpara,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,73.0,64.0,112.0,71.0,94.0,120.0,162.0,80.0,78.0,80.0,74.0,119.0,1127.0
Goalpara,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,1.0,3.0,1.0,15.0,22.0,11.0,5.0,1.0,3.0,11.0,10.0,84.0
Goalpara,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,74.0,65.0,115.0,72.0,109.0,142.0,173.0,85.0,79.0,83.0,85.0,129.0,1211.0
Goalpara,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,376.0,220.0,261.0,305.0,207.0,266.0,264.0,237.0,244.0,270.0,207.0,69.0,2926.0
Goalpara,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,348.0,451.0,340.0,457.0,333.0,417.0,398.0,310.0,376.0,189.0,370.0,213.0,4202.0
Goalpara,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,724.0,671.0,601.0,762.0,540.0,683.0,662.0,547.0,620.0,459.0,577.0,282.0,7128.0
Goalpara,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Goalpara,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Goalpara,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Goalpara,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Goalpara,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,3.0,0.0,65.0,0.0,62.0,35.0,0.0,91.0,71.0,37.0,2.0,5.0,371.0
Goalpara,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,30.0,0.0,0.0,0.0,0.0,111.0,0.0,0.0,30.0,0.0,171.0
Goalpara,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Goalpara,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,3.0,0.0,95.0,0.0,62.0,35.0,0.0,202.0,71.0,37.0,32.0,5.0,542.0
Goalpara,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Goalpara,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0,2.0,10.0,26.0
Goalpara,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Goalpara,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0,2.0,10.0,26.0
Goalpara,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Goalpara,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,4.0,0.0,1.0,3.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Goalpara,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,6.0,10.0,0.0,9.0,13.0,15.0,13.0,9.0,0.0,14.0,0.0,9.0,98.0
Goalpara,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Goalpara,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,10.0,10.0,1.0,12.0,13.0,16.0,13.0,9.0,0.0,14.0,0.0,9.0,107.0
Goalpara,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Goalpara,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,51.0,66.0,88.0,434.0,47.0,47.0,39.0,55.0,40.0,100.0,55.0,69.0,1091.0
Goalpara,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,49.0,54.0,71.0,140.0,57.0,58.0,54.0,62.0,75.0,53.0,60.0,72.0,805.0
Goalpara,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,49.0,60.0,65.0,89.0,60.0,63.0,69.0,80.0,107.0,121.0,98.0,144.0,1005.0
Goalpara,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,72.0,79.0,46.0,38.0,20.0,15.0,7.0,18.0,19.0,26.0,18.0,32.0,390.0
Goalpara,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Goalpara,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,221.0,259.0,270.0,701.0,184.0,183.0,169.0,215.0,241.0,300.0,231.0,317.0,3291.0
Goalpara,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,74.0,81.0,51.0,61.0,47.0,44.0,32.0,59.0,68.0,65.0,62.0,49.0,693.0
Goalpara,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Goalpara,9.06,Number of IUCD removals,TOTAL,79.0,28.0,49.0,39.0,38.0,33.0,33.0,41.0,18.0,59.0,37.0,41.0,495.0
Goalpara,9.07,Number of Oral Pills cycles distributed,TOTAL,5063.0,5579.0,5677.0,9180.0,5936.0,5727.0,6442.0,6519.0,5938.0,6007.0,6145.0,6326.0,74539.0
Goalpara,9.08,Number of Condom pieces distributed,TOTAL,18315.0,20621.0,21149.0,34357.0,19694.0,17070.0,21234.0,21380.0,21994.0,19496.0,20239.0,19539.0,255088.0
Goalpara,9.09,Number of Centchroman (weekly) pills given,TOTAL,92.0,0.0,60.0,0.0,20.0,12.0,0.0,11.0,110.0,0.0,251.0,57.0,613.0
Goalpara,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,49.0,91.0,119.0,356.0,131.0,159.0,146.0,140.0,226.0,143.0,207.0,111.0,1878.0
Goalpara,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Goalpara,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Goalpara,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Goalpara,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2028.0,1329.0,1682.0,2237.0,2051.0,1831.0,2007.0,1665.0,2531.0,2195.0,1921.0,2242.0,23719.0
Goalpara,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2076.0,2097.0,1940.0,1863.0,1711.0,1634.0,2031.0,2151.0,2059.0,2117.0,1205.0,154.0,21038.0
Goalpara,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1943.0,2037.0,2077.0,1942.0,1730.0,1533.0,1939.0,1964.0,2156.0,1965.0,2052.0,1627.0,22965.0
Goalpara,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1803.0,1930.0,1963.0,1976.0,1814.0,1553.0,1859.0,1766.0,1937.0,2018.0,1937.0,2125.0,22681.0
Goalpara,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,933.0,2050.0,2983.0
Goalpara,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,579.0,579.0
Goalpara,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Goalpara,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,720.0,411.0,424.0,506.0,501.0,519.0,387.0,518.0,599.0,667.0,601.0,608.0,6461.0
Goalpara,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1846.0,688.0,2461.0,1708.0,1002.0,1905.0,760.0,1732.0,1950.0,1831.0,2094.0,2290.0,20267.0
Goalpara,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1720.0,691.0,2146.0,1769.0,1049.0,1810.0,709.0,1545.0,1844.0,1822.0,2322.0,2278.0,19705.0
Goalpara,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1538.0,633.0,2005.0,1581.0,1087.0,1786.0,727.0,1419.0,1606.0,1799.0,2240.0,2544.0,18965.0
Goalpara,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,552.0,442.0,317.0,399.0,413.0,389.0,354.0,460.0,541.0,599.0,506.0,188.0,5160.0
Goalpara,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2244.0,2125.0,2022.0,1870.0,1692.0,1667.0,1710.0,2171.0,2039.0,2108.0,1166.0,455.0,21269.0
Goalpara,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1931.0,2052.0,2174.0,1995.0,1768.0,1589.0,1689.0,1932.0,2157.0,1982.0,2034.0,1627.0,22930.0
Goalpara,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1737.0,1821.0,1960.0,2053.0,1871.0,1625.0,1643.0,1792.0,1916.0,2014.0,1939.0,2118.0,22489.0
Goalpara,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1430.0,1658.0,1698.0,1746.0,1775.0,1652.0,1963.0,927.0,2533.0,2003.0,1999.0,2225.0,21609.0
Goalpara,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1146.0,1231.0,1284.0,1235.0,1315.0,1168.0,1220.0,663.0,1302.0,1104.0,1233.0,1564.0,14465.0
Goalpara,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,11.0,691.0,1296.0,805.0,49.0,35.0,589.0,2025.0,1671.0,1731.0,1985.0,10888.0
Goalpara,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,726.0,850.0,876.0,894.0,896.0,888.0,1007.0,489.0,1264.0,1030.0,1036.0,1143.0,11099.0
Goalpara,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,699.0,792.0,816.0,831.0,854.0,755.0,936.0,436.0,1239.0,960.0,961.0,1075.0,10354.0
Goalpara,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1425.0,1642.0,1692.0,1725.0,1750.0,1643.0,1943.0,925.0,2503.0,1990.0,1997.0,2218.0,21453.0
Goalpara,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1227.0,1344.0,1372.0,1307.0,1476.0,1220.0,1358.0,1288.0,1414.0,1211.0,1331.0,1661.0,16209.0
Goalpara,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1072.0,587.0,1479.0,1130.0,844.0,1306.0,529.0,1029.0,1158.0,1056.0,1323.0,1792.0,13305.0
Goalpara,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,353.0,319.0,268.0,291.0,320.0,285.0,259.0,243.0,319.0,251.0,263.0,310.0,3481.0
Goalpara,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,330.0,290.0,305.0,257.0,304.0,281.0,261.0,222.0,279.0,232.0,235.0,320.0,3316.0
Goalpara,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,683.0,609.0,573.0,548.0,624.0,566.0,520.0,465.0,598.0,483.0,498.0,630.0,6797.0
Goalpara,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,467.0,390.0,449.0,487.0,458.0,420.0,476.0,446.0,572.0,519.0,551.0,577.0,5812.0
Goalpara,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,437.0,430.0,388.0,437.0,362.0,379.0,432.0,401.0,440.0,438.0,492.0,460.0,5096.0
Goalpara,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,306.0,295.0,324.0,309.0,299.0,317.0,312.0,324.0,319.0,318.0,358.0,412.0,3893.0
Goalpara,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Goalpara,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,914.0,904.0,892.0,901.0,880.0,868.0,902.0,873.0,899.0,853.0,869.0,882.0,10637.0
Goalpara,10.4.2,Number of Immunisation sessions held during the month,TOTAL,860.0,866.0,866.0,882.0,811.0,762.0,847.0,858.0,881.0,814.0,825.0,869.0,10141.0
Goalpara,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,830.0,834.0,839.0,853.0,782.0,732.0,819.0,833.0,854.0,812.0,798.0,831.0,9817.0
Goalpara,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,4.0,31.0,379.0,676.0,3.0,0.0,5.0,48.0,66.0,132.0,238.0,535.0,2117.0
Goalpara,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1430.0,1679.0,1679.0,1743.0,1749.0,1595.0,1852.0,924.0,2250.0,1722.0,1767.0,1831.0,20221.0
Goalpara,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,180.0,203.0,223.0,244.0,915.0,735.0,217.0,172.0,229.0,222.0,1327.0,144.0,4811.0
Goalpara,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,261.0,242.0,263.0,288.0,992.0,695.0,293.0,270.0,246.0,291.0,1371.0,226.0,5438.0
Goalpara,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,1.0,1.0,0.0,35.0,8.0,0.0,0.0,0.0,0.0,2.0,0.0,108.0,155.0
Goalpara,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,509.0,320.0,275.0,389.0,373.0,468.0,321.0,261.0,275.0,298.0,374.0,260.0,4123.0
Goalpara,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2.0,7.0,12.0,5.0,1.0,1.0,0.0,1.0,2.0,0.0,2.0,4.0,37.0
Goalpara,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,240.0,132.0,142.0,80.0,72.0,83.0,260.0,42.0,55.0,38.0,58.0,15.0,1217.0
Goalpara,13.1,Number of Patients operated for cataract,TOTAL,125.0,118.0,75.0,123.0,135.0,146.0,131.0,156.0,185.0,117.0,139.0,162.0,1612.0
Goalpara,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,121.0,109.0,71.0,116.0,130.0,134.0,126.0,151.0,178.0,117.0,139.0,162.0,1554.0
Goalpara,13.3,Number of School children detected with Refractive errors,TOTAL,5.0,13.0,22.0,32.0,8.0,108.0,9.0,17.0,11.0,7.0,6.0,107.0,345.0
Goalpara,13.4,Number of children provided free glasses,TOTAL,1.0,28.0,5.0,0.0,2.0,119.0,2.0,9.0,16.0,0.0,0.0,0.0,182.0
Goalpara,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Goalpara,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,22.0,22.0,22.0,22.0,22.0,22.0,22.0,21.0,21.0,21.0,21.0,22.0,-1.0
Goalpara,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,560.0,568.0,574.0,567.0,529.0,483.0,552.0,557.0,566.0,545.0,541.0,574.0,-1.0
Goalpara,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,-1.0
Goalpara,14.05,Number of RKS meetings held during the month,TOTAL,17.0,14.0,18.0,10.0,14.0,12.0,14.0,11.0,12.0,11.0,13.0,17.0,163.0
Goalpara,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,22.0,22.0,21.0,20.0,21.0,20.0,22.0,22.0,23.0,24.0,24.0,22.0,-1.0
Goalpara,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,225.0,295.0,203.0,221.0,240.0,195.0,240.0,227.0,188.0,215.0,201.0,182.0,2632.0
Goalpara,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Goalpara,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Goalpara,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,340.0,248.0,255.0,288.0,209.0,207.0,153.0,133.0,122.0,123.0,217.0,214.0,2509.0
Goalpara,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,885.0,642.0,667.0,826.0,675.0,469.0,574.0,386.0,535.0,464.0,440.0,829.0,7392.0
Goalpara,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,324.0,194.0,326.0,344.0,202.0,185.0,192.0,155.0,147.0,140.0,184.0,170.0,2563.0
Goalpara,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1458.0,1179.0,1319.0,1518.0,1815.0,1628.0,1613.0,1627.0,1759.0,1773.0,1617.0,1747.0,19053.0
Goalpara,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,664.0,442.0,581.0,632.0,411.0,392.0,345.0,288.0,269.0,263.0,401.0,384.0,5072.0
Goalpara,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2343.0,1821.0,1986.0,2344.0,2490.0,2097.0,2187.0,2013.0,2294.0,2237.0,2057.0,2576.0,26445.0
Goalpara,14.10.2.a,Number of death cases of Inpatient males,TOTAL,15.0,21.0,13.0,19.0,16.0,11.0,12.0,16.0,25.0,15.0,21.0,19.0,203.0
Goalpara,14.10.2.b,Number of death cases of Inpatient females,TOTAL,9.0,5.0,9.0,8.0,13.0,10.0,11.0,15.0,7.0,12.0,4.0,9.0,112.0
Goalpara,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,24.0,26.0,22.0,27.0,29.0,21.0,23.0,31.0,32.0,27.0,25.0,28.0,315.0
Goalpara,14.11,In-Patient Head Count at midnight,TOTAL,3747.0,3727.0,3672.0,5089.0,3850.0,3913.0,3560.0,4170.0,4430.0,2884.0,3927.0,4648.0,47617.0
Goalpara,14.12.1,OPD attendance (All),TOTAL,87483.0,79324.0,79801.0,91021.0,76311.0,74400.0,72093.0,62580.0,52060.0,47952.0,54073.0,68940.0,846038.0
Goalpara,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,20.0,43.0,28.0,51.0,76.0,24.0,2.0,2.0,10.0,43.0,20.0,19.0,338.0
Goalpara,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Goalpara,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,20.0,18.0,10.0,19.0,51.0,35.0,13.0,17.0,12.0,11.0,11.0,21.0,238.0
Goalpara,14.14.a,Number of patients given AYUSH treatment,TOTAL,15404.0,13855.0,12163.0,14050.0,11060.0,9299.0,10500.0,8266.0,7447.0,5660.0,6621.0,9427.0,123752.0
Goalpara,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,857.0,703.0,909.0,903.0,845.0,743.0,1796.0,1039.0,783.0,894.0,863.0,978.0,11313.0
Goalpara,14.14.c,Number of Adolescents counselled,TOTAL,298.0,115.0,126.0,1066.0,138.0,124.0,69.0,119.0,102.0,96.0,50.0,103.0,2406.0
Goalpara,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5896.0,6298.0,6203.0,5885.0,6613.0,5673.0,6420.0,6509.0,6287.0,5818.0,5809.0,5909.0,73320.0
Goalpara,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,31.0,31.0,51.0,27.0,26.0,24.0,18.0,26.0,29.0,32.0,18.0,32.0,345.0
Goalpara,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,80.0,159.0,140.0,128.0,63.0,125.0,68.0,48.0,15.0,95.0,163.0,112.0,1196.0
Goalpara,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Goalpara,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,196.0,352.0,332.0,183.0,233.0,160.0,121.0,83.0,7.0,360.0,347.0,294.0,2668.0
Goalpara,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,432.0,707.0,671.0,565.0,221.0,530.0,739.0,589.0,16.0,667.0,698.0,562.0,6397.0
Goalpara,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Goalpara,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,708.0,1218.0,1143.0,876.0,517.0,815.0,928.0,720.0,38.0,1122.0,1208.0,968.0,10261.0
Goalpara,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Goalpara,15.2,Number of Widal tests conducted,Number tested,293.0,219.0,447.0,427.0,322.0,297.0,279.0,264.0,224.0,184.0,214.0,340.0,3510.0
Goalpara,15.3.a,Number of VDRL tests conducted on males,Number tested,41.0,448.0,2.0,2.0,5.0,3.0,3.0,4.0,17.0,37.0,21.0,12.0,595.0
Goalpara,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,6.0,10.0,10.0,3.0,30.0
Goalpara,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,548.0,105.0,549.0,466.0,470.0,596.0,679.0,652.0,598.0,589.0,563.0,598.0,6413.0
Goalpara,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,589.0,553.0,551.0,469.0,475.0,599.0,682.0,656.0,621.0,636.0,594.0,613.0,7038.0
Goalpara,15.4.1,Number of blood smears examined for Malaria,TOTAL,4765.0,5184.0,7478.0,10237.0,8300.0,7589.0,5357.0,5305.0,4200.0,2851.0,3872.0,4656.0,69794.0
Goalpara,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3.0,106.0,7.0,5.0,2.0,110.0,3.0,27.0,3.0,3.0,4.0,2.0,275.0
Goalpara,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,25.0,34.0,57.0,54.0,42.0,30.0,28.0,31.0,26.0,10.0,13.0,13.0,363.0
Goalpara,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,49630.0,46530.0,36530.0,24530.0,21680.0,27180.0,20980.0,33480.0,23180.0,21480.0,10280.0,16030.0,331510.0
Goalpara,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,0.0,10000.0,20000.0,0.0,20000.0,10000.0,0.0,0.0,15000.0,20000.0,95000.0
Goalpara,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,500.0,500.0,5000.0,1000.0,500.0,0.0,0.0,2000.0,250.0,0.0,9750.0
Goalpara,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3100.0,10000.0,11500.0,12350.0,9500.0,5200.0,7000.0,20300.0,1700.0,9200.0,9000.0,9200.0,108050.0
Goalpara,16.1.1,Stock position of DPT vaccines,5. Total Stock,46530.0,36530.0,24530.0,21680.0,27180.0,20980.0,33480.0,23180.0,21480.0,10280.0,16030.0,26830.0,308710.0
Goalpara,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,0.0,4500.0,4500.0
Goalpara,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,15000.0,9000.0,24000.0
Goalpara,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Goalpara,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,10500.0,3700.0,14200.0
Goalpara,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4500.0,9800.0,14300.0
Goalpara,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1360.0,0.0,26000.0,500.0,0.0,3700.0,0.0,10000.0,700.0,200.0,760.0,19560.0,62780.0
Goalpara,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,26000.0,0.0,0.0,20000.0,0.0,10000.0,2000.0,10000.0,199000.0,224000.0,20000.0,511000.0
Goalpara,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1360.0,0.0,25500.0,500.0,16300.0,3700.0,0.0,11300.0,10500.0,198440.0,205200.0,14000.0,486800.0
Goalpara,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,26000.0,500.0,0.0,3700.0,0.0,10000.0,700.0,200.0,760.0,19560.0,25560.0,86980.0
Goalpara,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,76950.0,74350.0,64350.0,57850.0,49150.0,41150.0,34550.0,49050.0,37650.0,35950.0,29800.0,35800.0,586600.0
Goalpara,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,20000.0,10000.0,0.0,0.0,10000.0,15000.0,55000.0
Goalpara,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,300.0,0.0,500.0,0.0,0.0,800.0
Goalpara,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2600.0,10000.0,6500.0,8700.0,8000.0,6600.0,5500.0,21100.0,1700.0,5650.0,4000.0,8000.0,88350.0
Goalpara,16.1.3,Stock position of TT vaccines,5. Total Stock,74350.0,64350.0,57850.0,49150.0,41150.0,34550.0,49050.0,37650.0,35950.0,29800.0,35800.0,42800.0,552450.0
Goalpara,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Goalpara,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Goalpara,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Goalpara,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Goalpara,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,10920.0,6320.0,13520.0,5520.0,5220.0,8220.0,3590.0,3590.0,9790.0,7790.0,1990.0,9890.0,86360.0
Goalpara,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,11000.0,0.0,11000.0,9500.0,0.0,0.0,16500.0,0.0,0.0,16500.0,15000.0,79500.0
Goalpara,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,500.0,0.0,200.0,0.0,0.0,100.0,0.0,800.0
Goalpara,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4600.0,3800.0,8000.0,11300.0,6500.0,4130.0,0.0,10100.0,2000.0,5800.0,8500.0,5710.0,70440.0
Goalpara,16.1.5,Stock position of BCG vaccines,5. Total Stock,6320.0,13520.0,5520.0,5220.0,8220.0,3590.0,3590.0,9790.0,7790.0,1990.0,9890.0,19180.0,94620.0
Goalpara,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,6000.0,5450.0,11200.0,6200.0,15750.0,12500.0,10575.0,7075.0,500.0,6500.0,250.0,7000.0,89000.0
Goalpara,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,10000.0,0.0,15000.0,2500.0,0.0,0.0,5000.0,10000.0,0.0,10000.0,10000.0,62500.0
Goalpara,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3925.0,0.0,650.0,0.0,0.0,4575.0
Goalpara,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,550.0,4250.0,5000.0,5450.0,5750.0,1925.0,3500.0,7650.0,4000.0,5600.0,3250.0,5150.0,52075.0
Goalpara,16.1.6,Stock position of Measles vaccines,5. Total Stock,5450.0,11200.0,6200.0,15750.0,12500.0,10575.0,7075.0,500.0,6500.0,250.0,7000.0,11850.0,94850.0
Goalpara,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,0.0,5000.0,0.0,5550.0,0.0,0.0,5000.0,1600.0,8750.0,3550.0,7550.0,37000.0
Goalpara,16.1.7,Stock position of JE vaccines,2. Stocks Received,,5000.0,0.0,25000.0,0.0,0.0,5000.0,5000.0,10000.0,0.0,5000.0,0.0,55000.0
Goalpara,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,0.0,5000.0,19450.0,5550.0,0.0,0.0,8400.0,2850.0,5200.0,1000.0,3300.0,50750.0
Goalpara,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,5000.0,0.0,5550.0,0.0,0.0,5000.0,1600.0,8750.0,3550.0,7550.0,4250.0,41250.0
Goalpara,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,16900.0,7800.0,20800.0,6800.0,5550.0,8500.0,3000.0,23000.0,15500.0,18700.0,10300.0,19150.0,156000.0
Goalpara,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,20500.0,0.0,11000.0,12000.0,0.0,20000.0,16000.0,5000.0,0.0,15000.0,5000.0,104500.0
Goalpara,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,150.0,0.0,150.0
Goalpara,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,9100.0,7500.0,14000.0,12250.0,9050.0,5500.0,0.0,23500.0,1800.0,8400.0,6000.0,9210.0,106310.0
Goalpara,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,7800.0,20800.0,6800.0,5550.0,8500.0,3000.0,23000.0,15500.0,18700.0,10300.0,19150.0,14940.0,154040.0
Goalpara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,650.0,1250.0,4350.0,850.0,1350.0,1350.0,1350.0,1350.0,250.0,250.0,0.0,0.0,13000.0
Goalpara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,600.0,3600.0,0.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5400.0
Goalpara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,500.0,3500.0,700.0,0.0,0.0,,1100.0,0.0,250.0,0.0,0.0,6050.0
Goalpara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1250.0,4350.0,850.0,1350.0,1350.0,1350.0,1350.0,250.0,250.0,0.0,0.0,0.0,12350.0
Goalpara,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,21180.0,21180.0,23300.0,0.0,0.0,10080.0,8080.0,33280.0,22820.0,63140.0,63140.0,53060.0,319260.0
Goalpara,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,20160.0,0.0,0.0,30240.0,0.0,30240.0,30240.0,40320.0,0.0,0.0,0.0,151200.0
Goalpara,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Goalpara,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,18040.0,23300.0,0.0,20160.0,0.0,5040.0,40700.0,0.0,0.0,10080.0,21160.0,138480.0
Goalpara,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,21180.0,23300.0,0.0,0.0,10080.0,8080.0,33280.0,22820.0,63140.0,63140.0,53060.0,31900.0,329980.0
Goalpara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,45100.0,44100.0,53100.0,44100.0,60900.0,54100.0,46100.0,43100.0,14700.0,17700.0,32700.0,32100.0,487800.0
Goalpara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,10000.0,0.0,27000.0,0.0,0.0,0.0,6600.0,3600.0,18000.0,0.0,0.0,65200.0
Goalpara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,2000.0,4000.0,0.0,6000.0,0.0,7000.0,0.0,0.0,0.0,0.0,19000.0
Goalpara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,1000.0,1000.0,7000.0,6200.0,6800.0,2000.0,3000.0,28000.0,600.0,3000.0,600.0,7200.0,66400.0
Goalpara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,44100.0,53100.0,44100.0,60900.0,54100.0,46100.0,43100.0,14700.0,17700.0,32700.0,32100.0,24900.0,467600.0
Goalpara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,4800.0,4800.0,4800.0,3800.0,2000.0,8300.0,8300.0,8300.0,3800.0,3800.0,13800.0,13800.0,80300.0
Goalpara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,7500.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,17500.0
Goalpara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,1000.0,1800.0,1200.0,0.0,0.0,4500.0,0.0,0.0,0.0,3700.0,12200.0
Goalpara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,4800.0,4800.0,3800.0,2000.0,8300.0,8300.0,8300.0,3800.0,3800.0,13800.0,13800.0,10100.0,85600.0
Goalpara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,2700.0,2700.0,2700.0,2600.0,2600.0,2600.0,2600.0,2600.0,2100.0,2100.0,2100.0,1600.0,29000.0
Goalpara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,100.0,0.0,0.0,0.0,0.0,500.0,0.0,0.0,500.0,0.0,1100.0
Goalpara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,2700.0,2700.0,2600.0,2600.0,2600.0,2600.0,2600.0,2100.0,2100.0,2100.0,1600.0,1600.0,27900.0
Goalpara,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Goalpara,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Goalpara,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Goalpara,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Goalpara,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Goalpara,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Goalpara,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Goalpara,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Goalpara,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Goalpara,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Goalpara,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Goalpara,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Goalpara,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Goalpara,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Goalpara,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Goalpara,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Goalpara,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Goalpara,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Goalpara,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Goalpara,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Goalpara,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Goalpara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Goalpara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Goalpara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Goalpara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Goalpara,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Goalpara,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Goalpara,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Goalpara,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Goalpara,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Goalpara,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Goalpara,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Goalpara,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Goalpara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Goalpara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Goalpara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Goalpara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Goalpara,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Goalpara,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Goalpara,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Goalpara,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Goalpara,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Goalpara,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Goalpara,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Goalpara,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,735.0,0.0,0.0,4200.0,1500.0,3200.0,1200.0,500.0,4000.0,2300.0,800.0,1700.0,20135.0
Goalpara,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,9900.0,0.0,3300.0,0.0,0.0,6600.0,0.0,0.0,4000.0,3300.0,27100.0
Goalpara,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,735.0,0.0,5700.0,2700.0,1600.0,2000.0,700.0,3100.0,1700.0,1500.0,3100.0,1400.0,24235.0
Goalpara,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,4200.0,1500.0,3200.0,1200.0,500.0,4000.0,2300.0,800.0,1700.0,3600.0,23000.0
Goalpara,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,108600.0,101400.0,87400.0,116600.0,113000.0,96200.0,83600.0,78800.0,63400.0,53800.0,42200.0,61400.0,1006400.0
Goalpara,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,0.0,84000.0,10800.0,12000.0,0.0,0.0,36000.0,0.0,0.0,33600.0,48000.0,224400.0
Goalpara,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,2000.0
Goalpara,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,7200.0,14000.0,54800.0,14400.0,28800.0,12600.0,4800.0,51400.0,9600.0,9600.0,14400.0,19200.0,240800.0
Goalpara,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,101400.0,87400.0,116600.0,113000.0,96200.0,83600.0,78800.0,63400.0,53800.0,42200.0,61400.0,90200.0,988000.0
Goalpara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,20270.0,20270.0,20470.0,21170.0,22570.0,22870.0,22270.0,21870.0,19670.0,18770.0,17870.0,16870.0,244940.0
Goalpara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,2000.0,6000.0,2000.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,16000.0
Goalpara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Goalpara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,1800.0,5300.0,600.0,1700.0,600.0,400.0,2200.0,900.0,900.0,1000.0,800.0,16200.0
Goalpara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,20270.0,20470.0,21170.0,22570.0,22870.0,22270.0,21870.0,19670.0,18770.0,17870.0,16870.0,20070.0,244740.0
Goalpara,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,3.0,,,1.0,1.0,,3.0,1.0,,,9.0
Goalpara,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,2.0,,,1.0,,,,,3.0
Goalpara,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Goalpara,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,2.0,,,1.0,,,,,3.0
Goalpara,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,4.0,2.0,5.0,3.0,5.0,7.0,5.0,1.0,,,32.0
Goalpara,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Goalpara,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,4.0,2.0,5.0,3.0,5.0,7.0,5.0,1.0,,,32.0
Goalpara,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,1.0,4.0,,,5.0,1.0,3.0,,2.0,1.0,1.0,19.0
Goalpara,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Goalpara,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,1.0,4.0,,,5.0,1.0,3.0,,2.0,1.0,1.0,19.0
Goalpara,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,2.0,6.0,2.0,4.0,2.0,4.0,7.0,15.0,8.0,2.0,8.0,60.0
Goalpara,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Goalpara,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,2.0,6.0,2.0,4.0,2.0,4.0,7.0,15.0,8.0,2.0,8.0,60.0
Goalpara,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,3.0,2.0,5.0,4.0,7.0,2.0,2.0,3.0,28.0
Goalpara,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,2.0,1.0,1.0,,,1.0,,,,5.0
Goalpara,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,2.0,4.0,3.0,5.0,4.0,8.0,2.0,2.0,3.0,33.0
Goalpara,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Goalpara,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Goalpara,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Goalpara,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,2.0,,1.0,2.0,1.0,4.0,,,,1.0,11.0
Goalpara,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Goalpara,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,2.0,,1.0,2.0,1.0,4.0,,,,1.0,11.0
Goalpara,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Goalpara,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Goalpara,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Goalpara,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,6.0,2.0,4.0,4.0,3.0,7.0,6.0,6.0,10.0,4.0,5.0,59.0
Goalpara,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,,2.0,1.0,2.0,,,,,,2.0,9.0
Goalpara,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,7.0,2.0,6.0,5.0,5.0,7.0,6.0,6.0,10.0,4.0,7.0,68.0
Goalpara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Goalpara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,3.0,,,,,,,,,,1.0,4.0
Goalpara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,3.0,,,,,,,,,,1.0,4.0
Goalpara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Goalpara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,1.0,1.0,,,,1.0,,,,3.0
Goalpara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,1.0,1.0,1.0,,,1.0,,,,4.0
Goalpara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Goalpara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,,,1.0,1.0,2.0,1.0,1.0,,,,,8.0
Goalpara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,3.0,1.0,1.0,,2.0,1.0,1.0,9.0
Goalpara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,,,1.0,1.0,5.0,2.0,3.0,,2.0,1.0,1.0,18.0
Goalpara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,2.0,1.0,,,,,,,,,3.0
Goalpara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,1.0,1.0,1.0,3.0
Goalpara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,2.0,1.0,,,,,,1.0,1.0,1.0,6.0
Goalpara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,4.0,2.0,3.0,3.0,4.0,,1.0,3.0,1.0,2.0,,1.0,24.0
Goalpara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,1.0,1.0,2.0,4.0,2.0,,4.0,2.0,,17.0
Goalpara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,4.0,2.0,4.0,4.0,5.0,2.0,5.0,5.0,1.0,6.0,2.0,1.0,41.0
Goalpara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Goalpara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Goalpara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Goalpara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Goalpara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,1.0,,7.0,2.0,,1.0,6.0,1.0,2.0,1.0,1.0,24.0
Goalpara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,1.0,4.0,,3.0,2.0,3.0,3.0,2.0,3.0,2.0,7.0,33.0
Goalpara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,5.0,2.0,4.0,7.0,5.0,2.0,4.0,9.0,3.0,5.0,3.0,9.0,58.0
Goalpara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,1.0,1.0,,1.0,,1.0,,1.0,1.0,,7.0
Goalpara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,,1.0,,1.0,,1.0,,,4.0
Goalpara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,1.0,1.0,1.0,,2.0,,2.0,,2.0,1.0,,11.0
Goalpara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,2.0,,,,,,,,,,2.0
Goalpara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Goalpara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,2.0,,,,,,,,,,2.0
Goalpara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Goalpara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Goalpara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Goalpara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,1.0,,,,,,,,,1.0,2.0
Goalpara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Goalpara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,,,,,,,,,1.0,2.0
Goalpara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,2.0,1.0,2.0,2.0,1.0,3.0,1.0,12.0
Goalpara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Goalpara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,2.0,1.0,2.0,2.0,1.0,3.0,1.0,12.0
Goalpara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,1.0,,1.0,,,,,,,2.0
Goalpara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Goalpara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,1.0,,1.0,,,,,,,2.0
Goalpara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,4.0,1.0,1.0,5.0,2.0,4.0,1.0,1.0,1.0,,21.0
Goalpara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Goalpara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,4.0,1.0,1.0,5.0,2.0,4.0,1.0,1.0,1.0,,21.0
Goalpara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,2.0,,1.0,1.0,,,,,,,5.0
Goalpara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,1.0,2.0,3.0,1.0,1.0,2.0,4.0,3.0,3.0,4.0,6.0,32.0
Goalpara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,1.0,1.0,,,,,2.0
Goalpara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,3.0,1.0,4.0,3.0,2.0,2.0,3.0,5.0,3.0,3.0,4.0,6.0,39.0
Goalpara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,3.0,1.0,5.0,1.0,,,2.0,1.0,2.0,1.0,3.0,21.0
Goalpara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,,1.0,1.0,1.0,,1.0,,,,1.0,6.0
Goalpara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,4.0,1.0,6.0,2.0,1.0,,3.0,1.0,2.0,1.0,4.0,27.0
Goalpara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Goalpara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,,,1.0,,,1.0,,,,,3.0
Goalpara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Goalpara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,,,,1.0,1.0,,1.0,,,,,5.0
Goalpara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,1.0,,,,1.0,2.0
Goalpara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,1.0,1.0,1.0,1.0,3.0,,2.0,1.0,1.0,,,12.0
Goalpara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,1.0,3.0,1.0,1.0,2.0,2.0,,10.0
Goalpara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,1.0,1.0,1.0,1.0,4.0,3.0,4.0,2.0,3.0,2.0,1.0,24.0
Goalpara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Goalpara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,3.0,2.0,2.0,2.0,1.0,5.0,5.0,,,1.0,2.0,24.0
Goalpara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,3.0,5.0,4.0,1.0,1.0,3.0,5.0,7.0,3.0,1.0,2.0,36.0
Goalpara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,2.0,6.0,7.0,6.0,3.0,2.0,8.0,10.0,7.0,3.0,2.0,4.0,60.0
Goalpara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,1.0,2.0,1.0,,,1.0,3.0,8.0
Goalpara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,16.0,11.0,10.0,10.0,11.0,3.0,13.0,11.0,11.0,10.0,11.0,6.0,123.0
Goalpara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,11.0,15.0,17.0,27.0,18.0,11.0,19.0,20.0,20.0,24.0,18.0,20.0,220.0
Goalpara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,27.0,26.0,27.0,37.0,29.0,15.0,34.0,32.0,31.0,34.0,30.0,29.0,351.0
Golaghat,1.1,Total number of pregnant women Registered for ANC,TOTAL,1866.0,2054.0,1930.0,1750.0,1636.0,1626.0,1425.0,1554.0,1347.0,1886.0,1767.0,2051.0,20892.0
Golaghat,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1452.0,1597.0,1549.0,1443.0,1316.0,1309.0,1143.0,1365.0,1179.0,1654.0,1517.0,1794.0,17318.0
Golaghat,1.2,Number of Pregnant women registered under JSY,TOTAL,1808.0,1969.0,1865.0,1707.0,1554.0,1614.0,1422.0,1497.0,1251.0,1843.0,1704.0,1953.0,20187.0
Golaghat,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1195.0,1500.0,1576.0,1542.0,1498.0,1632.0,1679.0,1705.0,1446.0,1666.0,1164.0,1695.0,18298.0
Golaghat,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1624.0,1718.0,1601.0,1551.0,1575.0,1632.0,1441.0,1432.0,1125.0,1315.0,1397.0,1747.0,18158.0
Golaghat,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1601.0,1756.0,1700.0,1501.0,1592.0,1686.0,1702.0,1689.0,1401.0,1383.0,1209.0,1626.0,18846.0
Golaghat,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1455.0,1618.0,1612.0,1789.0,1765.0,1698.0,1636.0,1699.0,1252.0,1867.0,1522.0,1759.0,19672.0
Golaghat,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,93.0,99.0,98.0,80.0,67.0,43.0,79.0,85.0,68.0,59.0,63.0,83.0,917.0
Golaghat,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,2.0,3.0,1.0,13.0
Golaghat,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1530.0,1594.0,1622.0,1878.0,1264.0,1246.0,1094.0,1313.0,969.0,1130.0,1130.0,1178.0,15948.0
Golaghat,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,3.0,9.0,9.0,15.0,24.0,4.0,12.0,44.0,15.0,8.0,15.0,16.0,174.0
Golaghat,1.8,Number of pregnancy test kits used at SC level,TOTAL,335.0,723.0,674.0,616.0,604.0,607.0,536.0,565.0,490.0,619.0,602.0,621.0,6992.0
Golaghat,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,2.0,1.0,5.0,35.0,13.0,18.0,28.0,27.0,23.0,15.0,19.0,188.0
Golaghat,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,62.0,62.0,45.0,49.0,28.0,45.0,48.0,26.0,26.0,30.0,36.0,19.0,476.0
Golaghat,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,64.0,64.0,46.0,54.0,63.0,58.0,66.0,54.0,53.0,53.0,51.0,38.0,664.0
Golaghat,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,39.0,47.0,31.0,46.0,56.0,44.0,46.0,37.0,48.0,49.0,47.0,34.0,524.0
Golaghat,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Golaghat,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,943.0,913.0,888.0,1131.0,1280.0,1326.0,1361.0,1239.0,1387.0,1360.0,1090.0,1033.0,13951.0
Golaghat,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,537.0,178.0,185.0,655.0,631.0,700.0,131.0,603.0,665.0,698.0,532.0,490.0,6005.0
Golaghat,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,818.0,1009.0,464.0,1090.0,1084.0,1327.0,1637.0,1347.0,1438.0,1345.0,1231.0,1146.0,13936.0
Golaghat,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,200.0,440.0,983.0,705.0,492.0,1874.0,562.0,1251.0,1629.0,903.0,838.0,9728.0,19605.0
Golaghat,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,195.0,171.0,173.0,222.0,279.0,248.0,260.0,278.0,288.0,279.0,236.0,230.0,2859.0
Golaghat,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,13.0,1.0,0.0,12.0,6.0,16.0,19.0,17.0,20.0,27.0,14.0,15.0,160.0
Golaghat,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,3.0,0.0,0.0,16.0,0.0,19.0,19.0,10.0,4.0,32.0,5.0,26.0,134.0
Golaghat,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Golaghat,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,,,0.0,,0.0,,,,,0.0,,0.0
Golaghat,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,91.0,86.0,91.0,94.0,80.0,75.0,70.0,64.0,91.0,103.0,101.0,99.0,1045.0
Golaghat,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Golaghat,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,91.0,86.0,91.0,94.0,80.0,75.0,70.0,64.0,91.0,103.0,101.0,99.0,1045.0
Golaghat,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,80.0,75.0,76.0,97.0,118.0,105.0,103.0,110.0,135.0,100.0,100.0,89.0,1188.0
Golaghat,4.1.1.a,Number of male live births,TOTAL,621.0,575.0,583.0,703.0,860.0,810.0,857.0,789.0,870.0,882.0,701.0,663.0,8914.0
Golaghat,4.1.1.b,Number of female live births,TOTAL,574.0,553.0,507.0,698.0,732.0,791.0,787.0,787.0,804.0,777.0,648.0,615.0,8273.0
Golaghat,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1195.0,1128.0,1090.0,1401.0,1592.0,1601.0,1644.0,1576.0,1674.0,1659.0,1349.0,1278.0,17187.0
Golaghat,4.1.2,Number of still births,TOTAL,30.0,34.0,29.0,31.0,49.0,42.0,49.0,23.0,57.0,42.0,31.0,27.0,444.0
Golaghat,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,94.0,122.0,131.0,109.0,102.0,93.0,108.0,104.0,89.0,86.0,126.0,117.0,1281.0
Golaghat,4.2.1,Number of Newborns weighed at birth,TOTAL,616.0,551.0,537.0,719.0,1409.0,1591.0,972.0,1471.0,1070.0,1041.0,798.0,750.0,11525.0
Golaghat,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,195.0,201.0,207.0,221.0,257.0,306.0,259.0,226.0,141.0,112.0,88.0,107.0,2320.0
Golaghat,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1045.0,1002.0,965.0,1133.0,1343.0,1428.0,1461.0,1533.0,1594.0,1643.0,1346.0,1195.0,15688.0
Golaghat,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,1.0,0.0,2.0,7.0,5.0,2.0,2.0,3.0,5.0,4.0,31.0
Golaghat,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,11.0,0.0,0.0,0.0,2.0,13.0,38.0,13.0,8.0,5.0,7.0,97.0
Golaghat,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,16.0,17.0,25.0,18.0,35.0,169.0,120.0,140.0,63.0,54.0,59.0,61.0,777.0
Golaghat,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Golaghat,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,16.0,28.0,26.0,18.0,37.0,178.0,138.0,180.0,78.0,65.0,69.0,72.0,905.0
Golaghat,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,481.0,464.0,14.0,21.0,216.0,298.0,695.0,153.0,152.0,331.0,253.0,242.0,3320.0
Golaghat,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5.0,4.0,10.0,4.0,7.0,12.0,12.0,18.0,25.0,15.0,14.0,13.0,139.0
Golaghat,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,373.0,416.0,486.0,68.0,248.0,603.0,709.0,261.0,268.0,521.0,297.0,357.0,4607.0
Golaghat,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,86.0,66.0,0.0,68.0,0.0,72.0,93.0,100.0,87.0,63.0,52.0,82.0,769.0
Golaghat,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,990.0,1004.0,866.0,1221.0,1390.0,1240.0,854.0,1425.0,1416.0,791.0,1060.0,1021.0,13278.0
Golaghat,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,782.0,815.0,642.0,818.0,862.0,1100.0,909.0,1124.0,1038.0,994.0,955.0,884.0,10923.0
Golaghat,6.3,PNC maternal complications attended,TOTAL,12.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0
Golaghat,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,68.0,57.0,50.0,56.0,55.0,45.0,55.0,42.0,46.0,45.0,47.0,52.0,618.0
Golaghat,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,15.0,18.0
Golaghat,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,68.0,57.0,50.0,56.0,56.0,45.0,55.0,42.0,46.0,47.0,47.0,67.0,636.0
Golaghat,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,24.0,35.0,18.0,75.0,82.0,36.0,26.0,21.0,14.0,24.0,22.0,100.0,477.0
Golaghat,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,91.0,59.0,119.0,79.0,136.0,33.0,36.0,33.0,19.0,33.0,24.0,129.0,791.0
Golaghat,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,115.0,94.0,137.0,154.0,218.0,69.0,62.0,54.0,33.0,57.0,46.0,229.0,1268.0
Golaghat,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,20.0,0.0,0.0,0.0,0.0,0.0,60.0,100.0,40.0,20.0,40.0,280.0
Golaghat,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Golaghat,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,17.0,0.0,0.0,0.0,0.0,0.0,0.0,27.0,41.0,24.0,29.0,141.0,279.0
Golaghat,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Golaghat,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,17.0,40.0,0.0,0.0,0.0,0.0,0.0,87.0,141.0,64.0,49.0,181.0,579.0
Golaghat,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,60.0,0.0,226.0,0.0,0.0,35.0,91.0,135.0,0.0,0.0,210.0,757.0
Golaghat,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,57.0,0.0,0.0,0.0,0.0,0.0,65.0,0.0,0.0,0.0,73.0,195.0
Golaghat,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,69.0,0.0,0.0,0.0,29.0,100.0,0.0,0.0,0.0,198.0
Golaghat,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Golaghat,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,117.0,0.0,295.0,0.0,0.0,35.0,185.0,235.0,0.0,0.0,283.0,1150.0
Golaghat,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Golaghat,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Golaghat,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,15.0,0.0,20.0,0.0,32.0,0.0,67.0
Golaghat,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Golaghat,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,15.0,0.0,20.0,0.0,32.0,0.0,70.0
Golaghat,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,55.0,77.0,85.0,347.0,62.0,111.0,62.0,48.0,53.0,40.0,39.0,61.0,1040.0
Golaghat,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,45.0,50.0,41.0,279.0,61.0,54.0,55.0,68.0,103.0,30.0,32.0,50.0,868.0
Golaghat,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,12.0,12.0,30.0,63.0,20.0,65.0,64.0,156.0,99.0,105.0,90.0,28.0,744.0
Golaghat,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,23.0,35.0,9.0,74.0,85.0,42.0,117.0,102.0,145.0,247.0,148.0,138.0,1165.0
Golaghat,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Golaghat,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,135.0,174.0,165.0,763.0,228.0,272.0,298.0,374.0,400.0,422.0,309.0,277.0,3817.0
Golaghat,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,397.0,440.0,222.0,293.0,310.0,243.0,249.0,231.0,318.0,418.0,257.0,194.0,3572.0
Golaghat,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,1.0,0.0,0.0,6.0,0.0,3.0,4.0,4.0,0.0,0.0,0.0,2.0,20.0
Golaghat,9.06,Number of IUCD removals,TOTAL,13.0,25.0,38.0,46.0,44.0,19.0,49.0,29.0,26.0,45.0,30.0,34.0,398.0
Golaghat,9.07,Number of Oral Pills cycles distributed,TOTAL,3692.0,4249.0,4395.0,7972.0,5322.0,5831.0,5537.0,5927.0,5794.0,4846.0,5255.0,4936.0,63756.0
Golaghat,9.08,Number of Condom pieces distributed,TOTAL,7966.0,8204.0,8846.0,10420.0,9150.0,10681.0,13284.0,14337.0,14314.0,13575.0,13993.0,14000.0,138770.0
Golaghat,9.09,Number of Centchroman (weekly) pills given,TOTAL,35.0,62.0,70.0,4.0,0.0,0.0,2.0,111.0,4.0,3.0,19.0,3.0,313.0
Golaghat,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,28.0,0.0,4.0,11.0,6.0,9.0,3.0,18.0,15.0,65.0,35.0,44.0,238.0
Golaghat,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,1.0,2.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Golaghat,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1627.0,906.0,926.0,1384.0,1907.0,1834.0,1482.0,1744.0,1895.0,2312.0,1894.0,1364.0,19275.0
Golaghat,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1422.0,1399.0,1312.0,1122.0,1223.0,1441.0,1611.0,1838.0,1440.0,1667.0,849.0,972.0,16296.0
Golaghat,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1511.0,1518.0,1470.0,1232.0,1098.0,1223.0,1374.0,1627.0,1743.0,1540.0,1440.0,1470.0,17246.0
Golaghat,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1374.0,1498.0,1398.0,1319.0,1174.0,1138.0,1160.0,1447.0,1572.0,1428.0,1301.0,1763.0,16572.0
Golaghat,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,759.0,1152.0,1911.0
Golaghat,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,564.0,566.0
Golaghat,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0,18.0
Golaghat,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,662.0,459.0,345.0,847.0,890.0,988.0,863.0,762.0,1046.0,1059.0,842.0,816.0,9579.0
Golaghat,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1361.0,875.0,1237.0,1217.0,1017.0,1391.0,1197.0,1768.0,1371.0,2040.0,1394.0,2122.0,16990.0
Golaghat,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1474.0,974.0,1320.0,1294.0,941.0,1172.0,965.0,1545.0,1549.0,1854.0,1466.0,2196.0,16750.0
Golaghat,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1340.0,920.0,1282.0,1317.0,978.0,1078.0,791.0,1370.0,1380.0,1575.0,1319.0,2253.0,15603.0
Golaghat,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,507.0,523.0,466.0,674.0,736.0,824.0,815.0,785.0,925.0,949.0,799.0,728.0,8731.0
Golaghat,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1200.0,1502.0,1412.0,1106.0,1227.0,1410.0,1609.0,1843.0,1436.0,1700.0,884.0,837.0,16166.0
Golaghat,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1233.0,1565.0,1564.0,1312.0,1123.0,1221.0,1396.0,1637.0,1736.0,1561.0,1460.0,1365.0,17173.0
Golaghat,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1061.0,1479.0,1475.0,1361.0,1242.0,1190.0,1164.0,1482.0,1593.0,1405.0,1330.0,1731.0,16513.0
Golaghat,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,957.0,1353.0,1459.0,1423.0,1478.0,1350.0,1183.0,1894.0,762.0,577.0,2015.0,2260.0,16711.0
Golaghat,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1227.0,1374.0,1376.0,1321.0,1287.0,1047.0,794.0,1176.0,635.0,358.0,1315.0,1686.0,13596.0
Golaghat,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,428.0,1181.0,1022.0,1051.0,501.0,552.0,550.0,348.0,668.0,590.0,1023.0,1382.0,9296.0
Golaghat,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,531.0,688.0,735.0,695.0,751.0,734.0,603.0,940.0,397.0,301.0,1032.0,1125.0,8532.0
Golaghat,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,456.0,613.0,697.0,692.0,702.0,612.0,566.0,915.0,347.0,269.0,945.0,1098.0,7912.0
Golaghat,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,987.0,1301.0,1432.0,1387.0,1453.0,1346.0,1169.0,1855.0,744.0,570.0,1977.0,2223.0,16444.0
Golaghat,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1276.0,1350.0,1411.0,1253.0,1350.0,1177.0,980.0,1348.0,1093.0,916.0,1224.0,1558.0,14936.0
Golaghat,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1230.0,899.0,1327.0,1205.0,1146.0,1098.0,717.0,1147.0,1037.0,912.0,1208.0,1643.0,13569.0
Golaghat,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,4.0
Golaghat,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,83.0,84.0,80.0,79.0,85.0,70.0,62.0,68.0,45.0,54.0,110.0,74.0,894.0
Golaghat,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,82.0,87.0,82.0,66.0,82.0,68.0,64.0,72.0,42.0,44.0,96.0,75.0,860.0
Golaghat,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,165.0,171.0,162.0,145.0,167.0,138.0,126.0,140.0,87.0,98.0,206.0,149.0,1754.0
Golaghat,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,473.0,617.0,552.0,698.0,691.0,581.0,510.0,690.0,696.0,630.0,698.0,710.0,7546.0
Golaghat,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,433.0,512.0,455.0,497.0,607.0,451.0,469.0,523.0,539.0,502.0,490.0,596.0,6074.0
Golaghat,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,342.0,378.0,379.0,414.0,406.0,376.0,388.0,377.0,392.0,366.0,370.0,469.0,4657.0
Golaghat,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Golaghat,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1202.0,1189.0,1193.0,1197.0,1202.0,1205.0,1193.0,1211.0,1204.0,1213.0,1198.0,1201.0,14408.0
Golaghat,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1180.0,1186.0,1182.0,1185.0,1169.0,1195.0,1190.0,1205.0,1199.0,1204.0,1183.0,1195.0,14273.0
Golaghat,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1173.0,1178.0,1174.0,1170.0,1160.0,1189.0,1182.0,1200.0,1193.0,1199.0,1176.0,1186.0,14180.0
Golaghat,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1043.0,1281.0,1236.0,1438.0,581.0,531.0,461.0,299.0,785.0,520.0,1082.0,1429.0,10686.0
Golaghat,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,983.0,1339.0,1450.0,1387.0,1487.0,1351.0,1201.0,1884.0,860.0,769.0,1820.0,1751.0,16282.0
Golaghat,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,403.0,447.0,523.0,483.0,1506.0,647.0,441.0,476.0,417.0,557.0,970.0,607.0,7477.0
Golaghat,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,422.0,471.0,454.0,481.0,1348.0,593.0,378.0,539.0,436.0,473.0,791.0,502.0,6888.0
Golaghat,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,28.0,30.0,31.0,14.0,16.0,24.0,13.0,17.0,6.0,10.0,6.0,13.0,208.0
Golaghat,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,271.0,348.0,461.0,417.0,428.0,229.0,185.0,166.0,115.0,172.0,187.0,217.0,3196.0
Golaghat,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Golaghat,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,52.0,37.0,38.0,2.0,58.0,144.0,68.0,0.0,10.0,36.0,38.0,41.0,524.0
Golaghat,13.1,Number of Patients operated for cataract,TOTAL,66.0,83.0,71.0,76.0,37.0,49.0,51.0,73.0,62.0,48.0,47.0,75.0,738.0
Golaghat,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,66.0,83.0,71.0,76.0,37.0,49.0,51.0,73.0,62.0,48.0,47.0,74.0,737.0
Golaghat,13.3,Number of School children detected with Refractive errors,TOTAL,24.0,34.0,0.0,0.0,18.0,0.0,285.0,119.0,23.0,32.0,36.0,45.0,616.0
Golaghat,13.4,Number of children provided free glasses,TOTAL,2.0,2.0,0.0,0.0,0.0,0.0,0.0,3.0,2.0,2.0,0.0,0.0,11.0
Golaghat,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Golaghat,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Golaghat,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Golaghat,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,21.0,21.0,22.0,22.0,22.0,22.0,23.0,22.0,23.0,25.0,26.0,25.0,-1.0
Golaghat,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1003.0,1000.0,1012.0,1001.0,992.0,1022.0,1010.0,1027.0,1019.0,1034.0,1025.0,1020.0,-1.0
Golaghat,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Golaghat,14.05,Number of RKS meetings held during the month,TOTAL,18.0,24.0,26.0,20.0,22.0,21.0,23.0,14.0,15.0,14.0,15.0,18.0,230.0
Golaghat,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,33.0,27.0,28.0,28.0,28.0,28.0,29.0,33.0,31.0,31.0,29.0,30.0,-1.0
Golaghat,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,708.0,589.0,867.0,755.0,677.0,804.0,639.0,598.0,565.0,491.0,454.0,487.0,7634.0
Golaghat,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Golaghat,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Golaghat,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,426.0,478.0,441.0,579.0,447.0,493.0,400.0,323.0,248.0,287.0,360.0,395.0,4877.0
Golaghat,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1321.0,1291.0,1247.0,1390.0,1163.0,1116.0,1257.0,922.0,898.0,945.0,862.0,933.0,13345.0
Golaghat,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,403.0,503.0,516.0,546.0,532.0,499.0,479.0,339.0,334.0,314.0,435.0,437.0,5337.0
Golaghat,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1791.0,2002.0,1981.0,2141.0,1957.0,1799.0,1946.0,1785.0,1603.0,1674.0,1528.0,1742.0,21949.0
Golaghat,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,829.0,981.0,957.0,1125.0,979.0,992.0,879.0,662.0,582.0,601.0,795.0,832.0,10214.0
Golaghat,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3112.0,3293.0,3228.0,3531.0,3120.0,2915.0,3203.0,2707.0,2501.0,2619.0,2390.0,2675.0,35294.0
Golaghat,14.10.2.a,Number of death cases of Inpatient males,TOTAL,29.0,33.0,21.0,27.0,26.0,36.0,44.0,26.0,27.0,31.0,28.0,24.0,352.0
Golaghat,14.10.2.b,Number of death cases of Inpatient females,TOTAL,18.0,14.0,23.0,29.0,22.0,15.0,23.0,24.0,19.0,16.0,14.0,13.0,230.0
Golaghat,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,47.0,47.0,44.0,56.0,48.0,51.0,67.0,50.0,46.0,47.0,42.0,37.0,582.0
Golaghat,14.11,In-Patient Head Count at midnight,TOTAL,399.0,404.0,493.0,452.0,515.0,87.0,486.0,122.0,358.0,400.0,87.0,106.0,3909.0
Golaghat,14.12.1,OPD attendance (All),TOTAL,83663.0,91857.0,101295.0,109659.0,91243.0,94346.0,81888.0,73371.0,66972.0,64669.0,73517.0,85736.0,1018216.0
Golaghat,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,33.0,60.0,56.0,44.0,24.0,31.0,31.0,26.0,28.0,18.0,36.0,40.0,427.0
Golaghat,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,1.0,7.0,10.0,11.0,2.0,2.0,0.0,0.0,4.0,1.0,2.0,3.0,43.0
Golaghat,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,13.0,21.0,15.0,17.0,9.0,49.0,43.0,14.0,38.0,43.0,30.0,31.0,323.0
Golaghat,14.14.a,Number of patients given AYUSH treatment,TOTAL,841.0,1233.0,1121.0,1266.0,1089.0,1099.0,762.0,876.0,711.0,970.0,845.0,1040.0,11853.0
Golaghat,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,763.0,603.0,807.0,741.0,634.0,1332.0,436.0,814.0,445.0,519.0,538.0,656.0,8288.0
Golaghat,14.14.c,Number of Adolescents counselled,TOTAL,110.0,137.0,148.0,93.0,64.0,107.0,52.0,100.0,62.0,59.0,62.0,83.0,1077.0
Golaghat,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4985.0,4318.0,5348.0,4825.0,5078.0,5110.0,4840.0,5319.0,4692.0,4493.0,4190.0,5077.0,58275.0
Golaghat,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,31.0,39.0,61.0,46.0,41.0,41.0,49.0,65.0,35.0,28.0,68.0,36.0,540.0
Golaghat,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,153.0,408.0,427.0,317.0,343.0,427.0,427.0,329.0,148.0,257.0,364.0,281.0,3881.0
Golaghat,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,3.0,2.0,3.0,3.0,2.0,2.0,1.0,0.0,0.0,2.0,4.0,22.0
Golaghat,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,119.0,212.0,226.0,154.0,125.0,168.0,130.0,136.0,58.0,48.0,88.0,177.0,1641.0
Golaghat,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,8.0
Golaghat,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,924.0,1769.0,1631.0,898.0,752.0,1208.0,988.0,736.0,665.0,719.0,1187.0,999.0,12476.0
Golaghat,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,4.0
Golaghat,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1196.0,2389.0,2284.0,1369.0,1220.0,1803.0,1545.0,1201.0,871.0,1024.0,1639.0,1457.0,17998.0
Golaghat,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,6.0,4.0,4.0,4.0,3.0,3.0,2.0,0.0,0.0,2.0,6.0,34.0
Golaghat,15.2,Number of Widal tests conducted,Number tested,87.0,116.0,104.0,174.0,193.0,113.0,136.0,137.0,76.0,89.0,80.0,149.0,1454.0
Golaghat,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,208.0,255.0,251.0,175.0,264.0,229.0,246.0,260.0,223.0,188.0,172.0,260.0,2731.0
Golaghat,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,208.0,255.0,251.0,175.0,264.0,229.0,246.0,260.0,223.0,188.0,172.0,260.0,2731.0
Golaghat,15.4.1,Number of blood smears examined for Malaria,TOTAL,7550.0,8936.0,11343.0,16873.0,14006.0,10863.0,7652.0,6335.0,5514.0,4011.0,5046.0,6344.0,104473.0
Golaghat,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,1.0,2.0,2.0,0.0,3.0,0.0,0.0,1.0,1.0,2.0,1.0,13.0
Golaghat,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,2.0,6.0,47.0,0.0,3.0,39.0,1.0,1.0,0.0,0.0,0.0,99.0
Golaghat,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,7290.0,11220.0,3590.0,5120.0,120.0,2120.0,3820.0,5820.0,520.0,10520.0,10020.0,1520.0,61680.0
Golaghat,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,0.0,10000.0,10000.0,16000.0,15000.0,10000.0,0.0,16000.0,8000.0,0.0,15000.0,110000.0
Golaghat,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,6070.0,7630.0,8470.0,15000.0,14000.0,13300.0,8000.0,5300.0,6000.0,8500.0,8500.0,5500.0,106270.0
Golaghat,16.1.1,Stock position of DPT vaccines,5. Total Stock,11220.0,3590.0,5120.0,120.0,2120.0,3820.0,5820.0,520.0,10520.0,10020.0,1520.0,11020.0,65410.0
Golaghat,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,19750.0,8000.0,0.0,22000.0,1000.0,6000.0,9000.0,8000.0,500.0,4300.0,4000.0,500.0,83050.0
Golaghat,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,40000.0,0.0,20000.0,18000.0,10000.0,0.0,10000.0,5000.0,0.0,20000.0,123000.0
Golaghat,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,11750.0,8000.0,18000.0,21000.0,15000.0,15000.0,11000.0,7500.0,6200.0,5300.0,3500.0,6800.0,129050.0
Golaghat,16.1.2,Stock position of OPV vaccines,5. Total Stock,8000.0,0.0,22000.0,1000.0,6000.0,9000.0,8000.0,500.0,4300.0,4000.0,500.0,13700.0,77000.0
Golaghat,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,9950.0,19950.0,7530.0,2950.0,450.0,1450.0,1450.0,7450.0,450.0,0.0,4400.0,200.0,56230.0
Golaghat,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,0.0,5000.0,10000.0,16000.0,15000.0,16000.0,0.0,0.0,10000.0,0.0,15000.0,97000.0
Golaghat,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.1.3,Stock position of TT vaccines,4. Stock Distributed,0.0,12420.0,9580.0,12500.0,15000.0,15000.0,10000.0,7000.0,450.0,5600.0,4200.0,4200.0,95950.0
Golaghat,16.1.3,Stock position of TT vaccines,5. Total Stock,19950.0,7530.0,2950.0,450.0,1450.0,1450.0,7450.0,450.0,0.0,4400.0,200.0,11000.0,57280.0
Golaghat,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,14160.0,22710.0,10870.0,3180.0,180.0,180.0,180.0,20.0,520.0,5520.0,8020.0,520.0,66060.0
Golaghat,16.1.5,Stock position of BCG vaccines,2. Stocks Received,13000.0,0.0,0.0,13000.0,10000.0,10000.0,0.0,8000.0,8500.0,10000.0,0.0,0.0,72500.0
Golaghat,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4450.0,11840.0,7690.0,16000.0,10000.0,10000.0,160.0,7500.0,3500.0,7500.0,7500.0,520.0,86660.0
Golaghat,16.1.5,Stock position of BCG vaccines,5. Total Stock,22710.0,10870.0,3180.0,180.0,180.0,180.0,20.0,520.0,5520.0,8020.0,520.0,0.0,51900.0
Golaghat,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,10080.0,11470.0,1910.0,4580.0,480.0,80.0,80.0,80.0,30.0,0.0,7400.0,600.0,36790.0
Golaghat,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,0.0,10000.0,10000.0,0.0,0.0,5000.0,0.0,0.0,15000.0,0.0,10000.0,55000.0
Golaghat,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3610.0,9560.0,7330.0,14100.0,400.0,0.0,5000.0,50.0,30.0,7600.0,6800.0,5500.0,59980.0
Golaghat,16.1.6,Stock position of Measles vaccines,5. Total Stock,11470.0,1910.0,4580.0,480.0,80.0,80.0,80.0,30.0,0.0,7400.0,600.0,5100.0,31810.0
Golaghat,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,2200.0,700.0,170.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,6000.0,0.0,11070.0
Golaghat,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,15000.0,5000.0,0.0,0.0,0.0,5000.0,10000.0,0.0,10000.0,45000.0
Golaghat,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.1.7,Stock position of JE vaccines,4. Stock Distributed,1500.0,530.0,170.0,15000.0,5000.0,0.0,0.0,0.0,3000.0,6000.0,6000.0,3500.0,40700.0
Golaghat,16.1.7,Stock position of JE vaccines,5. Total Stock,700.0,170.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,6000.0,0.0,6500.0,15370.0
Golaghat,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,25180.0,17420.0,4550.0,7040.0,5040.0,1040.0,1040.0,40.0,0.0,5000.0,7600.0,200.0,74150.0
Golaghat,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,13000.0,13000.0,16000.0,15000.0,0.0,0.0,10000.0,10000.0,0.0,15000.0,92000.0
Golaghat,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,7760.0,12870.0,10510.0,15000.0,20000.0,15000.0,1000.0,40.0,5000.0,7400.0,7400.0,4200.0,106180.0
Golaghat,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,17420.0,4550.0,7040.0,5040.0,1040.0,1040.0,40.0,0.0,5000.0,7600.0,200.0,11000.0,59970.0
Golaghat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,900.0,3260.0,260.0,1260.0,60.0,2560.0,4560.0,2560.0,1060.0,560.0,60.0,0.0,17100.0
Golaghat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,3000.0,0.0,3000.0,0.0,3000.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0
Golaghat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,640.0,3000.0,2000.0,1200.0,500.0,1000.0,2000.0,1500.0,500.0,500.0,60.0,0.0,12900.0
Golaghat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,3260.0,260.0,1260.0,60.0,2560.0,4560.0,2560.0,1060.0,560.0,60.0,0.0,0.0,16200.0
Golaghat,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,20000.0,20000.0,6000.0,5000.0,0.0,3000.0,5000.0,5000.0,1500.0,500.0,200.0,0.0,66200.0
Golaghat,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,8400.0,0.0,0.0,4500.0,5000.0,5000.0,10000.0,0.0,0.0,0.0,0.0,4000.0,36900.0
Golaghat,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,8400.0,14000.0,1000.0,9500.0,2000.0,3000.0,10000.0,3500.0,1000.0,300.0,200.0,4000.0,56900.0
Golaghat,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,20000.0,6000.0,5000.0,0.0,3000.0,5000.0,5000.0,1500.0,500.0,200.0,0.0,0.0,46200.0
Golaghat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,57000.0,38500.0,20500.0,18500.0,8500.0,8500.0,13500.0,500.0,0.0,0.0,0.0,0.0,165500.0
Golaghat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,3000.0,0.0,3000.0,10000.0,10000.0,10000.0,0.0,0.0,0.0,0.0,0.0,8000.0,44000.0
Golaghat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,21500.0,18000.0,5000.0,20000.0,10000.0,5000.0,13000.0,500.0,0.0,0.0,0.0,4000.0,97000.0
Golaghat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,38500.0,20500.0,18500.0,8500.0,8500.0,13500.0,500.0,0.0,0.0,0.0,0.0,4000.0,112500.0
Golaghat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,300.0,2300.0,300.0,0.0,0.0,5000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,67900.0
Golaghat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,2300.0,0.0,0.0,0.0,5000.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,12300.0
Golaghat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,300.0,2000.0,300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,6600.0
Golaghat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,2300.0,300.0,0.0,0.0,5000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,6000.0,73600.0
Golaghat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1110.0,1110.0
Golaghat,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4320.0,0.0,4320.0
Golaghat,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3210.0,0.0,3210.0
Golaghat,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1110.0,1110.0,2220.0
Golaghat,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,2100.0,1500.0,100.0,0.0,0.0,0.0,0.0,1050.0,2350.0,2750.0,300.0,300.0,10450.0
Golaghat,16.3.02,Stock Position of Gloves,2. Stocks Received,1000.0,0.0,0.0,0.0,0.0,0.0,2000.0,3300.0,3200.0,0.0,0.0,0.0,9500.0
Golaghat,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.3.02,Stock Position of Gloves,4. Stock Distributed,1600.0,1400.0,100.0,0.0,0.0,0.0,950.0,2000.0,2800.0,2450.0,0.0,0.0,11300.0
Golaghat,16.3.02,Stock Position of Gloves,5. Total Stock,1500.0,100.0,0.0,0.0,0.0,0.0,1050.0,2350.0,2750.0,300.0,300.0,300.0,8650.0
Golaghat,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,4274500.0,3584500.0,3406000.0,3059500.0,2897500.0,2783500.0,2667000.0,2613500.0,1280600.0,1010600.0,773100.0,642600.0,28992900.0
Golaghat,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,690000.0,178500.0,346500.0,162000.0,114000.0,116500.0,53500.0,1332900.0,270000.0,237500.0,130500.0,328100.0,3960000.0
Golaghat,16.3.07,Stock Position of IFA Tablets,5. Total Stock,3584500.0,3406000.0,3059500.0,2897500.0,2783500.0,2667000.0,2613500.0,1280600.0,1010600.0,773100.0,642600.0,314500.0,25032900.0
Golaghat,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,14300.0,14300.0,13800.0,12650.0,12650.0,12650.0,10800.0,8300.0,6700.0,6700.0,5550.0,6450.0,124850.0
Golaghat,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7600.0,0.0,7600.0
Golaghat,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,500.0,1150.0,0.0,0.0,1850.0,2500.0,1600.0,0.0,1150.0,6700.0,1200.0,16650.0
Golaghat,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,14300.0,13800.0,12650.0,12650.0,12650.0,10800.0,8300.0,6700.0,6700.0,5550.0,6450.0,5250.0,115800.0
Golaghat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Golaghat,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,200.0,200.0,200.0,50.0,50.0,100.0,50.0,0.0,0.0,0.0,0.0,0.0,850.0
Golaghat,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Golaghat,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,150.0,0.0,50.0,50.0,50.0,0.0,0.0,0.0,0.0,0.0,300.0
Golaghat,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,200.0,200.0,50.0,50.0,100.0,50.0,0.0,0.0,0.0,0.0,0.0,0.0,650.0
Golaghat,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,13467.0,7967.0,15667.0,8967.0,3117.0,6267.0,1547.0,172.0,322.0,1422.0,822.0,5497.0,65234.0
Golaghat,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,10000.0,0.0,0.0,7000.0,0.0,0.0,4200.0,4200.0,0.0,4800.0,0.0,30200.0
Golaghat,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,5500.0,2300.0,6700.0,5850.0,3850.0,4720.0,1375.0,4050.0,3100.0,600.0,125.0,0.0,38170.0
Golaghat,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,7967.0,15667.0,8967.0,3117.0,6267.0,1547.0,172.0,322.0,1422.0,822.0,5497.0,5497.0,57264.0
Golaghat,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,100.0,200.0,1800.0,1640.0,740.0,1540.0,2040.0,840.0,8900.0
Golaghat,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,3300.0,3300.0,6600.0,0.0,6600.0,3300.0,2000.0,0.0,0.0,25100.0
Golaghat,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,3200.0,3200.0,5000.0,160.0,7500.0,2500.0,1500.0,1200.0,840.0,25100.0
Golaghat,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,100.0,200.0,1800.0,1640.0,740.0,1540.0,2040.0,840.0,0.0,8900.0
Golaghat,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,65000.0,67900.0,46900.0,48900.0,38900.0,7900.0,6900.0,20900.0,5900.0,38900.0,46900.0,28900.0,423900.0
Golaghat,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,24000.0,0.0,24000.0,60000.0,24000.0,25000.0,36000.0,0.0,48000.0,24000.0,0.0,48000.0,313000.0
Golaghat,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,21100.0,21000.0,22000.0,70000.0,55000.0,26000.0,22000.0,15000.0,15000.0,16000.0,18000.0,25000.0,326100.0
Golaghat,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,67900.0,46900.0,48900.0,38900.0,7900.0,6900.0,20900.0,5900.0,38900.0,46900.0,28900.0,51900.0,410800.0
Golaghat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1000.0,2470.0,1270.0,1470.0,1470.0,1670.0,670.0,1170.0,370.0,3570.0,4470.0,2870.0,22470.0
Golaghat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000.0,0.0,2000.0,6000.0,2000.0,3000.0,4000.0,0.0,4000.0,2400.0,0.0,4000.0,31400.0
Golaghat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Golaghat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2530.0,1200.0,1800.0,6000.0,1800.0,4000.0,3500.0,800.0,800.0,1500.0,1600.0,2200.0,27730.0
Golaghat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2470.0,1270.0,1470.0,1470.0,1670.0,670.0,1170.0,370.0,3570.0,4470.0,2870.0,4670.0,26140.0
Golaghat,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,3.0,3.0,,,,,1.0,2.0,,9.0
Golaghat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,2.0,,2.0,1.0,6.0,,1.0,,4.0,1.0,1.0,,18.0
Golaghat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Golaghat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,2.0,,2.0,1.0,6.0,,1.0,,4.0,1.0,1.0,,18.0
Golaghat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,3.0,,2.0,2.0,1.0,,6.0,5.0,2.0,3.0,1.0,2.0,27.0
Golaghat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Golaghat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,3.0,,2.0,2.0,1.0,,6.0,5.0,2.0,3.0,1.0,2.0,27.0
Golaghat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,6.0,3.0,8.0,2.0,5.0,2.0,3.0,3.0,4.0,3.0,,1.0,40.0
Golaghat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Golaghat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,6.0,3.0,8.0,2.0,5.0,2.0,3.0,3.0,4.0,3.0,,1.0,40.0
Golaghat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,6.0,,7.0,2.0,2.0,,9.0,6.0,6.0,7.0,3.0,11.0,59.0
Golaghat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,,,,,1.0,,,,,2.0
Golaghat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,7.0,,7.0,2.0,2.0,,9.0,7.0,6.0,7.0,3.0,11.0,61.0
Golaghat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,1.0,1.0,3.0,4.0,,,1.0,3.0,13.0
Golaghat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Golaghat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,1.0,1.0,3.0,4.0,,,1.0,3.0,13.0
Golaghat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Golaghat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Golaghat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Golaghat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,1.0,,3.0,1.0,,2.0,,,,7.0
Golaghat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,,1.0,1.0,,,,,,,3.0
Golaghat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,1.0,1.0,4.0,1.0,,2.0,,,,10.0
Golaghat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Golaghat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Golaghat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Golaghat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,,5.0,2.0,3.0,1.0,5.0,7.0,1.0,3.0,4.0,3.0,37.0
Golaghat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,,,1.0,,,,,,,2.0,4.0
Golaghat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,,5.0,2.0,4.0,1.0,5.0,7.0,1.0,3.0,4.0,5.0,41.0
Golaghat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Golaghat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,1.0,,,,1.0,3.0
Golaghat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,1.0,1.0,1.0,,,,,3.0
Golaghat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,1.0,1.0,2.0,,,,1.0,6.0
Golaghat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,1.0,,,1.0,,,2.0
Golaghat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,3.0,6.0,4.0,1.0,,,3.0,2.0,2.0,3.0,1.0,26.0
Golaghat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,1.0,,1.0,1.0,,,,,,1.0,3.0,9.0
Golaghat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,3.0,4.0,6.0,5.0,2.0,,1.0,3.0,2.0,3.0,4.0,4.0,37.0
Golaghat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,1.0,,,,,,2.0,,,,3.0
Golaghat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,4.0,4.0,7.0,4.0,2.0,2.0,5.0,2.0,6.0,9.0,4.0,4.0,53.0
Golaghat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,4.0,3.0,5.0,3.0,3.0,2.0,7.0,3.0,,5.0,,1.0,36.0
Golaghat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,8.0,7.0,13.0,7.0,5.0,4.0,12.0,5.0,8.0,14.0,4.0,5.0,92.0
Golaghat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Golaghat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,,,,1.0,,,,,,2.0
Golaghat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Golaghat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,,,1.0,,,,,,2.0
Golaghat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,1.0,4.0,,1.0,,,,,,1.0,8.0
Golaghat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,2.0,2.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,3.0,3.0,20.0
Golaghat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,3.0,,5.0,3.0,,2.0,2.0,1.0,,2.0,,,18.0
Golaghat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,5.0,2.0,8.0,9.0,1.0,4.0,4.0,2.0,1.0,3.0,3.0,4.0,46.0
Golaghat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Golaghat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Golaghat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Golaghat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,1.0,,1.0
Golaghat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Golaghat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,5.0,5.0,5.0,6.0,6.0,2.0,6.0,8.0,3.0,9.0,8.0,3.0,66.0
Golaghat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,6.0,9.0,11.0,14.0,4.0,2.0,11.0,12.0,11.0,15.0,12.0,15.0,122.0
Golaghat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,12.0,14.0,16.0,20.0,10.0,4.0,17.0,20.0,14.0,24.0,20.0,18.0,189.0
Golaghat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Golaghat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,1.0,4.0,2.0,,,1.0,1.0,,1.0,2.0,,13.0
Golaghat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,2.0,2.0,1.0,1.0,,3.0,,,2.0,,1.0,12.0
Golaghat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,3.0,6.0,3.0,1.0,,4.0,1.0,,3.0,2.0,1.0,25.0
Golaghat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Golaghat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Golaghat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Golaghat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Golaghat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Golaghat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Golaghat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Golaghat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,1.0,,,,,,,,,,,,1.0
Golaghat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Golaghat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,,,,2.0,1.0,2.0,1.0,,1.0,8.0
Golaghat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Golaghat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,,,,2.0,1.0,2.0,1.0,,1.0,8.0
Golaghat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Golaghat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,,,,,,1.0,,2.0
Golaghat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Golaghat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,,,,,,1.0,,2.0
Golaghat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Golaghat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,1.0,1.0,,,,,2.0
Golaghat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Golaghat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,1.0,1.0,,,,,2.0
Golaghat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Golaghat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,4.0,,2.0,8.0,6.0,1.0,6.0,3.0,1.0,3.0,2.0,1.0,37.0
Golaghat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Golaghat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,4.0,,2.0,8.0,6.0,1.0,6.0,3.0,1.0,3.0,2.0,1.0,37.0
Golaghat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,1.0,,2.0,,,1.0,,1.0,5.0
Golaghat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,4.0,5.0,5.0,8.0,5.0,15.0,7.0,7.0,10.0,5.0,15.0,89.0
Golaghat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,,2.0,1.0,1.0,,1.0,4.0,1.0,1.0,1.0,3.0,17.0
Golaghat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,5.0,4.0,7.0,6.0,10.0,5.0,18.0,11.0,8.0,12.0,6.0,19.0,111.0
Golaghat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,1.0,1.0,,,,,,,,,2.0
Golaghat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,5.0,,5.0,3.0,4.0,,5.0,2.0,,3.0,,3.0,30.0
Golaghat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,3.0,1.0,,1.0,,,,,1.0,1.0,7.0
Golaghat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,5.0,,9.0,5.0,4.0,1.0,5.0,2.0,,3.0,1.0,4.0,39.0
Golaghat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Golaghat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,2.0,2.0,,,,,4.0
Golaghat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Golaghat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,,,,,2.0,2.0,,,,,5.0
Golaghat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,1.0,1.0,,,,,,,,,,3.0
Golaghat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,6.0,1.0,,5.0,2.0,,2.0,2.0,3.0,2.0,2.0,4.0,29.0
Golaghat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,1.0,4.0,7.0,1.0,4.0,1.0,1.0,1.0,8.0,3.0,4.0,38.0
Golaghat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,10.0,3.0,5.0,12.0,3.0,4.0,3.0,3.0,4.0,10.0,5.0,8.0,70.0
Golaghat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,1.0,1.0,,1.0,,3.0,,,,6.0
Golaghat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,11.0,6.0,12.0,14.0,11.0,14.0,18.0,16.0,15.0,11.0,14.0,11.0,153.0
Golaghat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,14.0,20.0,9.0,21.0,11.0,15.0,12.0,17.0,16.0,13.0,7.0,22.0,177.0
Golaghat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,25.0,26.0,21.0,36.0,23.0,29.0,31.0,33.0,34.0,24.0,21.0,33.0,336.0
Golaghat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,3.0,1.0,2.0,1.0,1.0,,1.0,1.0,,1.0,,11.0
Golaghat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,8.0,12.0,12.0,22.0,10.0,16.0,16.0,11.0,11.0,17.0,15.0,17.0,167.0
Golaghat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,27.0,21.0,24.0,23.0,17.0,13.0,14.0,19.0,27.0,23.0,14.0,17.0,239.0
Golaghat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,35.0,36.0,37.0,47.0,28.0,30.0,30.0,31.0,39.0,40.0,30.0,34.0,417.0
Hailakandi,1.1,Total number of pregnant women Registered for ANC,TOTAL,1815.0,1884.0,1772.0,1572.0,1943.0,1892.0,1606.0,1219.0,1728.0,1687.0,1230.0,1260.0,19608.0
Hailakandi,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1184.0,1185.0,1099.0,1042.0,1300.0,1298.0,1135.0,858.0,1230.0,1341.0,1031.0,1010.0,13713.0
Hailakandi,1.2,Number of Pregnant women registered under JSY,TOTAL,1815.0,1884.0,1772.0,1572.0,1943.0,1892.0,1606.0,1219.0,1728.0,1687.0,1230.0,1259.0,19607.0
Hailakandi,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1006.0,1093.0,1137.0,1216.0,1528.0,1551.0,1613.0,1315.0,1666.0,1479.0,1277.0,1387.0,16268.0
Hailakandi,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1035.0,1229.0,1250.0,1080.0,1348.0,1357.0,1287.0,912.0,1189.0,1110.0,995.0,1025.0,13817.0
Hailakandi,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1238.0,1367.0,1500.0,1448.0,1546.0,1744.0,1698.0,1251.0,1681.0,1394.0,1228.0,1324.0,17419.0
Hailakandi,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1428.0,1399.0,1431.0,1272.0,1684.0,1584.0,1608.0,1085.0,1665.0,1625.0,1238.0,1275.0,17294.0
Hailakandi,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,14.0,5.0,9.0,9.0,5.0,9.0,14.0,8.0,22.0,22.0,16.0,12.0,145.0
Hailakandi,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,3.0,0.0,1.0,1.0,2.0,2.0,0.0,0.0,0.0,9.0
Hailakandi,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,762.0,697.0,760.0,691.0,930.0,910.0,703.0,562.0,768.0,772.0,626.0,599.0,8780.0
Hailakandi,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,9.0,11.0,7.0,7.0,5.0,8.0,4.0,9.0,4.0,4.0,6.0,8.0,82.0
Hailakandi,1.8,Number of pregnancy test kits used at SC level,TOTAL,910.0,859.0,728.0,758.0,937.0,933.0,856.0,570.0,823.0,883.0,730.0,843.0,9830.0
Hailakandi,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,39.0,40.0,42.0,54.0,81.0,80.0,98.0,67.0,62.0,103.0,91.0,77.0,834.0
Hailakandi,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,372.0,344.0,330.0,262.0,345.0,308.0,362.0,405.0,407.0,334.0,271.0,334.0,4074.0
Hailakandi,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,411.0,384.0,372.0,316.0,426.0,388.0,460.0,472.0,469.0,437.0,362.0,411.0,4908.0
Hailakandi,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,213.0,252.0,212.0,203.0,253.0,242.0,313.0,253.0,360.0,325.0,293.0,267.0,3186.0
Hailakandi,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,5.0,1.0,2.0,0.0,3.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,14.0
Hailakandi,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,768.0,721.0,668.0,655.0,806.0,869.0,997.0,904.0,976.0,978.0,834.0,855.0,10031.0
Hailakandi,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,160.0,195.0,183.0,219.0,231.0,238.0,257.0,286.0,327.0,376.0,578.0,543.0,3593.0
Hailakandi,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,768.0,721.0,668.0,655.0,806.0,869.0,997.0,904.0,976.0,978.0,834.0,855.0,10031.0
Hailakandi,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,470.0,633.0,371.0,754.0,663.0,714.0,823.0,378.0,1057.0,435.0,439.0,1137.0,7874.0
Hailakandi,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,,,,,,,0.0,0.0,,0.0
Hailakandi,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Hailakandi,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Hailakandi,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,3.0,8.0,2.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,16.0,32.0
Hailakandi,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hailakandi,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,3.0,8.0,2.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,16.0,32.0
Hailakandi,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Hailakandi,4.1.1.a,Number of male live births,TOTAL,572.0,577.0,524.0,484.0,624.0,628.0,732.0,692.0,707.0,700.0,575.0,633.0,7448.0
Hailakandi,4.1.1.b,Number of female live births,TOTAL,578.0,511.0,493.0,476.0,586.0,606.0,677.0,648.0,697.0,667.0,577.0,600.0,7116.0
Hailakandi,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1150.0,1088.0,1017.0,960.0,1210.0,1234.0,1409.0,1340.0,1404.0,1367.0,1152.0,1233.0,14564.0
Hailakandi,4.1.2,Number of still births,TOTAL,39.0,27.0,40.0,32.0,30.0,34.0,55.0,45.0,52.0,68.0,46.0,48.0,516.0
Hailakandi,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,87.0,100.0,100.0,70.0,75.0,106.0,90.0,97.0,95.0,87.0,88.0,92.0,1087.0
Hailakandi,4.2.1,Number of Newborns weighed at birth,TOTAL,1146.0,1087.0,1016.0,959.0,1213.0,1232.0,1406.0,1330.0,1400.0,1362.0,1146.0,1231.0,14528.0
Hailakandi,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,133.0,102.0,120.0,114.0,140.0,137.0,186.0,186.0,217.0,159.0,127.0,167.0,1788.0
Hailakandi,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1144.0,1085.0,1015.0,957.0,1204.0,1234.0,1402.0,1332.0,1392.0,1209.0,1030.0,1224.0,14228.0
Hailakandi,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,35.0,40.0,42.0,51.0,50.0,14.0,52.0,55.0,94.0,76.0,37.0,47.0,593.0
Hailakandi,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,9.0,5.0,10.0,2.0,7.0,12.0,36.0,15.0,20.0,14.0,35.0,30.0,195.0
Hailakandi,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,11.0,24.0,6.0,12.0,12.0,5.0,21.0,12.0,10.0,17.0,8.0,8.0,146.0
Hailakandi,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hailakandi,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,55.0,69.0,58.0,65.0,69.0,31.0,109.0,82.0,124.0,107.0,80.0,85.0,934.0
Hailakandi,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,51.0,22.0,49.0,42.0,50.0,21.0,34.0,70.0,117.0,72.0,39.0,59.0,626.0
Hailakandi,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,10.0,24.0,3.0,8.0,10.0,12.0,19.0,9.0,18.0,19.0,10.0,7.0,149.0
Hailakandi,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,8.0,11.0,3.0,15.0,9.0,7.0,16.0,47.0,64.0,3.0,8.0,8.0,199.0
Hailakandi,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,4.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,2.0,1.0,11.0
Hailakandi,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,945.0,949.0,840.0,592.0,772.0,1000.0,1225.0,1032.0,1245.0,1140.0,1019.0,1076.0,11835.0
Hailakandi,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,725.0,775.0,674.0,604.0,741.0,772.0,816.0,739.0,952.0,881.0,806.0,822.0,9307.0
Hailakandi,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,42.0,29.0,50.0,43.0,46.0,40.0,32.0,34.0,39.0,36.0,35.0,30.0,456.0
Hailakandi,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Hailakandi,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,42.0,30.0,50.0,43.0,46.0,40.0,32.0,34.0,39.0,36.0,35.0,30.0,457.0
Hailakandi,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Hailakandi,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,79.0,90.0,80.0,1.0,45.0,1.0,0.0,28.0,0.0,47.0,44.0,43.0,458.0
Hailakandi,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,155.0,181.0,168.0,1.0,121.0,4.0,0.0,68.0,0.0,103.0,115.0,149.0,1065.0
Hailakandi,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,234.0,271.0,248.0,2.0,166.0,5.0,0.0,96.0,0.0,150.0,159.0,192.0,1523.0
Hailakandi,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,5.0,0.0,5.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,4.0,20.0
Hailakandi,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hailakandi,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,5.0,0.0,5.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,4.0,20.0
Hailakandi,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,37.0,23.0,79.0,18.0,47.0,29.0,0.0,14.0,34.0,0.0,0.0,281.0
Hailakandi,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,31.0,30.0,0.0,58.0,69.0,70.0,0.0,0.0,21.0,11.0,0.0,0.0,290.0
Hailakandi,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,7.0,11.0,8.0,9.0,11.0,4.0,0.0,1.0,9.0,0.0,7.0,10.0,77.0
Hailakandi,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hailakandi,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,38.0,78.0,31.0,146.0,98.0,121.0,29.0,1.0,44.0,45.0,7.0,10.0,648.0
Hailakandi,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hailakandi,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hailakandi,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,135.0,130.0,169.0,783.0,229.0,199.0,165.0,198.0,205.0,229.0,147.0,138.0,2727.0
Hailakandi,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,91.0,63.0,45.0,89.0,119.0,127.0,132.0,56.0,150.0,180.0,39.0,50.0,1141.0
Hailakandi,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,38.0,25.0,35.0,96.0,60.0,68.0,46.0,49.0,35.0,37.0,31.0,20.0,540.0
Hailakandi,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,21.0,11.0,52.0,72.0,29.0,40.0,44.0,32.0,38.0,39.0,37.0,40.0,455.0
Hailakandi,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hailakandi,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,285.0,229.0,301.0,1040.0,437.0,434.0,387.0,335.0,428.0,485.0,254.0,248.0,4863.0
Hailakandi,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,91.0,63.0,46.0,158.0,153.0,180.0,170.0,84.0,100.0,151.0,53.0,61.0,1310.0
Hailakandi,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.06,Number of IUCD removals,TOTAL,22.0,16.0,20.0,22.0,25.0,21.0,22.0,30.0,37.0,28.0,15.0,23.0,281.0
Hailakandi,9.07,Number of Oral Pills cycles distributed,TOTAL,2457.0,2158.0,2793.0,4581.0,2222.0,2488.0,2547.0,2364.0,2714.0,2921.0,2555.0,2747.0,32547.0
Hailakandi,9.08,Number of Condom pieces distributed,TOTAL,14469.0,16538.0,16642.0,16690.0,7737.0,9036.0,9069.0,8233.0,9494.0,8049.0,10992.0,9874.0,136823.0
Hailakandi,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,165.0,113.0,158.0,267.0,177.0,253.0,158.0,133.0,185.0,166.0,126.0,131.0,2032.0
Hailakandi,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,3.0
Hailakandi,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,1.0,2.0,2.0,2.0,1.0,1.0,2.0,3.0,2.0,1.0,2.0,-1.0
Hailakandi,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,697.0,1363.0,1097.0,281.0,231.0,3440.0,945.0,972.0,2527.0,2183.0,1655.0,1697.0,17088.0
Hailakandi,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1357.0,1439.0,1372.0,1248.0,1241.0,1411.0,1309.0,1107.0,1838.0,1654.0,933.0,185.0,15094.0
Hailakandi,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1264.0,1339.0,1361.0,1391.0,1246.0,1332.0,1221.0,1079.0,1519.0,1712.0,1473.0,1165.0,16102.0
Hailakandi,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1300.0,1322.0,1274.0,1274.0,1298.0,1314.0,1285.0,1009.0,1615.0,1489.0,1360.0,1536.0,16076.0
Hailakandi,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,514.0,1281.0,1795.0
Hailakandi,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,371.0,371.0
Hailakandi,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Hailakandi,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,478.0,238.0,499.0,429.0,318.0,651.0,517.0,372.0,683.0,656.0,592.0,601.0,6034.0
Hailakandi,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1275.0,1295.0,1249.0,1101.0,122.0,2327.0,820.0,849.0,1604.0,2373.0,1454.0,1618.0,16087.0
Hailakandi,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1179.0,1220.0,1258.0,1081.0,135.0,1710.0,1088.0,836.0,1365.0,2212.0,1794.0,1796.0,15674.0
Hailakandi,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1169.0,1183.0,1131.0,1002.0,123.0,1660.0,831.0,788.0,1531.0,1960.0,1633.0,2121.0,15132.0
Hailakandi,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,127.0,115.0,179.0,207.0,9.0,369.0,392.0,401.0,434.0,492.0,414.0,396.0,3535.0
Hailakandi,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1446.0,1598.0,1348.0,1181.0,456.0,1877.0,1363.0,1154.0,1820.0,1671.0,940.0,240.0,15094.0
Hailakandi,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1114.0,1507.0,1443.0,1340.0,425.0,1493.0,1509.0,1169.0,1627.0,1733.0,1456.0,1119.0,15935.0
Hailakandi,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1066.0,1273.0,1367.0,1273.0,449.0,1586.0,1318.0,1200.0,1722.0,1618.0,1385.0,1529.0,15786.0
Hailakandi,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,969.0,1098.0,1180.0,1152.0,1434.0,1523.0,1484.0,602.0,2073.0,1588.0,1299.0,1406.0,15808.0
Hailakandi,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,978.0,1073.0,1193.0,1123.0,1305.0,1136.0,938.0,481.0,1477.0,1131.0,897.0,1248.0,12980.0
Hailakandi,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,487.0,593.0,583.0,606.0,751.0,786.0,718.0,312.0,1027.0,824.0,693.0,711.0,8091.0
Hailakandi,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,472.0,502.0,574.0,538.0,666.0,743.0,720.0,266.0,988.0,745.0,587.0,656.0,7457.0
Hailakandi,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,959.0,1095.0,1157.0,1144.0,1417.0,1529.0,1438.0,578.0,2015.0,1569.0,1280.0,1367.0,15548.0
Hailakandi,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1051.0,1129.0,1276.0,1135.0,1358.0,1191.0,952.0,661.0,1113.0,1112.0,937.0,1255.0,13170.0
Hailakandi,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,985.0,1035.0,1178.0,939.0,183.0,1809.0,641.0,517.0,871.0,1364.0,911.0,1368.0,11801.0
Hailakandi,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,11.0,14.0,8.0,15.0,14.0,14.0,13.0,7.0,52.0,27.0,17.0,27.0,219.0
Hailakandi,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,8.0,23.0,9.0,14.0,11.0,15.0,9.0,16.0,40.0,23.0,16.0,27.0,211.0
Hailakandi,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,19.0,37.0,17.0,29.0,25.0,29.0,22.0,23.0,92.0,50.0,33.0,54.0,430.0
Hailakandi,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,588.0,669.0,687.0,636.0,836.0,707.0,598.0,487.0,588.0,671.0,547.0,612.0,7626.0
Hailakandi,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,895.0,895.0,898.0,914.0,946.0,923.0,893.0,731.0,862.0,955.0,826.0,827.0,10565.0
Hailakandi,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,723.0,746.0,667.0,708.0,737.0,692.0,731.0,586.0,727.0,757.0,651.0,684.0,8409.0
Hailakandi,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,661.0,666.0,666.0,662.0,662.0,656.0,657.0,657.0,662.0,652.0,657.0,657.0,7915.0
Hailakandi,10.4.2,Number of Immunisation sessions held during the month,TOTAL,649.0,646.0,647.0,645.0,645.0,647.0,652.0,647.0,664.0,648.0,632.0,645.0,7767.0
Hailakandi,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,606.0,598.0,602.0,601.0,593.0,600.0,624.0,507.0,610.0,597.0,577.0,597.0,7112.0
Hailakandi,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,972.0,1096.0,1178.0,1148.0,1461.0,1507.0,1478.0,585.0,2023.0,1553.0,1257.0,1233.0,15491.0
Hailakandi,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,241.0,298.0,277.0,231.0,4217.0,543.0,267.0,205.0,277.0,258.0,328.0,369.0,7511.0
Hailakandi,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,348.0,376.0,391.0,357.0,3109.0,553.0,310.0,287.0,292.0,309.0,302.0,413.0,7047.0
Hailakandi,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,1.0,2.0,1.0,0.0,3.0,4.0,1.0,0.0,2.0,6.0,3.0,20.0,43.0
Hailakandi,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,571.0,538.0,667.0,482.0,597.0,400.0,429.0,426.0,414.0,408.0,310.0,299.0,5541.0
Hailakandi,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,62.0,0.0,0.0,0.0,65.0
Hailakandi,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,46.0,220.0,289.0,234.0,292.0,362.0,104.0,123.0,77.0,73.0,136.0,153.0,2109.0
Hailakandi,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0,0.0,0.0,0.0,0.0,17.0
Hailakandi,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0,0.0,0.0,0.0,0.0,17.0
Hailakandi,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Hailakandi,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,8.0,6.0,8.0,7.0,7.0,8.0,7.0,7.0,6.0,6.0,7.0,6.0,-1.0
Hailakandi,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,572.0,576.0,574.0,566.0,569.0,584.0,587.0,573.0,595.0,586.0,561.0,577.0,-1.0
Hailakandi,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,2.0,2.0,2.0,2.0,-1.0
Hailakandi,14.05,Number of RKS meetings held during the month,TOTAL,3.0,4.0,4.0,5.0,4.0,5.0,3.0,7.0,4.0,4.0,5.0,4.0,52.0
Hailakandi,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,11.0,12.0,13.0,14.0,13.0,14.0,13.0,12.0,11.0,10.0,12.0,8.0,-1.0
Hailakandi,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,327.0,324.0,268.0,344.0,396.0,378.0,398.0,405.0,232.0,223.0,151.0,257.0,3703.0
Hailakandi,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Hailakandi,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Hailakandi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,220.0,184.0,345.0,166.0,175.0,200.0,138.0,195.0,182.0,112.0,352.0,62.0,2331.0
Hailakandi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,695.0,800.0,756.0,593.0,561.0,444.0,489.0,559.0,509.0,403.0,250.0,393.0,6452.0
Hailakandi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,301.0,248.0,321.0,188.0,202.0,183.0,177.0,175.0,186.0,147.0,172.0,167.0,2467.0
Hailakandi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1922.0,1808.0,1768.0,1468.0,1724.0,1730.0,1843.0,1534.0,1776.0,1691.0,1231.0,1467.0,19962.0
Hailakandi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,521.0,432.0,666.0,354.0,377.0,383.0,315.0,370.0,368.0,259.0,524.0,229.0,4798.0
Hailakandi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2617.0,2608.0,2524.0,2061.0,2285.0,2174.0,2332.0,2093.0,2285.0,2094.0,1481.0,1860.0,26414.0
Hailakandi,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7.0,14.0,11.0,12.0,8.0,13.0,6.0,25.0,29.0,18.0,9.0,11.0,163.0
Hailakandi,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,10.0,8.0,15.0,9.0,14.0,6.0,17.0,20.0,11.0,6.0,15.0,137.0
Hailakandi,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,13.0,24.0,19.0,27.0,17.0,27.0,12.0,42.0,49.0,29.0,15.0,26.0,300.0
Hailakandi,14.11,In-Patient Head Count at midnight,TOTAL,1703.0,1777.0,1954.0,1399.0,1550.0,1583.0,1487.0,1572.0,1476.0,1376.0,1146.0,1253.0,18276.0
Hailakandi,14.12.1,OPD attendance (All),TOTAL,42789.0,40962.0,49498.0,43349.0,42544.0,38944.0,36618.0,34348.0,28760.0,23810.0,18731.0,26563.0,426916.0
Hailakandi,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,8.0,9.0,9.0,9.0,2.0,3.0,0.0,6.0,6.0,8.0,6.0,10.0,76.0
Hailakandi,14.14.a,Number of patients given AYUSH treatment,TOTAL,232.0,222.0,220.0,202.0,197.0,233.0,125.0,227.0,1.0,214.0,217.0,236.0,2326.0
Hailakandi,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,14.14.c,Number of Adolescents counselled,TOTAL,2.0,20.0,18.0,2.0,2.0,0.0,0.0,4.0,5.0,5.0,7.0,2.0,67.0
Hailakandi,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3909.0,3781.0,4345.0,4083.0,4743.0,5242.0,4878.0,3589.0,4664.0,4461.0,3841.0,4127.0,51663.0
Hailakandi,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,7.0,13.0,18.0,15.0,11.0,18.0,14.0,35.0,18.0,13.0,8.0,12.0,182.0
Hailakandi,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,0.0,29.0,147.0,169.0,154.0,125.0,83.0,90.0,87.0,151.0,163.0,124.0,1322.0
Hailakandi,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Hailakandi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,0.0,351.0,158.0,147.0,166.0,279.0,55.0,139.0,116.0,279.0,77.0,156.0,1923.0
Hailakandi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Hailakandi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,53.0,203.0,288.0,382.0,333.0,285.0,96.0,180.0,175.0,203.0,200.0,210.0,2608.0
Hailakandi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,53.0,583.0,593.0,698.0,653.0,689.0,234.0,409.0,378.0,633.0,440.0,490.0,5853.0
Hailakandi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Hailakandi,15.2,Number of Widal tests conducted,Number tested,301.0,231.0,408.0,285.0,324.0,205.0,222.0,145.0,120.0,99.0,93.0,116.0,2549.0
Hailakandi,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,3.0,3.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Hailakandi,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,6.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Hailakandi,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,2.0,0.0,45.0,54.0,0.0,2.0,2.0,6.0,0.0,4.0,2.0,117.0
Hailakandi,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,6.0,2.0,8.0,48.0,58.0,0.0,2.0,2.0,6.0,0.0,4.0,2.0,138.0
Hailakandi,15.4.1,Number of blood smears examined for Malaria,TOTAL,3925.0,4073.0,5885.0,6444.0,6563.0,6210.0,4217.0,3823.0,3657.0,3483.0,4650.0,4211.0,57141.0
Hailakandi,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,6.0,43.0,9.0,5.0,5.0,4.0,0.0,5.0,3.0,1.0,3.0,86.0
Hailakandi,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,10.0,14.0,31.0,28.0,23.0,18.0,19.0,34.0,51.0,11.0,7.0,6.0,252.0
Hailakandi,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2650.0,2250.0,2900.0,2325.0,1575.0,2025.0,950.0,750.0,1650.0,3450.0,2850.0,2250.0,25625.0
Hailakandi,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,1500.0,0.0,0.0,1000.0,0.0,0.0,2000.0,2000.0,0.0,0.0,1000.0,7500.0
Hailakandi,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,400.0,850.0,575.0,750.0,550.0,1075.0,200.0,1100.0,200.0,600.0,600.0,350.0,7250.0
Hailakandi,16.1.1,Stock position of DPT vaccines,5. Total Stock,2250.0,2900.0,2325.0,1575.0,2025.0,950.0,750.0,1650.0,3450.0,2850.0,2250.0,2900.0,25875.0
Hailakandi,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Hailakandi,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Hailakandi,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Hailakandi,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Hailakandi,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,375.0,25.0,10.0,225.0,15.0,940.0,0.0,0.0,25.0,475.0,0.0,450.0,2540.0
Hailakandi,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,400.0,750.0,0.0,925.0,0.0,0.0,550.0,450.0,0.0,800.0,0.0,3875.0
Hailakandi,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,350.0,415.0,535.0,210.0,0.0,940.0,0.0,525.0,0.0,475.0,350.0,150.0,3950.0
Hailakandi,16.1.2,Stock position of OPV vaccines,5. Total Stock,25.0,10.0,225.0,15.0,940.0,0.0,0.0,25.0,475.0,0.0,450.0,300.0,2465.0
Hailakandi,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4750.0,4450.0,6100.0,4950.0,5280.0,9280.0,7440.0,6590.0,10115.0,7315.0,6315.0,5765.0,78350.0
Hailakandi,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,3900.0,0.0,2400.0,4200.0,3200.0,0.0,6800.0,0.0,0.0,1000.0,0.0,21500.0
Hailakandi,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.3,Stock position of TT vaccines,4. Stock Distributed,300.0,2250.0,1150.0,2070.0,200.0,5040.0,850.0,3275.0,2800.0,1000.0,1550.0,1000.0,21485.0
Hailakandi,16.1.3,Stock position of TT vaccines,5. Total Stock,4450.0,6100.0,4950.0,5280.0,9280.0,7440.0,6590.0,10115.0,7315.0,6315.0,5765.0,4765.0,78365.0
Hailakandi,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0.0,0.0,50.0,10.0,10.0,910.0,25.0,0.0,100.0,2000.0,1275.0,825.0,5205.0
Hailakandi,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,750.0,0.0,0.0,900.0,0.0,0.0,800.0,2000.0,0.0,0.0,800.0,5250.0
Hailakandi,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,0.0,700.0,40.0,0.0,0.0,885.0,25.0,700.0,100.0,725.0,450.0,400.0,4025.0
Hailakandi,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,50.0,10.0,10.0,910.0,25.0,0.0,100.0,2000.0,1275.0,825.0,1225.0,6430.0
Hailakandi,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2150.0,1550.0,2600.0,3100.0,2150.0,1850.0,700.0,550.0,1350.0,1800.0,850.0,100.0,18750.0
Hailakandi,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,2000.0,1000.0,0.0,0.0,0.0,0.0,2000.0,1000.0,0.0,0.0,1000.0,7000.0
Hailakandi,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,550.0,0.0,0.0,0.0,0.0,550.0
Hailakandi,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,600.0,950.0,500.0,950.0,300.0,1150.0,150.0,650.0,550.0,950.0,750.0,400.0,7900.0
Hailakandi,16.1.6,Stock position of Measles vaccines,5. Total Stock,1550.0,2600.0,3100.0,2150.0,1850.0,700.0,550.0,1350.0,1800.0,850.0,100.0,700.0,17300.0
Hailakandi,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1500.0,450.0,675.0,400.0,0.0,2000.0,2000.0,1730.0,1500.0,2250.0,1675.0,1225.0,15405.0
Hailakandi,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,750.0,0.0,0.0,2000.0,0.0,0.0,1000.0,1000.0,0.0,0.0,1000.0,5750.0
Hailakandi,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1050.0,525.0,275.0,400.0,0.0,0.0,270.0,1230.0,250.0,575.0,450.0,300.0,5325.0
Hailakandi,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,450.0,675.0,400.0,0.0,2000.0,2000.0,1730.0,1500.0,2250.0,1675.0,1225.0,1925.0,15830.0
Hailakandi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,25.0,0.0,300.0,1900.0,1800.0,2400.0,1600.0,1600.0,200.0,0.0,0.0,0.0,9825.0
Hailakandi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,1200.0,1800.0,600.0,600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4200.0
Hailakandi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,25.0,900.0,200.0,700.0,0.0,800.0,0.0,1400.0,200.0,0.0,0.0,0.0,4225.0
Hailakandi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,300.0,1900.0,1800.0,2400.0,1600.0,1600.0,200.0,0.0,0.0,0.0,0.0,9800.0
Hailakandi,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,18000.0,12000.0,6000.0,0.0,3320.0,28020.0,2520.0,2520.0,7560.0,30240.0,17600.0,12560.0,140340.0
Hailakandi,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,6000.0,25200.0,0.0,0.0,10080.0,30240.0,0.0,0.0,0.0,71520.0
Hailakandi,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,6000.0,6000.0,6000.0,2680.0,500.0,25500.0,0.0,5040.0,7560.0,12600.0,5040.0,0.0,76920.0
Hailakandi,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,12000.0,6000.0,0.0,3320.0,28020.0,2520.0,2520.0,7560.0,30240.0,17640.0,12560.0,12560.0,134940.0
Hailakandi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,78.0,39.0,39.0,39.0,4239.0,6239.0,5239.0,5239.0,2000.0,2000.0,800.0,800.0,26751.0
Hailakandi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,2000.0,13200.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17200.0
Hailakandi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,39.0,0.0,2000.0,9000.0,0.0,1000.0,0.0,3239.0,0.0,1200.0,0.0,0.0,16478.0
Hailakandi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,39.0,39.0,39.0,4239.0,6239.0,5239.0,5239.0,2000.0,2000.0,800.0,800.0,800.0,27473.0
Hailakandi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1600.0,1600.0,1000.0,0.0,5100.0,5100.0,1550.0,1550.0,1050.0,1050.0,1000.0,500.0,21100.0
Hailakandi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0
Hailakandi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,600.0,1000.0,900.0,0.0,3550.0,0.0,500.0,0.0,50.0,500.0,200.0,7300.0
Hailakandi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1600.0,1000.0,0.0,5100.0,5100.0,1550.0,1550.0,1050.0,1050.0,1000.0,500.0,300.0,19800.0
Hailakandi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,2700.0,2700.0,2700.0,2700.0,3700.0,3700.0,3700.0,2700.0,3700.0,3700.0,3700.0,3700.0,39400.0
Hailakandi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,2000.0
Hailakandi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,1000.0
Hailakandi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,2700.0,2700.0,2700.0,3700.0,3700.0,3700.0,2700.0,3700.0,3700.0,3700.0,3700.0,3700.0,40400.0
Hailakandi,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,50.0,950.0,250.0,100.0,2100.0,350.0,650.0,300.0,850.0,0.0,0.0,0.0,5600.0
Hailakandi,16.3.02,Stock Position of Gloves,2. Stocks Received,3000.0,0.0,0.0,4000.0,0.0,1500.0,0.0,3400.0,0.0,0.0,0.0,0.0,11900.0
Hailakandi,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.02,Stock Position of Gloves,4. Stock Distributed,2100.0,700.0,150.0,2000.0,1750.0,1200.0,350.0,2850.0,850.0,0.0,0.0,0.0,11950.0
Hailakandi,16.3.02,Stock Position of Gloves,5. Total Stock,950.0,250.0,100.0,2100.0,350.0,650.0,300.0,850.0,0.0,0.0,0.0,0.0,5550.0
Hailakandi,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,1200.0,300.0,100.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,1700.0
Hailakandi,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0
Hailakandi,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,3800.0,900.0,200.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0
Hailakandi,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,1200.0,300.0,100.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1700.0
Hailakandi,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,689560.0,1445560.0,1182260.0,918960.0,678260.0,552260.0,415760.0,37760.0,6260.0,6260.0,4260.0,3260.0,5940420.0
Hailakandi,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,997500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,1002500.0
Hailakandi,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,241500.0,210000.0,263300.0,240700.0,126000.0,136500.0,378000.0,31500.0,0.0,2000.0,1000.0,2000.0,1632500.0
Hailakandi,16.3.07,Stock Position of IFA Tablets,5. Total Stock,1445560.0,1235560.0,918960.0,678260.0,552260.0,415760.0,37760.0,6260.0,6260.0,4260.0,3260.0,6260.0,5310420.0
Hailakandi,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,7100.0,7100.0,6100.0,6100.0,4850.0,3450.0,2500.0,2500.0,1500.0,500.0,400.0,300.0,42400.0
Hailakandi,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,1000.0,0.0,1250.0,1400.0,950.0,1000.0,1000.0,1000.0,100.0,100.0,0.0,7800.0
Hailakandi,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,7100.0,6100.0,6100.0,4850.0,3450.0,2500.0,1500.0,1500.0,500.0,400.0,300.0,300.0,34600.0
Hailakandi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,400.0,50.0,50.0,50.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,650.0
Hailakandi,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,100.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0
Hailakandi,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,350.0,0.0,0.0,50.0,0.0,200.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0
Hailakandi,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,50.0,50.0,50.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,250.0
Hailakandi,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,4000.0,1700.0,2400.0,1200.0,9100.0,4000.0,0.0,0.0,0.0,0.0,0.0,0.0,22400.0
Hailakandi,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,4800.0,0.0,11800.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18600.0
Hailakandi,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,2300.0,4100.0,1200.0,3900.0,7100.0,4000.0,0.0,0.0,0.0,0.0,0.0,0.0,22600.0
Hailakandi,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,1700.0,2400.0,1200.0,9100.0,4000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18400.0
Hailakandi,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,7700.0,5900.0,5300.0,3800.0,3400.0,8900.0,5600.0,5600.0,7100.0,6600.0,7800.0,5800.0,73500.0
Hailakandi,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,6600.0,0.0,0.0,3300.0,2000.0,2000.0,0.0,2000.0,15900.0
Hailakandi,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1800.0,600.0,1500.0,400.0,1100.0,3300.0,0.0,1800.0,2500.0,800.0,2000.0,1500.0,17300.0
Hailakandi,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,5900.0,5300.0,3800.0,3400.0,8900.0,5600.0,5600.0,7100.0,6600.0,7800.0,5800.0,6300.0,72100.0
Hailakandi,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,28000.0,10000.0,24400.0,17500.0,52900.0,46900.0,43700.0,15700.0,9500.0,26700.0,25920.0,13920.0,315140.0
Hailakandi,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,24000.0,0.0,46000.0,0.0,0.0,0.0,36000.0,24000.0,0.0,0.0,24000.0,154000.0
Hailakandi,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,18000.0,9600.0,6900.0,10600.0,6000.0,3200.0,28000.0,42200.0,6800.0,780.0,12000.0,12000.0,156080.0
Hailakandi,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,10000.0,24400.0,17500.0,52900.0,46900.0,43700.0,15700.0,9500.0,26700.0,25920.0,13920.0,25920.0,313060.0
Hailakandi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,17700.0,14600.0,18600.0,18000.0,15800.0,15200.0,13600.0,12300.0,10000.0,12900.0,11300.0,11800.0,171800.0
Hailakandi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4000.0,0.0,0.0,0.0,4800.0,0.0,0.0,4000.0,0.0,2000.0,32000.0,46800.0
Hailakandi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hailakandi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3100.0,0.0,600.0,2200.0,600.0,6400.0,1300.0,2300.0,1100.0,1600.0,1500.0,1200.0,21900.0
Hailakandi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,14600.0,18600.0,18000.0,15800.0,15200.0,13600.0,12300.0,10000.0,12900.0,11300.0,11800.0,42600.0,196700.0
Hailakandi,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,,,,,2.0,,2.0,,,,5.0
Hailakandi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,2.0,4.0,1.0,1.0,4.0,1.0,6.0,6.0,4.0,1.0,1.0,31.0
Hailakandi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Hailakandi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,2.0,4.0,1.0,1.0,4.0,1.0,6.0,6.0,4.0,1.0,1.0,31.0
Hailakandi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,8.0,5.0,6.0,7.0,4.0,5.0,5.0,8.0,4.0,7.0,5.0,3.0,67.0
Hailakandi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Hailakandi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,8.0,5.0,6.0,7.0,4.0,5.0,5.0,8.0,4.0,7.0,5.0,3.0,67.0
Hailakandi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,2.0,2.0,3.0,1.0,1.0,4.0,1.0,4.0,2.0,,3.0,24.0
Hailakandi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Hailakandi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,2.0,2.0,3.0,1.0,1.0,4.0,1.0,4.0,2.0,,3.0,24.0
Hailakandi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,2.0,3.0,1.0,2.0,10.0,9.0,3.0,8.0,5.0,4.0,4.0,51.0
Hailakandi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,2.0,,,,1.0,2.0,1.0,,,,,,6.0
Hailakandi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,2.0,3.0,1.0,3.0,12.0,10.0,3.0,8.0,5.0,4.0,4.0,57.0
Hailakandi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,,1.0,1.0,3.0,6.0,3.0,,2.0,17.0
Hailakandi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,1.0,,,1.0,2.0
Hailakandi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,1.0,,1.0,1.0,3.0,7.0,3.0,,3.0,19.0
Hailakandi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Hailakandi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hailakandi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Hailakandi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,1.0,,,1.0,4.0,,,,6.0
Hailakandi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Hailakandi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,1.0,,,1.0,4.0,,,1.0,7.0
Hailakandi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Hailakandi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hailakandi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Hailakandi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,6.0,1.0,3.0,5.0,3.0,4.0,10.0,1.0,9.0,9.0,8.0,7.0,66.0
Hailakandi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,2.0,1.0,,3.0,2.0,,5.0,,,,13.0
Hailakandi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,1.0,5.0,6.0,3.0,7.0,12.0,1.0,14.0,9.0,8.0,7.0,79.0
Hailakandi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Hailakandi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Hailakandi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Hailakandi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,1.0,1.0,1.0,,,,3.0
Hailakandi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Hailakandi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,,,,,1.0,1.0,1.0,,,,4.0
Hailakandi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Hailakandi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,3.0,3.0,1.0,,4.0,2.0,1.0,,1.0,16.0
Hailakandi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,2.0,,,,1.0,1.0,1.0,2.0,3.0,,5.0,17.0
Hailakandi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,3.0,,4.0,3.0,2.0,1.0,5.0,4.0,4.0,,6.0,34.0
Hailakandi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Hailakandi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Hailakandi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Hailakandi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Hailakandi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,2.0,,1.0,1.0,,,,1.0,1.0,,1.0,8.0
Hailakandi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,,2.0,,,1.0,,5.0,2.0,1.0,2.0,14.0
Hailakandi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,2.0,,3.0,1.0,,1.0,,6.0,4.0,1.0,3.0,23.0
Hailakandi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Hailakandi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Hailakandi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Hailakandi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Hailakandi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,1.0,,2.0,,3.0,,1.0,3.0,2.0,1.0,,14.0
Hailakandi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,4.0,2.0,3.0,3.0,2.0,3.0,6.0,3.0,5.0,4.0,3.0,41.0
Hailakandi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,5.0,3.0,5.0,3.0,5.0,3.0,7.0,6.0,7.0,5.0,3.0,56.0
Hailakandi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,1.0,,,,1.0,,,,,3.0
Hailakandi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,2.0,,,,,1.0,,3.0,,,1.0,8.0
Hailakandi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,3.0,,1.0,,,1.0,1.0,3.0,,,1.0,11.0
Hailakandi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,1.0,,,1.0,,,,,,,2.0
Hailakandi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Hailakandi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,1.0,,,1.0,,,,,,,2.0
Hailakandi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Hailakandi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Hailakandi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Hailakandi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,1.0,,1.0,,,,,,,2.0
Hailakandi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Hailakandi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,1.0,,1.0,,,,,,,2.0
Hailakandi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Hailakandi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Hailakandi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Hailakandi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Hailakandi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Hailakandi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Hailakandi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,2.0,,3.0,1.0,3.0,2.0,3.0,1.0,3.0,1.0,1.0,20.0
Hailakandi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Hailakandi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,2.0,,3.0,1.0,3.0,2.0,3.0,1.0,3.0,1.0,1.0,20.0
Hailakandi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,,1.0,1.0,,,1.0,,,,,5.0
Hailakandi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,1.0,1.0,,,2.0,,,,2.0,2.0,,10.0
Hailakandi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,,,,,,,,,,1.0,2.0
Hailakandi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,3.0,3.0,1.0,1.0,1.0,2.0,,1.0,,2.0,2.0,1.0,17.0
Hailakandi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,1.0,,,,,1.0,,1.0,,,,3.0
Hailakandi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,1.0,1.0,1.0,,,,3.0
Hailakandi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,,,,,2.0,1.0,2.0,,,,6.0
Hailakandi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,,,,,1.0,,,,,,2.0
Hailakandi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Hailakandi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,,,,,1.0,,,,,,2.0
Hailakandi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,,1.0,,,1.0,,,,,3.0
Hailakandi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,4.0,,2.0,2.0,2.0,1.0,2.0,4.0,3.0,1.0,,23.0
Hailakandi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,3.0,,2.0,1.0,,,1.0,1.0,1.0,1.0,4.0,16.0
Hailakandi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,4.0,8.0,,4.0,4.0,2.0,1.0,4.0,5.0,4.0,2.0,4.0,42.0
Hailakandi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Hailakandi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,2.0,,,1.0,,1.0,,1.0,2.0,1.0,1.0,11.0
Hailakandi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,3.0,4.0,,,1.0,2.0,6.0,1.0,9.0,3.0,2.0,6.0,37.0
Hailakandi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,5.0,6.0,,,2.0,2.0,7.0,1.0,10.0,5.0,3.0,7.0,48.0
Hailakandi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,1.0,,3.0,2.0,2.0,3.0,2.0,,1.0,,15.0
Hailakandi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,17.0,11.0,14.0,4.0,13.0,19.0,37.0,17.0,42.0,13.0,17.0,11.0,215.0
Hailakandi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,41.0,23.0,32.0,29.0,24.0,54.0,50.0,27.0,86.0,30.0,70.0,36.0,502.0
Hailakandi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,59.0,34.0,47.0,33.0,40.0,75.0,89.0,47.0,130.0,43.0,88.0,47.0,732.0
Jorhat,1.1,Total number of pregnant women Registered for ANC,TOTAL,1932.0,2096.0,1939.0,1997.0,1924.0,1646.0,1528.0,1578.0,1501.0,1655.0,1929.0,2134.0,21859.0
Jorhat,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1778.0,1876.0,1743.0,1792.0,1629.0,1443.0,1348.0,1415.0,1348.0,1494.0,1753.0,1956.0,19575.0
Jorhat,1.2,Number of Pregnant women registered under JSY,TOTAL,1737.0,1867.0,1704.0,1746.0,1630.0,1411.0,1368.0,1385.0,1501.0,1632.0,1653.0,1896.0,19530.0
Jorhat,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1226.0,1368.0,1501.0,1510.0,1610.0,1560.0,1568.0,1576.0,1206.0,1206.0,1290.0,1338.0,16959.0
Jorhat,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1537.0,1717.0,1529.0,1714.0,1698.0,1527.0,1381.0,1345.0,1029.0,1242.0,1416.0,1632.0,17767.0
Jorhat,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1558.0,1632.0,1752.0,1787.0,1709.0,1720.0,1550.0,1569.0,1200.0,1193.0,1348.0,1576.0,18594.0
Jorhat,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1272.0,1382.0,1326.0,1473.0,1392.0,1232.0,1229.0,1326.0,1180.0,1238.0,1312.0,1636.0,15998.0
Jorhat,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,62.0,69.0,71.0,72.0,92.0,45.0,29.0,49.0,72.0,67.0,37.0,51.0,716.0
Jorhat,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,2.0,2.0,2.0,0.0,7.0,1.0,9.0,0.0,2.0,3.0,0.0,29.0
Jorhat,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1172.0,1110.0,1301.0,1407.0,997.0,1048.0,963.0,813.0,790.0,948.0,969.0,1017.0,12535.0
Jorhat,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,33.0,20.0,31.0,21.0,6.0,28.0,13.0,7.0,8.0,2.0,4.0,3.0,176.0
Jorhat,1.8,Number of pregnancy test kits used at SC level,TOTAL,446.0,612.0,498.0,524.0,431.0,428.0,365.0,347.0,367.0,472.0,466.0,535.0,5491.0
Jorhat,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,6.0,16.0,10.0,14.0,16.0,20.0,22.0,16.0,12.0,15.0,10.0,10.0,167.0
Jorhat,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,7.0,1.0,4.0,1.0,3.0,1.0,0.0,1.0,2.0,4.0,2.0,2.0,28.0
Jorhat,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,13.0,17.0,14.0,15.0,19.0,21.0,22.0,17.0,14.0,19.0,12.0,12.0,195.0
Jorhat,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,14.0,17.0,12.0,15.0,23.0,21.0,20.0,16.0,13.0,14.0,12.0,9.0,186.0
Jorhat,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1003.0,991.0,919.0,1154.0,1444.0,1362.0,1506.0,1368.0,1451.0,1358.0,1250.0,1105.0,14911.0
Jorhat,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,247.0,149.0,181.0,73.0,44.0,49.0,51.0,83.0,144.0,447.0,386.0,312.0,2166.0
Jorhat,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,957.0,941.0,956.0,1083.0,1401.0,1193.0,1467.0,1367.0,1520.0,1404.0,1279.0,1187.0,14755.0
Jorhat,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,426.0,525.0,666.0,599.0,779.0,1308.0,807.0,1044.0,2892.0,876.0,991.0,1406.0,12319.0
Jorhat,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,178.0,211.0,206.0,170.0,213.0,219.0,171.0,254.0,79.0,90.0,215.0,126.0,2132.0
Jorhat,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,324.0,302.0,281.0,332.0,420.0,376.0,405.0,410.0,391.0,365.0,362.0,353.0,4321.0
Jorhat,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jorhat,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,324.0,302.0,281.0,332.0,420.0,376.0,405.0,410.0,391.0,365.0,362.0,353.0,4321.0
Jorhat,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,88.0,60.0,67.0,57.0,48.0,69.0,40.0,78.0,0.0,0.0,0.0,0.0,507.0
Jorhat,4.1.1.a,Number of male live births,TOTAL,611.0,598.0,597.0,689.0,877.0,824.0,840.0,830.0,824.0,740.0,683.0,615.0,8728.0
Jorhat,4.1.1.b,Number of female live births,TOTAL,549.0,604.0,496.0,632.0,788.0,769.0,836.0,796.0,694.0,699.0,684.0,559.0,8106.0
Jorhat,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1160.0,1202.0,1093.0,1321.0,1665.0,1593.0,1676.0,1626.0,1518.0,1439.0,1367.0,1174.0,16834.0
Jorhat,4.1.2,Number of still births,TOTAL,21.0,21.0,24.0,23.0,27.0,21.0,39.0,25.0,32.0,34.0,24.0,13.0,304.0
Jorhat,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,196.0,202.0,218.0,138.0,181.0,215.0,141.0,142.0,236.0,171.0,217.0,202.0,2259.0
Jorhat,4.2.1,Number of Newborns weighed at birth,TOTAL,1182.0,1207.0,1112.0,1319.0,1663.0,1593.0,1674.0,1627.0,1517.0,1435.0,1366.0,1173.0,16868.0
Jorhat,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,452.0,468.0,442.0,502.0,665.0,538.0,710.0,620.0,397.0,657.0,550.0,484.0,6485.0
Jorhat,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1171.0,1198.0,1110.0,1317.0,1629.0,1583.0,1630.0,1613.0,1513.0,1397.0,1258.0,1131.0,16550.0
Jorhat,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,1.0,1.0,4.0,6.0,1.0,0.0,1.0,2.0,0.0,1.0,0.0,17.0
Jorhat,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,2.0,11.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,2.0,17.0
Jorhat,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,349.0,302.0,281.0,316.0,420.0,357.0,328.0,410.0,202.0,219.0,121.0,578.0,3883.0
Jorhat,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jorhat,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,349.0,305.0,293.0,320.0,426.0,358.0,329.0,412.0,204.0,219.0,122.0,580.0,3917.0
Jorhat,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,88.0,60.0,67.0,57.0,48.0,69.0,40.0,78.0,0.0,0.0,32.0,0.0,539.0
Jorhat,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,414.0,420.0,496.0,594.0,496.0,501.0,619.0,599.0,596.0,576.0,564.0,546.0,6421.0
Jorhat,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,261.0,217.0,227.0,262.0,336.0,291.0,236.0,249.0,318.0,132.0,256.0,280.0,3065.0
Jorhat,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,770.0,484.0,542.0,511.0,543.0,583.0,747.0,717.0,604.0,638.0,658.0,565.0,7362.0
Jorhat,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,29.0,54.0,26.0,27.0,21.0,138.0,115.0,48.0,14.0,45.0,35.0,41.0,593.0
Jorhat,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1000.0,920.0,874.0,1249.0,1579.0,1506.0,1614.0,1594.0,1505.0,1377.0,826.0,540.0,14584.0
Jorhat,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1111.0,1089.0,1033.0,998.0,1266.0,1312.0,1316.0,1324.0,1197.0,1339.0,870.0,678.0,13533.0
Jorhat,6.3,PNC maternal complications attended,TOTAL,7.0,0.0,1.0,31.0,3.0,0.0,4.0,0.0,0.0,10.0,9.0,13.0,78.0
Jorhat,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,163.0,150.0,174.0,166.0,151.0,130.0,114.0,125.0,177.0,152.0,152.0,183.0,1837.0
Jorhat,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,3.0,1.0,1.0,2.0,1.0,2.0,1.0,2.0,2.0,5.0,2.0,23.0
Jorhat,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,164.0,153.0,175.0,167.0,153.0,131.0,116.0,126.0,179.0,154.0,157.0,185.0,1860.0
Jorhat,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,2.0,1.0,4.0,26.0,4.0,2.0,2.0,55.0,82.0,29.0,57.0,77.0,341.0
Jorhat,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,20.0,27.0,23.0,43.0,17.0,16.0,15.0,66.0,62.0,40.0,30.0,132.0,491.0
Jorhat,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,22.0,28.0,27.0,69.0,21.0,18.0,17.0,121.0,144.0,69.0,87.0,209.0,832.0
Jorhat,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,48.0,0.0,0.0,0.0,0.0,48.0
Jorhat,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,21.0,24.0,1.0,23.0,0.0,22.0,0.0,21.0,0.0,9.0,0.0,121.0
Jorhat,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jorhat,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,21.0,24.0,1.0,23.0,0.0,22.0,48.0,21.0,0.0,9.0,0.0,169.0
Jorhat,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Jorhat,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,1.0,0.0,0.0,313.0,141.0,25.0,151.0,48.0,194.0,113.0,65.0,145.0,1196.0
Jorhat,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,22.0,38.0,0.0,25.0,0.0,0.0,0.0,0.0,0.0,85.0
Jorhat,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,134.0,39.0,116.0,94.0,147.0,159.0,106.0,149.0,163.0,0.0,4.0,3.0,1114.0
Jorhat,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jorhat,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,135.0,39.0,116.0,429.0,326.0,184.0,282.0,197.0,357.0,113.0,69.0,148.0,2395.0
Jorhat,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,6.0,9.0,0.0,0.0,3.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,21.0
Jorhat,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,3.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0,0.0,25.0
Jorhat,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,38.0,30.0,0.0,29.0,0.0,0.0,0.0,0.0,0.0,43.0,28.0,26.0,194.0
Jorhat,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jorhat,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,41.0,31.0,0.0,29.0,0.0,0.0,0.0,0.0,0.0,43.0,49.0,26.0,219.0
Jorhat,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,3.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Jorhat,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Jorhat,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Jorhat,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,38.0,30.0,29.0,29.0,46.0,37.0,56.0,46.0,40.0,43.0,28.0,26.0,448.0
Jorhat,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jorhat,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,38.0,30.0,29.0,35.0,46.0,37.0,56.0,46.0,40.0,43.0,28.0,26.0,454.0
Jorhat,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,3.0,1.0,4.0,0.0,3.0,0.0,6.0,2.0,0.0,0.0,0.0,0.0,19.0
Jorhat,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,42.0,36.0,63.0,248.0,54.0,44.0,33.0,36.0,27.0,33.0,25.0,40.0,681.0
Jorhat,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,89.0,67.0,106.0,194.0,76.0,60.0,51.0,75.0,58.0,79.0,57.0,79.0,991.0
Jorhat,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,14.0,23.0,59.0,38.0,18.0,13.0,17.0,24.0,19.0,19.0,22.0,16.0,282.0
Jorhat,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,65.0,31.0,116.0,128.0,116.0,101.0,91.0,57.0,55.0,17.0,21.0,27.0,825.0
Jorhat,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jorhat,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,210.0,157.0,344.0,608.0,264.0,218.0,192.0,192.0,159.0,148.0,125.0,162.0,2779.0
Jorhat,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,39.0,3.0,97.0,160.0,116.0,107.0,76.0,67.0,55.0,19.0,21.0,21.0,781.0
Jorhat,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,6.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Jorhat,9.06,Number of IUCD removals,TOTAL,157.0,10.0,32.0,16.0,13.0,19.0,6.0,3.0,117.0,3.0,12.0,7.0,395.0
Jorhat,9.07,Number of Oral Pills cycles distributed,TOTAL,2899.0,3077.0,3418.0,6825.0,3403.0,3917.0,4330.0,3954.0,4922.0,3422.0,3245.0,3570.0,46982.0
Jorhat,9.08,Number of Condom pieces distributed,TOTAL,19259.0,19876.0,25003.0,41536.0,24739.0,21975.0,23880.0,24786.0,22386.0,21509.0,20077.0,23186.0,288212.0
Jorhat,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,6.0
Jorhat,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,10.0,17.0,11.0,33.0,13.0,20.0,21.0,26.0,15.0,18.0,14.0,31.0,229.0
Jorhat,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,1.0,,-1.0
Jorhat,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1276.0,1311.0,1200.0,1213.0,1544.0,1663.0,1735.0,1753.0,1579.0,1468.0,1639.0,1365.0,17746.0
Jorhat,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1546.0,1632.0,1342.0,1382.0,1392.0,1469.0,1702.0,1736.0,1535.0,1671.0,1111.0,56.0,16574.0
Jorhat,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1667.0,1641.0,1523.0,1503.0,1335.0,1367.0,1401.0,1746.0,1628.0,1517.0,1699.0,1248.0,18275.0
Jorhat,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1694.0,1669.0,1592.0,1601.0,1397.0,1319.0,1335.0,1417.0,1647.0,1583.0,1578.0,1691.0,18523.0
Jorhat,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,576.0,1552.0,2128.0
Jorhat,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,547.0,547.0
Jorhat,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Jorhat,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1010.0,904.0,954.0,1008.0,1283.0,1423.0,1417.0,1391.0,1194.0,1124.0,1224.0,1004.0,13936.0
Jorhat,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1559.0,1632.0,1351.0,1391.0,1396.0,1461.0,1692.0,1729.0,1526.0,1664.0,1164.0,1245.0,17810.0
Jorhat,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1677.0,1641.0,1532.0,1511.0,1335.0,1363.0,1402.0,1740.0,1618.0,1510.0,1685.0,1448.0,18462.0
Jorhat,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1704.0,1669.0,1601.0,1606.0,1413.0,1314.0,1309.0,1411.0,1639.0,1579.0,1572.0,1674.0,18491.0
Jorhat,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,601.0,545.0,639.0,668.0,758.0,848.0,872.0,867.0,863.0,682.0,741.0,553.0,8637.0
Jorhat,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1546.0,1632.0,1341.0,1382.0,1392.0,1469.0,1702.0,1736.0,1538.0,1675.0,1064.0,66.0,16543.0
Jorhat,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1667.0,1641.0,1522.0,1506.0,1335.0,1370.0,1399.0,1746.0,1625.0,1519.0,1651.0,1241.0,18222.0
Jorhat,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1694.0,1669.0,1591.0,1601.0,1397.0,1319.0,1335.0,1417.0,1647.0,1589.0,1534.0,1692.0,18485.0
Jorhat,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1314.0,1568.0,1568.0,1684.0,1680.0,1603.0,1736.0,1112.0,1955.0,1357.0,1385.0,1675.0,18637.0
Jorhat,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1170.0,1453.0,1315.0,1508.0,1398.0,1202.0,1141.0,629.0,1085.0,966.0,1104.0,1272.0,14243.0
Jorhat,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,980.0,1480.0,1697.0,1970.0,1810.0,1143.0,1700.0,1499.0,1678.0,1372.0,1287.0,1334.0,17950.0
Jorhat,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,675.0,831.0,847.0,878.0,876.0,825.0,896.0,565.0,1037.0,695.0,703.0,975.0,9803.0
Jorhat,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,638.0,731.0,736.0,806.0,795.0,778.0,838.0,507.0,906.0,655.0,671.0,847.0,8908.0
Jorhat,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1313.0,1562.0,1583.0,1684.0,1671.0,1603.0,1734.0,1072.0,1943.0,1350.0,1374.0,1822.0,18711.0
Jorhat,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1360.0,1596.0,1572.0,1591.0,1557.0,1365.0,1234.0,1384.0,1206.0,1152.0,1314.0,1457.0,16788.0
Jorhat,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1359.0,1594.0,1575.0,1589.0,1557.0,1367.0,1233.0,1383.0,1206.0,1152.0,1282.0,1456.0,16753.0
Jorhat,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,12.0,30.0,43.0,57.0,30.0,47.0,29.0,27.0,28.0,29.0,59.0,47.0,438.0
Jorhat,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,26.0,47.0,29.0,46.0,28.0,41.0,27.0,31.0,45.0,32.0,45.0,31.0,428.0
Jorhat,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,38.0,77.0,72.0,103.0,58.0,88.0,56.0,58.0,73.0,61.0,104.0,78.0,866.0
Jorhat,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,885.0,1077.0,1053.0,1251.0,1095.0,998.0,969.0,1036.0,1165.0,978.0,1229.0,1541.0,13277.0
Jorhat,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,904.0,963.0,921.0,1044.0,972.0,914.0,903.0,882.0,993.0,867.0,956.0,1428.0,11747.0
Jorhat,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,744.0,705.0,752.0,817.0,760.0,738.0,779.0,795.0,840.0,694.0,794.0,1127.0,9545.0
Jorhat,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Jorhat,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,11.0,1.0,1.0,6.0,1.0,1.0,0.0,1.0,4.0,4.0,4.0,7.0,41.0
Jorhat,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1038.0,1059.0,1068.0,1043.0,1026.0,996.0,947.0,973.0,981.0,1010.0,1066.0,1028.0,12235.0
Jorhat,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1016.0,1028.0,1052.0,1035.0,1014.0,983.0,933.0,967.0,970.0,988.0,995.0,1015.0,11996.0
Jorhat,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,945.0,1000.0,1008.0,955.0,949.0,906.0,879.0,942.0,938.0,956.0,958.0,954.0,11390.0
Jorhat,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1297.0,1374.0,2148.0,2254.0,1818.0,829.0,1133.0,1240.0,1185.0,1200.0,1134.0,1239.0,16851.0
Jorhat,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1287.0,1498.0,1530.0,1512.0,1854.0,1532.0,1547.0,990.0,1685.0,1181.0,1025.0,1383.0,17024.0
Jorhat,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,609.0,637.0,655.0,587.0,2217.0,794.0,565.0,543.0,482.0,479.0,737.0,641.0,8946.0
Jorhat,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,673.0,739.0,843.0,844.0,2457.0,807.0,645.0,658.0,674.0,636.0,804.0,733.0,10513.0
Jorhat,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,7.0
Jorhat,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,421.0,356.0,456.0,485.0,407.0,331.0,282.0,270.0,199.0,284.0,285.0,349.0,4125.0
Jorhat,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,87.0,71.0,112.0,59.0,15.0,13.0,10.0,4.0,15.0,16.0,53.0,60.0,515.0
Jorhat,13.1,Number of Patients operated for cataract,TOTAL,161.0,239.0,203.0,150.0,177.0,179.0,183.0,211.0,127.0,44.0,118.0,174.0,1966.0
Jorhat,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,97.0,125.0,99.0,48.0,86.0,89.0,90.0,135.0,73.0,30.0,68.0,145.0,1085.0
Jorhat,13.3,Number of School children detected with Refractive errors,TOTAL,10.0,0.0,0.0,3.0,9.0,14.0,15.0,10.0,10.0,5.0,0.0,0.0,76.0
Jorhat,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,3.0,9.0,14.0,15.0,10.0,10.0,5.0,0.0,0.0,66.0
Jorhat,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,4.0,4.0,5.0,5.0,5.0,5.0,4.0,4.0,5.0,5.0,-1.0
Jorhat,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,21.0,12.0,12.0,21.0,23.0,21.0,20.0,21.0,23.0,18.0,19.0,21.0,-1.0
Jorhat,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,782.0,697.0,715.0,797.0,722.0,765.0,823.0,1013.0,859.0,784.0,771.0,765.0,-1.0
Jorhat,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,-1.0
Jorhat,14.05,Number of RKS meetings held during the month,TOTAL,23.0,31.0,22.0,22.0,24.0,20.0,19.0,17.0,19.0,18.0,11.0,19.0,245.0
Jorhat,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,23.0,22.0,19.0,19.0,23.0,21.0,22.0,21.0,24.0,19.0,18.0,19.0,-1.0
Jorhat,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,81.0,88.0,67.0,119.0,90.0,85.0,97.0,112.0,55.0,53.0,43.0,40.0,930.0
Jorhat,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,-1.0
Jorhat,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,4.0,4.0,3.0,4.0,4.0,4.0,4.0,4.0,4.0,3.0,4.0,-1.0
Jorhat,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,561.0,534.0,617.0,574.0,633.0,707.0,669.0,479.0,608.0,502.0,623.0,594.0,7101.0
Jorhat,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1597.0,1863.0,1787.0,1957.0,1634.0,1391.0,1579.0,1327.0,1497.0,1350.0,1328.0,1514.0,18824.0
Jorhat,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,417.0,449.0,479.0,501.0,499.0,506.0,457.0,418.0,422.0,357.0,446.0,520.0,5471.0
Jorhat,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1927.0,2452.0,2048.0,1912.0,2275.0,2120.0,2366.0,2216.0,2303.0,2045.0,1931.0,2101.0,25696.0
Jorhat,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,978.0,983.0,1096.0,1075.0,1132.0,1213.0,1126.0,897.0,1030.0,859.0,1069.0,1114.0,12572.0
Jorhat,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3524.0,4315.0,3835.0,3869.0,3909.0,3511.0,3945.0,3543.0,3800.0,3395.0,3259.0,3615.0,44520.0
Jorhat,14.10.2.a,Number of death cases of Inpatient males,TOTAL,37.0,43.0,31.0,56.0,56.0,51.0,33.0,38.0,33.0,47.0,36.0,31.0,492.0
Jorhat,14.10.2.b,Number of death cases of Inpatient females,TOTAL,26.0,30.0,28.0,37.0,38.0,32.0,43.0,32.0,45.0,36.0,32.0,20.0,399.0
Jorhat,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,63.0,73.0,59.0,93.0,94.0,83.0,76.0,70.0,78.0,83.0,68.0,51.0,891.0
Jorhat,14.11,In-Patient Head Count at midnight,TOTAL,657.0,706.0,634.0,810.0,630.0,520.0,470.0,525.0,373.0,394.0,395.0,428.0,6542.0
Jorhat,14.12.1,OPD attendance (All),TOTAL,82152.0,106385.0,123709.0,107525.0,109598.0,103701.0,88974.0,75715.0,75107.0,72420.0,70587.0,89239.0,1105112.0
Jorhat,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,367.0,242.0,209.0,230.0,190.0,382.0,304.0,355.0,258.0,129.0,170.0,239.0,3075.0
Jorhat,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,169.0,291.0,100.0,108.0,99.0,113.0,99.0,37.0,119.0,80.0,35.0,101.0,1351.0
Jorhat,14.14.a,Number of patients given AYUSH treatment,TOTAL,995.0,350.0,314.0,658.0,543.0,614.0,763.0,600.0,609.0,551.0,371.0,532.0,6900.0
Jorhat,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1040.0,543.0,702.0,1598.0,919.0,836.0,926.0,740.0,858.0,724.0,510.0,1198.0,10594.0
Jorhat,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6393.0,5665.0,4621.0,4889.0,4267.0,5947.0,4092.0,5451.0,3858.0,3693.0,5575.0,5897.0,60348.0
Jorhat,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,34.0,69.0,377.0,58.0,63.0,82.0,45.0,48.0,53.0,55.0,114.0,112.0,1110.0
Jorhat,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,280.0,405.0,323.0,169.0,200.0,166.0,381.0,173.0,100.0,265.0,247.0,287.0,2996.0
Jorhat,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,1.0,5.0,3.0,1.0,3.0,4.0,2.0,3.0,1.0,4.0,3.0,31.0
Jorhat,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,169.0,260.0,196.0,202.0,150.0,140.0,162.0,91.0,97.0,128.0,168.0,322.0,2085.0
Jorhat,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,0.0,4.0,0.0,3.0,1.0,1.0,1.0,1.0,4.0,2.0,18.0
Jorhat,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1006.0,1360.0,1262.0,826.0,1105.0,1546.0,498.0,644.0,268.0,797.0,978.0,772.0,11062.0
Jorhat,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,27.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,33.0
Jorhat,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1455.0,2025.0,1781.0,1197.0,1455.0,1852.0,1041.0,908.0,465.0,1190.0,1393.0,1381.0,16143.0
Jorhat,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,29.0,6.0,8.0,1.0,6.0,5.0,3.0,5.0,3.0,8.0,5.0,82.0
Jorhat,15.2,Number of Widal tests conducted,Number tested,149.0,225.0,283.0,428.0,297.0,37.0,184.0,176.0,143.0,111.0,101.0,232.0,2366.0
Jorhat,15.3.a,Number of VDRL tests conducted on males,Number tested,4.0,3.0,7.0,145.0,3.0,4.0,4.0,3.0,6.0,3.0,2.0,3.0,187.0
Jorhat,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,141.0,523.0,164.0,36.0,209.0,237.0,181.0,175.0,750.0,241.0,231.0,198.0,3086.0
Jorhat,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,645.0,792.0,761.0,224.0,614.0,1323.0,1038.0,739.0,396.0,793.0,756.0,809.0,8890.0
Jorhat,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,790.0,1318.0,932.0,405.0,826.0,1564.0,1223.0,917.0,1152.0,1037.0,989.0,1010.0,12163.0
Jorhat,15.4.1,Number of blood smears examined for Malaria,TOTAL,7835.0,7397.0,10054.0,20314.0,16307.0,9462.0,8756.0,5476.0,5988.0,5237.0,5702.0,6188.0,108716.0
Jorhat,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,0.0,1.0,7.0,5.0,3.0,5.0,0.0,0.0,0.0,2.0,0.0,25.0
Jorhat,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,1.0,4.0,7.0,10.0,5.0,6.0,3.0,4.0,0.0,1.0,2.0,44.0
Jorhat,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,80210.0,70470.0,61820.0,75990.0,68730.0,58800.0,40180.0,32130.0,,,,,488330.0
Jorhat,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,,30000.0,,,10000.0,,14000.0,,,,,54000.0
Jorhat,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,9740.0,8650.0,15830.0,7260.0,9930.0,28620.0,8050.0,12500.0,,,,,100580.0
Jorhat,16.1.1,Stock position of DPT vaccines,5. Total Stock,70470.0,61820.0,75990.0,68730.0,58800.0,40180.0,32130.0,33630.0,0.0,0.0,0.0,0.0,441750.0
Jorhat,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,108400.0,96580.0,82880.0,87480.0,67920.0,53400.0,33040.0,14220.0,,,,,543920.0
Jorhat,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,,35000.0,,,,,9000.0,,,,,44000.0
Jorhat,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,11820.0,13700.0,30400.0,19560.0,14520.0,20360.0,18820.0,15420.0,,,,,144600.0
Jorhat,16.1.2,Stock position of OPV vaccines,5. Total Stock,96580.0,82880.0,87480.0,67920.0,53400.0,33040.0,14220.0,7800.0,0.0,0.0,0.0,0.0,443320.0
Jorhat,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,46310.0,38430.0,31140.0,18290.0,9150.0,17030.0,37860.0,30260.0,,,,,228470.0
Jorhat,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,15000.0,30000.0,,12000.0,,,,,57000.0
Jorhat,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.1.3,Stock position of TT vaccines,4. Stock Distributed,7880.0,7290.0,12850.0,9140.0,7120.0,9170.0,7600.0,9730.0,,,,,70780.0
Jorhat,16.1.3,Stock position of TT vaccines,5. Total Stock,38430.0,31140.0,18290.0,9150.0,17030.0,37860.0,30260.0,32530.0,0.0,0.0,0.0,0.0,214690.0
Jorhat,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,15730.0,10830.0,5970.0,7010.0,14240.0,9550.0,16390.0,10550.0,,,,,90270.0
Jorhat,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,11500.0,11500.0,,14000.0,,7500.0,,,,,44500.0
Jorhat,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4900.0,4860.0,10460.0,4270.0,4690.0,7160.0,5840.0,7090.0,,,,,49270.0
Jorhat,16.1.5,Stock position of BCG vaccines,5. Total Stock,10830.0,5970.0,7010.0,14240.0,9550.0,16390.0,10550.0,10960.0,0.0,0.0,0.0,0.0,85500.0
Jorhat,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,18825.0,15400.0,11620.0,17900.0,12375.0,8250.0,3305.0,0.0,,,,,87675.0
Jorhat,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,15000.0,,,,,10000.0,,,,,25000.0
Jorhat,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3425.0,3780.0,8720.0,5525.0,4125.0,4945.0,3305.0,3625.0,,,,,37450.0
Jorhat,16.1.6,Stock position of Measles vaccines,5. Total Stock,15400.0,11620.0,17900.0,12375.0,8250.0,3305.0,0.0,6375.0,0.0,0.0,0.0,0.0,75225.0
Jorhat,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,1825.0,1560.0,590.0,35910.0,10855.0,0.0,5395.0,905.0,,,,,57040.0
Jorhat,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,37600.0,10000.0,,10000.0,,5000.0,,,,,62600.0
Jorhat,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,170.0,,,,,,,,170.0
Jorhat,16.1.7,Stock position of JE vaccines,4. Stock Distributed,265.0,970.0,2280.0,35055.0,10685.0,4605.0,4490.0,4405.0,,,,,62755.0
Jorhat,16.1.7,Stock position of JE vaccines,5. Total Stock,1560.0,590.0,35910.0,10855.0,0.0,5395.0,905.0,1500.0,0.0,0.0,0.0,0.0,56715.0
Jorhat,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,33270.0,26020.0,18730.0,1840.0,4150.0,460.0,22120.0,12210.0,,,,,118800.0
Jorhat,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,10000.0,,30000.0,,12000.0,,,,,52000.0
Jorhat,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,7250.0,7290.0,16890.0,7690.0,3690.0,8340.0,9910.0,11380.0,,,,,72440.0
Jorhat,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,26020.0,18730.0,1840.0,4150.0,460.0,22120.0,12210.0,12830.0,0.0,0.0,0.0,0.0,98360.0
Jorhat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Jorhat,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Jorhat,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Jorhat,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jorhat,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,7072.0,5349.0,4609.0,13149.0,11599.0,8999.0,8049.0,4139.0,,,,,62965.0
Jorhat,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,9900.0,,,3300.0,,6600.0,,,,,19800.0
Jorhat,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1723.0,740.0,1360.0,1550.0,2600.0,4250.0,3910.0,3970.0,,,,,20103.0
Jorhat,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,5349.0,4609.0,13149.0,11599.0,8999.0,8049.0,4139.0,6769.0,0.0,0.0,0.0,0.0,62662.0
Jorhat,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,152326.0,148326.0,137226.0,163626.0,138276.0,95766.0,92646.0,189476.0,,,,,1117668.0
Jorhat,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,48000.0,,,24000.0,120000.0,60000.0,,,,,252000.0
Jorhat,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,4000.0,11100.0,21600.0,25350.0,42510.0,27120.0,23170.0,32340.0,,,,,187190.0
Jorhat,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,148326.0,137226.0,163626.0,138276.0,95766.0,92646.0,189476.0,217136.0,0.0,0.0,0.0,0.0,1182478.0
Jorhat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,10851.0,10500.0,9300.0,14950.0,12820.0,8800.0,11491.0,8786.0,,,,,87498.0
Jorhat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,8000.0,,,5000.0,,4000.0,,,,,17000.0
Jorhat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Jorhat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,351.0,1200.0,2350.0,2130.0,4020.0,2309.0,2705.0,4010.0,,,,,19075.0
Jorhat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,10500.0,9300.0,14950.0,12820.0,8800.0,11491.0,8786.0,8776.0,0.0,0.0,0.0,0.0,85423.0
Jorhat,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Jorhat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,1.0,1.0
Jorhat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jorhat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,1.0,1.0
Jorhat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,1.0,,,,,,1.0
Jorhat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jorhat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,1.0,,,,,,1.0
Jorhat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,1.0,,,,,,,1.0
Jorhat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jorhat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,1.0,,,,,,,1.0
Jorhat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,,,,1.0,2.0,1.0,3.0,,1.0,,9.0
Jorhat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jorhat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,,,,1.0,2.0,1.0,3.0,,1.0,,9.0
Jorhat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Jorhat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jorhat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,1.0,,,,1.0
Jorhat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jorhat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jorhat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Jorhat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jorhat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jorhat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Jorhat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jorhat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jorhat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Jorhat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,,,,,,1.0,1.0,,,,3.0
Jorhat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Jorhat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,,,,,,,1.0,1.0,,,,3.0
Jorhat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Jorhat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Jorhat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Jorhat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Jorhat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Jorhat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,1.0,,,,,,,,,1.0,2.0
Jorhat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Jorhat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,1.0,,1.0,2.0,,,,,4.0
Jorhat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,1.0,,1.0,2.0,,,,,4.0
Jorhat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Jorhat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Jorhat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Jorhat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Jorhat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Jorhat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Jorhat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,2.0,,,,,,,,,2.0
Jorhat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Jorhat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Jorhat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Jorhat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Jorhat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,2.0,,1.0,2.0,,2.0,2.0,4.0,1.0,2.0,17.0
Jorhat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,2.0,2.0,2.0,1.0,1.0,,1.0,,1.0,1.0,,11.0
Jorhat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,3.0,4.0,2.0,2.0,3.0,,3.0,2.0,5.0,2.0,3.0,29.0
Jorhat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Jorhat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Jorhat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,1.0,,,,,1.0,,,,2.0
Jorhat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Jorhat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Jorhat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Jorhat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,1.0,1.0,,,1.0,1.0,,1.0,2.0,,7.0
Jorhat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Jorhat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,1.0,1.0,,,1.0,1.0,,1.0,2.0,,7.0
Jorhat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,1.0,1.0,1.0,,,1.0,4.0
Jorhat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Jorhat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,1.0,1.0,1.0,,,1.0,4.0
Jorhat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,1.0,1.0,1.0,,,2.0,,,1.0,1.0,,8.0
Jorhat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Jorhat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,1.0,1.0,1.0,,,2.0,,,1.0,1.0,,8.0
Jorhat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,1.0,,,1.0,1.0,1.0,5.0
Jorhat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Jorhat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,1.0,,,1.0,1.0,1.0,5.0
Jorhat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,,2.0,,2.0,1.0,2.0,,2.0,,,,11.0
Jorhat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Jorhat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,,2.0,,2.0,1.0,2.0,,2.0,,,,11.0
Jorhat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Jorhat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,1.0,1.0,,1.0,1.0,,,,,,,5.0
Jorhat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Jorhat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,1.0,1.0,,1.0,2.0,,,,,,,7.0
Jorhat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,1.0,,,,,,,,1.0,,,2.0
Jorhat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Jorhat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,,,,,,,,1.0,,,2.0
Jorhat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Jorhat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Jorhat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Jorhat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Jorhat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,2.0,,,1.0,,,,,,1.0,4.0
Jorhat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,1.0,1.0,,,1.0,1.0,,1.0,5.0
Jorhat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,2.0,,1.0,2.0,,1.0,1.0,1.0,,2.0,10.0
Jorhat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,,2.0,2.0,3.0,1.0,,1.0,1.0,1.0,3.0,15.0
Jorhat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,2.0,7.0,2.0,3.0,6.0,8.0,3.0,4.0,5.0,4.0,,44.0
Jorhat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,3.0,7.0,4.0,5.0,9.0,9.0,3.0,5.0,6.0,5.0,3.0,59.0
Jorhat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Jorhat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,,1.0,1.0,2.0,3.0,,1.0,1.0,2.0,1.0,1.0,15.0
Jorhat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,4.0,1.0,6.0,7.0,3.0,10.0,5.0,4.0,7.0,9.0,4.0,61.0
Jorhat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,3.0,4.0,2.0,7.0,9.0,6.0,10.0,6.0,5.0,9.0,10.0,5.0,76.0
Kamrup M,1.1,Total number of pregnant women Registered for ANC,TOTAL,3217.0,3636.0,3556.0,3558.0,3423.0,3283.0,3238.0,3569.0,3488.0,3334.0,3158.0,3764.0,41224.0
Kamrup M,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2527.0,2802.0,2783.0,2759.0,2667.0,2642.0,2554.0,2767.0,2778.0,2654.0,2556.0,3001.0,32490.0
Kamrup M,1.2,Number of Pregnant women registered under JSY,TOTAL,2386.0,3376.0,3303.0,3325.0,2802.0,2586.0,2399.0,2709.0,2851.0,2599.0,2544.0,2728.0,33608.0
Kamrup M,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2605.0,2553.0,2391.0,2968.0,3042.0,2938.0,2965.0,3240.0,2953.0,2947.0,2702.0,2852.0,34156.0
Kamrup M,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2763.0,3011.0,2739.0,3002.0,2661.0,3634.0,3183.0,3224.0,2498.0,2640.0,2495.0,3630.0,35480.0
Kamrup M,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2977.0,2807.0,2649.0,2849.0,2605.0,4015.0,3169.0,3262.0,2555.0,2407.0,2306.0,3873.0,35474.0
Kamrup M,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2578.0,2897.0,2927.0,2827.0,1742.0,3264.0,3533.0,3589.0,2939.0,2659.0,2795.0,3669.0,35419.0
Kamrup M,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,89.0,81.0,95.0,63.0,75.0,87.0,96.0,91.0,90.0,29.0,104.0,86.0,986.0
Kamrup M,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,0.0,75.0,0.0,0.0,0.0,0.0,8.0,11.0,3.0,19.0,0.0,118.0
Kamrup M,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1852.0,2574.0,1856.0,1709.0,1724.0,1476.0,1552.0,1620.0,1456.0,1498.0,1563.0,1284.0,20164.0
Kamrup M,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,32.0,13.0,6.0,5.0,11.0,3.0,2.0,12.0,7.0,16.0,1.0,7.0,115.0
Kamrup M,1.8,Number of pregnancy test kits used at SC level,TOTAL,289.0,240.0,193.0,304.0,339.0,338.0,301.0,108.0,61.0,81.0,147.0,151.0,2552.0
Kamrup M,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,6.0,1.0,3.0,9.0,2.0,3.0,4.0,4.0,3.0,4.0,3.0,3.0,45.0
Kamrup M,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,44.0,44.0,51.0,50.0,42.0,42.0,56.0,55.0,61.0,43.0,45.0,26.0,559.0
Kamrup M,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,50.0,45.0,54.0,59.0,44.0,45.0,60.0,59.0,64.0,47.0,48.0,29.0,604.0
Kamrup M,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,47.0,44.0,52.0,52.0,41.0,40.0,55.0,57.0,62.0,46.0,47.0,28.0,571.0
Kamrup M,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,5.0
Kamrup M,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1751.0,1657.0,1652.0,2063.0,2108.0,2147.0,2233.0,2075.0,2163.0,2278.0,2153.0,1798.0,24078.0
Kamrup M,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,8.0,8.0,14.0,18.0,11.0,21.0,15.0,26.0,26.0,3.0,12.0,16.0,178.0
Kamrup M,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1227.0,1261.0,1154.0,1403.0,1465.0,1574.0,1425.0,1366.0,1436.0,1480.0,1487.0,1445.0,16723.0
Kamrup M,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,699.0,305.0,719.0,387.0,847.0,652.0,649.0,460.0,798.0,426.0,503.0,855.0,7300.0
Kamrup M,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,0.0,,,,,,,,,,0.0
Kamrup M,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,452.0,705.0,580.0,598.0,578.0,521.0,526.0,515.0,616.0,621.0,705.0,521.0,6938.0
Kamrup M,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,44.0,48.0,40.0,45.0,55.0,46.0,46.0,55.0,28.0,28.0,34.0,46.0,515.0
Kamrup M,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Kamrup M,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,40.0,41.0,34.0,43.0,41.0,42.0,44.0,43.0,31.0,26.0,33.0,34.0,452.0
Kamrup M,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,881.0,894.0,777.0,937.0,990.0,976.0,985.0,948.0,942.0,1021.0,937.0,949.0,11237.0
Kamrup M,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup M,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,921.0,935.0,811.0,980.0,1031.0,1018.0,1029.0,991.0,973.0,1047.0,970.0,983.0,11689.0
Kamrup M,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,281.0,410.0,391.0,413.0,356.0,349.0,308.0,313.0,373.0,394.0,484.0,349.0,4421.0
Kamrup M,4.1.1.a,Number of male live births,TOTAL,1104.0,1217.0,1108.0,1350.0,1359.0,1375.0,1388.0,1350.0,1402.0,1409.0,1606.0,1191.0,15859.0
Kamrup M,4.1.1.b,Number of female live births,TOTAL,1090.0,1131.0,1095.0,1293.0,1309.0,1286.0,1344.0,1272.0,1361.0,1449.0,1230.0,1080.0,14940.0
Kamrup M,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2194.0,2348.0,2203.0,2643.0,2668.0,2661.0,2732.0,2622.0,2763.0,2858.0,2836.0,2271.0,30799.0
Kamrup M,4.1.2,Number of still births,TOTAL,59.0,63.0,87.0,82.0,69.0,74.0,94.0,60.0,128.0,89.0,74.0,78.0,957.0
Kamrup M,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,136.0,174.0,240.0,255.0,176.0,266.0,233.0,207.0,198.0,244.0,181.0,207.0,2517.0
Kamrup M,4.2.1,Number of Newborns weighed at birth,TOTAL,2249.0,2403.0,2276.0,2709.0,2725.0,2661.0,2816.0,2584.0,2882.0,2934.0,2896.0,2337.0,31472.0
Kamrup M,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,258.0,219.0,207.0,234.0,353.0,574.0,296.0,215.0,259.0,252.0,484.0,232.0,3583.0
Kamrup M,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2193.0,2346.0,2203.0,2642.0,2667.0,2652.0,2717.0,2579.0,2762.0,2856.0,2841.0,2267.0,30725.0
Kamrup M,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,20.0,0.0,0.0,0.0,0.0,38.0,63.0,63.0,72.0,25.0,0.0,42.0,323.0
Kamrup M,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,32.0,32.0,26.0,28.0,29.0,33.0,34.0,35.0,46.0,50.0,29.0,26.0,400.0
Kamrup M,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,969.0,961.0,950.0,935.0,879.0,1073.0,1024.0,876.0,933.0,234.0,913.0,162.0,9909.0
Kamrup M,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup M,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,1021.0,993.0,976.0,963.0,908.0,1144.0,1121.0,974.0,1051.0,309.0,942.0,230.0,10632.0
Kamrup M,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,61.0,70.0,69.0,69.0,96.0,161.0,141.0,195.0,378.0,371.0,204.0,161.0,1976.0
Kamrup M,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,129.0,152.0,118.0,147.0,127.0,825.0,306.0,297.0,1107.0,703.0,1160.0,403.0,5474.0
Kamrup M,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,3.0,3.0,10.0,8.0,11.0,13.0,107.0,26.0,66.0,100.0,123.0,45.0,515.0
Kamrup M,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,116.0,107.0,98.0,181.0,132.0,829.0,206.0,298.0,1099.0,718.0,1167.0,355.0,5306.0
Kamrup M,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,3.0,1.0,5.0,9.0,10.0,91.0,10.0,18.0,44.0,52.0,44.0,16.0,303.0
Kamrup M,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2237.0,2341.0,2269.0,2296.0,2270.0,2675.0,2804.0,2623.0,2892.0,2919.0,2887.0,2281.0,30494.0
Kamrup M,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1539.0,1728.0,1674.0,1324.0,1600.0,1410.0,1203.0,1761.0,1743.0,1891.0,1797.0,1261.0,18931.0
Kamrup M,6.3,PNC maternal complications attended,TOTAL,5.0,10.0,0.0,0.0,0.0,10.0,0.0,0.0,13.0,1.0,2.0,2.0,43.0
Kamrup M,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,72.0,100.0,103.0,102.0,61.0,99.0,98.0,137.0,108.0,115.0,54.0,154.0,1203.0
Kamrup M,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,2.0,0.0,5.0,0.0,1.0,2.0,1.0,2.0,0.0,0.0,4.0,17.0
Kamrup M,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,72.0,102.0,103.0,107.0,61.0,100.0,100.0,138.0,110.0,115.0,54.0,158.0,1220.0
Kamrup M,7.2,Number of MTPs conducted at Private Facilities,TOTAL,14.0,28.0,31.0,30.0,30.0,43.0,40.0,40.0,26.0,24.0,20.0,43.0,369.0
Kamrup M,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,30.0,182.0,226.0,123.0,218.0,109.0,48.0,49.0,188.0,72.0,158.0,7.0,1410.0
Kamrup M,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,30.0,142.0,202.0,122.0,163.0,78.0,111.0,108.0,143.0,52.0,106.0,7.0,1264.0
Kamrup M,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,60.0,324.0,428.0,245.0,381.0,187.0,159.0,157.0,331.0,124.0,264.0,14.0,2674.0
Kamrup M,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,48.0,0.0,48.0
Kamrup M,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,34.0,0.0,0.0,0.0,0.0,34.0
Kamrup M,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,4.0,2.0,26.0,8.0,12.0,6.0,60.0,44.0,72.0,31.0,15.0,280.0
Kamrup M,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,16.0,0.0,3.0,0.0,2.0,2.0,0.0,3.0,1.0,28.0
Kamrup M,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup M,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,4.0,3.0,42.0,8.0,15.0,6.0,96.0,46.0,72.0,34.0,16.0,342.0
Kamrup M,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,26.0,137.0,0.0,42.0,0.0,43.0,16.0,0.0,23.0,56.0,343.0
Kamrup M,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,30.0,5.0,12.0,120.0,37.0,33.0,18.0,29.0,32.0,18.0,32.0,96.0,462.0
Kamrup M,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,1.0,8.0,9.0,40.0,5.0,9.0,2.0,5.0,9.0,12.0,6.0,5.0,111.0
Kamrup M,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup M,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,31.0,13.0,47.0,297.0,42.0,84.0,20.0,77.0,57.0,30.0,61.0,157.0,916.0
Kamrup M,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,49.0,26.0,32.0,30.0,20.0,18.0,16.0,15.0,20.0,25.0,33.0,18.0,302.0
Kamrup M,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,26.0,19.0,16.0,14.0,12.0,7.0,8.0,6.0,8.0,12.0,13.0,7.0,148.0
Kamrup M,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Kamrup M,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,12.0,0.0,18.0,8.0,20.0,7.0,13.0,62.0,31.0,51.0,49.0,41.0,312.0
Kamrup M,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup M,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,38.0,19.0,34.0,22.0,32.0,14.0,21.0,68.0,39.0,64.0,62.0,48.0,461.0
Kamrup M,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,26.0,19.0,16.0,14.0,12.0,7.0,8.0,6.0,8.0,12.0,13.0,7.0,148.0
Kamrup M,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,16.0,7.0,7.0,8.0,6.0,4.0,8.0,4.0,3.0,9.0,5.0,4.0,81.0
Kamrup M,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,91.0,22.0,114.0,29.0,43.0,141.0,157.0,151.0,110.0,144.0,732.0,130.0,1864.0
Kamrup M,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup M,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,107.0,29.0,121.0,37.0,49.0,145.0,165.0,155.0,113.0,153.0,737.0,134.0,1945.0
Kamrup M,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,18.0,24.0,11.0,10.0,0.0,8.0,6.0,11.0,0.0,0.0,19.0,8.0,115.0
Kamrup M,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,43.0,24.0,35.0,74.0,35.0,34.0,39.0,25.0,37.0,29.0,30.0,29.0,434.0
Kamrup M,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,89.0,81.0,62.0,210.0,71.0,119.0,72.0,52.0,53.0,47.0,61.0,72.0,989.0
Kamrup M,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,16.0,13.0,16.0,28.0,14.0,14.0,10.0,15.0,8.0,8.0,9.0,24.0,175.0
Kamrup M,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,667.0,668.0,615.0,789.0,722.0,888.0,1095.0,1124.0,1089.0,1097.0,963.0,718.0,10435.0
Kamrup M,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup M,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,815.0,786.0,728.0,1101.0,842.0,1055.0,1216.0,1216.0,1187.0,1181.0,1063.0,843.0,12033.0
Kamrup M,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,5.0,180.0,179.0,233.0,32.0,888.0,1104.0,303.0,356.0,337.0,261.0,260.0,4138.0
Kamrup M,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,18.0,13.0,7.0,7.0,11.0,11.0,12.0,11.0,11.0,16.0,10.0,11.0,138.0
Kamrup M,9.06,Number of IUCD removals,TOTAL,28.0,44.0,43.0,55.0,31.0,36.0,42.0,52.0,46.0,50.0,50.0,25.0,502.0
Kamrup M,9.07,Number of Oral Pills cycles distributed,TOTAL,1868.0,2039.0,2081.0,2540.0,2004.0,2149.0,2312.0,2409.0,2034.0,2218.0,1880.0,2051.0,25585.0
Kamrup M,9.08,Number of Condom pieces distributed,TOTAL,6864.0,8072.0,5827.0,8577.0,6788.0,6672.0,6896.0,7071.0,6296.0,6715.0,6274.0,7653.0,83705.0
Kamrup M,9.09,Number of Centchroman (weekly) pills given,TOTAL,5.0,0.0,100.0,13.0,0.0,140.0,1.0,2.0,7.0,8.0,27.0,4.0,307.0
Kamrup M,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,79.0,118.0,114.0,116.0,106.0,123.0,77.0,90.0,78.0,79.0,60.0,75.0,1115.0
Kamrup M,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,1.0,7.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,11.0
Kamrup M,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Kamrup M,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0
Kamrup M,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,2.0,2.0,,2.0,2.0,3.0,2.0,3.0,2.0,2.0,1.0,-1.0
Kamrup M,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1946.0,3166.0,2258.0,2435.0,2526.0,2432.0,2516.0,2325.0,3057.0,2659.0,2478.0,2449.0,30247.0
Kamrup M,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1957.0,2529.0,1929.0,1959.0,1943.0,1927.0,1988.0,2175.0,2089.0,2125.0,1397.0,393.0,22411.0
Kamrup M,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2095.0,2210.0,1993.0,2025.0,1798.0,1899.0,1757.0,2053.0,2219.0,2004.0,2036.0,1396.0,23485.0
Kamrup M,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1990.0,2200.0,2095.0,2012.0,1876.0,1897.0,1808.0,1865.0,2065.0,2051.0,2028.0,2000.0,23887.0
Kamrup M,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,727.0,1746.0,2473.0
Kamrup M,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,664.0,664.0
Kamrup M,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,6.0
Kamrup M,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1796.0,1856.0,1587.0,1743.0,1414.0,2036.0,1636.0,1796.0,1671.0,1591.0,1713.0,1840.0,20679.0
Kamrup M,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1957.0,2104.0,1929.0,1736.0,1790.0,1920.0,1299.0,2127.0,1966.0,1944.0,2862.0,1670.0,23304.0
Kamrup M,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2095.0,2174.0,1993.0,1781.0,1639.0,1895.0,1103.0,1958.0,2076.0,1794.0,1958.0,1808.0,22274.0
Kamrup M,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1990.0,2146.0,2095.0,1764.0,1695.0,1897.0,1090.0,1868.0,1935.0,1842.0,1875.0,1982.0,22179.0
Kamrup M,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1227.0,1784.0,922.0,891.0,745.0,939.0,903.0,1096.0,1151.0,1023.0,1273.0,870.0,12824.0
Kamrup M,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1947.0,2529.0,2245.0,1956.0,2465.0,2458.0,2257.0,2721.0,2725.0,2417.0,1897.0,1109.0,26726.0
Kamrup M,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2097.0,2212.0,1989.0,1986.0,1782.0,1927.0,1766.0,2071.0,2219.0,2001.0,1889.0,1368.0,23307.0
Kamrup M,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1993.0,2199.0,2096.0,1977.0,1851.0,1882.0,1789.0,1955.0,2078.0,2041.0,1933.0,1990.0,23784.0
Kamrup M,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1637.0,1943.0,1748.0,1954.0,2102.0,1883.0,1071.0,2512.0,2348.0,2207.0,2391.0,1795.0,23591.0
Kamrup M,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1367.0,1467.0,1139.0,1314.0,1596.0,1401.0,656.0,1708.0,1414.0,1288.0,1253.0,1546.0,16149.0
Kamrup M,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,113.0,0.0,50.0,0.0,0.0,0.0,1.0,164.0
Kamrup M,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,839.0,961.0,872.0,912.0,1030.0,924.0,538.0,1251.0,1259.0,1223.0,888.0,900.0,11597.0
Kamrup M,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,719.0,937.0,874.0,913.0,1031.0,959.0,533.0,1241.0,1071.0,926.0,799.0,814.0,10817.0
Kamrup M,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1558.0,1898.0,1746.0,1825.0,2061.0,1883.0,1071.0,2492.0,2330.0,2149.0,1687.0,1714.0,22414.0
Kamrup M,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1544.0,1727.0,1396.0,1522.0,1651.0,1635.0,1135.0,1808.0,1545.0,1495.0,1373.0,1646.0,18477.0
Kamrup M,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1544.0,1719.0,1399.0,1373.0,1535.0,1640.0,711.0,1771.0,1463.0,1318.0,1339.0,1604.0,17416.0
Kamrup M,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,66.0,8.0,0.0,0.0,0.0,12.0,15.0,15.0,10.0,15.0,36.0,9.0,186.0
Kamrup M,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,174.0,137.0,175.0,171.0,186.0,195.0,138.0,207.0,246.0,168.0,201.0,180.0,2178.0
Kamrup M,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,129.0,151.0,155.0,178.0,185.0,185.0,155.0,193.0,245.0,161.0,187.0,166.0,2090.0
Kamrup M,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,303.0,288.0,330.0,349.0,371.0,380.0,293.0,400.0,491.0,329.0,388.0,346.0,4268.0
Kamrup M,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,764.0,793.0,786.0,985.0,944.0,928.0,850.0,922.0,1078.0,926.0,905.0,920.0,10801.0
Kamrup M,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,596.0,609.0,725.0,742.0,700.0,711.0,641.0,772.0,769.0,771.0,727.0,739.0,8502.0
Kamrup M,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,429.0,485.0,621.0,588.0,550.0,590.0,519.0,605.0,547.0,558.0,559.0,612.0,6663.0
Kamrup M,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kamrup M,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,10.0,0.0,6.0,5.0,5.0,0.0,106.0,153.0,105.0,112.0,0.0,502.0
Kamrup M,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,653.0,657.0,659.0,660.0,660.0,653.0,664.0,645.0,660.0,658.0,659.0,660.0,7888.0
Kamrup M,10.4.2,Number of Immunisation sessions held during the month,TOTAL,650.0,650.0,650.0,657.0,651.0,652.0,657.0,653.0,653.0,638.0,608.0,654.0,7773.0
Kamrup M,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,647.0,649.0,639.0,652.0,646.0,644.0,647.0,604.0,644.0,622.0,603.0,650.0,7647.0
Kamrup M,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1364.0,1534.0,1576.0,1474.0,1771.0,1644.0,1055.0,2084.0,1151.0,626.0,812.0,498.0,15589.0
Kamrup M,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,550.0,645.0,590.0,536.0,1530.0,697.0,500.0,504.0,370.0,175.0,390.0,205.0,6692.0
Kamrup M,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,715.0,723.0,658.0,671.0,1511.0,821.0,666.0,631.0,485.0,219.0,241.0,268.0,7609.0
Kamrup M,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,7.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,12.0
Kamrup M,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,308.0,361.0,457.0,292.0,469.0,301.0,338.0,275.0,241.0,243.0,357.0,193.0,3835.0
Kamrup M,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kamrup M,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,226.0,163.0,247.0,272.0,227.0,280.0,269.0,158.0,162.0,199.0,221.0,187.0,2611.0
Kamrup M,13.1,Number of Patients operated for cataract,TOTAL,53.0,303.0,92.0,132.0,89.0,120.0,52.0,196.0,156.0,107.0,149.0,179.0,1628.0
Kamrup M,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,10.0,5.0,4.0,0.0,0.0,0.0,12.0,8.0,9.0,9.0,15.0,72.0
Kamrup M,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,5.0,5.0,5.0,8.0,18.0,157.0,3.0,2.0,3.0,6.0,4.0,216.0
Kamrup M,13.4,Number of children provided free glasses,TOTAL,0.0,5.0,3.0,5.0,8.0,18.0,157.0,6.0,2.0,3.0,6.0,4.0,217.0
Kamrup M,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Kamrup M,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,9.0,8.0,9.0,9.0,9.0,10.0,8.0,9.0,8.0,7.0,9.0,9.0,-1.0
Kamrup M,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,199.0,198.0,198.0,198.0,196.0,198.0,198.0,198.0,198.0,195.0,198.0,197.0,-1.0
Kamrup M,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,2.0,3.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Kamrup M,14.05,Number of RKS meetings held during the month,TOTAL,5.0,3.0,3.0,9.0,6.0,9.0,4.0,5.0,7.0,7.0,3.0,4.0,65.0
Kamrup M,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,13.0,13.0,14.0,14.0,13.0,11.0,13.0,13.0,12.0,13.0,12.0,12.0,-1.0
Kamrup M,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,452.0,151.0,145.0,187.0,182.0,111.0,189.0,102.0,346.0,94.0,77.0,39.0,2075.0
Kamrup M,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,-1.0
Kamrup M,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Kamrup M,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,193.0,231.0,237.0,226.0,202.0,277.0,213.0,314.0,302.0,144.0,132.0,289.0,2760.0
Kamrup M,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3854.0,4075.0,4080.0,4047.0,4299.0,3184.0,2714.0,1245.0,4032.0,2539.0,5318.0,7845.0,47232.0
Kamrup M,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,222.0,210.0,178.0,192.0,145.0,246.0,165.0,235.0,238.0,123.0,162.0,203.0,2319.0
Kamrup M,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5028.0,5361.0,5582.0,5757.0,6091.0,5635.0,3476.0,3390.0,5621.0,3144.0,4911.0,5387.0,59383.0
Kamrup M,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,415.0,441.0,415.0,418.0,347.0,523.0,378.0,549.0,540.0,267.0,294.0,492.0,5079.0
Kamrup M,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,8882.0,9436.0,9662.0,9804.0,10390.0,8819.0,6190.0,4635.0,9653.0,5683.0,10229.0,13232.0,106615.0
Kamrup M,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,356.0,0.0,0.0,2.0,2.0,1.0,3.0,3.0,0.0,2.0,1.0,370.0
Kamrup M,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,172.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,176.0
Kamrup M,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,528.0,0.0,0.0,3.0,3.0,1.0,4.0,4.0,0.0,2.0,1.0,546.0
Kamrup M,14.11,In-Patient Head Count at midnight,TOTAL,8609.0,5617.0,6587.0,5064.0,5605.0,7043.0,8219.0,9302.0,10089.0,7323.0,6972.0,6992.0,87422.0
Kamrup M,14.12.1,OPD attendance (All),TOTAL,123401.0,128870.0,144728.0,136691.0,125125.0,126183.0,117243.0,116526.0,116452.0,91834.0,112477.0,127615.0,1467145.0
Kamrup M,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,161.0,453.0,458.0,83.0,201.0,136.0,173.0,233.0,145.0,123.0,109.0,218.0,2493.0
Kamrup M,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,1.0,2.0,50.0,36.0,0.0,10.0,16.0,2.0,0.0,0.0,1.0,118.0
Kamrup M,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,298.0,282.0,289.0,42.0,96.0,257.0,228.0,254.0,294.0,343.0,360.0,142.0,2885.0
Kamrup M,14.14.a,Number of patients given AYUSH treatment,TOTAL,883.0,787.0,1194.0,564.0,1216.0,1068.0,607.0,461.0,1996.0,1785.0,3289.0,2285.0,16135.0
Kamrup M,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,458.0,482.0,417.0,459.0,480.0,351.0,565.0,467.0,3679.0
Kamrup M,14.14.c,Number of Adolescents counselled,TOTAL,9.0,10.0,0.0,0.0,12.0,5.0,6.0,7.0,5.0,7.0,7.0,8.0,76.0
Kamrup M,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2644.0,2975.0,3328.0,2842.0,4540.0,3822.0,4342.0,4241.0,3341.0,3533.0,3444.0,4163.0,43215.0
Kamrup M,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,34.0,44.0,83.0,43.0,55.0,120.0,69.0,94.0,127.0,74.0,56.0,60.0,859.0
Kamrup M,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,116.0,86.0,94.0,83.0,132.0,140.0,145.0,133.0,159.0,124.0,157.0,142.0,1511.0
Kamrup M,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,2.0,0.0,1.0,2.0,0.0,0.0,0.0,1.0,2.0,2.0,1.0,14.0
Kamrup M,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,105.0,41.0,66.0,74.0,95.0,39.0,55.0,94.0,76.0,51.0,95.0,90.0,881.0
Kamrup M,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,4.0,0.0,9.0
Kamrup M,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1549.0,1335.0,1341.0,1285.0,735.0,1013.0,1303.0,1151.0,835.0,1386.0,1484.0,1701.0,15118.0
Kamrup M,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,2.0,1.0,8.0,0.0,2.0,2.0,2.0,0.0,1.0,4.0,1.0,23.0
Kamrup M,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1770.0,1462.0,1501.0,1442.0,962.0,1192.0,1503.0,1378.0,1070.0,1561.0,1736.0,1933.0,17510.0
Kamrup M,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4.0,5.0,1.0,9.0,3.0,2.0,2.0,4.0,1.0,3.0,10.0,2.0,46.0
Kamrup M,15.2,Number of Widal tests conducted,Number tested,135.0,155.0,306.0,274.0,314.0,236.0,204.0,248.0,138.0,116.0,249.0,318.0,2693.0
Kamrup M,15.3.a,Number of VDRL tests conducted on males,Number tested,1.0,1.0,5.0,18.0,0.0,22.0,15.0,15.0,19.0,18.0,18.0,23.0,155.0
Kamrup M,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,56.0,7.0,11.0,16.0,3.0,4.0,6.0,8.0,41.0,9.0,20.0,10.0,191.0
Kamrup M,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,285.0,426.0,339.0,363.0,311.0,343.0,179.0,327.0,310.0,248.0,281.0,299.0,3711.0
Kamrup M,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,342.0,434.0,355.0,397.0,314.0,369.0,200.0,350.0,370.0,275.0,319.0,332.0,4057.0
Kamrup M,15.4.1,Number of blood smears examined for Malaria,TOTAL,3580.0,2906.0,7298.0,6809.0,5560.0,4506.0,3370.0,3288.0,2446.0,1720.0,3012.0,3021.0,47516.0
Kamrup M,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,6.0,4.0,6.0,129.0,3.0,15.0,22.0,0.0,0.0,0.0,185.0
Kamrup M,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,0.0,14.0,22.0,18.0,11.0,7.0,14.0,14.0,0.0,0.0,0.0,102.0
Kamrup M,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,13000.0,8500.0,11500.0,8000.0,18170.0,18170.0,,6560.0,700.0,12500.0,6970.0,6470.0,110540.0
Kamrup M,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,10000.0,1000.0,17500.0,17500.0,0.0,,10000.0,20000.0,0.0,0.0,10000.0,86000.0
Kamrup M,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0
Kamrup M,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4500.0,7000.0,4500.0,7330.0,17500.0,14110.0,,7000.0,8150.0,5530.0,500.0,9860.0,85980.0
Kamrup M,16.1.1,Stock position of DPT vaccines,5. Total Stock,8500.0,11500.0,8000.0,18170.0,18170.0,4060.0,0.0,9560.0,12550.0,6970.0,6470.0,6610.0,110560.0
Kamrup M,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,0.0,0.0,0.0,,,,,0.0,0.0,0.0
Kamrup M,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,0.0,0.0,0.0,,,,,0.0,0.0,0.0
Kamrup M,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,0.0,0.0,0.0,,,,,0.0,0.0,0.0
Kamrup M,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,0.0,0.0,0.0,,,,,0.0,0.0,0.0
Kamrup M,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,4000.0,0.0,0.0,3000.0,3080.0,3080.0,,0.0,2500.0,0.0,2540.0,0.0,18200.0
Kamrup M,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,9000.0,19000.0,18000.0,18000.0,7000.0,,2500.0,12000.0,6000.0,0.0,13000.0,104500.0
Kamrup M,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,4000.0,9000.0,16000.0,17920.0,18000.0,10080.0,,2500.0,14500.0,3460.0,2540.0,1160.0,99160.0
Kamrup M,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,3000.0,3080.0,3080.0,0.0,0.0,0.0,0.0,2540.0,0.0,11840.0,23540.0
Kamrup M,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2000.0,200.0,6000.0,10000.0,15240.0,15240.0,,10270.0,10270.0,20200.0,24970.0,4970.0,119360.0
Kamrup M,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,10000.0,10000.0,10000.0,10000.0,0.0,,10000.0,15800.0,10000.0,0.0,5000.0,80800.0
Kamrup M,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,5240.0,0.0,0.0,0.0,0.0,5240.0
Kamrup M,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1800.0,4200.0,6000.0,4760.0,10000.0,8510.0,,7950.0,5870.0,5230.0,20000.0,2010.0,76330.0
Kamrup M,16.1.3,Stock position of TT vaccines,5. Total Stock,200.0,6000.0,10000.0,15240.0,15240.0,6730.0,0.0,7080.0,20200.0,24970.0,4970.0,7960.0,118590.0
Kamrup M,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1500.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,11850.0,15370.0,7600.0,36320.0
Kamrup M,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,0.0,980.0,0.0,12500.0,,10500.0,20000.0,10000.0,0.0,0.0,53980.0
Kamrup M,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1500.0,0.0,0.0,980.0,0.0,12500.0,,9800.0,8150.0,6480.0,7770.0,4920.0,52100.0
Kamrup M,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,700.0,11850.0,15370.0,7600.0,2680.0,38200.0
Kamrup M,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0.0,3250.0,1750.0,3250.0,2855.0,2855.0,,250.0,250.0,5140.0,6215.0,2070.0,27885.0
Kamrup M,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,5000.0,5000.0,5000.0,5000.0,0.0,,5000.0,10000.0,5000.0,0.0,5000.0,50000.0
Kamrup M,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1750.0,6500.0,3500.0,5395.0,5000.0,2855.0,,3350.0,5110.0,3925.0,4145.0,1930.0,43460.0
Kamrup M,16.1.6,Stock position of Measles vaccines,5. Total Stock,3250.0,1750.0,3250.0,2855.0,2855.0,0.0,0.0,1900.0,5140.0,6215.0,2070.0,5140.0,34425.0
Kamrup M,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,0.0,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,4730.0,4730.0,15210.0,14740.0,9230.0,48640.0
Kamrup M,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,10000.0,20000.0,5000.0,0.0,0.0,35000.0
Kamrup M,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,8200.0,9520.0,5470.0,5510.0,2930.0,31630.0
Kamrup M,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6530.0,15210.0,14740.0,9230.0,6300.0,52010.0
Kamrup M,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup M,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Kamrup M,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Kamrup M,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Kamrup M,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,300.0,0.0,,0.0,6728.0,6728.0,148.0,1148.0,1148.0,5148.0,5208.0,2628.0,29184.0
Kamrup M,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,,8200.0,0.0,0.0,1000.0,3300.0,7300.0,20000.0,0.0,1000.0,40800.0
Kamrup M,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,300.0,0.0,,1472.0,0.0,6580.0,0.0,4448.0,3300.0,19940.0,2580.0,3628.0,42248.0
Kamrup M,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,6728.0,6728.0,148.0,1148.0,0.0,5148.0,5208.0,2628.0,0.0,27736.0
Kamrup M,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,,0.0,38770.0,38770.0,50940.0,39740.0,39740.0,119940.0,105920.0,94670.0,528490.0
Kamrup M,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,,64200.0,0.0,24000.0,0.0,2000.0,96000.0,0.0,0.0,3420.0,189620.0
Kamrup M,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,,25430.0,0.0,11830.0,11200.0,15640.0,15800.0,14020.0,11250.0,0.0,105170.0
Kamrup M,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,38770.0,38770.0,50940.0,39740.0,26100.0,119940.0,105920.0,94670.0,98090.0,612940.0
Kamrup M,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1000.0,0.0,,0.0,9100.0,9100.0,7440.0,6440.0,6440.0,10740.0,11740.0,10566.0,72566.0
Kamrup M,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,,10000.0,0.0,0.0,7640.0,2000.0,6000.0,2000.0,0.0,0.0,27640.0
Kamrup M,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup M,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1000.0,0.0,,900.0,0.0,1660.0,8640.0,100.0,1700.0,1000.0,1174.0,371.0,16545.0
Kamrup M,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,9100.0,9100.0,7440.0,6440.0,8340.0,10740.0,11740.0,10566.0,10195.0,83661.0
Kamrup M,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,1.0,,1.0
Kamrup M,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,,,,,,,,2.0,,3.0
Kamrup M,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kamrup M,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,,,,,,,,2.0,,3.0
Kamrup M,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,,,,,,,,,,,,1.0
Kamrup M,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kamrup M,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,,,,,,,,,,,,1.0
Kamrup M,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,1.0,,1.0
Kamrup M,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kamrup M,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,1.0,,1.0
Kamrup M,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,1.0,2.0,,,,,,,,,,5.0
Kamrup M,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kamrup M,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,1.0,2.0,,,,,,,,,,5.0
Kamrup M,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,,,,,,,,,,1.0
Kamrup M,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kamrup M,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,,,,,,,,1.0
Kamrup M,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kamrup M,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kamrup M,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Kamrup M,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kamrup M,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kamrup M,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Kamrup M,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kamrup M,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kamrup M,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Kamrup M,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,2.0,,,,,,,,,,2.0
Kamrup M,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Kamrup M,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,2.0,,,,,,,,,,2.0
Kamrup M,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Kamrup M,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,1.0,,1.0
Kamrup M,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Kamrup M,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Kamrup M,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Kamrup M,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Kamrup M,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,2.0,,2.0,4.0,,,2.0,2.0,,12.0
Kamrup M,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,2.0,,2.0,4.0,,,2.0,2.0,,12.0
Kamrup M,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Kamrup M,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup M,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup M,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Kamrup R,1.1,Total number of pregnant women Registered for ANC,TOTAL,3330.0,3359.0,3112.0,3140.0,3326.0,2575.0,3042.0,2702.0,2459.0,2681.0,2661.0,3383.0,35770.0
Kamrup R,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2891.0,2920.0,2756.0,2757.0,2815.0,2262.0,2507.0,2289.0,2246.0,2470.0,2440.0,3186.0,31539.0
Kamrup R,1.2,Number of Pregnant women registered under JSY,TOTAL,3218.0,3317.0,3066.0,3108.0,3225.0,2516.0,2951.0,2629.0,2358.0,2630.0,2625.0,3340.0,34983.0
Kamrup R,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2102.0,2381.0,2473.0,2595.0,2824.0,2759.0,2986.0,2903.0,2792.0,2541.0,2389.0,2658.0,31403.0
Kamrup R,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2141.0,2670.0,2475.0,2595.0,2792.0,2425.0,2659.0,2393.0,2258.0,2097.0,2116.0,2656.0,29277.0
Kamrup R,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2209.0,2510.0,2731.0,2695.0,2754.0,2644.0,2955.0,2950.0,2584.0,2215.0,2177.0,2477.0,30901.0
Kamrup R,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2300.0,2507.0,2603.0,2806.0,3088.0,2900.0,3145.0,3104.0,2700.0,2726.0,2777.0,3164.0,33820.0
Kamrup R,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,26.0,37.0,28.0,23.0,33.0,51.0,56.0,31.0,45.0,77.0,48.0,22.0,477.0
Kamrup R,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1957.0,2301.0,2375.0,2347.0,2696.0,2026.0,2787.0,2115.0,2542.0,1704.0,1939.0,2464.0,27253.0
Kamrup R,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,6.0,9.0,1.0,1.0,0.0,7.0,0.0,1.0,3.0,4.0,1.0,8.0,41.0
Kamrup R,1.8,Number of pregnancy test kits used at SC level,TOTAL,958.0,1075.0,1073.0,1622.0,1291.0,1112.0,1261.0,1053.0,1103.0,1094.0,1332.0,1567.0,14541.0
Kamrup R,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,30.0,37.0,26.0,32.0,82.0,85.0,91.0,107.0,65.0,52.0,54.0,47.0,708.0
Kamrup R,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,64.0,65.0,68.0,75.0,50.0,43.0,72.0,41.0,46.0,44.0,44.0,68.0,680.0
Kamrup R,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,94.0,102.0,94.0,107.0,132.0,128.0,163.0,148.0,111.0,96.0,98.0,115.0,1388.0
Kamrup R,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,69.0,79.0,67.0,84.0,97.0,126.0,163.0,147.0,101.0,88.0,94.0,96.0,1211.0
Kamrup R,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,1.0,0.0,6.0
Kamrup R,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1573.0,1505.0,1433.0,1789.0,1827.0,1945.0,2094.0,2189.0,2156.0,2035.0,1706.0,1713.0,21965.0
Kamrup R,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,883.0,808.0,746.0,944.0,581.0,639.0,610.0,483.0,431.0,449.0,344.0,358.0,7276.0
Kamrup R,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1562.0,1500.0,1473.0,1609.0,1860.0,1499.0,1657.0,2843.0,1972.0,1905.0,1762.0,1480.0,21122.0
Kamrup R,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,984.0,1022.0,1139.0,1029.0,1485.0,2606.0,1231.0,1370.0,1312.0,1335.0,1302.0,1914.0,16729.0
Kamrup R,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Kamrup R,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Kamrup R,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Kamrup R,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Kamrup R,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Kamrup R,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,79.0,111.0,112.0,81.0,101.0,111.0,80.0,167.0,136.0,73.0,105.0,101.0,1257.0
Kamrup R,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,36.0,22.0,24.0,25.0,37.0,32.0,15.0,39.0,33.0,22.0,16.0,36.0,337.0
Kamrup R,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup R,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,115.0,133.0,136.0,106.0,138.0,143.0,95.0,206.0,169.0,95.0,121.0,137.0,1594.0
Kamrup R,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Kamrup R,4.1.1.a,Number of male live births,TOTAL,858.0,853.0,792.0,985.0,1041.0,1080.0,1159.0,1224.0,1161.0,1109.0,891.0,950.0,12103.0
Kamrup R,4.1.1.b,Number of female live births,TOTAL,802.0,738.0,732.0,903.0,903.0,979.0,1079.0,1099.0,1092.0,1014.0,899.0,862.0,11102.0
Kamrup R,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1660.0,1591.0,1524.0,1888.0,1944.0,2059.0,2238.0,2323.0,2253.0,2123.0,1790.0,1812.0,23205.0
Kamrup R,4.1.2,Number of still births,TOTAL,15.0,21.0,12.0,21.0,24.0,24.0,28.0,26.0,23.0,18.0,26.0,21.0,259.0
Kamrup R,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,474.0,560.0,450.0,486.0,444.0,409.0,443.0,365.0,437.0,390.0,408.0,528.0,5394.0
Kamrup R,4.2.1,Number of Newborns weighed at birth,TOTAL,1571.0,1537.0,1472.0,1870.0,1899.0,2030.0,2219.0,2307.0,2254.0,2125.0,1797.0,1817.0,22898.0
Kamrup R,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,156.0,206.0,196.0,225.0,176.0,208.0,240.0,302.0,237.0,372.0,274.0,203.0,2795.0
Kamrup R,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1631.0,1532.0,1476.0,1862.0,1933.0,2032.0,2217.0,2287.0,2248.0,2122.0,1787.0,1809.0,22936.0
Kamrup R,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,13.0,0.0,0.0,0.0,0.0,2.0,5.0,4.0,7.0,7.0,6.0,44.0
Kamrup R,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,26.0,70.0,53.0,87.0,48.0,49.0,33.0,47.0,41.0,29.0,33.0,40.0,556.0
Kamrup R,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup R,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,26.0,83.0,53.0,87.0,48.0,49.0,35.0,52.0,45.0,36.0,40.0,46.0,600.0
Kamrup R,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Kamrup R,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,378.0,306.0,324.0,401.0,217.0,316.0,253.0,262.0,192.0,217.0,127.0,177.0,3170.0
Kamrup R,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,47.0,52.0,60.0,74.0,5.0,6.0,4.0,4.0,22.0,23.0,27.0,22.0,346.0
Kamrup R,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,354.0,415.0,454.0,434.0,262.0,394.0,196.0,267.0,207.0,233.0,230.0,236.0,3682.0
Kamrup R,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,21.0,22.0,38.0,26.0,22.0,14.0,7.0,10.0,9.0,18.0,12.0,12.0,211.0
Kamrup R,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1180.0,1196.0,1210.0,1388.0,1393.0,1600.0,1607.0,1700.0,1681.0,1483.0,1208.0,1371.0,17017.0
Kamrup R,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1405.0,1425.0,1296.0,1678.0,1655.0,1822.0,1994.0,1933.0,1920.0,1846.0,1565.0,1720.0,20259.0
Kamrup R,6.3,PNC maternal complications attended,TOTAL,14.0,2.0,2.0,1.0,1.0,2.0,0.0,4.0,13.0,3.0,20.0,3.0,65.0
Kamrup R,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,379.0,375.0,296.0,300.0,334.0,275.0,355.0,255.0,299.0,296.0,319.0,429.0,3912.0
Kamrup R,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,44.0,72.0,80.0,53.0,33.0,17.0,36.0,45.0,27.0,38.0,24.0,12.0,481.0
Kamrup R,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,423.0,447.0,376.0,353.0,367.0,292.0,391.0,300.0,326.0,334.0,343.0,441.0,4393.0
Kamrup R,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,7.0,7.0,6.0,3.0,4.0,6.0,3.0,3.0,4.0,2.0,9.0,5.0,59.0
Kamrup R,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,58.0,47.0,26.0,43.0,37.0,19.0,27.0,16.0,35.0,30.0,27.0,13.0,378.0
Kamrup R,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,65.0,54.0,32.0,46.0,41.0,25.0,30.0,19.0,39.0,32.0,36.0,18.0,437.0
Kamrup R,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,67.0,0.0,52.0,4.0,1.0,2.0,37.0,163.0
Kamrup R,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,3.0,29.0,3.0,19.0,80.0,35.0,0.0,18.0,30.0,217.0
Kamrup R,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup R,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,3.0,29.0,70.0,19.0,132.0,39.0,1.0,20.0,67.0,380.0
Kamrup R,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kamrup R,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,35.0,30.0,184.0,119.0,61.0,133.0,123.0,33.0,0.0,247.0,965.0
Kamrup R,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,55.0,40.0,182.0,116.0,41.0,117.0,53.0,218.0,150.0,23.0,1.0,237.0,1233.0
Kamrup R,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup R,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,55.0,40.0,217.0,146.0,225.0,236.0,114.0,351.0,273.0,56.0,1.0,484.0,2198.0
Kamrup R,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kamrup R,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,4.0
Kamrup R,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup R,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,4.0
Kamrup R,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kamrup R,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,11.0,19.0,9.0,19.0,18.0,16.0,38.0,25.0,9.0,7.0,14.0,19.0,204.0
Kamrup R,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,5.0,0.0,0.0,5.0,3.0,4.0,2.0,3.0,4.0,3.0,2.0,3.0,34.0
Kamrup R,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup R,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,16.0,19.0,9.0,24.0,21.0,20.0,40.0,28.0,13.0,10.0,16.0,22.0,238.0
Kamrup R,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kamrup R,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,173.0,190.0,213.0,1474.0,284.0,236.0,212.0,231.0,235.0,258.0,223.0,344.0,4073.0
Kamrup R,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,33.0,72.0,68.0,90.0,48.0,28.0,53.0,53.0,32.0,40.0,41.0,38.0,596.0
Kamrup R,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,65.0,90.0,87.0,104.0,68.0,102.0,124.0,144.0,155.0,182.0,163.0,170.0,1454.0
Kamrup R,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,3.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,6.0
Kamrup R,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kamrup R,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,274.0,352.0,370.0,1668.0,400.0,366.0,389.0,428.0,422.0,480.0,427.0,553.0,6129.0
Kamrup R,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,14.0,18.0,11.0,16.0,17.0,34.0,37.0,63.0,109.0,99.0,76.0,75.0,569.0
Kamrup R,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kamrup R,9.06,Number of IUCD removals,TOTAL,35.0,42.0,54.0,50.0,44.0,51.0,57.0,34.0,37.0,34.0,55.0,88.0,581.0
Kamrup R,9.07,Number of Oral Pills cycles distributed,TOTAL,6281.0,7441.0,7454.0,10907.0,8072.0,8486.0,8178.0,8320.0,7787.0,7561.0,7625.0,8669.0,96781.0
Kamrup R,9.08,Number of Condom pieces distributed,TOTAL,21096.0,21834.0,19779.0,42828.0,26595.0,26985.0,25165.0,26503.0,25666.0,25080.0,25057.0,28821.0,315409.0
Kamrup R,9.09,Number of Centchroman (weekly) pills given,TOTAL,129.0,21.0,103.0,22.0,6.0,63.0,87.0,48.0,34.0,34.0,44.0,53.0,644.0
Kamrup R,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,82.0,140.0,156.0,317.0,433.0,94.0,114.0,103.0,95.0,205.0,399.0,168.0,2306.0
Kamrup R,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kamrup R,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,1.0,0.0,2.0,0.0,3.0,0.0,0.0,0.0,0.0,1.0,7.0
Kamrup R,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Kamrup R,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2150.0,1880.0,1351.0,2302.0,2152.0,2371.0,2297.0,2210.0,3426.0,3225.0,2403.0,3210.0,28977.0
Kamrup R,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2464.0,2591.0,2137.0,2203.0,2274.0,2024.0,2793.0,2872.0,2677.0,3065.0,1649.0,148.0,26897.0
Kamrup R,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2509.0,2679.0,2511.0,2348.0,2172.0,2014.0,2272.0,2804.0,2860.0,2540.0,2810.0,2767.0,30286.0
Kamrup R,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2487.0,2752.0,2563.0,2626.0,2250.0,1921.0,2187.0,2447.0,2697.0,2693.0,2442.0,3679.0,30744.0
Kamrup R,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1241.0,3109.0,4350.0
Kamrup R,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,984.0,984.0
Kamrup R,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Kamrup R,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,942.0,840.0,657.0,811.0,998.0,855.0,457.0,805.0,1195.0,1169.0,950.0,1135.0,10814.0
Kamrup R,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2477.0,2557.0,2121.0,2160.0,1976.0,2163.0,2016.0,2543.0,2575.0,2698.0,2957.0,3332.0,29575.0
Kamrup R,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2498.0,2652.0,2496.0,2278.0,1883.0,2091.0,1646.0,2392.0,2606.0,2276.0,3185.0,4102.0,30105.0
Kamrup R,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2493.0,2731.0,2536.0,2561.0,1965.0,2001.0,1647.0,2138.0,2446.0,2304.0,2714.0,4446.0,29982.0
Kamrup R,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,468.0,432.0,315.0,508.0,594.0,559.0,471.0,780.0,883.0,806.0,632.0,679.0,7127.0
Kamrup R,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2569.0,2675.0,2038.0,2120.0,2329.0,2029.0,2537.0,2784.0,2672.0,3135.0,1686.0,127.0,26701.0
Kamrup R,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2497.0,2778.0,2443.0,2258.0,2202.0,2073.0,2046.0,2731.0,2860.0,2639.0,2868.0,2779.0,30174.0
Kamrup R,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2416.0,2792.0,2474.0,2559.0,2334.0,1953.0,2040.0,2415.0,2661.0,2720.0,2550.0,3631.0,30545.0
Kamrup R,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1820.0,2398.0,2398.0,2577.0,2696.0,2269.0,2142.0,3484.0,2678.0,2326.0,2249.0,3249.0,30286.0
Kamrup R,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2025.0,2569.0,2471.0,2337.0,2538.0,1794.0,1459.0,2288.0,2088.0,1927.0,2004.0,2464.0,25964.0
Kamrup R,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1726.0,2254.0,2221.0,2391.0,2163.0,1558.0,1717.0,3366.0,2481.0,1632.0,2219.0,3312.0,27040.0
Kamrup R,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1025.0,1236.0,1203.0,1298.0,1333.0,1173.0,1044.0,1776.0,1414.0,1238.0,1178.0,1742.0,15660.0
Kamrup R,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,797.0,1135.0,1195.0,1255.0,1345.0,1075.0,1075.0,1691.0,1233.0,1066.0,1064.0,1485.0,14416.0
Kamrup R,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1822.0,2371.0,2398.0,2553.0,2678.0,2248.0,2119.0,3467.0,2647.0,2304.0,2242.0,3227.0,30076.0
Kamrup R,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2049.0,2588.0,2507.0,2394.0,2575.0,1879.0,1850.0,2332.0,2162.0,1866.0,1978.0,2451.0,26631.0
Kamrup R,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2047.0,2558.0,2497.0,2355.0,2262.0,1997.0,1496.0,2073.0,2094.0,1647.0,2058.0,2617.0,25701.0
Kamrup R,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Kamrup R,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,231.0,315.0,320.0,308.0,366.0,202.0,165.0,275.0,212.0,186.0,211.0,235.0,3026.0
Kamrup R,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,215.0,267.0,279.0,320.0,328.0,187.0,161.0,241.0,205.0,200.0,207.0,219.0,2829.0
Kamrup R,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,446.0,582.0,599.0,628.0,694.0,389.0,326.0,516.0,417.0,386.0,418.0,454.0,5855.0
Kamrup R,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1045.0,1078.0,1080.0,1285.0,1388.0,1146.0,1034.0,1112.0,1191.0,1285.0,1241.0,1273.0,14158.0
Kamrup R,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,835.0,817.0,780.0,994.0,820.0,770.0,771.0,826.0,863.0,836.0,842.0,1033.0,10187.0
Kamrup R,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,530.0,564.0,612.0,646.0,537.0,557.0,601.0,592.0,641.0,559.0,568.0,756.0,7163.0
Kamrup R,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,6.0
Kamrup R,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,2.0,3.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,11.0
Kamrup R,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1053.0,1043.0,1072.0,1051.0,1058.0,1046.0,1053.0,1057.0,1057.0,1034.0,1042.0,1064.0,12630.0
Kamrup R,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1035.0,1037.0,1055.0,1040.0,1028.0,981.0,1053.0,1052.0,1060.0,1012.0,1022.0,1058.0,12433.0
Kamrup R,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1029.0,1025.0,1053.0,1038.0,1024.0,981.0,1050.0,1050.0,1058.0,1007.0,1023.0,1051.0,12389.0
Kamrup R,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2027.0,2538.0,2466.0,2268.0,2149.0,1358.0,1332.0,2415.0,2142.0,1423.0,1927.0,2639.0,24684.0
Kamrup R,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1854.0,2366.0,2374.0,2557.0,2702.0,2239.0,2136.0,3349.0,2530.0,2192.0,2042.0,2528.0,28869.0
Kamrup R,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,558.0,650.0,728.0,697.0,2882.0,1067.0,678.0,696.0,642.0,605.0,1282.0,789.0,11274.0
Kamrup R,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,717.0,773.0,823.0,950.0,2419.0,1017.0,786.0,852.0,847.0,881.0,1429.0,912.0,12406.0
Kamrup R,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,5.0,2.0,0.0,5.0,1.0,3.0,1.0,1.0,0.0,5.0,2.0,28.0
Kamrup R,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,140.0,208.0,257.0,246.0,201.0,123.0,130.0,140.0,140.0,109.0,155.0,168.0,2017.0
Kamrup R,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,5.0
Kamrup R,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,7.0,1.0,1.0,0.0,12.0,13.0,5.0,15.0,54.0
Kamrup R,13.1,Number of Patients operated for cataract,TOTAL,99.0,109.0,102.0,80.0,80.0,46.0,35.0,41.0,140.0,59.0,140.0,96.0,1027.0
Kamrup R,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,116.0,90.0,96.0,57.0,53.0,39.0,22.0,23.0,73.0,48.0,77.0,75.0,769.0
Kamrup R,13.3,Number of School children detected with Refractive errors,TOTAL,58.0,54.0,137.0,2.0,42.0,121.0,33.0,168.0,57.0,95.0,99.0,364.0,1230.0
Kamrup R,13.4,Number of children provided free glasses,TOTAL,45.0,18.0,14.0,8.0,35.0,118.0,22.0,107.0,39.0,7.0,67.0,185.0,665.0
Kamrup R,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,-1.0
Kamrup R,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,16.0,16.0,15.0,16.0,15.0,16.0,16.0,16.0,15.0,15.0,15.0,16.0,-1.0
Kamrup R,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1395.0,1391.0,1443.0,1425.0,1399.0,1395.0,1436.0,1447.0,1453.0,1432.0,1427.0,1440.0,-1.0
Kamrup R,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,12.0,13.0,13.0,13.0,13.0,13.0,13.0,13.0,13.0,13.0,13.0,13.0,-1.0
Kamrup R,14.05,Number of RKS meetings held during the month,TOTAL,30.0,35.0,31.0,30.0,29.0,29.0,31.0,32.0,26.0,27.0,28.0,27.0,355.0
Kamrup R,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,30.0,29.0,26.0,30.0,29.0,30.0,29.0,29.0,29.0,29.0,30.0,29.0,-1.0
Kamrup R,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,337.0,314.0,362.0,322.0,353.0,365.0,322.0,345.0,324.0,333.0,272.0,253.0,3902.0
Kamrup R,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Kamrup R,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,-1.0
Kamrup R,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,251.0,172.0,229.0,238.0,557.0,199.0,389.0,183.0,278.0,140.0,119.0,508.0,3263.0
Kamrup R,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,470.0,300.0,450.0,471.0,695.0,405.0,705.0,395.0,467.0,221.0,232.0,640.0,5451.0
Kamrup R,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,221.0,296.0,340.0,255.0,455.0,186.0,248.0,227.0,274.0,186.0,160.0,415.0,3263.0
Kamrup R,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1190.0,1062.0,1166.0,1200.0,1521.0,1133.0,1188.0,1370.0,1249.0,1015.0,963.0,1145.0,14202.0
Kamrup R,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,472.0,468.0,569.0,493.0,1012.0,385.0,637.0,410.0,552.0,326.0,279.0,923.0,6526.0
Kamrup R,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1660.0,1362.0,1616.0,1671.0,2216.0,1538.0,1893.0,1765.0,1716.0,1236.0,1195.0,1785.0,19653.0
Kamrup R,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kamrup R,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kamrup R,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Kamrup R,14.11,In-Patient Head Count at midnight,TOTAL,1032.0,927.0,899.0,1492.0,2181.0,2158.0,2104.0,2107.0,2182.0,1920.0,1947.0,1970.0,20919.0
Kamrup R,14.12.1,OPD attendance (All),TOTAL,121415.0,120778.0,143083.0,143603.0,119232.0,114331.0,110962.0,100534.0,92269.0,83730.0,99894.0,117993.0,1367824.0
Kamrup R,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,16.0,11.0,10.0,5.0,7.0,10.0,4.0,7.0,1.0,7.0,2.0,7.0,87.0
Kamrup R,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,5.0
Kamrup R,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,109.0,119.0,138.0,167.0,143.0,129.0,104.0,122.0,142.0,125.0,88.0,141.0,1527.0
Kamrup R,14.14.a,Number of patients given AYUSH treatment,TOTAL,3617.0,5277.0,5594.0,6119.0,5030.0,5361.0,3759.0,3312.0,2684.0,2317.0,2429.0,2862.0,48361.0
Kamrup R,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,644.0,658.0,791.0,689.0,1045.0,854.0,687.0,653.0,647.0,572.0,614.0,770.0,8624.0
Kamrup R,14.14.c,Number of Adolescents counselled,TOTAL,189.0,181.0,170.0,179.0,140.0,159.0,132.0,143.0,157.0,134.0,109.0,145.0,1838.0
Kamrup R,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8140.0,9189.0,9426.0,9483.0,10179.0,9965.0,10662.0,10202.0,9441.0,8639.0,8199.0,10604.0,114129.0
Kamrup R,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,42.0,53.0,90.0,58.0,67.0,71.0,100.0,70.0,60.0,78.0,29.0,102.0,820.0
Kamrup R,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,350.0,449.0,417.0,417.0,397.0,355.0,336.0,288.0,250.0,341.0,347.0,368.0,4315.0
Kamrup R,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,1.0,2.0,1.0,2.0,0.0,2.0,0.0,0.0,2.0,1.0,0.0,11.0
Kamrup R,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,186.0,246.0,449.0,224.0,145.0,158.0,176.0,151.0,112.0,313.0,173.0,175.0,2508.0
Kamrup R,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1910.0,2086.0,1739.0,1763.0,1851.0,2064.0,2252.0,1503.0,860.0,1320.0,1878.0,2186.0,21412.0
Kamrup R,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,1.0,0.0,2.0,31.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,36.0
Kamrup R,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2446.0,2781.0,2605.0,2404.0,2393.0,2577.0,2764.0,1942.0,1222.0,1974.0,2398.0,2729.0,28235.0
Kamrup R,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,2.0,2.0,3.0,33.0,0.0,2.0,1.0,0.0,2.0,1.0,0.0,47.0
Kamrup R,15.2,Number of Widal tests conducted,Number tested,547.0,446.0,883.0,1326.0,740.0,690.0,430.0,471.0,227.0,210.0,293.0,495.0,6758.0
Kamrup R,15.3.a,Number of VDRL tests conducted on males,Number tested,49.0,47.0,9.0,7.0,41.0,10.0,8.0,0.0,3.0,84.0,5.0,4.0,267.0
Kamrup R,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,30.0,17.0,13.0,40.0,78.0,36.0,27.0,12.0,11.0,7.0,17.0,7.0,295.0
Kamrup R,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1535.0,1721.0,1486.0,1648.0,1722.0,1973.0,2056.0,1579.0,1875.0,1565.0,1615.0,2033.0,20808.0
Kamrup R,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1614.0,1785.0,1508.0,1695.0,1841.0,2019.0,2091.0,1591.0,1889.0,1656.0,1637.0,2044.0,21370.0
Kamrup R,15.4.1,Number of blood smears examined for Malaria,TOTAL,15850.0,18910.0,32794.0,51921.0,30843.0,23750.0,19477.0,16935.0,14684.0,11953.0,11442.0,15207.0,263766.0
Kamrup R,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,4.0,5.0,4.0,8.0,2.0,5.0,5.0,2.0,4.0,0.0,1.0,40.0
Kamrup R,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,9.0,14.0,29.0,18.0,4.0,11.0,13.0,26.0,4.0,2.0,4.0,134.0
Kamrup R,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,16500.0,6300.0,7600.0,100.0,9000.0,12900.0,9550.0,1710.0,5410.0,20380.0,20380.0,,109830.0
Kamrup R,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,15000.0,10000.0,15000.0,15000.0,10000.0,10000.0,10000.0,30000.0,12000.0,12000.0,,139000.0
Kamrup R,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,10200.0,13700.0,17500.0,6100.0,11100.0,13350.0,17840.0,6300.0,15030.0,18950.0,18950.0,,149020.0
Kamrup R,16.1.1,Stock position of DPT vaccines,5. Total Stock,6300.0,7600.0,100.0,9000.0,12900.0,9550.0,1710.0,5410.0,20380.0,13430.0,13430.0,0.0,99810.0
Kamrup R,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,0.0,0.0,,0.0
Kamrup R,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,12000.0,12000.0,,24000.0
Kamrup R,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,0.0,0.0,,0.0
Kamrup R,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,12000.0,0.0,24000.0
Kamrup R,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,14900.0,4300.0,11800.0,9100.0,0.0,3900.0,0.0,0.0,0.0,0.0,0.0,,44000.0
Kamrup R,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,11000.0,21000.0,0.0,22000.0,3000.0,12000.0,2000.0,12000.0,297000.0,297000.0,,677000.0
Kamrup R,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,10600.0,3500.0,23700.0,9100.0,18100.0,6900.0,12000.0,2000.0,12000.0,273500.0,273500.0,,644900.0
Kamrup R,16.1.2,Stock position of OPV vaccines,5. Total Stock,4300.0,11800.0,9100.0,0.0,3900.0,0.0,0.0,0.0,0.0,23500.0,23500.0,0.0,76100.0
Kamrup R,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,8900.0,200.0,1300.0,800.0,2400.0,5600.0,12790.0,7190.0,12590.0,1190.0,1190.0,,54150.0
Kamrup R,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,0.0,15000.0,15000.0,,100000.0
Kamrup R,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.1.3,Stock position of TT vaccines,4. Stock Distributed,8700.0,8900.0,10500.0,8400.0,6800.0,2810.0,15600.0,4600.0,11400.0,4790.0,4790.0,,87290.0
Kamrup R,16.1.3,Stock position of TT vaccines,5. Total Stock,200.0,1300.0,800.0,2400.0,5600.0,12790.0,7190.0,12590.0,1190.0,11400.0,11400.0,0.0,66860.0
Kamrup R,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,11860.0,9610.0,10160.0,9260.0,400.0,0.0,1500.0,0.0,550.0,10000.0,10000.0,,63340.0
Kamrup R,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,10500.0,0.0,10500.0,0.0,12000.0,0.0,10000.0,20000.0,10000.0,10000.0,,83000.0
Kamrup R,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2250.0,9950.0,900.0,19360.0,400.0,10500.0,1500.0,9450.0,10550.0,11800.0,11800.0,,88460.0
Kamrup R,16.1.5,Stock position of BCG vaccines,5. Total Stock,9610.0,10160.0,9260.0,400.0,0.0,1500.0,0.0,550.0,10000.0,8200.0,8200.0,0.0,57880.0
Kamrup R,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4730.0,10380.0,8530.0,5030.0,2000.0,2200.0,0.0,325.0,100.0,10000.0,10000.0,,53295.0
Kamrup R,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,5000.0,5000.0,5000.0,5000.0,0.0,5000.0,5000.0,15000.0,5000.0,5000.0,,65000.0
Kamrup R,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4350.0,6850.0,8500.0,8030.0,4800.0,2200.0,4675.0,5225.0,5100.0,10400.0,10400.0,,70530.0
Kamrup R,16.1.6,Stock position of Measles vaccines,5. Total Stock,10380.0,8530.0,5030.0,2000.0,2200.0,0.0,325.0,100.0,10000.0,4600.0,4600.0,0.0,47765.0
Kamrup R,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,4860.0,2710.0,5210.0,6160.0,35.0,2105.0,8630.0,930.0,750.0,2400.0,2400.0,,36190.0
Kamrup R,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,10000.0,10000.0,0.0,7000.0,11700.0,0.0,5000.0,7400.0,10000.0,10000.0,,71100.0
Kamrup R,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2150.0,7500.0,9050.0,6125.0,4930.0,5175.0,7700.0,5180.0,5750.0,5250.0,5250.0,,64060.0
Kamrup R,16.1.7,Stock position of JE vaccines,5. Total Stock,2710.0,5210.0,6160.0,35.0,2105.0,8630.0,930.0,750.0,2400.0,7150.0,7150.0,0.0,43230.0
Kamrup R,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,27270.0,18070.0,14270.0,12070.0,0.0,330.0,3580.0,400.0,1000.0,16700.0,16700.0,,110390.0
Kamrup R,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,10500.0,0.0,10500.0,10200.0,20000.0,10000.0,10000.0,30000.0,10000.0,10000.0,,121200.0
Kamrup R,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,9200.0,14300.0,2200.0,22570.0,9870.0,16750.0,13180.0,9400.0,14300.0,18200.0,18200.0,,148170.0
Kamrup R,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,18070.0,14270.0,12070.0,0.0,330.0,3580.0,400.0,1000.0,16700.0,8500.0,8500.0,0.0,83420.0
Kamrup R,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Kamrup R,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Kamrup R,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Kamrup R,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kamrup R,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,11520.0,10180.0,8840.0,8240.0,4400.0,6550.0,1450.0,50.0,3050.0,8750.0,8750.0,,71780.0
Kamrup R,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,13200.0,3300.0,0.0,0.0,6600.0,10600.0,4000.0,4000.0,,41700.0
Kamrup R,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1340.0,1340.0,600.0,17040.0,1150.0,5100.0,1400.0,3600.0,4900.0,7800.0,7800.0,,52070.0
Kamrup R,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,10180.0,8840.0,8240.0,4400.0,6550.0,1450.0,50.0,3050.0,8750.0,4950.0,4950.0,0.0,61410.0
Kamrup R,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,189840.0,163840.0,137840.0,105840.0,81440.0,62000.0,139600.0,69000.0,56400.0,105800.0,105800.0,,1217400.0
Kamrup R,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,9600.0,57600.0,88000.0,0.0,0.0,94000.0,24000.0,24000.0,,297200.0
Kamrup R,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,26000.0,26000.0,32000.0,34000.0,77040.0,10400.0,70600.0,12600.0,44600.0,39000.0,39000.0,,411240.0
Kamrup R,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,163840.0,137840.0,105840.0,81440.0,62000.0,139600.0,69000.0,56400.0,105800.0,90800.0,90800.0,0.0,1103360.0
Kamrup R,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,13990.0,12090.0,8490.0,5990.0,7400.0,10400.0,8900.0,5650.0,4450.0,5400.0,5400.0,,88160.0
Kamrup R,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,8000.0,4000.0,0.0,0.0,0.0,6000.0,2000.0,2000.0,,22000.0
Kamrup R,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Kamrup R,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1900.0,3600.0,2500.0,6590.0,1000.0,1500.0,3250.0,1200.0,5050.0,4000.0,4000.0,,34590.0
Kamrup R,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,12090.0,8490.0,5990.0,7400.0,10400.0,8900.0,5650.0,4450.0,5400.0,3400.0,3400.0,0.0,75570.0
Kamrup R,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,1.0,2.0,,2.0,1.0,2.0,,,,,8.0
Kamrup R,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,1.0,1.0,1.0,,,,3.0
Kamrup R,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kamrup R,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,1.0,1.0,1.0,,,,3.0
Kamrup R,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,1.0,2.0,,1.0,1.0,5.0
Kamrup R,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kamrup R,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,1.0,2.0,,1.0,1.0,5.0
Kamrup R,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,,,1.0,2.0,1.0,3.0,3.0,3.0,,2.0,2.0,19.0
Kamrup R,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kamrup R,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,,,1.0,2.0,1.0,3.0,3.0,3.0,,2.0,2.0,19.0
Kamrup R,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,3.0,4.0,,,2.0,1.0,5.0,3.0,,3.0,1.0,23.0
Kamrup R,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kamrup R,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,3.0,4.0,,,2.0,1.0,5.0,3.0,,3.0,1.0,23.0
Kamrup R,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,1.0,,,,,,,1.0
Kamrup R,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kamrup R,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,1.0,,,,,,,1.0
Kamrup R,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kamrup R,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
Kamrup R,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,,,,,,,,,,,1.0
Kamrup R,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,1.0,,1.0,,,,,,3.0
Kamrup R,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,1.0,1.0,,,,,,2.0
Kamrup R,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,1.0,1.0,2.0,,,,,,5.0
Kamrup R,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kamrup R,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kamrup R,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Kamrup R,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,1.0,,,3.0,1.0,2.0,,1.0,2.0,2.0,3.0,18.0
Kamrup R,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,,1.0,,,,,,,1.0,1.0,,5.0
Kamrup R,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,1.0,1.0,,3.0,1.0,2.0,,1.0,3.0,3.0,3.0,23.0
Kamrup R,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Kamrup R,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup R,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Kamrup R,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,3.0,3.0,2.0,,,,,,3.0,,,,11.0
Kamrup R,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,2.0,,,,1.0,1.0,,4.0
Kamrup R,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,3.0,3.0,2.0,,,2.0,,,3.0,1.0,1.0,,15.0
Kamrup R,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,1.0,,,1.0,,2.0,,,,,5.0
Kamrup R,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,3.0,1.0,1.0,3.0,,1.0,1.0,1.0,1.0,2.0,1.0,16.0
Kamrup R,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,3.0,2.0,1.0,3.0,1.0,1.0,3.0,1.0,1.0,2.0,1.0,21.0
Kamrup R,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Kamrup R,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Kamrup R,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,1.0,,,,,,1.0,,2.0
Kamrup R,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,3.0,1.0,,2.0,1.0,,,,,8.0
Kamrup R,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,,5.0,,,1.0,,,,,,7.0
Kamrup R,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,1.0,,8.0,1.0,,3.0,1.0,,,,,15.0
Kamrup R,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Kamrup R,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Kamrup R,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,1.0,,,1.0
Kamrup R,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,5.0,4.0,1.0,3.0,1.0,1.0,1.0,1.0,2.0,1.0,5.0,28.0
Kamrup R,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,7.0,8.0,8.0,4.0,3.0,7.0,2.0,3.0,5.0,9.0,2.0,3.0,61.0
Kamrup R,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,10.0,13.0,12.0,5.0,6.0,8.0,3.0,4.0,6.0,11.0,3.0,8.0,89.0
Kamrup R,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,1.0,1.0,1.0,,,3.0,2.0,2.0,3.0,1.0,14.0
Kamrup R,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,2.0,,,1.0,,,,1.0,1.0,2.0,,7.0
Kamrup R,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,2.0,1.0,1.0,2.0,,,3.0,3.0,3.0,5.0,1.0,21.0
Kamrup R,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Kamrup R,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kamrup R,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,1.0,,,,,,,,,,1.0
Kamrup R,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Kamrup R,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kamrup R,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,1.0,,,,,,,,,1.0
Kamrup R,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Kamrup R,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kamrup R,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Kamrup R,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,1.0,,,,1.0,,1.0,,4.0
Kamrup R,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kamrup R,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,1.0,,,,1.0,,1.0,,4.0
Kamrup R,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Kamrup R,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kamrup R,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Kamrup R,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,,1.0,,,2.0,,,1.0,,,6.0
Kamrup R,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Kamrup R,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,,1.0,,,2.0,,,1.0,,,6.0
Kamrup R,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,1.0,,1.0,,,1.0,,,1.0,,5.0
Kamrup R,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,8.0,3.0,7.0,5.0,5.0,4.0,4.0,6.0,7.0,9.0,4.0,8.0,70.0
Kamrup R,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,2.0,,1.0,,,1.0,,,2.0,2.0,,10.0
Kamrup R,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,11.0,5.0,8.0,6.0,6.0,4.0,5.0,7.0,7.0,11.0,7.0,8.0,85.0
Kamrup R,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,1.0,,,,1.0,1.0,,,,1.0,5.0
Kamrup R,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,6.0,2.0,10.0,5.0,4.0,4.0,4.0,7.0,1.0,2.0,2.0,50.0
Kamrup R,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,,,1.0,1.0,,3.0,,,1.0,,7.0
Kamrup R,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,7.0,3.0,10.0,6.0,5.0,5.0,8.0,7.0,1.0,3.0,3.0,62.0
Kamrup R,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,3.0,1.0,,,,,1.0,,1.0,6.0
Kamrup R,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,1.0,1.0,,,,,1.0,2.0,,,,6.0
Kamrup R,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,1.0,1.0,3.0,1.0,,,1.0,2.0,1.0,,1.0,12.0
Kamrup R,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Kamrup R,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,4.0,1.0,1.0,1.0,2.0,,2.0,4.0,1.0,6.0,4.0,30.0
Kamrup R,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,4.0,2.0,4.0,2.0,2.0,5.0,8.0,4.0,4.0,5.0,7.0,50.0
Kamrup R,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,7.0,8.0,3.0,5.0,3.0,4.0,5.0,10.0,8.0,5.0,11.0,11.0,80.0
Kamrup R,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Kamrup R,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,5.0,4.0,3.0,3.0,3.0,4.0,6.0,5.0,4.0,3.0,9.0,8.0,57.0
Kamrup R,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,3.0,11.0,6.0,4.0,15.0,8.0,4.0,10.0,16.0,3.0,5.0,17.0,102.0
Kamrup R,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,8.0,15.0,9.0,7.0,18.0,12.0,10.0,15.0,20.0,7.0,14.0,25.0,160.0
Kamrup R,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,1.0,4.0,,1.0,,,,2.0,,1.0,2.0,14.0
Kamrup R,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,36.0,35.0,21.0,22.0,23.0,24.0,22.0,29.0,45.0,28.0,29.0,40.0,354.0
Kamrup R,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,67.0,41.0,68.0,51.0,56.0,40.0,42.0,63.0,65.0,67.0,63.0,81.0,704.0
Kamrup R,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,106.0,77.0,93.0,73.0,80.0,64.0,64.0,92.0,112.0,95.0,93.0,123.0,1072.0
Karbi Anglong,1.1,Total number of pregnant women Registered for ANC,TOTAL,1952.0,2032.0,2072.0,1994.0,2122.0,1873.0,1747.0,1932.0,1781.0,2111.0,1952.0,1987.0,23555.0
Karbi Anglong,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1303.0,1378.0,1336.0,1374.0,1343.0,1174.0,1139.0,1215.0,1191.0,1383.0,1318.0,1301.0,15455.0
Karbi Anglong,1.2,Number of Pregnant women registered under JSY,TOTAL,1805.0,1967.0,2002.0,1874.0,2105.0,1772.0,1703.0,1903.0,1751.0,2067.0,1932.0,1958.0,22839.0
Karbi Anglong,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1206.0,1322.0,1349.0,1493.0,1502.0,1350.0,1344.0,1494.0,1486.0,1236.0,1224.0,1190.0,16196.0
Karbi Anglong,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1671.0,1794.0,1816.0,1817.0,1875.0,1665.0,1542.0,1647.0,1567.0,1775.0,1726.0,1775.0,20670.0
Karbi Anglong,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1694.0,1702.0,1899.0,1819.0,1865.0,1883.0,1638.0,1691.0,1685.0,1665.0,1631.0,1822.0,20994.0
Karbi Anglong,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1149.0,1384.0,1454.0,1365.0,1404.0,1477.0,1494.0,1633.0,1610.0,1613.0,1605.0,1504.0,17692.0
Karbi Anglong,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,31.0,33.0,50.0,19.0,33.0,28.0,26.0,29.0,41.0,35.0,36.0,38.0,399.0
Karbi Anglong,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,0.0,3.0,0.0,2.0,0.0,2.0,3.0,2.0,0.0,2.0,1.0,17.0
Karbi Anglong,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,728.0,901.0,981.0,815.0,703.0,676.0,705.0,607.0,622.0,576.0,698.0,955.0,8967.0
Karbi Anglong,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,23.0,20.0,40.0,0.0,30.0,32.0,10.0,38.0,27.0,10.0,18.0,29.0,277.0
Karbi Anglong,1.8,Number of pregnancy test kits used at SC level,TOTAL,218.0,226.0,276.0,280.0,263.0,236.0,227.0,301.0,333.0,333.0,404.0,422.0,3519.0
Karbi Anglong,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,20.0,25.0,21.0,28.0,31.0,35.0,36.0,33.0,31.0,44.0,28.0,34.0,366.0
Karbi Anglong,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,176.0,175.0,159.0,151.0,197.0,175.0,165.0,168.0,162.0,224.0,182.0,185.0,2119.0
Karbi Anglong,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,196.0,200.0,180.0,179.0,228.0,210.0,201.0,201.0,193.0,268.0,210.0,219.0,2485.0
Karbi Anglong,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,120.0,110.0,109.0,106.0,147.0,115.0,121.0,127.0,132.0,171.0,126.0,112.0,1496.0
Karbi Anglong,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1165.0,1190.0,1133.0,1343.0,1489.0,1494.0,1406.0,1471.0,1462.0,1454.0,1300.0,1399.0,16306.0
Karbi Anglong,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,851.0,886.0,708.0,883.0,1056.0,1094.0,1111.0,921.0,1069.0,1059.0,993.0,1009.0,11640.0
Karbi Anglong,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,372.0,785.0,1745.0,1000.0,1028.0,1452.0,916.0,1302.0,1168.0,1662.0,1609.0,2304.0,15343.0
Karbi Anglong,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,164.0,506.0,1517.0,1464.0,867.0,3550.0,301.0,819.0,661.0,2159.0,958.0,2796.0,15762.0
Karbi Anglong,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Karbi Anglong,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,3.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Karbi Anglong,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,0.0,,,0.0,,,0.0
Karbi Anglong,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,0.0,,,0.0,,,0.0
Karbi Anglong,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Karbi Anglong,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Karbi Anglong,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,59.0,62.0,56.0,61.0,59.0,75.0,48.0,63.0,56.0,44.0,53.0,68.0,704.0
Karbi Anglong,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karbi Anglong,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,59.0,62.0,56.0,61.0,59.0,75.0,48.0,63.0,56.0,44.0,53.0,68.0,704.0
Karbi Anglong,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Karbi Anglong,4.1.1.a,Number of male live births,TOTAL,702.0,716.0,679.0,812.0,908.0,911.0,806.0,914.0,909.0,908.0,787.0,849.0,9901.0
Karbi Anglong,4.1.1.b,Number of female live births,TOTAL,639.0,649.0,606.0,685.0,776.0,763.0,778.0,733.0,724.0,789.0,696.0,742.0,8580.0
Karbi Anglong,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1341.0,1365.0,1285.0,1497.0,1684.0,1674.0,1584.0,1647.0,1633.0,1697.0,1483.0,1591.0,18481.0
Karbi Anglong,4.1.2,Number of still births,TOTAL,32.0,34.0,36.0,38.0,38.0,43.0,35.0,40.0,25.0,43.0,33.0,35.0,432.0
Karbi Anglong,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,169.0,212.0,308.0,274.0,296.0,180.0,215.0,194.0,225.0,277.0,275.0,354.0,2979.0
Karbi Anglong,4.2.1,Number of Newborns weighed at birth,TOTAL,1308.0,1342.0,1267.0,1478.0,1663.0,1632.0,1570.0,1614.0,1617.0,1673.0,1451.0,1571.0,18186.0
Karbi Anglong,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,119.0,136.0,128.0,143.0,122.0,176.0,150.0,177.0,172.0,197.0,170.0,194.0,1884.0
Karbi Anglong,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1293.0,1309.0,1124.0,1455.0,1645.0,1610.0,1523.0,1594.0,1586.0,1644.0,1426.0,1533.0,17742.0
Karbi Anglong,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3.0,12.0,16.0,0.0,0.0,0.0,0.0,2.0,0.0,5.0,6.0,2.0,46.0
Karbi Anglong,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,10.0,62.0,2.0,0.0,1.0,1.0,1.0,77.0
Karbi Anglong,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,97.0,62.0,95.0,84.0,85.0,88.0,73.0,80.0,72.0,45.0,75.0,89.0,945.0
Karbi Anglong,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karbi Anglong,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,100.0,74.0,111.0,84.0,85.0,98.0,135.0,84.0,72.0,51.0,82.0,92.0,1068.0
Karbi Anglong,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,,,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Karbi Anglong,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,99.0,74.0,110.0,84.0,85.0,81.0,111.0,82.0,72.0,46.0,80.0,69.0,993.0
Karbi Anglong,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,11.0,10.0,14.0,5.0,11.0,8.0,14.0,18.0,15.0,0.0,20.0,17.0,143.0
Karbi Anglong,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,99.0,74.0,110.0,78.0,85.0,88.0,68.0,82.0,72.0,46.0,75.0,92.0,969.0
Karbi Anglong,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,7.0,4.0,14.0,18.0,13.0,16.0,6.0,7.0,8.0,1.0,13.0,17.0,124.0
Karbi Anglong,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,762.0,873.0,817.0,966.0,1116.0,1072.0,1005.0,1070.0,1036.0,1060.0,927.0,813.0,11517.0
Karbi Anglong,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,732.0,801.0,751.0,804.0,804.0,852.0,807.0,774.0,784.0,874.0,756.0,739.0,9478.0
Karbi Anglong,6.3,PNC maternal complications attended,TOTAL,9.0,0.0,1.0,28.0,3.0,12.0,0.0,12.0,0.0,6.0,2.0,0.0,73.0
Karbi Anglong,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,128.0,118.0,196.0,142.0,149.0,142.0,129.0,168.0,156.0,172.0,185.0,203.0,1888.0
Karbi Anglong,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,4.0,18.0,5.0,16.0,16.0,27.0,10.0,16.0,4.0,16.0,7.0,12.0,151.0
Karbi Anglong,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,132.0,136.0,201.0,158.0,165.0,169.0,139.0,184.0,160.0,188.0,192.0,215.0,2039.0
Karbi Anglong,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Karbi Anglong,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,4.0,4.0,0.0,3.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,16.0
Karbi Anglong,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,7.0,13.0,0.0,4.0,7.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0,35.0
Karbi Anglong,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,11.0,17.0,0.0,7.0,9.0,0.0,2.0,0.0,0.0,0.0,0.0,5.0,51.0
Karbi Anglong,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karbi Anglong,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,11.0
Karbi Anglong,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karbi Anglong,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,11.0
Karbi Anglong,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karbi Anglong,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,11.0,0.0,0.0,0.0,0.0,6.0,0.0,6.0,0.0,0.0,23.0
Karbi Anglong,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karbi Anglong,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,11.0,0.0,0.0,0.0,0.0,6.0,0.0,6.0,0.0,0.0,23.0
Karbi Anglong,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,91.0,131.0,113.0,1139.0,101.0,80.0,83.0,103.0,126.0,100.0,128.0,211.0,2406.0
Karbi Anglong,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,33.0,43.0,28.0,149.0,49.0,39.0,30.0,21.0,27.0,21.0,35.0,68.0,543.0
Karbi Anglong,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,24.0,26.0,19.0,84.0,28.0,34.0,33.0,19.0,34.0,28.0,29.0,33.0,391.0
Karbi Anglong,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,32.0,23.0,12.0,53.0,18.0,33.0,30.0,15.0,31.0,25.0,14.0,41.0,327.0
Karbi Anglong,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karbi Anglong,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,180.0,223.0,172.0,1425.0,196.0,186.0,176.0,158.0,218.0,174.0,206.0,353.0,3667.0
Karbi Anglong,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,16.0,16.0,11.0,22.0,13.0,28.0,19.0,13.0,25.0,16.0,8.0,26.0,213.0
Karbi Anglong,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.06,Number of IUCD removals,TOTAL,54.0,43.0,46.0,105.0,59.0,29.0,40.0,25.0,29.0,22.0,34.0,62.0,548.0
Karbi Anglong,9.07,Number of Oral Pills cycles distributed,TOTAL,3804.0,3367.0,4538.0,10629.0,4010.0,3954.0,4589.0,4037.0,4287.0,4233.0,4709.0,4244.0,56401.0
Karbi Anglong,9.08,Number of Condom pieces distributed,TOTAL,18262.0,19524.0,24337.0,49681.0,22260.0,22620.0,21855.0,22897.0,21829.0,21128.0,23019.0,24563.0,291975.0
Karbi Anglong,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,4.0,5.0,0.0,5.0,2.0,0.0,0.0,2.0,0.0,0.0,1.0,19.0
Karbi Anglong,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,14.0,17.0,13.0,32.0,4.0,13.0,14.0,25.0,15.0,31.0,19.0,32.0,229.0
Karbi Anglong,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Karbi Anglong,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Karbi Anglong,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1491.0,1368.0,1619.0,1549.0,1404.0,1326.0,1649.0,1909.0,1611.0,1821.0,1750.0,1630.0,19127.0
Karbi Anglong,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1528.0,1507.0,1613.0,1508.0,1429.0,1437.0,1686.0,1852.0,1696.0,1760.0,1112.0,309.0,17437.0
Karbi Anglong,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1612.0,1558.0,1655.0,1656.0,1563.0,1370.0,1530.0,1703.0,1746.0,1716.0,1534.0,1405.0,19048.0
Karbi Anglong,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1613.0,1534.0,1639.0,1634.0,1596.0,1477.0,1519.0,1632.0,1645.0,1571.0,1513.0,1584.0,18957.0
Karbi Anglong,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,446.0,1288.0,1734.0
Karbi Anglong,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,271.0,273.0
Karbi Anglong,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0,14.0
Karbi Anglong,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,574.0,533.0,549.0,600.0,562.0,678.0,622.0,737.0,676.0,544.0,626.0,615.0,7316.0
Karbi Anglong,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1525.0,1507.0,1611.0,1508.0,1422.0,1433.0,1686.0,1839.0,1709.0,1760.0,1360.0,1111.0,18471.0
Karbi Anglong,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1612.0,1558.0,1657.0,1656.0,1562.0,1359.0,1530.0,1695.0,1752.0,1716.0,1540.0,1559.0,19196.0
Karbi Anglong,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1613.0,1544.0,1639.0,1634.0,1596.0,1469.0,1519.0,1625.0,1651.0,1571.0,1508.0,1586.0,18955.0
Karbi Anglong,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,300.0,308.0,319.0,376.0,277.0,434.0,396.0,464.0,384.0,335.0,343.0,347.0,4283.0
Karbi Anglong,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1495.0,1488.0,1595.0,1514.0,1424.0,1436.0,1686.0,1850.0,1689.0,1755.0,1104.0,311.0,17347.0
Karbi Anglong,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1600.0,1531.0,1653.0,1653.0,1554.0,1375.0,1530.0,1702.0,1746.0,1716.0,1534.0,1392.0,18986.0
Karbi Anglong,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1583.0,1514.0,1617.0,1627.0,1586.0,1477.0,1519.0,1633.0,1650.0,1571.0,1515.0,1598.0,18890.0
Karbi Anglong,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1182.0,1419.0,1624.0,1517.0,1637.0,1593.0,1537.0,1624.0,1510.0,1450.0,1488.0,1562.0,18143.0
Karbi Anglong,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,965.0,963.0,1106.0,1085.0,1286.0,1119.0,1171.0,1118.0,1106.0,971.0,1159.0,1197.0,13246.0
Karbi Anglong,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,590.0,741.0,827.0,795.0,837.0,825.0,785.0,831.0,776.0,742.0,761.0,783.0,9293.0
Karbi Anglong,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,586.0,678.0,795.0,722.0,800.0,764.0,752.0,783.0,734.0,708.0,713.0,778.0,8813.0
Karbi Anglong,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1176.0,1419.0,1622.0,1517.0,1637.0,1589.0,1537.0,1614.0,1510.0,1450.0,1474.0,1561.0,18106.0
Karbi Anglong,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1044.0,1059.0,1237.0,1191.0,1399.0,1181.0,1138.0,1147.0,1170.0,1049.0,1239.0,1251.0,14105.0
Karbi Anglong,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1040.0,1057.0,1237.0,1191.0,1395.0,1180.0,1138.0,1144.0,1170.0,1049.0,1239.0,1251.0,14091.0
Karbi Anglong,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,32.0,33.0,48.0,59.0,41.0,47.0,45.0,66.0,64.0,47.0,68.0,67.0,617.0
Karbi Anglong,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,43.0,43.0,42.0,59.0,45.0,48.0,47.0,60.0,63.0,40.0,50.0,51.0,591.0
Karbi Anglong,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,75.0,76.0,90.0,118.0,86.0,95.0,92.0,126.0,127.0,87.0,118.0,118.0,1208.0
Karbi Anglong,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,460.0,496.0,524.0,638.0,778.0,637.0,510.0,537.0,581.0,545.0,624.0,598.0,6928.0
Karbi Anglong,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,472.0,539.0,582.0,632.0,622.0,601.0,589.0,537.0,508.0,529.0,551.0,585.0,6747.0
Karbi Anglong,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,478.0,534.0,571.0,545.0,611.0,585.0,536.0,499.0,477.0,452.0,495.0,540.0,6323.0
Karbi Anglong,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Karbi Anglong,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,5.0,12.0,8.0,11.0,10.0,3.0,4.0,3.0,5.0,61.0
Karbi Anglong,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1236.0,1081.0,1099.0,1289.0,1105.0,1095.0,1238.0,1096.0,1236.0,1078.0,1072.0,1084.0,13709.0
Karbi Anglong,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1147.0,1031.0,1074.0,1233.0,1067.0,1065.0,1141.0,1077.0,1169.0,1063.0,1039.0,1075.0,13181.0
Karbi Anglong,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1134.0,1012.0,1054.0,1219.0,1056.0,1055.0,1133.0,1059.0,1154.0,1045.0,1027.0,1047.0,12995.0
Karbi Anglong,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1175.0,1396.0,1608.0,1522.0,1581.0,1586.0,1528.0,1611.0,1501.0,1408.0,1391.0,1454.0,17761.0
Karbi Anglong,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,194.0,180.0,215.0,259.0,2282.0,939.0,219.0,242.0,217.0,209.0,386.0,725.0,6067.0
Karbi Anglong,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,282.0,309.0,324.0,389.0,2614.0,1272.0,345.0,393.0,394.0,329.0,485.0,803.0,7939.0
Karbi Anglong,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,14.0,6.0,3.0,0.0,9.0,5.0,3.0,8.0,1.0,8.0,12.0,7.0,76.0
Karbi Anglong,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,251.0,326.0,322.0,430.0,425.0,291.0,255.0,285.0,169.0,190.0,293.0,305.0,3542.0
Karbi Anglong,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,11.0,21.0,13.0,51.0,26.0,29.0,23.0,7.0,10.0,13.0,14.0,4.0,222.0
Karbi Anglong,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,159.0,159.0,109.0,173.0,131.0,253.0,83.0,83.0,85.0,55.0,74.0,139.0,1503.0
Karbi Anglong,13.1,Number of Patients operated for cataract,TOTAL,76.0,93.0,91.0,110.0,66.0,76.0,51.0,89.0,114.0,56.0,27.0,152.0,1001.0
Karbi Anglong,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,75.0,93.0,91.0,110.0,66.0,76.0,51.0,88.0,111.0,56.0,27.0,151.0,995.0
Karbi Anglong,13.3,Number of School children detected with Refractive errors,TOTAL,80.0,132.0,40.0,40.0,63.0,33.0,16.0,13.0,119.0,61.0,26.0,42.0,665.0
Karbi Anglong,13.4,Number of children provided free glasses,TOTAL,36.0,122.0,33.0,40.0,49.0,4.0,3.0,3.0,41.0,47.0,20.0,28.0,426.0
Karbi Anglong,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Karbi Anglong,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,11.0,11.0,12.0,11.0,13.0,13.0,13.0,14.0,14.0,14.0,14.0,14.0,-1.0
Karbi Anglong,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,972.0,881.0,901.0,1039.0,871.0,898.0,989.0,927.0,974.0,898.0,863.0,873.0,-1.0
Karbi Anglong,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,-1.0
Karbi Anglong,14.05,Number of RKS meetings held during the month,TOTAL,7.0,9.0,5.0,6.0,6.0,7.0,5.0,5.0,6.0,4.0,5.0,7.0,72.0
Karbi Anglong,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,21.0,21.0,23.0,22.0,21.0,23.0,22.0,27.0,27.0,25.0,27.0,28.0,-1.0
Karbi Anglong,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,234.0,231.0,251.0,195.0,252.0,255.0,288.0,206.0,189.0,241.0,173.0,260.0,2775.0
Karbi Anglong,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,,,,,,,,,,,,-1.0
Karbi Anglong,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,-1.0
Karbi Anglong,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,180.0,183.0,393.0,649.0,213.0,362.0,170.0,124.0,81.0,145.0,42.0,307.0,2849.0
Karbi Anglong,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,498.0,555.0,345.0,671.0,413.0,464.0,370.0,456.0,409.0,350.0,483.0,538.0,5552.0
Karbi Anglong,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,257.0,239.0,213.0,298.0,255.0,448.0,135.0,165.0,171.0,220.0,47.0,156.0,2604.0
Karbi Anglong,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1368.0,1236.0,1193.0,1560.0,1256.0,1064.0,1328.0,1414.0,1257.0,1122.0,1235.0,1726.0,15759.0
Karbi Anglong,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,437.0,422.0,606.0,947.0,468.0,810.0,305.0,289.0,252.0,365.0,89.0,463.0,5453.0
Karbi Anglong,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1866.0,1791.0,1538.0,2231.0,1669.0,1528.0,1698.0,1870.0,1666.0,1472.0,1718.0,2264.0,21311.0
Karbi Anglong,14.10.2.a,Number of death cases of Inpatient males,TOTAL,17.0,17.0,23.0,23.0,21.0,23.0,25.0,10.0,25.0,15.0,16.0,17.0,232.0
Karbi Anglong,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5.0,7.0,8.0,9.0,19.0,9.0,15.0,15.0,9.0,9.0,10.0,6.0,121.0
Karbi Anglong,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,22.0,24.0,31.0,32.0,40.0,32.0,40.0,25.0,34.0,24.0,26.0,23.0,353.0
Karbi Anglong,14.11,In-Patient Head Count at midnight,TOTAL,4366.0,550.0,5176.0,5222.0,3669.0,5400.0,5119.0,4265.0,3998.0,3550.0,3529.0,4881.0,49725.0
Karbi Anglong,14.12.1,OPD attendance (All),TOTAL,47319.0,45782.0,57309.0,62637.0,52799.0,52217.0,41923.0,39239.0,35009.0,32982.0,35975.0,48261.0,551452.0
Karbi Anglong,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,29.0,18.0,94.0,0.0,100.0,21.0,57.0,77.0,65.0,26.0,26.0,54.0,567.0
Karbi Anglong,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,1.0,1.0,3.0,0.0,3.0,1.0,2.0,2.0,2.0,2.0,1.0,2.0,20.0
Karbi Anglong,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,6.0,4.0,0.0,7.0,4.0,14.0,5.0,7.0,6.0,4.0,17.0,74.0
Karbi Anglong,14.14.a,Number of patients given AYUSH treatment,TOTAL,407.0,555.0,379.0,338.0,521.0,403.0,300.0,250.0,515.0,432.0,172.0,276.0,4548.0
Karbi Anglong,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,181.0,248.0,150.0,263.0,25.0,210.0,160.0,206.0,242.0,210.0,210.0,294.0,2399.0
Karbi Anglong,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,88.0,0.0,0.0,72.0,34.0,34.0,24.0,21.0,74.0,92.0,439.0
Karbi Anglong,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1826.0,2040.0,2113.0,2452.0,2180.0,2101.0,1770.0,1863.0,1811.0,1797.0,1820.0,1898.0,23671.0
Karbi Anglong,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,26.0,61.0,53.0,4.0,35.0,53.0,18.0,55.0,32.0,18.0,120.0,1.0,476.0
Karbi Anglong,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,133.0,170.0,181.0,3.0,5.0,141.0,126.0,77.0,0.0,54.0,136.0,92.0,1118.0
Karbi Anglong,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,6.0
Karbi Anglong,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,10.0,15.0,22.0,2.0,0.0,7.0,11.0,9.0,0.0,8.0,21.0,10.0,115.0
Karbi Anglong,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,5.0
Karbi Anglong,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,280.0,398.0,558.0,81.0,38.0,357.0,263.0,355.0,81.0,151.0,412.0,340.0,3314.0
Karbi Anglong,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,0.0,0.0,3.0,1.0,1.0,0.0,0.0,2.0,0.0,8.0
Karbi Anglong,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,423.0,583.0,761.0,86.0,43.0,505.0,400.0,441.0,81.0,213.0,569.0,442.0,4547.0
Karbi Anglong,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,0.0,8.0,0.0,0.0,3.0,1.0,1.0,0.0,0.0,3.0,2.0,19.0
Karbi Anglong,15.2,Number of Widal tests conducted,Number tested,34.0,50.0,66.0,89.0,88.0,41.0,32.0,16.0,16.0,13.0,15.0,35.0,495.0
Karbi Anglong,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,12.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0
Karbi Anglong,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,43.0,72.0,64.0,69.0,42.0,38.0,20.0,25.0,23.0,32.0,27.0,60.0,515.0
Karbi Anglong,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,55.0,72.0,64.0,69.0,51.0,38.0,20.0,25.0,23.0,32.0,27.0,60.0,536.0
Karbi Anglong,15.4.1,Number of blood smears examined for Malaria,TOTAL,5713.0,5139.0,5952.0,10535.0,7628.0,7266.0,4400.0,3531.0,2702.0,2199.0,2642.0,4378.0,62085.0
Karbi Anglong,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,24.0,22.0,37.0,71.0,94.0,73.0,30.0,21.0,48.0,6.0,23.0,24.0,473.0
Karbi Anglong,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,187.0,187.0,286.0,501.0,308.0,206.0,138.0,133.0,86.0,49.0,60.0,134.0,2275.0
Karbi Anglong,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,36700.0,35610.0,40570.0,31990.0,19910.0,24340.0,13990.0,23410.0,12570.0,23490.0,17440.0,15800.0,295820.0
Karbi Anglong,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,16000.0,0.0,0.0,10000.0,0.0,20000.0,0.0,15000.0,0.0,5000.0,0.0,66000.0
Karbi Anglong,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1090.0,11040.0,8580.0,12080.0,5570.0,10350.0,10580.0,10840.0,4080.0,6050.0,6640.0,2830.0,89730.0
Karbi Anglong,16.1.1,Stock position of DPT vaccines,5. Total Stock,35610.0,40570.0,31990.0,19910.0,24340.0,13990.0,23410.0,12570.0,23490.0,17440.0,15800.0,12970.0,272090.0
Karbi Anglong,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,0.0,12070.0,12070.0
Karbi Anglong,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,15000.0,0.0,15000.0
Karbi Anglong,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,2930.0,3810.0,6740.0
Karbi Anglong,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12070.0,8260.0,20330.0
Karbi Anglong,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1880.0,700.0,500.0,9740.0,80.0,11960.0,4300.0,9000.0,440.0,10440.0,140.0,2500.0,51680.0
Karbi Anglong,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,11000.0,23000.0,0.0,23000.0,3500.0,9000.0,1500.0,18000.0,160000.0,168000.0,0.0,417000.0
Karbi Anglong,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1180.0,11200.0,13760.0,9660.0,11120.0,11160.0,4300.0,10060.0,8000.0,170300.0,165640.0,2500.0,418880.0
Karbi Anglong,16.1.2,Stock position of OPV vaccines,5. Total Stock,700.0,500.0,9740.0,80.0,11960.0,4300.0,9000.0,440.0,10440.0,140.0,2500.0,0.0,49800.0
Karbi Anglong,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,16900.0,15310.0,18260.0,10970.0,15390.0,19300.0,17920.0,26340.0,15100.0,12220.0,5070.0,6840.0,179620.0
Karbi Anglong,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,15000.0,0.0,16000.0,9000.0,10000.0,20000.0,0.0,0.0,0.0,7500.0,0.0,77500.0
Karbi Anglong,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1590.0,12050.0,7290.0,11580.0,5090.0,11380.0,11580.0,11240.0,2880.0,7150.0,5730.0,3380.0,90940.0
Karbi Anglong,16.1.3,Stock position of TT vaccines,5. Total Stock,15310.0,18260.0,10970.0,15390.0,19300.0,17920.0,26340.0,15100.0,12220.0,5070.0,6840.0,3460.0,166180.0
Karbi Anglong,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Karbi Anglong,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Karbi Anglong,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Karbi Anglong,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4800.0,3800.0,6260.0,2370.0,4690.0,1340.0,6220.0,160.0,2950.0,19790.0,9980.0,17690.0,80050.0
Karbi Anglong,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,11500.0,0.0,11500.0,0.0,9000.0,0.0,7500.0,22500.0,0.0,15000.0,0.0,77000.0
Karbi Anglong,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1000.0,9040.0,3890.0,9180.0,3350.0,4120.0,6060.0,4710.0,5660.0,9810.0,7290.0,4510.0,68620.0
Karbi Anglong,16.1.5,Stock position of BCG vaccines,5. Total Stock,3800.0,6260.0,2370.0,4690.0,1340.0,6220.0,160.0,2950.0,19790.0,9980.0,17690.0,13180.0,88430.0
Karbi Anglong,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,11060.0,10265.0,8595.0,9360.0,13860.0,16335.0,11755.0,7500.0,6655.0,8740.0,3110.0,4525.0,111760.0
Karbi Anglong,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,5000.0,5000.0,10000.0,5000.0,0.0,5000.0,5000.0,5000.0,0.0,5000.0,0.0,45000.0
Karbi Anglong,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,4020.0,,,,,,4020.0
Karbi Anglong,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,795.0,6670.0,4235.0,5500.0,2525.0,4580.0,5235.0,5845.0,2915.0,5630.0,3585.0,2165.0,49680.0
Karbi Anglong,16.1.6,Stock position of Measles vaccines,5. Total Stock,10265.0,8595.0,9360.0,13860.0,16335.0,11755.0,7500.0,6655.0,8740.0,3110.0,4525.0,2360.0,103060.0
Karbi Anglong,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Karbi Anglong,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Karbi Anglong,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Karbi Anglong,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,400.0,100.0,4700.0,1070.0,2970.0,9010.0,20350.0,15050.0,14340.0,25760.0,16330.0,17010.0,127090.0
Karbi Anglong,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,11500.0,0.0,11500.0,11400.0,20000.0,5000.0,10000.0,15000.0,0.0,5000.0,0.0,89400.0
Karbi Anglong,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,300.0,6900.0,3630.0,9600.0,5360.0,8660.0,10300.0,10710.0,3580.0,9430.0,4320.0,2370.0,75160.0
Karbi Anglong,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,100.0,4700.0,1070.0,2970.0,9010.0,20350.0,15050.0,14340.0,25760.0,16330.0,17010.0,14640.0,141330.0
Karbi Anglong,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,150.0,80.0,30.0,1180.0,320.0,320.0,320.0,270.0,270.0,229.0,229.0,229.0,3627.0
Karbi Anglong,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,,2400.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3600.0
Karbi Anglong,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,70.0,50.0,1250.0,2060.0,0.0,0.0,50.0,0.0,41.0,0.0,0.0,50.0,3571.0
Karbi Anglong,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,80.0,30.0,1180.0,320.0,320.0,320.0,270.0,270.0,229.0,229.0,229.0,179.0,3656.0
Karbi Anglong,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,20680.0,20680.0,0.0,0.0,10080.0,10080.0,10080.0,45360.0,40320.0,30240.0,5040.0,5040.0,197600.0
Karbi Anglong,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,30240.0,0.0,0.0,35280.0,0.0,0.0,0.0,0.0,0.0,65520.0
Karbi Anglong,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,10600.0,,,,,,,,,,,10600.0
Karbi Anglong,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,10080.0,0.0,20160.0,0.0,0.0,0.0,5040.0,10080.0,25200.0,0.0,0.0,70560.0
Karbi Anglong,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,20680.0,0.0,0.0,10080.0,10080.0,10080.0,45360.0,40320.0,30240.0,5040.0,5040.0,5040.0,181960.0
Karbi Anglong,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,148800.0,148800.0,145200.0,137200.0,117400.0,117400.0,101800.0,103600.0,88600.0,88600.0,71800.0,71800.0,1341000.0
Karbi Anglong,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,30800.0,0.0,,4800.0,0.0,0.0,,0.0,0.0,35600.0
Karbi Anglong,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,3600.0,8000.0,50600.0,0.0,15600.0,3000.0,15000.0,0.0,16800.0,0.0,0.0,112600.0
Karbi Anglong,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,148800.0,145200.0,137200.0,117400.0,117400.0,101800.0,103600.0,88600.0,88600.0,71800.0,71800.0,71800.0,1264000.0
Karbi Anglong,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,5800.0,5800.0,5800.0,4800.0,11700.0,11700.0,6900.0,11100.0,8400.0,8400.0,8400.0,8400.0,97200.0
Karbi Anglong,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,13500.0,0.0,,6000.0,0.0,0.0,,0.0,0.0,19500.0
Karbi Anglong,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,1000.0,6600.0,0.0,4800.0,1800.0,2700.0,0.0,0.0,0.0,600.0,17500.0
Karbi Anglong,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,5800.0,5800.0,4800.0,11700.0,11700.0,6900.0,11100.0,8400.0,8400.0,8400.0,8400.0,7800.0,99200.0
Karbi Anglong,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,12000.0
Karbi Anglong,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,0.0,0.0,0.0,,0.0,0.0,0.0
Karbi Anglong,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,12000.0
Karbi Anglong,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Karbi Anglong,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Karbi Anglong,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Karbi Anglong,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Karbi Anglong,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Karbi Anglong,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Karbi Anglong,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Karbi Anglong,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Karbi Anglong,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Karbi Anglong,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Karbi Anglong,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Karbi Anglong,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Karbi Anglong,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Karbi Anglong,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Karbi Anglong,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Karbi Anglong,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Karbi Anglong,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Karbi Anglong,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Karbi Anglong,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Karbi Anglong,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Karbi Anglong,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Karbi Anglong,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Karbi Anglong,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Karbi Anglong,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Karbi Anglong,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Karbi Anglong,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Karbi Anglong,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Karbi Anglong,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Karbi Anglong,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Karbi Anglong,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Karbi Anglong,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Karbi Anglong,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Karbi Anglong,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Karbi Anglong,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karbi Anglong,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,720.0,320.0,0.0,1120.0,20.0,4500.0,1850.0,50.0,4600.0,2080.0,80.0,335.0,15675.0
Karbi Anglong,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,3300.0,0.0,6600.0,0.0,0.0,6600.0,0.0,0.0,2000.0,0.0,18500.0
Karbi Anglong,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,400.0,320.0,2180.0,1100.0,2120.0,2650.0,1800.0,2050.0,2520.0,2000.0,1745.0,335.0,19220.0
Karbi Anglong,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,320.0,0.0,1120.0,20.0,4500.0,1850.0,50.0,4600.0,2080.0,80.0,335.0,0.0,14955.0
Karbi Anglong,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,33900.0,30100.0,44500.0,55300.0,29100.0,45900.0,57300.0,69100.0,90500.0,100100.0,47100.0,61500.0,664400.0
Karbi Anglong,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,24000.0,33600.0,24000.0,24000.0,33600.0,24000.0,48000.0,38400.0,0.0,21600.0,312000.0,583200.0
Karbi Anglong,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,3800.0,9600.0,22800.0,50200.0,7200.0,22200.0,12200.0,26600.0,28800.0,53000.0,7200.0,302800.0,546400.0
Karbi Anglong,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,30100.0,44500.0,55300.0,29100.0,45900.0,57300.0,69100.0,90500.0,100100.0,47100.0,61500.0,70700.0,701200.0
Karbi Anglong,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4150.0,3750.0,3230.0,4530.0,4630.0,7230.0,6430.0,5730.0,8030.0,9430.0,6330.0,7130.0,70600.0
Karbi Anglong,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4000.0,4000.0,4000.0,4000.0,2000.0,2000.0,4000.0,4000.0,0.0,2000.0,46000.0,76000.0
Karbi Anglong,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Karbi Anglong,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,400.0,4520.0,2700.0,3900.0,1400.0,2800.0,2700.0,1700.0,2600.0,3100.0,1200.0,40500.0,67520.0
Karbi Anglong,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3750.0,3230.0,4530.0,4630.0,7230.0,6430.0,5730.0,8030.0,9430.0,6330.0,7130.0,12630.0,79080.0
Karbi Anglong,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,2.0,,,,,,,2.0,5.0
Karbi Anglong,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Karbi Anglong,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Karbi Anglong,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Karbi Anglong,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,1.0,1.0,,,,,1.0,,3.0
Karbi Anglong,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Karbi Anglong,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,1.0,1.0,,,,,1.0,,3.0
Karbi Anglong,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,,,2.0,,,,1.0,,,,4.0
Karbi Anglong,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Karbi Anglong,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,,,2.0,,,,1.0,,,,4.0
Karbi Anglong,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,,3.0,,2.0,1.0,1.0,2.0,,3.0,2.0,16.0
Karbi Anglong,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Karbi Anglong,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,1.0,,3.0,,2.0,1.0,1.0,2.0,,3.0,2.0,16.0
Karbi Anglong,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,1.0,,,,1.0,3.0,2.0,,,,8.0
Karbi Anglong,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,3.0,1.0,3.0,,,,,,,7.0
Karbi Anglong,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,1.0,3.0,1.0,3.0,1.0,3.0,2.0,,,,15.0
Karbi Anglong,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Karbi Anglong,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Karbi Anglong,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Karbi Anglong,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,2.0,,,1.0,,,,,1.0,4.0
Karbi Anglong,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Karbi Anglong,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,2.0,,,1.0,,,,,2.0,5.0
Karbi Anglong,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Karbi Anglong,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Karbi Anglong,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Karbi Anglong,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,6.0,1.0,,1.0,2.0,,6.0,2.0,2.0,4.0,2.0,2.0,28.0
Karbi Anglong,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,3.0,,2.0,1.0,3.0,2.0,,,,,11.0
Karbi Anglong,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,1.0,3.0,1.0,4.0,1.0,9.0,4.0,2.0,4.0,2.0,2.0,39.0
Karbi Anglong,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,1.0,1.0,,,,,,,,,2.0
Karbi Anglong,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Karbi Anglong,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,,,,,,,1.0,,,,2.0
Karbi Anglong,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,1.0,1.0,1.0,,,,1.0,,,,5.0
Karbi Anglong,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Karbi Anglong,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,3.0,3.0,4.0,3.0,4.0,1.0,1.0,2.0,2.0,,24.0
Karbi Anglong,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,1.0,,2.0,2.0,,1.0,,,,6.0
Karbi Anglong,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,3.0,4.0,4.0,5.0,6.0,1.0,2.0,2.0,2.0,,30.0
Karbi Anglong,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Karbi Anglong,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,,1.0,,,,4.0,,,1.0,7.0
Karbi Anglong,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,,,,,1.0,2.0,1.0,,,5.0
Karbi Anglong,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,1.0,,1.0,1.0,,1.0,6.0,1.0,,1.0,13.0
Karbi Anglong,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,1.0,,2.0,,,,,,3.0
Karbi Anglong,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,1.0,,,2.0,,2.0,1.0,,,,1.0,7.0
Karbi Anglong,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Karbi Anglong,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,,,3.0,,5.0,1.0,,,,1.0,11.0
Karbi Anglong,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,,2.0,,,,,1.0,,,4.0
Karbi Anglong,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,4.0,4.0,2.0,3.0,1.0,,2.0,2.0,3.0,2.0,,24.0
Karbi Anglong,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,1.0,,,,,,,,1.0,2.0,,5.0
Karbi Anglong,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,6.0,4.0,2.0,5.0,1.0,,2.0,2.0,5.0,4.0,,33.0
Karbi Anglong,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Karbi Anglong,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Karbi Anglong,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Karbi Anglong,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Karbi Anglong,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Karbi Anglong,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,3.0,2.0,6.0,6.0,4.0,2.0,5.0,2.0,4.0,3.0,7.0,45.0
Karbi Anglong,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,2.0,2.0,1.0,4.0,19.0
Karbi Anglong,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,4.0,3.0,7.0,7.0,6.0,5.0,6.0,4.0,6.0,4.0,11.0,65.0
Karbi Anglong,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Karbi Anglong,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,,,2.0,,2.0,,1.0,,1.0,,,8.0
Karbi Anglong,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,1.0,1.0,2.0,4.0
Karbi Anglong,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,,,2.0,,2.0,,1.0,,2.0,1.0,2.0,12.0
Karbi Anglong,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Karbi Anglong,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Karbi Anglong,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Karbi Anglong,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Karbi Anglong,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Karbi Anglong,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Karbi Anglong,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Karbi Anglong,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Karbi Anglong,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Karbi Anglong,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Karbi Anglong,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Karbi Anglong,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Karbi Anglong,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Karbi Anglong,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,2.0,,,,,,,,,1.0,1.0,1.0,5.0
Karbi Anglong,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Karbi Anglong,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,2.0,,,,,,,,,1.0,1.0,1.0,5.0
Karbi Anglong,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Karbi Anglong,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,1.0,,2.0,,,,2.0,,,5.0
Karbi Anglong,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Karbi Anglong,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,1.0,,2.0,,,,2.0,,,5.0
Karbi Anglong,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Karbi Anglong,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,3.0,1.0,2.0,1.0,1.0,1.0,2.0,,1.0,,,13.0
Karbi Anglong,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Karbi Anglong,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,3.0,1.0,2.0,1.0,1.0,1.0,2.0,,1.0,,,13.0
Karbi Anglong,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Karbi Anglong,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,1.0,3.0,3.0,,,3.0,2.0,2.0,,3.0,2.0,20.0
Karbi Anglong,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,1.0,,,,,,,,,1.0,2.0
Karbi Anglong,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,1.0,4.0,4.0,,,3.0,2.0,2.0,,3.0,3.0,23.0
Karbi Anglong,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Karbi Anglong,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,1.0,,,,,,2.0,1.0,,,2.0,6.0
Karbi Anglong,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,1.0,,,,1.0,2.0
Karbi Anglong,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,,,,1.0,,3.0,1.0,,,3.0,9.0
Karbi Anglong,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Karbi Anglong,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Karbi Anglong,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Karbi Anglong,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,,,,,,,,,,,1.0
Karbi Anglong,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Karbi Anglong,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,1.0,,,2.0,,5.0,1.0,,,1.0,1.0,13.0
Karbi Anglong,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Karbi Anglong,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,1.0,,1.0,2.0,1.0,5.0,1.0,,,1.0,1.0,15.0
Karbi Anglong,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Karbi Anglong,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,1.0,2.0,,1.0,,4.0,3.0,1.0,3.0,4.0,,21.0
Karbi Anglong,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,,4.0,1.0,1.0,3.0,3.0,2.0,1.0,2.0,2.0,1.0,21.0
Karbi Anglong,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,2.0,6.0,1.0,2.0,3.0,7.0,5.0,2.0,5.0,6.0,1.0,43.0
Karbi Anglong,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,1.0,2.0,1.0,2.0,,1.0,1.0,,,,,10.0
Karbi Anglong,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,7.0,9.0,4.0,10.0,10.0,5.0,6.0,5.0,8.0,5.0,5.0,6.0,80.0
Karbi Anglong,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,7.0,12.0,14.0,9.0,7.0,10.0,4.0,10.0,9.0,19.0,8.0,15.0,124.0
Karbi Anglong,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,16.0,22.0,20.0,20.0,19.0,15.0,11.0,16.0,17.0,24.0,13.0,21.0,214.0
Karimganj,1.1,Total number of pregnant women Registered for ANC,TOTAL,3375.0,3500.0,3277.0,2840.0,3663.0,3212.0,2828.0,2650.0,2630.0,2727.0,2499.0,2636.0,35837.0
Karimganj,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2782.0,2788.0,2714.0,2285.0,2884.0,2522.0,2149.0,1939.0,2000.0,2131.0,2057.0,2144.0,28395.0
Karimganj,1.2,Number of Pregnant women registered under JSY,TOTAL,3268.0,3406.0,3156.0,2684.0,3521.0,3120.0,2721.0,2553.0,2519.0,2597.0,2368.0,2460.0,34373.0
Karimganj,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2016.0,1986.0,2249.0,2183.0,2612.0,2719.0,2787.0,2525.0,2673.0,2503.0,2013.0,2167.0,28433.0
Karimganj,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1921.0,2158.0,2222.0,2009.0,2497.0,2475.0,2271.0,2221.0,2101.0,1805.0,1626.0,1976.0,25282.0
Karimganj,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2407.0,2384.0,2627.0,2339.0,2968.0,3079.0,2981.0,2763.0,2926.0,2645.0,2099.0,2395.0,31613.0
Karimganj,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3108.0,3103.0,3164.0,2767.0,3530.0,3662.0,2608.0,2333.0,2405.0,2339.0,1994.0,2350.0,33363.0
Karimganj,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,49.0,63.0,35.0,26.0,34.0,28.0,36.0,46.0,49.0,37.0,73.0,28.0,504.0
Karimganj,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,1.0,4.0,3.0,4.0,1.0,1.0,2.0,2.0,5.0,8.0,0.0,34.0
Karimganj,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1393.0,1314.0,1867.0,1458.0,1608.0,1749.0,1489.0,1509.0,1601.0,1835.0,1358.0,1471.0,18652.0
Karimganj,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,3.0,2.0,0.0,0.0,3.0,0.0,2.0,5.0,0.0,3.0,3.0,22.0
Karimganj,1.8,Number of pregnancy test kits used at SC level,TOTAL,489.0,910.0,1144.0,1047.0,664.0,504.0,414.0,321.0,263.0,355.0,308.0,285.0,6704.0
Karimganj,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,117.0,95.0,73.0,122.0,97.0,136.0,159.0,116.0,91.0,68.0,73.0,60.0,1207.0
Karimganj,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,762.0,814.0,616.0,634.0,721.0,686.0,881.0,1046.0,990.0,957.0,861.0,882.0,9850.0
Karimganj,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,879.0,909.0,689.0,756.0,818.0,822.0,1040.0,1162.0,1081.0,1025.0,934.0,942.0,11057.0
Karimganj,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,653.0,678.0,504.0,605.0,632.0,610.0,806.0,909.0,895.0,746.0,772.0,784.0,8594.0
Karimganj,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,4.0,5.0,10.0,0.0,0.0,0.0,0.0,13.0,0.0,0.0,0.0,32.0
Karimganj,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1175.0,1154.0,996.0,1067.0,1069.0,1132.0,1035.0,1188.0,1422.0,1427.0,1152.0,1240.0,14057.0
Karimganj,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,488.0,432.0,415.0,390.0,364.0,373.0,372.0,540.0,576.0,580.0,596.0,606.0,5732.0
Karimganj,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,936.0,1147.0,866.0,904.0,1015.0,1040.0,858.0,1298.0,1092.0,1193.0,949.0,1086.0,12384.0
Karimganj,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,319.0,607.0,319.0,541.0,727.0,684.0,779.0,670.0,664.0,768.0,994.0,1428.0,8500.0
Karimganj,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,232.0,237.0,235.0,234.0,248.0,248.0,312.0,317.0,336.0,310.0,283.0,306.0,3298.0
Karimganj,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,172.0,173.0,174.0,164.0,164.0,151.0,212.0,244.0,248.0,225.0,200.0,197.0,2324.0
Karimganj,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,24.0,37.0,19.0,24.0,19.0,22.0,11.0,9.0,37.0,17.0,22.0,9.0,250.0
Karimganj,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karimganj,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,24.0,37.0,19.0,24.0,19.0,22.0,11.0,9.0,37.0,17.0,22.0,9.0,250.0
Karimganj,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,82.0,103.0,111.0,104.0,129.0,137.0,131.0,148.0,162.0,140.0,132.0,127.0,1506.0
Karimganj,4.1.1.a,Number of male live births,TOTAL,1173.0,1148.0,1024.0,1073.0,1115.0,1138.0,1201.0,1344.0,1455.0,1420.0,1213.0,1326.0,14630.0
Karimganj,4.1.1.b,Number of female live births,TOTAL,1075.0,1089.0,860.0,944.0,981.0,1002.0,1136.0,1291.0,1336.0,1294.0,1121.0,1107.0,13236.0
Karimganj,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2248.0,2237.0,1884.0,2017.0,2096.0,2140.0,2337.0,2635.0,2791.0,2714.0,2334.0,2433.0,27866.0
Karimganj,4.1.2,Number of still births,TOTAL,68.0,62.0,51.0,60.0,73.0,62.0,68.0,73.0,104.0,83.0,55.0,54.0,813.0
Karimganj,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,225.0,243.0,235.0,240.0,162.0,167.0,142.0,145.0,136.0,116.0,175.0,104.0,2090.0
Karimganj,4.2.1,Number of Newborns weighed at birth,TOTAL,2252.0,2235.0,1876.0,2020.0,2089.0,2146.0,2332.0,2636.0,2771.0,2701.0,2329.0,2432.0,27819.0
Karimganj,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,211.0,261.0,256.0,182.0,259.0,258.0,209.0,285.0,247.0,255.0,212.0,187.0,2822.0
Karimganj,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2176.0,2147.0,1788.0,1911.0,2068.0,2026.0,2240.0,2532.0,2668.0,2556.0,2188.0,2343.0,26643.0
Karimganj,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,132.0,106.0,81.0,89.0,95.0,41.0,55.0,42.0,41.0,43.0,70.0,48.0,843.0
Karimganj,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,20.0,16.0,19.0,15.0,0.0,0.0,0.0,0.0,47.0,32.0,24.0,31.0,204.0
Karimganj,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,8.0,9.0,9.0,9.0,6.0,5.0,5.0,6.0,8.0,5.0,5.0,,75.0
Karimganj,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karimganj,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,160.0,131.0,109.0,113.0,101.0,46.0,60.0,48.0,96.0,80.0,99.0,79.0,1122.0
Karimganj,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,35.0,36.0,21.0,1.0,5.0,15.0,41.0,35.0,5.0,43.0,7.0,18.0,262.0
Karimganj,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1067.0,1092.0,873.0,856.0,892.0,902.0,1048.0,965.0,630.0,1149.0,812.0,865.0,11151.0
Karimganj,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,105.0,206.0,205.0,403.0,202.0,11.0,33.0,38.0,214.0,208.0,212.0,257.0,2094.0
Karimganj,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,301.0,330.0,350.0,599.0,215.0,194.0,379.0,352.0,395.0,572.0,263.0,702.0,4652.0
Karimganj,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,26.0,18.0,9.0,10.0,10.0,15.0,6.0,21.0,15.0,5.0,10.0,11.0,156.0
Karimganj,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1410.0,1486.0,1219.0,1327.0,1317.0,1462.0,1554.0,1725.0,1876.0,1816.0,1446.0,1359.0,17997.0
Karimganj,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1311.0,1247.0,1066.0,1012.0,1172.0,1243.0,1382.0,1477.0,1463.0,1413.0,1341.0,1271.0,15398.0
Karimganj,6.3,PNC maternal complications attended,TOTAL,2.0,2.0,2.0,3.0,1.0,1.0,2.0,3.0,6.0,7.0,4.0,0.0,33.0
Karimganj,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,83.0,89.0,84.0,77.0,43.0,52.0,43.0,57.0,60.0,55.0,36.0,0.0,679.0
Karimganj,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,83.0,89.0,84.0,77.0,43.0,52.0,43.0,57.0,60.0,55.0,36.0,0.0,679.0
Karimganj,7.2,Number of MTPs conducted at Private Facilities,TOTAL,28.0,26.0,23.0,21.0,17.0,12.0,17.0,22.0,22.0,23.0,27.0,31.0,269.0
Karimganj,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,181.0,192.0,171.0,187.0,73.0,67.0,67.0,73.0,77.0,83.0,74.0,0.0,1245.0
Karimganj,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,159.0,166.0,145.0,158.0,100.0,92.0,89.0,91.0,89.0,91.0,82.0,0.0,1262.0
Karimganj,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,340.0,358.0,316.0,345.0,173.0,159.0,156.0,164.0,166.0,174.0,156.0,0.0,2507.0
Karimganj,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,5.0,0.0,0.0,0.0,9.0
Karimganj,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Karimganj,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karimganj,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,5.0,1.0,0.0,0.0,10.0
Karimganj,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,120.0,91.0,37.0,74.0,20.0,19.0,6.0,65.0,39.0,58.0,104.0,633.0
Karimganj,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,34.0,0.0,0.0,30.0,5.0,0.0,0.0,23.0,0.0,0.0,37.0,129.0
Karimganj,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,2.0,4.0,12.0,7.0,7.0,11.0,4.0,2.0,0.0,0.0,0.0,0.0,49.0
Karimganj,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karimganj,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,2.0,158.0,103.0,44.0,111.0,36.0,23.0,8.0,88.0,39.0,58.0,141.0,811.0
Karimganj,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Karimganj,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karimganj,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Karimganj,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,16.0,19.0,24.0,15.0,20.0,23.0,29.0,12.0,7.0,8.0,11.0,10.0,194.0
Karimganj,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,1.0,3.0,1.0,4.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,11.0
Karimganj,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karimganj,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,1.0,3.0,1.0,4.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,11.0
Karimganj,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,16.0,19.0,24.0,22.0,20.0,23.0,29.0,12.0,7.0,8.0,11.0,10.0,201.0
Karimganj,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,80.0,85.0,56.0,408.0,184.0,107.0,132.0,122.0,220.0,106.0,112.0,65.0,1677.0
Karimganj,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,16.0,13.0,17.0,52.0,31.0,11.0,18.0,68.0,14.0,13.0,9.0,9.0,271.0
Karimganj,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,4.0,2.0,0.0,3.0,10.0,0.0,0.0,0.0,0.0,43.0,0.0,1.0,63.0
Karimganj,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,1.0,4.0,5.0,5.0,1.0,2.0,2.0,2.0,5.0,1.0,3.0,,31.0
Karimganj,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Karimganj,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,101.0,104.0,78.0,468.0,226.0,120.0,152.0,192.0,239.0,163.0,124.0,75.0,2042.0
Karimganj,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,8.0,11.0,12.0,4.0,10.0,7.0,55.0
Karimganj,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,2.0,3.0,2.0,3.0,1.0,0.0,3.0,3.0,0.0,4.0,2.0,7.0,30.0
Karimganj,9.06,Number of IUCD removals,TOTAL,37.0,34.0,85.0,67.0,45.0,42.0,64.0,23.0,39.0,14.0,16.0,18.0,484.0
Karimganj,9.07,Number of Oral Pills cycles distributed,TOTAL,3553.0,3857.0,4104.0,5328.0,4439.0,4353.0,4998.0,4314.0,4675.0,4313.0,4469.0,4605.0,53008.0
Karimganj,9.08,Number of Condom pieces distributed,TOTAL,16778.0,16753.0,13218.0,17918.0,13434.0,10675.0,8483.0,8356.0,6952.0,4706.0,5722.0,6045.0,129040.0
Karimganj,9.09,Number of Centchroman (weekly) pills given,TOTAL,23.0,31.0,29.0,188.0,18.0,20.0,18.0,20.0,2.0,0.0,21.0,21.0,391.0
Karimganj,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,24.0,32.0,35.0,114.0,64.0,99.0,106.0,113.0,103.0,81.0,62.0,102.0,935.0
Karimganj,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0
Karimganj,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Karimganj,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,,-1.0
Karimganj,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2820.0,1585.0,1542.0,2267.0,2396.0,2188.0,2648.0,1937.0,2779.0,2679.0,2314.0,2540.0,27695.0
Karimganj,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2386.0,2469.0,2360.0,2185.0,2204.0,2163.0,2181.0,2091.0,2358.0,2489.0,1477.0,365.0,24728.0
Karimganj,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2248.0,2357.0,2289.0,2236.0,2151.0,2256.0,2108.0,2028.0,4051.0,2286.0,2194.0,3179.0,29383.0
Karimganj,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2193.0,2144.0,2264.0,2159.0,2261.0,2243.0,2139.0,1974.0,2419.0,2132.0,2039.0,2383.0,26350.0
Karimganj,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,421.0,1325.0,1746.0
Karimganj,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0,258.0,281.0
Karimganj,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Karimganj,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,779.0,226.0,503.0,705.0,287.0,285.0,724.0,837.0,812.0,755.0,786.0,939.0,7638.0
Karimganj,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1840.0,242.0,2602.0,2707.0,359.0,697.0,3486.0,2625.0,1955.0,2687.0,2334.0,2584.0,24118.0
Karimganj,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1721.0,262.0,2142.0,2679.0,363.0,738.0,2710.0,3055.0,2168.0,2447.0,2685.0,2981.0,23951.0
Karimganj,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1591.0,238.0,2004.0,2353.0,348.0,723.0,2526.0,2693.0,2273.0,2460.0,2357.0,3357.0,22923.0
Karimganj,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,489.0,306.0,393.0,516.0,298.0,246.0,549.0,581.0,623.0,600.0,508.0,623.0,5732.0
Karimganj,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,3429.0,2120.0,2168.0,1970.0,1431.0,786.0,2830.0,2328.0,2462.0,2320.0,1489.0,682.0,24015.0
Karimganj,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2332.0,2211.0,2301.0,2344.0,1353.0,769.0,2429.0,2620.0,2830.0,2563.0,2232.0,2123.0,26107.0
Karimganj,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2084.0,1733.0,2064.0,2134.0,1442.0,933.0,2442.0,2275.0,2729.0,2504.0,2244.0,2608.0,25192.0
Karimganj,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1599.0,1888.0,1804.0,1966.0,2233.0,2460.0,2162.0,1875.0,2369.0,2188.0,1960.0,2561.0,25065.0
Karimganj,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1479.0,1526.0,1627.0,1632.0,1553.0,1679.0,1495.0,1243.0,1575.0,1432.0,1455.0,1626.0,18322.0
Karimganj,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,808.0,922.0,816.0,1003.0,1043.0,1126.0,1113.0,907.0,1117.0,1090.0,977.0,1339.0,12261.0
Karimganj,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,688.0,824.0,835.0,881.0,984.0,1115.0,998.0,841.0,1049.0,1006.0,950.0,1201.0,11372.0
Karimganj,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1496.0,1746.0,1651.0,1884.0,2027.0,2241.0,2111.0,1748.0,2166.0,2096.0,1927.0,2540.0,23633.0
Karimganj,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1584.0,1717.0,1839.0,1747.0,1711.0,1786.0,1625.0,1397.0,1609.0,1511.0,1527.0,1795.0,19848.0
Karimganj,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1288.0,236.0,1884.0,1852.0,289.0,617.0,1911.0,1498.0,1274.0,1561.0,1674.0,1917.0,16001.0
Karimganj,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,6.0,12.0,9.0,3.0,4.0,6.0,5.0,0.0,7.0,5.0,57.0
Karimganj,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,270.0,166.0,320.0,254.0,205.0,206.0,267.0,260.0,258.0,276.0,320.0,301.0,3103.0
Karimganj,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,268.0,148.0,302.0,293.0,175.0,210.0,252.0,231.0,240.0,258.0,308.0,335.0,3020.0
Karimganj,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,538.0,314.0,622.0,547.0,380.0,416.0,519.0,491.0,498.0,534.0,628.0,636.0,6123.0
Karimganj,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,676.0,785.0,813.0,777.0,836.0,797.0,697.0,705.0,796.0,764.0,832.0,824.0,9302.0
Karimganj,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1125.0,1121.0,1073.0,1017.0,953.0,1008.0,1052.0,1017.0,1084.0,1035.0,976.0,1075.0,12536.0
Karimganj,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,833.0,909.0,854.0,795.0,707.0,876.0,830.0,934.0,876.0,799.0,796.0,875.0,10084.0
Karimganj,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1192.0,1176.0,1170.0,1159.0,1192.0,1200.0,1214.0,1180.0,1193.0,1205.0,1157.0,1169.0,14207.0
Karimganj,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1141.0,1131.0,1139.0,1104.0,1108.0,1146.0,1126.0,1124.0,1150.0,1121.0,1049.0,1115.0,13454.0
Karimganj,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1060.0,1069.0,1078.0,1031.0,1050.0,1068.0,1074.0,864.0,1075.0,1049.0,970.0,1038.0,12426.0
Karimganj,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1597.0,1824.0,1748.0,1949.0,2346.0,2486.0,2176.0,1800.0,2354.0,2147.0,1911.0,2637.0,24975.0
Karimganj,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,494.0,550.0,591.0,570.0,3570.0,2151.0,630.0,607.0,662.0,580.0,663.0,660.0,11728.0
Karimganj,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,276.0,378.0,393.0,369.0,4836.0,1586.0,397.0,377.0,411.0,424.0,451.0,474.0,10372.0
Karimganj,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,8.0,15.0,11.0,11.0,11.0,47.0,9.0,6.0,12.0,20.0,13.0,29.0,192.0
Karimganj,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1099.0,1040.0,917.0,1078.0,902.0,910.0,781.0,871.0,783.0,823.0,933.0,738.0,10875.0
Karimganj,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,1.0,5.0
Karimganj,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,141.0,161.0,161.0,126.0,129.0,66.0,118.0,123.0,129.0,120.0,119.0,118.0,1511.0
Karimganj,13.1,Number of Patients operated for cataract,TOTAL,62.0,122.0,140.0,78.0,127.0,141.0,96.0,160.0,156.0,96.0,97.0,15.0,1290.0
Karimganj,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,58.0,110.0,136.0,78.0,127.0,140.0,91.0,155.0,150.0,92.0,91.0,0.0,1228.0
Karimganj,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,1.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Karimganj,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,-1.0
Karimganj,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,11.0,11.0,11.0,9.0,9.0,9.0,9.0,10.0,9.0,7.0,8.0,8.0,-1.0
Karimganj,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1051.0,1019.0,1024.0,1016.0,999.0,1003.0,999.0,1040.0,1013.0,994.0,926.0,981.0,-1.0
Karimganj,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,1.0,2.0,2.0,2.0,2.0,1.0,-1.0
Karimganj,14.05,Number of RKS meetings held during the month,TOTAL,9.0,8.0,7.0,5.0,8.0,8.0,8.0,5.0,4.0,7.0,5.0,7.0,81.0
Karimganj,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,21.0,21.0,20.0,17.0,17.0,19.0,18.0,18.0,18.0,16.0,18.0,17.0,-1.0
Karimganj,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,315.0,246.0,219.0,239.0,244.0,294.0,319.0,323.0,320.0,258.0,171.0,106.0,3054.0
Karimganj,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,-1.0
Karimganj,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Karimganj,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,336.0,264.0,265.0,271.0,255.0,254.0,268.0,308.0,313.0,298.0,280.0,83.0,3195.0
Karimganj,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,606.0,502.0,518.0,547.0,543.0,680.0,501.0,517.0,584.0,599.0,490.0,249.0,6336.0
Karimganj,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,388.0,356.0,386.0,360.0,358.0,365.0,353.0,355.0,408.0,369.0,324.0,294.0,4316.0
Karimganj,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1917.0,1788.0,1796.0,1526.0,1560.0,1404.0,1549.0,1649.0,1664.0,1704.0,1518.0,810.0,18885.0
Karimganj,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,724.0,620.0,651.0,631.0,613.0,619.0,621.0,663.0,721.0,667.0,604.0,377.0,7511.0
Karimganj,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2523.0,2290.0,2314.0,2073.0,2103.0,2084.0,2050.0,2166.0,2248.0,2303.0,2008.0,1059.0,25221.0
Karimganj,14.10.2.a,Number of death cases of Inpatient males,TOTAL,28.0,17.0,26.0,21.0,26.0,37.0,34.0,33.0,43.0,40.0,23.0,3.0,331.0
Karimganj,14.10.2.b,Number of death cases of Inpatient females,TOTAL,17.0,15.0,13.0,29.0,12.0,15.0,22.0,22.0,25.0,28.0,27.0,5.0,230.0
Karimganj,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,45.0,32.0,39.0,50.0,38.0,52.0,56.0,55.0,68.0,68.0,50.0,8.0,561.0
Karimganj,14.11,In-Patient Head Count at midnight,TOTAL,3092.0,281.0,264.0,257.0,2006.0,1844.0,2050.0,1922.0,265.0,2502.0,1771.0,1678.0,17932.0
Karimganj,14.12.1,OPD attendance (All),TOTAL,69907.0,65779.0,67250.0,64646.0,63563.0,63616.0,51319.0,54665.0,49072.0,45785.0,46419.0,46530.0,688551.0
Karimganj,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,102.0,128.0,118.0,117.0,129.0,126.0,147.0,93.0,190.0,135.0,121.0,74.0,1480.0
Karimganj,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,2.0,1.0,4.0,2.0,6.0,0.0,2.0,2.0,0.0,1.0,2.0,1.0,23.0
Karimganj,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,139.0,57.0,90.0,174.0,127.0,127.0,117.0,109.0,114.0,109.0,101.0,80.0,1344.0
Karimganj,14.14.a,Number of patients given AYUSH treatment,TOTAL,1154.0,1700.0,1831.0,1809.0,1992.0,1965.0,1612.0,1619.0,1761.0,1255.0,1146.0,1166.0,19010.0
Karimganj,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,416.0,878.0,836.0,803.0,612.0,805.0,668.0,557.0,569.0,528.0,626.0,103.0,7401.0
Karimganj,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5778.0,6776.0,7334.0,6644.0,8214.0,7219.0,6799.0,5762.0,6168.0,6641.0,5585.0,4721.0,77641.0
Karimganj,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,132.0,101.0,81.0,87.0,87.0,119.0,92.0,112.0,161.0,166.0,146.0,104.0,1388.0
Karimganj,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,84.0,129.0,205.0,116.0,84.0,106.0,0.0,1.0,98.0,213.0,155.0,2.0,1193.0
Karimganj,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,5.0,5.0,3.0,1.0,7.0,0.0,0.0,3.0,3.0,5.0,0.0,34.0
Karimganj,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,41.0,106.0,42.0,195.0,180.0,246.0,9.0,5.0,132.0,307.0,285.0,5.0,1553.0
Karimganj,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,6.0,1.0,1.0,0.0,2.0,0.0,0.0,0.0,2.0,1.0,0.0,14.0
Karimganj,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,212.0,377.0,397.0,438.0,353.0,353.0,271.0,399.0,319.0,267.0,330.0,85.0,3801.0
Karimganj,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,2.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,6.0
Karimganj,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,337.0,612.0,644.0,749.0,617.0,705.0,280.0,405.0,549.0,787.0,770.0,92.0,6547.0
Karimganj,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,13.0,7.0,5.0,2.0,9.0,0.0,0.0,3.0,6.0,6.0,0.0,54.0
Karimganj,15.2,Number of Widal tests conducted,Number tested,108.0,112.0,194.0,163.0,196.0,169.0,177.0,135.0,137.0,118.0,160.0,136.0,1805.0
Karimganj,15.3.a,Number of VDRL tests conducted on males,Number tested,81.0,83.0,76.0,90.0,77.0,14.0,12.0,13.0,15.0,93.0,83.0,21.0,658.0
Karimganj,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,153.0,176.0,244.0,86.0,241.0,48.0,42.0,42.0,40.0,81.0,198.0,26.0,1377.0
Karimganj,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,444.0,316.0,351.0,410.0,623.0,538.0,810.0,719.0,726.0,814.0,646.0,347.0,6744.0
Karimganj,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,678.0,575.0,671.0,586.0,941.0,600.0,864.0,774.0,781.0,988.0,927.0,394.0,8779.0
Karimganj,15.4.1,Number of blood smears examined for Malaria,TOTAL,3631.0,3364.0,5902.0,6818.0,5873.0,5237.0,2839.0,2965.0,2818.0,1822.0,2447.0,2795.0,46511.0
Karimganj,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,6.0,669.0,7.0,12.0,22.0,27.0,14.0,15.0,7.0,12.0,7.0,4.0,802.0
Karimganj,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,6.0,6.0,31.0,24.0,39.0,20.0,15.0,16.0,13.0,11.0,8.0,7.0,196.0
Karimganj,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,53750.0,46750.0,32750.0,44250.0,50750.0,38750.0,24500.0,28000.0,25000.0,21500.0,9000.0,13000.0,388000.0
Karimganj,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,,30000.0,16000.0,,,10000.0,5000.0,10000.0,0.0,10000.0,,81000.0
Karimganj,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,,,,,,0.0,,,,,,0.0
Karimganj,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,7000.0,14000.0,18500.0,9500.0,12000.0,14250.0,6500.0,8000.0,13500.0,12500.0,6000.0,10500.0,132250.0
Karimganj,16.1.1,Stock position of DPT vaccines,5. Total Stock,46750.0,32750.0,44250.0,50750.0,38750.0,24500.0,28000.0,25000.0,21500.0,9000.0,13000.0,2500.0,336750.0
Karimganj,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8500.0,8500.0
Karimganj,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,,0.0,,,,,,0.0,0.0,15000.0,,15000.0
Karimganj,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,,,,0.0,,,,,0.0,6500.0,,6500.0
Karimganj,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8500.0,8500.0,17000.0
Karimganj,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,900.0,400.0,400.0,8800.0,600.0,,5500.0,8500.0,0.0,500.0,7500.0,14000.0,47100.0
Karimganj,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,,36000.0,,,28000.0,14000.0,2000.0,14000.0,7000.0,14000.0,,115000.0
Karimganj,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,,,,,,0.0,,,,,,0.0
Karimganj,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,500.0,,27600.0,8200.0,600.0,22500.0,11000.0,10500.0,13500.0,0.0,7500.0,10000.0,111900.0
Karimganj,16.1.2,Stock position of OPV vaccines,5. Total Stock,400.0,400.0,8800.0,600.0,0.0,5500.0,8500.0,0.0,500.0,7500.0,14000.0,4000.0,50200.0
Karimganj,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,25300.0,19800.0,9300.0,7800.0,19800.0,9000.0,9500.0,22500.0,17000.0,9000.0,5000.0,16500.0,170500.0
Karimganj,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,,10000.0,20000.0,,10000.0,20000.0,5000.0,,5000.0,15000.0,,85000.0
Karimganj,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.1.3,Stock position of TT vaccines,4. Stock Distributed,5500.0,10500.0,11500.0,8000.0,10800.0,9500.0,7000.0,10500.0,8000.0,9000.0,3500.0,11000.0,104800.0
Karimganj,16.1.3,Stock position of TT vaccines,5. Total Stock,19800.0,9300.0,7800.0,19800.0,9000.0,9500.0,22500.0,17000.0,9000.0,5000.0,16500.0,5500.0,150700.0
Karimganj,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Karimganj,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,,0.0,,,0.0,,0.0,,0.0,0.0,,0.0
Karimganj,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,,,,,0.0,,,,,,,0.0
Karimganj,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,,0.0,,0.0,0.0,,0.0,,0.0,0.0,,0.0
Karimganj,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2250.0,250.0,250.0,1750.0,7250.0,250.0,5250.0,2250.0,7250.0,7750.0,10250.0,15250.0,60000.0
Karimganj,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,,12000.0,11500.0,,16000.0,,11500.0,5000.0,10000.0,10000.0,,76000.0
Karimganj,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2000.0,,10500.0,6000.0,7000.0,11000.0,3000.0,6500.0,4500.0,7500.0,5000.0,7000.0,70000.0
Karimganj,16.1.5,Stock position of BCG vaccines,5. Total Stock,250.0,250.0,1750.0,7250.0,250.0,5250.0,2250.0,7250.0,7750.0,10250.0,15250.0,8250.0,66000.0
Karimganj,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,9000.0,8000.0,3500.0,11000.0,18000.0,13500.0,5750.0,4500.0,6750.0,5750.0,3750.0,5750.0,95250.0
Karimganj,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,,15000.0,10000.0,,,5000.0,10000.0,5000.0,3000.0,5000.0,,53000.0
Karimganj,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1000.0,4500.0,7500.0,3000.0,4500.0,7750.0,6250.0,7750.0,6000.0,5000.0,3000.0,5500.0,61750.0
Karimganj,16.1.6,Stock position of Measles vaccines,5. Total Stock,8000.0,3500.0,11000.0,18000.0,13500.0,5750.0,4500.0,6750.0,5750.0,3750.0,5750.0,250.0,86500.0
Karimganj,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Karimganj,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,0.0,,,,,,,0.0,0.0,220000.0,220000.0
Karimganj,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,,0.0,,0.0,0.0,,0.0,,0.0,0.0,210000.0,210000.0
Karimganj,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,10000.0
Karimganj,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2900.0,1900.0,400.0,1200.0,600.0,600.0,7000.0,19000.0,6500.0,13500.0,8000.0,18000.0,79600.0
Karimganj,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,,11500.0,11500.0,,22000.0,20000.0,,15000.0,5000.0,15000.0,,100000.0
Karimganj,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,,,,,,0.0,,,,,,0.0
Karimganj,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1000.0,1500.0,10700.0,12100.0,0.0,15600.0,8000.0,12500.0,8000.0,10500.0,5000.0,4500.0,89400.0
Karimganj,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1900.0,400.0,1200.0,600.0,600.0,7000.0,19000.0,6500.0,13500.0,8000.0,18000.0,13500.0,90200.0
Karimganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,40.0,40.0,40.0,40.0,850.0,200.0,800.0,600.0,600.0,600.0,600.0,350.0,4760.0
Karimganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,,,2400.0,0.0,600.0,,,,,,,3000.0
Karimganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,,,1590.0,650.0,,200.0,,,,250.0,,2690.0
Karimganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,40.0,40.0,40.0,850.0,200.0,800.0,600.0,600.0,600.0,600.0,350.0,350.0,5070.0
Karimganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,4000.0,4000.0,0.0,0.0,0.0,1680.0,1680.0,1680.0,1680.0,1680.0,1680.0,1680.0,19760.0
Karimganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,,,,1680.0,,,,,,,,1680.0
Karimganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,4000.0,,,,,,,,,,1680.0,5680.0
Karimganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,4000.0,0.0,0.0,0.0,1680.0,1680.0,1680.0,1680.0,1680.0,1680.0,1680.0,0.0,15760.0
Karimganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,28000.0,28000.0,9000.0,9000.0,7000.0,7000.0,4000.0,4000.0,4000.0,1000.0,1000.0,1000.0,103000.0
Karimganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,,22000.0,,,,,,,,,22000.0
Karimganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,19000.0,,24000.0,,3000.0,,,3000.0,,,,49000.0
Karimganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,28000.0,9000.0,9000.0,7000.0,7000.0,4000.0,4000.0,4000.0,1000.0,1000.0,1000.0,1000.0,76000.0
Karimganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,200.0,200.0,200.0,200.0,1700.0,1100.0,1100.0,1100.0,1100.0,5100.0,5100.0,4100.0,21200.0
Karimganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,,7500.0,,,,,4000.0,,,,11500.0
Karimganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,,,6000.0,600.0,,,,,,1000.0,,7600.0
Karimganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,200.0,200.0,200.0,1700.0,1100.0,1100.0,1100.0,1100.0,5100.0,5100.0,4100.0,4100.0,25100.0
Karimganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,100.0,100.0,100.0,500.0,3500.0,3000.0,3000.0,3000.0,3000.0,3000.0,3000.0,3000.0,25300.0
Karimganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,,1500.0,3000.0,,,,,,,,,4500.0
Karimganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,,1100.0,0.0,500.0,,,,,,0.0,,1600.0
Karimganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,100.0,100.0,500.0,3500.0,3000.0,3000.0,3000.0,3000.0,3000.0,3000.0,3000.0,3000.0,28200.0
Karimganj,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Karimganj,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,2600.0,1100.0,4350.0,1150.0,300.0,0.0,200.0,0.0,1200.0,400.0,0.0,,11300.0
Karimganj,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,4000.0,,,,1000.0,,1200.0,,,,,6200.0
Karimganj,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Karimganj,16.3.02,Stock Position of Gloves,4. Stock Distributed,1500.0,750.0,3200.0,850.0,300.0,800.0,200.0,,800.0,400.0,,,8800.0
Karimganj,16.3.02,Stock Position of Gloves,5. Total Stock,1100.0,4350.0,1150.0,300.0,0.0,200.0,0.0,1200.0,400.0,0.0,0.0,0.0,8700.0
Karimganj,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Karimganj,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,7793544.0,7601544.0,7446544.0,7152544.0,6342544.0,6182044.0,6018044.0,5934044.0,5839544.0,5763544.0,5569044.0,4812544.0,76455528.0
Karimganj,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,192000.0,155000.0,294000.0,810000.0,160500.0,164000.0,84000.0,94500.0,76000.0,194500.0,756500.0,1260000.0,4241000.0
Karimganj,16.3.07,Stock Position of IFA Tablets,5. Total Stock,7601544.0,7446544.0,7152544.0,6342544.0,6182044.0,6018044.0,5934044.0,5839544.0,5763544.0,5569044.0,4812544.0,3552544.0,72214528.0
Karimganj,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,27000.0,20200.0,17800.0,12100.0,10550.0,8150.0,4260.0,2460.0,60.0,0.0,0.0,9850.0,112430.0
Karimganj,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,,,,,,,,,,10850.0,,10850.0
Karimganj,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,6800.0,2400.0,5700.0,1550.0,2400.0,3890.0,1800.0,2400.0,60.0,,1000.0,3800.0,31800.0
Karimganj,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,20200.0,17800.0,12100.0,10550.0,8150.0,4260.0,2460.0,60.0,0.0,0.0,9850.0,6050.0,91480.0
Karimganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Karimganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,,,,,,,,,,,19040.0,19040.0
Karimganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,,,,,,,,,,,100.0,100.0
Karimganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18940.0,18940.0
Karimganj,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,50.0,50.0,0.0,,0.0,0.0,,,,,0.0,,100.0
Karimganj,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,,,,100.0,,,,,,,,100.0
Karimganj,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,50.0,,,100.0,,,,,,,,150.0
Karimganj,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,50.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Karimganj,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,2100.0,1100.0,50600.0,37000.0,23000.0,5000.0,5000.0,4000.0,7500.0,3300.0,23900.0,13900.0,176400.0
Karimganj,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,50000.0,,20000.0,,1300.0,,5200.0,,24000.0,0.0,4800.0,105300.0
Karimganj,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,1000.0,500.0,13600.0,34000.0,18000.0,1300.0,1000.0,1700.0,4200.0,3400.0,10000.0,550.0,89250.0
Karimganj,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,1100.0,50600.0,37000.0,23000.0,5000.0,5000.0,4000.0,7500.0,3300.0,23900.0,13900.0,18150.0,192450.0
Karimganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,500.0,300.0,100.0,100.0,5200.0,1200.0,1500.0,,1900.0,6300.0,5300.0,5800.0,28200.0
Karimganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,,,9900.0,,6600.0,,3300.0,6600.0,2000.0,2000.0,,30400.0
Karimganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,200.0,200.0,0.0,4800.0,4000.0,6300.0,1500.0,1400.0,2200.0,3000.0,1500.0,4200.0,29300.0
Karimganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,300.0,100.0,100.0,5200.0,1200.0,1500.0,0.0,1900.0,6300.0,5300.0,5800.0,1600.0,29300.0
Karimganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,21900.0,15900.0,3900.0,0.0,70000.0,48000.0,18000.0,15000.0,107800.0,71800.0,57400.0,68400.0,498100.0
Karimganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,,,84000.0,,,7200.0,110400.0,,0.0,24000.0,405400.0,631000.0
Karimganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,6000.0,12000.0,3900.0,14000.0,22000.0,30000.0,10200.0,17600.0,36000.0,14400.0,13000.0,261000.0,440100.0
Karimganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,15900.0,3900.0,0.0,70000.0,48000.0,18000.0,15000.0,107800.0,71800.0,57400.0,68400.0,212800.0,689000.0
Karimganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,,0.0,3500.0,6800.0,6100.0,6100.0,7000.0,5000.0,4000.0,4000.0,5800.0,48300.0
Karimganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,,8000.0,4000.0,,2000.0,2000.0,0.0,2000.0,2000.0,2000.0,58000.0,80000.0
Karimganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Karimganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,,4500.0,700.0,700.0,2000.0,1100.0,2000.0,3000.0,2000.0,200.0,46700.0,62900.0
Karimganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,3500.0,6800.0,6100.0,6100.0,7000.0,5000.0,4000.0,4000.0,5800.0,17100.0,65400.0
Karimganj,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,3.0,,2.0,1.0,,,,,,,,6.0
Karimganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,1.0,1.0,,,,,3.0,,1.0,,7.0
Karimganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Karimganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,1.0,1.0,1.0,,,,,3.0,,1.0,,7.0
Karimganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,4.0,,1.0,4.0,,6.0,4.0,1.0,5.0,4.0,2.0,1.0,32.0
Karimganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Karimganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,4.0,,1.0,4.0,,6.0,4.0,1.0,5.0,4.0,2.0,1.0,32.0
Karimganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,6.0,4.0,2.0,3.0,5.0,1.0,5.0,6.0,3.0,4.0,3.0,1.0,43.0
Karimganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Karimganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,6.0,4.0,2.0,3.0,5.0,1.0,5.0,6.0,3.0,4.0,3.0,1.0,43.0
Karimganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,7.0,7.0,2.0,5.0,3.0,3.0,6.0,9.0,3.0,2.0,3.0,7.0,57.0
Karimganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,1.0,,1.0
Karimganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,7.0,7.0,2.0,5.0,3.0,3.0,6.0,9.0,3.0,2.0,4.0,7.0,58.0
Karimganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,,1.0,2.0,1.0,3.0,,1.0,,,2.0,11.0
Karimganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Karimganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,1.0,2.0,1.0,3.0,,1.0,,,2.0,11.0
Karimganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,1.0,,,,,1.0,1.0,1.0,1.0,,,,5.0
Karimganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Karimganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,1.0,,,,1.0,1.0,1.0,1.0,1.0,,,,6.0
Karimganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,1.0,3.0,3.0,3.0,,2.0,1.0,1.0,,1.0,16.0
Karimganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,1.0,,1.0,,,,,,,3.0
Karimganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,2.0,1.0,4.0,3.0,4.0,,2.0,1.0,1.0,,1.0,19.0
Karimganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,1.0,1.0,1.0,,,,,,,3.0
Karimganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Karimganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,1.0,1.0,1.0,,,,,,,3.0
Karimganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,1.0,5.0,3.0,3.0,,4.0,10.0,9.0,7.0,6.0,4.0,54.0
Karimganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,1.0,2.0,3.0,2.0,1.0,,1.0,,,,,12.0
Karimganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,2.0,7.0,6.0,5.0,1.0,4.0,11.0,9.0,7.0,6.0,4.0,66.0
Karimganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Karimganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Karimganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Karimganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,1.0,,,,,,1.0
Karimganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Karimganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,1.0,1.0,1.0,,,,1.0,,,,5.0
Karimganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Karimganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,1.0,1.0,1.0,,,,1.0,,,,5.0
Karimganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Karimganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,2.0,,2.0,,,,,1.0,3.0,,,8.0
Karimganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,4.0,4.0,1.0,1.0,1.0,1.0,2.0,3.0,2.0,1.0,,22.0
Karimganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,6.0,4.0,3.0,1.0,1.0,1.0,2.0,4.0,5.0,1.0,,30.0
Karimganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Karimganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Karimganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Karimganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,,,,,,,,,,,1.0
Karimganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,2.0,,,,,,,,,,3.0
Karimganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,1.0,3.0,,,2.0,1.0,,2.0,,1.0,,11.0
Karimganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Karimganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,1.0,5.0,,,2.0,1.0,,2.0,,2.0,,15.0
Karimganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Karimganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Karimganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Karimganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,1.0,,,,,,,,,,,1.0
Karimganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Karimganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,2.0,1.0,2.0,1.0,1.0,3.0,2.0,4.0,3.0,4.0,5.0,31.0
Karimganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,8.0,7.0,6.0,7.0,5.0,5.0,3.0,2.0,7.0,3.0,4.0,7.0,64.0
Karimganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,11.0,9.0,8.0,9.0,6.0,6.0,6.0,4.0,11.0,6.0,8.0,12.0,96.0
Karimganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,1.0,1.0,,,,,,,2.0
Karimganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,,,,1.0,1.0,2.0,,1.0,1.0,1.0,3.0,12.0
Karimganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,3.0,1.0,3.0,3.0,1.0,3.0,6.0,4.0,1.0,2.0,7.0,5.0,39.0
Karimganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,5.0,1.0,3.0,3.0,3.0,5.0,8.0,4.0,2.0,3.0,8.0,8.0,53.0
Karimganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Karimganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Karimganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Karimganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Karimganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Karimganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,1.0,,,1.0,1.0,,,,,,3.0
Karimganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Karimganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,1.0,,,1.0,1.0,,,,,,3.0
Karimganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Karimganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,1.0,1.0,,,,,1.0,3.0
Karimganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Karimganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,1.0,1.0,,,,,1.0,3.0
Karimganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Karimganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,2.0,,1.0,2.0,,,,,5.0
Karimganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Karimganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,2.0,,1.0,2.0,,,,,5.0
Karimganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Karimganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,2.0,,,,,,2.0
Karimganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Karimganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,2.0,,,,,,2.0
Karimganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Karimganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,,,,,4.0,3.0,2.0,2.0,1.0,1.0,14.0
Karimganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Karimganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,,,,,4.0,3.0,2.0,2.0,1.0,1.0,14.0
Karimganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,,,1.0,,1.0,,,,,3.0
Karimganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,2.0,2.0,2.0,3.0,3.0,,1.0,1.0,1.0,1.0,,18.0
Karimganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,2.0,,2.0,,,,1.0,,,,2.0,7.0
Karimganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,5.0,2.0,4.0,3.0,4.0,,3.0,1.0,1.0,1.0,2.0,28.0
Karimganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Karimganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,,1.0,,,1.0,,1.0,,,1.0,,5.0
Karimganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Karimganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,,1.0,,,1.0,,1.0,,1.0,1.0,,6.0
Karimganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Karimganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,1.0,1.0,1.0,,,,,1.0,,4.0
Karimganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,,1.0,1.0,1.0,1.0,,1.0,1.0,1.0,1.0,1.0,10.0
Karimganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,1.0,2.0,2.0,2.0,,1.0,1.0,1.0,2.0,1.0,14.0
Karimganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,,2.0,,,,2.0,,,,5.0
Karimganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,,2.0,2.0,2.0,2.0,3.0,,,2.0,,3.0,17.0
Karimganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,1.0,1.0,,2.0,,2.0,1.0,2.0,,2.0,,12.0
Karimganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,2.0,3.0,2.0,6.0,2.0,5.0,1.0,4.0,2.0,2.0,3.0,34.0
Karimganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,,,1.0,,,,1.0,1.0,,4.0
Karimganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,,3.0,1.0,3.0,2.0,4.0,2.0,5.0,4.0,1.0,2.0,30.0
Karimganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,8.0,3.0,5.0,5.0,4.0,5.0,9.0,11.0,12.0,10.0,8.0,8.0,88.0
Karimganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,11.0,3.0,9.0,6.0,7.0,8.0,13.0,13.0,17.0,15.0,10.0,10.0,122.0
Karimganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,2.0,,,,,,1.0,,3.0
Karimganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,9.0,8.0,10.0,16.0,13.0,3.0,10.0,8.0,8.0,3.0,5.0,9.0,102.0
Karimganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,22.0,19.0,31.0,28.0,19.0,11.0,31.0,25.0,21.0,20.0,21.0,15.0,263.0
Karimganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,31.0,27.0,41.0,44.0,34.0,14.0,41.0,33.0,29.0,23.0,27.0,24.0,368.0
Kokrajhar,1.1,Total number of pregnant women Registered for ANC,TOTAL,2023.0,1799.0,2079.0,2028.0,1873.0,1734.0,1630.0,1568.0,1379.0,1659.0,1551.0,1866.0,21189.0
Kokrajhar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1250.0,1075.0,1262.0,1210.0,1203.0,1078.0,1045.0,973.0,872.0,1025.0,1017.0,1173.0,13183.0
Kokrajhar,1.2,Number of Pregnant women registered under JSY,TOTAL,1916.0,1743.0,2052.0,1912.0,1818.0,1620.0,1541.0,1486.0,1272.0,1594.0,1475.0,1790.0,20219.0
Kokrajhar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1272.0,1297.0,1497.0,1551.0,1423.0,1538.0,1583.0,1498.0,1341.0,1367.0,1089.0,1318.0,16774.0
Kokrajhar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1546.0,1525.0,1601.0,1695.0,1630.0,1732.0,1429.0,1385.0,1204.0,1313.0,1198.0,1435.0,17693.0
Kokrajhar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1417.0,1519.0,1545.0,1733.0,1573.0,1659.0,1729.0,1665.0,1457.0,1346.0,1174.0,1355.0,18172.0
Kokrajhar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1483.0,1509.0,1599.0,1641.0,1610.0,1584.0,1447.0,1481.0,1662.0,1520.0,1474.0,1622.0,18632.0
Kokrajhar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,18.0,33.0,21.0,15.0,55.0,57.0,9.0,16.0,86.0,51.0,41.0,57.0,459.0
Kokrajhar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,3.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,2.0,1.0,0.0,10.0
Kokrajhar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1186.0,938.0,1102.0,1025.0,1074.0,1144.0,871.0,903.0,671.0,730.0,714.0,723.0,11081.0
Kokrajhar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,55.0,37.0,44.0,64.0,59.0,70.0,7.0,8.0,5.0,7.0,13.0,12.0,381.0
Kokrajhar,1.8,Number of pregnancy test kits used at SC level,TOTAL,268.0,290.0,274.0,188.0,178.0,155.0,118.0,110.0,169.0,121.0,152.0,150.0,2173.0
Kokrajhar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,62.0,53.0,46.0,87.0,98.0,44.0,59.0,51.0,64.0,69.0,77.0,70.0,780.0
Kokrajhar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,80.0,108.0,84.0,100.0,80.0,96.0,106.0,85.0,82.0,106.0,58.0,68.0,1053.0
Kokrajhar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,142.0,161.0,130.0,187.0,178.0,140.0,165.0,136.0,146.0,175.0,135.0,138.0,1833.0
Kokrajhar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,99.0,138.0,90.0,145.0,157.0,120.0,151.0,124.0,141.0,164.0,131.0,131.0,1591.0
Kokrajhar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1158.0,989.0,1033.0,1186.0,1386.0,1371.0,1541.0,1430.0,1458.0,1480.0,1252.0,1192.0,15476.0
Kokrajhar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,643.0,708.0,770.0,841.0,978.0,1200.0,1128.0,990.0,1063.0,1163.0,908.0,906.0,11298.0
Kokrajhar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1125.0,971.0,981.0,1149.0,1363.0,1342.0,1546.0,1386.0,1403.0,1463.0,1210.0,1326.0,15265.0
Kokrajhar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,797.0,513.0,651.0,831.0,1010.0,1143.0,914.0,962.0,948.0,999.0,791.0,837.0,10396.0
Kokrajhar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,0.0,,,0.0,0.0
Kokrajhar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,39.0,36.0,33.0,,,23.0,34.0,36.0,62.0,50.0,44.0,33.0,390.0
Kokrajhar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Kokrajhar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Kokrajhar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Kokrajhar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Kokrajhar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,86.0,51.0,70.0,65.0,88.0,90.0,98.0,95.0,90.0,90.0,91.0,109.0,1023.0
Kokrajhar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kokrajhar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,86.0,51.0,70.0,65.0,88.0,90.0,98.0,95.0,90.0,90.0,91.0,109.0,1023.0
Kokrajhar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,32.0,24.0,29.0,,,19.0,31.0,29.0,53.0,45.0,40.0,25.0,327.0
Kokrajhar,4.1.1.a,Number of male live births,TOTAL,695.0,657.0,638.0,757.0,868.0,866.0,947.0,887.0,882.0,908.0,796.0,729.0,9630.0
Kokrajhar,4.1.1.b,Number of female live births,TOTAL,643.0,521.0,551.0,653.0,727.0,680.0,794.0,708.0,779.0,799.0,626.0,622.0,8103.0
Kokrajhar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1338.0,1178.0,1189.0,1410.0,1595.0,1546.0,1741.0,1595.0,1661.0,1707.0,1422.0,1351.0,17733.0
Kokrajhar,4.1.2,Number of still births,TOTAL,21.0,21.0,20.0,16.0,20.0,19.0,31.0,29.0,33.0,20.0,27.0,25.0,282.0
Kokrajhar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,104.0,144.0,106.0,104.0,150.0,112.0,140.0,164.0,95.0,111.0,110.0,130.0,1470.0
Kokrajhar,4.2.1,Number of Newborns weighed at birth,TOTAL,1328.0,1183.0,1180.0,1400.0,1585.0,1547.0,1726.0,1595.0,1657.0,1665.0,1376.0,1317.0,17559.0
Kokrajhar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,294.0,317.0,244.0,331.0,437.0,319.0,376.0,335.0,422.0,332.0,332.0,457.0,4196.0
Kokrajhar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1188.0,1120.0,1025.0,1050.0,1316.0,1255.0,1346.0,1434.0,1261.0,1397.0,1077.0,1003.0,14472.0
Kokrajhar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,56.0,40.0,38.0,65.0,45.0,72.0,38.0,69.0,38.0,9.0,0.0,31.0,501.0
Kokrajhar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,20.0,13.0,12.0,11.0,0.0,0.0,0.0,0.0,21.0,0.0,0.0,0.0,77.0
Kokrajhar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,7.0,8.0,11.0,14.0,14.0,15.0,36.0,31.0,27.0,24.0,18.0,18.0,223.0
Kokrajhar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kokrajhar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,83.0,61.0,61.0,90.0,59.0,87.0,74.0,100.0,86.0,33.0,18.0,49.0,801.0
Kokrajhar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Kokrajhar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,31.0,37.0,34.0,46.0,41.0,44.0,47.0,50.0,69.0,36.0,28.0,31.0,494.0
Kokrajhar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,54.0,7.0,5.0,7.0,7.0,19.0,26.0,23.0,19.0,12.0,18.0,18.0,215.0
Kokrajhar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,11.0,26.0,33.0,45.0,29.0,36.0,35.0,38.0,29.0,27.0,18.0,35.0,362.0
Kokrajhar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,6.0,8.0,5.0,10.0,6.0,7.0,8.0,6.0,11.0,7.0,6.0,10.0,90.0
Kokrajhar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,418.0,423.0,541.0,628.0,857.0,748.0,717.0,620.0,764.0,732.0,614.0,579.0,7641.0
Kokrajhar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,529.0,580.0,600.0,698.0,980.0,993.0,916.0,752.0,822.0,840.0,726.0,634.0,9070.0
Kokrajhar,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,4.0,9.0,9.0,37.0,2.0,0.0,6.0,27.0,18.0,13.0,125.0
Kokrajhar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,70.0,75.0,70.0,68.0,89.0,64.0,72.0,99.0,58.0,44.0,54.0,63.0,826.0
Kokrajhar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,8.0,19.0,9.0,6.0,7.0,20.0,10.0,7.0,11.0,17.0,19.0,33.0,166.0
Kokrajhar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,78.0,94.0,79.0,74.0,96.0,84.0,82.0,106.0,69.0,61.0,73.0,96.0,992.0
Kokrajhar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,5.0,11.0,84.0,85.0,4.0,97.0,100.0,78.0,104.0,93.0,60.0,721.0
Kokrajhar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,0.0,10.0,19.0,131.0,140.0,5.0,168.0,135.0,123.0,151.0,269.0,224.0,1375.0
Kokrajhar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,0.0,15.0,30.0,215.0,225.0,9.0,265.0,235.0,201.0,255.0,362.0,284.0,2096.0
Kokrajhar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kokrajhar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kokrajhar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kokrajhar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kokrajhar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,9.0,0.0,12.0,0.0,0.0,16.0,14.0,1.0,1.0,0.0,0.0,0.0,53.0
Kokrajhar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kokrajhar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,9.0,0.0,12.0,0.0,0.0,16.0,14.0,1.0,1.0,0.0,0.0,0.0,53.0
Kokrajhar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kokrajhar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,6.0,7.0,12.0,17.0,17.0,13.0,0.0,19.0,0.0,16.0,16.0,23.0,146.0
Kokrajhar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kokrajhar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,6.0,7.0,12.0,17.0,17.0,13.0,0.0,19.0,0.0,16.0,16.0,23.0,146.0
Kokrajhar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kokrajhar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kokrajhar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kokrajhar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,30.0,29.0,23.0,44.0,37.0,23.0,34.0,16.0,26.0,37.0,20.0,37.0,356.0
Kokrajhar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,110.0,121.0,117.0,80.0,252.0,107.0,99.0,60.0,103.0,84.0,94.0,117.0,1344.0
Kokrajhar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,10.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,18.0
Kokrajhar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,5.0,38.0,7.0,17.0,44.0,70.0,37.0,48.0,74.0,18.0,68.0,61.0,487.0
Kokrajhar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kokrajhar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,155.0,188.0,147.0,141.0,333.0,200.0,178.0,124.0,203.0,139.0,182.0,215.0,2205.0
Kokrajhar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Kokrajhar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kokrajhar,9.06,Number of IUCD removals,TOTAL,30.0,34.0,66.0,43.0,41.0,31.0,44.0,60.0,26.0,44.0,54.0,43.0,516.0
Kokrajhar,9.07,Number of Oral Pills cycles distributed,TOTAL,4625.0,4490.0,4813.0,5071.0,5437.0,5575.0,5577.0,4846.0,5161.0,4915.0,5581.0,5998.0,62089.0
Kokrajhar,9.08,Number of Condom pieces distributed,TOTAL,12116.0,12296.0,12483.0,12574.0,12046.0,11972.0,9965.0,10794.0,9695.0,10356.0,10802.0,10805.0,135904.0
Kokrajhar,9.09,Number of Centchroman (weekly) pills given,TOTAL,6.0,50.0,27.0,27.0,90.0,160.0,0.0,2.0,2.0,0.0,28.0,72.0,464.0
Kokrajhar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,66.0,104.0,88.0,118.0,44.0,67.0,91.0,99.0,78.0,74.0,213.0,101.0,1143.0
Kokrajhar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Kokrajhar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,1.0,,-1.0
Kokrajhar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1204.0,736.0,1505.0,1554.0,1360.0,1589.0,1235.0,1150.0,1605.0,1478.0,1672.0,1563.0,16651.0
Kokrajhar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1510.0,1273.0,1402.0,1411.0,1360.0,1375.0,1453.0,1551.0,1460.0,1609.0,1046.0,835.0,16285.0
Kokrajhar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1424.0,1380.0,1456.0,1504.0,1331.0,1282.0,1423.0,1419.0,1484.0,1489.0,1415.0,1438.0,17045.0
Kokrajhar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1346.0,1285.0,1309.0,1448.0,1305.0,1391.0,1336.0,1365.0,1382.0,1495.0,1329.0,1692.0,16683.0
Kokrajhar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,187.0,569.0,756.0
Kokrajhar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0,130.0,143.0
Kokrajhar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,437.0,262.0,382.0,439.0,273.0,180.0,345.0,130.0,279.0,494.0,357.0,337.0,3915.0
Kokrajhar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1501.0,1219.0,1378.0,1383.0,1162.0,1383.0,1440.0,1507.0,1438.0,1594.0,1130.0,1161.0,16296.0
Kokrajhar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1394.0,1342.0,1446.0,1441.0,1233.0,1288.0,1383.0,1380.0,1466.0,1495.0,1392.0,1484.0,16744.0
Kokrajhar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1315.0,1255.0,1309.0,1380.0,1242.0,1387.0,1286.0,1343.0,1357.0,1489.0,1333.0,1678.0,16374.0
Kokrajhar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,75.0,61.0,99.0,121.0,140.0,313.0,271.0,68.0,239.0,448.0,257.0,217.0,2309.0
Kokrajhar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1383.0,1246.0,1346.0,1394.0,1138.0,1290.0,1418.0,1595.0,1418.0,1564.0,1059.0,781.0,15632.0
Kokrajhar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1270.0,1305.0,1414.0,1466.0,1240.0,1215.0,1351.0,1392.0,1476.0,1478.0,1340.0,1382.0,16329.0
Kokrajhar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1206.0,1188.0,1254.0,1393.0,1205.0,1348.0,1271.0,1341.0,1325.0,1478.0,1296.0,1585.0,15890.0
Kokrajhar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,974.0,1086.0,1192.0,1331.0,1263.0,1367.0,1386.0,1434.0,1254.0,1328.0,1182.0,1420.0,15217.0
Kokrajhar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,457.0,485.0,556.0,543.0,537.0,503.0,486.0,478.0,524.0,696.0,598.0,697.0,6560.0
Kokrajhar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0,19.0
Kokrajhar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,510.0,557.0,605.0,705.0,662.0,707.0,736.0,733.0,673.0,669.0,615.0,702.0,7874.0
Kokrajhar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,455.0,512.0,563.0,625.0,601.0,675.0,645.0,691.0,582.0,657.0,563.0,625.0,7194.0
Kokrajhar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,965.0,1069.0,1168.0,1330.0,1263.0,1382.0,1381.0,1424.0,1255.0,1326.0,1178.0,1327.0,15068.0
Kokrajhar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,884.0,878.0,889.0,893.0,969.0,937.0,870.0,842.0,851.0,808.0,857.0,1011.0,10689.0
Kokrajhar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,882.0,866.0,942.0,857.0,923.0,929.0,842.0,826.0,846.0,811.0,861.0,1013.0,10598.0
Kokrajhar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,92.0,111.0,114.0,105.0,113.0,104.0,97.0,107.0,119.0,212.0,91.0,157.0,1422.0
Kokrajhar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,88.0,91.0,110.0,113.0,90.0,112.0,105.0,112.0,129.0,151.0,86.0,143.0,1330.0
Kokrajhar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,180.0,202.0,224.0,218.0,203.0,216.0,202.0,219.0,248.0,363.0,177.0,300.0,2752.0
Kokrajhar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,385.0,404.0,354.0,395.0,409.0,359.0,343.0,385.0,419.0,407.0,438.0,441.0,4739.0
Kokrajhar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,438.0,405.0,297.0,416.0,399.0,384.0,351.0,368.0,339.0,395.0,413.0,463.0,4668.0
Kokrajhar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,382.0,366.0,328.0,349.0,364.0,350.0,302.0,355.0,327.0,351.0,340.0,421.0,4235.0
Kokrajhar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Kokrajhar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Kokrajhar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,982.0,929.0,958.0,992.0,960.0,928.0,980.0,948.0,958.0,946.0,963.0,967.0,11511.0
Kokrajhar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,949.0,901.0,931.0,985.0,943.0,912.0,945.0,928.0,913.0,923.0,935.0,951.0,11216.0
Kokrajhar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,932.0,887.0,917.0,961.0,925.0,914.0,942.0,919.0,895.0,908.0,918.0,922.0,11040.0
Kokrajhar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,944.0,1021.0,1136.0,1287.0,1461.0,1366.0,1308.0,1378.0,1169.0,1281.0,1086.0,1256.0,14693.0
Kokrajhar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,299.0,276.0,311.0,366.0,1229.0,562.0,365.0,333.0,359.0,355.0,415.0,473.0,5343.0
Kokrajhar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,189.0,221.0,235.0,278.0,969.0,363.0,297.0,257.0,227.0,306.0,276.0,390.0,4008.0
Kokrajhar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,8.0,4.0,3.0,0.0,0.0,6.0,4.0,4.0,6.0,0.0,6.0,44.0
Kokrajhar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,308.0,339.0,446.0,316.0,1168.0,567.0,228.0,283.0,316.0,357.0,149.0,165.0,4642.0
Kokrajhar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,2.0,3.0,2.0,2.0,0.0,1.0,65.0,110.0,185.0
Kokrajhar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,17.0,17.0,21.0,22.0,15.0,23.0,33.0,15.0,39.0,28.0,13.0,18.0,261.0
Kokrajhar,13.1,Number of Patients operated for cataract,TOTAL,102.0,120.0,118.0,148.0,141.0,94.0,135.0,140.0,99.0,108.0,102.0,113.0,1420.0
Kokrajhar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,102.0,120.0,118.0,148.0,141.0,94.0,135.0,140.0,99.0,108.0,102.0,113.0,1420.0
Kokrajhar,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,72.0,84.0,10.0,0.0,0.0,0.0,0.0,166.0
Kokrajhar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,72.0,0.0,0.0,0.0,0.0,0.0,0.0,72.0
Kokrajhar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,3.0,2.0,2.0,2.0,2.0,4.0,3.0,2.0,2.0,1.0,-1.0
Kokrajhar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,20.0,23.0,22.0,19.0,18.0,21.0,19.0,22.0,23.0,24.0,21.0,21.0,-1.0
Kokrajhar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,788.0,778.0,780.0,824.0,799.0,812.0,798.0,783.0,776.0,778.0,775.0,778.0,-1.0
Kokrajhar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,3.0,3.0,2.0,-1.0
Kokrajhar,14.05,Number of RKS meetings held during the month,TOTAL,26.0,28.0,21.0,20.0,23.0,25.0,22.0,20.0,20.0,20.0,21.0,25.0,271.0
Kokrajhar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,17.0,16.0,17.0,16.0,19.0,19.0,18.0,18.0,20.0,19.0,18.0,18.0,-1.0
Kokrajhar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,174.0,164.0,91.0,145.0,81.0,100.0,165.0,120.0,145.0,161.0,114.0,149.0,1609.0
Kokrajhar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,2.0,-1.0
Kokrajhar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Kokrajhar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,111.0,87.0,121.0,54.0,96.0,78.0,76.0,77.0,72.0,70.0,88.0,146.0,1076.0
Kokrajhar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,543.0,569.0,407.0,296.0,554.0,482.0,495.0,512.0,176.0,375.0,346.0,606.0,5361.0
Kokrajhar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,78.0,56.0,91.0,370.0,55.0,140.0,56.0,61.0,339.0,89.0,64.0,81.0,1480.0
Kokrajhar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1128.0,847.0,954.0,1229.0,1178.0,1208.0,1395.0,1219.0,1221.0,1087.0,1096.0,1023.0,13585.0
Kokrajhar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,189.0,143.0,212.0,424.0,151.0,218.0,132.0,138.0,411.0,159.0,152.0,227.0,2556.0
Kokrajhar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1671.0,1416.0,1361.0,1525.0,1732.0,1690.0,1890.0,1731.0,1397.0,1462.0,1442.0,1629.0,18946.0
Kokrajhar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8.0,7.0,6.0,15.0,12.0,12.0,17.0,22.0,20.0,13.0,13.0,22.0,167.0
Kokrajhar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,14.0,18.0,12.0,4.0,3.0,8.0,10.0,14.0,7.0,9.0,12.0,113.0
Kokrajhar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,10.0,21.0,24.0,27.0,16.0,15.0,25.0,32.0,34.0,20.0,22.0,34.0,280.0
Kokrajhar,14.11,In-Patient Head Count at midnight,TOTAL,1577.0,260.0,1247.0,1399.0,1519.0,1287.0,1488.0,1269.0,1336.0,1275.0,223.0,1664.0,14544.0
Kokrajhar,14.12.1,OPD attendance (All),TOTAL,50925.0,40554.0,52239.0,59700.0,48888.0,49125.0,45121.0,35797.0,32860.0,31022.0,35752.0,46063.0,528046.0
Kokrajhar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,101.0,84.0,81.0,87.0,128.0,99.0,103.0,130.0,79.0,95.0,80.0,117.0,1184.0
Kokrajhar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,14.0,6.0,4.0,12.0,10.0,6.0,13.0,0.0,2.0,2.0,9.0,78.0
Kokrajhar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,39.0,46.0,58.0,47.0,39.0,29.0,20.0,15.0,20.0,17.0,40.0,42.0,412.0
Kokrajhar,14.14.a,Number of patients given AYUSH treatment,TOTAL,540.0,300.0,287.0,588.0,432.0,679.0,250.0,251.0,231.0,321.0,316.0,301.0,4496.0
Kokrajhar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,302.0,315.0,296.0,333.0,327.0,318.0,347.0,307.0,327.0,333.0,318.0,337.0,3860.0
Kokrajhar,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2078.0,1894.0,2249.0,2074.0,2264.0,2305.0,2126.0,1906.0,1774.0,1797.0,1728.0,1831.0,24026.0
Kokrajhar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,100.0,54.0,65.0,110.0,91.0,98.0,73.0,107.0,105.0,117.0,99.0,115.0,1134.0
Kokrajhar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,154.0,147.0,151.0,167.0,166.0,53.0,177.0,222.0,134.0,121.0,182.0,172.0,1846.0
Kokrajhar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,0.0,1.0,1.0,0.0,1.0,3.0,0.0,0.0,0.0,1.0,0.0,10.0
Kokrajhar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,185.0,218.0,211.0,216.0,219.0,114.0,175.0,202.0,157.0,252.0,261.0,251.0,2461.0
Kokrajhar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,0.0,2.0,1.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,8.0
Kokrajhar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,675.0,598.0,796.0,704.0,705.0,870.0,592.0,390.0,73.0,472.0,593.0,614.0,7082.0
Kokrajhar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1014.0,963.0,1158.0,1087.0,1090.0,1037.0,944.0,814.0,364.0,845.0,1036.0,1037.0,11389.0
Kokrajhar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,5.0,0.0,3.0,2.0,0.0,1.0,5.0,0.0,0.0,1.0,1.0,0.0,18.0
Kokrajhar,15.2,Number of Widal tests conducted,Number tested,155.0,125.0,135.0,310.0,177.0,156.0,119.0,63.0,47.0,73.0,121.0,147.0,1628.0
Kokrajhar,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,246.0,3.0,3.0,0.0,4.0,0.0,0.0,0.0,90.0,48.0,394.0
Kokrajhar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,2.0,3.0,0.0,62.0,0.0,0.0,0.0,192.0,180.0,439.0
Kokrajhar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,35.0,46.0,0.0,0.0,40.0,12.0,5.0,58.0,54.0,250.0
Kokrajhar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,246.0,40.0,52.0,0.0,66.0,40.0,12.0,5.0,340.0,282.0,1083.0
Kokrajhar,15.4.1,Number of blood smears examined for Malaria,TOTAL,3144.0,2893.0,6527.0,8070.0,5535.0,6051.0,4425.0,4078.0,3507.0,2323.0,3096.0,3759.0,53408.0
Kokrajhar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,159.0,6.0,192.0,41.0,16.0,519.0,5.0,168.0,13.0,10.0,4.0,8.0,1141.0
Kokrajhar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,29.0,10.0,28.0,51.0,31.0,17.0,34.0,56.0,108.0,58.0,15.0,10.0,447.0
Kokrajhar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,19900.0,12350.0,24630.0,25420.0,23900.0,10910.0,22290.0,31550.0,26600.0,24800.0,24520.0,14570.0,261440.0
Kokrajhar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,15000.0,15000.0,0.0,5000.0,15000.0,15000.0,10000.0,10000.0,0.0,5000.0,10000.0,100000.0
Kokrajhar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,7550.0,2720.0,14210.0,1520.0,17990.0,3620.0,5740.0,14950.0,11800.0,280.0,14950.0,10600.0,105930.0
Kokrajhar,16.1.1,Stock position of DPT vaccines,5. Total Stock,12350.0,24630.0,25420.0,23900.0,10910.0,22290.0,31550.0,26600.0,24800.0,24520.0,14570.0,13970.0,255510.0
Kokrajhar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Kokrajhar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Kokrajhar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Kokrajhar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Kokrajhar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,9220.0,6460.0,19840.0,7620.0,3750.0,5820.0,3600.0,9860.0,14180.0,6480.0,500.0,3780.0,91110.0
Kokrajhar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,19000.0,8000.0,0.0,18000.0,0.0,9000.0,13000.0,9000.0,0.0,10000.0,18000.0,104000.0
Kokrajhar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2760.0,5620.0,20220.0,3870.0,15930.0,2220.0,2740.0,8680.0,16700.0,5980.0,6720.0,9800.0,101240.0
Kokrajhar,16.1.2,Stock position of OPV vaccines,5. Total Stock,6460.0,19840.0,7620.0,3750.0,5820.0,3600.0,9860.0,14180.0,6480.0,500.0,3780.0,11980.0,93870.0
Kokrajhar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,10900.0,3350.0,14850.0,9350.0,6850.0,3660.0,12590.0,16350.0,10400.0,2050.0,2050.0,2300.0,94700.0
Kokrajhar,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,15000.0,10000.0,0.0,10000.0,10000.0,10000.0,10000.0,0.0,0.0,5000.0,10000.0,80000.0
Kokrajhar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,7550.0,3500.0,15500.0,2500.0,13190.0,1070.0,6240.0,15950.0,8350.0,0.0,4750.0,11300.0,89900.0
Kokrajhar,16.1.3,Stock position of TT vaccines,5. Total Stock,3350.0,14850.0,9350.0,6850.0,3660.0,12590.0,16350.0,10400.0,2050.0,2050.0,2300.0,1000.0,84800.0
Kokrajhar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1250.0,0.0,6920.0,6800.0,4850.0,3800.0,3680.0,610.0,15000.0,6000.0,5430.0,4380.0,58720.0
Kokrajhar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,9500.0,9500.0,0.0,9000.0,0.0,0.0,15000.0,0.0,0.0,5000.0,0.0,48000.0
Kokrajhar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1250.0,2580.0,9620.0,1950.0,10050.0,120.0,3070.0,610.0,9000.0,570.0,6050.0,4230.0,49100.0
Kokrajhar,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,6920.0,6800.0,4850.0,3800.0,3680.0,610.0,15000.0,6000.0,5430.0,4380.0,150.0,57620.0
Kokrajhar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,7615.0,5830.0,14430.0,6800.0,6300.0,2170.0,2160.0,5250.0,10000.0,7100.0,7000.0,3920.0,78575.0
Kokrajhar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,10000.0,5000.0,0.0,2500.0,0.0,5000.0,10000.0,5000.0,0.0,5000.0,10000.0,52500.0
Kokrajhar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1785.0,1400.0,12630.0,500.0,6630.0,10.0,1910.0,5250.0,7900.0,100.0,8080.0,5500.0,51695.0
Kokrajhar,16.1.6,Stock position of Measles vaccines,5. Total Stock,5830.0,14430.0,6800.0,6300.0,2170.0,2160.0,5250.0,10000.0,7100.0,7000.0,3920.0,8420.0,79380.0
Kokrajhar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,22250.0,9610.0,15850.0,5810.0,4800.0,7010.0,15790.0,21220.0,27120.0,23410.0,23230.0,12670.0,188770.0
Kokrajhar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,9500.0,0.0,0.0,12000.0,10000.0,10000.0,20000.0,10000.0,0.0,5000.0,10000.0,86500.0
Kokrajhar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,12640.0,3260.0,10040.0,1010.0,9790.0,1220.0,4570.0,14100.0,13710.0,180.0,15560.0,9700.0,95780.0
Kokrajhar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,9610.0,15850.0,5810.0,4800.0,7010.0,15790.0,21220.0,27120.0,23410.0,23230.0,12670.0,12970.0,179490.0
Kokrajhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,111.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,111.0
Kokrajhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0
Kokrajhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,111.0,0.0,0.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1311.0
Kokrajhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,9320.0,1340.0,1340.0,1340.0,100.0,100.0,50500.0,6840.0,70880.0
Kokrajhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,10080.0,0.0,0.0,0.0,0.0,0.0,50400.0,0.0,0.0,60480.0
Kokrajhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,760.0,7980.0,0.0,0.0,1240.0,0.0,0.0,43660.0,1040.0,54680.0
Kokrajhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,9320.0,1340.0,1340.0,1340.0,100.0,100.0,50500.0,6840.0,5800.0,76680.0
Kokrajhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1200.0,0.0,0.0,0.0,44800.0,17000.0,17000.0,17000.0,1400.0,1400.0,19400.0,2000.0,121200.0
Kokrajhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,45000.0,0.0,0.0,0.0,0.0,0.0,18000.0,0.0,0.0,63000.0
Kokrajhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,1200.0,0.0,0.0,200.0,27800.0,0.0,0.0,15600.0,0.0,0.0,17400.0,100.0,62300.0
Kokrajhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,44800.0,17000.0,17000.0,17000.0,1400.0,1400.0,19400.0,2000.0,1900.0,121900.0
Kokrajhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,50.0,0.0,0.0,0.0,5400.0,300.0,300.0,300.0,300.0,300.0,3000.0,0.0,9950.0
Kokrajhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,7500.0,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,10500.0
Kokrajhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,50.0,0.0,0.0,2100.0,5100.0,0.0,0.0,0.0,0.0,300.0,3000.0,0.0,10550.0
Kokrajhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,5400.0,300.0,300.0,300.0,300.0,300.0,3000.0,0.0,0.0,9900.0
Kokrajhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,18000.0
Kokrajhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,18000.0
Kokrajhar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1715.0,815.0,700.0,4900.0,4180.0,4300.0,4100.0,2650.0,8040.0,4140.0,3940.0,2140.0,41620.0
Kokrajhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,6600.0,0.0,3300.0,0.0,0.0,6600.0,0.0,0.0,0.0,0.0,16500.0
Kokrajhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,900.0,115.0,2400.0,720.0,3180.0,200.0,1450.0,1210.0,3900.0,200.0,1800.0,2000.0,18075.0
Kokrajhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,815.0,700.0,4900.0,4180.0,4300.0,4100.0,2650.0,8040.0,4140.0,3940.0,2140.0,140.0,40045.0
Kokrajhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,19960.0,18060.0,37000.0,70350.0,67550.0,43350.0,83350.0,101350.0,80150.0,23550.0,23550.0,4550.0,572770.0
Kokrajhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,24000.0,60000.0,0.0,24000.0,40000.0,24000.0,48000.0,0.0,0.0,0.0,24000.0,244000.0
Kokrajhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,1900.0,5060.0,26650.0,2800.0,48200.0,0.0,6000.0,69200.0,56600.0,0.0,19000.0,28550.0,263960.0
Kokrajhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,18060.0,37000.0,70350.0,67550.0,43350.0,83350.0,101350.0,80150.0,23550.0,23550.0,4550.0,0.0,552810.0
Kokrajhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5210.0,3110.0,6000.0,5710.0,5610.0,5510.0,9510.0,11810.0,11310.0,8505.0,8505.0,5705.0,86495.0
Kokrajhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4000.0,4000.0,0.0,2000.0,4000.0,4000.0,4000.0,0.0,0.0,0.0,4000.0,26000.0
Kokrajhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kokrajhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2100.0,1110.0,4290.0,100.0,2100.0,0.0,1700.0,4500.0,2805.0,0.0,2800.0,5900.0,27405.0
Kokrajhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3110.0,6000.0,5710.0,5610.0,5510.0,9510.0,11810.0,11310.0,8505.0,8505.0,5705.0,3805.0,85090.0
Kokrajhar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,1.0,,,,,,,,1.0
Kokrajhar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kokrajhar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kokrajhar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Kokrajhar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,,1.0,,1.0,,,,,,,1.0,4.0
Kokrajhar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kokrajhar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,,1.0,,1.0,,,,,,,1.0,4.0
Kokrajhar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,1.0,,,4.0,1.0,,,,,,7.0
Kokrajhar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kokrajhar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,1.0,1.0,,,4.0,1.0,,,,,,7.0
Kokrajhar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,1.0,,1.0,,,,,2.0,1.0,1.0,7.0
Kokrajhar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kokrajhar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,1.0,,1.0,,,,,2.0,1.0,1.0,7.0
Kokrajhar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,2.0,1.0,,1.0,4.0
Kokrajhar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kokrajhar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,2.0,1.0,,1.0,4.0
Kokrajhar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kokrajhar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kokrajhar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Kokrajhar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,1.0,3.0,,,,,,4.0
Kokrajhar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,,,,1.0,,,2.0,,,4.0
Kokrajhar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,,1.0,4.0,,,2.0,,,8.0
Kokrajhar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kokrajhar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kokrajhar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Kokrajhar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,,,,,1.0,1.0,1.0,,1.0,1.0,6.0
Kokrajhar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,1.0,,,,1.0,,1.0,3.0
Kokrajhar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,,,,1.0,1.0,1.0,1.0,1.0,1.0,2.0,9.0
Kokrajhar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Kokrajhar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Kokrajhar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,1.0,,,,,1.0
Kokrajhar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,,,,,1.0,3.0,,,,,6.0
Kokrajhar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,1.0,,,2.0,,,,,3.0
Kokrajhar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,1.0,,,1.0,,1.0,5.0,,,,,9.0
Kokrajhar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,2.0,,2.0,,,1.0,3.0,1.0,,2.0,12.0
Kokrajhar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,1.0,2.0,3.0,,1.0,1.0,,2.0,,1.0,,13.0
Kokrajhar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,3.0,1.0,4.0,3.0,2.0,1.0,1.0,1.0,5.0,1.0,1.0,2.0,25.0
Kokrajhar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Kokrajhar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Kokrajhar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,1.0,,,,,,,,,1.0
Kokrajhar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Kokrajhar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,1.0,6.0,2.0,1.0,2.0,9.0,4.0,,,1.0,27.0
Kokrajhar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,3.0,1.0,,1.0,,1.0,5.0,,1.0,1.0,,13.0
Kokrajhar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,4.0,2.0,6.0,3.0,1.0,4.0,14.0,4.0,1.0,1.0,1.0,41.0
Kokrajhar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,1.0,1.0,,,,,,,,,,2.0
Kokrajhar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Kokrajhar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,1.0,1.0,,,,,,,,,,2.0
Kokrajhar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,2.0,,,2.0
Kokrajhar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,5.0,4.0,3.0,,1.0,11.0,6.0,8.0,3.0,4.0,6.0,54.0
Kokrajhar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,4.0,5.0,5.0,4.0,5.0,5.0,6.0,6.0,6.0,2.0,3.0,52.0
Kokrajhar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,9.0,9.0,8.0,4.0,6.0,16.0,12.0,14.0,11.0,6.0,9.0,108.0
Kokrajhar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,1.0,,4.0,2.0,1.0,1.0,2.0,,,,2.0,14.0
Kokrajhar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,1.0,,,1.0,,,1.0,3.0
Kokrajhar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,1.0,,4.0,2.0,2.0,1.0,2.0,1.0,,,3.0,17.0
Kokrajhar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kokrajhar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Kokrajhar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,1.0,,,,,,,,,1.0,2.0
Kokrajhar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kokrajhar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,1.0,,,,,,,,,1.0,2.0
Kokrajhar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,2.0,,,,,,,,,,3.0
Kokrajhar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kokrajhar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,2.0,,,,,,,,,,3.0
Kokrajhar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,1.0,,,1.0,2.0
Kokrajhar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kokrajhar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,1.0,,,1.0,2.0
Kokrajhar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kokrajhar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Kokrajhar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,7.0,3.0,1.0,,1.0,1.0,1.0,1.0,1.0,3.0,20.0
Kokrajhar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Kokrajhar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,7.0,3.0,1.0,,1.0,1.0,1.0,1.0,1.0,3.0,20.0
Kokrajhar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,1.0,,,,,,,,1.0,2.0
Kokrajhar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,1.0,2.0,2.0,1.0,3.0,2.0,4.0,5.0,3.0,1.0,2.0,26.0
Kokrajhar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Kokrajhar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,1.0,2.0,3.0,1.0,3.0,2.0,4.0,6.0,3.0,1.0,3.0,29.0
Kokrajhar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,2.0,2.0,2.0,,,1.0,1.0,3.0,11.0
Kokrajhar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,,,2.0,,,,,,,,3.0
Kokrajhar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,,,4.0,2.0,2.0,,,1.0,1.0,3.0,14.0
Kokrajhar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Kokrajhar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Kokrajhar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,1.0,,,,,,,1.0
Kokrajhar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,2.0,10.0,3.0,4.0,4.0,,2.0,2.0,,7.0,35.0
Kokrajhar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,1.0,4.0,3.0,3.0,6.0,4.0,,5.0,,1.0,28.0
Kokrajhar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,2.0,3.0,14.0,6.0,7.0,10.0,4.0,2.0,7.0,,8.0,63.0
Kokrajhar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Kokrajhar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,5.0,4.0,5.0,4.0,4.0,1.0,4.0,5.0,4.0,4.0,1.0,43.0
Kokrajhar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,7.0,3.0,7.0,3.0,7.0,5.0,2.0,6.0,1.0,4.0,6.0,53.0
Kokrajhar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,4.0,12.0,7.0,12.0,7.0,11.0,6.0,6.0,11.0,5.0,8.0,7.0,96.0
Kokrajhar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,1.0,1.0,2.0,,,,,,,4.0
Kokrajhar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,6.0,10.0,6.0,6.0,8.0,6.0,3.0,9.0,12.0,10.0,7.0,5.0,88.0
Kokrajhar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,14.0,18.0,17.0,11.0,5.0,9.0,7.0,9.0,16.0,15.0,19.0,21.0,161.0
Kokrajhar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,20.0,28.0,23.0,18.0,14.0,17.0,10.0,18.0,28.0,25.0,26.0,26.0,253.0
Lakhimpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,1915.0,2047.0,2087.0,1979.0,2096.0,1775.0,1705.0,1664.0,1618.0,1918.0,1783.0,2173.0,22760.0
Lakhimpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1509.0,1663.0,1667.0,1638.0,1737.0,1459.0,1397.0,1411.0,1427.0,1674.0,1558.0,1858.0,18998.0
Lakhimpur,1.2,Number of Pregnant women registered under JSY,TOTAL,1873.0,2000.0,2043.0,1938.0,2073.0,1750.0,1690.0,1657.0,1587.0,1867.0,1761.0,2130.0,22369.0
Lakhimpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1395.0,1488.0,1749.0,1647.0,1718.0,1702.0,1639.0,1709.0,1646.0,1578.0,1439.0,1536.0,19246.0
Lakhimpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1777.0,1828.0,1805.0,1748.0,1889.0,1656.0,1583.0,1484.0,1370.0,1656.0,1482.0,1850.0,20128.0
Lakhimpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1813.0,1882.0,1901.0,1775.0,1840.0,1865.0,1744.0,1634.0,1577.0,1469.0,1469.0,1722.0,20691.0
Lakhimpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1204.0,1608.0,1679.0,1520.0,1633.0,1505.0,1541.0,1359.0,1388.0,1488.0,1377.0,1512.0,17814.0
Lakhimpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,12.0,13.0,28.0,10.0,31.0,20.0,26.0,18.0,15.0,17.0,8.0,8.0,206.0
Lakhimpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,1.0,2.0,2.0,4.0,3.0,1.0,2.0,6.0,5.0,1.0,0.0,27.0
Lakhimpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,910.0,1369.0,1354.0,1196.0,1314.0,1326.0,1335.0,1221.0,1135.0,1337.0,1075.0,1147.0,14719.0
Lakhimpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,6.0,6.0,0.0,1.0,2.0,10.0,0.0,0.0,1.0,4.0,30.0
Lakhimpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,654.0,633.0,563.0,656.0,559.0,638.0,485.0,484.0,510.0,622.0,490.0,609.0,6903.0
Lakhimpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,8.0,3.0,1.0,6.0,6.0,4.0,1.0,0.0,1.0,3.0,2.0,0.0,35.0
Lakhimpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,17.0,16.0,32.0,18.0,20.0,24.0,31.0,16.0,19.0,26.0,19.0,17.0,255.0
Lakhimpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,25.0,19.0,33.0,24.0,26.0,28.0,32.0,16.0,20.0,29.0,21.0,17.0,290.0
Lakhimpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,20.0,19.0,24.0,17.0,20.0,19.0,26.0,16.0,20.0,28.0,20.0,12.0,241.0
Lakhimpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1163.0,1210.0,1160.0,1562.0,1758.0,1627.0,1915.0,1517.0,1724.0,1797.0,1410.0,1328.0,18171.0
Lakhimpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,420.0,467.0,462.0,524.0,689.0,653.0,978.0,594.0,825.0,937.0,600.0,460.0,7609.0
Lakhimpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1115.0,1229.0,1091.0,1512.0,1715.0,1570.0,1844.0,1525.0,1745.0,1761.0,1403.0,1337.0,17847.0
Lakhimpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,711.0,634.0,1091.0,1746.0,811.0,1645.0,1691.0,1254.0,1489.0,1126.0,928.0,2166.0,15292.0
Lakhimpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,114.0,119.0,103.0,142.0,151.0,170.0,164.0,144.0,162.0,146.0,123.0,110.0,1648.0
Lakhimpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,29.0,24.0,19.0,41.0,39.0,40.0,39.0,47.0,151.0,31.0,48.0,86.0,594.0
Lakhimpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,14.0,3.0,0.0,12.0,9.0,6.0,4.0,7.0,4.0,2.0,5.0,212.0,278.0
Lakhimpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,0.0,0.0,0.0,0.0,0.0
Lakhimpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,,,,,,,,,,,0.0,0.0
Lakhimpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,157.0,166.0,166.0,140.0,228.0,183.0,215.0,172.0,207.0,216.0,170.0,189.0,2209.0
Lakhimpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhimpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,157.0,166.0,166.0,140.0,228.0,183.0,215.0,172.0,207.0,216.0,170.0,189.0,2209.0
Lakhimpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,76.0,76.0,42.0,78.0,67.0,116.0,90.0,72.0,73.0,67.0,46.0,30.0,833.0
Lakhimpur,4.1.1.a,Number of male live births,TOTAL,688.0,658.0,644.0,826.0,1012.0,880.0,971.0,826.0,855.0,998.0,754.0,755.0,9867.0
Lakhimpur,4.1.1.b,Number of female live births,TOTAL,577.0,633.0,578.0,822.0,849.0,861.0,997.0,798.0,957.0,898.0,762.0,661.0,9393.0
Lakhimpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1265.0,1291.0,1222.0,1648.0,1861.0,1741.0,1968.0,1624.0,1812.0,1896.0,1516.0,1416.0,19260.0
Lakhimpur,4.1.2,Number of still births,TOTAL,37.0,15.0,32.0,29.0,19.0,36.0,83.0,53.0,33.0,33.0,38.0,39.0,447.0
Lakhimpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,778.0,966.0,1027.0,710.0,719.0,733.0,600.0,514.0,637.0,738.0,770.0,884.0,9076.0
Lakhimpur,4.2.1,Number of Newborns weighed at birth,TOTAL,1265.0,1291.0,1222.0,1634.0,1854.0,1741.0,1967.0,1624.0,1812.0,1769.0,1516.0,1404.0,19099.0
Lakhimpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,269.0,263.0,232.0,382.0,402.0,507.0,692.0,457.0,555.0,565.0,409.0,492.0,5225.0
Lakhimpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1261.0,1287.0,1213.0,1630.0,1820.0,1692.0,1953.0,1620.0,1772.0,1750.0,1485.0,1413.0,18896.0
Lakhimpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,15.0,15.0,5.0,17.0,18.0,0.0,0.0,13.0,1.0,0.0,6.0,1.0,91.0
Lakhimpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,4.0
Lakhimpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,2.0,1.0,3.0,2.0,4.0,3.0,11.0,3.0,8.0,22.0,3.0,14.0,76.0
Lakhimpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhimpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,17.0,16.0,8.0,19.0,22.0,3.0,11.0,16.0,9.0,26.0,9.0,15.0,171.0
Lakhimpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,605.0,425.0,401.0,482.0,633.0,482.0,698.0,693.0,582.0,558.0,525.0,519.0,6603.0
Lakhimpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5.0,28.0,28.0,47.0,16.0,10.0,7.0,14.0,7.0,8.0,2.0,3.0,175.0
Lakhimpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,366.0,399.0,370.0,440.0,623.0,469.0,684.0,461.0,585.0,564.0,297.0,519.0,5777.0
Lakhimpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,66.0,35.0,51.0,27.0,53.0,59.0,32.0,30.0,77.0,47.0,58.0,35.0,570.0
Lakhimpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,966.0,977.0,972.0,1330.0,1437.0,1437.0,1426.0,1345.0,1545.0,1299.0,1232.0,1284.0,15250.0
Lakhimpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2855.0,2884.0,2659.0,3262.0,3503.0,3638.0,3954.0,3475.0,3531.0,3700.0,3379.0,3345.0,40185.0
Lakhimpur,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,2.0,9.0
Lakhimpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,389.0,483.0,506.0,348.0,355.0,364.0,300.0,257.0,312.0,364.0,368.0,432.0,4478.0
Lakhimpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,8.0,10.0,23.0
Lakhimpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,389.0,483.0,506.0,348.0,355.0,364.0,300.0,257.0,312.0,369.0,376.0,442.0,4501.0
Lakhimpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,144.0,50.0,148.0,114.0,99.0,10.0,19.0,170.0,90.0,78.0,18.0,104.0,1044.0
Lakhimpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,402.0,103.0,358.0,328.0,298.0,26.0,16.0,179.0,119.0,125.0,40.0,379.0,2373.0
Lakhimpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,546.0,153.0,506.0,442.0,397.0,36.0,35.0,349.0,209.0,203.0,58.0,483.0,3417.0
Lakhimpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Lakhimpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,1.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Lakhimpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,9.0,0.0,6.0,10.0,0.0,0.0,2.0,5.0,3.0,0.0,1.0,4.0,40.0
Lakhimpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhimpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,9.0,0.0,6.0,11.0,3.0,0.0,2.0,5.0,3.0,1.0,1.0,4.0,45.0
Lakhimpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,16.0,36.0,36.0,0.0,0.0,0.0,44.0,0.0,0.0,132.0
Lakhimpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,61.0,0.0,152.0,84.0,0.0,0.0,0.0,0.0,23.0,0.0,0.0,320.0
Lakhimpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,67.0,117.0,73.0,313.0,40.0,24.0,26.0,21.0,29.0,14.0,50.0,232.0,1006.0
Lakhimpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhimpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,67.0,178.0,73.0,481.0,160.0,60.0,26.0,21.0,29.0,81.0,50.0,232.0,1458.0
Lakhimpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhimpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,28.0,42.0,0.0,16.0,0.0,28.0,28.0,0.0,0.0,142.0
Lakhimpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhimpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,28.0,42.0,0.0,16.0,0.0,28.0,28.0,0.0,0.0,142.0
Lakhimpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,48.0,50.0,39.0,255.0,72.0,40.0,36.0,38.0,34.0,35.0,38.0,50.0,735.0
Lakhimpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,23.0,23.0,17.0,78.0,18.0,23.0,18.0,15.0,17.0,14.0,18.0,28.0,292.0
Lakhimpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,27.0,22.0,22.0,58.0,27.0,20.0,20.0,14.0,20.0,15.0,15.0,31.0,291.0
Lakhimpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,3.0,3.0,3.0,11.0,13.0,8.0,10.0,13.0,3.0,2.0,3.0,5.0,77.0
Lakhimpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhimpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,101.0,98.0,81.0,402.0,130.0,91.0,84.0,80.0,74.0,66.0,74.0,114.0,1395.0
Lakhimpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,9.0,9.0,1.0,4.0,7.0,6.0,14.0,8.0,0.0,58.0
Lakhimpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.06,Number of IUCD removals,TOTAL,36.0,21.0,43.0,64.0,42.0,51.0,78.0,7.0,4.0,8.0,7.0,8.0,369.0
Lakhimpur,9.07,Number of Oral Pills cycles distributed,TOTAL,4186.0,4324.0,4390.0,7562.0,5189.0,5221.0,5485.0,5426.0,5138.0,4865.0,4956.0,5050.0,61792.0
Lakhimpur,9.08,Number of Condom pieces distributed,TOTAL,8125.0,7569.0,7873.0,17155.0,9589.0,9652.0,8923.0,8974.0,10386.0,8435.0,7171.0,10010.0,113862.0
Lakhimpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,84.0,77.0,96.0,297.0,125.0,150.0,129.0,196.0,131.0,145.0,119.0,174.0,1723.0
Lakhimpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,1.0,1.0,-1.0
Lakhimpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1682.0,1372.0,1436.0,1736.0,2025.0,2105.0,2086.0,1678.0,2149.0,2121.0,1811.0,1742.0,21943.0
Lakhimpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1723.0,1645.0,1527.0,1526.0,1471.0,1603.0,1840.0,2015.0,1872.0,1712.0,1000.0,45.0,17979.0
Lakhimpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1869.0,1757.0,1719.0,1611.0,1446.0,1425.0,1610.0,1829.0,1947.0,1764.0,1407.0,1363.0,19747.0
Lakhimpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1676.0,1797.0,1826.0,1847.0,1494.0,1457.0,1414.0,1648.0,1731.0,1734.0,1495.0,1734.0,19853.0
Lakhimpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,645.0,2050.0,2695.0
Lakhimpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,608.0,608.0
Lakhimpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,800.0,772.0,760.0,1023.0,1047.0,1277.0,1374.0,1023.0,1263.0,1290.0,1106.0,995.0,12730.0
Lakhimpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1723.0,1647.0,1523.0,1521.0,1261.0,1556.0,1732.0,1958.0,1656.0,1724.0,1136.0,1618.0,19055.0
Lakhimpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1869.0,1766.0,1713.0,1606.0,1219.0,1436.0,1517.0,1790.0,1708.0,1775.0,1403.0,1605.0,19407.0
Lakhimpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1676.0,1792.0,1825.0,1840.0,1259.0,1441.0,1336.0,1612.0,1564.0,1738.0,1485.0,1703.0,19271.0
Lakhimpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,732.0,765.0,602.0,897.0,1157.0,1203.0,1253.0,1028.0,1231.0,1167.0,1090.0,812.0,11937.0
Lakhimpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1699.0,1656.0,1528.0,1530.0,1473.0,1563.0,1839.0,2013.0,1863.0,1712.0,1001.0,58.0,17935.0
Lakhimpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1843.0,1748.0,1742.0,1615.0,1428.0,1403.0,1609.0,1829.0,1924.0,1763.0,1400.0,1406.0,19710.0
Lakhimpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1636.0,1773.0,1829.0,1844.0,1500.0,1432.0,1420.0,1652.0,1729.0,1732.0,1489.0,1718.0,19754.0
Lakhimpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1355.0,1692.0,1773.0,1908.0,1724.0,1566.0,1629.0,1955.0,1690.0,1452.0,1206.0,1739.0,19689.0
Lakhimpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1425.0,1407.0,1496.0,1486.0,1353.0,1370.0,1181.0,1306.0,1235.0,1244.0,1140.0,1482.0,16125.0
Lakhimpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1306.0,1655.0,1715.0,1833.0,1190.0,631.0,1332.0,1801.0,1632.0,1385.0,1141.0,1695.0,17316.0
Lakhimpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,719.0,861.0,864.0,927.0,834.0,809.0,832.0,961.0,849.0,748.0,611.0,895.0,9910.0
Lakhimpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,636.0,831.0,863.0,950.0,830.0,743.0,771.0,993.0,807.0,682.0,583.0,826.0,9515.0
Lakhimpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1355.0,1692.0,1727.0,1877.0,1664.0,1552.0,1603.0,1954.0,1656.0,1430.0,1194.0,1721.0,19425.0
Lakhimpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1425.0,1409.0,1496.0,1502.0,1402.0,1377.0,1245.0,1340.0,1243.0,1249.0,1140.0,1491.0,16319.0
Lakhimpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1421.0,1417.0,1496.0,1489.0,1173.0,1369.0,1161.0,1313.0,1070.0,1253.0,1125.0,1500.0,15787.0
Lakhimpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,87.0,94.0,132.0,105.0,91.0,79.0,49.0,43.0,51.0,69.0,46.0,42.0,888.0
Lakhimpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,74.0,83.0,115.0,98.0,77.0,84.0,34.0,42.0,40.0,58.0,48.0,41.0,794.0
Lakhimpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,161.0,177.0,247.0,203.0,168.0,163.0,83.0,85.0,91.0,127.0,94.0,83.0,1682.0
Lakhimpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,711.0,770.0,773.0,824.0,802.0,735.0,748.0,781.0,781.0,769.0,709.0,861.0,9264.0
Lakhimpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,603.0,647.0,659.0,631.0,638.0,616.0,619.0,623.0,627.0,639.0,585.0,717.0,7604.0
Lakhimpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,429.0,475.0,483.0,487.0,486.0,435.0,450.0,471.0,491.0,438.0,418.0,526.0,5589.0
Lakhimpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1333.0,1271.0,1342.0,1301.0,1227.0,1311.0,1269.0,1322.0,1334.0,1276.0,1210.0,1294.0,15490.0
Lakhimpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1271.0,1242.0,1301.0,1224.0,1155.0,1231.0,1228.0,1266.0,1281.0,1218.0,1145.0,1203.0,14765.0
Lakhimpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1257.0,1236.0,1288.0,1218.0,1147.0,1226.0,1223.0,1252.0,1261.0,1195.0,1135.0,1197.0,14635.0
Lakhimpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1349.0,1335.0,1451.0,1461.0,939.0,484.0,1015.0,1161.0,1171.0,1184.0,1087.0,1412.0,14049.0
Lakhimpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1354.0,1646.0,1737.0,1881.0,1702.0,1465.0,1548.0,1851.0,1639.0,1473.0,1082.0,1379.0,18757.0
Lakhimpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,483.0,496.0,492.0,535.0,3287.0,675.0,478.0,531.0,469.0,435.0,424.0,431.0,8736.0
Lakhimpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,451.0,467.0,463.0,493.0,2954.0,633.0,484.0,523.0,481.0,464.0,414.0,459.0,8286.0
Lakhimpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,12.0,40.0,11.0,2.0,3.0,3.0,1.0,9.0,1.0,7.0,1.0,1.0,91.0
Lakhimpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,534.0,617.0,691.0,667.0,683.0,509.0,480.0,468.0,398.0,404.0,388.0,551.0,6390.0
Lakhimpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,3.0,3.0,4.0,8.0,1.0,5.0,2.0,2.0,0.0,0.0,0.0,0.0,28.0
Lakhimpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,299.0,288.0,176.0,58.0,58.0,237.0,227.0,154.0,85.0,192.0,154.0,91.0,2019.0
Lakhimpur,13.1,Number of Patients operated for cataract,TOTAL,84.0,91.0,74.0,71.0,72.0,0.0,0.0,73.0,0.0,69.0,41.0,42.0,617.0
Lakhimpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,84.0,91.0,74.0,71.0,72.0,0.0,0.0,73.0,0.0,69.0,41.0,42.0,617.0
Lakhimpur,13.3,Number of School children detected with Refractive errors,TOTAL,5.0,7.0,7.0,7.0,25.0,16.0,0.0,54.0,0.0,21.0,19.0,63.0,224.0
Lakhimpur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,62.0,34.0,0.0,0.0,0.0,0.0,0.0,0.0,96.0
Lakhimpur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Lakhimpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,14.0,16.0,16.0,19.0,16.0,16.0,15.0,15.0,15.0,15.0,16.0,15.0,-1.0
Lakhimpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1093.0,1103.0,1116.0,1064.0,1067.0,1055.0,1084.0,1069.0,1074.0,1044.0,1035.0,1061.0,-1.0
Lakhimpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,9.0,8.0,8.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,-1.0
Lakhimpur,14.05,Number of RKS meetings held during the month,TOTAL,10.0,8.0,11.0,9.0,11.0,8.0,10.0,11.0,11.0,8.0,9.0,8.0,114.0
Lakhimpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,29.0,29.0,28.0,28.0,29.0,29.0,29.0,29.0,30.0,29.0,29.0,30.0,-1.0
Lakhimpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,448.0,489.0,477.0,630.0,476.0,364.0,450.0,268.0,348.0,391.0,303.0,350.0,4994.0
Lakhimpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Lakhimpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,0.0,4.0,4.0,4.0,-1.0
Lakhimpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,462.0,421.0,529.0,687.0,412.0,534.0,567.0,405.0,451.0,476.0,440.0,576.0,5960.0
Lakhimpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3752.0,3579.0,3750.0,3918.0,4177.0,3518.0,3875.0,1038.0,1491.0,983.0,948.0,1372.0,32401.0
Lakhimpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,300.0,277.0,341.0,355.0,315.0,294.0,298.0,465.0,425.0,402.0,357.0,508.0,4337.0
Lakhimpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5380.0,5882.0,5842.0,5882.0,6347.0,5496.0,6297.0,1821.0,2174.0,1966.0,1480.0,2085.0,50652.0
Lakhimpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,762.0,698.0,870.0,1042.0,727.0,828.0,865.0,870.0,876.0,878.0,797.0,1084.0,10297.0
Lakhimpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,9132.0,9461.0,9592.0,9800.0,10524.0,9014.0,10172.0,2859.0,3665.0,2949.0,2428.0,3457.0,83053.0
Lakhimpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,27.0,3.0,28.0,39.0,18.0,36.0,0.0,40.0,0.0,0.0,0.0,0.0,191.0
Lakhimpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,17.0,1.0,24.0,14.0,10.0,23.0,3.0,24.0,0.0,0.0,0.0,0.0,116.0
Lakhimpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,44.0,4.0,52.0,53.0,28.0,59.0,3.0,64.0,0.0,0.0,0.0,0.0,307.0
Lakhimpur,14.11,In-Patient Head Count at midnight,TOTAL,8813.0,384.0,8650.0,563.0,458.0,455.0,89.0,5178.0,93.0,63.0,417.0,1048.0,26211.0
Lakhimpur,14.12.1,OPD attendance (All),TOTAL,81461.0,80951.0,103860.0,98802.0,85644.0,79263.0,70457.0,61340.0,55031.0,52235.0,55682.0,72929.0,897655.0
Lakhimpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,312.0,312.0,268.0,254.0,557.0,227.0,186.0,145.0,48.0,108.0,41.0,110.0,2568.0
Lakhimpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,7.0,11.0,0.0,145.0,0.0,13.0,128.0,2.0,2.0,5.0,0.0,4.0,317.0
Lakhimpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,17.0,9.0,23.0,22.0,34.0,13.0,16.0,47.0,16.0,37.0,20.0,23.0,277.0
Lakhimpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,234.0,232.0,308.0,435.0,330.0,0.0,0.0,193.0,130.0,283.0,144.0,232.0,2521.0
Lakhimpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,697.0,702.0,656.0,589.0,457.0,290.0,220.0,552.0,539.0,561.0,401.0,615.0,6279.0
Lakhimpur,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4634.0,4964.0,6814.0,6842.0,6511.0,6022.0,6109.0,5838.0,5560.0,5727.0,5217.0,6411.0,70649.0
Lakhimpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,73.0,147.0,150.0,105.0,69.0,97.0,134.0,56.0,68.0,82.0,73.0,346.0,1400.0
Lakhimpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,400.0,94.0,446.0,413.0,340.0,272.0,486.0,308.0,357.0,293.0,468.0,436.0,4313.0
Lakhimpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0
Lakhimpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,290.0,302.0,290.0,293.0,36.0,34.0,152.0,40.0,32.0,35.0,409.0,408.0,2321.0
Lakhimpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,18.0
Lakhimpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,334.0,542.0,983.0,967.0,912.0,563.0,813.0,555.0,340.0,774.0,798.0,1102.0,8683.0
Lakhimpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,28.0,22.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,53.0
Lakhimpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1024.0,938.0,1719.0,1673.0,1288.0,869.0,1451.0,903.0,729.0,1102.0,1675.0,1946.0,15317.0
Lakhimpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,2.0,28.0,23.0,0.0,16.0,0.0,0.0,0.0,0.0,3.0,2.0,74.0
Lakhimpur,15.2,Number of Widal tests conducted,Number tested,358.0,512.0,1122.0,1269.0,624.0,444.0,377.0,345.0,177.0,173.0,213.0,318.0,5932.0
Lakhimpur,15.3.a,Number of VDRL tests conducted on males,Number tested,322.0,26.0,379.0,325.0,324.0,257.0,265.0,261.0,329.0,271.0,336.0,336.0,3431.0
Lakhimpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,4.0,23.0,44.0,4.0,5.0,50.0,3.0,0.0,9.0,12.0,4.0,3.0,161.0
Lakhimpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,345.0,443.0,460.0,414.0,441.0,464.0,468.0,436.0,426.0,296.0,483.0,678.0,5354.0
Lakhimpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,671.0,492.0,883.0,743.0,770.0,771.0,736.0,697.0,764.0,579.0,823.0,1017.0,8946.0
Lakhimpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,6172.0,10781.0,16272.0,22517.0,18294.0,12379.0,7718.0,7009.0,5857.0,4789.0,4899.0,6854.0,123541.0
Lakhimpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,5.0,148.0,195.0,6.0,1.0,0.0,2.0,5.0,0.0,0.0,418.0,1.0,781.0
Lakhimpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,7.0,5.0,41.0,43.0,14.0,6.0,2.0,6.0,0.0,0.0,1.0,0.0,125.0
Lakhimpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,70800.0,56300.0,58300.0,51300.0,56600.0,50100.0,42600.0,33800.0,32800.0,35800.0,30800.0,26800.0,546000.0
Lakhimpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,16000.0,0.0,15800.0,10000.0,0.0,10000.0,10000.0,10000.0,0.0,0.0,0.0,71800.0
Lakhimpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,14500.0,14000.0,7000.0,10500.0,16500.0,7500.0,18800.0,11000.0,7000.0,5000.0,4000.0,1500.0,117300.0
Lakhimpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,56300.0,58300.0,51300.0,56600.0,50100.0,42600.0,33800.0,32800.0,35800.0,30800.0,26800.0,25300.0,500500.0
Lakhimpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0,4900.0,19900.0
Lakhimpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0,0.0,6000.0,21000.0
Lakhimpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10100.0,0.0,10100.0
Lakhimpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0,4900.0,10900.0,30800.0
Lakhimpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,481740.0,473740.0,471240.0,421240.0,415840.0,418240.0,416240.0,411740.0,410740.0,409740.0,412240.0,409740.0,5152480.0
Lakhimpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,11000.0,0.0,0.0,21000.0,0.0,11000.0,2000.0,2000.0,202000.0,200000.0,0.0,449000.0
Lakhimpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,8000.0,13500.0,50000.0,5400.0,18600.0,2000.0,15500.0,3000.0,3000.0,199500.0,202500.0,34000.0,555000.0
Lakhimpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,473740.0,471240.0,421240.0,415840.0,418240.0,416240.0,411740.0,410740.0,409740.0,412240.0,409740.0,375740.0,5046480.0
Lakhimpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,65000.0,60500.0,66000.0,51000.0,50500.0,38000.0,41500.0,32500.0,32000.0,37000.0,32500.0,29500.0,536000.0
Lakhimpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,20000.0,0.0,10000.0,0.0,10000.0,10000.0,10000.0,10000.0,0.0,0.0,0.0,70000.0
Lakhimpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,4500.0,14500.0,15000.0,10500.0,12500.0,6500.0,19000.0,10500.0,5000.0,4500.0,3000.0,1500.0,107000.0
Lakhimpur,16.1.3,Stock position of TT vaccines,5. Total Stock,60500.0,66000.0,51000.0,50500.0,38000.0,41500.0,32500.0,32000.0,37000.0,32500.0,29500.0,28000.0,499000.0
Lakhimpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,25200.0,18700.0,18900.0,11900.0,11900.0,12900.0,11300.0,10900.0,11400.0,11900.0,27900.0,17900.0,190800.0
Lakhimpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,5500.0,0.0,11000.0,10500.0,0.0,0.0,9000.0,9000.0,18000.0,0.0,0.0,63000.0
Lakhimpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6500.0,5300.0,7000.0,11000.0,9500.0,1600.0,400.0,8500.0,8500.0,2000.0,10000.0,2500.0,72800.0
Lakhimpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,18700.0,18900.0,11900.0,11900.0,12900.0,11300.0,10900.0,11400.0,11900.0,27900.0,17900.0,15400.0,181000.0
Lakhimpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,30250.0,25250.0,27000.0,17000.0,14500.0,14000.0,12000.0,12500.0,12500.0,16750.0,16750.0,12750.0,211250.0
Lakhimpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,10000.0,0.0,0.0,5000.0,0.0,5000.0,5000.0,10000.0,5000.0,0.0,0.0,40000.0
Lakhimpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5000.0,8250.0,10000.0,2500.0,5500.0,2000.0,4500.0,5000.0,5750.0,5000.0,4000.0,7500.0,65000.0
Lakhimpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,25250.0,27000.0,17000.0,14500.0,14000.0,12000.0,12500.0,12500.0,16750.0,16750.0,12750.0,5250.0,186250.0
Lakhimpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,540950.0,538200.0,533200.0,463200.0,462200.0,462200.0,462450.0,242450.0,97450.0,100700.0,102200.0,97700.0,4102900.0
Lakhimpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,5000.0,0.0,5000.0,0.0,5000.0,10000.0,5000.0,0.0,0.0,30000.0
Lakhimpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2750.0,5000.0,70000.0,6000.0,0.0,4750.0,220000.0,150000.0,6750.0,3500.0,4500.0,60000.0,533250.0
Lakhimpur,16.1.7,Stock position of JE vaccines,5. Total Stock,538200.0,533200.0,463200.0,462200.0,462200.0,462450.0,242450.0,97450.0,100700.0,102200.0,97700.0,37700.0,3599650.0
Lakhimpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,33830.0,17330.0,14330.0,12330.0,10830.0,14130.0,19330.0,20330.0,19330.0,22330.0,16830.0,12330.0,213260.0
Lakhimpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,11000.0,0.0,11000.0,15000.0,15000.0,10000.0,10000.0,10000.0,0.0,0.0,0.0,82000.0
Lakhimpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,16500.0,14000.0,2000.0,12500.0,11700.0,9800.0,9000.0,11000.0,7000.0,5500.0,4500.0,2000.0,105500.0
Lakhimpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,17330.0,14330.0,12330.0,10830.0,14130.0,19330.0,20330.0,19330.0,22330.0,16830.0,12330.0,10330.0,189760.0
Lakhimpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,696000.0,593000.0,593000.0,543000.0,543000.0,483000.0,483000.0,483000.0,233000.0,183000.0,133000.0,43000.0,5009000.0
Lakhimpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,103000.0,0.0,50000.0,0.0,60000.0,0.0,0.0,250000.0,50000.0,50000.0,90000.0,40000.0,693000.0
Lakhimpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,593000.0,593000.0,543000.0,543000.0,483000.0,483000.0,483000.0,233000.0,183000.0,133000.0,43000.0,3000.0,4316000.0
Lakhimpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Lakhimpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Lakhimpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3600.0,2400.0,0.0,0.0,4100.0,6300.0,3500.0,2900.0,1800.0,700.0,3400.0,1000.0,29700.0
Lakhimpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,10050.0,6600.0,0.0,0.0,3300.0,3300.0,4000.0,0.0,3300.0,30550.0
Lakhimpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1200.0,2400.0,0.0,5950.0,4400.0,2800.0,600.0,4400.0,4400.0,1300.0,2400.0,800.0,30650.0
Lakhimpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2400.0,0.0,0.0,4100.0,6300.0,3500.0,2900.0,1800.0,700.0,3400.0,1000.0,3500.0,29600.0
Lakhimpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,668400.0,653600.0,636800.0,629800.0,613000.0,591400.0,589000.0,721000.0,680200.0,653800.0,593800.0,581800.0,7612600.0
Lakhimpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,24000.0,0.0,24000.0,160800.0,0.0,24000.0,0.0,0.0,0.0,232800.0
Lakhimpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,14800.0,16800.0,7000.0,40800.0,21600.0,26400.0,28800.0,40800.0,50400.0,60000.0,12000.0,64000.0,383400.0
Lakhimpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,653600.0,636800.0,629800.0,613000.0,591400.0,589000.0,721000.0,680200.0,653800.0,593800.0,581800.0,517800.0,7462000.0
Lakhimpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,135200.0,132400.0,128700.0,121700.0,115600.0,112200.0,109800.0,108000.0,75000.0,78500.0,78900.0,77000.0,1273000.0
Lakhimpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,2000.0,0.0,0.0,8000.0
Lakhimpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhimpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2800.0,3700.0,7000.0,6100.0,3400.0,2400.0,1800.0,33000.0,2500.0,1600.0,1900.0,6000.0,72200.0
Lakhimpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,132400.0,128700.0,121700.0,115600.0,112200.0,109800.0,108000.0,75000.0,78500.0,78900.0,77000.0,71000.0,1208800.0
Lakhimpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,,2.0,,,2.0,8.0,4.0,1.0,5.0,1.0,2.0,28.0
Lakhimpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,3.0,2.0,,3.0,3.0,,1.0,1.0,,,1.0,,14.0
Lakhimpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lakhimpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,3.0,2.0,,3.0,3.0,,1.0,1.0,,,1.0,,14.0
Lakhimpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,7.0,5.0,8.0,6.0,13.0,25.0,7.0,4.0,10.0,6.0,11.0,104.0
Lakhimpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lakhimpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,7.0,5.0,8.0,6.0,13.0,25.0,7.0,4.0,10.0,6.0,11.0,104.0
Lakhimpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,2.0,1.0,2.0,3.0,4.0,7.0,3.0,4.0,6.0,3.0,,39.0
Lakhimpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lakhimpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,2.0,1.0,2.0,3.0,4.0,7.0,3.0,4.0,6.0,3.0,,39.0
Lakhimpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,3.0,7.0,7.0,9.0,8.0,13.0,4.0,1.0,8.0,6.0,8.0,77.0
Lakhimpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Lakhimpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,3.0,7.0,8.0,9.0,8.0,13.0,4.0,1.0,8.0,6.0,8.0,78.0
Lakhimpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,1.0,1.0,1.0,4.0,1.0,3.0,9.0,,,1.0,22.0
Lakhimpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,1.0,1.0,1.0,,1.0,2.0,6.0
Lakhimpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,1.0,1.0,1.0,4.0,2.0,4.0,10.0,,1.0,3.0,28.0
Lakhimpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Lakhimpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,1.0,,,,,,,,1.0,2.0
Lakhimpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,,,,,,,,2.0,3.0
Lakhimpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,1.0,,,,1.0,,,,2.0,1.0,6.0
Lakhimpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,1.0,,,,1.0,,,,,3.0
Lakhimpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,2.0,1.0,1.0,,,1.0,1.0,,,2.0,1.0,9.0
Lakhimpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lakhimpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lakhimpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Lakhimpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,3.0,,1.0,2.0,7.0,1.0,10.0,,2.0,2.0,9.0,38.0
Lakhimpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,2.0,,9.0,2.0,,1.0,6.0,,,5.0,,25.0
Lakhimpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,5.0,,10.0,4.0,7.0,2.0,16.0,,2.0,7.0,9.0,63.0
Lakhimpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Lakhimpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,1.0,,1.0,1.0,,,,,,,3.0
Lakhimpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhimpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,,1.0,2.0,,,,,,,4.0
Lakhimpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Lakhimpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,2.0,,,,,,,,,1.0,3.0
Lakhimpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Lakhimpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,2.0,1.0,,,1.0,,,,,1.0,5.0
Lakhimpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,1.0,,,,1.0,,,2.0
Lakhimpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,1.0,1.0,,,,,2.0,,4.0
Lakhimpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,1.0,2.0,,,,1.0,2.0,,6.0
Lakhimpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhimpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhimpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Lakhimpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,2.0,,,,,2.0
Lakhimpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,1.0,1.0,,,,,1.0,,,2.0,,6.0
Lakhimpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,1.0,,,,,2.0,,,,,4.0
Lakhimpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,1.0,2.0,,,,,5.0,,,2.0,,12.0
Lakhimpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhimpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhimpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Lakhimpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,1.0,,6.0,2.0,1.0,,1.0,1.0,,,,13.0
Lakhimpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,4.0,2.0,1.0,5.0,2.0,,2.0,1.0,1.0,2.0,4.0,1.0,25.0
Lakhimpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,5.0,3.0,1.0,11.0,4.0,1.0,2.0,2.0,2.0,2.0,4.0,1.0,38.0
Lakhimpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,1.0,2.0,,2.0,2.0,,1.0,1.0,2.0,12.0
Lakhimpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,2.0,,2.0,,1.0,1.0,1.0,,1.0,,,8.0
Lakhimpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,3.0,,3.0,2.0,1.0,3.0,3.0,,2.0,1.0,2.0,20.0
Lakhimpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Lakhimpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Lakhimpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Lakhimpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Lakhimpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,1.0,,,,,,,,,,1.0
Lakhimpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,2.0,,,1.0,,,,4.0
Lakhimpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Lakhimpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,2.0,,,1.0,,,,4.0
Lakhimpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Lakhimpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Lakhimpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,1.0,,,,,,1.0
Lakhimpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Lakhimpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Lakhimpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,3.0,1.0,4.0,1.0,1.0,2.0,2.0,5.0,2.0,,,2.0,23.0
Lakhimpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Lakhimpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,3.0,1.0,4.0,1.0,1.0,2.0,2.0,5.0,2.0,,,2.0,23.0
Lakhimpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Lakhimpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,4.0,2.0,1.0,1.0,,3.0,1.0,,3.0,3.0,2.0,2.0,22.0
Lakhimpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhimpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,2.0,1.0,1.0,,4.0,1.0,,3.0,3.0,2.0,2.0,23.0
Lakhimpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,2.0,,,1.0,,1.0,1.0,1.0,1.0,,7.0
Lakhimpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,1.0,,1.0,1.0,,,,,,1.0,,5.0
Lakhimpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,1.0,2.0,1.0,1.0,1.0,,1.0,1.0,1.0,2.0,,12.0
Lakhimpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Lakhimpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Lakhimpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Lakhimpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,1.0,1.0,2.0
Lakhimpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,1.0,,,,,,,,1.0,2.0
Lakhimpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,2.0,1.0,2.0,,1.0,,,4.0,1.0,2.0,2.0,16.0
Lakhimpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,2.0,1.0,3.0,3.0,3.0,2.0,3.0,3.0,4.0,1.0,2.0,28.0
Lakhimpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,4.0,2.0,6.0,3.0,4.0,2.0,3.0,7.0,5.0,3.0,5.0,46.0
Lakhimpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,1.0,,,,,,1.0,,,2.0
Lakhimpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,2.0,,2.0,3.0,2.0,1.0,,2.0,2.0,4.0,1.0,20.0
Lakhimpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,5.0,10.0,3.0,3.0,5.0,1.0,2.0,6.0,7.0,4.0,4.0,2.0,52.0
Lakhimpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,6.0,12.0,3.0,6.0,8.0,3.0,3.0,6.0,9.0,7.0,8.0,3.0,74.0
Lakhimpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,3.0,,2.0,,,1.0,,1.0,,,,7.0
Lakhimpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,8.0,10.0,11.0,13.0,11.0,15.0,17.0,10.0,14.0,11.0,8.0,12.0,140.0
Lakhimpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,13.0,9.0,23.0,19.0,22.0,19.0,29.0,21.0,19.0,18.0,21.0,16.0,229.0
Lakhimpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,21.0,22.0,34.0,34.0,33.0,34.0,47.0,31.0,34.0,29.0,29.0,28.0,376.0
Marigaon,1.1,Total number of pregnant women Registered for ANC,TOTAL,2497.0,2514.0,1894.0,2251.0,2531.0,2432.0,2073.0,2190.0,1697.0,1937.0,1866.0,2183.0,26065.0
Marigaon,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1701.0,1618.0,1375.0,1496.0,1649.0,1429.0,1371.0,1983.0,1570.0,1688.0,1668.0,1933.0,19481.0
Marigaon,1.2,Number of Pregnant women registered under JSY,TOTAL,2398.0,2403.0,1812.0,2132.0,2452.0,2301.0,1960.0,2038.0,1645.0,1890.0,1807.0,2072.0,24910.0
Marigaon,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1529.0,1672.0,1608.0,1709.0,1860.0,1987.0,1955.0,2231.0,2093.0,1797.0,1765.0,1901.0,22107.0
Marigaon,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2346.0,2172.0,1626.0,1761.0,2104.0,1859.0,1881.0,1984.0,1477.0,1698.0,1677.0,1833.0,22418.0
Marigaon,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2057.0,2553.0,1918.0,1978.0,2040.0,2209.0,2342.0,2339.0,2120.0,1835.0,1800.0,1886.0,25077.0
Marigaon,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1692.0,2067.0,1613.0,1837.0,2274.0,2287.0,1781.0,2190.0,1695.0,1837.0,1837.0,2145.0,23255.0
Marigaon,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,14.0,20.0,14.0,32.0,28.0,22.0,27.0,34.0,35.0,30.0,29.0,35.0,320.0
Marigaon,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Marigaon,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1382.0,1468.0,1322.0,1406.0,1378.0,1349.0,1446.0,912.0,1044.0,817.0,856.0,1185.0,14565.0
Marigaon,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,7.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Marigaon,1.8,Number of pregnancy test kits used at SC level,TOTAL,40.0,79.0,46.0,154.0,65.0,47.0,62.0,91.0,161.0,131.0,115.0,179.0,1170.0
Marigaon,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,32.0,26.0,19.0,26.0,40.0,44.0,41.0,105.0,84.0,91.0,82.0,50.0,640.0
Marigaon,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,155.0,168.0,138.0,156.0,185.0,241.0,254.0,139.0,163.0,154.0,145.0,155.0,2053.0
Marigaon,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,187.0,194.0,157.0,182.0,225.0,285.0,295.0,244.0,247.0,245.0,227.0,205.0,2693.0
Marigaon,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,90.0,102.0,96.0,98.0,195.0,241.0,243.0,241.0,238.0,223.0,227.0,182.0,2176.0
Marigaon,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1176.0,1126.0,1150.0,1349.0,1430.0,1537.0,1521.0,1540.0,1703.0,1699.0,1430.0,1379.0,17040.0
Marigaon,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,502.0,322.0,425.0,614.0,598.0,530.0,634.0,83.0,152.0,199.0,137.0,140.0,4336.0
Marigaon,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,957.0,1168.0,1278.0,1223.0,1294.0,1432.0,1522.0,1479.0,1633.0,1405.0,1670.0,1541.0,16602.0
Marigaon,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,280.0,167.0,743.0,1627.0,189.0,1481.0,248.0,310.0,741.0,569.0,1061.0,952.0,8368.0
Marigaon,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Marigaon,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,5.0,2.0,2.0,1.0,2.0,6.0,2.0,3.0,3.0,4.0,3.0,5.0,38.0
Marigaon,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Marigaon,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Marigaon,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Marigaon,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,77.0,81.0,84.0,85.0,89.0,75.0,46.0,88.0,72.0,89.0,66.0,76.0,928.0
Marigaon,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Marigaon,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,77.0,81.0,84.0,85.0,89.0,75.0,46.0,88.0,72.0,89.0,66.0,76.0,928.0
Marigaon,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Marigaon,4.1.1.a,Number of male live births,TOTAL,650.0,662.0,631.0,760.0,828.0,917.0,929.0,915.0,967.0,983.0,857.0,792.0,9891.0
Marigaon,4.1.1.b,Number of female live births,TOTAL,702.0,641.0,656.0,757.0,806.0,895.0,876.0,864.0,963.0,951.0,794.0,791.0,9696.0
Marigaon,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1352.0,1303.0,1287.0,1517.0,1634.0,1812.0,1805.0,1779.0,1930.0,1934.0,1651.0,1583.0,19587.0
Marigaon,4.1.2,Number of still births,TOTAL,21.0,23.0,30.0,17.0,24.0,19.0,27.0,10.0,27.0,21.0,12.0,8.0,239.0
Marigaon,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,109.0,123.0,123.0,112.0,87.0,87.0,57.0,55.0,47.0,57.0,36.0,64.0,957.0
Marigaon,4.2.1,Number of Newborns weighed at birth,TOTAL,1359.0,1315.0,1297.0,1523.0,1643.0,1816.0,1803.0,1781.0,1941.0,1941.0,1653.0,1584.0,19656.0
Marigaon,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,314.0,308.0,337.0,400.0,411.0,475.0,393.0,203.0,267.0,198.0,210.0,177.0,3693.0
Marigaon,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1351.0,1295.0,1256.0,1440.0,1586.0,1586.0,1754.0,1772.0,1822.0,1896.0,1611.0,1556.0,18925.0
Marigaon,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,4.0,9.0,0.0,10.0,7.0,0.0,0.0,39.0,6.0,3.0,5.0,6.0,89.0
Marigaon,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,54.0,54.0,72.0,37.0,57.0,81.0,88.0,0.0,0.0,0.0,34.0,43.0,520.0
Marigaon,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,34.0,36.0,27.0,30.0,38.0,165.0
Marigaon,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Marigaon,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,58.0,63.0,72.0,47.0,64.0,81.0,88.0,73.0,42.0,30.0,69.0,87.0,774.0
Marigaon,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Marigaon,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1091.0,2261.0,856.0,1603.0,1873.0,1129.0,1088.0,970.0,637.0,1554.0,1095.0,1747.0,15904.0
Marigaon,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,10.0,14.0,15.0,18.0,26.0,12.0,15.0,20.0,0.0,0.0,10.0,0.0,140.0
Marigaon,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,490.0,597.0,324.0,680.0,337.0,410.0,694.0,300.0,4.0,111.0,129.0,240.0,4316.0
Marigaon,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,135.0,123.0,112.0,112.0,482.0
Marigaon,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,946.0,1005.0,889.0,1052.0,1122.0,1124.0,1129.0,967.0,1164.0,1158.0,1067.0,986.0,12609.0
Marigaon,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,679.0,622.0,461.0,840.0,854.0,928.0,859.0,742.0,878.0,1055.0,977.0,903.0,9798.0
Marigaon,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,46.0,51.0,55.0,47.0,37.0,29.0,13.0,21.0,20.0,22.0,13.0,32.0,386.0
Marigaon,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,6.0,2.0,3.0,2.0,1.0,3.0,1.0,1.0,0.0,2.0,3.0,0.0,24.0
Marigaon,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,52.0,53.0,58.0,49.0,38.0,32.0,14.0,22.0,20.0,24.0,16.0,32.0,410.0
Marigaon,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Marigaon,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,30.0,78.0,40.0,29.0,33.0,30.0,44.0,32.0,35.0,37.0,33.0,54.0,475.0
Marigaon,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,85.0,88.0,95.0,62.0,79.0,44.0,57.0,64.0,70.0,63.0,72.0,140.0,919.0
Marigaon,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,115.0,166.0,135.0,91.0,112.0,74.0,101.0,96.0,105.0,100.0,105.0,194.0,1394.0
Marigaon,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,41.0,0.0,25.0,0.0,0.0,0.0,0.0,17.0,0.0,83.0
Marigaon,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,0.0,0.0,0.0,16.0,16.0,0.0,0.0,0.0,0.0,0.0,32.0
Marigaon,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Marigaon,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,41.0,0.0,41.0,16.0,0.0,0.0,0.0,17.0,0.0,115.0
Marigaon,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Marigaon,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,88.0,0.0,256.0,0.0,65.0,0.0,0.0,0.0,0.0,42.0,40.0,491.0
Marigaon,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,89.0,0.0,70.0,0.0,0.0,0.0,0.0,41.0,0.0,200.0
Marigaon,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,74.0,0.0,74.0,0.0,0.0,0.0,0.0,0.0,0.0,73.0,35.0,256.0
Marigaon,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Marigaon,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,162.0,0.0,419.0,0.0,135.0,0.0,0.0,0.0,0.0,156.0,75.0,947.0
Marigaon,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Marigaon,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Marigaon,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Marigaon,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Marigaon,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,4.0,4.0,5.0,3.0,0.0,3.0,3.0,4.0,7.0,4.0,7.0,9.0,53.0
Marigaon,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Marigaon,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,4.0,4.0,5.0,3.0,0.0,3.0,3.0,4.0,7.0,4.0,7.0,9.0,53.0
Marigaon,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Marigaon,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,72.0,77.0,73.0,764.0,114.0,114.0,112.0,105.0,82.0,77.0,113.0,312.0,2015.0
Marigaon,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,14.0,16.0,21.0,68.0,50.0,41.0,45.0,38.0,64.0,33.0,25.0,174.0,589.0
Marigaon,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,5.0,3.0,1.0,2.0,0.0,2.0,3.0,2.0,2.0,0.0,2.0,55.0,77.0
Marigaon,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,9.0,9.0,4.0,21.0,5.0,4.0,6.0,3.0,3.0,6.0,43.0,7.0,120.0
Marigaon,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Marigaon,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,100.0,105.0,99.0,855.0,169.0,161.0,166.0,148.0,151.0,116.0,183.0,548.0,2801.0
Marigaon,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,16.0,18.0,10.0,9.0,10.0,25.0,25.0,23.0,6.0,28.0,39.0,38.0,247.0
Marigaon,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Marigaon,9.06,Number of IUCD removals,TOTAL,13.0,42.0,21.0,21.0,11.0,16.0,16.0,33.0,8.0,8.0,8.0,35.0,232.0
Marigaon,9.07,Number of Oral Pills cycles distributed,TOTAL,4206.0,4965.0,3847.0,7397.0,3942.0,3466.0,3354.0,3175.0,3105.0,3305.0,3749.0,3747.0,48258.0
Marigaon,9.08,Number of Condom pieces distributed,TOTAL,6857.0,7031.0,5648.0,7870.0,3357.0,3503.0,4961.0,5114.0,6005.0,6853.0,7353.0,7265.0,71817.0
Marigaon,9.09,Number of Centchroman (weekly) pills given,TOTAL,31.0,20.0,14.0,4.0,0.0,5.0,13.0,20.0,15.0,30.0,98.0,150.0,400.0
Marigaon,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,20.0,20.0,19.0,28.0,55.0,32.0,65.0,83.0,58.0,30.0,40.0,25.0,475.0
Marigaon,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,5.0
Marigaon,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,3.0,2.0,1.0,0.0,0.0,3.0,13.0
Marigaon,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,2.0,2.0,2.0,2.0,3.0,2.0,3.0,2.0,2.0,2.0,2.0,-1.0
Marigaon,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2092.0,1829.0,1109.0,1464.0,1594.0,1812.0,1622.0,2084.0,2229.0,1848.0,2110.0,2278.0,22071.0
Marigaon,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1952.0,1938.0,1291.0,1445.0,1492.0,1870.0,1830.0,2183.0,1969.0,2041.0,1332.0,335.0,19678.0
Marigaon,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1879.0,2013.0,1616.0,1491.0,1386.0,1729.0,1716.0,1879.0,2158.0,1863.0,1927.0,1624.0,21281.0
Marigaon,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1869.0,1954.0,1662.0,1641.0,1452.0,1609.0,1601.0,1792.0,1943.0,1977.0,1722.0,2143.0,21365.0
Marigaon,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,640.0,2037.0,2677.0
Marigaon,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,602.0,602.0
Marigaon,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,499.0,408.0,441.0,492.0,349.0,721.0,770.0,836.0,779.0,734.0,930.0,737.0,7696.0
Marigaon,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1858.0,1799.0,1216.0,1418.0,1307.0,1801.0,1666.0,1896.0,1292.0,2003.0,1648.0,1982.0,19886.0
Marigaon,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1804.0,1827.0,1484.0,1465.0,1208.0,1635.0,1626.0,1621.0,1419.0,1758.0,2038.0,1936.0,19821.0
Marigaon,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1788.0,1760.0,1479.0,1609.0,1261.0,1502.0,1571.0,1559.0,1231.0,1850.0,1861.0,2068.0,19539.0
Marigaon,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,392.0,323.0,343.0,440.0,317.0,467.0,715.0,731.0,919.0,709.0,786.0,711.0,6853.0
Marigaon,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1879.0,1935.0,1304.0,1445.0,1493.0,1866.0,1827.0,2149.0,1918.0,2011.0,1349.0,331.0,19507.0
Marigaon,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1814.0,1985.0,1619.0,1500.0,1395.0,1714.0,1702.0,1857.0,2122.0,1834.0,1865.0,1558.0,20965.0
Marigaon,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1811.0,1936.0,1666.0,1672.0,1451.0,1599.0,1591.0,1777.0,1905.0,1943.0,1703.0,2077.0,21131.0
Marigaon,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1382.0,1697.0,1482.0,1733.0,1913.0,2227.0,1770.0,2164.0,1913.0,1376.0,1822.0,2050.0,21529.0
Marigaon,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1430.0,1649.0,963.0,1296.0,1471.0,1502.0,1395.0,1568.0,1586.0,1132.0,1575.0,1839.0,17406.0
Marigaon,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,629.0,629.0
Marigaon,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,720.0,877.0,753.0,858.0,993.0,1109.0,890.0,1127.0,990.0,689.0,942.0,1026.0,10974.0
Marigaon,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,658.0,818.0,728.0,871.0,918.0,1065.0,869.0,1033.0,923.0,677.0,875.0,1020.0,10455.0
Marigaon,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1378.0,1695.0,1481.0,1729.0,1911.0,2174.0,1759.0,2160.0,1913.0,1366.0,1817.0,2046.0,21429.0
Marigaon,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1439.0,1659.0,963.0,1308.0,1497.0,1512.0,1524.0,1583.0,1586.0,1265.0,1633.0,1827.0,17796.0
Marigaon,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1434.0,1527.0,945.0,1292.0,1421.0,1484.0,1514.0,1570.0,1347.0,1195.0,1654.0,1848.0,17231.0
Marigaon,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,152.0,352.0,138.0,158.0,180.0,155.0,174.0,268.0,206.0,135.0,173.0,208.0,2299.0
Marigaon,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,154.0,344.0,116.0,141.0,166.0,142.0,144.0,292.0,196.0,128.0,160.0,198.0,2181.0
Marigaon,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,306.0,696.0,254.0,299.0,346.0,297.0,318.0,560.0,402.0,263.0,333.0,406.0,4480.0
Marigaon,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,761.0,807.0,545.0,640.0,763.0,900.0,857.0,1026.0,1212.0,1122.0,1182.0,1190.0,11005.0
Marigaon,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,710.0,685.0,487.0,502.0,547.0,943.0,880.0,1282.0,1171.0,1132.0,1230.0,1140.0,10709.0
Marigaon,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,491.0,486.0,403.0,407.0,408.0,627.0,611.0,695.0,956.0,830.0,827.0,851.0,7592.0
Marigaon,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,982.0,975.0,1001.0,993.0,979.0,985.0,986.0,984.0,986.0,974.0,993.0,996.0,11834.0
Marigaon,10.4.2,Number of Immunisation sessions held during the month,TOTAL,969.0,967.0,985.0,975.0,937.0,964.0,963.0,971.0,970.0,964.0,976.0,968.0,11609.0
Marigaon,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,954.0,947.0,976.0,961.0,931.0,945.0,953.0,949.0,958.0,952.0,962.0,954.0,11442.0
Marigaon,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,491.0,491.0
Marigaon,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1295.0,1599.0,1328.0,1512.0,1856.0,1995.0,1605.0,1898.0,1757.0,1299.0,1693.0,1741.0,19578.0
Marigaon,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,277.0,335.0,228.0,249.0,1864.0,718.0,341.0,313.0,345.0,338.0,574.0,865.0,6447.0
Marigaon,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,531.0,525.0,344.0,381.0,1908.0,799.0,625.0,742.0,808.0,714.0,786.0,929.0,9092.0
Marigaon,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,248.0,239.0,446.0,397.0,321.0,281.0,209.0,169.0,136.0,158.0,156.0,262.0,3022.0
Marigaon,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Marigaon,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,6.0,2.0,318.0,568.0,65.0,78.0,63.0,45.0,65.0,61.0,72.0,42.0,1385.0
Marigaon,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,60.0,76.0,81.0,76.0,54.0,49.0,91.0,487.0
Marigaon,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,75.0,78.0,0.0,50.0,49.0,90.0,342.0
Marigaon,13.3,Number of School children detected with Refractive errors,TOTAL,1.0,2.0,3.0,3.0,3.0,78.0,55.0,3.0,67.0,49.0,71.0,3.0,338.0
Marigaon,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,333.0,5.0,0.0,0.0,0.0,0.0,2.0,3.0,343.0
Marigaon,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Marigaon,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,11.0,11.0,12.0,14.0,14.0,13.0,13.0,13.0,12.0,13.0,13.0,12.0,-1.0
Marigaon,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,889.0,904.0,861.0,864.0,846.0,855.0,853.0,853.0,856.0,855.0,861.0,859.0,-1.0
Marigaon,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,4.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Marigaon,14.05,Number of RKS meetings held during the month,TOTAL,17.0,17.0,16.0,18.0,19.0,16.0,18.0,21.0,19.0,20.0,21.0,25.0,227.0
Marigaon,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,14.0,17.0,16.0,19.0,20.0,20.0,21.0,20.0,19.0,18.0,19.0,20.0,-1.0
Marigaon,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,342.0,308.0,296.0,270.0,320.0,296.0,417.0,364.0,347.0,320.0,297.0,294.0,3871.0
Marigaon,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Marigaon,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Marigaon,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,298.0,351.0,453.0,465.0,496.0,377.0,372.0,367.0,285.0,271.0,313.0,320.0,4368.0
Marigaon,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,920.0,717.0,1034.0,979.0,831.0,775.0,737.0,527.0,570.0,604.0,653.0,864.0,9211.0
Marigaon,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,233.0,281.0,430.0,427.0,430.0,341.0,308.0,333.0,276.0,284.0,370.0,297.0,4010.0
Marigaon,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1431.0,1422.0,1391.0,1713.0,1620.0,1418.0,1455.0,1380.0,1312.0,1341.0,1292.0,1445.0,17220.0
Marigaon,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,531.0,632.0,883.0,892.0,926.0,718.0,680.0,700.0,561.0,555.0,683.0,617.0,8378.0
Marigaon,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2351.0,2139.0,2425.0,2692.0,2451.0,2193.0,2192.0,1907.0,1882.0,1945.0,1945.0,2309.0,26431.0
Marigaon,14.10.2.a,Number of death cases of Inpatient males,TOTAL,11.0,6.0,7.0,9.0,5.0,7.0,8.0,6.0,12.0,12.0,12.0,12.0,107.0
Marigaon,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,11.0,6.0,6.0,4.0,9.0,10.0,7.0,5.0,5.0,6.0,7.0,82.0
Marigaon,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,17.0,17.0,13.0,15.0,9.0,16.0,18.0,13.0,17.0,17.0,18.0,19.0,189.0
Marigaon,14.11,In-Patient Head Count at midnight,TOTAL,0.0,3734.0,3532.0,3628.0,3526.0,3299.0,2814.0,2984.0,2915.0,2576.0,2655.0,2970.0,34633.0
Marigaon,14.12.1,OPD attendance (All),TOTAL,93416.0,85343.0,86277.0,89736.0,81068.0,79048.0,69457.0,64904.0,59153.0,59287.0,66717.0,73028.0,907434.0
Marigaon,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,54.0,70.0,156.0,142.0,141.0,117.0,73.0,152.0,121.0,140.0,104.0,16.0,1286.0
Marigaon,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,4.0,0.0,4.0,2.0,2.0,3.0,3.0,4.0,2.0,2.0,4.0,4.0,34.0
Marigaon,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,1.0,24.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0
Marigaon,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,49.0,130.0,68.0,150.0,112.0,120.0,125.0,152.0,170.0,180.0,122.0,158.0,1536.0
Marigaon,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0,0.0,0.0,0.0,25.0
Marigaon,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8914.0,5528.0,4929.0,5625.0,6377.0,6558.0,6273.0,6099.0,5820.0,4972.0,4894.0,5449.0,71438.0
Marigaon,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,12.0,40.0,29.0,41.0,66.0,45.0,37.0,37.0,39.0,18.0,19.0,19.0,402.0
Marigaon,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,105.0,139.0,119.0,124.0,84.0,101.0,68.0,87.0,54.0,34.0,104.0,96.0,1115.0
Marigaon,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Marigaon,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,146.0,269.0,181.0,116.0,174.0,120.0,156.0,163.0,162.0,109.0,183.0,180.0,1959.0
Marigaon,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0
Marigaon,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,530.0,760.0,32.0,769.0,675.0,902.0,832.0,755.0,624.0,1023.0,750.0,636.0,8288.0
Marigaon,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Marigaon,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,781.0,1168.0,332.0,1009.0,933.0,1123.0,1056.0,1005.0,840.0,1166.0,1037.0,912.0,11362.0
Marigaon,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,5.0
Marigaon,15.2,Number of Widal tests conducted,Number tested,83.0,113.0,107.0,216.0,149.0,203.0,134.0,69.0,41.0,21.0,64.0,92.0,1292.0
Marigaon,15.3.a,Number of VDRL tests conducted on males,Number tested,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,3.0
Marigaon,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,5.0
Marigaon,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,119.0,209.0,31.0,74.0,44.0,66.0,278.0,234.0,226.0,195.0,142.0,251.0,1869.0
Marigaon,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,120.0,209.0,31.0,74.0,44.0,66.0,278.0,239.0,226.0,195.0,143.0,252.0,1877.0
Marigaon,15.4.1,Number of blood smears examined for Malaria,TOTAL,5386.0,5273.0,7479.0,9911.0,8037.0,6311.0,5395.0,6034.0,4701.0,3772.0,4793.0,6030.0,73122.0
Marigaon,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,2.0,5.0,7.0,5.0,0.0,551.0,4.0,4.0,1.0,2.0,85.0,666.0
Marigaon,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,8.0,14.0,2.0,2.0,4.0,1.0,1.0,0.0,0.0,0.0,32.0
Marigaon,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1961.0,810.0,1706.0,804.0,704.0,314.0,379.0,1829.0,1799.0,944.0,1294.0,2294.0,14838.0
Marigaon,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,1500.0,0.0,1000.0,0.0,2000.0,1600.0,1000.0,0.0,1500.0,1500.0,0.0,10100.0
Marigaon,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Marigaon,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1151.0,604.0,902.0,1100.0,390.0,1935.0,150.0,1030.0,855.0,1150.0,500.0,500.0,10267.0
Marigaon,16.1.1,Stock position of DPT vaccines,5. Total Stock,810.0,1706.0,804.0,704.0,314.0,379.0,1829.0,1799.0,944.0,1294.0,2294.0,1794.0,14671.0
Marigaon,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,0.0,520.0,520.0
Marigaon,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,1500.0,0.0,1500.0
Marigaon,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Marigaon,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,980.0,250.0,1230.0
Marigaon,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,520.0,270.0,790.0
Marigaon,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,435.0,10.0,271.0,371.0,21.0,0.0,,0.0,,0.0,400.0,275.0,1783.0
Marigaon,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,550.0,1050.0,0.0,0.0,1000.0,,0.0,,700.0,9200.0,0.0,12500.0
Marigaon,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0
Marigaon,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,425.0,289.0,950.0,350.0,21.0,1000.0,,0.0,,300.0,9325.0,275.0,12935.0
Marigaon,16.1.2,Stock position of OPV vaccines,5. Total Stock,10.0,271.0,371.0,21.0,0.0,0.0,0.0,0.0,0.0,400.0,275.0,0.0,1348.0
Marigaon,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1559.0,754.0,305.0,0.0,350.0,105.0,345.0,1215.0,1235.0,555.0,448.0,948.0,7819.0
Marigaon,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,0.0,1000.0,0.0,2000.0,1000.0,1000.0,0.0,1000.0,1000.0,0.0,7000.0
Marigaon,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.1.3,Stock position of TT vaccines,4. Stock Distributed,805.0,449.0,305.0,650.0,245.0,1760.0,130.0,980.0,680.0,1107.0,500.0,360.0,7971.0
Marigaon,16.1.3,Stock position of TT vaccines,5. Total Stock,754.0,305.0,0.0,350.0,105.0,345.0,1215.0,1235.0,555.0,448.0,948.0,588.0,6848.0
Marigaon,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Marigaon,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Marigaon,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Marigaon,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Marigaon,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,910.0,807.0,542.0,0.0,420.0,0.0,,0.0,,0.0,550.0,625.0,3854.0
Marigaon,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,200.0,0.0,1000.0,0.0,1000.0,,850.0,,1000.0,650.0,0.0,5700.0
Marigaon,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0
Marigaon,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1103.0,465.0,542.0,580.0,420.0,880.0,,580.0,,450.0,575.0,515.0,6110.0
Marigaon,16.1.5,Stock position of BCG vaccines,5. Total Stock,807.0,542.0,0.0,420.0,0.0,120.0,0.0,270.0,0.0,550.0,625.0,110.0,3444.0
Marigaon,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1618.0,719.0,209.0,1193.0,1173.0,838.0,0.0,810.0,1010.0,0.0,310.0,700.0,8580.0
Marigaon,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,2000.0,1000.0,0.0,0.0,1000.0,1000.0,0.0,1000.0,1000.0,0.0,7000.0
Marigaon,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,899.0,510.0,1016.0,1020.0,335.0,838.0,190.0,800.0,1010.0,690.0,610.0,660.0,8578.0
Marigaon,16.1.6,Stock position of Measles vaccines,5. Total Stock,719.0,209.0,1193.0,1173.0,838.0,0.0,810.0,1010.0,0.0,310.0,700.0,40.0,7002.0
Marigaon,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,0.0,420.0,1120.0,1540.0
Marigaon,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,1000.0,1000.0,0.0,2000.0
Marigaon,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Marigaon,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,580.0,300.0,410.0,1290.0
Marigaon,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,420.0,1120.0,710.0,2250.0
Marigaon,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1900.0,608.0,1675.0,922.0,887.0,477.0,591.0,1551.0,621.0,0.0,526.0,1076.0,10834.0
Marigaon,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,1950.0,0.0,1000.0,0.0,2000.0,1000.0,0.0,0.0,1000.0,1000.0,0.0,7950.0
Marigaon,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1292.0,883.0,753.0,1035.0,410.0,1886.0,40.0,930.0,621.0,474.0,450.0,430.0,9204.0
Marigaon,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,608.0,1675.0,922.0,887.0,477.0,591.0,1551.0,621.0,0.0,526.0,1076.0,646.0,9580.0
Marigaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Marigaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Marigaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Marigaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Marigaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,,,,,,0.0,12000.0,8000.0,20000.0
Marigaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,,,,,,24000.0,0.0,0.0,24000.0
Marigaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,,,,,,0.0,0.0,0.0,0.0
Marigaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,,,,,,12000.0,4000.0,8000.0,24000.0
Marigaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,8000.0,0.0,20000.0
Marigaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3300.0,0.0,3900.0,2400.0,3800.0,1300.0,100.0,600.0,400.0,0.0,11000.0,3800.0,30600.0
Marigaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,5000.0,0.0,9000.0,0.0,0.0,1000.0,0.0,0.0,19200.0,0.0,0.0,34200.0
Marigaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,2500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2500.0
Marigaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,3300.0,1100.0,1500.0,7600.0,,1200.0,500.0,200.0,400.0,8200.0,7200.0,2400.0,33600.0
Marigaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,3900.0,2400.0,3800.0,1300.0,100.0,600.0,400.0,0.0,11000.0,3800.0,1400.0,28700.0
Marigaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,2000.0,1650.0,3100.0,1600.0,50.0,5050.0,4550.0,3950.0,7450.0,7050.0,36450.0
Marigaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,2000.0,0.0,4500.0,0.0,0.0,5000.0,0.0,0.0,4500.0,0.0,0.0,16000.0
Marigaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,350.0,3050.0,1500.0,1550.0,0.0,500.0,600.0,1000.0,400.0,1000.0,9950.0
Marigaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,2000.0,1650.0,3100.0,1600.0,50.0,5050.0,4550.0,3950.0,7450.0,7050.0,6050.0,42500.0
Marigaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Marigaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Marigaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Marigaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Marigaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,0.0,0.0,2110.0,2110.0
Marigaon,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,0.0,4320.0,4320.0,8640.0
Marigaon,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Marigaon,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,0.0,2210.0,3000.0,5210.0
Marigaon,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2110.0,3430.0,5540.0
Marigaon,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,324.0,124.0,1724.0,2749.0,2299.0,749.0,374.0,1100.0,675.0,350.0,200.0,200.0,10868.0
Marigaon,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,4000.0,2000.0,1000.0,0.0,0.0,4400.0,1000.0,0.0,0.0,1000.0,1000.0,14400.0
Marigaon,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.3.02,Stock Position of Gloves,4. Stock Distributed,200.0,2400.0,975.0,1450.0,1550.0,375.0,3674.0,1425.0,325.0,150.0,1000.0,725.0,14249.0
Marigaon,16.3.02,Stock Position of Gloves,5. Total Stock,124.0,1724.0,2749.0,2299.0,749.0,374.0,1100.0,675.0,350.0,200.0,200.0,475.0,11019.0
Marigaon,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Marigaon,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Marigaon,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Marigaon,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Marigaon,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Marigaon,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Marigaon,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Marigaon,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Marigaon,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Marigaon,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Marigaon,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Marigaon,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Marigaon,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Marigaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Marigaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Marigaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Marigaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,0.0,0.0,,0.0
Marigaon,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,8300.0,0.0,,8300.0
Marigaon,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Marigaon,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,8300.0,0.0,,8300.0
Marigaon,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Marigaon,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Marigaon,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Marigaon,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Marigaon,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Marigaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Marigaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Marigaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Marigaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,0.0,0.0,,0.0
Marigaon,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,0.0,0.0,,0.0
Marigaon,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Marigaon,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,0.0,0.0,,0.0
Marigaon,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,0.0,0.0,,0.0
Marigaon,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,0.0,0.0,,0.0
Marigaon,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Marigaon,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,0.0,0.0,,0.0
Marigaon,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2500.0,500.0,0.0,7300.0,4600.0,3300.0,1800.0,1200.0,1700.0,1500.0,1100.0,300.0,25800.0
Marigaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,9900.0,0.0,0.0,3300.0,0.0,3300.0,2000.0,2000.0,0.0,0.0,20500.0
Marigaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2000.0,500.0,2600.0,2700.0,1300.0,4800.0,600.0,2800.0,2200.0,2400.0,800.0,300.0,23000.0
Marigaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,500.0,0.0,7300.0,4600.0,3300.0,1800.0,1200.0,1700.0,1500.0,1100.0,300.0,0.0,23300.0
Marigaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,31400.0,245400.0,54600.0,47800.0,56000.0,48400.0,41200.0,75800.0,81000.0,63400.0,57400.0,54600.0,857000.0
Marigaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,240000.0,36000.0,0.0,24000.0,0.0,48000.0,36000.0,24000.0,0.0,24000.0,24000.0,0.0,456000.0
Marigaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,26000.0,226800.0,6800.0,15800.0,7600.0,55200.0,1400.0,18800.0,17600.0,30000.0,26800.0,5000.0,437800.0
Marigaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,245400.0,54600.0,47800.0,56000.0,48400.0,41200.0,75800.0,81000.0,63400.0,57400.0,54600.0,49600.0,875200.0
Marigaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,6200.0,3500.0,1500.0,1200.0,700.0,300.0,500.0,400.0,1300.0,0.0,1000.0,1500.0,18100.0
Marigaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,6000.0,0.0,2000.0,500.0,5000.0,0.0,2000.0,0.0,2000.0,2000.0,0.0,19500.0
Marigaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Marigaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2700.0,8000.0,300.0,2500.0,900.0,4800.0,100.0,1100.0,1300.0,1000.0,1500.0,400.0,24600.0
Marigaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3500.0,1500.0,1200.0,700.0,300.0,500.0,400.0,1300.0,0.0,1000.0,1500.0,1100.0,13000.0
Marigaon,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,1.0,,,,,,,,1.0
Marigaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,1.0,,,,,,,1.0,,2.0
Marigaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,1.0,1.0
Marigaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,1.0,,,,,,,1.0,1.0,3.0
Marigaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,3.0,2.0,2.0,2.0,3.0,3.0,1.0,4.0,2.0,2.0,,2.0,26.0
Marigaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,1.0,,,,,2.0
Marigaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,3.0,2.0,2.0,2.0,3.0,3.0,2.0,5.0,2.0,2.0,,2.0,28.0
Marigaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,3.0,5.0,5.0,4.0,12.0,7.0,5.0,4.0,7.0,7.0,8.0,69.0
Marigaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Marigaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,4.0,5.0,5.0,4.0,12.0,7.0,5.0,4.0,7.0,7.0,8.0,70.0
Marigaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,1.0,3.0,3.0,3.0,4.0,1.0,6.0,12.0,6.0,6.0,46.0
Marigaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,5.0,5.0,2.0,2.0,2.0,16.0
Marigaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,1.0,3.0,3.0,3.0,4.0,6.0,11.0,14.0,8.0,8.0,62.0
Marigaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,2.0,1.0,2.0,3.0,3.0,14.0,9.0,5.0,7.0,7.0,10.0,64.0
Marigaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,1.0,,,,3.0,1.0,1.0,1.0,,,7.0
Marigaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,2.0,2.0,2.0,3.0,3.0,17.0,10.0,6.0,8.0,7.0,10.0,71.0
Marigaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Marigaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,1.0,,,,,,,,,,1.0
Marigaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,1.0,,,,,,,,,,1.0
Marigaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,2.0,2.0,1.0,3.0,3.0,4.0,2.0,1.0,,1.0,2.0,1.0,22.0
Marigaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,1.0,1.0,,1.0,1.0,1.0,5.0
Marigaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,2.0,2.0,1.0,3.0,3.0,4.0,3.0,2.0,,2.0,3.0,2.0,27.0
Marigaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Marigaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Marigaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Marigaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,7.0,4.0,8.0,9.0,10.0,13.0,13.0,9.0,10.0,11.0,9.0,9.0,112.0
Marigaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,2.0,,,,,1.0,1.0,1.0,,2.0,,7.0
Marigaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,7.0,6.0,8.0,9.0,10.0,13.0,14.0,10.0,11.0,11.0,11.0,9.0,119.0
Marigaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Marigaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,,,,1.0,,,,,2.0
Marigaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,1.0,,,1.0,2.0
Marigaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,,,,2.0,1.0,,,1.0,5.0
Marigaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Marigaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,,,,,2.0,,,1.0,,,4.0
Marigaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,1.0,2.0,1.0,,1.0,1.0,1.0,7.0
Marigaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,,,,1.0,4.0,1.0,,2.0,1.0,1.0,11.0
Marigaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Marigaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,3.0,,,,1.0,,1.0,5.0,5.0,3.0,,18.0
Marigaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,1.0,3.0,1.0,,,1.0,,4.0,4.0,5.0,2.0,23.0
Marigaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,4.0,3.0,1.0,,1.0,1.0,1.0,9.0,9.0,8.0,2.0,41.0
Marigaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Marigaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Marigaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Marigaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,1.0,,,,,,1.0
Marigaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Marigaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,1.0,3.0,2.0,3.0,1.0,2.0,2.0,4.0,3.0,1.0,1.0,25.0
Marigaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,1.0,1.0,2.0,2.0,3.0,2.0,1.0,2.0,2.0,2.0,1.0,20.0
Marigaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,3.0,2.0,4.0,4.0,5.0,5.0,4.0,3.0,6.0,5.0,3.0,2.0,46.0
Marigaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Marigaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Marigaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Marigaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Marigaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,1.0,1.0,,,,,2.0
Marigaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,,5.0,2.0,5.0,12.0,8.0,6.0,7.0,6.0,7.0,9.0,70.0
Marigaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,15.0,4.0,9.0,11.0,11.0,10.0,13.0,10.0,8.0,11.0,5.0,5.0,112.0
Marigaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,18.0,4.0,14.0,13.0,16.0,22.0,22.0,17.0,15.0,17.0,12.0,14.0,184.0
Marigaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Marigaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,5.0,,1.0,,,,,,1.0,,,1.0,8.0
Marigaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,3.0,,,,3.0,1.0,2.0,2.0,1.0,3.0,,2.0,17.0
Marigaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,8.0,,1.0,,3.0,1.0,3.0,2.0,2.0,3.0,,3.0,26.0
Marigaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Marigaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Marigaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Marigaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Marigaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Marigaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Marigaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Marigaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,1.0,1.0
Marigaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Marigaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,2.0,1.0,1.0,1.0,15.0
Marigaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Marigaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,2.0,1.0,1.0,1.0,15.0
Marigaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Marigaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,1.0,,,,,,,2.0
Marigaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Marigaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,1.0,,,,,,,2.0
Marigaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Marigaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Marigaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Marigaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Marigaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Marigaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,2.0,3.0,5.0,2.0,3.0,3.0,3.0,1.0,,2.0,2.0,28.0
Marigaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Marigaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,2.0,3.0,5.0,2.0,3.0,3.0,3.0,1.0,,2.0,2.0,28.0
Marigaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,4.0,,,1.0,1.0,1.0,7.0
Marigaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,5.0,4.0,3.0,4.0,1.0,5.0,1.0,1.0,4.0,,1.0,31.0
Marigaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,3.0,,,,,1.0,,,1.0,,1.0,6.0
Marigaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,8.0,4.0,3.0,4.0,1.0,10.0,1.0,1.0,6.0,1.0,3.0,44.0
Marigaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Marigaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,2.0,1.0,,,2.0,2.0,2.0,4.0,,1.0,1.0,16.0
Marigaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,2.0,1.0,,,,1.0,,,,,5.0
Marigaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,2.0,3.0,1.0,,2.0,3.0,3.0,4.0,,1.0,1.0,22.0
Marigaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Marigaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,2.0,,,,1.0,1.0,,,,,4.0
Marigaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,,,,,1.0,2.0,,,4.0
Marigaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,3.0,,,1.0,1.0,1.0,1.0,2.0,,,9.0
Marigaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,1.0,2.0,,1.0,,,,,,5.0
Marigaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,7.0,5.0,7.0,7.0,3.0,2.0,,3.0,3.0,2.0,2.0,45.0
Marigaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,6.0,4.0,9.0,6.0,5.0,6.0,4.0,3.0,5.0,2.0,,53.0
Marigaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,8.0,13.0,9.0,17.0,15.0,8.0,9.0,4.0,6.0,8.0,4.0,2.0,103.0
Marigaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Marigaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,9.0,3.0,8.0,10.0,7.0,4.0,7.0,9.0,4.0,2.0,7.0,9.0,79.0
Marigaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,12.0,17.0,12.0,7.0,7.0,7.0,6.0,7.0,10.0,14.0,11.0,10.0,120.0
Marigaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,22.0,20.0,20.0,17.0,14.0,11.0,13.0,16.0,14.0,16.0,18.0,19.0,200.0
Marigaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,1.0,,,,1.0,,,1.0,,,3.0
Marigaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,4.0,4.0,6.0,7.0,9.0,5.0,4.0,6.0,10.0,6.0,9.0,7.0,77.0
Marigaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,6.0,16.0,14.0,12.0,20.0,9.0,12.0,8.0,15.0,10.0,23.0,10.0,155.0
Marigaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,10.0,20.0,21.0,19.0,29.0,14.0,17.0,14.0,25.0,17.0,32.0,17.0,235.0
Nagaon,1.1,Total number of pregnant women Registered for ANC,TOTAL,6358.0,6858.0,6465.0,5630.0,6846.0,6672.0,5584.0,6286.0,5667.0,5524.0,5608.0,6353.0,73851.0
Nagaon,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,5191.0,5392.0,5171.0,4470.0,5369.0,5385.0,4563.0,5069.0,4433.0,4348.0,4562.0,5242.0,59195.0
Nagaon,1.2,Number of Pregnant women registered under JSY,TOTAL,6155.0,6498.0,6180.0,5366.0,6607.0,6471.0,5447.0,6167.0,5430.0,5374.0,4945.0,5992.0,70632.0
Nagaon,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5052.0,5388.0,5665.0,5048.0,5659.0,5784.0,5398.0,6021.0,5518.0,5255.0,5186.0,5350.0,65324.0
Nagaon,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,5507.0,5890.0,5664.0,4854.0,5755.0,5654.0,4886.0,5385.0,4402.0,4523.0,4635.0,4863.0,62018.0
Nagaon,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5305.0,5721.0,6182.0,5502.0,5669.0,6000.0,5812.0,5777.0,5715.0,4899.0,5008.0,5110.0,66700.0
Nagaon,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,6554.0,6895.0,6611.0,5777.0,6775.0,6793.0,6142.0,6406.0,5553.0,5262.0,5137.0,5921.0,73826.0
Nagaon,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,88.0,98.0,64.0,62.0,107.0,58.0,84.0,66.0,113.0,108.0,82.0,40.0,970.0
Nagaon,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,13.0,7.0,7.0,4.0,2.0,1.0,0.0,0.0,5.0,4.0,4.0,0.0,47.0
Nagaon,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3379.0,4107.0,3306.0,2960.0,3676.0,3233.0,3194.0,3485.0,3201.0,3014.0,2987.0,3116.0,39658.0
Nagaon,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,12.0,10.0,25.0,15.0,7.0,17.0,13.0,8.0,9.0,14.0,14.0,15.0,159.0
Nagaon,1.8,Number of pregnancy test kits used at SC level,TOTAL,2403.0,2341.0,2361.0,2274.0,2339.0,2337.0,1665.0,2203.0,1641.0,1738.0,1440.0,1886.0,24628.0
Nagaon,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,36.0,40.0,35.0,49.0,54.0,69.0,72.0,103.0,97.0,97.0,101.0,105.0,858.0
Nagaon,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,344.0,425.0,350.0,397.0,430.0,444.0,456.0,467.0,404.0,461.0,310.0,308.0,4796.0
Nagaon,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,380.0,465.0,385.0,446.0,484.0,513.0,528.0,570.0,501.0,558.0,411.0,413.0,5654.0
Nagaon,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,353.0,422.0,360.0,409.0,463.0,482.0,506.0,553.0,487.0,534.0,400.0,397.0,5366.0
Nagaon,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3758.0,3625.0,3172.0,3920.0,4285.0,4229.0,4594.0,4466.0,4802.0,4830.0,4315.0,4163.0,50159.0
Nagaon,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1379.0,1662.0,1227.0,1567.0,1802.0,1980.0,2051.0,1709.0,1872.0,2262.0,1889.0,1787.0,21187.0
Nagaon,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2891.0,2911.0,3545.0,2984.0,4018.0,3376.0,4504.0,4400.0,3064.0,5132.0,2299.0,4372.0,43496.0
Nagaon,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,986.0,1919.0,2638.0,3904.0,1753.0,4515.0,1673.0,2880.0,1585.0,4252.0,1171.0,7422.0,34698.0
Nagaon,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,0.0,,,,,,,,,,,0.0
Nagaon,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,646.0,640.0,675.0,748.0,832.0,911.0,907.0,859.0,797.0,915.0,816.0,748.0,9494.0
Nagaon,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Nagaon,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Nagaon,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Nagaon,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,15.0,16.0,19.0,22.0,14.0,10.0,9.0,9.0,10.0,6.0,8.0,11.0,149.0
Nagaon,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,64.0,61.0,46.0,59.0,78.0,78.0,73.0,67.0,61.0,69.0,50.0,59.0,765.0
Nagaon,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nagaon,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,79.0,77.0,65.0,81.0,92.0,88.0,82.0,76.0,71.0,75.0,58.0,70.0,914.0
Nagaon,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,497.0,480.0,506.0,549.0,618.0,692.0,719.0,651.0,572.0,701.0,641.0,563.0,7189.0
Nagaon,4.1.1.a,Number of male live births,TOTAL,2485.0,2425.0,2157.0,2592.0,2895.0,2900.0,3046.0,3006.0,3134.0,3202.0,2879.0,2808.0,33529.0
Nagaon,4.1.1.b,Number of female live births,TOTAL,2196.0,2193.0,1984.0,2396.0,2587.0,2625.0,2853.0,2763.0,2804.0,2963.0,2552.0,2416.0,30332.0
Nagaon,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4681.0,4618.0,4141.0,4988.0,5482.0,5525.0,5899.0,5769.0,5938.0,6165.0,5431.0,5224.0,63861.0
Nagaon,4.1.2,Number of still births,TOTAL,126.0,135.0,106.0,138.0,143.0,153.0,150.0,162.0,175.0,159.0,127.0,111.0,1685.0
Nagaon,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,431.0,688.0,723.0,648.0,656.0,665.0,474.0,457.0,383.0,422.0,497.0,529.0,6573.0
Nagaon,4.2.1,Number of Newborns weighed at birth,TOTAL,4689.0,4602.0,4147.0,4980.0,5442.0,5510.0,5904.0,5775.0,5963.0,6188.0,5465.0,5230.0,63895.0
Nagaon,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,568.0,659.0,562.0,673.0,770.0,802.0,781.0,900.0,732.0,838.0,695.0,642.0,8622.0
Nagaon,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4505.0,4451.0,4010.0,4808.0,5314.0,5329.0,5709.0,5634.0,5766.0,5986.0,5334.0,5050.0,61896.0
Nagaon,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,84.0,14.0,30.0,71.0,91.0,59.0,60.0,11.0,19.0,12.0,19.0,15.0,485.0
Nagaon,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,109.0,28.0,29.0,27.0,32.0,46.0,39.0,29.0,78.0,17.0,29.0,37.0,500.0
Nagaon,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,153.0,135.0,90.0,124.0,148.0,156.0,150.0,149.0,149.0,121.0,114.0,89.0,1578.0
Nagaon,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nagaon,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,346.0,177.0,149.0,222.0,271.0,261.0,249.0,189.0,246.0,150.0,162.0,141.0,2563.0
Nagaon,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Nagaon,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,157.0,77.0,24.0,29.0,69.0,31.0,51.0,37.0,42.0,82.0,26.0,21.0,646.0
Nagaon,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,10.0,9.0,12.0,5.0,51.0,1.0,5.0,5.0,24.0,5.0,5.0,4.0,136.0
Nagaon,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,36.0,48.0,32.0,27.0,59.0,17.0,7.0,3.0,29.0,101.0,7.0,6.0,372.0
Nagaon,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,99.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,103.0
Nagaon,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,3441.0,3510.0,2835.0,3234.0,3823.0,3322.0,4430.0,3562.0,4195.0,4450.0,3366.0,3558.0,43726.0
Nagaon,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,4014.0,3340.0,3676.0,3646.0,3822.0,3855.0,4061.0,4548.0,4691.0,4855.0,4145.0,4427.0,49080.0
Nagaon,6.3,PNC maternal complications attended,TOTAL,8.0,11.0,17.0,12.0,10.0,17.0,16.0,10.0,17.0,2.0,11.0,27.0,158.0
Nagaon,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,431.0,467.0,491.0,431.0,414.0,411.0,324.0,337.0,354.0,343.0,303.0,459.0,4765.0
Nagaon,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,69.0,56.0,24.0,50.0,49.0,49.0,28.0,19.0,23.0,29.0,21.0,41.0,458.0
Nagaon,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,500.0,523.0,515.0,481.0,463.0,460.0,352.0,356.0,377.0,372.0,324.0,500.0,5223.0
Nagaon,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,16.0,59.0,59.0,67.0,41.0,24.0,26.0,0.0,25.0,26.0,0.0,39.0,382.0
Nagaon,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,97.0,94.0,100.0,103.0,131.0,117.0,123.0,1.0,109.0,150.0,1.0,146.0,1172.0
Nagaon,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,113.0,153.0,159.0,170.0,172.0,141.0,149.0,1.0,134.0,176.0,1.0,185.0,1554.0
Nagaon,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,22.0,0.0,2.0,32.0,70.0,22.0,0.0,29.0,177.0
Nagaon,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,13.0,18.0,12.0,2.0,13.0,6.0,11.0,0.0,9.0,85.0
Nagaon,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nagaon,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,13.0,40.0,12.0,4.0,45.0,76.0,33.0,0.0,38.0,262.0
Nagaon,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,11.0,65.0,0.0,79.0,67.0,68.0,95.0,18.0,31.0,0.0,82.0,516.0
Nagaon,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,11.0,0.0,40.0,74.0,55.0,27.0,0.0,0.0,0.0,0.0,0.0,207.0
Nagaon,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,7.0,11.0,9.0,12.0,,10.0,10.0,4.0,,2.0,4.0,11.0,80.0
Nagaon,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nagaon,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,7.0,33.0,74.0,52.0,153.0,132.0,105.0,99.0,18.0,33.0,4.0,93.0,803.0
Nagaon,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,12.0,0.0,38.0,25.0,17.0,22.0,0.0,0.0,0.0,0.0,114.0
Nagaon,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Nagaon,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,0.0,,0.0,,,,,,,,,0.0
Nagaon,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nagaon,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Nagaon,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,4.0,2.0,10.0,9.0,12.0,9.0,9.0,15.0,8.0,9.0,5.0,8.0,100.0
Nagaon,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,1.0,3.0,3.0,3.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Nagaon,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,0.0,,,,,,,,,0.0,,0.0
Nagaon,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nagaon,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1.0,3.0,3.0,3.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Nagaon,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,55.0,51.0,60.0,71.0,69.0,80.0,84.0,72.0,53.0,58.0,10.0,8.0,671.0
Nagaon,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,204.0,170.0,189.0,1195.0,377.0,166.0,139.0,167.0,147.0,145.0,229.0,130.0,3258.0
Nagaon,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,55.0,74.0,46.0,135.0,63.0,57.0,54.0,39.0,78.0,53.0,69.0,73.0,796.0
Nagaon,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,29.0,27.0,31.0,25.0,35.0,28.0,8.0,7.0,8.0,18.0,15.0,21.0,252.0
Nagaon,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,47.0,70.0,56.0,61.0,74.0,37.0,23.0,,9.0,32.0,14.0,17.0,440.0
Nagaon,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nagaon,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,335.0,341.0,322.0,1416.0,549.0,288.0,224.0,213.0,242.0,248.0,327.0,241.0,4746.0
Nagaon,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,39.0,60.0,68.0,59.0,72.0,36.0,16.0,38.0,8.0,26.0,23.0,14.0,459.0
Nagaon,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33.0,0.0,0.0,0.0,33.0
Nagaon,9.06,Number of IUCD removals,TOTAL,27.0,35.0,28.0,63.0,68.0,73.0,65.0,18.0,22.0,128.0,20.0,29.0,576.0
Nagaon,9.07,Number of Oral Pills cycles distributed,TOTAL,5840.0,7012.0,7334.0,12443.0,9642.0,8350.0,7849.0,8934.0,9168.0,8726.0,8723.0,8311.0,102332.0
Nagaon,9.08,Number of Condom pieces distributed,TOTAL,8812.0,8754.0,10783.0,18393.0,12115.0,11036.0,9752.0,10015.0,10046.0,8670.0,9631.0,8693.0,126700.0
Nagaon,9.09,Number of Centchroman (weekly) pills given,TOTAL,207.0,256.0,79.0,5.0,50.0,24.0,8.0,29.0,61.0,50.0,300.0,30.0,1099.0
Nagaon,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,20.0,40.0,41.0,97.0,111.0,117.0,90.0,114.0,284.0,170.0,154.0,192.0,1430.0
Nagaon,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Nagaon,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Nagaon,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,3.0,0.0,2.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Nagaon,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Nagaon,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,2.0,3.0,1.0,1.0,3.0,1.0,3.0,2.0,1.0,2.0,3.0,-1.0
Nagaon,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4586.0,3145.0,4345.0,5051.0,5073.0,4840.0,4610.0,6090.0,6074.0,5817.0,5896.0,5102.0,60629.0
Nagaon,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,5009.0,5204.0,4817.0,4145.0,4407.0,4546.0,4913.0,6090.0,4978.0,5082.0,3767.0,686.0,53644.0
Nagaon,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,5032.0,4878.0,5157.0,4471.0,4384.0,4329.0,4473.0,5198.0,5590.0,5021.0,5147.0,4413.0,58093.0
Nagaon,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,5062.0,4902.0,5001.0,4484.0,4408.0,4381.0,4293.0,4843.0,4914.0,5202.0,5085.0,5419.0,57994.0
Nagaon,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2320.0,4782.0,7102.0
Nagaon,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1340.0,1340.0
Nagaon,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,16.0
Nagaon,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2613.0,2298.0,2384.0,2988.0,2349.0,2244.0,2563.0,3117.0,3013.0,3022.0,3224.0,2792.0,32607.0
Nagaon,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4918.0,4419.0,4657.0,4144.0,3535.0,4541.0,4407.0,5972.0,3958.0,5296.0,4605.0,4644.0,55096.0
Nagaon,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4926.0,4209.0,4932.0,4392.0,3536.0,4232.0,4015.0,5129.0,4339.0,5267.0,5615.0,5135.0,55727.0
Nagaon,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4917.0,4296.0,4811.0,4407.0,3622.0,4368.0,3896.0,4722.0,3814.0,5272.0,5416.0,5530.0,55071.0
Nagaon,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1677.0,1505.0,1320.0,1684.0,1670.0,1377.0,1585.0,2215.0,1991.0,2122.0,2029.0,1812.0,20987.0
Nagaon,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4804.0,5359.0,4828.0,4123.0,4140.0,4518.0,4850.0,6138.0,4959.0,5127.0,3844.0,860.0,53550.0
Nagaon,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,4758.0,4866.0,5150.0,4408.0,4109.0,4315.0,4384.0,5186.0,5572.0,5064.0,5033.0,4505.0,57350.0
Nagaon,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,4733.0,4910.0,4971.0,4466.0,4210.0,4407.0,4312.0,4937.0,4875.0,5203.0,4923.0,5363.0,57310.0
Nagaon,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4107.0,4408.0,4643.0,4342.0,4882.0,4982.0,3941.0,5616.0,5500.0,4693.0,4838.0,5211.0,57163.0
Nagaon,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2898.0,3324.0,3709.0,3404.0,3508.0,3181.0,2506.0,3386.0,3569.0,3237.0,3128.0,3558.0,39408.0
Nagaon,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3897.0,4043.0,4146.0,3796.0,4042.0,1940.0,3487.0,5513.0,4947.0,4351.0,4288.0,4775.0,49225.0
Nagaon,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2156.0,2290.0,2415.0,2283.0,2543.0,2543.0,2054.0,2990.0,2630.0,2493.0,2436.0,2666.0,29499.0
Nagaon,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1950.0,2049.0,2169.0,2050.0,2306.0,2330.0,1918.0,2727.0,2485.0,2147.0,2296.0,2358.0,26785.0
Nagaon,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4106.0,4339.0,4584.0,4333.0,4849.0,4873.0,3972.0,5717.0,5115.0,4640.0,4732.0,5024.0,56284.0
Nagaon,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3101.0,3525.0,3881.0,3640.0,3766.0,3449.0,3205.0,4008.0,3916.0,3457.0,3369.0,3892.0,43209.0
Nagaon,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3057.0,3152.0,3712.0,3604.0,3132.0,3276.0,2823.0,3746.0,2972.0,3428.0,3343.0,3840.0,40085.0
Nagaon,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,336.0,393.0,347.0,388.0,430.0,407.0,296.0,449.0,489.0,346.0,399.0,556.0,4836.0
Nagaon,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,342.0,365.0,304.0,355.0,433.0,348.0,271.0,377.0,432.0,304.0,367.0,492.0,4390.0
Nagaon,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,678.0,758.0,651.0,743.0,863.0,755.0,567.0,826.0,921.0,650.0,766.0,1048.0,9226.0
Nagaon,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1483.0,1649.0,1723.0,1736.0,1870.0,1790.0,1546.0,1874.0,2022.0,1857.0,1733.0,1939.0,21222.0
Nagaon,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1339.0,1458.0,1567.0,1533.0,1491.0,1499.0,1420.0,1677.0,1781.0,1664.0,1557.0,1779.0,18765.0
Nagaon,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,963.0,950.0,1020.0,1063.0,1025.0,971.0,979.0,1127.0,1106.0,1150.0,1166.0,1258.0,12778.0
Nagaon,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Nagaon,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,3.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Nagaon,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2244.0,2168.0,2202.0,2224.0,2173.0,2103.0,2195.0,2126.0,2150.0,2177.0,2199.0,2118.0,26079.0
Nagaon,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2136.0,2107.0,2137.0,2101.0,2041.0,2087.0,2095.0,2065.0,2100.0,2089.0,2082.0,2023.0,25063.0
Nagaon,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2037.0,2004.0,2032.0,2057.0,1959.0,2052.0,2006.0,2031.0,2068.0,2007.0,1979.0,2003.0,24235.0
Nagaon,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2769.0,3058.0,3299.0,3252.0,2931.0,1348.0,2356.0,3198.0,3313.0,3134.0,2925.0,3368.0,34951.0
Nagaon,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4001.0,4407.0,4587.0,4321.0,5238.0,4889.0,3995.0,5341.0,5212.0,4324.0,4538.0,4517.0,55370.0
Nagaon,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1512.0,1281.0,1361.0,1372.0,5629.0,2321.0,1288.0,1385.0,1370.0,1398.0,2275.0,1499.0,22691.0
Nagaon,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1377.0,1106.0,1268.0,1340.0,5417.0,2069.0,1162.0,1345.0,1425.0,1458.0,2144.0,1497.0,21608.0
Nagaon,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,4.0,41.0,20.0,3.0,10.0,13.0,15.0,5.0,31.0,14.0,26.0,128.0,310.0
Nagaon,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,719.0,787.0,965.0,1214.0,1156.0,868.0,692.0,567.0,487.0,446.0,458.0,587.0,8946.0
Nagaon,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0
Nagaon,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,63.0,56.0,77.0,70.0,68.0,67.0,52.0,101.0,94.0,67.0,66.0,57.0,838.0
Nagaon,13.1,Number of Patients operated for cataract,TOTAL,132.0,162.0,145.0,126.0,138.0,0.0,67.0,142.0,126.0,67.0,139.0,201.0,1445.0
Nagaon,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,130.0,157.0,135.0,119.0,133.0,0.0,63.0,135.0,121.0,67.0,138.0,199.0,1397.0
Nagaon,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,100.0
Nagaon,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,5.0,4.0,10.0,0.0,45.0,4.0,0.0,0.0,0.0,0.0,68.0
Nagaon,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,6.0,6.0,5.0,6.0,5.0,6.0,6.0,6.0,5.0,6.0,-1.0
Nagaon,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,20.0,21.0,23.0,23.0,23.0,25.0,26.0,23.0,23.0,23.0,22.0,22.0,-1.0
Nagaon,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2036.0,2086.0,2128.0,2078.0,2060.0,1998.0,2022.0,2085.0,2073.0,2015.0,2032.0,1938.0,-1.0
Nagaon,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,10.0,10.0,11.0,11.0,10.0,9.0,8.0,9.0,10.0,11.0,9.0,10.0,-1.0
Nagaon,14.05,Number of RKS meetings held during the month,TOTAL,14.0,15.0,16.0,11.0,14.0,22.0,13.0,19.0,22.0,16.0,14.0,13.0,189.0
Nagaon,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,27.0,27.0,28.0,30.0,30.0,32.0,28.0,27.0,30.0,29.0,26.0,30.0,-1.0
Nagaon,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,250.0,245.0,270.0,205.0,239.0,234.0,220.0,174.0,185.0,175.0,161.0,145.0,2503.0
Nagaon,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,-1.0
Nagaon,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Nagaon,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,216.0,171.0,242.0,203.0,240.0,352.0,282.0,189.0,175.0,128.0,140.0,226.0,2564.0
Nagaon,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1843.0,1849.0,2149.0,1610.0,2770.0,1883.0,1839.0,1592.0,1479.0,1441.0,1656.0,2075.0,22186.0
Nagaon,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,384.0,186.0,259.0,258.0,297.0,382.0,345.0,179.0,249.0,289.0,158.0,199.0,3185.0
Nagaon,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3586.0,3072.0,3561.0,3614.0,3099.0,4068.0,3513.0,3505.0,3559.0,3410.0,3672.0,3888.0,42547.0
Nagaon,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,600.0,357.0,501.0,461.0,537.0,734.0,627.0,368.0,424.0,417.0,298.0,425.0,5749.0
Nagaon,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5429.0,4921.0,5710.0,5224.0,5869.0,5951.0,5352.0,5097.0,5038.0,4851.0,5328.0,5963.0,64733.0
Nagaon,14.10.2.a,Number of death cases of Inpatient males,TOTAL,32.0,31.0,26.0,24.0,70.0,34.0,23.0,36.0,2.0,37.0,23.0,22.0,360.0
Nagaon,14.10.2.b,Number of death cases of Inpatient females,TOTAL,36.0,29.0,18.0,25.0,62.0,29.0,22.0,36.0,0.0,41.0,40.0,32.0,370.0
Nagaon,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,68.0,60.0,44.0,49.0,132.0,63.0,45.0,72.0,2.0,78.0,63.0,54.0,730.0
Nagaon,14.11,In-Patient Head Count at midnight,TOTAL,836.0,915.0,1786.0,1118.0,1049.0,865.0,694.0,726.0,654.0,664.0,618.0,810.0,10735.0
Nagaon,14.12.1,OPD attendance (All),TOTAL,134060.0,141546.0,170671.0,176628.0,176403.0,190025.0,185672.0,189801.0,193050.0,184675.0,199005.0,232579.0,2174115.0
Nagaon,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,82.0,125.0,136.0,110.0,110.0,107.0,90.0,98.0,82.0,82.0,89.0,107.0,1218.0
Nagaon,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,5.0,4.0,7.0,2.0,3.0,4.0,1.0,1.0,1.0,2.0,2.0,4.0,36.0
Nagaon,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,10.0,24.0,14.0,27.0,17.0,19.0,16.0,25.0,23.0,13.0,18.0,10.0,216.0
Nagaon,14.14.a,Number of patients given AYUSH treatment,TOTAL,210.0,822.0,1295.0,525.0,140.0,320.0,750.0,860.0,320.0,165.0,165.0,170.0,5742.0
Nagaon,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,99.0,364.0,57.0,63.0,65.0,80.0,48.0,385.0,55.0,64.0,52.0,68.0,1400.0
Nagaon,14.14.c,Number of Adolescents counselled,TOTAL,9.0,10.0,0.0,6.0,4.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,31.0
Nagaon,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9038.0,10375.0,10775.0,8644.0,9553.0,10045.0,9429.0,9592.0,8693.0,7980.0,7674.0,8342.0,110140.0
Nagaon,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,302.0,309.0,148.0,200.0,125.0,106.0,114.0,242.0,157.0,146.0,164.0,62.0,2075.0
Nagaon,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,321.0,431.0,427.0,439.0,406.0,188.0,199.0,106.0,60.0,239.0,145.0,344.0,3305.0
Nagaon,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,7.0,5.0,6.0,5.0,1.0,3.0,1.0,0.0,2.0,3.0,3.0,40.0
Nagaon,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,521.0,521.0,363.0,307.0,365.0,136.0,350.0,42.0,56.0,340.0,69.0,396.0,3466.0
Nagaon,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,4.0,1.0,0.0,3.0,0.0,3.0,0.0,0.0,2.0,2.0,4.0,20.0
Nagaon,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1717.0,2282.0,2274.0,1786.0,1851.0,2386.0,1915.0,1341.0,804.0,1535.0,1705.0,1012.0,20608.0
Nagaon,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,1.0,0.0,1.0,1.0,58.0,77.0,101.0,50.0,66.0,41.0,397.0
Nagaon,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2559.0,3234.0,3064.0,2532.0,2622.0,2710.0,2464.0,1489.0,920.0,2114.0,1919.0,1752.0,27379.0
Nagaon,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,6.0,11.0,7.0,6.0,9.0,2.0,64.0,78.0,101.0,54.0,71.0,48.0,457.0
Nagaon,15.2,Number of Widal tests conducted,Number tested,299.0,298.0,426.0,425.0,491.0,330.0,385.0,259.0,220.0,97.0,117.0,283.0,3630.0
Nagaon,15.3.a,Number of VDRL tests conducted on males,Number tested,35.0,54.0,95.0,24.0,10.0,40.0,38.0,0.0,41.0,33.0,30.0,207.0,607.0
Nagaon,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,23.0,93.0,97.0,49.0,6.0,14.0,0.0,0.0,17.0,118.0,9.0,165.0,591.0
Nagaon,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,409.0,917.0,866.0,200.0,523.0,538.0,623.0,620.0,393.0,504.0,327.0,611.0,6531.0
Nagaon,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,467.0,1064.0,1058.0,273.0,539.0,592.0,661.0,620.0,451.0,655.0,366.0,983.0,7729.0
Nagaon,15.4.1,Number of blood smears examined for Malaria,TOTAL,12262.0,13114.0,14963.0,18541.0,17817.0,14959.0,11811.0,8947.0,9086.0,8091.0,7355.0,10028.0,146974.0
Nagaon,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,52.0,377.0,580.0,722.0,3.0,0.0,363.0,260.0,216.0,213.0,280.0,7.0,3073.0
Nagaon,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,9.0,2.0,12.0,19.0,16.0,8.0,15.0,5.0,4.0,5.0,4.0,4.0,103.0
Nagaon,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,40700.0,,21300.0,,,,38590.0,,,,,,100590.0
Nagaon,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,,0.0,,,,10000.0,,,,,,10000.0
Nagaon,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,26200.0,,10900.0,,,,14500.0,,,,,,51600.0
Nagaon,16.1.1,Stock position of DPT vaccines,5. Total Stock,14500.0,0.0,10400.0,0.0,0.0,0.0,34090.0,0.0,0.0,0.0,0.0,0.0,58990.0
Nagaon,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,14300.0,,,,,,20720.0,,,,,,35020.0
Nagaon,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,,,,,,0.0,,,,,,0.0
Nagaon,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,14300.0,,,,,,15500.0,,,,,,29800.0
Nagaon,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,5220.0,0.0,0.0,0.0,0.0,0.0,5220.0
Nagaon,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,32500.0,,,,,,22840.0,,,,,,55340.0
Nagaon,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,,,,,,10000.0,,,,,,10000.0
Nagaon,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.3,Stock position of TT vaccines,4. Stock Distributed,25200.0,,,,,,13000.0,,,,,,38200.0
Nagaon,16.1.3,Stock position of TT vaccines,5. Total Stock,7300.0,0.0,0.0,0.0,0.0,0.0,19840.0,0.0,0.0,0.0,0.0,0.0,27140.0
Nagaon,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,6600.0,,,,,,16430.0,,,,,,23030.0
Nagaon,16.1.5,Stock position of BCG vaccines,2. Stocks Received,20000.0,,,,,,3000.0,,,,,,23000.0
Nagaon,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,9360.0,,,,,,7900.0,,,,,,17260.0
Nagaon,16.1.5,Stock position of BCG vaccines,5. Total Stock,17240.0,0.0,0.0,0.0,0.0,0.0,11530.0,0.0,0.0,0.0,0.0,0.0,28770.0
Nagaon,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,9020.0,,,,,,0.0,,,,,,9020.0
Nagaon,16.1.6,Stock position of Measles vaccines,2. Stocks Received,20000.0,,,,,,15000.0,,,,,,35000.0
Nagaon,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,12325.0,,,,,,1340.0,,,,,,13665.0
Nagaon,16.1.6,Stock position of Measles vaccines,5. Total Stock,16695.0,0.0,0.0,0.0,0.0,0.0,13660.0,0.0,0.0,0.0,0.0,0.0,30355.0
Nagaon,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,9825.0,,,,,,10000.0,,,,,,19825.0
Nagaon,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,,,,,5000.0,,,,,,5000.0
Nagaon,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.7,Stock position of JE vaccines,4. Stock Distributed,7925.0,,,,,,9000.0,,,,,,16925.0
Nagaon,16.1.7,Stock position of JE vaccines,5. Total Stock,1900.0,0.0,0.0,0.0,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,0.0,7900.0
Nagaon,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,39530.0,,,,,,33843.0,,,,,,73373.0
Nagaon,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,,,,,,20000.0,,,,,,20000.0
Nagaon,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Nagaon,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,29700.0,,,,,,16400.0,,,,,,46100.0
Nagaon,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,9830.0,0.0,0.0,0.0,0.0,0.0,37443.0,0.0,0.0,0.0,0.0,0.0,47273.0
Nagaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Nagaon,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Nagaon,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Nagaon,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Nagaon,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nagaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,800.0,,,,,,7850.0,,,,,,8650.0
Nagaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,,,,,,0.0,,,,,,0.0
Nagaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Nagaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,800.0,,,,,,5500.0,,,,,,6300.0
Nagaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,2350.0,0.0,0.0,0.0,0.0,0.0,2350.0
Nagaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,72100.0,,,,,,189600.0,,,,,,261700.0
Nagaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,48000.0,,,,,,48000.0,,,,,,96000.0
Nagaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Nagaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,41000.0,,,,,,145600.0,,,,,,186600.0
Nagaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,79100.0,0.0,0.0,0.0,0.0,0.0,92000.0,0.0,0.0,0.0,0.0,0.0,171100.0
Nagaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2200.0,,,,,,8100.0,,,,,,10300.0
Nagaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,6000.0,,,,,,6000.0,,,,,,12000.0
Nagaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Nagaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,,,,,,4000.0,,,,,,4000.0
Nagaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,8200.0,0.0,0.0,0.0,0.0,0.0,10100.0,0.0,0.0,0.0,0.0,0.0,18300.0
Nagaon,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,1.0,,,,,1.0
Nagaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Nagaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nagaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Nagaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Nagaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nagaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Nagaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,2.0,3.0,1.0,3.0,1.0,1.0,1.0,6.0,1.0,1.0,1.0,21.0
Nagaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nagaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,2.0,3.0,1.0,3.0,1.0,1.0,1.0,6.0,1.0,1.0,1.0,21.0
Nagaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,3.0,7.0,3.0,3.0,5.0,9.0,7.0,12.0,6.0,10.0,6.0,71.0
Nagaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nagaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,3.0,7.0,3.0,3.0,5.0,9.0,7.0,12.0,6.0,10.0,6.0,71.0
Nagaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,1.0,,,,2.0,,1.0,,,5.0
Nagaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nagaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,1.0,,,,2.0,,1.0,,,5.0
Nagaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nagaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nagaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Nagaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,1.0,,,1.0,,,,,,3.0
Nagaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,1.0,,,,,,,2.0
Nagaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,1.0,1.0,1.0,1.0,,,,,,5.0
Nagaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nagaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nagaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Nagaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,2.0,3.0,2.0,2.0,1.0,1.0,,,1.0,4.0,,16.0
Nagaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,2.0,,,,,,,2.0
Nagaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,2.0,3.0,2.0,2.0,3.0,1.0,,,1.0,4.0,,18.0
Nagaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Nagaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Nagaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Nagaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,,,,,,,,,,1.0
Nagaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Nagaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,2.0,1.0,3.0,,,1.0,,1.0,,,,8.0
Nagaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,,,,,,1.0,,,2.0,,4.0
Nagaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,2.0,1.0,3.0,,,1.0,1.0,1.0,,2.0,,12.0
Nagaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Nagaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Nagaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,1.0,1.0,1.0,1.0,1.0,,,,,,6.0
Nagaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,,1.0,1.0,1.0,1.0,1.0,,,,1.0,,7.0
Nagaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Nagaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Nagaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Nagaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,,,,,,,,,1.0
Nagaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Nagaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,1.0,,,,,1.0,1.0,1.0,1.0,6.0
Nagaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,1.0,,,,,,1.0,,,,3.0
Nagaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,2.0,1.0,,,,,2.0,1.0,1.0,1.0,9.0
Nagaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Nagaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Nagaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Nagaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,1.0,,,1.0
Nagaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Nagaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,4.0,,8.0,2.0,,,5.0,2.0,2.0,2.0,3.0,30.0
Nagaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,6.0,9.0,3.0,2.0,3.0,4.0,4.0,1.0,8.0,5.0,5.0,52.0
Nagaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,10.0,9.0,11.0,4.0,3.0,4.0,9.0,3.0,10.0,7.0,8.0,82.0
Nagaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Nagaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,1.0,,1.0,1.0,1.0,3.0,,,,,7.0
Nagaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,,1.0,1.0,,3.0,1.0,1.0,2.0,,,1.0,12.0
Nagaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,,2.0,2.0,1.0,4.0,2.0,4.0,2.0,,,1.0,20.0
Nagaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Nagaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Nagaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Nagaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,1.0,,,,,,,,1.0
Nagaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Nagaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Nagaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Nagaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Nagaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Nagaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,11.0
Nagaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Nagaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,11.0
Nagaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Nagaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,2.0,,,,,2.0,1.0,,,,,,5.0
Nagaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Nagaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,2.0,,,,,2.0,1.0,,,,,,5.0
Nagaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Nagaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Nagaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Nagaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,1.0,,,,,,1.0
Nagaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Nagaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,,,1.0,2.0,,3.0,2.0,2.0,,11.0
Nagaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Nagaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,,,1.0,2.0,,3.0,2.0,2.0,,11.0
Nagaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,1.0,,1.0,,,,,,,,2.0
Nagaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,4.0,1.0,1.0,1.0,2.0,,,2.0,1.0,2.0,14.0
Nagaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,1.0,1.0,,,,1.0,,,1.0,4.0
Nagaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,5.0,2.0,3.0,1.0,2.0,,1.0,2.0,1.0,3.0,20.0
Nagaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,1.0,1.0,,2.0
Nagaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,1.0,,3.0,1.0,1.0,2.0,,,1.0,,9.0
Nagaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Nagaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,1.0,,4.0,1.0,1.0,2.0,,1.0,2.0,,12.0
Nagaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Nagaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Nagaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Nagaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,1.0,,,,,,,,2.0
Nagaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Nagaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,1.0,,,1.0,,1.0,2.0,1.0,2.0,8.0
Nagaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,1.0,1.0,3.0,6.0,2.0,4.0,,3.0,5.0,1.0,2.0,30.0
Nagaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,1.0,1.0,4.0,6.0,2.0,5.0,,5.0,7.0,2.0,4.0,39.0
Nagaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,3.0,,,1.0,,,4.0
Nagaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,3.0,1.0,2.0,4.0,,2.0,3.0,1.0,4.0,1.0,2.0,25.0
Nagaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,6.0,4.0,5.0,7.0,8.0,2.0,3.0,6.0,4.0,7.0,11.0,4.0,67.0
Nagaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,8.0,7.0,6.0,9.0,12.0,2.0,8.0,9.0,5.0,12.0,12.0,6.0,96.0
Nagaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,1.0,1.0,,,1.0,,,,,,4.0
Nagaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,11.0,6.0,8.0,14.0,9.0,6.0,13.0,5.0,9.0,13.0,9.0,14.0,117.0
Nagaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,14.0,16.0,19.0,22.0,13.0,7.0,17.0,15.0,28.0,21.0,12.0,20.0,204.0
Nagaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,25.0,23.0,28.0,37.0,22.0,13.0,31.0,20.0,37.0,34.0,21.0,34.0,325.0
Nalbari,1.1,Total number of pregnant women Registered for ANC,TOTAL,1507.0,1547.0,1260.0,1422.0,1462.0,1236.0,1139.0,989.0,1002.0,1141.0,1221.0,1327.0,15253.0
Nalbari,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1245.0,1279.0,1009.0,1222.0,1261.0,1007.0,1032.0,892.0,913.0,1054.0,1110.0,1207.0,13231.0
Nalbari,1.2,Number of Pregnant women registered under JSY,TOTAL,1506.0,1544.0,1260.0,1417.0,1462.0,1232.0,1138.0,989.0,1002.0,1141.0,1221.0,1327.0,15239.0
Nalbari,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,852.0,976.0,890.0,1153.0,1326.0,1333.0,1282.0,1309.0,1200.0,1035.0,907.0,949.0,13212.0
Nalbari,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1069.0,1289.0,1056.0,1220.0,1308.0,1372.0,1251.0,989.0,968.0,876.0,872.0,1010.0,13280.0
Nalbari,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,981.0,1153.0,1091.0,1231.0,1233.0,1425.0,1399.0,1275.0,1076.0,903.0,810.0,1010.0,13587.0
Nalbari,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,996.0,1273.0,1018.0,1321.0,1418.0,1473.0,1417.0,1119.0,1155.0,1004.0,952.0,1150.0,14296.0
Nalbari,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,17.0,16.0,7.0,20.0,13.0,17.0,11.0,16.0,16.0,6.0,10.0,5.0,154.0
Nalbari,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Nalbari,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,462.0,556.0,393.0,431.0,442.0,405.0,400.0,273.0,297.0,373.0,348.0,462.0,4842.0
Nalbari,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,0.0,0.0,0.0,3.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,6.0
Nalbari,1.8,Number of pregnancy test kits used at SC level,TOTAL,76.0,180.0,111.0,186.0,170.0,128.0,114.0,110.0,116.0,111.0,51.0,188.0,1541.0
Nalbari,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,45.0,45.0,40.0,74.0,76.0,95.0,118.0,117.0,111.0,95.0,107.0,46.0,969.0
Nalbari,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,83.0,75.0,71.0,35.0,39.0,57.0,50.0,31.0,35.0,22.0,18.0,39.0,555.0
Nalbari,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,128.0,120.0,111.0,109.0,115.0,152.0,168.0,148.0,146.0,117.0,125.0,85.0,1524.0
Nalbari,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,120.0,115.0,107.0,109.0,110.0,151.0,139.0,148.0,143.0,116.0,125.0,78.0,1461.0
Nalbari,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,590.0,639.0,565.0,662.0,682.0,706.0,791.0,798.0,865.0,810.0,697.0,691.0,8496.0
Nalbari,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,139.0,50.0,83.0,86.0,62.0,55.0,77.0,104.0,78.0,84.0,62.0,57.0,937.0
Nalbari,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,522.0,665.0,566.0,644.0,646.0,724.0,799.0,762.0,883.0,763.0,678.0,742.0,8394.0
Nalbari,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,264.0,560.0,495.0,475.0,671.0,837.0,501.0,614.0,943.0,681.0,679.0,1330.0,8050.0
Nalbari,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Nalbari,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,277.0,288.0,287.0,356.0,382.0,407.0,413.0,368.0,377.0,404.0,364.0,360.0,4283.0
Nalbari,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Nalbari,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Nalbari,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Nalbari,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Nalbari,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,3.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,1.0,4.0,19.0
Nalbari,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,58.0,67.0,61.0,64.0,53.0,56.0,59.0,53.0,61.0,64.0,55.0,61.0,712.0
Nalbari,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalbari,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,58.0,70.0,62.0,65.0,54.0,57.0,60.0,55.0,63.0,66.0,56.0,65.0,731.0
Nalbari,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,204.0,201.0,191.0,256.0,288.0,301.0,322.0,277.0,277.0,306.0,271.0,285.0,3179.0
Nalbari,4.1.1.a,Number of male live births,TOTAL,510.0,536.0,511.0,544.0,644.0,677.0,707.0,664.0,702.0,632.0,621.0,584.0,7332.0
Nalbari,4.1.1.b,Number of female live births,TOTAL,480.0,499.0,442.0,574.0,531.0,580.0,642.0,637.0,681.0,697.0,556.0,538.0,6857.0
Nalbari,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,990.0,1035.0,953.0,1118.0,1175.0,1257.0,1349.0,1301.0,1383.0,1329.0,1177.0,1122.0,14189.0
Nalbari,4.1.2,Number of still births,TOTAL,8.0,16.0,16.0,12.0,14.0,16.0,32.0,18.0,19.0,16.0,19.0,20.0,206.0
Nalbari,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,375.0,715.0,635.0,693.0,638.0,411.0,479.0,501.0,658.0,589.0,673.0,800.0,7167.0
Nalbari,4.2.1,Number of Newborns weighed at birth,TOTAL,990.0,1034.0,951.0,1118.0,1176.0,1256.0,1349.0,1301.0,1382.0,1329.0,1177.0,1122.0,14185.0
Nalbari,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,113.0,179.0,156.0,186.0,152.0,162.0,179.0,184.0,201.0,157.0,146.0,162.0,1977.0
Nalbari,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,973.0,1009.0,933.0,1091.0,1146.0,1222.0,1306.0,1273.0,1364.0,1283.0,1148.0,1080.0,13828.0
Nalbari,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3.0,0.0,0.0,5.0,3.0,1.0,0.0,9.0,1.0,3.0,0.0,1.0,26.0
Nalbari,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,46.0,117.0,58.0,88.0,86.0,61.0,90.0,70.0,72.0,65.0,65.0,112.0,930.0
Nalbari,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,2.0,2.0,2.0,2.0,1.0,4.0,2.0,3.0,5.0,3.0,5.0,4.0,35.0
Nalbari,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalbari,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,51.0,119.0,60.0,95.0,90.0,66.0,92.0,82.0,78.0,71.0,70.0,117.0,991.0
Nalbari,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,144.0,129.0,138.0,124.0,129.0,136.0,126.0,122.0,133.0,136.0,122.0,127.0,1566.0
Nalbari,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,150.0,159.0,146.0,136.0,123.0,95.0,78.0,136.0,101.0,106.0,126.0,194.0,1550.0
Nalbari,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,43.0,14.0,17.0,28.0,19.0,6.0,8.0,9.0,14.0,12.0,10.0,16.0,196.0
Nalbari,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,137.0,176.0,134.0,120.0,123.0,124.0,116.0,115.0,102.0,113.0,115.0,140.0,1515.0
Nalbari,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,45.0,9.0,12.0,5.0,3.0,6.0,4.0,4.0,2.0,2.0,31.0,16.0,139.0
Nalbari,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,802.0,750.0,695.0,824.0,802.0,888.0,949.0,988.0,1030.0,1013.0,902.0,900.0,10543.0
Nalbari,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,651.0,714.0,665.0,812.0,829.0,871.0,1127.0,983.0,1007.0,1073.0,983.0,1044.0,10759.0
Nalbari,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,241.0,247.0,204.0,260.0,212.0,219.0,151.0,167.0,201.0,186.0,184.0,245.0,2517.0
Nalbari,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,241.0,247.0,204.0,260.0,212.0,219.0,151.0,167.0,201.0,186.0,184.0,245.0,2517.0
Nalbari,7.2,Number of MTPs conducted at Private Facilities,TOTAL,112.0,210.0,221.0,215.0,189.0,145.0,145.0,207.0,253.0,234.0,301.0,298.0,2530.0
Nalbari,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,83.0,103.0,105.0,92.0,19.0,53.0,45.0,77.0,87.0,69.0,76.0,64.0,873.0
Nalbari,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,137.0,146.0,145.0,158.0,119.0,149.0,151.0,134.0,109.0,234.0,231.0,614.0,2327.0
Nalbari,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,220.0,249.0,250.0,250.0,138.0,202.0,196.0,211.0,196.0,303.0,307.0,678.0,3200.0
Nalbari,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,20.0,0.0,0.0,20.0,26.0,23.0,0.0,0.0,65.0,154.0
Nalbari,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,2.0,23.0,7.0,16.0,0.0,0.0,50.0
Nalbari,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,0.0,0.0,1.0,1.0,2.0,3.0,8.0,5.0,1.0,22.0
Nalbari,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalbari,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,20.0,2.0,1.0,23.0,51.0,33.0,24.0,5.0,66.0,226.0
Nalbari,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,73.0,39.0,80.0,0.0,93.0,46.0,30.0,90.0,26.0,0.0,60.0,537.0
Nalbari,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,37.0,20.0,71.0,63.0,0.0,45.0,4.0,35.0,4.0,32.0,21.0,332.0
Nalbari,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Nalbari,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalbari,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,110.0,59.0,153.0,63.0,93.0,91.0,34.0,125.0,30.0,32.0,81.0,871.0
Nalbari,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalbari,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,2.0,1.0,4.0,3.0,3.0,3.0,1.0,3.0,4.0,0.0,0.0,4.0,28.0
Nalbari,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,4.0,9.0
Nalbari,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,4.0,5.0,3.0,4.0,4.0,1.0,2.0,1.0,3.0,7.0,3.0,4.0,41.0
Nalbari,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalbari,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,4.0,7.0,4.0,4.0,4.0,1.0,2.0,1.0,3.0,8.0,4.0,8.0,50.0
Nalbari,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,11.0,15.0,12.0,11.0,16.0,13.0,26.0,23.0,23.0,11.0,7.0,5.0,173.0
Nalbari,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,15.0,19.0,13.0,123.0,44.0,37.0,30.0,39.0,60.0,40.0,27.0,41.0,488.0
Nalbari,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,26.0,77.0,21.0,193.0,36.0,46.0,38.0,38.0,52.0,31.0,36.0,29.0,623.0
Nalbari,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,23.0,24.0,35.0,123.0,27.0,34.0,43.0,24.0,23.0,22.0,18.0,21.0,417.0
Nalbari,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,7.0,4.0,24.0,21.0,24.0,7.0,6.0,3.0,8.0,11.0,15.0,5.0,135.0
Nalbari,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalbari,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,71.0,124.0,93.0,460.0,131.0,124.0,117.0,104.0,143.0,104.0,96.0,96.0,1663.0
Nalbari,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,15.0,7.0,40.0,25.0,25.0,22.0,17.0,21.0,12.0,20.0,18.0,17.0,239.0
Nalbari,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,8.0,35.0,17.0,27.0,22.0,14.0,9.0,14.0,9.0,5.0,6.0,13.0,179.0
Nalbari,9.06,Number of IUCD removals,TOTAL,24.0,28.0,28.0,34.0,31.0,30.0,30.0,28.0,25.0,15.0,25.0,34.0,332.0
Nalbari,9.07,Number of Oral Pills cycles distributed,TOTAL,3497.0,3768.0,3629.0,3704.0,3684.0,3667.0,3692.0,3735.0,4025.0,3590.0,3366.0,3728.0,44085.0
Nalbari,9.08,Number of Condom pieces distributed,TOTAL,16498.0,16295.0,15931.0,17148.0,15025.0,15375.0,15101.0,14131.0,13964.0,13783.0,12657.0,13937.0,179845.0
Nalbari,9.09,Number of Centchroman (weekly) pills given,TOTAL,4.0,95.0,0.0,91.0,0.0,0.0,0.0,0.0,5.0,6.0,0.0,0.0,201.0
Nalbari,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,34.0,32.0,25.0,25.0,22.0,23.0,33.0,45.0,37.0,37.0,29.0,22.0,364.0
Nalbari,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,5.0
Nalbari,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Nalbari,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,3.0
Nalbari,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Nalbari,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1129.0,984.0,1007.0,1085.0,1258.0,1356.0,1413.0,1460.0,1415.0,1498.0,1265.0,1286.0,15156.0
Nalbari,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1374.0,1242.0,1173.0,1147.0,1282.0,1371.0,1489.0,1459.0,1282.0,1514.0,797.0,239.0,14369.0
Nalbari,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1249.0,1441.0,1116.0,1136.0,1174.0,1241.0,1269.0,1318.0,1427.0,1210.0,1256.0,1077.0,14914.0
Nalbari,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1330.0,1322.0,1197.0,1264.0,1186.0,1190.0,1219.0,1144.0,1209.0,1358.0,1034.0,1340.0,14793.0
Nalbari,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,628.0,1266.0,1894.0
Nalbari,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,404.0,409.0
Nalbari,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Nalbari,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,719.0,604.0,704.0,761.0,817.0,863.0,785.0,828.0,909.0,1036.0,859.0,803.0,9688.0
Nalbari,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1377.0,1268.0,1110.0,1074.0,1221.0,1241.0,988.0,1153.0,933.0,1472.0,1057.0,1494.0,14388.0
Nalbari,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1261.0,1441.0,1106.0,1151.0,1180.0,1153.0,850.0,1046.0,1067.0,1152.0,1251.0,1376.0,14034.0
Nalbari,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1313.0,1324.0,1183.0,1239.0,1173.0,1142.0,820.0,858.0,930.0,1251.0,1014.0,1312.0,13559.0
Nalbari,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,423.0,482.0,380.0,433.0,576.0,576.0,599.0,640.0,699.0,781.0,623.0,546.0,6758.0
Nalbari,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1661.0,1387.0,1074.0,1214.0,1276.0,1362.0,1512.0,1462.0,1340.0,1557.0,874.0,344.0,15063.0
Nalbari,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1270.0,1597.0,1122.0,1156.0,1155.0,1173.0,1233.0,1272.0,1345.0,1186.0,1212.0,1047.0,14768.0
Nalbari,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1240.0,1316.0,1171.0,1298.0,1163.0,1165.0,1172.0,1095.0,1197.0,1339.0,993.0,1300.0,14449.0
Nalbari,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1021.0,1166.0,904.0,1183.0,1325.0,1290.0,1519.0,1405.0,1010.0,1080.0,1016.0,1103.0,14022.0
Nalbari,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1021.0,1181.0,697.0,974.0,1172.0,1108.0,890.0,821.0,720.0,790.0,774.0,947.0,11095.0
Nalbari,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,8.0,220.0,324.0,609.0,650.0,88.0,18.0,100.0,560.0,2577.0
Nalbari,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,535.0,608.0,462.0,570.0,686.0,651.0,768.0,718.0,545.0,560.0,510.0,559.0,7172.0
Nalbari,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,486.0,543.0,439.0,598.0,632.0,627.0,742.0,677.0,462.0,518.0,499.0,537.0,6760.0
Nalbari,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1021.0,1151.0,901.0,1168.0,1318.0,1278.0,1510.0,1395.0,1007.0,1078.0,1009.0,1096.0,13932.0
Nalbari,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1069.0,1231.0,743.0,1031.0,1249.0,1169.0,975.0,890.0,850.0,889.0,833.0,1026.0,11955.0
Nalbari,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1062.0,1223.0,745.0,1027.0,1246.0,1158.0,646.0,711.0,716.0,879.0,843.0,1030.0,11286.0
Nalbari,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,70.0,60.0,38.0,57.0,47.0,33.0,63.0,36.0,71.0,34.0,28.0,35.0,572.0
Nalbari,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,46.0,47.0,33.0,36.0,34.0,41.0,64.0,41.0,60.0,32.0,22.0,20.0,476.0
Nalbari,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,116.0,107.0,71.0,93.0,81.0,74.0,127.0,77.0,131.0,66.0,50.0,55.0,1048.0
Nalbari,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,456.0,450.0,345.0,482.0,609.0,494.0,468.0,432.0,539.0,444.0,471.0,489.0,5679.0
Nalbari,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,377.0,426.0,313.0,474.0,450.0,408.0,389.0,357.0,424.0,397.0,396.0,428.0,4839.0
Nalbari,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,295.0,298.0,311.0,392.0,373.0,334.0,357.0,319.0,322.0,304.0,305.0,336.0,3946.0
Nalbari,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,11.0,7.0,3.0,7.0,6.0,1.0,2.0,2.0,6.0,0.0,2.0,25.0,72.0
Nalbari,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,777.0,777.0,770.0,777.0,771.0,779.0,788.0,784.0,785.0,757.0,753.0,750.0,9268.0
Nalbari,10.4.2,Number of Immunisation sessions held during the month,TOTAL,765.0,769.0,745.0,765.0,748.0,766.0,777.0,773.0,776.0,741.0,732.0,748.0,9105.0
Nalbari,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,722.0,737.0,698.0,723.0,705.0,722.0,731.0,725.0,723.0,691.0,686.0,704.0,8567.0
Nalbari,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,4.0,0.0,0.0,0.0,21.0,19.0,0.0,6.0,4.0,43.0,275.0,372.0
Nalbari,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,865.0,1001.0,738.0,1019.0,1087.0,1139.0,1266.0,1164.0,812.0,781.0,798.0,820.0,11490.0
Nalbari,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,108.0,127.0,105.0,158.0,479.0,575.0,191.0,152.0,163.0,173.0,187.0,132.0,2550.0
Nalbari,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,352.0,301.0,243.0,280.0,606.0,940.0,333.0,327.0,376.0,311.0,322.0,320.0,4711.0
Nalbari,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,24.0,15.0,17.0,18.0,20.0,20.0,7.0,3.0,2.0,14.0,14.0,20.0,174.0
Nalbari,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,538.0,593.0,511.0,529.0,584.0,465.0,330.0,245.0,365.0,402.0,353.0,376.0,5291.0
Nalbari,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,2.0,0.0,9.0
Nalbari,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,461.0,491.0,519.0,305.0,559.0,645.0,576.0,443.0,437.0,448.0,315.0,425.0,5624.0
Nalbari,13.1,Number of Patients operated for cataract,TOTAL,180.0,187.0,111.0,166.0,217.0,131.0,149.0,154.0,115.0,86.0,134.0,142.0,1772.0
Nalbari,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,180.0,187.0,111.0,166.0,213.0,131.0,149.0,154.0,114.0,85.0,133.0,142.0,1765.0
Nalbari,13.3,Number of School children detected with Refractive errors,TOTAL,28.0,21.0,14.0,15.0,11.0,43.0,16.0,22.0,8.0,18.0,20.0,28.0,244.0
Nalbari,13.4,Number of children provided free glasses,TOTAL,20.0,15.0,13.0,14.0,11.0,43.0,14.0,22.0,7.0,12.0,19.0,25.0,215.0
Nalbari,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,2.0,-1.0
Nalbari,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,10.0,13.0,13.0,13.0,14.0,14.0,14.0,13.0,13.0,13.0,14.0,14.0,-1.0
Nalbari,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,526.0,522.0,516.0,517.0,514.0,521.0,520.0,523.0,525.0,513.0,517.0,525.0,-1.0
Nalbari,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,6.0,7.0,7.0,7.0,7.0,7.0,8.0,8.0,8.0,8.0,8.0,-1.0
Nalbari,14.05,Number of RKS meetings held during the month,TOTAL,19.0,12.0,12.0,11.0,13.0,15.0,14.0,18.0,13.0,13.0,14.0,16.0,170.0
Nalbari,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,20.0,21.0,21.0,21.0,21.0,22.0,21.0,23.0,23.0,23.0,23.0,22.0,-1.0
Nalbari,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,116.0,123.0,135.0,136.0,164.0,134.0,158.0,132.0,126.0,116.0,112.0,80.0,1532.0
Nalbari,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Nalbari,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Nalbari,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,368.0,310.0,403.0,324.0,305.0,342.0,331.0,216.0,175.0,202.0,243.0,312.0,3531.0
Nalbari,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,692.0,678.0,743.0,754.0,827.0,692.0,646.0,541.0,419.0,375.0,401.0,560.0,7328.0
Nalbari,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,345.0,309.0,331.0,297.0,285.0,271.0,284.0,287.0,128.0,138.0,187.0,245.0,3107.0
Nalbari,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1213.0,1177.0,1315.0,1403.0,1304.0,1187.0,1154.0,1080.0,1001.0,947.0,878.0,1194.0,13853.0
Nalbari,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,713.0,619.0,734.0,621.0,590.0,613.0,615.0,503.0,303.0,340.0,430.0,557.0,6638.0
Nalbari,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1905.0,1855.0,2058.0,2157.0,2131.0,1879.0,1800.0,1621.0,1420.0,1322.0,1279.0,1754.0,21181.0
Nalbari,14.10.2.a,Number of death cases of Inpatient males,TOTAL,9.0,6.0,9.0,7.0,10.0,10.0,9.0,17.0,13.0,14.0,8.0,7.0,119.0
Nalbari,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,9.0,3.0,9.0,7.0,1.0,7.0,9.0,6.0,12.0,9.0,7.0,85.0
Nalbari,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,15.0,15.0,12.0,16.0,17.0,11.0,16.0,26.0,19.0,26.0,17.0,14.0,204.0
Nalbari,14.11,In-Patient Head Count at midnight,TOTAL,4351.0,4330.0,4794.0,4206.0,4309.0,3795.0,4091.0,3769.0,3418.0,3390.0,3283.0,3877.0,47613.0
Nalbari,14.12.1,OPD attendance (All),TOTAL,80654.0,74776.0,82297.0,82991.0,76359.0,76182.0,69010.0,58745.0,50950.0,46421.0,52912.0,67766.0,819063.0
Nalbari,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,9.0,72.0,70.0,70.0,58.0,69.0,11.0,11.0,67.0,71.0,78.0,5.0,591.0
Nalbari,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,16.0,31.0,13.0,24.0,30.0,33.0,37.0,28.0,19.0,21.0,24.0,34.0,310.0
Nalbari,14.14.a,Number of patients given AYUSH treatment,TOTAL,13777.0,13264.0,16604.0,16482.0,13595.0,13887.0,9944.0,7782.0,7784.0,6636.0,7166.0,10277.0,137198.0
Nalbari,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1435.0,1394.0,1406.0,1251.0,1329.0,1356.0,1405.0,1474.0,1382.0,1412.0,1329.0,1444.0,16617.0
Nalbari,14.14.c,Number of Adolescents counselled,TOTAL,38.0,72.0,62.0,31.0,36.0,32.0,23.0,23.0,21.0,21.0,18.0,0.0,377.0
Nalbari,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4652.0,5022.0,5112.0,4093.0,4374.0,4150.0,3996.0,3922.0,3542.0,3358.0,3592.0,3607.0,49420.0
Nalbari,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,22.0,40.0,22.0,10.0,5.0,54.0,7.0,14.0,9.0,14.0,5.0,3.0,205.0
Nalbari,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,159.0,179.0,149.0,177.0,187.0,141.0,151.0,168.0,50.0,215.0,196.0,159.0,1931.0
Nalbari,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,4.0
Nalbari,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,262.0,229.0,254.0,167.0,198.0,236.0,202.0,137.0,37.0,271.0,334.0,344.0,2671.0
Nalbari,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Nalbari,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,860.0,881.0,683.0,699.0,756.0,783.0,668.0,461.0,279.0,540.0,701.0,720.0,8031.0
Nalbari,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1281.0,1289.0,1086.0,1043.0,1141.0,1160.0,1021.0,766.0,366.0,1026.0,1231.0,1223.0,12633.0
Nalbari,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,5.0
Nalbari,15.2,Number of Widal tests conducted,Number tested,363.0,271.0,648.0,661.0,568.0,577.0,422.0,292.0,194.0,156.0,210.0,262.0,4624.0
Nalbari,15.3.a,Number of VDRL tests conducted on males,Number tested,80.0,101.0,103.0,91.0,18.0,52.0,45.0,76.0,87.0,64.0,71.0,64.0,852.0
Nalbari,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,62.0,142.0,178.0,177.0,166.0,187.0,150.0,151.0,103.0,226.0,228.0,225.0,1995.0
Nalbari,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,176.0,128.0,169.0,513.0,492.0,561.0,507.0,441.0,377.0,399.0,596.0,641.0,5000.0
Nalbari,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,318.0,371.0,450.0,781.0,676.0,800.0,702.0,668.0,567.0,689.0,895.0,930.0,7847.0
Nalbari,15.4.1,Number of blood smears examined for Malaria,TOTAL,3546.0,4016.0,7933.0,10423.0,7423.0,5353.0,4275.0,3450.0,2801.0,2196.0,2451.0,3247.0,57114.0
Nalbari,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,2.0,0.0,2.0,5.0,1.0,3.0,1.0,1.0,2.0,0.0,0.0,18.0
Nalbari,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,2.0,1.0,1.0,1.0,3.0,2.0,4.0,0.0,0.0,0.0,14.0
Nalbari,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,23258.0,15990.0,19403.0,23144.0,25305.0,19892.0,18606.0,22993.0,17176.0,19979.0,16600.0,13384.0,235730.0
Nalbari,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,10000.0,10000.0,10000.0,5000.0,5000.0,10000.0,0.0,10000.0,0.0,5000.0,10000.0,75000.0
Nalbari,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,7268.0,6587.0,6259.0,7839.0,10413.0,6286.0,5613.0,5817.0,7197.0,3379.0,8216.0,3525.0,78399.0
Nalbari,16.1.1,Stock position of DPT vaccines,5. Total Stock,15990.0,19403.0,23144.0,25305.0,19892.0,18606.0,22993.0,17176.0,19979.0,16600.0,13384.0,19859.0,232331.0
Nalbari,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Nalbari,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Nalbari,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Nalbari,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Nalbari,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,18434.0,7880.0,8786.0,14581.0,5496.0,4352.0,1121.0,5223.0,297.0,720.0,5231.0,6195.0,78316.0
Nalbari,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,10000.0,20000.0,6000.0,12000.0,0.0,7000.0,0.0,6000.0,6500.0,9000.0,16664.0,93164.0
Nalbari,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,10554.0,9094.0,14205.0,15085.0,13144.0,3231.0,2898.0,4926.0,5577.0,1989.0,8036.0,3768.0,92507.0
Nalbari,16.1.2,Stock position of OPV vaccines,5. Total Stock,7880.0,8786.0,14581.0,5496.0,4352.0,1121.0,5223.0,297.0,720.0,5231.0,6195.0,19091.0,78973.0
Nalbari,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,22110.0,15665.0,10376.0,6276.0,10184.0,20526.0,19495.0,25512.0,18963.0,12019.0,9577.0,11529.0,182232.0
Nalbari,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,0.0,10000.0,18000.0,5000.0,10000.0,0.0,0.0,0.0,10000.0,10000.0,63000.0
Nalbari,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6445.0,5289.0,4100.0,6092.0,7658.0,6031.0,3983.0,6549.0,6944.0,2442.0,8048.0,2386.0,65967.0
Nalbari,16.1.3,Stock position of TT vaccines,5. Total Stock,15665.0,10376.0,6276.0,10184.0,20526.0,19495.0,25512.0,18963.0,12019.0,9577.0,11529.0,19143.0,179265.0
Nalbari,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Nalbari,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Nalbari,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nalbari,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Nalbari,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,8110.0,4410.0,9770.0,6470.0,10940.0,10120.0,7050.0,4310.0,810.0,6430.0,3680.0,8130.0,80230.0
Nalbari,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,9500.0,0.0,9500.0,6000.0,0.0,0.0,0.0,10500.0,0.0,10000.0,0.0,45500.0
Nalbari,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,3700.0,4140.0,3300.0,5030.0,6820.0,3070.0,2740.0,3500.0,4880.0,2750.0,5550.0,1700.0,47180.0
Nalbari,16.1.5,Stock position of BCG vaccines,5. Total Stock,4410.0,9770.0,6470.0,10940.0,10120.0,7050.0,4310.0,810.0,6430.0,3680.0,8130.0,6430.0,78550.0
Nalbari,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,15720.0,12265.0,8265.0,8780.0,8235.0,7590.0,4920.0,6895.0,2775.0,5470.0,2060.0,2420.0,85395.0
Nalbari,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,5000.0,5000.0,5000.0,0.0,5000.0,0.0,5000.0,0.0,5000.0,10000.0,40000.0
Nalbari,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3455.0,4000.0,4485.0,5545.0,5645.0,2670.0,3025.0,4120.0,2305.0,3410.0,4640.0,2410.0,45710.0
Nalbari,16.1.6,Stock position of Measles vaccines,5. Total Stock,12265.0,8265.0,8780.0,8235.0,7590.0,4920.0,6895.0,2775.0,5470.0,2060.0,2420.0,10010.0,79685.0
Nalbari,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,0.0,90.0,1465.0,620.0,150.0,0.0,0.0,2355.0,4680.0
Nalbari,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,1250.0,5000.0,0.0,0.0,0.0,0.0,5000.0,10000.0,21250.0
Nalbari,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nalbari,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,1160.0,3625.0,845.0,470.0,150.0,0.0,2645.0,1850.0,10745.0
Nalbari,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,90.0,1465.0,620.0,150.0,0.0,0.0,2355.0,10505.0,15185.0
Nalbari,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,24000.0,14514.0,17353.0,10731.0,15558.0,16705.0,15700.0,21640.0,15187.0,16580.0,12310.0,8705.0,188983.0
Nalbari,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,9000.0,0.0,9500.0,20100.0,5000.0,10000.0,0.0,10000.0,0.0,5000.0,15000.0,83600.0
Nalbari,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,9486.0,6161.0,6622.0,4673.0,18953.0,6005.0,4060.0,6453.0,8607.0,4270.0,8605.0,2340.0,86235.0
Nalbari,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,14514.0,17353.0,10731.0,15558.0,16705.0,15700.0,21640.0,15187.0,16580.0,12310.0,8705.0,21365.0,186348.0
Nalbari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nalbari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nalbari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nalbari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nalbari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nalbari,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nalbari,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nalbari,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nalbari,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nalbari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nalbari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nalbari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nalbari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nalbari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nalbari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nalbari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nalbari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nalbari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nalbari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nalbari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nalbari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,980.0,980.0,980.0,980.0,980.0,980.0,980.0,980.0,980.0,0.0,0.0,0.0,8820.0
Nalbari,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50320.0,50320.0
Nalbari,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,980.0,0.0,0.0,2120.0,3100.0
Nalbari,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,980.0,980.0,980.0,980.0,980.0,980.0,980.0,980.0,0.0,0.0,0.0,48200.0,56040.0
Nalbari,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Nalbari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,5999200.0,5323859.0,5058859.0,4943359.0,4666009.0,3770059.0,3738559.0,3378559.0,2475559.0,15500.0,5500.0,5500.0,39380522.0
Nalbari,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,1890000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1890000.0
Nalbari,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,2565341.0,265000.0,115500.0,277350.0,895950.0,31500.0,360000.0,903000.0,2460059.0,10000.0,0.0,0.0,7883700.0
Nalbari,16.3.07,Stock Position of IFA Tablets,5. Total Stock,5323859.0,5058859.0,4943359.0,4666009.0,3770059.0,3738559.0,3378559.0,2475559.0,15500.0,5500.0,5500.0,5500.0,33386822.0
Nalbari,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,15700.0,12410.0,11180.0,9750.0,6430.0,6300.0,6300.0,6300.0,6300.0,0.0,6900.0,1700.0,89270.0
Nalbari,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0,0.0,0.0,9000.0
Nalbari,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,3290.0,1230.0,1430.0,3320.0,130.0,0.0,0.0,0.0,6300.0,2100.0,5200.0,1700.0,24700.0
Nalbari,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,12410.0,11180.0,9750.0,6430.0,6300.0,6300.0,6300.0,6300.0,0.0,6900.0,1700.0,0.0,73570.0
Nalbari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,2240.0,2240.0,2240.0,2240.0,2240.0,2240.0,2240.0,2240.0,2240.0,0.0,0.0,0.0,20160.0
Nalbari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2240.0,0.0,0.0,0.0,2240.0
Nalbari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,2240.0,2240.0,2240.0,2240.0,2240.0,2240.0,2240.0,2240.0,0.0,0.0,0.0,0.0,17920.0
Nalbari,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,85.0,55.0,55.0,55.0,20.0,20.0,10.0,300.0
Nalbari,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Nalbari,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,15.0,30.0,0.0,0.0,35.0,0.0,10.0,0.0,90.0
Nalbari,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,85.0,55.0,55.0,55.0,20.0,20.0,10.0,10.0,310.0
Nalbari,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,39508.0,38808.0,37808.0,53008.0,35308.0,32408.0,36228.0,34318.0,35678.0,1150.0,150.0,140.0,344512.0
Nalbari,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,6000.0,0.0,20000.0,20000.0,0.0,5980.0,0.0,28000.0,0.0,0.0,0.0,700000.0,779980.0
Nalbari,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,6700.0,1000.0,4800.0,37700.0,2900.0,2160.0,1910.0,26640.0,34528.0,1000.0,10.0,195000.0,314348.0
Nalbari,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,38808.0,37808.0,53008.0,35308.0,32408.0,36228.0,34318.0,35678.0,1150.0,150.0,140.0,505140.0,810144.0
Nalbari,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,79.0,0.0,0.0,5170.0,3370.0,5570.0,4870.0,4270.0,2470.0,7370.0,5570.0,5570.0,44309.0
Nalbari,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,6600.0,0.0,3300.0,0.0,0.0,0.0,6600.0,0.0,2000.0,0.0,18500.0
Nalbari,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,79.0,0.0,1430.0,1800.0,1100.0,700.0,600.0,1800.0,1700.0,1800.0,2000.0,500.0,13509.0
Nalbari,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,5170.0,3370.0,5570.0,4870.0,4270.0,2470.0,7370.0,5570.0,5570.0,5070.0,49300.0
Nalbari,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,41200.0,27000.0,37380.0,22980.0,32580.0,53780.0,47780.0,58380.0,43980.0,39180.0,31780.0,41380.0,477400.0
Nalbari,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,24000.0,0.0,24000.0,36000.0,0.0,24000.0,0.0,12000.0,0.0,24000.0,24000.0,168000.0
Nalbari,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,14200.0,13620.0,14400.0,14400.0,14800.0,6000.0,13400.0,14400.0,16800.0,7400.0,14400.0,7200.0,151020.0
Nalbari,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,27000.0,37380.0,22980.0,32580.0,53780.0,47780.0,58380.0,43980.0,39180.0,31780.0,41380.0,58180.0,494380.0
Nalbari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5000.0,2980.0,1000.0,0.0,3860.0,6860.0,6160.0,7760.0,5060.0,7160.0,5960.0,5260.0,57060.0
Nalbari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4000.0,0.0,6780.0,6000.0,0.0,2000.0,0.0,4000.0,0.0,2000.0,4000.0,28780.0
Nalbari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalbari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2020.0,5980.0,1000.0,2920.0,3000.0,700.0,400.0,2700.0,1900.0,1200.0,2700.0,1000.0,25520.0
Nalbari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2980.0,1000.0,0.0,3860.0,6860.0,6160.0,7760.0,5060.0,7160.0,5960.0,5260.0,8260.0,60320.0
Nalbari,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,4.0,,1.0,,,,2.0,1.0,,,,9.0
Nalbari,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,1.0,,1.0,,1.0,1.0,1.0,,,5.0
Nalbari,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nalbari,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,1.0,,1.0,,1.0,1.0,1.0,,,5.0
Nalbari,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,1.0,2.0,1.0,3.0,3.0,2.0,3.0,5.0,4.0,4.0,2.0,32.0
Nalbari,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nalbari,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,1.0,2.0,1.0,3.0,3.0,2.0,3.0,5.0,4.0,4.0,2.0,32.0
Nalbari,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,3.0,,2.0,1.0,,,3.0,2.0,3.0,1.0,,16.0
Nalbari,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nalbari,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,3.0,,2.0,1.0,,,3.0,2.0,3.0,1.0,,16.0
Nalbari,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,,1.0,1.0,1.0,1.0,1.0,,2.0,1.0,1.0,10.0
Nalbari,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nalbari,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,,1.0,1.0,1.0,1.0,1.0,,2.0,1.0,1.0,10.0
Nalbari,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,2.0,,1.0,,3.0,1.0,,,7.0
Nalbari,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,1.0,,1.0
Nalbari,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,2.0,,1.0,,3.0,1.0,1.0,,8.0
Nalbari,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nalbari,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nalbari,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Nalbari,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nalbari,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nalbari,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Nalbari,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nalbari,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nalbari,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Nalbari,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,,1.0,2.0,2.0,2.0,2.0,2.0,2.0,,,,15.0
Nalbari,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Nalbari,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,,1.0,2.0,2.0,2.0,2.0,2.0,3.0,,,,16.0
Nalbari,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Nalbari,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Nalbari,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,,,,,,,,,,1.0
Nalbari,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Nalbari,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,,,,,,,,1.0,2.0
Nalbari,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,1.0,,,,,,,,,1.0,3.0
Nalbari,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,5.0,3.0,,4.0,4.0,2.0,4.0,4.0,3.0,4.0,4.0,2.0,39.0
Nalbari,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,4.0,5.0,4.0,6.0,4.0,4.0,6.0,9.0,5.0,7.0,6.0,6.0,66.0
Nalbari,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,9.0,8.0,4.0,10.0,8.0,6.0,10.0,13.0,8.0,11.0,10.0,8.0,105.0
Nalbari,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,1.0,1.0,,,,,,,,2.0
Nalbari,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Nalbari,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,,1.0,1.0,,,,,,,,3.0
Nalbari,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Nalbari,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Nalbari,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,1.0,1.0,,,,,,,2.0
Nalbari,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,1.0,1.0,,1.0,1.0,,,,4.0
Nalbari,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Nalbari,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Nalbari,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Nalbari,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,,,,,,,,,1.0,,,2.0
Nalbari,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,1.0,2.0,1.0,2.0,2.0,5.0,2.0,3.0,2.0,3.0,4.0,28.0
Nalbari,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,1.0,1.0,3.0,2.0,3.0,2.0,1.0,2.0,1.0,2.0,2.0,20.0
Nalbari,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,2.0,3.0,4.0,4.0,5.0,7.0,3.0,5.0,4.0,5.0,6.0,50.0
Nalbari,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,1.0,1.0,1.0,,1.0,4.0
Nalbari,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,10.0
Nalbari,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,,1.0,14.0
Nalbari,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Nalbari,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Nalbari,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Nalbari,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Nalbari,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Nalbari,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Nalbari,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Nalbari,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Nalbari,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Nalbari,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Nalbari,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Nalbari,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Nalbari,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Nalbari,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Nalbari,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Nalbari,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,1.0,1.0,,,1.0,3.0
Nalbari,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Nalbari,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,1.0,1.0,,,1.0,3.0
Nalbari,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,1.0,1.0,1.0,2.0,,2.0,1.0,,,,,10.0
Nalbari,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,1.0,,,1.0,,1.0,,3.0
Nalbari,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,1.0,1.0,1.0,2.0,1.0,2.0,1.0,1.0,,1.0,,13.0
Nalbari,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,1.0,3.0,1.0,,,1.0,,,1.0,,,10.0
Nalbari,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,1.0,1.0,1.0,,,,,,,,4.0
Nalbari,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,1.0,4.0,2.0,1.0,,1.0,,,1.0,,,14.0
Nalbari,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Nalbari,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Nalbari,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,2.0,,,,,,,,,,,2.0
Nalbari,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,2.0,,,,,,,,,,3.0
Nalbari,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,1.0,,1.0,1.0,2.0,,1.0,1.0,1.0,1.0,,11.0
Nalbari,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,1.0,,2.0,1.0,1.0,1.0,1.0,,,1.0,9.0
Nalbari,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,2.0,3.0,1.0,3.0,3.0,1.0,2.0,2.0,1.0,1.0,1.0,23.0
Nalbari,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,4.0,2.0,1.0,2.0,4.0,1.0,1.0,3.0,1.0,1.0,,4.0,24.0
Nalbari,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,5.0,5.0,2.0,4.0,3.0,7.0,3.0,5.0,10.0,14.0,4.0,9.0,71.0
Nalbari,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,9.0,7.0,3.0,6.0,7.0,8.0,4.0,8.0,11.0,15.0,4.0,13.0,95.0
Nalbari,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Nalbari,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,8.0,2.0,3.0,6.0,1.0,3.0,4.0,2.0,1.0,4.0,4.0,3.0,41.0
Nalbari,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,7.0,7.0,8.0,12.0,11.0,9.0,10.0,12.0,12.0,15.0,9.0,9.0,121.0
Nalbari,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,15.0,9.0,11.0,18.0,12.0,12.0,14.0,14.0,13.0,19.0,13.0,12.0,162.0
North Cachar Hills,1.1,Total number of pregnant women Registered for ANC,TOTAL,469.0,435.0,477.0,459.0,430.0,444.0,468.0,483.0,362.0,348.0,423.0,449.0,5247.0
North Cachar Hills,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,230.0,212.0,212.0,242.0,210.0,206.0,248.0,245.0,218.0,186.0,237.0,263.0,2709.0
North Cachar Hills,1.2,Number of Pregnant women registered under JSY,TOTAL,289.0,274.0,380.0,417.0,397.0,422.0,392.0,442.0,349.0,290.0,350.0,354.0,4356.0
North Cachar Hills,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,268.0,250.0,297.0,307.0,344.0,365.0,301.0,311.0,309.0,279.0,269.0,285.0,3585.0
North Cachar Hills,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,394.0,366.0,392.0,335.0,368.0,342.0,361.0,376.0,289.0,265.0,310.0,344.0,4142.0
North Cachar Hills,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,360.0,387.0,361.0,369.0,381.0,378.0,420.0,397.0,348.0,319.0,296.0,340.0,4356.0
North Cachar Hills,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,257.0,271.0,227.0,296.0,307.0,307.0,295.0,337.0,239.0,222.0,269.0,261.0,3288.0
North Cachar Hills,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,7.0,8.0,10.0,6.0,6.0,9.0,4.0,7.0,4.0,3.0,3.0,4.0,71.0
North Cachar Hills,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,1.0,0.0,0.0,1.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,6.0
North Cachar Hills,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,204.0,152.0,210.0,221.0,273.0,264.0,323.0,278.0,186.0,223.0,266.0,233.0,2833.0
North Cachar Hills,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,2.0,3.0,1.0,1.0,5.0,2.0,1.0,1.0,0.0,1.0,2.0,20.0
North Cachar Hills,1.8,Number of pregnancy test kits used at SC level,TOTAL,116.0,106.0,120.0,147.0,120.0,101.0,119.0,109.0,69.0,63.0,54.0,80.0,1204.0
North Cachar Hills,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,19.0,20.0,22.0,21.0,24.0,25.0,29.0,29.0,22.0,12.0,15.0,18.0,256.0
North Cachar Hills,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,129.0,118.0,128.0,118.0,101.0,118.0,139.0,141.0,127.0,128.0,111.0,133.0,1491.0
North Cachar Hills,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,148.0,138.0,150.0,139.0,125.0,143.0,168.0,170.0,149.0,140.0,126.0,151.0,1747.0
North Cachar Hills,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,51.0,74.0,64.0,62.0,38.0,56.0,58.0,73.0,74.0,40.0,51.0,47.0,688.0
North Cachar Hills,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,235.0,186.0,191.0,205.0,198.0,203.0,238.0,218.0,210.0,208.0,198.0,186.0,2476.0
North Cachar Hills,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,45.0,111.0,39.0,50.0,30.0,30.0,44.0,34.0,31.0,28.0,29.0,29.0,500.0
North Cachar Hills,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,214.0,200.0,180.0,200.0,192.0,197.0,248.0,215.0,209.0,217.0,195.0,185.0,2452.0
North Cachar Hills,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,88.0,113.0,90.0,112.0,103.0,121.0,152.0,110.0,82.0,141.0,110.0,99.0,1321.0
North Cachar Hills,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
North Cachar Hills,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,4.0,2.0,0.0,2.0,4.0,3.0,2.0,0.0,0.0,3.0,2.0,2.0,24.0
North Cachar Hills,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,4.0
North Cachar Hills,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0
North Cachar Hills,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
North Cachar Hills,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
North Cachar Hills,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,51.0,34.0,37.0,31.0,35.0,35.0,34.0,48.0,45.0,27.0,39.0,29.0,445.0
North Cachar Hills,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North Cachar Hills,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,51.0,34.0,37.0,31.0,35.0,35.0,34.0,48.0,45.0,27.0,39.0,29.0,445.0
North Cachar Hills,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
North Cachar Hills,4.1.1.a,Number of male live births,TOTAL,188.0,172.0,169.0,174.0,154.0,190.0,210.0,199.0,195.0,185.0,142.0,168.0,2146.0
North Cachar Hills,4.1.1.b,Number of female live births,TOTAL,202.0,150.0,168.0,167.0,163.0,161.0,201.0,190.0,180.0,164.0,167.0,165.0,2078.0
North Cachar Hills,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,390.0,322.0,337.0,341.0,317.0,351.0,411.0,389.0,375.0,349.0,309.0,333.0,4224.0
North Cachar Hills,4.1.2,Number of still births,TOTAL,12.0,7.0,6.0,8.0,11.0,4.0,8.0,6.0,6.0,8.0,19.0,10.0,105.0
North Cachar Hills,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,59.0,36.0,53.0,54.0,40.0,51.0,42.0,29.0,42.0,28.0,23.0,38.0,495.0
North Cachar Hills,4.2.1,Number of Newborns weighed at birth,TOTAL,346.0,291.0,302.0,326.0,304.0,324.0,303.0,275.0,345.0,325.0,282.0,294.0,3717.0
North Cachar Hills,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,30.0,22.0,18.0,19.0,33.0,24.0,22.0,9.0,26.0,26.0,21.0,29.0,279.0
North Cachar Hills,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,370.0,318.0,333.0,341.0,310.0,351.0,400.0,363.0,344.0,343.0,293.0,321.0,4087.0
North Cachar Hills,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
North Cachar Hills,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,32.0,26.0,23.0,0.0,35.0,28.0,30.0,28.0,0.0,0.0,0.0,0.0,202.0
North Cachar Hills,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,56.0,38.0,47.0,32.0,35.0,35.0,34.0,48.0,45.0,29.0,39.0,29.0,467.0
North Cachar Hills,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North Cachar Hills,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,88.0,64.0,70.0,33.0,70.0,63.0,64.0,76.0,45.0,29.0,39.0,29.0,670.0
North Cachar Hills,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,59.0,39.0,41.0,75.0,40.0,39.0,39.0,50.0,45.0,29.0,39.0,29.0,524.0
North Cachar Hills,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,16.0,5.0,6.0,1.0,1.0,2.0,0.0,1.0,0.0,1.0,1.0,0.0,34.0
North Cachar Hills,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,83.0,60.0,57.0,52.0,65.0,63.0,59.0,74.0,45.0,29.0,39.0,29.0,655.0
North Cachar Hills,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,33.0,25.0,30.0,25.0,27.0,12.0,25.0,28.0,37.0,22.0,24.0,24.0,312.0
North Cachar Hills,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,255.0,219.0,226.0,215.0,209.0,186.0,230.0,276.0,241.0,206.0,194.0,224.0,2681.0
North Cachar Hills,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,222.0,205.0,205.0,162.0,177.0,178.0,200.0,266.0,220.0,114.0,111.0,143.0,2203.0
North Cachar Hills,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,1.0,16.0,12.0,7.0,2.0,13.0,56.0
North Cachar Hills,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,12.0,10.0,9.0,7.0,8.0,24.0,23.0,9.0,22.0,14.0,11.0,16.0,165.0
North Cachar Hills,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,9.0,3.0,1.0,13.0,4.0,2.0,6.0,6.0,4.0,4.0,0.0,7.0,59.0
North Cachar Hills,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,21.0,13.0,10.0,20.0,12.0,26.0,29.0,15.0,26.0,18.0,11.0,23.0,224.0
North Cachar Hills,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
North Cachar Hills,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,15.0,23.0,22.0,26.0,18.0,13.0,18.0,12.0,13.0,14.0,17.0,15.0,206.0
North Cachar Hills,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,37.0,34.0,30.0,36.0,60.0,72.0,60.0,65.0,45.0,33.0,35.0,50.0,557.0
North Cachar Hills,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,52.0,57.0,52.0,62.0,78.0,85.0,78.0,77.0,58.0,47.0,52.0,65.0,763.0
North Cachar Hills,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North Cachar Hills,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North Cachar Hills,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,1.0,1.0
North Cachar Hills,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North Cachar Hills,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
North Cachar Hills,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,7.0,3.0,9.0,9.0,6.0,7.0,4.0,5.0,4.0,,0.0,3.0,57.0
North Cachar Hills,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North Cachar Hills,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,7.0,3.0,9.0,9.0,6.0,7.0,4.0,5.0,4.0,0.0,0.0,3.0,57.0
North Cachar Hills,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,2.0,3.0,25.0,14.0,38.0,11.0,6.0,13.0,2.0,3.0,3.0,5.0,125.0
North Cachar Hills,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,15.0,11.0,7.0,19.0,30.0,4.0,9.0,6.0,4.0,9.0,4.0,1.0,119.0
North Cachar Hills,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,12.0,3.0,17.0,9.0,16.0,10.0,7.0,6.0,8.0,19.0,7.0,3.0,117.0
North Cachar Hills,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,33.0,33.0,31.0,30.0,31.0,38.0,37.0,19.0,16.0,18.0,11.0,6.0,303.0
North Cachar Hills,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North Cachar Hills,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,62.0,50.0,80.0,72.0,115.0,63.0,59.0,44.0,30.0,49.0,25.0,15.0,664.0
North Cachar Hills,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,3.0,2.0,17.0,17.0,21.0,24.0,26.0,9.0,20.0,9.0,8.0,13.0,169.0
North Cachar Hills,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.06,Number of IUCD removals,TOTAL,8.0,6.0,17.0,9.0,4.0,10.0,11.0,12.0,10.0,12.0,8.0,10.0,117.0
North Cachar Hills,9.07,Number of Oral Pills cycles distributed,TOTAL,758.0,974.0,783.0,880.0,849.0,821.0,895.0,917.0,847.0,850.0,826.0,785.0,10185.0
North Cachar Hills,9.08,Number of Condom pieces distributed,TOTAL,2886.0,2742.0,2800.0,2762.0,2728.0,2538.0,2702.0,2667.0,2431.0,2114.0,2373.0,2774.0,31517.0
North Cachar Hills,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,30.0,0.0,0.0,0.0,0.0,0.0,30.0
North Cachar Hills,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,10.0,5.0,3.0,3.0,9.0,8.0,9.0,2.0,6.0,13.0,28.0,96.0
North Cachar Hills,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
North Cachar Hills,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,422.0,332.0,383.0,352.0,303.0,415.0,484.0,344.0,383.0,385.0,345.0,363.0,4511.0
North Cachar Hills,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,362.0,347.0,353.0,346.0,400.0,304.0,379.0,414.0,311.0,360.0,187.0,22.0,3785.0
North Cachar Hills,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,381.0,330.0,374.0,326.0,363.0,373.0,364.0,323.0,359.0,303.0,324.0,256.0,4076.0
North Cachar Hills,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,349.0,334.0,303.0,342.0,334.0,389.0,395.0,321.0,315.0,337.0,277.0,336.0,4032.0
North Cachar Hills,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,164.0,324.0,488.0
North Cachar Hills,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,129.0,129.0
North Cachar Hills,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,300.0,218.0,260.0,223.0,194.0,259.0,300.0,244.0,250.0,245.0,209.0,207.0,2909.0
North Cachar Hills,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,362.0,347.0,353.0,346.0,400.0,304.0,379.0,414.0,310.0,360.0,333.0,346.0,4254.0
North Cachar Hills,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,381.0,330.0,374.0,326.0,363.0,373.0,364.0,318.0,359.0,303.0,324.0,385.0,4200.0
North Cachar Hills,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,349.0,334.0,303.0,342.0,334.0,389.0,395.0,326.0,315.0,337.0,277.0,336.0,4037.0
North Cachar Hills,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,209.0,170.0,163.0,175.0,168.0,197.0,209.0,192.0,182.0,201.0,170.0,153.0,2189.0
North Cachar Hills,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,362.0,347.0,353.0,346.0,400.0,304.0,379.0,411.0,304.0,360.0,184.0,22.0,3772.0
North Cachar Hills,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,381.0,330.0,374.0,326.0,363.0,373.0,364.0,322.0,355.0,303.0,320.0,257.0,4068.0
North Cachar Hills,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,349.0,334.0,303.0,342.0,334.0,389.0,395.0,321.0,315.0,337.0,270.0,338.0,4027.0
North Cachar Hills,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,272.0,297.0,281.0,270.0,348.0,340.0,373.0,344.0,251.0,265.0,306.0,284.0,3631.0
North Cachar Hills,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,237.0,256.0,260.0,209.0,324.0,253.0,244.0,263.0,238.0,188.0,235.0,215.0,2922.0
North Cachar Hills,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,131.0,133.0,142.0,134.0,174.0,176.0,193.0,158.0,128.0,133.0,144.0,139.0,1785.0
North Cachar Hills,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,141.0,161.0,138.0,136.0,175.0,163.0,175.0,186.0,123.0,132.0,162.0,145.0,1837.0
North Cachar Hills,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,272.0,294.0,280.0,270.0,349.0,339.0,368.0,344.0,251.0,265.0,306.0,284.0,3622.0
North Cachar Hills,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,237.0,256.0,260.0,217.0,328.0,253.0,243.0,263.0,261.0,185.0,235.0,215.0,2953.0
North Cachar Hills,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,237.0,256.0,260.0,217.0,328.0,253.0,243.0,263.0,261.0,185.0,235.0,215.0,2953.0
North Cachar Hills,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,70.0,70.0,77.0,57.0,106.0,61.0,82.0,107.0,70.0,54.0,90.0,79.0,923.0
North Cachar Hills,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,61.0,72.0,64.0,69.0,83.0,71.0,76.0,87.0,78.0,66.0,97.0,91.0,915.0
North Cachar Hills,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,131.0,142.0,141.0,126.0,189.0,132.0,158.0,194.0,148.0,120.0,187.0,170.0,1838.0
North Cachar Hills,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,103.0,84.0,77.0,118.0,84.0,82.0,109.0,114.0,143.0,96.0,119.0,88.0,1217.0
North Cachar Hills,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,142.0,112.0,111.0,110.0,103.0,96.0,137.0,152.0,145.0,133.0,118.0,112.0,1471.0
North Cachar Hills,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,104.0,94.0,105.0,91.0,95.0,75.0,104.0,94.0,110.0,106.0,75.0,84.0,1137.0
North Cachar Hills,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,3.0,1.0,0.0,0.0,2.0,1.0,9.0
North Cachar Hills,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,47.0,45.0,61.0,48.0,56.0,50.0,30.0,43.0,380.0
North Cachar Hills,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,394.0,406.0,397.0,432.0,404.0,363.0,384.0,372.0,395.0,375.0,360.0,388.0,4670.0
North Cachar Hills,10.4.2,Number of Immunisation sessions held during the month,TOTAL,387.0,369.0,374.0,352.0,376.0,361.0,363.0,350.0,371.0,367.0,351.0,390.0,4411.0
North Cachar Hills,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,337.0,318.0,323.0,306.0,354.0,297.0,343.0,329.0,350.0,319.0,308.0,345.0,3929.0
North Cachar Hills,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,272.0,302.0,281.0,270.0,356.0,340.0,369.0,344.0,275.0,267.0,303.0,291.0,3670.0
North Cachar Hills,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,62.0,69.0,80.0,73.0,512.0,94.0,78.0,79.0,77.0,63.0,169.0,101.0,1457.0
North Cachar Hills,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,62.0,56.0,47.0,63.0,465.0,60.0,68.0,79.0,68.0,65.0,149.0,71.0,1253.0
North Cachar Hills,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
North Cachar Hills,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
North Cachar Hills,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,1.0,1.0,4.0,4.0,3.0,0.0,5.0,1.0,1.0,7.0,5.0,35.0
North Cachar Hills,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,352.0,315.0,380.0,380.0,362.0,272.0,283.0,249.0,227.0,192.0,222.0,262.0,3496.0
North Cachar Hills,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,8.0,4.0,0.0,9.0,17.0,12.0,10.0,2.0,1.0,3.0,2.0,1.0,69.0
North Cachar Hills,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,100.0,74.0,73.0,99.0,116.0,81.0,105.0,129.0,55.0,83.0,71.0,206.0,1192.0
North Cachar Hills,13.1,Number of Patients operated for cataract,TOTAL,5.0,4.0,3.0,7.0,3.0,2.0,3.0,2.0,5.0,1.0,3.0,0.0,38.0
North Cachar Hills,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,5.0,4.0,3.0,7.0,3.0,2.0,3.0,2.0,5.0,1.0,3.0,0.0,38.0
North Cachar Hills,13.3,Number of School children detected with Refractive errors,TOTAL,20.0,20.0,17.0,27.0,18.0,28.0,19.0,17.0,15.0,18.0,15.0,25.0,239.0
North Cachar Hills,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
North Cachar Hills,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
North Cachar Hills,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,146.0,157.0,165.0,161.0,153.0,154.0,176.0,149.0,176.0,169.0,154.0,162.0,-1.0
North Cachar Hills,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
North Cachar Hills,14.05,Number of RKS meetings held during the month,TOTAL,4.0,6.0,4.0,5.0,4.0,5.0,4.0,4.0,4.0,4.0,4.0,5.0,53.0
North Cachar Hills,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,11.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,9.0,9.0,9.0,10.0,-1.0
North Cachar Hills,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,35.0,22.0,39.0,36.0,46.0,34.0,39.0,26.0,27.0,28.0,14.0,38.0,384.0
North Cachar Hills,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
North Cachar Hills,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
North Cachar Hills,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,84.0,65.0,122.0,121.0,108.0,99.0,93.0,73.0,63.0,64.0,56.0,80.0,1028.0
North Cachar Hills,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,300.0,316.0,408.0,362.0,300.0,277.0,325.0,284.0,237.0,208.0,240.0,272.0,3529.0
North Cachar Hills,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,88.0,71.0,121.0,97.0,119.0,145.0,71.0,89.0,43.0,39.0,52.0,118.0,1053.0
North Cachar Hills,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,511.0,531.0,594.0,595.0,533.0,471.0,529.0,442.0,391.0,371.0,387.0,387.0,5742.0
North Cachar Hills,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,172.0,136.0,243.0,218.0,227.0,244.0,164.0,162.0,106.0,103.0,108.0,198.0,2081.0
North Cachar Hills,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,811.0,847.0,1002.0,957.0,833.0,748.0,854.0,726.0,628.0,579.0,627.0,659.0,9271.0
North Cachar Hills,14.10.2.a,Number of death cases of Inpatient males,TOTAL,6.0,4.0,10.0,13.0,10.0,14.0,14.0,12.0,7.0,7.0,9.0,11.0,117.0
North Cachar Hills,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,5.0,10.0,6.0,8.0,11.0,5.0,3.0,6.0,4.0,2.0,4.0,70.0
North Cachar Hills,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,12.0,9.0,20.0,19.0,18.0,25.0,19.0,15.0,13.0,11.0,11.0,15.0,187.0
North Cachar Hills,14.11,In-Patient Head Count at midnight,TOTAL,3222.0,3124.0,3731.0,4027.0,3601.0,2764.0,2925.0,2859.0,2240.0,1961.0,2133.0,3093.0,35680.0
North Cachar Hills,14.12.1,OPD attendance (All),TOTAL,20118.0,20926.0,22639.0,25623.0,22974.0,20990.0,19251.0,17863.0,15139.0,13832.0,14796.0,17986.0,232137.0
North Cachar Hills,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,10.0,22.0,20.0,18.0,24.0,10.0,8.0,61.0,58.0,39.0,49.0,41.0,360.0
North Cachar Hills,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,3.0
North Cachar Hills,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,41.0,18.0,15.0,22.0,22.0,42.0,43.0,23.0,32.0,20.0,20.0,37.0,335.0
North Cachar Hills,14.14.a,Number of patients given AYUSH treatment,TOTAL,1142.0,1003.0,1237.0,1792.0,827.0,633.0,589.0,731.0,613.0,470.0,718.0,670.0,10425.0
North Cachar Hills,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,45.0,68.0,60.0,32.0,29.0,30.0,24.0,22.0,24.0,17.0,19.0,41.0,411.0
North Cachar Hills,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,21.0,37.0
North Cachar Hills,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,478.0,650.0,617.0,714.0,720.0,516.0,721.0,572.0,441.0,435.0,384.0,341.0,6589.0
North Cachar Hills,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,31.0,24.0,14.0,14.0,19.0,28.0,23.0,27.0,18.0,11.0,10.0,23.0,242.0
North Cachar Hills,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,74.0,52.0,30.0,55.0,42.0,20.0,68.0,86.0,23.0,16.0,37.0,89.0,592.0
North Cachar Hills,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,4.0
North Cachar Hills,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,34.0,32.0,24.0,47.0,71.0,62.0,37.0,19.0,18.0,8.0,18.0,45.0,415.0
North Cachar Hills,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,3.0
North Cachar Hills,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,178.0,131.0,150.0,182.0,156.0,162.0,148.0,61.0,118.0,183.0,189.0,200.0,1858.0
North Cachar Hills,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
North Cachar Hills,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,286.0,215.0,204.0,284.0,269.0,244.0,253.0,166.0,159.0,207.0,244.0,334.0,2865.0
North Cachar Hills,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0,2.0,8.0
North Cachar Hills,15.2,Number of Widal tests conducted,Number tested,64.0,76.0,95.0,118.0,139.0,129.0,64.0,113.0,68.0,36.0,32.0,72.0,1006.0
North Cachar Hills,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,2.0,20.0,21.0,18.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,64.0
North Cachar Hills,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,11.0,1.0,25.0,30.0,66.0,18.0,6.0,7.0,10.0,13.0,7.0,0.0,194.0
North Cachar Hills,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,70.0,41.0,192.0,209.0,186.0,25.0,59.0,37.0,37.0,39.0,40.0,36.0,971.0
North Cachar Hills,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,81.0,44.0,237.0,260.0,270.0,43.0,65.0,47.0,47.0,52.0,47.0,36.0,1229.0
North Cachar Hills,15.4.1,Number of blood smears examined for Malaria,TOTAL,1053.0,1264.0,2464.0,3039.0,2727.0,2246.0,2728.0,1603.0,1192.0,721.0,759.0,1218.0,21014.0
North Cachar Hills,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,16.0,34.0,20.0,43.0,48.0,30.0,19.0,18.0,11.0,3.0,0.0,4.0,246.0
North Cachar Hills,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,22.0,42.0,103.0,186.0,231.0,135.0,98.0,60.0,34.0,22.0,26.0,45.0,1004.0
North Cachar Hills,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,40650.0,47850.0,46150.0,44150.0,41500.0,,,,,,,,220300.0
North Cachar Hills,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,,0.0,0.0,0.0,,,,,,,,10000.0
North Cachar Hills,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2800.0,1700.0,2000.0,2650.0,1800.0,,,,,,,,10950.0
North Cachar Hills,16.1.1,Stock position of DPT vaccines,5. Total Stock,47850.0,46150.0,44150.0,41500.0,39700.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,219350.0
North Cachar Hills,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
North Cachar Hills,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
North Cachar Hills,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
North Cachar Hills,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,18060.0,19660.0,17420.0,13520.0,9320.0,,,,,,,,77980.0
North Cachar Hills,16.1.2,Stock position of OPV vaccines,2. Stocks Received,5000.0,,0.0,0.0,5000.0,,,,,,,,10000.0
North Cachar Hills,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,3400.0,2240.0,3900.0,4200.0,3400.0,,,,,,,,17140.0
North Cachar Hills,16.1.2,Stock position of OPV vaccines,5. Total Stock,19660.0,17420.0,13520.0,9320.0,10920.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,70840.0
North Cachar Hills,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,19860.0,16660.0,15260.0,13210.0,11060.0,,,,,,,,76050.0
North Cachar Hills,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
North Cachar Hills,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.1.3,Stock position of TT vaccines,4. Stock Distributed,3200.0,1400.0,2050.0,2150.0,1950.0,,,,,,,,10750.0
North Cachar Hills,16.1.3,Stock position of TT vaccines,5. Total Stock,16660.0,15260.0,13210.0,11060.0,9110.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,65300.0
North Cachar Hills,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
North Cachar Hills,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
North Cachar Hills,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
North Cachar Hills,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,10040.0,10490.0,8140.0,6240.0,4140.0,,,,,,,,39050.0
North Cachar Hills,16.1.5,Stock position of BCG vaccines,2. Stocks Received,3000.0,,0.0,0.0,2000.0,,,,,,,,5000.0
North Cachar Hills,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2550.0,2350.0,1900.0,2100.0,1300.0,,,,,,,,10200.0
North Cachar Hills,16.1.5,Stock position of BCG vaccines,5. Total Stock,10490.0,8140.0,6240.0,4140.0,4840.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33850.0
North Cachar Hills,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3200.0,6875.0,5700.0,4700.0,550.0,,,,,,,,21025.0
North Cachar Hills,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4625.0,,0.0,0.0,5000.0,,,,,,,,9625.0
North Cachar Hills,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,950.0,1175.0,1000.0,4150.0,800.0,,,,,,,,8075.0
North Cachar Hills,16.1.6,Stock position of Measles vaccines,5. Total Stock,6875.0,5700.0,4700.0,550.0,4750.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22575.0
North Cachar Hills,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
North Cachar Hills,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
North Cachar Hills,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
North Cachar Hills,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,9380.0,15680.0,13630.0,11480.0,8130.0,,,,,,,,58300.0
North Cachar Hills,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,9000.0,,0.0,0.0,0.0,,,,,,,,9000.0
North Cachar Hills,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2700.0,2050.0,2150.0,3350.0,1750.0,,,,,,,,12000.0
North Cachar Hills,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,15680.0,13630.0,11480.0,8130.0,6380.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,55300.0
North Cachar Hills,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,350.0,350.0,50.0,50.0,50.0,,,,,,,,850.0
North Cachar Hills,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
North Cachar Hills,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,300.0,0.0,0.0,50.0,,,,,,,,350.0
North Cachar Hills,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,350.0,50.0,50.0,50.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0
North Cachar Hills,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,3040.0,3040.0,4040.0,4040.0,4040.0,,,,,,,,18200.0
North Cachar Hills,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,1000.0,0.0,0.0,0.0,,,,,,,,1000.0
North Cachar Hills,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,0.0,0.0,,,,,,,,0.0
North Cachar Hills,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,3040.0,4040.0,4040.0,4040.0,4040.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19200.0
North Cachar Hills,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,4100.0,4100.0,4100.0,4100.0,4100.0,,,,,,,,20500.0
North Cachar Hills,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
North Cachar Hills,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,0.0,0.0,,,,,,,,0.0
North Cachar Hills,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,4100.0,4100.0,4100.0,4100.0,4100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20500.0
North Cachar Hills,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
North Cachar Hills,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
North Cachar Hills,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
North Cachar Hills,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
North Cachar Hills,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
North Cachar Hills,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
North Cachar Hills,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
North Cachar Hills,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
North Cachar Hills,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
North Cachar Hills,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,18000.0,13800.0,8500.0,7550.0,,,,,,,,47850.0
North Cachar Hills,16.3.02,Stock Position of Gloves,2. Stocks Received,25000.0,,0.0,0.0,0.0,,,,,,,,25000.0
North Cachar Hills,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.3.02,Stock Position of Gloves,4. Stock Distributed,7000.0,4200.0,5300.0,950.0,510.0,,,,,,,,17960.0
North Cachar Hills,16.3.02,Stock Position of Gloves,5. Total Stock,18000.0,13800.0,8500.0,7550.0,7040.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,54890.0
North Cachar Hills,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
North Cachar Hills,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
North Cachar Hills,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
North Cachar Hills,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
North Cachar Hills,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
North Cachar Hills,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
North Cachar Hills,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
North Cachar Hills,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
North Cachar Hills,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
North Cachar Hills,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
North Cachar Hills,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
North Cachar Hills,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
North Cachar Hills,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,738900.0,601400.0,601400.0,514400.0,514400.0,,,,,,,,2970500.0
North Cachar Hills,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
North Cachar Hills,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,137500.0,0.0,87000.0,0.0,21000.0,,,,,,,,245500.0
North Cachar Hills,16.3.07,Stock Position of IFA Tablets,5. Total Stock,601400.0,601400.0,514400.0,514400.0,493400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2725000.0
North Cachar Hills,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,16100.0,14900.0,14900.0,0.0,12000.0,,,,,,,,57900.0
North Cachar Hills,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,0.0,12000.0,,,,,,,,,12000.0
North Cachar Hills,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,1200.0,0.0,14900.0,0.0,1000.0,,,,,,,,17100.0
North Cachar Hills,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,14900.0,14900.0,0.0,12000.0,11000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,52800.0
North Cachar Hills,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
North Cachar Hills,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
North Cachar Hills,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
North Cachar Hills,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North Cachar Hills,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,50.0,50.0,50.0,40.0,40.0,,,,,,,,230.0
North Cachar Hills,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,0.0,0.0,100.0,,,,,,,,100.0
North Cachar Hills,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,0.0,10.0,0.0,0.0,,,,,,,,10.0
North Cachar Hills,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,50.0,50.0,40.0,40.0,140.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,320.0
North Cachar Hills,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,9805.0,1425.0,0.0,0.0,0.0,,,,,,,,11230.0
North Cachar Hills,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,0.0,,5000.0,,,,,,,,5000.0
North Cachar Hills,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,8380.0,1425.0,,,1500.0,,,,,,,,11305.0
North Cachar Hills,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,1425.0,0.0,0.0,0.0,3500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4925.0
North Cachar Hills,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,10500.0,9100.0,8300.0,6500.0,5900.0,,,,,,,,40300.0
North Cachar Hills,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
North Cachar Hills,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1400.0,800.0,1800.0,600.0,400.0,,,,,,,,5000.0
North Cachar Hills,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,9100.0,8300.0,6500.0,5900.0,5500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,35300.0
North Cachar Hills,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,32000.0,29400.0,25600.0,18000.0,15400.0,,,,,,,,120400.0
North Cachar Hills,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
North Cachar Hills,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,2600.0,3800.0,7600.0,2600.0,1400.0,,,,,,,,18000.0
North Cachar Hills,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,29400.0,25600.0,18000.0,15400.0,14000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,102400.0
North Cachar Hills,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5900.0,5200.0,5200.0,4000.0,3100.0,,,,,,,,23400.0
North Cachar Hills,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
North Cachar Hills,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
North Cachar Hills,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,700.0,0.0,1200.0,900.0,600.0,,,,,,,,3400.0
North Cachar Hills,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,5200.0,5200.0,4000.0,3100.0,2500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0
North Cachar Hills,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,8.0
North Cachar Hills,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,1.0,,,,,,,,,1.0
North Cachar Hills,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
North Cachar Hills,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,1.0,,,,,,,,,1.0
North Cachar Hills,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,1.0,,2.0,2.0,,1.0,,,1.0,,8.0
North Cachar Hills,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
North Cachar Hills,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,1.0,,2.0,2.0,,1.0,,,1.0,,8.0
North Cachar Hills,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,,,1.0,1.0,1.0,1.0,2.0,1.0,1.0,,9.0
North Cachar Hills,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
North Cachar Hills,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,,,1.0,1.0,1.0,1.0,2.0,1.0,1.0,,9.0
North Cachar Hills,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,2.0,,1.0,1.0,4.0,,1.0,1.0,3.0,2.0,2.0,17.0
North Cachar Hills,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,,1.0
North Cachar Hills,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,2.0,,1.0,1.0,4.0,,1.0,1.0,4.0,2.0,2.0,18.0
North Cachar Hills,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,1.0,6.0,1.0,1.0,3.0,1.0,,,14.0
North Cachar Hills,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,1.0,,,,,,1.0
North Cachar Hills,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,1.0,6.0,2.0,1.0,3.0,1.0,,,15.0
North Cachar Hills,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
North Cachar Hills,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
North Cachar Hills,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,1.0,1.0
North Cachar Hills,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,1.0,,,1.0,1.0,1.0,,,5.0
North Cachar Hills,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,,,,,,,,,,1.0
North Cachar Hills,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,2.0,,1.0,,,1.0,1.0,1.0,,,6.0
North Cachar Hills,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
North Cachar Hills,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
North Cachar Hills,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
North Cachar Hills,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,2.0,7.0,1.0,3.0,,3.0,,2.0,2.0,2.0,5.0,29.0
North Cachar Hills,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
North Cachar Hills,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,2.0,7.0,1.0,3.0,,3.0,,2.0,3.0,2.0,5.0,30.0
North Cachar Hills,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
North Cachar Hills,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
North Cachar Hills,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
North Cachar Hills,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,,1.0,,2.0,,,1.0,,1.0,,,7.0
North Cachar Hills,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,1.0,,1.0,1.0,1.0,,,,,5.0
North Cachar Hills,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,,2.0,1.0,2.0,1.0,1.0,2.0,,1.0,,,12.0
North Cachar Hills,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,1.0,,,,,1.0,2.0
North Cachar Hills,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,1.0,1.0,,1.0,2.0,1.0,,,1.0,1.0,9.0
North Cachar Hills,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,,,2.0,,1.0,,,,,1.0,5.0
North Cachar Hills,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,1.0,1.0,1.0,2.0,1.0,4.0,1.0,,,1.0,3.0,16.0
North Cachar Hills,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,,1.0,,1.0,,,,,,3.0
North Cachar Hills,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
North Cachar Hills,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,1.0,,1.0,,,,,,3.0
North Cachar Hills,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,1.0,1.0,1.0,,3.0,,,,,7.0
North Cachar Hills,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,1.0,,2.0,1.0,3.0,1.0,2.0,,10.0
North Cachar Hills,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,1.0,2.0,1.0,2.0,4.0,3.0,1.0,2.0,,17.0
North Cachar Hills,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
North Cachar Hills,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
North Cachar Hills,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
North Cachar Hills,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
North Cachar Hills,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,,,,,1.0,1.0,,1.0,,,2.0,6.0
North Cachar Hills,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,1.0,,1.0,,,2.0,,1.0,,,2.0,9.0
North Cachar Hills,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3.0,1.0,1.0,1.0,,1.0,3.0,,2.0,,,4.0,16.0
North Cachar Hills,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,,,,,,,2.0,4.0,1.0,8.0
North Cachar Hills,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,2.0,1.0,,1.0,,1.0,2.0,2.0,1.0,,11.0
North Cachar Hills,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,2.0,2.0,1.0,,1.0,,1.0,2.0,4.0,5.0,1.0,19.0
North Cachar Hills,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
North Cachar Hills,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
North Cachar Hills,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
North Cachar Hills,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
North Cachar Hills,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,1.0,,,,,,,,,,,,1.0
North Cachar Hills,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
North Cachar Hills,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
North Cachar Hills,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,1.0,,,1.0
North Cachar Hills,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
North Cachar Hills,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
North Cachar Hills,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
North Cachar Hills,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
North Cachar Hills,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,2.0,,1.0,,,1.0,,2.0,,,7.0
North Cachar Hills,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
North Cachar Hills,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,2.0,,1.0,,,1.0,,2.0,,,7.0
North Cachar Hills,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,,4.0,1.0,3.0,19.0
North Cachar Hills,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,2.0,,,,,,,1.0,,,4.0
North Cachar Hills,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,3.0,1.0,3.0,1.0,1.0,3.0,1.0,1.0,,5.0,1.0,3.0,23.0
North Cachar Hills,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
North Cachar Hills,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,1.0,,,,,1.0,,2.0
North Cachar Hills,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
North Cachar Hills,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,1.0,1.0,,,,1.0,1.0,4.0
North Cachar Hills,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
North Cachar Hills,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
North Cachar Hills,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
North Cachar Hills,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,,,,,,,,,,1.0
North Cachar Hills,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,2.0,,1.0,,,1.0,,,,4.0
North Cachar Hills,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,1.0,1.0,4.0,,,,1.0,1.0,,2.0,1.0,13.0
North Cachar Hills,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,3.0,1.0,,,1.0,,,,1.0,1.0,7.0
North Cachar Hills,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,1.0,4.0,7.0,,1.0,1.0,1.0,2.0,,3.0,2.0,24.0
North Cachar Hills,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
North Cachar Hills,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,,,2.0,2.0,6.0,3.0,1.0,1.0,2.0,2.0,5.0,27.0
North Cachar Hills,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,3.0,2.0,6.0,3.0,3.0,1.0,7.0,5.0,4.0,5.0,6.0,4.0,49.0
North Cachar Hills,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,7.0,2.0,6.0,5.0,5.0,7.0,10.0,6.0,5.0,7.0,8.0,9.0,77.0
North Cachar Hills,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,1.0,2.0,1.0,2.0,1.0,1.0,,1.0,,,9.0
North Cachar Hills,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,5.0,11.0,11.0,11.0,10.0,8.0,4.0,7.0,10.0,3.0,7.0,5.0,92.0
North Cachar Hills,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,14.0,15.0,11.0,9.0,15.0,13.0,12.0,16.0,16.0,17.0,12.0,14.0,164.0
North Cachar Hills,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,19.0,26.0,23.0,22.0,26.0,23.0,17.0,24.0,26.0,21.0,19.0,19.0,265.0
Sibsagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,1973.0,2057.0,2027.0,1890.0,1951.0,1625.0,1573.0,1747.0,1574.0,1787.0,1881.0,2116.0,22201.0
Sibsagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1668.0,1719.0,1732.0,1578.0,1575.0,1295.0,1254.0,1438.0,1335.0,1508.0,1588.0,1752.0,18442.0
Sibsagar,1.2,Number of Pregnant women registered under JSY,TOTAL,1886.0,1974.0,1961.0,1794.0,1855.0,1537.0,1472.0,1650.0,1481.0,1685.0,1803.0,2031.0,21129.0
Sibsagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1374.0,1611.0,1637.0,1765.0,1691.0,1710.0,1711.0,1657.0,1530.0,1509.0,1257.0,1365.0,18817.0
Sibsagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1662.0,1778.0,1524.0,1556.0,1751.0,1523.0,1437.0,1238.0,1197.0,1235.0,1270.0,1627.0,17798.0
Sibsagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1604.0,1757.0,1733.0,1711.0,1653.0,1695.0,1674.0,1559.0,1372.0,1277.0,1177.0,1495.0,18707.0
Sibsagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1414.0,1668.0,1676.0,1522.0,1528.0,1337.0,1261.0,1711.0,1513.0,1761.0,1652.0,2005.0,19048.0
Sibsagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,64.0,56.0,97.0,71.0,66.0,88.0,60.0,72.0,61.0,46.0,96.0,71.0,848.0
Sibsagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,1.0,0.0,2.0,0.0,2.0,1.0,2.0,0.0,0.0,0.0,0.0,8.0
Sibsagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1040.0,1493.0,1339.0,1375.0,1317.0,1056.0,1058.0,1104.0,965.0,1068.0,1551.0,1442.0,14808.0
Sibsagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,69.0,79.0,93.0,43.0,19.0,20.0,34.0,25.0,43.0,0.0,3.0,72.0,500.0
Sibsagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,904.0,893.0,811.0,830.0,788.0,751.0,527.0,595.0,580.0,634.0,676.0,680.0,8669.0
Sibsagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,11.0,13.0,10.0,18.0,14.0,11.0,27.0,14.0,9.0,19.0,12.0,10.0,168.0
Sibsagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,12.0,11.0,13.0,15.0,24.0,18.0,15.0,21.0,28.0,20.0,15.0,19.0,211.0
Sibsagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,23.0,24.0,23.0,33.0,38.0,29.0,42.0,35.0,37.0,39.0,27.0,29.0,379.0
Sibsagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,19.0,17.0,18.0,25.0,25.0,21.0,30.0,24.0,29.0,27.0,22.0,22.0,279.0
Sibsagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,8.0
Sibsagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,742.0,791.0,768.0,851.0,1030.0,1055.0,1116.0,999.0,1115.0,1242.0,1017.0,948.0,11674.0
Sibsagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,123.0,116.0,114.0,111.0,148.0,134.0,151.0,184.0,78.0,138.0,120.0,106.0,1523.0
Sibsagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,818.0,824.0,882.0,908.0,1153.0,1204.0,1254.0,1088.0,1178.0,1278.0,1146.0,1096.0,12829.0
Sibsagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,392.0,671.0,895.0,1404.0,1340.0,2147.0,950.0,1538.0,1285.0,1449.0,1474.0,2094.0,15639.0
Sibsagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,0.0,,,,,,,,,,,0.0
Sibsagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,248.0,265.0,277.0,334.0,391.0,421.0,422.0,373.0,391.0,446.0,359.0,318.0,4245.0
Sibsagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,17.0,29.0,23.0,37.0,35.0,43.0,32.0,32.0,126.0,154.0,76.0,46.0,650.0
Sibsagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,15.0,16.0,11.0,14.0,15.0,25.0,19.0,28.0,20.0,20.0,13.0,12.0,208.0
Sibsagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,0.0,,,,,0.0
Sibsagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Sibsagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,24.0,14.0,19.0,19.0,25.0,21.0,23.0,30.0,21.0,21.0,25.0,19.0,261.0
Sibsagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,45.0,57.0,52.0,43.0,54.0,50.0,48.0,42.0,70.0,67.0,65.0,57.0,650.0
Sibsagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sibsagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,69.0,71.0,71.0,62.0,79.0,71.0,71.0,72.0,91.0,88.0,90.0,76.0,911.0
Sibsagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,91.0,95.0,114.0,134.0,170.0,173.0,179.0,138.0,145.0,157.0,119.0,121.0,1636.0
Sibsagar,4.1.1.a,Number of male live births,TOTAL,527.0,545.0,556.0,662.0,729.0,774.0,778.0,717.0,811.0,885.0,729.0,648.0,8361.0
Sibsagar,4.1.1.b,Number of female live births,TOTAL,480.0,519.0,506.0,548.0,719.0,709.0,777.0,695.0,719.0,829.0,666.0,639.0,7806.0
Sibsagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1007.0,1064.0,1062.0,1210.0,1448.0,1483.0,1555.0,1412.0,1530.0,1714.0,1395.0,1287.0,16167.0
Sibsagar,4.1.2,Number of still births,TOTAL,21.0,28.0,21.0,22.0,19.0,31.0,29.0,22.0,30.0,20.0,16.0,28.0,287.0
Sibsagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,423.0,373.0,316.0,278.0,244.0,163.0,236.0,210.0,278.0,223.0,255.0,347.0,3346.0
Sibsagar,4.2.1,Number of Newborns weighed at birth,TOTAL,998.0,1052.0,1056.0,1201.0,1439.0,1475.0,1551.0,1388.0,1521.0,1705.0,1383.0,1281.0,16050.0
Sibsagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,239.0,214.0,259.0,284.0,345.0,340.0,337.0,309.0,339.0,360.0,263.0,223.0,3512.0
Sibsagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,929.0,961.0,960.0,1102.0,1276.0,1379.0,1442.0,1276.0,1397.0,1573.0,1318.0,1242.0,14855.0
Sibsagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,1.0,2.0,15.0,8.0,0.0,10.0,0.0,1.0,0.0,0.0,0.0,37.0
Sibsagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,111.0,149.0,123.0,127.0,180.0,177.0,198.0,188.0,216.0,227.0,188.0,173.0,2057.0
Sibsagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,549.0,583.0,606.0,701.0,746.0,782.0,760.0,636.0,744.0,779.0,646.0,498.0,8030.0
Sibsagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sibsagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,660.0,733.0,731.0,843.0,934.0,959.0,968.0,824.0,961.0,1006.0,834.0,671.0,10124.0
Sibsagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,623.0,726.0,725.0,807.0,902.0,939.0,912.0,766.0,901.0,939.0,779.0,616.0,9635.0
Sibsagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,13.0,12.0,12.0,15.0,18.0,20.0,23.0,20.0,18.0,12.0,11.0,18.0,192.0
Sibsagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,511.0,644.0,602.0,710.0,836.0,883.0,845.0,737.0,740.0,907.0,808.0,663.0,8886.0
Sibsagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,45.0,48.0,60.0,74.0,74.0,61.0,33.0,32.0,41.0,39.0,50.0,52.0,609.0
Sibsagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,642.0,864.0,868.0,982.0,1385.0,1413.0,1474.0,1364.0,1429.0,1592.0,1077.0,974.0,14064.0
Sibsagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,876.0,1072.0,1061.0,1069.0,1403.0,1353.0,1445.0,1378.0,1376.0,1469.0,1031.0,910.0,14443.0
Sibsagar,6.3,PNC maternal complications attended,TOTAL,5.0,12.0,10.0,16.0,14.0,13.0,9.0,0.0,16.0,0.0,4.0,33.0,132.0
Sibsagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,284.0,262.0,222.0,191.0,158.0,99.0,167.0,145.0,170.0,170.0,202.0,275.0,2345.0
Sibsagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,8.0,11.0,17.0,40.0
Sibsagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,284.0,262.0,222.0,191.0,158.0,99.0,167.0,145.0,174.0,178.0,213.0,292.0,2385.0
Sibsagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,7.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Sibsagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,2.0,0.0,5.0,4.0,2.0,0.0,10.0,2.0,3.0,18.0,24.0,35.0,105.0
Sibsagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,2.0,2.0,5.0,5.0,3.0,1.0,12.0,2.0,63.0,22.0,45.0,75.0,237.0
Sibsagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,4.0,2.0,10.0,9.0,5.0,1.0,22.0,4.0,66.0,40.0,69.0,110.0,342.0
Sibsagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,7.0,0.0,0.0,0.0,40.0,0.0,0.0,0.0,45.0,92.0
Sibsagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,20.0,0.0,0.0,0.0,21.0,21.0,0.0,24.0,0.0,86.0
Sibsagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,6.0,7.0,9.0,0.0,5.0,0.0,80.0,148.0,137.0,104.0,115.0,611.0
Sibsagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sibsagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,6.0,7.0,36.0,0.0,5.0,0.0,141.0,169.0,137.0,128.0,160.0,789.0
Sibsagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,40.0,0.0,0.0,330.0,40.0,0.0,0.0,0.0,0.0,67.0,0.0,458.0,935.0
Sibsagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,42.0,0.0,0.0,0.0,0.0,66.0,0.0,0.0,0.0,108.0
Sibsagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,19.0,6.0,11.0,27.0,33.0,97.0
Sibsagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sibsagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,40.0,0.0,0.0,372.0,40.0,0.0,1.0,19.0,72.0,78.0,27.0,491.0,1140.0
Sibsagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,42.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0
Sibsagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sibsagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,1.0,1.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Sibsagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1.0,2.0,0.0,2.0,0.0,2.0,2.0,3.0,2.0,1.0,1.0,0.0,16.0
Sibsagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sibsagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,3.0,1.0,4.0,0.0,2.0,2.0,3.0,2.0,1.0,1.0,0.0,21.0
Sibsagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,44.0,90.0,130.0,1199.0,90.0,68.0,49.0,58.0,47.0,63.0,52.0,71.0,1961.0
Sibsagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,34.0,51.0,48.0,330.0,57.0,34.0,45.0,39.0,46.0,50.0,28.0,41.0,803.0
Sibsagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,5.0,8.0,20.0,41.0,9.0,107.0,107.0,101.0,20.0,21.0,10.0,0.0,449.0
Sibsagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,122.0,34.0,44.0,86.0,124.0,127.0,122.0,103.0,49.0,65.0,39.0,72.0,987.0
Sibsagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sibsagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,205.0,183.0,242.0,1656.0,280.0,336.0,323.0,301.0,162.0,199.0,129.0,184.0,4200.0
Sibsagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,72.0,53.0,45.0,61.0,76.0,170.0,178.0,224.0,138.0,44.0,48.0,68.0,1177.0
Sibsagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,8.0,4.0,24.0,8.0,0.0,0.0,2.0,0.0,0.0,1.0,20.0,67.0
Sibsagar,9.06,Number of IUCD removals,TOTAL,16.0,46.0,18.0,23.0,261.0,15.0,10.0,21.0,192.0,12.0,17.0,20.0,651.0
Sibsagar,9.07,Number of Oral Pills cycles distributed,TOTAL,3939.0,4602.0,5072.0,6132.0,5961.0,5204.0,5885.0,5161.0,5081.0,5261.0,5048.0,4729.0,62075.0
Sibsagar,9.08,Number of Condom pieces distributed,TOTAL,11184.0,17544.0,13775.0,16412.0,14239.0,13733.0,13404.0,15200.0,14187.0,12596.0,13580.0,14287.0,170141.0
Sibsagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,156.0,48.0,37.0,56.0,67.0,35.0,55.0,79.0,100.0,100.0,100.0,113.0,946.0
Sibsagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,1.0,3.0,0.0,8.0,12.0,12.0,55.0,25.0,67.0,33.0,29.0,57.0,302.0
Sibsagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Sibsagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,3.0,3.0,3.0,2.0,3.0,3.0,2.0,3.0,3.0,3.0,3.0,-1.0
Sibsagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1328.0,1214.0,1141.0,1179.0,1485.0,1538.0,1723.0,1542.0,1550.0,1685.0,1664.0,1599.0,17648.0
Sibsagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1566.0,1534.0,1263.0,1163.0,1247.0,1376.0,1753.0,1781.0,1538.0,1634.0,807.0,220.0,15882.0
Sibsagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1594.0,1634.0,1520.0,1384.0,1148.0,1279.0,1393.0,1598.0,1772.0,1582.0,1457.0,1208.0,17569.0
Sibsagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1515.0,1605.0,1660.0,1537.0,1323.0,1208.0,1222.0,1320.0,1540.0,1643.0,1454.0,1683.0,17710.0
Sibsagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,704.0,1616.0,2320.0
Sibsagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,552.0,553.0
Sibsagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Sibsagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,509.0,485.0,496.0,563.0,689.0,684.0,615.0,602.0,720.0,891.0,849.0,864.0,7967.0
Sibsagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1550.0,1530.0,1264.0,1157.0,1216.0,1372.0,1404.0,1215.0,1071.0,1712.0,1340.0,1593.0,16424.0
Sibsagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1604.0,1609.0,1527.0,1367.0,1124.0,1281.0,1135.0,1012.0,1197.0,1609.0,1562.0,1745.0,16772.0
Sibsagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1505.0,1605.0,1670.0,1525.0,1247.0,1260.0,966.0,819.0,979.0,1545.0,1577.0,1785.0,16483.0
Sibsagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,356.0,365.0,378.0,413.0,571.0,559.0,494.0,571.0,737.0,841.0,717.0,740.0,6742.0
Sibsagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1481.0,1748.0,1391.0,1057.0,1237.0,1342.0,1750.0,1732.0,1532.0,1596.0,827.0,251.0,15944.0
Sibsagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1460.0,1731.0,1771.0,1363.0,1191.0,1222.0,1439.0,1637.0,1775.0,1584.0,1451.0,1227.0,17851.0
Sibsagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1457.0,1668.0,1812.0,1585.0,1409.0,1213.0,1273.0,1417.0,1574.0,1644.0,1437.0,1581.0,18070.0
Sibsagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1062.0,1513.0,1466.0,1633.0,1430.0,1603.0,1598.0,367.0,1678.0,1356.0,1739.0,1622.0,17067.0
Sibsagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1187.0,1404.0,1526.0,1607.0,1123.0,1087.0,1227.0,270.0,859.0,917.0,1313.0,1625.0,14145.0
Sibsagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1093.0,1437.0,1436.0,1692.0,746.0,396.0,207.0,1027.0,1595.0,1411.0,1579.0,1596.0,14215.0
Sibsagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,559.0,768.0,760.0,845.0,698.0,795.0,771.0,176.0,827.0,699.0,888.0,813.0,8599.0
Sibsagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,494.0,717.0,693.0,766.0,667.0,781.0,787.0,176.0,798.0,652.0,806.0,798.0,8135.0
Sibsagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1053.0,1485.0,1453.0,1611.0,1365.0,1576.0,1558.0,352.0,1625.0,1351.0,1694.0,1611.0,16734.0
Sibsagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1347.0,1546.0,1536.0,1526.0,1255.0,1263.0,1303.0,1248.0,1142.0,1173.0,1360.0,1609.0,16308.0
Sibsagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1351.0,1565.0,1529.0,1506.0,1235.0,1261.0,1087.0,885.0,845.0,1153.0,1400.0,1662.0,15479.0
Sibsagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,228.0,262.0,284.0,268.0,197.0,196.0,232.0,73.0,181.0,181.0,258.0,268.0,2628.0
Sibsagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,215.0,235.0,243.0,251.0,183.0,234.0,223.0,43.0,192.0,189.0,243.0,267.0,2518.0
Sibsagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,443.0,497.0,527.0,519.0,380.0,430.0,455.0,116.0,373.0,370.0,501.0,535.0,5146.0
Sibsagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,501.0,508.0,503.0,695.0,537.0,618.0,603.0,576.0,622.0,674.0,741.0,721.0,7299.0
Sibsagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,435.0,453.0,448.0,585.0,479.0,528.0,528.0,452.0,435.0,513.0,580.0,551.0,5987.0
Sibsagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,329.0,346.0,321.0,436.0,319.0,343.0,394.0,353.0,321.0,337.0,345.0,401.0,4245.0
Sibsagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1170.0,1172.0,1169.0,1166.0,1173.0,1192.0,1163.0,1173.0,1184.0,1161.0,1157.0,1141.0,14021.0
Sibsagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1119.0,1129.0,1124.0,1119.0,1123.0,1128.0,1110.0,1112.0,1122.0,1106.0,1096.0,1106.0,13394.0
Sibsagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1094.0,1100.0,1088.0,1086.0,1091.0,1092.0,1074.0,1070.0,1074.0,1070.0,1051.0,1054.0,12944.0
Sibsagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1157.0,1287.0,1399.0,1889.0,605.0,273.0,135.0,759.0,900.0,943.0,1258.0,1503.0,12108.0
Sibsagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1061.0,1475.0,1448.0,1594.0,1421.0,1600.0,1598.0,777.0,1575.0,1430.0,1658.0,1518.0,17155.0
Sibsagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,484.0,541.0,524.0,613.0,1235.0,693.0,572.0,550.0,547.0,587.0,899.0,585.0,7830.0
Sibsagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,411.0,441.0,354.0,507.0,908.0,595.0,464.0,484.0,475.0,522.0,854.0,527.0,6542.0
Sibsagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,5.0,10.0,35.0,16.0,9.0,2.0,5.0,2.0,1.0,3.0,14.0,7.0,109.0
Sibsagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,615.0,450.0,392.0,543.0,530.0,387.0,306.0,353.0,336.0,452.0,330.0,480.0,5174.0
Sibsagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,6.0
Sibsagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,18.0,30.0,15.0,60.0,29.0,25.0,47.0,23.0,44.0,22.0,22.0,80.0,415.0
Sibsagar,13.1,Number of Patients operated for cataract,TOTAL,80.0,151.0,177.0,93.0,68.0,109.0,96.0,61.0,47.0,69.0,99.0,107.0,1157.0
Sibsagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,80.0,151.0,177.0,93.0,68.0,109.0,96.0,61.0,47.0,69.0,99.0,107.0,1157.0
Sibsagar,13.3,Number of School children detected with Refractive errors,TOTAL,127.0,8.0,0.0,211.0,21.0,7.0,17.0,45.0,16.0,23.0,21.0,26.0,522.0
Sibsagar,13.4,Number of children provided free glasses,TOTAL,1.0,0.0,0.0,0.0,21.0,0.0,0.0,0.0,0.0,15.0,7.0,0.0,44.0
Sibsagar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Sibsagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,14.0,16.0,15.0,14.0,15.0,17.0,15.0,15.0,17.0,19.0,16.0,16.0,-1.0
Sibsagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,845.0,852.0,855.0,873.0,867.0,854.0,860.0,846.0,845.0,860.0,838.0,872.0,-1.0
Sibsagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Sibsagar,14.05,Number of RKS meetings held during the month,TOTAL,11.0,13.0,15.0,12.0,12.0,12.0,11.0,10.0,12.0,11.0,10.0,10.0,139.0
Sibsagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,28.0,28.0,30.0,27.0,29.0,27.0,31.0,32.0,35.0,34.0,29.0,32.0,-1.0
Sibsagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,609.0,622.0,680.0,748.0,917.0,895.0,763.0,707.0,791.0,822.0,774.0,784.0,9112.0
Sibsagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Sibsagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Sibsagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,312.0,388.0,429.0,554.0,534.0,513.0,473.0,459.0,319.0,294.0,239.0,298.0,4812.0
Sibsagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1380.0,1692.0,2251.0,2698.0,2348.0,2276.0,2416.0,1898.0,1360.0,1156.0,1170.0,1325.0,21970.0
Sibsagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,263.0,352.0,372.0,540.0,484.0,507.0,441.0,413.0,276.0,218.0,200.0,259.0,4325.0
Sibsagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1982.0,2612.0,3557.0,4074.0,3946.0,4029.0,3930.0,2973.0,2792.0,2688.0,1965.0,2635.0,37183.0
Sibsagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,575.0,740.0,801.0,1094.0,1018.0,1020.0,914.0,872.0,595.0,512.0,439.0,557.0,9137.0
Sibsagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3362.0,4304.0,5808.0,6772.0,6294.0,6305.0,6346.0,4871.0,4152.0,3844.0,3135.0,3960.0,59153.0
Sibsagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,21.0,23.0,23.0,18.0,18.0,23.0,28.0,20.0,27.0,19.0,21.0,20.0,261.0
Sibsagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,11.0,19.0,20.0,15.0,11.0,15.0,11.0,6.0,11.0,12.0,15.0,16.0,162.0
Sibsagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,32.0,42.0,43.0,33.0,29.0,38.0,39.0,26.0,38.0,31.0,36.0,36.0,423.0
Sibsagar,14.11,In-Patient Head Count at midnight,TOTAL,2607.0,2409.0,1951.0,2197.0,2228.0,2286.0,2300.0,2089.0,2227.0,2252.0,1881.0,2278.0,26705.0
Sibsagar,14.12.1,OPD attendance (All),TOTAL,109065.0,114355.0,128110.0,157909.0,149758.0,139196.0,139658.0,130851.0,109875.0,123542.0,99394.0,142821.0,1544534.0
Sibsagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,105.0,135.0,118.0,100.0,102.0,100.0,140.0,102.0,112.0,100.0,19.0,118.0,1251.0
Sibsagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Sibsagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,15.0,14.0,16.0,23.0,992.0,1030.0,957.0,11.0,11.0,13.0,97.0,59.0,3238.0
Sibsagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,381.0,561.0,657.0,407.0,493.0,402.0,390.0,1372.0,1267.0,1024.0,1241.0,1057.0,9252.0
Sibsagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1033.0,1223.0,914.0,1269.0,1120.0,990.0,876.0,986.0,856.0,541.0,539.0,637.0,10984.0
Sibsagar,14.14.c,Number of Adolescents counselled,TOTAL,0.0,2.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Sibsagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3374.0,3781.0,3609.0,3555.0,3424.0,3702.0,3025.0,3214.0,3215.0,2824.0,2847.0,2999.0,39569.0
Sibsagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,89.0,119.0,69.0,83.0,52.0,86.0,74.0,78.0,87.0,71.0,68.0,113.0,989.0
Sibsagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,120.0,167.0,131.0,129.0,96.0,108.0,116.0,112.0,157.0,159.0,158.0,183.0,1636.0
Sibsagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,1.0,2.0,2.0,1.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,11.0
Sibsagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,144.0,151.0,149.0,138.0,110.0,91.0,62.0,62.0,66.0,84.0,114.0,195.0,1366.0
Sibsagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,10.0
Sibsagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,361.0,497.0,449.0,383.0,332.0,315.0,377.0,641.0,519.0,437.0,587.0,659.0,5557.0
Sibsagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Sibsagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,625.0,815.0,729.0,650.0,538.0,514.0,555.0,815.0,742.0,680.0,859.0,1037.0,8559.0
Sibsagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,2.0,3.0,4.0,2.0,2.0,0.0,1.0,1.0,8.0,2.0,0.0,25.0
Sibsagar,15.2,Number of Widal tests conducted,Number tested,94.0,153.0,222.0,303.0,289.0,253.0,249.0,151.0,114.0,60.0,59.0,89.0,2036.0
Sibsagar,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,24.0,91.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,115.0
Sibsagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,171.0,94.0,162.0,100.0,0.0,7.0,0.0,7.0,6.0,547.0
Sibsagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,101.0,66.0,4.0,4.0,41.0,38.0,49.0,23.0,91.0,20.0,36.0,29.0,502.0
Sibsagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,101.0,66.0,28.0,266.0,135.0,200.0,149.0,23.0,98.0,20.0,43.0,35.0,1164.0
Sibsagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,7602.0,10492.0,14053.0,22224.0,12173.0,12930.0,8361.0,6419.0,6106.0,5084.0,6413.0,6064.0,117921.0
Sibsagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,37.0,263.0,1.0,33.0,307.0,5.0,125.0,137.0,5.0,5.0,0.0,919.0
Sibsagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,15.0,0.0,8.0,7.0,51.0,1.0,2.0,1.0,1.0,32.0,0.0,0.0,118.0
Sibsagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,953.0,1481.0,91.0,2340.0,2342.0,892.0,322.0,2002.0,889.0,1818.0,4178.0,5228.0,22536.0
Sibsagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,0.0,3000.0,1000.0,0.0,0.0,2000.0,0.0,1500.0,3000.0,1500.0,0.0,14000.0
Sibsagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1472.0,1390.0,751.0,998.0,1450.0,570.0,320.0,1113.0,571.0,640.0,450.0,531.0,10256.0
Sibsagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,1481.0,91.0,2340.0,2342.0,892.0,322.0,2002.0,889.0,1818.0,4178.0,5228.0,4697.0,26280.0
Sibsagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,222.0,222.0
Sibsagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,222.0,222.0
Sibsagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,44.0,342.0,2.0,1022.0,318.0,18.0,18.0,518.0,8.0,8.0,8.0,378.0,2684.0
Sibsagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,950.0,0.0,2000.0,0.0,0.0,0.0,500.0,0.0,500.0,0.0,700.0,0.0,4650.0
Sibsagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,652.0,340.0,980.0,704.0,300.0,0.0,0.0,510.0,500.0,0.0,330.0,73.0,4389.0
Sibsagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,342.0,2.0,1022.0,318.0,18.0,18.0,518.0,8.0,8.0,8.0,378.0,305.0,2945.0
Sibsagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2477.0,3492.0,2732.0,1777.0,1004.0,354.0,54.0,1654.0,744.0,34.0,1392.0,2042.0,17756.0
Sibsagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,0.0,0.0,0.0,0.0,0.0,1600.0,0.0,0.0,2000.0,1000.0,0.0,6600.0
Sibsagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,985.0,760.0,955.0,773.0,650.0,300.0,0.0,910.0,710.0,642.0,350.0,398.0,7433.0
Sibsagar,16.1.3,Stock position of TT vaccines,5. Total Stock,3492.0,2732.0,1777.0,1004.0,354.0,54.0,1654.0,744.0,34.0,1392.0,2042.0,1644.0,16923.0
Sibsagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,536.0,1249.0,749.0,1183.0,1809.0,797.0,264.0,4.0,44.0,294.0,1270.0,890.0,9089.0
Sibsagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1350.0,0.0,1000.0,1000.0,0.0,0.0,0.0,800.0,800.0,1500.0,0.0,0.0,6450.0
Sibsagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,637.0,500.0,566.0,374.0,1012.0,533.0,260.0,760.0,550.0,524.0,380.0,546.0,6642.0
Sibsagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,1249.0,749.0,1183.0,1809.0,797.0,264.0,4.0,44.0,294.0,1270.0,890.0,344.0,8897.0
Sibsagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3340.0,4094.0,3174.0,4842.0,5221.0,3366.0,2139.0,960.0,10.0,30.0,2064.0,2081.0,31321.0
Sibsagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,0.0,3000.0,1000.0,0.0,0.0,0.0,0.0,1000.0,3000.0,1000.0,0.0,11000.0
Sibsagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1246.0,920.0,1332.0,621.0,1855.0,1227.0,1179.0,950.0,980.0,966.0,983.0,823.0,13082.0
Sibsagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,4094.0,3174.0,4842.0,5221.0,3366.0,2139.0,960.0,10.0,30.0,2064.0,2081.0,1258.0,29239.0
Sibsagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,210.0,0.0,0.0,0.0,1000.0,5.0,5.0,1035.0,1135.0,3390.0
Sibsagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,1000.0,1000.0,0.0,0.0,1000.0,0.0,1000.0,2000.0,1000.0,0.0,7000.0
Sibsagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,790.0,1210.0,0.0,0.0,0.0,995.0,1000.0,970.0,900.0,780.0,6645.0
Sibsagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,210.0,0.0,0.0,0.0,1000.0,5.0,5.0,1035.0,1135.0,355.0,3745.0
Sibsagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,185.0,1842.0,1012.0,236.0,2901.0,2436.0,1485.0,2735.0,1720.0,1860.0,2406.0,2926.0,21744.0
Sibsagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,0.0,0.0,3380.0,0.0,0.0,2000.0,0.0,1000.0,1250.0,1000.0,0.0,11630.0
Sibsagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1343.0,830.0,776.0,715.0,465.0,951.0,750.0,1015.0,860.0,704.0,480.0,539.0,9428.0
Sibsagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1842.0,1012.0,236.0,2901.0,2436.0,1485.0,2735.0,1720.0,1860.0,2406.0,2926.0,2387.0,23946.0
Sibsagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Sibsagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Sibsagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,7000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7000.0
Sibsagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,7000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7000.0
Sibsagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,2.0,2.0,2.0,2.0,2.0,0.0,0.0,0.0,10.0
Sibsagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,40.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,40.0
Sibsagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,38.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,40.0
Sibsagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,2.0,2.0,2.0,2.0,2.0,0.0,0.0,0.0,0.0,10.0
Sibsagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,900.0,0.0,0.0,0.0,2600.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,20300.0
Sibsagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0
Sibsagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,900.0,0.0,0.0,400.0,200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0
Sibsagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,2600.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,21800.0
Sibsagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,600.0
Sibsagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4320.0,13200.0,17520.0
Sibsagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3720.0,2010.0,5730.0
Sibsagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,11790.0,12390.0
Sibsagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,4000.0,0.0,0.0,0.0,4600.0,2200.0,0.0,0.0,0.0,1000.0,11800.0
Sibsagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,4000.0,0.0,0.0,0.0,4600.0,2200.0,0.0,0.0,0.0,1000.0,11800.0
Sibsagar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,400.0
Sibsagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,5000.0,9000.0
Sibsagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,1600.0,400.0,0.0,0.0,2000.0,0.0,0.0,0.0,4300.0,8300.0
Sibsagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,700.0,1100.0
Sibsagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,6203950.0,5893950.0,4899950.0,4658950.0,3581950.0,2881950.0,2631950.0,2296950.0,1912950.0,1807950.0,1429950.0,1030950.0,39231400.0
Sibsagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,310000.0,994000.0,241000.0,1077000.0,700000.0,250000.0,335000.0,384000.0,105000.0,378000.0,399000.0,967950.0,6140950.0
Sibsagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,5893950.0,4899950.0,4658950.0,3581950.0,2881950.0,2631950.0,2296950.0,1912950.0,1807950.0,1429950.0,1030950.0,63000.0,33090450.0
Sibsagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,12400.0,7400.0,3800.0,800.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,26400.0
Sibsagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,4000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0
Sibsagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,5000.0,3600.0,3000.0,2800.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16400.0
Sibsagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,7400.0,3800.0,800.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14000.0
Sibsagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,3900.0,3200.0,2900.0,1350.0,300.0,0.0,1100.0,12750.0
Sibsagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,4000.0,0.0,0.0,0.0,0.0,0.0,2000.0,2000.0,8000.0
Sibsagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,100.0,700.0,300.0,1550.0,1050.0,300.0,900.0,1550.0,6450.0
Sibsagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,3900.0,3200.0,2900.0,1350.0,300.0,0.0,1100.0,1550.0,14300.0
Sibsagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,500.0,459.0,445.0,250.0,75.0,57.0,50.0,0.0,0.0,0.0,0.0,0.0,1836.0
Sibsagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Sibsagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,41.0,14.0,195.0,175.0,118.0,7.0,50.0,0.0,0.0,0.0,0.0,0.0,600.0
Sibsagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,459.0,445.0,250.0,75.0,57.0,50.0,0.0,0.0,0.0,0.0,0.0,0.0,1336.0
Sibsagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,41300.0,30150.0,18650.0,5300.0,14700.0,0.0,0.0,0.0,17500.0,12500.0,4250.0,92800.0,237150.0
Sibsagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,20400.0,500.0,0.0,0.0,46200.0,0.0,0.0,109800.0,145800.0,322700.0
Sibsagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,11150.0,11500.0,13350.0,11000.0,15200.0,0.0,0.0,28700.0,5000.0,8250.0,21250.0,143330.0,268730.0
Sibsagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,30150.0,18650.0,5300.0,14700.0,0.0,0.0,0.0,17500.0,12500.0,4250.0,92800.0,95270.0,291120.0
Sibsagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,500.0,2100.0,0.0,4900.0,4900.0,1400.0,0.0,0.0,2000.0,3000.0,3000.0,0.0,21800.0
Sibsagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3300.0,0.0,9900.0,0.0,0.0,0.0,0.0,6600.0,3300.0,0.0,0.0,0.0,23100.0
Sibsagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1700.0,2100.0,5000.0,0.0,3500.0,1400.0,0.0,4600.0,2300.0,0.0,3000.0,0.0,23600.0
Sibsagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2100.0,0.0,4900.0,4900.0,1400.0,0.0,0.0,2000.0,3000.0,3000.0,0.0,0.0,21300.0
Sibsagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,91600.0,76900.0,63700.0,103300.0,88000.0,64000.0,46000.0,75000.0,57000.0,87000.0,87000.0,102300.0,941800.0
Sibsagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,48000.0,48000.0,0.0,0.0,40000.0,0.0,48000.0,0.0,24000.0,0.0,208000.0
Sibsagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,14700.0,13200.0,8400.0,63300.0,24000.0,18000.0,11000.0,18000.0,18000.0,0.0,8700.0,9200.0,206500.0
Sibsagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,76900.0,63700.0,103300.0,88000.0,64000.0,46000.0,75000.0,57000.0,87000.0,87000.0,102300.0,93100.0,943300.0
Sibsagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3550.0,7450.0,5250.0,11050.0,8550.0,6300.0,3600.0,5000.0,2400.0,2000.0,2000.0,2400.0,59550.0
Sibsagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,6000.0,0.0,8000.0,4000.0,0.0,4800.0,4000.0,0.0,2000.0,0.0,2000.0,100000.0,130800.0
Sibsagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sibsagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2100.0,2200.0,2200.0,6500.0,2250.0,7500.0,2600.0,2600.0,2400.0,0.0,1600.0,71000.0,102950.0
Sibsagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,7450.0,5250.0,11050.0,8550.0,6300.0,3600.0,5000.0,2400.0,2000.0,2000.0,2400.0,31400.0,87400.0
Sibsagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,1.0,,1.0,,2.0
Sibsagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,,,,,,,,,,1.0,2.0
Sibsagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sibsagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,1.0,,,,,,,,,,1.0,2.0
Sibsagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,,,2.0,,,,,3.0,,,,7.0
Sibsagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sibsagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,,,2.0,,,,,3.0,,,,7.0
Sibsagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,1.0,,,,1.0,2.0,1.0,2.0,2.0,1.0,,12.0
Sibsagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sibsagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,1.0,,,,1.0,2.0,1.0,2.0,2.0,1.0,,12.0
Sibsagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,1.0,1.0,3.0,1.0,4.0,3.0,2.0,2.0,17.0
Sibsagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sibsagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,1.0,1.0,3.0,1.0,4.0,3.0,2.0,2.0,17.0
Sibsagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,1.0,,1.0,,,,1.0,,,4.0
Sibsagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Sibsagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,1.0,,1.0,,,,1.0,,1.0,5.0
Sibsagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sibsagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sibsagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Sibsagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,1.0,1.0,2.0
Sibsagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,9.0
Sibsagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,11.0
Sibsagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sibsagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sibsagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Sibsagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,,1.0,,1.0,2.0,2.0,2.0,1.0,2.0,2.0,14.0
Sibsagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,3.0,,,1.0,,1.0,,1.0,,6.0
Sibsagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,,,4.0,,1.0,3.0,2.0,3.0,1.0,3.0,2.0,20.0
Sibsagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Sibsagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Sibsagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,1.0,,,,,1.0,,2.0
Sibsagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,1.0,,,,1.0,1.0,,3.0
Sibsagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Sibsagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,1.0,2.0,1.0,,1.0,,,1.0,1.0,1.0,9.0
Sibsagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,1.0,,,,,1.0,2.0,1.0,,5.0
Sibsagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,1.0,3.0,1.0,,1.0,,1.0,3.0,2.0,1.0,14.0
Sibsagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,1.0,,1.0,,,,1.0,3.0
Sibsagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,2.0,1.0,1.0,3.0,1.0,2.0,2.0,3.0,15.0
Sibsagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,,,1.0,1.0,1.0,1.0,,,2.0,1.0,8.0
Sibsagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,,,,3.0,3.0,2.0,5.0,1.0,2.0,4.0,5.0,26.0
Sibsagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Sibsagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Sibsagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Sibsagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,,,,,,,,,1.0
Sibsagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,1.0,,,,,,,,,,2.0
Sibsagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,2.0,,,1.0,3.0,2.0,2.0,1.0,1.0,12.0
Sibsagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,1.0,1.0,,,1.0,,,,3.0
Sibsagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,1.0,2.0,1.0,1.0,1.0,3.0,3.0,2.0,1.0,1.0,17.0
Sibsagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Sibsagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Sibsagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Sibsagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Sibsagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Sibsagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,5.0,,1.0,1.0,1.0,2.0,2.0,2.0,5.0,3.0,4.0,4.0,30.0
Sibsagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,3.0,6.0,9.0,10.0,8.0,8.0,11.0,12.0,12.0,14.0,16.0,109.0
Sibsagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,5.0,3.0,7.0,10.0,11.0,10.0,10.0,13.0,18.0,15.0,18.0,20.0,140.0
Sibsagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Sibsagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,,1.0,2.0,1.0,1.0,2.0,3.0,2.0,3.0,2.0,18.0
Sibsagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,,1.0,1.0,,,1.0,,1.0,1.0,,,6.0
Sibsagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,,1.0,2.0,2.0,1.0,2.0,2.0,4.0,3.0,3.0,2.0,24.0
Sibsagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Sibsagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Sibsagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Sibsagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Sibsagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Sibsagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Sibsagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Sibsagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,1.0,,,,,,,,,,1.0
Sibsagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Sibsagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Sibsagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Sibsagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Sibsagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Sibsagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Sibsagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Sibsagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Sibsagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Sibsagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Sibsagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Sibsagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Sibsagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Sibsagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,5.0,2.0,3.0,1.0,3.0,2.0,2.0,6.0,3.0,3.0,2.0,33.0
Sibsagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Sibsagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,5.0,2.0,3.0,1.0,3.0,2.0,2.0,6.0,3.0,3.0,2.0,33.0
Sibsagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,1.0,1.0,1.0,1.0,4.0
Sibsagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,5.0,1.0,4.0,5.0,3.0,1.0,3.0,3.0,,,3.0,29.0
Sibsagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,,,1.0,,,,1.0,,,,3.0
Sibsagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,6.0,1.0,4.0,6.0,3.0,1.0,3.0,5.0,1.0,1.0,4.0,36.0
Sibsagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Sibsagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,4.0,3.0,2.0,2.0,1.0,,1.0,,,4.0,2.0,20.0
Sibsagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,2.0,1.0,1.0,,,,,,4.0
Sibsagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,4.0,3.0,2.0,4.0,2.0,1.0,1.0,,,4.0,2.0,24.0
Sibsagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Sibsagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,2.0,2.0,1.0,,,,,,5.0
Sibsagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Sibsagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,2.0,2.0,1.0,,,,1.0,,6.0
Sibsagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,2.0,,,,2.0
Sibsagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,2.0,2.0,2.0,6.0,5.0,3.0,2.0,1.0,2.0,25.0
Sibsagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,,2.0,4.0,8.0,5.0,7.0,9.0,9.0,13.0,8.0,66.0
Sibsagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,,4.0,6.0,10.0,11.0,12.0,14.0,11.0,14.0,10.0,93.0
Sibsagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,1.0,1.0,1.0,,,,,,,3.0
Sibsagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,4.0,4.0,2.0,3.0,6.0,5.0,7.0,6.0,5.0,6.0,3.0,5.0,56.0
Sibsagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,4.0,3.0,7.0,10.0,11.0,10.0,12.0,18.0,12.0,13.0,12.0,114.0
Sibsagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,6.0,8.0,5.0,11.0,17.0,17.0,17.0,18.0,23.0,18.0,16.0,17.0,173.0
Sibsagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,3.0,,1.0,2.0,3.0,1.0,1.0,,,,11.0
Sibsagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,15.0,21.0,16.0,18.0,11.0,8.0,17.0,17.0,19.0,14.0,15.0,14.0,185.0
Sibsagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,19.0,16.0,19.0,23.0,17.0,27.0,21.0,22.0,35.0,35.0,34.0,33.0,301.0
Sibsagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,34.0,37.0,38.0,41.0,29.0,37.0,41.0,40.0,55.0,49.0,49.0,47.0,497.0
Sonitpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,3727.0,3831.0,3655.0,3475.0,3543.0,3073.0,2856.0,2959.0,2630.0,3085.0,3278.0,3470.0,39582.0
Sonitpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2998.0,3132.0,2997.0,2668.0,2704.0,2435.0,2231.0,2287.0,2129.0,2405.0,2715.0,2905.0,31606.0
Sonitpur,1.2,Number of Pregnant women registered under JSY,TOTAL,3096.0,3331.0,3009.0,3242.0,3250.0,2703.0,2517.0,2534.0,2247.0,2620.0,2834.0,3032.0,34415.0
Sonitpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2480.0,2552.0,2704.0,2764.0,2908.0,2847.0,2887.0,2873.0,2727.0,2494.0,2628.0,2916.0,32780.0
Sonitpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3436.0,3708.0,3436.0,3204.0,3333.0,3016.0,2696.0,2804.0,2370.0,2835.0,2971.0,3221.0,37030.0
Sonitpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3137.0,3347.0,3523.0,3358.0,3152.0,3395.0,3089.0,2782.0,2696.0,2422.0,2777.0,3111.0,36789.0
Sonitpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3330.0,3826.0,4625.0,3928.0,2800.0,4012.0,2494.0,2889.0,3029.0,3135.0,3024.0,3153.0,40245.0
Sonitpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,141.0,107.0,115.0,125.0,110.0,154.0,233.0,131.0,143.0,108.0,105.0,96.0,1568.0
Sonitpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,2.0,0.0,1.0,2.0,0.0,0.0,4.0,0.0,2.0,0.0,1.0,15.0
Sonitpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2587.0,3212.0,2886.0,2832.0,2606.0,2676.0,2298.0,2406.0,2307.0,2249.0,2383.0,2365.0,30807.0
Sonitpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,74.0,39.0,26.0,33.0,45.0,61.0,63.0,34.0,72.0,55.0,58.0,98.0,658.0
Sonitpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,1153.0,1432.0,1217.0,1344.0,1170.0,983.0,835.0,830.0,889.0,941.0,1081.0,1126.0,13001.0
Sonitpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,91.0,85.0,62.0,86.0,66.0,66.0,80.0,36.0,41.0,36.0,57.0,73.0,779.0
Sonitpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,286.0,283.0,294.0,364.0,398.0,391.0,410.0,447.0,418.0,424.0,396.0,286.0,4397.0
Sonitpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,377.0,368.0,356.0,450.0,464.0,457.0,490.0,483.0,459.0,460.0,453.0,359.0,5176.0
Sonitpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,243.0,212.0,220.0,237.0,244.0,262.0,260.0,268.0,224.0,230.0,206.0,190.0,2796.0
Sonitpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,1.0,0.0,3.0,0.0,3.0,0.0,0.0,0.0,0.0,2.0,10.0
Sonitpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1542.0,1622.0,1518.0,1956.0,2075.0,2021.0,2210.0,2145.0,2254.0,2262.0,1985.0,1820.0,23410.0
Sonitpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,885.0,910.0,576.0,825.0,673.0,933.0,920.0,781.0,661.0,857.0,396.0,432.0,8849.0
Sonitpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,762.0,1783.0,1358.0,1531.0,1427.0,1749.0,1442.0,2039.0,2089.0,1911.0,1557.0,2150.0,19798.0
Sonitpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,451.0,1388.0,1708.0,1190.0,1369.0,2205.0,1167.0,1943.0,1484.0,1527.0,1553.0,3509.0,19494.0
Sonitpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Sonitpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,405.0,511.0,398.0,468.0,421.0,468.0,616.0,454.0,505.0,473.0,401.0,381.0,5501.0
Sonitpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,12.0,48.0,38.0,27.0,42.0,42.0,56.0,47.0,22.0,72.0,67.0,38.0,511.0
Sonitpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,9.0,5.0,4.0,4.0,0.0,9.0,0.0,0.0,6.0,0.0,25.0,62.0
Sonitpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Sonitpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Sonitpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,49.0,49.0,58.0,59.0,56.0,85.0,78.0,104.0,98.0,92.0,78.0,71.0,877.0
Sonitpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,124.0,134.0,110.0,153.0,161.0,75.0,86.0,221.0,219.0,222.0,204.0,238.0,1947.0
Sonitpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sonitpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,173.0,183.0,168.0,212.0,217.0,160.0,164.0,325.0,317.0,314.0,282.0,309.0,2824.0
Sonitpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,233.0,303.0,250.0,252.0,206.0,249.0,353.0,234.0,234.0,253.0,212.0,209.0,2988.0
Sonitpur,4.1.1.a,Number of male live births,TOTAL,1180.0,1321.0,1200.0,1467.0,1449.0,1494.0,1656.0,1454.0,1476.0,1474.0,1304.0,1289.0,16764.0
Sonitpur,4.1.1.b,Number of female live births,TOTAL,1139.0,1183.0,1057.0,1343.0,1391.0,1432.0,1615.0,1393.0,1518.0,1465.0,1228.0,1226.0,15990.0
Sonitpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2319.0,2504.0,2257.0,2810.0,2840.0,2926.0,3271.0,2847.0,2994.0,2939.0,2532.0,2515.0,32754.0
Sonitpur,4.1.2,Number of still births,TOTAL,64.0,56.0,45.0,66.0,78.0,59.0,55.0,59.0,57.0,52.0,46.0,56.0,693.0
Sonitpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,218.0,386.0,294.0,278.0,245.0,268.0,255.0,157.0,194.0,154.0,220.0,170.0,2839.0
Sonitpur,4.2.1,Number of Newborns weighed at birth,TOTAL,2217.0,2338.0,2180.0,2190.0,2192.0,2709.0,3087.0,2659.0,2435.0,2697.0,2436.0,2246.0,29386.0
Sonitpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,529.0,537.0,522.0,531.0,578.0,677.0,665.0,629.0,510.0,545.0,446.0,528.0,6697.0
Sonitpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2232.0,2276.0,2106.0,2375.0,2627.0,2477.0,2874.0,2536.0,2514.0,2499.0,2298.0,2079.0,28893.0
Sonitpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,14.0,25.0,32.0,77.0
Sonitpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,2.0,4.0,6.0,5.0,8.0,6.0,12.0,13.0,13.0,10.0,35.0,35.0,149.0
Sonitpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,76.0,24.0,62.0,76.0,380.0,299.0,4.0,71.0,108.0,139.0,143.0,50.0,1432.0
Sonitpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sonitpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,78.0,28.0,68.0,81.0,388.0,305.0,16.0,90.0,121.0,163.0,203.0,117.0,1658.0
Sonitpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,4.0
Sonitpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,429.0,521.0,538.0,532.0,367.0,343.0,379.0,286.0,351.0,316.0,260.0,272.0,4594.0
Sonitpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,30.0,24.0,22.0,13.0,13.0,20.0,36.0,34.0,17.0,28.0,10.0,47.0,294.0
Sonitpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,377.0,293.0,331.0,382.0,287.0,252.0,292.0,201.0,308.0,313.0,355.0,242.0,3633.0
Sonitpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,9.0,24.0,15.0,9.0,161.0,0.0,9.0,4.0,6.0,0.0,10.0,0.0,247.0
Sonitpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1595.0,1471.0,1523.0,1884.0,1924.0,1962.0,2053.0,1862.0,2053.0,2133.0,1831.0,1736.0,22027.0
Sonitpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1434.0,1471.0,1372.0,2143.0,2114.0,2155.0,1904.0,2148.0,1903.0,1879.0,1722.0,1563.0,21808.0
Sonitpur,6.3,PNC maternal complications attended,TOTAL,22.0,24.0,51.0,52.0,64.0,62.0,54.0,73.0,61.0,65.0,47.0,11.0,586.0
Sonitpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,165.0,368.0,254.0,232.0,211.0,217.0,211.0,123.0,158.0,132.0,143.0,124.0,2338.0
Sonitpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,0.0,10.0,8.0,0.0,20.0,0.0,0.0,10.0,0.0,0.0,14.0,63.0
Sonitpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,166.0,368.0,264.0,240.0,211.0,237.0,211.0,123.0,168.0,132.0,143.0,138.0,2401.0
Sonitpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,25.0,0.0,40.0,156.0,18.0,82.0,27.0,46.0,72.0,80.0,54.0,68.0,668.0
Sonitpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,31.0,23.0,22.0,24.0,17.0,20.0,267.0,20.0,23.0,34.0,35.0,39.0,555.0
Sonitpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,89.0,105.0,143.0,112.0,118.0,92.0,323.0,138.0,172.0,126.0,214.0,204.0,1836.0
Sonitpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,120.0,128.0,165.0,136.0,135.0,112.0,590.0,158.0,195.0,160.0,249.0,243.0,2391.0
Sonitpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,59.0,0.0,0.0,0.0,54.0,85.0,54.0,0.0,0.0,252.0
Sonitpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,6.0,0.0,15.0,0.0,22.0,0.0,22.0,0.0,0.0,0.0,0.0,65.0
Sonitpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sonitpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,6.0,0.0,74.0,0.0,22.0,0.0,76.0,85.0,54.0,0.0,0.0,317.0
Sonitpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,7.0,21.0
Sonitpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,164.0,200.0,134.0,173.0,133.0,196.0,151.0,441.0,482.0,210.0,168.0,335.0,2787.0
Sonitpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sonitpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,164.0,200.0,134.0,173.0,133.0,196.0,165.0,441.0,482.0,210.0,168.0,342.0,2808.0
Sonitpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Sonitpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sonitpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Sonitpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,18.0,21.0,15.0,14.0,16.0,13.0,26.0,13.0,20.0,21.0,18.0,21.0,216.0
Sonitpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sonitpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,18.0,21.0,15.0,14.0,16.0,13.0,26.0,13.0,20.0,21.0,18.0,21.0,216.0
Sonitpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,75.0,56.0,65.0,510.0,121.0,75.0,35.0,42.0,50.0,40.0,57.0,87.0,1213.0
Sonitpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,12.0,20.0,40.0,493.0,20.0,27.0,31.0,38.0,16.0,32.0,39.0,27.0,795.0
Sonitpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,8.0,19.0,15.0,12.0,9.0,10.0,9.0,12.0,4.0,6.0,5.0,5.0,114.0
Sonitpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,1.0,3.0,3.0,32.0,0.0,0.0,0.0,12.0,5.0,0.0,2.0,0.0,58.0
Sonitpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sonitpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,96.0,98.0,123.0,1047.0,150.0,112.0,75.0,104.0,75.0,78.0,103.0,119.0,2180.0
Sonitpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,16.0,20.0,18.0,0.0,8.0,4.0,13.0,14.0,14.0,16.0,30.0,17.0,170.0
Sonitpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,3.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,7.0
Sonitpur,9.06,Number of IUCD removals,TOTAL,67.0,93.0,48.0,193.0,39.0,23.0,16.0,10.0,22.0,117.0,142.0,21.0,791.0
Sonitpur,9.07,Number of Oral Pills cycles distributed,TOTAL,9874.0,9885.0,9664.0,16384.0,10630.0,11106.0,10081.0,10376.0,9849.0,9910.0,9198.0,9932.0,126889.0
Sonitpur,9.08,Number of Condom pieces distributed,TOTAL,15617.0,15325.0,16314.0,21027.0,15539.0,16530.0,13541.0,13633.0,12981.0,13817.0,12652.0,13297.0,180273.0
Sonitpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,16.0,424.0,24.0,119.0,606.0,321.0,38.0,8.0,45.0,153.0,26.0,8.0,1788.0
Sonitpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,107.0,63.0,70.0,42.0,59.0,59.0,95.0,43.0,62.0,49.0,33.0,60.0,742.0
Sonitpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Sonitpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,2.0,2.0,1.0,,,1.0,4.0,1.0,,1.0,1.0,-1.0
Sonitpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2457.0,2174.0,1803.0,3464.0,3620.0,3766.0,3541.0,3981.0,3473.0,3501.0,3679.0,3743.0,39202.0
Sonitpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3023.0,2883.0,2345.0,2594.0,2659.0,2941.0,3153.0,3565.0,2959.0,3523.0,2234.0,344.0,32223.0
Sonitpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3163.0,3187.0,2700.0,2694.0,2398.0,2634.0,2781.0,3151.0,3203.0,3047.0,3236.0,2463.0,34657.0
Sonitpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3235.0,3215.0,2918.0,2806.0,2556.0,2318.0,2525.0,2820.0,2869.0,3070.0,2936.0,3312.0,34580.0
Sonitpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1017.0,2632.0,3649.0
Sonitpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,1024.0,1028.0
Sonitpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,41.0,41.0
Sonitpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,656.0,828.0,868.0,1236.0,1102.0,1361.0,1200.0,1735.0,1329.0,1804.0,1643.0,1549.0,15311.0
Sonitpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2925.0,2101.0,2485.0,2630.0,2347.0,2881.0,2688.0,3406.0,2481.0,3474.0,2889.0,2873.0,33180.0
Sonitpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3077.0,2359.0,2734.0,2777.0,2147.0,2460.0,2397.0,3010.0,2688.0,2980.0,3374.0,3145.0,33148.0
Sonitpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3150.0,2421.0,2959.0,2838.0,2302.0,2293.0,2205.0,2664.0,2356.0,2993.0,3084.0,3553.0,32818.0
Sonitpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,543.0,779.0,676.0,958.0,1190.0,1287.0,1405.0,1582.0,1643.0,1752.0,1428.0,1329.0,14572.0
Sonitpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,3003.0,2907.0,2484.0,2548.0,2640.0,2898.0,3124.0,3559.0,2954.0,3497.0,2294.0,321.0,32229.0
Sonitpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3159.0,3219.0,2718.0,2638.0,2410.0,2513.0,2788.0,3126.0,3145.0,3021.0,3127.0,2378.0,34242.0
Sonitpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3235.0,3232.0,2988.0,2770.0,2582.0,2295.0,2512.0,2857.0,2827.0,3034.0,2803.0,3116.0,34251.0
Sonitpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2343.0,2925.0,2858.0,2827.0,3266.0,2887.0,2190.0,3845.0,2584.0,2671.0,2614.0,3073.0,34083.0
Sonitpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2687.0,2631.0,2509.0,2544.0,2610.0,2142.0,1483.0,2323.0,2055.0,2293.0,2176.0,2445.0,27898.0
Sonitpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,2584.0,2946.0,2832.0,3875.0,5339.0,1530.0,2589.0,2234.0,1882.0,2885.0,2473.0,2231.0,33400.0
Sonitpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1223.0,1426.0,1466.0,1449.0,1685.0,1455.0,1127.0,1985.0,1308.0,1348.0,1319.0,1553.0,17344.0
Sonitpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1113.0,1374.0,1367.0,1352.0,1572.0,1385.0,1061.0,1823.0,1247.0,1264.0,1283.0,1551.0,16392.0
Sonitpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2336.0,2800.0,2833.0,2801.0,3257.0,2840.0,2188.0,3808.0,2555.0,2612.0,2602.0,3104.0,33736.0
Sonitpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2888.0,2841.0,2831.0,2756.0,2920.0,2594.0,2333.0,2721.0,2595.0,2436.0,2455.0,2894.0,32264.0
Sonitpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2842.0,2274.0,2886.0,2744.0,2673.0,2507.0,2083.0,2611.0,2226.0,2370.0,2486.0,3022.0,30724.0
Sonitpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,6.0,4.0,8.0,1.0,8.0,0.0,6.0,10.0,13.0,5.0,6.0,9.0,76.0
Sonitpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,285.0,272.0,378.0,362.0,335.0,312.0,250.0,298.0,302.0,287.0,274.0,290.0,3645.0
Sonitpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,297.0,266.0,321.0,324.0,324.0,273.0,231.0,286.0,309.0,288.0,271.0,313.0,3503.0
Sonitpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,582.0,538.0,699.0,686.0,659.0,585.0,481.0,584.0,611.0,575.0,545.0,603.0,7148.0
Sonitpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1321.0,1371.0,1441.0,1556.0,1819.0,1528.0,1317.0,1414.0,1558.0,1464.0,1424.0,1525.0,17738.0
Sonitpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1356.0,1377.0,1444.0,1531.0,1459.0,1426.0,1304.0,1528.0,1418.0,1323.0,1314.0,1472.0,16952.0
Sonitpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1034.0,1135.0,1138.0,1151.0,1092.0,1097.0,1064.0,1094.0,1117.0,1104.0,1012.0,1137.0,13175.0
Sonitpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,4.0,1.0,8.0
Sonitpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Sonitpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,6.0,12.0,2.0,0.0,8.0,10.0,6.0,4.0,0.0,48.0
Sonitpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1827.0,1761.0,1781.0,1804.0,1829.0,1764.0,1758.0,1812.0,1738.0,1750.0,1746.0,1745.0,21315.0
Sonitpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1798.0,1719.0,1752.0,1792.0,1767.0,1701.0,1705.0,1749.0,1680.0,1690.0,1681.0,1708.0,20742.0
Sonitpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1752.0,1668.0,1699.0,1742.0,1721.0,1658.0,1664.0,1703.0,1668.0,1636.0,1644.0,1667.0,20222.0
Sonitpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,3053.0,3025.0,2523.0,3382.0,2748.0,1211.0,2008.0,1601.0,1634.0,2246.0,2228.0,2069.0,27728.0
Sonitpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2197.0,2674.0,2796.0,2674.0,3855.0,2695.0,2236.0,3398.0,2481.0,2294.0,2267.0,2270.0,31837.0
Sonitpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,717.0,708.0,884.0,889.0,5121.0,1180.0,775.0,771.0,821.0,747.0,1208.0,2119.0,15940.0
Sonitpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,725.0,700.0,790.0,914.0,4913.0,1029.0,655.0,667.0,812.0,702.0,996.0,2275.0,15178.0
Sonitpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,2.0,0.0,0.0,9.0,11.0,2.0,2.0,3.0,0.0,4.0,3.0,36.0
Sonitpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,442.0,499.0,541.0,612.0,490.0,323.0,212.0,158.0,161.0,124.0,157.0,163.0,3882.0
Sonitpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Sonitpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,35.0,51.0,24.0,49.0,13.0,16.0,24.0,8.0,8.0,14.0,11.0,15.0,268.0
Sonitpur,13.1,Number of Patients operated for cataract,TOTAL,14.0,51.0,46.0,37.0,36.0,13.0,22.0,8.0,13.0,25.0,19.0,6.0,290.0
Sonitpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,10.0,45.0,44.0,33.0,31.0,9.0,18.0,6.0,6.0,16.0,11.0,18.0,247.0
Sonitpur,13.3,Number of School children detected with Refractive errors,TOTAL,126.0,50.0,54.0,29.0,40.0,51.0,46.0,59.0,185.0,31.0,84.0,33.0,788.0
Sonitpur,13.4,Number of children provided free glasses,TOTAL,86.0,2.0,2.0,16.0,0.0,2.0,3.0,4.0,146.0,0.0,0.0,2.0,263.0
Sonitpur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,2.0,3.0,3.0,3.0,2.0,3.0,3.0,4.0,4.0,4.0,-1.0
Sonitpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,23.0,23.0,22.0,22.0,18.0,18.0,21.0,19.0,20.0,18.0,18.0,19.0,-1.0
Sonitpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1699.0,1686.0,1627.0,1718.0,1641.0,1642.0,1633.0,1645.0,1680.0,1585.0,1575.0,1647.0,-1.0
Sonitpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,7.0,7.0,6.0,6.0,6.0,7.0,6.0,7.0,7.0,7.0,6.0,-1.0
Sonitpur,14.05,Number of RKS meetings held during the month,TOTAL,19.0,19.0,20.0,18.0,16.0,21.0,20.0,20.0,23.0,17.0,19.0,21.0,233.0
Sonitpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,45.0,45.0,44.0,44.0,41.0,44.0,43.0,40.0,43.0,43.0,38.0,41.0,-1.0
Sonitpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,558.0,634.0,608.0,674.0,649.0,528.0,485.0,567.0,486.0,521.0,455.0,450.0,6615.0
Sonitpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,2.0,2.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Sonitpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Sonitpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,456.0,489.0,561.0,772.0,512.0,1292.0,356.0,404.0,292.0,355.0,388.0,639.0,6516.0
Sonitpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1730.0,1719.0,1900.0,2130.0,2127.0,2207.0,1604.0,1496.0,1325.0,1423.0,1370.0,1488.0,20519.0
Sonitpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,448.0,471.0,626.0,736.0,527.0,408.0,429.0,351.0,537.0,353.0,385.0,558.0,5829.0
Sonitpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3675.0,3604.0,3500.0,4398.0,4328.0,3707.0,3930.0,3521.0,3015.0,3095.0,3140.0,3494.0,43407.0
Sonitpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,904.0,960.0,1187.0,1508.0,1039.0,1700.0,785.0,755.0,829.0,708.0,773.0,1197.0,12345.0
Sonitpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5405.0,5323.0,5400.0,6528.0,6455.0,5914.0,5534.0,5017.0,4340.0,4518.0,4510.0,4982.0,63926.0
Sonitpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,2.0,7.0,7.0,7.0,19.0,3.0,16.0,10.0,14.0,19.0,7.0,7.0,118.0
Sonitpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,9.0,11.0,6.0,14.0,0.0,19.0,8.0,7.0,8.0,7.0,4.0,95.0
Sonitpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,4.0,16.0,18.0,13.0,33.0,3.0,35.0,18.0,21.0,27.0,14.0,11.0,213.0
Sonitpur,14.11,In-Patient Head Count at midnight,TOTAL,1972.0,2923.0,2937.0,3387.0,3044.0,2836.0,3277.0,2828.0,2667.0,969.0,2384.0,2951.0,32175.0
Sonitpur,14.12.1,OPD attendance (All),TOTAL,197247.0,200365.0,214523.0,265421.0,218735.0,206814.0,166361.0,175704.0,145259.0,143595.0,145590.0,187525.0,2267139.0
Sonitpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,231.0,319.0,237.0,240.0,112.0,138.0,67.0,174.0,161.0,154.0,221.0,180.0,2234.0
Sonitpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,10.0,12.0,18.0,4.0,14.0,0.0,7.0,18.0,24.0,7.0,13.0,21.0,148.0
Sonitpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,65.0,43.0,31.0,37.0,37.0,33.0,32.0,44.0,36.0,26.0,36.0,53.0,473.0
Sonitpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,685.0,751.0,616.0,1019.0,876.0,758.0,412.0,778.0,839.0,565.0,808.0,675.0,8782.0
Sonitpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,789.0,929.0,603.0,219.0,199.0,556.0,687.0,679.0,602.0,216.0,673.0,791.0,6943.0
Sonitpur,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9413.0,10060.0,10355.0,11603.0,9917.0,8848.0,7241.0,8020.0,7766.0,7756.0,7542.0,8902.0,107423.0
Sonitpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,493.0,452.0,225.0,331.0,296.0,327.0,323.0,236.0,263.0,213.0,263.0,303.0,3725.0
Sonitpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,315.0,442.0,571.0,378.0,249.0,248.0,168.0,201.0,167.0,338.0,425.0,432.0,3934.0
Sonitpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,1.0,2.0,1.0,2.0,3.0,1.0,0.0,0.0,0.0,1.0,1.0,14.0
Sonitpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,238.0,33.0,354.0,169.0,65.0,206.0,141.0,35.0,172.0,208.0,436.0,401.0,2458.0
Sonitpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,1.0,3.0,1.0,0.0,0.0,0.0,1.0,0.0,6.0
Sonitpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1700.0,1000.0,1703.0,1143.0,1290.0,1237.0,1395.0,1133.0,830.0,1557.0,1584.0,1526.0,16098.0
Sonitpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,3.0
Sonitpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2253.0,1475.0,2628.0,1690.0,1604.0,1691.0,1704.0,1369.0,1169.0,2103.0,2445.0,2359.0,22490.0
Sonitpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,1.0,2.0,2.0,3.0,6.0,2.0,1.0,1.0,0.0,2.0,1.0,23.0
Sonitpur,15.2,Number of Widal tests conducted,Number tested,270.0,416.0,1037.0,863.0,601.0,432.0,311.0,288.0,234.0,93.0,276.0,384.0,5205.0
Sonitpur,15.3.a,Number of VDRL tests conducted on males,Number tested,52.0,19.0,18.0,17.0,17.0,35.0,28.0,20.0,19.0,27.0,14.0,32.0,298.0
Sonitpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,69.0,97.0,133.0,130.0,116.0,96.0,82.0,133.0,160.0,140.0,153.0,216.0,1525.0
Sonitpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1242.0,1372.0,1255.0,984.0,1181.0,1067.0,941.0,849.0,844.0,760.0,878.0,1101.0,12474.0
Sonitpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1363.0,1488.0,1406.0,1131.0,1314.0,1198.0,1051.0,1002.0,1023.0,927.0,1045.0,1349.0,14297.0
Sonitpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,12969.0,13134.0,17947.0,24141.0,18591.0,11131.0,10175.0,9237.0,6616.0,6395.0,6652.0,9810.0,146798.0
Sonitpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3.0,5.0,11.0,33.0,2.0,2.0,4.0,1.0,0.0,5.0,0.0,2.0,68.0
Sonitpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,52.0,4.0,12.0,35.0,11.0,5.0,5.0,8.0,12.0,4.0,2.0,1.0,151.0
Sonitpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3258.0,1439.0,500.0,1900.0,1937.0,228.0,877.0,1593.0,750.0,,820.0,200.0,13502.0
Sonitpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,1000.0,3000.0,2000.0,1600.0,2000.0,2000.0,0.0,1500.0,,0.0,750.0,13850.0
Sonitpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1819.0,1939.0,1600.0,1963.0,3309.0,1351.0,1284.0,843.0,1363.0,,620.0,750.0,16841.0
Sonitpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,1439.0,500.0,1900.0,1937.0,228.0,877.0,1593.0,750.0,887.0,0.0,200.0,200.0,10511.0
Sonitpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,450.0,450.0
Sonitpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,0.0,0.0
Sonitpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Sonitpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,250.0,250.0
Sonitpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,200.0
Sonitpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,275.0,90.0,0.0,1075.0,0.0,475.0,43.0,75.0,0.0,,426.0,175.0,2634.0
Sonitpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,2600.0,0.0,1650.0,0.0,850.0,125.0,850.0,,400.0,1500.0,7975.0
Sonitpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,47.0,0.0,0.0,0.0,0.0,,0.0,0.0,47.0
Sonitpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,185.0,90.0,1525.0,1075.0,1128.0,432.0,818.0,200.0,782.0,,651.0,775.0,7661.0
Sonitpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,90.0,0.0,1075.0,0.0,475.0,43.0,75.0,0.0,68.0,0.0,175.0,900.0,2901.0
Sonitpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1817.0,344.0,650.0,800.0,1975.0,794.0,1477.0,1104.0,900.0,,2088.0,2000.0,13949.0
Sonitpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,,2000.0,1600.0,2000.0,2000.0,2000.0,1000.0,500.0,830.0,,0.0,1500.0,13430.0
Sonitpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1473.0,1694.0,1450.0,825.0,3181.0,1317.0,1373.0,704.0,1622.0,,88.0,1750.0,15477.0
Sonitpur,16.1.3,Stock position of TT vaccines,5. Total Stock,344.0,650.0,800.0,1975.0,794.0,1477.0,1104.0,900.0,108.0,0.0,2000.0,1750.0,11902.0
Sonitpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1208.0,228.0,850.0,750.0,1733.0,1450.0,462.0,106.0,460.0,,2582.0,1800.0,11629.0
Sonitpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,1700.0,0.0,1700.0,1650.0,0.0,0.0,1400.0,1400.0,,1700.0,0.0,9550.0
Sonitpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,980.0,1078.0,100.0,717.0,1933.0,988.0,356.0,1046.0,1137.0,,2482.0,1050.0,11867.0
Sonitpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,228.0,850.0,750.0,1733.0,1450.0,462.0,106.0,460.0,723.0,0.0,1800.0,750.0,9312.0
Sonitpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4197.0,2588.0,2500.0,5750.0,1981.0,450.0,15.0,612.0,800.0,,3126.0,10.0,22029.0
Sonitpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,2000.0,6500.0,1950.0,1000.0,0.0,2000.0,2000.0,2000.0,,0.0,1000.0,18450.0
Sonitpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,0.0,0.0,0.0,145.0,0.0,0.0,0.0,0.0,,0.0,0.0,145.0
Sonitpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1609.0,2088.0,3250.0,5719.0,2386.0,435.0,1403.0,1812.0,1611.0,,3116.0,1010.0,24439.0
Sonitpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,2588.0,2500.0,5750.0,1981.0,450.0,15.0,612.0,800.0,1189.0,0.0,10.0,0.0,15895.0
Sonitpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,3176.0,903.0,1800.0,2000.0,5500.0,25.0,770.0,0.0,0.0,,2150.0,100.0,16424.0
Sonitpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,3000.0,2000.0,8000.0,2500.0,2000.0,0.0,1000.0,3000.0,,0.0,0.0,21500.0
Sonitpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2273.0,2103.0,1800.0,4500.0,7975.0,1255.0,770.0,1000.0,2620.0,,2050.0,100.0,26446.0
Sonitpur,16.1.7,Stock position of JE vaccines,5. Total Stock,903.0,1800.0,2000.0,5500.0,25.0,770.0,0.0,0.0,380.0,0.0,100.0,0.0,11478.0
Sonitpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3821.0,1892.0,500.0,900.0,1824.0,930.0,910.0,1139.0,73.0,,806.0,10.0,12805.0
Sonitpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,1700.0,500.0,1700.0,2010.0,1800.0,1800.0,0.0,1500.0,,0.0,1500.0,12510.0
Sonitpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,0.0,0.0,0.0,301.0,0.0,0.0,0.0,0.0,,0.0,0.0,301.0
Sonitpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1929.0,3092.0,100.0,776.0,2603.0,1820.0,1571.0,1066.0,1200.0,,796.0,1060.0,16013.0
Sonitpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1892.0,500.0,900.0,1824.0,930.0,910.0,1139.0,73.0,373.0,0.0,10.0,450.0,9001.0
Sonitpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,0.0,600.0,600.0,1200.0,1150.0,1150.0,490.0,400.0,,400.0,400.0,6390.0
Sonitpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,1800.0,0.0,1200.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,3000.0
Sonitpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,1200.0,0.0,600.0,50.0,0.0,660.0,90.0,0.0,,0.0,0.0,2600.0
Sonitpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,600.0,600.0,1200.0,1150.0,1150.0,490.0,400.0,400.0,0.0,400.0,400.0,6790.0
Sonitpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,9000.0,3000.0,3000.0,3300.0,5820.0,4980.0,4140.0,4140.0,40.0,,12600.0,12600.0,62620.0
Sonitpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,0.0,3300.0,10080.0,0.0,0.0,0.0,0.0,60480.0,,0.0,0.0,73860.0
Sonitpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,6000.0,0.0,3000.0,7560.0,840.0,840.0,0.0,4100.0,40320.0,,8600.0,8550.0,79810.0
Sonitpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,3000.0,3000.0,3300.0,5820.0,4980.0,4140.0,4140.0,40.0,20200.0,0.0,4000.0,4050.0,56670.0
Sonitpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1300.0,1100.0,1100.0,1100.0,24500.0,23900.0,23000.0,23000.0,4000.0,,300.0,300.0,103600.0
Sonitpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,28400.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,28400.0
Sonitpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,200.0,0.0,0.0,5000.0,600.0,900.0,0.0,19000.0,1000.0,,0.0,0.0,26700.0
Sonitpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1100.0,1100.0,1100.0,24500.0,23900.0,23000.0,23000.0,4000.0,3000.0,0.0,300.0,300.0,105300.0
Sonitpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,18000.0,18000.0,18000.0,9600.0,0.0,,0.0,0.0,63600.0
Sonitpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,0.0,21000.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,21000.0
Sonitpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,0.0,3000.0,0.0,0.0,8400.0,9600.0,0.0,,0.0,0.0,21000.0
Sonitpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,18000.0,18000.0,18000.0,9600.0,0.0,0.0,0.0,0.0,0.0,63600.0
Sonitpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,400.0,400.0,1900.0,1900.0,4600.0,4000.0,3700.0,1500.0,1500.0,,1200.0,1200.0,22300.0
Sonitpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,2000.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,5000.0
Sonitpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,500.0,0.0,300.0,600.0,300.0,2200.0,0.0,300.0,,0.0,0.0,4200.0
Sonitpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,400.0,1900.0,1900.0,4600.0,4000.0,3700.0,1500.0,1500.0,1200.0,0.0,1200.0,1200.0,23100.0
Sonitpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,,,,,,,,,,,,0.0
Sonitpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Sonitpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Sonitpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Sonitpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Sonitpur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Sonitpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Sonitpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Sonitpur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Sonitpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Sonitpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Sonitpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Sonitpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sonitpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Sonitpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sonitpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sonitpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Sonitpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Sonitpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Sonitpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Sonitpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Sonitpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Sonitpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Sonitpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Sonitpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,4907950.0,,,,,,4907950.0
Sonitpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,0.0,,,,,,0.0
Sonitpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,4695850.0,,,,,,4695850.0
Sonitpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,212100.0,,,,,,212100.0
Sonitpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Sonitpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Sonitpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Sonitpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Sonitpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Sonitpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Sonitpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Sonitpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Sonitpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Sonitpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Sonitpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Sonitpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Sonitpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Sonitpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Sonitpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Sonitpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Sonitpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sonitpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,0.0,10000.0,8645.0,9235.0,1875.0,1045.0,2185.0,,6500.0,500.0,39985.0
Sonitpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,16500.0,0.0,9900.0,0.0,0.0,6600.0,6600.0,,2000.0,0.0,41600.0
Sonitpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,6500.0,1355.0,9310.0,7360.0,830.0,5460.0,6000.0,,8000.0,500.0,45315.0
Sonitpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,10000.0,8645.0,9235.0,1875.0,1045.0,2185.0,2785.0,0.0,500.0,0.0,36270.0
Sonitpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,68440.0,25740.0,18000.0,38000.0,29435.0,37445.0,27610.0,106270.0,72670.0,,56970.0,24000.0,504580.0
Sonitpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,33600.0,48000.0,67200.0,91200.0,24000.0,115200.0,0.0,28800.0,,0.0,0.0,408000.0
Sonitpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,42700.0,41340.0,28000.0,75765.0,83190.0,33835.0,36540.0,33600.0,32500.0,,32970.0,14000.0,454440.0
Sonitpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,25740.0,18000.0,38000.0,29435.0,37445.0,27610.0,106270.0,72670.0,68970.0,0.0,24000.0,10000.0,458140.0
Sonitpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,9806.0,5778.0,1600.0,4000.0,9024.0,7064.0,821.0,3180.0,1550.0,,4800.0,4000.0,51623.0
Sonitpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,8000.0,6000.0,8000.0,8000.0,0.0,4000.0,4000.0,4000.0,,0.0,0.0,42000.0
Sonitpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sonitpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4028.0,12178.0,3600.0,2976.0,9960.0,6243.0,1641.0,5630.0,3164.0,,800.0,4000.0,54220.0
Sonitpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,5778.0,1600.0,4000.0,9024.0,7064.0,821.0,3180.0,1550.0,2386.0,0.0,4000.0,0.0,39403.0
Sonitpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,2.0,,2.0,,,,,1.0,5.0
Sonitpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,2.0,,,,,,,,,,,2.0
Sonitpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sonitpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,2.0,,,,,,,,,,,2.0
Sonitpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,3.0,1.0,1.0,3.0,,2.0,,,3.0,,2.0,16.0
Sonitpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sonitpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,3.0,1.0,1.0,3.0,,2.0,,,3.0,,2.0,16.0
Sonitpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,5.0,2.0,1.0,5.0,2.0,2.0,4.0,2.0,6.0,2.0,4.0,2.0,37.0
Sonitpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Sonitpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,5.0,2.0,1.0,5.0,2.0,2.0,4.0,2.0,7.0,2.0,4.0,2.0,38.0
Sonitpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,6.0,2.0,1.0,3.0,6.0,4.0,6.0,,5.0,9.0,8.0,8.0,58.0
Sonitpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sonitpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,6.0,2.0,1.0,3.0,6.0,4.0,6.0,,5.0,9.0,8.0,8.0,58.0
Sonitpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,1.0,3.0,4.0,,3.0,,,2.0,14.0
Sonitpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Sonitpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,1.0,1.0,3.0,4.0,1.0,3.0,,,2.0,15.0
Sonitpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sonitpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sonitpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Sonitpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,4.0,1.0,1.0,,3.0,,2.0,,11.0
Sonitpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sonitpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,4.0,1.0,1.0,,3.0,,2.0,,11.0
Sonitpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sonitpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sonitpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Sonitpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,2.0,3.0,2.0,2.0,3.0,3.0,12.0,4.0,6.0,2.0,3.0,44.0
Sonitpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,1.0,,,1.0,,1.0,,1.0,4.0
Sonitpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,2.0,3.0,2.0,3.0,3.0,3.0,13.0,4.0,7.0,2.0,4.0,48.0
Sonitpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Sonitpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Sonitpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Sonitpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,,1.0,,,,,,2.0
Sonitpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Sonitpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,1.0,,1.0,4.0,2.0,,2.0,1.0,2.0,2.0,16.0
Sonitpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,,1.0,3.0,,3.0,2.0,,2.0,2.0,,15.0
Sonitpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,2.0,1.0,1.0,4.0,4.0,5.0,2.0,2.0,3.0,4.0,2.0,32.0
Sonitpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Sonitpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,4.0,,5.0,,,1.0,,3.0,,,1.0,1.0,15.0
Sonitpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,2.0,1.0,4.0,5.0,,,,,1.0,1.0,,16.0
Sonitpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,6.0,2.0,6.0,4.0,5.0,1.0,,3.0,,1.0,2.0,1.0,31.0
Sonitpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Sonitpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Sonitpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Sonitpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,1.0,,,,1.0
Sonitpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Sonitpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,3.0,,3.0,1.0,,,2.0,1.0,1.0,,1.0,13.0
Sonitpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,3.0,,1.0,3.0,1.0,,2.0,1.0,2.0,1.0,,2.0,16.0
Sonitpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,4.0,3.0,1.0,6.0,2.0,,2.0,3.0,4.0,2.0,,3.0,30.0
Sonitpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Sonitpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Sonitpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Sonitpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,1.0,,,1.0
Sonitpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Sonitpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,8.0,12.0,2.0,2.0,5.0,2.0,11.0,10.0,3.0,8.0,7.0,3.0,73.0
Sonitpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,17.0,16.0,11.0,7.0,17.0,5.0,16.0,15.0,15.0,22.0,7.0,6.0,154.0
Sonitpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,25.0,28.0,13.0,9.0,22.0,7.0,27.0,25.0,18.0,30.0,14.0,9.0,227.0
Sonitpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Sonitpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,1.0,1.0,2.0,1.0,,1.0,1.0,2.0,,,10.0
Sonitpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,5.0,2.0,2.0,3.0,5.0,6.0,4.0,1.0,2.0,4.0,4.0,3.0,41.0
Sonitpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,6.0,2.0,3.0,4.0,7.0,7.0,4.0,2.0,3.0,6.0,4.0,3.0,51.0
Sonitpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Sonitpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Sonitpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Sonitpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Sonitpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Sonitpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,,,1.0,,,,1.0,,,,3.0
Sonitpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Sonitpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,,,1.0,,,,1.0,,,,3.0
Sonitpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Sonitpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Sonitpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Sonitpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,1.0,,,,,,1.0
Sonitpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Sonitpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,2.0,,,,1.0,1.0,,,,,5.0
Sonitpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Sonitpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,2.0,,,,1.0,1.0,,,,,5.0
Sonitpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Sonitpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Sonitpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Sonitpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,,,,,,,1.0
Sonitpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Sonitpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,2.0,2.0,,4.0,2.0,2.0,,5.0,3.0,,1.0,23.0
Sonitpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Sonitpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,2.0,2.0,,4.0,2.0,2.0,,5.0,3.0,,1.0,23.0
Sonitpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,3.0,2.0,,,1.0,1.0,2.0,,,,,,9.0
Sonitpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,7.0,12.0,9.0,10.0,5.0,1.0,5.0,9.0,5.0,13.0,9.0,2.0,87.0
Sonitpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,4.0,1.0,,3.0,2.0,4.0,2.0,2.0,1.0,2.0,2.0,1.0,24.0
Sonitpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,14.0,15.0,9.0,13.0,8.0,6.0,9.0,11.0,6.0,15.0,11.0,3.0,120.0
Sonitpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Sonitpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,6.0,4.0,2.0,5.0,4.0,3.0,5.0,2.0,5.0,4.0,8.0,2.0,50.0
Sonitpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,2.0,,,2.0,,2.0,1.0,,1.0,1.0,,,9.0
Sonitpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,8.0,4.0,3.0,7.0,4.0,5.0,6.0,2.0,6.0,5.0,8.0,2.0,60.0
Sonitpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Sonitpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,1.0,1.0,,1.0,,,,3.0
Sonitpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,,,,,1.0,,,,,,,2.0
Sonitpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,,,,3.0,1.0,,1.0,,,,6.0
Sonitpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,,,,,,1.0,,,,2.0
Sonitpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,6.0,9.0,7.0,6.0,2.0,2.0,8.0,2.0,1.0,,,47.0
Sonitpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,8.0,15.0,6.0,13.0,6.0,5.0,5.0,9.0,10.0,4.0,8.0,8.0,97.0
Sonitpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,12.0,21.0,16.0,20.0,12.0,7.0,7.0,17.0,13.0,5.0,8.0,8.0,146.0
Sonitpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,1.0,,1.0,1.0,,,,,3.0
Sonitpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,5.0,3.0,5.0,3.0,6.0,17.0,7.0,4.0,4.0,3.0,4.0,6.0,67.0
Sonitpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,12.0,10.0,16.0,9.0,9.0,12.0,15.0,8.0,14.0,19.0,19.0,11.0,154.0
Sonitpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,17.0,13.0,21.0,12.0,16.0,29.0,23.0,13.0,18.0,22.0,23.0,17.0,224.0
Sonitpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,2.0,3.0,,3.0,1.0,1.0,2.0,1.0,1.0,2.0,17.0
Sonitpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,12.0,15.0,22.0,21.0,16.0,21.0,28.0,39.0,37.0,33.0,22.0,26.0,292.0
Sonitpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,35.0,34.0,47.0,65.0,35.0,36.0,37.0,46.0,49.0,46.0,36.0,53.0,519.0
Sonitpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,47.0,50.0,71.0,89.0,51.0,60.0,66.0,86.0,88.0,80.0,59.0,81.0,828.0
Tinsukia,1.1,Total number of pregnant women Registered for ANC,TOTAL,2370.0,2466.0,2602.0,2258.0,2176.0,2202.0,1930.0,2220.0,1860.0,2208.0,2091.0,2704.0,27087.0
Tinsukia,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1755.0,1786.0,1926.0,1701.0,1560.0,1624.0,1362.0,1568.0,1407.0,1727.0,1693.0,2067.0,20176.0
Tinsukia,1.2,Number of Pregnant women registered under JSY,TOTAL,2179.0,2327.0,2431.0,2151.0,2041.0,2013.0,1768.0,2034.0,1718.0,2096.0,1960.0,2601.0,25319.0
Tinsukia,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1556.0,1663.0,1910.0,1952.0,2051.0,1799.0,1967.0,1945.0,1810.0,1700.0,1703.0,2093.0,22149.0
Tinsukia,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1904.0,1937.0,2019.0,1857.0,1939.0,1877.0,1742.0,1755.0,1624.0,1699.0,1499.0,2014.0,21866.0
Tinsukia,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1981.0,2111.0,2116.0,2090.0,2043.0,1945.0,2136.0,1847.0,1806.0,1683.0,1641.0,2096.0,23495.0
Tinsukia,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2182.0,2079.0,2329.0,2296.0,2215.0,2070.0,1966.0,2097.0,1909.0,1751.0,1731.0,2107.0,24732.0
Tinsukia,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,68.0,49.0,33.0,35.0,48.0,40.0,38.0,31.0,40.0,59.0,64.0,74.0,579.0
Tinsukia,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1312.0,1248.0,1197.0,1080.0,1116.0,1095.0,997.0,1113.0,981.0,1168.0,1059.0,1356.0,13722.0
Tinsukia,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,18.0,7.0,13.0,11.0,3.0,0.0,0.0,1.0,4.0,1.0,7.0,3.0,68.0
Tinsukia,1.8,Number of pregnancy test kits used at SC level,TOTAL,487.0,634.0,894.0,1014.0,806.0,739.0,675.0,826.0,787.0,876.0,855.0,1056.0,9649.0
Tinsukia,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,14.0,14.0,27.0,18.0,12.0,24.0,21.0,17.0,19.0,9.0,11.0,35.0,221.0
Tinsukia,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,109.0,96.0,94.0,99.0,123.0,101.0,190.0,141.0,127.0,119.0,107.0,103.0,1409.0
Tinsukia,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,123.0,110.0,121.0,117.0,135.0,125.0,211.0,158.0,146.0,128.0,118.0,138.0,1630.0
Tinsukia,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,119.0,82.0,111.0,104.0,127.0,118.0,205.0,141.0,127.0,111.0,104.0,128.0,1477.0
Tinsukia,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1057.0,1059.0,987.0,1290.0,1432.0,1601.0,1567.0,1414.0,1400.0,1449.0,1244.0,1248.0,15748.0
Tinsukia,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,110.0,66.0,104.0,276.0,111.0,113.0,110.0,312.0,435.0,333.0,82.0,73.0,2125.0
Tinsukia,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1086.0,1256.0,1020.0,1415.0,1659.0,1744.0,1405.0,1736.0,1951.0,1807.0,1450.0,2779.0,19308.0
Tinsukia,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,509.0,541.0,769.0,823.0,1352.0,1735.0,682.0,1144.0,2236.0,1964.0,1142.0,1514.0,14411.0
Tinsukia,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,0.0,,0.0
Tinsukia,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,490.0,508.0,467.0,578.0,654.0,654.0,716.0,609.0,668.0,636.0,506.0,558.0,7044.0
Tinsukia,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,59.0,43.0,43.0,60.0,87.0,72.0,87.0,61.0,82.0,83.0,71.0,71.0,819.0
Tinsukia,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,0.0,0.0,,0.0
Tinsukia,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Tinsukia,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,78.0,57.0,74.0,76.0,98.0,95.0,84.0,52.0,60.0,74.0,55.0,50.0,853.0
Tinsukia,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,150.0,192.0,134.0,192.0,186.0,205.0,230.0,189.0,107.0,173.0,85.0,179.0,2022.0
Tinsukia,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tinsukia,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,228.0,249.0,208.0,268.0,284.0,300.0,314.0,241.0,167.0,247.0,140.0,229.0,2875.0
Tinsukia,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,97.0,108.0,106.0,120.0,120.0,127.0,140.0,111.0,139.0,129.0,103.0,81.0,1381.0
Tinsukia,4.1.1.a,Number of male live births,TOTAL,865.0,871.0,804.0,1068.0,1166.0,1170.0,1340.0,1102.0,1136.0,1096.0,1049.0,1016.0,12683.0
Tinsukia,4.1.1.b,Number of female live births,TOTAL,794.0,789.0,748.0,901.0,1037.0,1185.0,1124.0,1058.0,1061.0,1095.0,807.0,906.0,11505.0
Tinsukia,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1659.0,1660.0,1552.0,1969.0,2203.0,2355.0,2464.0,2160.0,2197.0,2191.0,1856.0,1922.0,24188.0
Tinsukia,4.1.2,Number of still births,TOTAL,20.0,27.0,25.0,29.0,23.0,32.0,39.0,43.0,20.0,41.0,27.0,28.0,354.0
Tinsukia,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,246.0,318.0,269.0,184.0,246.0,187.0,226.0,186.0,226.0,160.0,194.0,224.0,2666.0
Tinsukia,4.2.1,Number of Newborns weighed at birth,TOTAL,1642.0,1643.0,1464.0,1965.0,2197.0,2354.0,2452.0,2157.0,2195.0,2182.0,1780.0,1918.0,23949.0
Tinsukia,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,347.0,468.0,380.0,516.0,396.0,390.0,515.0,471.0,401.0,428.0,408.0,336.0,5056.0
Tinsukia,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1633.0,1624.0,1455.0,1953.0,2181.0,2338.0,2438.0,2136.0,2157.0,1899.0,1605.0,1908.0,23327.0
Tinsukia,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,39.0,14.0,65.0,65.0,87.0,93.0,14.0,10.0,9.0,11.0,12.0,15.0,434.0
Tinsukia,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,51.0,102.0,96.0,166.0,186.0,320.0,127.0,165.0,241.0,266.0,275.0,203.0,2198.0
Tinsukia,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,150.0,192.0,134.0,192.0,186.0,205.0,231.0,189.0,107.0,177.0,113.0,186.0,2062.0
Tinsukia,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tinsukia,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,240.0,308.0,295.0,423.0,459.0,618.0,372.0,364.0,357.0,454.0,400.0,404.0,4694.0
Tinsukia,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,11.0,22.0,8.0,12.0,10.0,18.0,14.0,15.0,6.0,22.0,26.0,3.0,167.0
Tinsukia,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,218.0,271.0,213.0,379.0,361.0,411.0,355.0,315.0,283.0,220.0,29.0,197.0,3252.0
Tinsukia,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,32.0,10.0,11.0,64.0,6.0,2.0,2.0,5.0,0.0,7.0,8.0,2.0,149.0
Tinsukia,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,87.0,119.0,140.0,201.0,246.0,244.0,104.0,184.0,237.0,276.0,291.0,215.0,2344.0
Tinsukia,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,10.0,17.0,45.0,18.0,8.0,16.0,8.0,0.0,6.0,8.0,8.0,7.0,151.0
Tinsukia,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1651.0,1519.0,1465.0,1970.0,2149.0,2225.0,2330.0,1993.0,2054.0,2045.0,1841.0,1845.0,23087.0
Tinsukia,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1275.0,1014.0,985.0,1312.0,1517.0,1580.0,1421.0,1269.0,1247.0,1245.0,1229.0,1407.0,15501.0
Tinsukia,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,15.0
Tinsukia,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,203.0,310.0,227.0,178.0,179.0,142.0,169.0,132.0,144.0,122.0,151.0,122.0,2079.0
Tinsukia,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,2.0,0.0,4.0,0.0,0.0,0.0,1.0,2.0,1.0,0.0,25.0,35.0
Tinsukia,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,203.0,312.0,227.0,182.0,179.0,142.0,169.0,133.0,146.0,123.0,151.0,147.0,2114.0
Tinsukia,7.2,Number of MTPs conducted at Private Facilities,TOTAL,35.0,40.0,47.0,44.0,68.0,41.0,51.0,64.0,57.0,77.0,70.0,93.0,687.0
Tinsukia,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,13.0,97.0,76.0,157.0,131.0,176.0,104.0,139.0,105.0,114.0,95.0,163.0,1370.0
Tinsukia,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,48.0,122.0,146.0,216.0,135.0,151.0,148.0,192.0,123.0,79.0,153.0,321.0,1834.0
Tinsukia,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,61.0,219.0,222.0,373.0,266.0,327.0,252.0,331.0,228.0,193.0,248.0,484.0,3204.0
Tinsukia,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,44.0,0.0,0.0,0.0,55.0,43.0,0.0,25.0,69.0,236.0
Tinsukia,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,33.0,35.0,0.0,32.0,0.0,0.0,21.0,10.0,20.0,0.0,40.0,191.0
Tinsukia,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,,0.0,,,0.0,0.0,0.0,,,0.0,0.0,0.0
Tinsukia,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tinsukia,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,33.0,35.0,44.0,32.0,0.0,0.0,76.0,53.0,20.0,25.0,109.0,427.0
Tinsukia,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,815.0,0.0,0.0,0.0,0.0,97.0,0.0,0.0,321.0,1233.0
Tinsukia,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,150.0,101.0,46.0,321.0,140.0,126.0,84.0,47.0,260.0,240.0,282.0,255.0,2052.0
Tinsukia,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,4.0,0.0,0.0,30.0,,,,11.0,8.0,0.0,10.0,0.0,63.0
Tinsukia,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tinsukia,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,154.0,101.0,46.0,1166.0,140.0,126.0,84.0,58.0,365.0,240.0,292.0,576.0,3348.0
Tinsukia,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,7.0,6.0,3.0,1.0,0.0,2.0,8.0,1.0,1.0,0.0,2.0,31.0
Tinsukia,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,3.0,10.0,6.0,6.0,10.0,10.0,12.0,8.0,13.0,21.0,12.0,9.0,120.0
Tinsukia,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,3.0,0.0,,,1.0,1.0,1.0,0.0,2.0,9.0
Tinsukia,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tinsukia,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,4.0,10.0,6.0,9.0,10.0,10.0,12.0,9.0,14.0,22.0,12.0,11.0,129.0
Tinsukia,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,7.0,3.0,5.0,6.0,10.0,10.0,12.0,10.0,12.0,21.0,12.0,9.0,117.0
Tinsukia,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,8.0,15.0,12.0,20.0,,,4.0,0.0,,1.0,0.0,2.0,62.0
Tinsukia,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tinsukia,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,15.0,18.0,17.0,26.0,10.0,10.0,16.0,10.0,12.0,22.0,12.0,11.0,179.0
Tinsukia,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,165.0,170.0,112.0,761.0,99.0,106.0,97.0,89.0,134.0,90.0,98.0,254.0,2175.0
Tinsukia,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,54.0,50.0,44.0,254.0,54.0,67.0,49.0,55.0,77.0,44.0,37.0,57.0,842.0
Tinsukia,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,119.0,93.0,60.0,243.0,123.0,111.0,100.0,92.0,33.0,40.0,95.0,98.0,1207.0
Tinsukia,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,68.0,80.0,54.0,66.0,25.0,4.0,8.0,12.0,34.0,68.0,54.0,44.0,517.0
Tinsukia,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tinsukia,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,406.0,393.0,270.0,1324.0,301.0,288.0,254.0,248.0,278.0,242.0,284.0,453.0,4741.0
Tinsukia,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,165.0,130.0,90.0,167.0,146.0,108.0,97.0,95.0,123.0,152.0,131.0,117.0,1521.0
Tinsukia,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,25.0,32.0,41.0,80.0,25.0,45.0,40.0,14.0,18.0,31.0,37.0,30.0,418.0
Tinsukia,9.06,Number of IUCD removals,TOTAL,20.0,26.0,68.0,26.0,18.0,21.0,15.0,33.0,19.0,34.0,52.0,29.0,361.0
Tinsukia,9.07,Number of Oral Pills cycles distributed,TOTAL,3503.0,4208.0,4054.0,5616.0,4503.0,4048.0,3990.0,4127.0,3652.0,3452.0,3590.0,3824.0,48567.0
Tinsukia,9.08,Number of Condom pieces distributed,TOTAL,3269.0,4431.0,4294.0,6448.0,3922.0,3609.0,3432.0,3390.0,3580.0,3827.0,4130.0,4626.0,48958.0
Tinsukia,9.09,Number of Centchroman (weekly) pills given,TOTAL,13.0,10.0,53.0,50.0,159.0,49.0,123.0,120.0,34.0,17.0,7.0,14.0,649.0
Tinsukia,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,88.0,29.0,34.0,46.0,12.0,27.0,44.0,47.0,45.0,34.0,50.0,68.0,524.0
Tinsukia,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,9.12,Number of Institutions having NSV trained doctors,TOTAL,,1.0,1.0,1.0,1.0,,,1.0,1.0,1.0,2.0,1.0,-1.0
Tinsukia,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2605.0,1690.0,1961.0,2019.0,2051.0,2290.0,2245.0,2019.0,2538.0,1483.0,547.0,254.0,21702.0
Tinsukia,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2014.0,1864.0,1822.0,1690.0,1671.0,1798.0,2228.0,2409.0,2170.0,2165.0,1168.0,439.0,21438.0
Tinsukia,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1944.0,2012.0,1910.0,1907.0,1645.0,1678.0,1791.0,2138.0,2336.0,2110.0,1844.0,1808.0,23123.0
Tinsukia,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2048.0,1892.0,2050.0,2025.0,1786.0,1621.0,1639.0,1745.0,2098.0,2276.0,1788.0,2314.0,23282.0
Tinsukia,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,702.0,2008.0,2710.0
Tinsukia,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,577.0,579.0
Tinsukia,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,799.0,682.0,688.0,805.0,439.0,1026.0,948.0,704.0,561.0,971.0,709.0,745.0,9077.0
Tinsukia,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2032.0,1730.0,1737.0,1717.0,1018.0,1911.0,1655.0,1925.0,1768.0,2041.0,1875.0,2224.0,21633.0
Tinsukia,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1971.0,1863.0,1818.0,1912.0,961.0,1694.0,1354.0,1589.0,1748.0,1948.0,1998.0,2348.0,21204.0
Tinsukia,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2105.0,1739.0,1946.0,1959.0,1050.0,1597.0,1215.0,1256.0,1542.0,1906.0,1819.0,2485.0,20619.0
Tinsukia,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,571.0,564.0,541.0,571.0,741.0,796.0,779.0,818.0,790.0,821.0,631.0,706.0,8329.0
Tinsukia,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2309.0,2288.0,1892.0,1453.0,1542.0,1941.0,2137.0,2469.0,2193.0,2191.0,1226.0,508.0,22149.0
Tinsukia,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1739.0,2379.0,2177.0,1778.0,1514.0,1862.0,1828.0,2201.0,2391.0,2192.0,1845.0,1756.0,23662.0
Tinsukia,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1818.0,1867.0,2225.0,1936.0,1768.0,1811.0,1683.0,1924.0,2184.0,2293.0,1798.0,2207.0,23514.0
Tinsukia,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1466.0,1802.0,2006.0,2142.0,2204.0,1646.0,1360.0,2003.0,1570.0,2118.0,893.0,2353.0,21563.0
Tinsukia,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1686.0,1716.0,1719.0,1635.0,1589.0,1102.0,880.0,1050.0,971.0,1372.0,603.0,1541.0,15864.0
Tinsukia,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1250.0,1494.0,1819.0,2022.0,1527.0,844.0,652.0,1040.0,2290.0,1846.0,706.0,2223.0,17713.0
Tinsukia,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,775.0,961.0,1057.0,1086.0,1106.0,837.0,675.0,1009.0,809.0,1037.0,477.0,1257.0,11086.0
Tinsukia,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,652.0,832.0,925.0,990.0,971.0,778.0,601.0,899.0,756.0,1034.0,411.0,1089.0,9938.0
Tinsukia,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1427.0,1793.0,1982.0,2076.0,2077.0,1615.0,1276.0,1908.0,1565.0,2071.0,888.0,2346.0,21024.0
Tinsukia,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1962.0,1926.0,1812.0,1689.0,1719.0,1522.0,1404.0,1615.0,1460.0,1465.0,1448.0,1769.0,19791.0
Tinsukia,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1953.0,1820.0,1727.0,1684.0,993.0,1478.0,1112.0,1234.0,1163.0,1298.0,1498.0,1786.0,17746.0
Tinsukia,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,6.0,7.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,25.0
Tinsukia,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,99.0,42.0,15.0,46.0,58.0,71.0,78.0,73.0,51.0,56.0,14.0,56.0,659.0
Tinsukia,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,90.0,33.0,14.0,40.0,62.0,54.0,59.0,59.0,49.0,66.0,26.0,56.0,608.0
Tinsukia,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,189.0,75.0,29.0,86.0,120.0,125.0,137.0,132.0,100.0,122.0,40.0,112.0,1267.0
Tinsukia,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,697.0,807.0,755.0,1027.0,980.0,774.0,838.0,892.0,964.0,985.0,911.0,840.0,10470.0
Tinsukia,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,595.0,568.0,582.0,800.0,636.0,543.0,585.0,557.0,613.0,584.0,603.0,653.0,7319.0
Tinsukia,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,452.0,510.0,464.0,600.0,523.0,444.0,448.0,415.0,482.0,396.0,369.0,451.0,5554.0
Tinsukia,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,959.0,983.0,969.0,969.0,967.0,991.0,1024.0,1016.0,965.0,976.0,975.0,983.0,11777.0
Tinsukia,10.4.2,Number of Immunisation sessions held during the month,TOTAL,958.0,977.0,971.0,968.0,957.0,983.0,1010.0,1010.0,962.0,963.0,955.0,978.0,11692.0
Tinsukia,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,923.0,950.0,931.0,949.0,936.0,964.0,982.0,982.0,941.0,945.0,941.0,959.0,11403.0
Tinsukia,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1605.0,1684.0,1676.0,1851.0,1639.0,700.0,464.0,761.0,1626.0,1279.0,693.0,1480.0,15458.0
Tinsukia,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1380.0,1626.0,1761.0,1918.0,1991.0,1510.0,1488.0,2001.0,1488.0,1781.0,1085.0,1701.0,19730.0
Tinsukia,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,539.0,586.0,544.0,539.0,1369.0,1321.0,513.0,543.0,516.0,501.0,1495.0,474.0,8940.0
Tinsukia,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,625.0,658.0,648.0,768.0,1351.0,1121.0,703.0,735.0,783.0,758.0,1638.0,605.0,10393.0
Tinsukia,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,5.0,11.0,11.0,17.0,6.0,1.0,17.0,0.0,0.0,1.0,1.0,73.0
Tinsukia,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1266.0,1351.0,971.0,1178.0,841.0,709.0,591.0,387.0,367.0,334.0,407.0,401.0,8803.0
Tinsukia,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,20.0,7.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,29.0
Tinsukia,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,55.0,43.0,28.0,35.0,14.0,44.0,36.0,34.0,42.0,33.0,44.0,124.0,532.0
Tinsukia,13.1,Number of Patients operated for cataract,TOTAL,56.0,118.0,123.0,170.0,126.0,188.0,63.0,30.0,68.0,112.0,106.0,263.0,1423.0
Tinsukia,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,23.0,25.0,11.0,0.0,3.0,3.0,0.0,20.0,85.0
Tinsukia,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,524.0,0.0,74.0,0.0,0.0,0.0,103.0,701.0
Tinsukia,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,164.0,0.0,74.0,0.0,0.0,0.0,103.0,341.0
Tinsukia,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Tinsukia,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,14.0,12.0,14.0,13.0,13.0,15.0,14.0,14.0,12.0,14.0,13.0,13.0,-1.0
Tinsukia,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,787.0,824.0,805.0,849.0,856.0,859.0,883.0,891.0,881.0,863.0,863.0,869.0,-1.0
Tinsukia,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,-1.0
Tinsukia,14.05,Number of RKS meetings held during the month,TOTAL,14.0,14.0,19.0,19.0,15.0,15.0,16.0,17.0,16.0,15.0,15.0,21.0,196.0
Tinsukia,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,18.0,16.0,18.0,16.0,17.0,19.0,18.0,16.0,16.0,17.0,16.0,16.0,-1.0
Tinsukia,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,94.0,153.0,153.0,217.0,281.0,298.0,322.0,277.0,261.0,240.0,243.0,288.0,2827.0
Tinsukia,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Tinsukia,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,3.0,2.0,3.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Tinsukia,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,216.0,191.0,236.0,243.0,215.0,272.0,257.0,224.0,165.0,146.0,192.0,287.0,2644.0
Tinsukia,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1225.0,1450.0,1664.0,2141.0,1391.0,2063.0,1455.0,1748.0,1647.0,1306.0,1065.0,1318.0,18473.0
Tinsukia,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,205.0,199.0,229.0,225.0,200.0,226.0,191.0,207.0,153.0,145.0,194.0,261.0,2435.0
Tinsukia,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2034.0,2421.0,2398.0,1980.0,2706.0,4055.0,2377.0,2238.0,2065.0,2023.0,1527.0,1840.0,27664.0
Tinsukia,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,421.0,390.0,465.0,468.0,415.0,498.0,448.0,431.0,318.0,291.0,386.0,548.0,5079.0
Tinsukia,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3259.0,3871.0,4062.0,4121.0,4097.0,6118.0,3832.0,3986.0,3712.0,3329.0,2592.0,3158.0,46137.0
Tinsukia,14.10.2.a,Number of death cases of Inpatient males,TOTAL,10.0,16.0,9.0,23.0,17.0,6.0,10.0,13.0,14.0,11.0,18.0,15.0,162.0
Tinsukia,14.10.2.b,Number of death cases of Inpatient females,TOTAL,8.0,15.0,9.0,12.0,9.0,12.0,14.0,10.0,8.0,8.0,6.0,15.0,126.0
Tinsukia,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,18.0,31.0,18.0,35.0,26.0,18.0,24.0,23.0,22.0,19.0,24.0,30.0,288.0
Tinsukia,14.11,In-Patient Head Count at midnight,TOTAL,91.0,3838.0,3998.0,193.0,153.0,4134.0,3311.0,102.0,106.0,108.0,106.0,120.0,16260.0
Tinsukia,14.12.1,OPD attendance (All),TOTAL,115222.0,126060.0,154921.0,165625.0,139270.0,142308.0,127956.0,122857.0,100035.0,92042.0,89239.0,119092.0,1494627.0
Tinsukia,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,197.0,311.0,312.0,454.0,413.0,399.0,303.0,294.0,299.0,314.0,230.0,242.0,3768.0
Tinsukia,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,60.0,15.0,19.0,13.0,15.0,14.0,15.0,5.0,5.0,14.0,22.0,197.0
Tinsukia,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,211.0,194.0,183.0,57.0,31.0,110.0,140.0,114.0,107.0,117.0,60.0,64.0,1388.0
Tinsukia,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,212.0,308.0,64.0,268.0,175.0,0.0,251.0,202.0,235.0,0.0,384.0,2099.0
Tinsukia,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,382.0,473.0,521.0,462.0,421.0,259.0,376.0,483.0,458.0,437.0,373.0,475.0,5120.0
Tinsukia,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,181.0,0.0,0.0,0.0,0.0,205.0,235.0,341.0,317.0,264.0,1543.0
Tinsukia,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4959.0,6750.0,6918.0,7353.0,6107.0,5550.0,5056.0,5263.0,5235.0,4706.0,4992.0,5373.0,68262.0
Tinsukia,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,278.0,401.0,305.0,348.0,205.0,206.0,156.0,225.0,140.0,141.0,250.0,240.0,2895.0
Tinsukia,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,170.0,306.0,51.0,39.0,63.0,130.0,76.0,91.0,98.0,162.0,178.0,124.0,1488.0
Tinsukia,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,4.0
Tinsukia,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,77.0,94.0,39.0,31.0,43.0,93.0,48.0,39.0,88.0,125.0,160.0,204.0,1041.0
Tinsukia,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,4.0
Tinsukia,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,499.0,651.0,361.0,334.0,515.0,912.0,707.0,812.0,548.0,526.0,701.0,912.0,7478.0
Tinsukia,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Tinsukia,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,746.0,1051.0,451.0,404.0,621.0,1135.0,831.0,942.0,734.0,813.0,1039.0,1240.0,10007.0
Tinsukia,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,2.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,5.0,11.0
Tinsukia,15.2,Number of Widal tests conducted,Number tested,108.0,133.0,129.0,133.0,39.0,53.0,43.0,25.0,31.0,16.0,28.0,22.0,760.0
Tinsukia,15.3.a,Number of VDRL tests conducted on males,Number tested,98.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0,123.0
Tinsukia,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,90.0,0.0,0.0,0.0,16.0,25.0,0.0,3.0,0.0,0.0,0.0,209.0,343.0
Tinsukia,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,320.0,158.0,131.0,37.0,139.0,57.0,78.0,86.0,82.0,129.0,76.0,82.0,1375.0
Tinsukia,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,508.0,158.0,131.0,37.0,155.0,82.0,78.0,89.0,82.0,129.0,76.0,316.0,1841.0
Tinsukia,15.4.1,Number of blood smears examined for Malaria,TOTAL,2221.0,6555.0,7734.0,11530.0,8017.0,8001.0,5820.0,6004.0,4557.0,3468.0,3944.0,4906.0,72757.0
Tinsukia,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,4.0,7.0,11.0,19.0,17.0,18.0,17.0,11.0,6.0,0.0,214.0,199.0,523.0
Tinsukia,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,6.0,3.0,3.0,11.0,4.0,2.0,8.0,3.0,6.0,0.0,0.0,0.0,46.0
Tinsukia,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1424.0,302.0,731.0,1856.0,2465.0,3623.0,2298.0,4474.0,4153.0,5142.0,4315.0,3330.0,34113.0
Tinsukia,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,1600.0,3000.0,1600.0,2000.0,0.0,4000.0,0.0,2000.0,0.0,0.0,3000.0,17200.0
Tinsukia,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1122.0,1171.0,1875.0,991.0,842.0,1325.0,1824.0,321.0,1011.0,827.0,985.0,1052.0,13346.0
Tinsukia,16.1.1,Stock position of DPT vaccines,5. Total Stock,302.0,731.0,1856.0,2465.0,3623.0,2298.0,4474.0,4153.0,5142.0,4315.0,3330.0,5278.0,37967.0
Tinsukia,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,70.0,70.0
Tinsukia,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,900.0,2100.0
Tinsukia,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1130.0,350.0,1480.0
Tinsukia,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,70.0,620.0,690.0
Tinsukia,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,372.0,80.0,144.0,75.0,0.0,1150.0,0.0,79.0,0.0,30.0,225.0,0.0,2155.0
Tinsukia,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,550.0,1100.0,0.0,1200.0,0.0,600.0,0.0,600.0,11270.0,0.0,2408.0,17728.0
Tinsukia,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,282.0,486.0,1169.0,75.0,50.0,1150.0,521.0,79.0,570.0,11075.0,225.0,733.0,16415.0
Tinsukia,16.1.2,Stock position of OPV vaccines,5. Total Stock,90.0,144.0,75.0,0.0,1150.0,0.0,79.0,0.0,30.0,225.0,0.0,1675.0,3468.0
Tinsukia,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2306.0,1453.0,2600.0,507.0,1398.0,2428.0,1190.0,2207.0,1887.0,1182.0,570.0,0.0,17728.0
Tinsukia,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,1000.0,400.0,2000.0,2000.0,0.0,2250.0,0.0,0.0,0.0,0.0,2000.0,9650.0
Tinsukia,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.1.3,Stock position of TT vaccines,4. Stock Distributed,853.0,873.0,2493.0,1109.0,970.0,1338.0,1233.0,320.0,705.0,612.0,570.0,1195.0,12271.0
Tinsukia,16.1.3,Stock position of TT vaccines,5. Total Stock,1453.0,1580.0,507.0,1398.0,2428.0,1090.0,2207.0,1887.0,1182.0,570.0,0.0,805.0,15107.0
Tinsukia,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,311.0,0.0,459.0,0.0,215.0,1300.0,243.0,0.0,319.0,0.0,0.0,0.0,2847.0
Tinsukia,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,1100.0,0.0,1100.0,1300.0,0.0,0.0,1000.0,150.0,0.0,0.0,0.0,4650.0
Tinsukia,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,311.0,641.0,459.0,885.0,215.0,1057.0,243.0,681.0,469.0,0.0,0.0,0.0,4961.0
Tinsukia,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,459.0,0.0,215.0,1300.0,243.0,0.0,319.0,0.0,0.0,0.0,0.0,2536.0
Tinsukia,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1367.0,579.0,1948.0,2328.0,1462.0,360.0,0.0,201.0,0.0,770.0,0.0,0.0,9015.0
Tinsukia,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,2000.0,2000.0,0.0,0.0,0.0,1000.0,0.0,2000.0,0.0,0.0,4000.0,11000.0
Tinsukia,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,788.0,631.0,1620.0,905.0,1102.0,360.0,799.0,201.0,1230.0,770.0,0.0,1911.0,10317.0
Tinsukia,16.1.6,Stock position of Measles vaccines,5. Total Stock,579.0,1948.0,2328.0,1423.0,360.0,0.0,201.0,0.0,770.0,0.0,0.0,2089.0,9698.0
Tinsukia,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,560.0,7265.0,8651.0,7088.0,3150.0,0.0,0.0,0.0,482.0,302.0,0.0,0.0,27498.0
Tinsukia,16.1.7,Stock position of JE vaccines,2. Stocks Received,7700.0,2000.0,0.0,2000.0,1080.0,0.0,0.0,2000.0,1000.0,0.0,0.0,2000.0,17780.0
Tinsukia,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.1.7,Stock position of JE vaccines,4. Stock Distributed,683.0,614.0,1563.0,5938.0,4230.0,0.0,0.0,1518.0,1180.0,302.0,0.0,1910.0,17938.0
Tinsukia,16.1.7,Stock position of JE vaccines,5. Total Stock,7577.0,8651.0,7088.0,3150.0,0.0,0.0,0.0,482.0,302.0,0.0,0.0,90.0,27340.0
Tinsukia,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1998.0,780.0,762.0,0.0,254.0,2000.0,271.0,1198.0,648.0,1233.0,567.0,0.0,9711.0
Tinsukia,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,1100.0,0.0,1100.0,2000.0,0.0,2250.0,0.0,1500.0,0.0,0.0,2000.0,9950.0
Tinsukia,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1218.0,1118.0,762.0,846.0,254.0,1729.0,1323.0,550.0,915.0,666.0,567.0,1325.0,11273.0
Tinsukia,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,780.0,762.0,0.0,254.0,2000.0,271.0,1198.0,648.0,1233.0,567.0,0.0,675.0,8388.0
Tinsukia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,350.0,100.0,0.0,0.0,1250.0,1200.0,1000.0,800.0,700.0,500.0,400.0,0.0,6300.0
Tinsukia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,300.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3300.0
Tinsukia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,250.0,100.0,300.0,1750.0,50.0,200.0,200.0,100.0,200.0,100.0,400.0,0.0,3650.0
Tinsukia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,100.0,0.0,0.0,1250.0,1200.0,1000.0,800.0,700.0,500.0,400.0,0.0,0.0,5950.0
Tinsukia,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,35082.0,27942.0,12822.0,7782.0,17442.0,1902.0,1902.0,222.0,222.0,222.0,50400.0,34980.0,190920.0
Tinsukia,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,10080.0,0.0,0.0,0.0,0.0,0.0,50400.0,0.0,0.0,60480.0
Tinsukia,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,7140.0,15120.0,5040.0,420.0,15540.0,0.0,1680.0,0.0,0.0,222.0,15420.0,15120.0,75702.0
Tinsukia,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,27942.0,12822.0,7782.0,17442.0,1902.0,1902.0,222.0,222.0,222.0,50400.0,34980.0,19860.0,175698.0
Tinsukia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,66277.0,59677.0,49477.0,41877.0,54077.0,34877.0,32477.0,28277.0,28777.0,28277.0,26477.0,22277.0,472824.0
Tinsukia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,14000.0,0.0,0.0,0.0,0.0,0.0,9600.0,0.0,0.0,23600.0
Tinsukia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,6600.0,10200.0,7600.0,1800.0,19200.0,2400.0,4200.0,0.0,0.0,11400.0,4200.0,7800.0,75400.0
Tinsukia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,59677.0,49477.0,41877.0,54077.0,34877.0,32477.0,28277.0,28277.0,28777.0,26477.0,22277.0,14477.0,421024.0
Tinsukia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,400.0,300.0,100.0,100.0,6000.0,2400.0,2400.0,2400.0,2400.0,1800.0,22300.0,19300.0,59900.0
Tinsukia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,0.0,22000.0,0.0,0.0,28000.0
Tinsukia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,100.0,200.0,0.0,100.0,3600.0,0.0,0.0,0.0,600.0,1500.0,3000.0,5000.0,14100.0
Tinsukia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,300.0,100.0,100.0,6000.0,2400.0,2400.0,2400.0,2400.0,1800.0,22300.0,19300.0,14300.0,73800.0
Tinsukia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,200.0,200.0,100.0,100.0,1700.0,1500.0,1500.0,1500.0,1500.0,1000.0,5750.0,5750.0,20800.0
Tinsukia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,4750.0,0.0,0.0,7750.0
Tinsukia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,100.0,0.0,1100.0,200.0,0.0,0.0,0.0,500.0,0.0,0.0,0.0,1900.0
Tinsukia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,200.0,100.0,100.0,2000.0,1500.0,1500.0,1500.0,1500.0,1000.0,5750.0,5750.0,5750.0,26650.0
Tinsukia,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1772.0,1772.0
Tinsukia,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2160.0,2160.0,4320.0
Tinsukia,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,388.0,3360.0,3748.0
Tinsukia,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1772.0,572.0,2344.0
Tinsukia,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,200.0,200.0,0.0,1300.0,1040.0,140.0,140.0,1600.0,1850.0,2600.0,800.0,300.0,10170.0
Tinsukia,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,2000.0,2000.0,0.0,0.0,2000.0,2000.0,2000.0,0.0,0.0,1000.0,11000.0
Tinsukia,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.02,Stock Position of Gloves,4. Stock Distributed,200.0,200.0,700.0,2260.0,900.0,0.0,540.0,1750.0,1250.0,1800.0,500.0,950.0,11050.0
Tinsukia,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,1300.0,1040.0,140.0,140.0,1600.0,1850.0,2600.0,800.0,300.0,350.0,10120.0
Tinsukia,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,5000.0
Tinsukia,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3500.0,3500.0
Tinsukia,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0,1500.0
Tinsukia,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,6061030.0,7587530.0,2111358.0,1972858.0,1486658.0,1070158.0,667158.0,327158.0,61158.0,0.0,0.0,0.0,21345066.0
Tinsukia,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,1606500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1606500.0
Tinsukia,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,80000.0,5476172.0,138500.0,486200.0,416500.0,403000.0,340000.0,266000.0,61158.0,0.0,0.0,0.0,7667530.0
Tinsukia,16.3.07,Stock Position of IFA Tablets,5. Total Stock,7587530.0,2111358.0,1972858.0,1486658.0,1070158.0,667158.0,327158.0,61158.0,0.0,0.0,0.0,0.0,15284036.0
Tinsukia,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,38700.0,36700.0,23400.0,23400.0,15700.0,8050.0,4850.0,2350.0,0.0,0.0,0.0,3100.0,156250.0
Tinsukia,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10200.0,0.0,10200.0
Tinsukia,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,2000.0,13300.0,0.0,7700.0,7650.0,3200.0,2500.0,2350.0,0.0,0.0,7100.0,1500.0,47300.0
Tinsukia,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,36700.0,23400.0,23400.0,15700.0,8050.0,4850.0,2350.0,0.0,0.0,0.0,3100.0,1600.0,119150.0
Tinsukia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,150.0,0.0,100.0,100.0,50.0,0.0,0.0,0.0,10.0,3.0,0.0,0.0,413.0
Tinsukia,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,100.0
Tinsukia,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,150.0,0.0,0.0,50.0,50.0,0.0,0.0,90.0,7.0,3.0,0.0,0.0,350.0
Tinsukia,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,100.0,50.0,0.0,0.0,0.0,10.0,3.0,0.0,0.0,0.0,163.0
Tinsukia,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,2340.0,0.0,1300.0,2100.0,1000.0,0.0,0.0,0.0,47700.0,29500.0,18730.0,2630.0,105300.0
Tinsukia,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,2400.0,2000.0,5000.0,2000.0,0.0,0.0,58800.0,0.0,0.0,0.0,0.0,70200.0
Tinsukia,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,2340.0,1100.0,1200.0,6100.0,3000.0,0.0,0.0,11100.0,18200.0,10770.0,16100.0,2630.0,72540.0
Tinsukia,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,1300.0,2100.0,1000.0,0.0,0.0,0.0,47700.0,29500.0,18730.0,2630.0,0.0,102960.0
Tinsukia,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2030.0,630.0,0.0,10300.0,7100.0,11500.0,8100.0,6300.0,9300.0,10500.0,9700.0,9200.0,84660.0
Tinsukia,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,13200.0,0.0,6600.0,0.0,0.0,6600.0,3300.0,0.0,0.0,4000.0,33700.0
Tinsukia,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1400.0,630.0,2900.0,3200.0,2200.0,3400.0,1800.0,3600.0,2100.0,800.0,500.0,500.0,23030.0
Tinsukia,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,630.0,0.0,10300.0,7100.0,11500.0,8100.0,6300.0,9300.0,10500.0,9700.0,9200.0,12700.0,95330.0
Tinsukia,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,73000.0,53200.0,36200.0,36200.0,44400.0,67500.0,52100.0,66900.0,50500.0,214900.0,191500.0,163300.0,1049700.0
Tinsukia,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,19200.0,24000.0,48000.0,0.0,36000.0,0.0,189600.0,0.0,0.0,14400.0,331200.0
Tinsukia,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,19800.0,17000.0,19200.0,15800.0,24900.0,15400.0,21200.0,16400.0,25200.0,23400.0,28200.0,43200.0,269700.0
Tinsukia,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,53200.0,36200.0,36200.0,44400.0,67500.0,52100.0,66900.0,50500.0,214900.0,191500.0,163300.0,134500.0,1111200.0
Tinsukia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3300.0,2700.0,3000.0,4300.0,4100.0,5900.0,2900.0,2000.0,200.0,60600.0,58500.0,57900.0,205400.0
Tinsukia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,2000.0,4000.0,2000.0,4000.0,0.0,0.0,0.0,62000.0,0.0,0.0,4000.0,78000.0
Tinsukia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tinsukia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,600.0,1700.0,2700.0,2200.0,2200.0,3000.0,900.0,1800.0,1600.0,2100.0,600.0,8200.0,27600.0
Tinsukia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2700.0,3000.0,4300.0,4100.0,5900.0,2900.0,2000.0,200.0,60600.0,58500.0,57900.0,53700.0,255800.0
Tinsukia,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,1.0,1.0,1.0,,4.0,1.0,,1.0,,,10.0
Tinsukia,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Tinsukia,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tinsukia,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Tinsukia,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,1.0,,1.0,1.0,1.0,1.0,5.0
Tinsukia,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tinsukia,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,1.0,,1.0,1.0,1.0,1.0,5.0
Tinsukia,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,1.0,,1.0,1.0,2.0,2.0,1.0,2.0,3.0,4.0,17.0
Tinsukia,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tinsukia,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,1.0,,1.0,1.0,2.0,2.0,1.0,2.0,3.0,4.0,17.0
Tinsukia,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,4.0,6.0,6.0,7.0,2.0,7.0,6.0,3.0,4.0,3.0,50.0
Tinsukia,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tinsukia,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,1.0,4.0,6.0,6.0,7.0,2.0,7.0,6.0,3.0,4.0,3.0,50.0
Tinsukia,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,2.0,1.0,,,1.0,3.0,,,1.0,,,10.0
Tinsukia,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,1.0,,,,1.0,,2.0
Tinsukia,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,2.0,2.0,1.0,,,1.0,4.0,,,1.0,1.0,,12.0
Tinsukia,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,1.0,1.0,,,1.0,3.0
Tinsukia,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tinsukia,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,1.0,1.0,,,1.0,3.0
Tinsukia,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,1.0,1.0,,,1.0,,1.0,1.0,1.0,1.0,,8.0
Tinsukia,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,,,,,,,,,1.0
Tinsukia,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,1.0,1.0,,1.0,,1.0,1.0,1.0,1.0,,9.0
Tinsukia,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tinsukia,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tinsukia,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Tinsukia,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,2.0,1.0,1.0,3.0,4.0,4.0,4.0,4.0,4.0,3.0,3.0,36.0
Tinsukia,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,3.0,3.0,2.0,1.0,1.0,4.0,1.0,,,1.0,17.0
Tinsukia,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,2.0,4.0,4.0,5.0,5.0,5.0,8.0,5.0,4.0,3.0,4.0,53.0
Tinsukia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Tinsukia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,2.0,,,,,,,,2.0
Tinsukia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,2.0,,3.0,,,,,,5.0
Tinsukia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,4.0,,3.0,,,,,,8.0
Tinsukia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,1.0,,,,,,,,,1.0,2.0
Tinsukia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,7.0,8.0,7.0,9.0,7.0,5.0,3.0,6.0,7.0,3.0,4.0,4.0,70.0
Tinsukia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,3.0,1.0,1.0,1.0,1.0,2.0,3.0,1.0,,1.0,16.0
Tinsukia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,8.0,9.0,11.0,10.0,8.0,6.0,4.0,8.0,10.0,4.0,4.0,6.0,88.0
Tinsukia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,2.0,,,,,1.0,,,,3.0
Tinsukia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,10.0,6.0,6.0,8.0,7.0,6.0,11.0,9.0,8.0,2.0,2.0,7.0,82.0
Tinsukia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,,4.0,3.0,2.0,2.0,4.0,3.0,9.0,6.0,9.0,5.0,49.0
Tinsukia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,12.0,6.0,10.0,13.0,9.0,8.0,15.0,12.0,18.0,8.0,11.0,12.0,134.0
Tinsukia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Tinsukia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Tinsukia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Tinsukia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,1.0,,,1.0,2.0
Tinsukia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,,,,,,,,1.0,1.0,,3.0
Tinsukia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,4.0,2.0,2.0,6.0,4.0,2.0,,2.0,1.0,,3.0,2.0,28.0
Tinsukia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,2.0,1.0,1.0,1.0,,,2.0,1.0,,2.0,10.0
Tinsukia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,5.0,2.0,4.0,7.0,5.0,3.0,,2.0,3.0,2.0,4.0,4.0,41.0
Tinsukia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Tinsukia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Tinsukia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Tinsukia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,1.0,,,,,,,,,1.0
Tinsukia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,1.0,,,,,1.0,,1.0,,,,4.0
Tinsukia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,10.0,18.0,12.0,11.0,4.0,7.0,10.0,13.0,19.0,8.0,16.0,13.0,141.0
Tinsukia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,16.0,13.0,21.0,12.0,15.0,12.0,14.0,15.0,18.0,11.0,15.0,21.0,183.0
Tinsukia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,27.0,32.0,33.0,23.0,19.0,19.0,25.0,28.0,38.0,19.0,31.0,34.0,328.0
Tinsukia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Tinsukia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,5.0,8.0,4.0,1.0,2.0,,2.0,4.0,2.0,4.0,1.0,,33.0
Tinsukia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,4.0,5.0,3.0,4.0,1.0,1.0,2.0,5.0,2.0,4.0,,5.0,36.0
Tinsukia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,9.0,13.0,7.0,5.0,3.0,1.0,4.0,9.0,4.0,8.0,1.0,5.0,69.0
Tinsukia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Tinsukia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Tinsukia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Tinsukia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Tinsukia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Tinsukia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Tinsukia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Tinsukia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,1.0,,,,,,,,,,1.0
Tinsukia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Tinsukia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,,,,,1.0,,,,,,2.0
Tinsukia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Tinsukia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,,,,,1.0,,,,,,2.0
Tinsukia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Tinsukia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,1.0,1.0,,,1.0,,,,4.0
Tinsukia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Tinsukia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,1.0,1.0,,,1.0,,,,4.0
Tinsukia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Tinsukia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Tinsukia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Tinsukia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Tinsukia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Tinsukia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,3.0,5.0,2.0,2.0,3.0,3.0,4.0,4.0,3.0,2.0,3.0,3.0,37.0
Tinsukia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Tinsukia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,3.0,5.0,2.0,2.0,3.0,3.0,4.0,4.0,3.0,2.0,3.0,3.0,37.0
Tinsukia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,3.0,1.0,1.0,1.0,3.0,,,,,11.0
Tinsukia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,4.0,4.0,6.0,3.0,1.0,6.0,10.0,4.0,6.0,10.0,3.0,8.0,65.0
Tinsukia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,1.0,2.0,,1.0,,2.0,2.0,1.0,1.0,1.0,1.0,13.0
Tinsukia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,5.0,6.0,9.0,6.0,3.0,7.0,13.0,9.0,7.0,11.0,4.0,9.0,89.0
Tinsukia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,1.0,,1.0,,,,2.0
Tinsukia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,4.0,6.0,7.0,8.0,8.0,1.0,3.0,6.0,4.0,7.0,10.0,68.0
Tinsukia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,2.0,3.0,,,,2.0,1.0,,,1.0,1.0,,10.0
Tinsukia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,6.0,7.0,6.0,7.0,8.0,10.0,3.0,3.0,7.0,5.0,8.0,10.0,80.0
Tinsukia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,,,,,1.0,,,,,,2.0
Tinsukia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,1.0,1.0,1.0,,,,,,3.0
Tinsukia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Tinsukia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,,,1.0,1.0,2.0,,,,,,5.0
Tinsukia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Tinsukia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,6.0,6.0,6.0,6.0,8.0,6.0,2.0,5.0,7.0,2.0,4.0,2.0,60.0
Tinsukia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,8.0,3.0,3.0,4.0,3.0,2.0,3.0,4.0,4.0,7.0,4.0,46.0
Tinsukia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,8.0,14.0,9.0,9.0,12.0,9.0,4.0,8.0,11.0,6.0,11.0,6.0,107.0
Tinsukia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,2.0,,1.0,,,,1.0,,,,5.0
Tinsukia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,5.0,9.0,8.0,16.0,17.0,9.0,19.0,9.0,12.0,12.0,11.0,11.0,138.0
Tinsukia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,9.0,8.0,6.0,17.0,13.0,10.0,7.0,11.0,19.0,14.0,12.0,11.0,137.0
Tinsukia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,14.0,18.0,16.0,33.0,31.0,19.0,26.0,20.0,32.0,26.0,23.0,22.0,280.0
Tinsukia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,3.0,3.0,1.0,2.0,3.0,4.0,5.0,1.0,2.0,2.0,3.0,30.0
Tinsukia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,27.0,47.0,46.0,38.0,49.0,28.0,52.0,39.0,32.0,39.0,33.0,43.0,473.0
Tinsukia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,40.0,38.0,27.0,49.0,41.0,40.0,46.0,41.0,47.0,45.0,25.0,48.0,487.0
Tinsukia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,68.0,88.0,76.0,88.0,92.0,71.0,102.0,85.0,80.0,86.0,60.0,94.0,990.0
Udalguri,1.1,Total number of pregnant women Registered for ANC,TOTAL,1486.0,1607.0,1349.0,1382.0,1420.0,1248.0,1270.0,1160.0,1036.0,1466.0,1277.0,1528.0,16229.0
Udalguri,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1254.0,1342.0,1152.0,1193.0,1212.0,1041.0,988.0,934.0,899.0,1263.0,1105.0,1309.0,13692.0
Udalguri,1.2,Number of Pregnant women registered under JSY,TOTAL,1331.0,1575.0,1335.0,1365.0,1418.0,1233.0,1261.0,1155.0,1036.0,1461.0,1264.0,1525.0,15959.0
Udalguri,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,917.0,907.0,1088.0,1089.0,1098.0,1349.0,1289.0,1270.0,1141.0,1150.0,970.0,1171.0,13439.0
Udalguri,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1155.0,1403.0,1211.0,1189.0,1316.0,1242.0,1220.0,1081.0,899.0,1193.0,1034.0,1168.0,14111.0
Udalguri,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1067.0,1268.0,1371.0,1217.0,1288.0,1363.0,1356.0,1219.0,1068.0,1058.0,1015.0,1193.0,14483.0
Udalguri,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1068.0,1201.0,1165.0,1168.0,1408.0,1218.0,1286.0,1111.0,995.0,1224.0,978.0,1205.0,14027.0
Udalguri,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,66.0,56.0,31.0,57.0,48.0,47.0,38.0,33.0,35.0,60.0,15.0,30.0,516.0
Udalguri,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,7.0,12.0,5.0,7.0,4.0,2.0,42.0
Udalguri,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,796.0,1013.0,776.0,749.0,884.0,1045.0,867.0,864.0,756.0,860.0,886.0,963.0,10459.0
Udalguri,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,2.0,1.0,0.0,0.0,2.0,0.0,4.0,4.0,1.0,0.0,1.0,15.0
Udalguri,1.8,Number of pregnancy test kits used at SC level,TOTAL,231.0,201.0,262.0,366.0,197.0,240.0,234.0,273.0,236.0,266.0,315.0,277.0,3098.0
Udalguri,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,3.0,3.0,4.0,2.0,5.0,6.0,11.0,19.0,10.0,11.0,7.0,3.0,84.0
Udalguri,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,78.0,77.0,71.0,86.0,80.0,93.0,87.0,78.0,86.0,81.0,74.0,70.0,961.0
Udalguri,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,81.0,80.0,75.0,88.0,85.0,99.0,98.0,97.0,96.0,92.0,81.0,73.0,1045.0
Udalguri,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,34.0,58.0,43.0,47.0,48.0,87.0,86.0,95.0,76.0,89.0,74.0,63.0,800.0
Udalguri,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,702.0,631.0,585.0,727.0,781.0,842.0,887.0,890.0,911.0,820.0,711.0,611.0,9098.0
Udalguri,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,406.0,372.0,332.0,426.0,490.0,443.0,540.0,549.0,489.0,418.0,357.0,385.0,5207.0
Udalguri,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,577.0,738.0,587.0,673.0,834.0,721.0,971.0,916.0,901.0,852.0,700.0,659.0,9129.0
Udalguri,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,186.0,732.0,521.0,686.0,834.0,1265.0,757.0,790.0,858.0,968.0,543.0,2099.0,10239.0
Udalguri,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Udalguri,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,82.0,65.0,87.0,98.0,124.0,130.0,133.0,120.0,127.0,106.0,109.0,91.0,1272.0
Udalguri,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,22.0,71.0,86.0,86.0,70.0,97.0,106.0,122.0,103.0,92.0,196.0,82.0,1133.0
Udalguri,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,21.0,20.0,3.0,70.0,91.0,0.0,33.0,69.0,70.0,62.0,148.0,587.0
Udalguri,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Udalguri,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Udalguri,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Udalguri,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udalguri,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Udalguri,4.1.1.a,Number of male live births,TOTAL,456.0,405.0,382.0,477.0,509.0,502.0,561.0,540.0,605.0,534.0,439.0,397.0,5807.0
Udalguri,4.1.1.b,Number of female live births,TOTAL,399.0,359.0,353.0,419.0,471.0,557.0,537.0,558.0,518.0,480.0,453.0,369.0,5473.0
Udalguri,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,855.0,764.0,735.0,896.0,980.0,1059.0,1098.0,1098.0,1123.0,1014.0,892.0,766.0,11280.0
Udalguri,4.1.2,Number of still births,TOTAL,15.0,13.0,16.0,23.0,14.0,15.0,25.0,15.0,14.0,10.0,9.0,16.0,185.0
Udalguri,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,220.0,276.0,138.0,220.0,192.0,184.0,211.0,197.0,231.0,212.0,214.0,196.0,2491.0
Udalguri,4.2.1,Number of Newborns weighed at birth,TOTAL,815.0,734.0,723.0,874.0,964.0,1040.0,1084.0,1090.0,1105.0,992.0,872.0,756.0,11049.0
Udalguri,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,152.0,141.0,153.0,227.0,234.0,234.0,198.0,235.0,168.0,197.0,161.0,134.0,2234.0
Udalguri,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,814.0,727.0,717.0,848.0,922.0,1015.0,1026.0,1041.0,1092.0,934.0,847.0,753.0,10736.0
Udalguri,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,24.0,4.0,7.0,9.0,14.0,12.0,6.0,17.0,9.0,11.0,8.0,27.0,148.0
Udalguri,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,10.0,0.0,0.0,0.0,21.0,24.0,31.0,17.0,17.0,15.0,135.0
Udalguri,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,31.0,28.0,1.0,27.0,18.0,20.0,0.0,0.0,17.0,14.0,6.0,5.0,167.0
Udalguri,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udalguri,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,55.0,32.0,18.0,36.0,32.0,32.0,27.0,41.0,57.0,42.0,31.0,47.0,450.0
Udalguri,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Udalguri,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1.0,7.0,1.0,3.0,4.0,3.0,3.0,6.0,2.0,3.0,6.0,22.0,61.0
Udalguri,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,1.0,0.0,1.0,0.0,4.0,0.0,0.0,1.0,3.0,1.0,0.0,13.0
Udalguri,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,20.0,5.0,0.0,1.0,0.0,1.0,2.0,0.0,0.0,3.0,2.0,25.0,59.0
Udalguri,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,721.0,583.0,674.0,516.0,732.0,599.0,934.0,784.0,751.0,670.0,702.0,678.0,8344.0
Udalguri,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,423.0,348.0,491.0,373.0,525.0,522.0,597.0,535.0,502.0,544.0,487.0,576.0,5923.0
Udalguri,6.3,PNC maternal complications attended,TOTAL,5.0,6.0,10.0,10.0,19.0,17.0,18.0,18.0,12.0,12.0,10.0,6.0,143.0
Udalguri,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,147.0,192.0,137.0,167.0,133.0,130.0,142.0,148.0,117.0,157.0,163.0,160.0,1793.0
Udalguri,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,19.0,23.0,25.0,26.0,24.0,0.0,120.0
Udalguri,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,147.0,192.0,137.0,167.0,133.0,133.0,161.0,171.0,142.0,183.0,187.0,160.0,1913.0
Udalguri,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,0.0,,,,,,,,0.0
Udalguri,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,49.0,3.0,35.0,2.0,38.0,35.0,31.0,31.0,30.0,29.0,37.0,48.0,368.0
Udalguri,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,87.0,85.0,95.0,4.0,66.0,65.0,55.0,77.0,41.0,58.0,73.0,90.0,796.0
Udalguri,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,136.0,88.0,130.0,6.0,104.0,100.0,86.0,108.0,71.0,87.0,110.0,138.0,1164.0
Udalguri,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,22.0,0.0,0.0,0.0,48.0,0.0,0.0,0.0,0.0,70.0
Udalguri,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Udalguri,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udalguri,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,22.0,0.0,0.0,0.0,48.0,0.0,0.0,0.0,0.0,70.0
Udalguri,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,30.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0
Udalguri,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Udalguri,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udalguri,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,30.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0
Udalguri,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Udalguri,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udalguri,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Udalguri,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udalguri,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,22.0,30.0,33.0,501.0,37.0,17.0,10.0,16.0,8.0,16.0,24.0,26.0,740.0
Udalguri,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,28.0,42.0,30.0,450.0,68.0,38.0,42.0,33.0,26.0,31.0,39.0,33.0,860.0
Udalguri,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,29.0,88.0,101.0,203.0,33.0,46.0,47.0,50.0,17.0,16.0,16.0,20.0,666.0
Udalguri,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,1.0,3.0,2.0,1.0,2.0,2.0,3.0,2.0,3.0,,3.0,3.0,25.0
Udalguri,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udalguri,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,80.0,163.0,166.0,1155.0,140.0,103.0,102.0,101.0,54.0,63.0,82.0,82.0,2291.0
Udalguri,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,11.0,0.0,59.0,6.0,5.0,4.0,0.0,0.0,0.0,0.0,0.0,85.0
Udalguri,9.06,Number of IUCD removals,TOTAL,11.0,34.0,32.0,40.0,32.0,28.0,64.0,38.0,17.0,19.0,24.0,41.0,380.0
Udalguri,9.07,Number of Oral Pills cycles distributed,TOTAL,2395.0,2317.0,2413.0,3548.0,2549.0,2980.0,2303.0,2714.0,2649.0,2565.0,2536.0,2388.0,31357.0
Udalguri,9.08,Number of Condom pieces distributed,TOTAL,2729.0,2918.0,3226.0,3851.0,2817.0,3054.0,2746.0,3455.0,3277.0,3011.0,2852.0,3347.0,37283.0
Udalguri,9.09,Number of Centchroman (weekly) pills given,TOTAL,4.0,0.0,26.0,98.0,74.0,0.0,16.0,11.0,11.0,14.0,5.0,5.0,264.0
Udalguri,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,15.0,27.0,18.0,39.0,17.0,20.0,53.0,20.0,1.0,13.0,9.0,233.0,465.0
Udalguri,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Udalguri,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Udalguri,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,789.0,918.0,851.0,884.0,1039.0,1069.0,823.0,1176.0,1110.0,1053.0,1187.0,1014.0,11913.0
Udalguri,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1079.0,1236.0,1016.0,965.0,1048.0,1059.0,1244.0,1479.0,1089.0,1503.0,1081.0,459.0,13258.0
Udalguri,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1155.0,1219.0,1127.0,1144.0,909.0,989.0,1150.0,1297.0,1310.0,1271.0,1256.0,1235.0,14062.0
Udalguri,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1214.0,1213.0,1089.0,1211.0,1074.0,934.0,1065.0,1078.0,1114.0,1330.0,1086.0,1441.0,13849.0
Udalguri,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,146.0,888.0,1036.0
Udalguri,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,131.0,131.0
Udalguri,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Udalguri,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,385.0,346.0,287.0,328.0,310.0,416.0,231.0,424.0,336.0,489.0,438.0,359.0,4349.0
Udalguri,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1040.0,1157.0,978.0,907.0,910.0,980.0,616.0,1457.0,628.0,1604.0,1297.0,1420.0,12994.0
Udalguri,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1133.0,1128.0,1086.0,1073.0,798.0,915.0,543.0,1185.0,748.0,1411.0,1451.0,1488.0,12959.0
Udalguri,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1198.0,1110.0,1046.0,1140.0,890.0,888.0,514.0,1025.0,665.0,1391.0,1187.0,1614.0,12668.0
Udalguri,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,285.0,223.0,247.0,233.0,294.0,386.0,332.0,370.0,413.0,426.0,367.0,309.0,3885.0
Udalguri,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1074.0,1246.0,1011.0,951.0,1056.0,1040.0,1252.0,1483.0,1101.0,1494.0,1123.0,532.0,13363.0
Udalguri,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1125.0,1241.0,1130.0,1128.0,951.0,987.0,1156.0,1296.0,1306.0,1246.0,1251.0,1240.0,14057.0
Udalguri,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1220.0,1212.0,1098.0,1231.0,1081.0,944.0,1079.0,1096.0,1105.0,1324.0,1079.0,1425.0,13894.0
Udalguri,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,719.0,1120.0,1119.0,1173.0,1242.0,1242.0,1356.0,1396.0,1108.0,1207.0,1016.0,1213.0,13911.0
Udalguri,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,839.0,1074.0,1060.0,1013.0,1187.0,991.0,947.0,1032.0,853.0,912.0,955.0,1127.0,11990.0
Udalguri,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,693.0,1066.0,1054.0,1132.0,763.0,231.0,698.0,1423.0,1079.0,1170.0,978.0,1141.0,11428.0
Udalguri,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,361.0,571.0,587.0,606.0,646.0,620.0,683.0,721.0,569.0,596.0,529.0,611.0,7100.0
Udalguri,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,349.0,537.0,527.0,548.0,588.0,620.0,647.0,662.0,535.0,603.0,486.0,597.0,6699.0
Udalguri,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,710.0,1108.0,1114.0,1154.0,1234.0,1240.0,1330.0,1383.0,1104.0,1199.0,1015.0,1208.0,13799.0
Udalguri,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,929.0,1136.0,1081.0,1082.0,1183.0,1041.0,955.0,1065.0,869.0,1003.0,984.0,1128.0,12456.0
Udalguri,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,923.0,1051.0,1025.0,1040.0,1013.0,961.0,466.0,1021.0,524.0,1074.0,1085.0,1178.0,11361.0
Udalguri,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,38.0,61.0,53.0,66.0,58.0,36.0,55.0,70.0,27.0,57.0,64.0,61.0,646.0
Udalguri,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,22.0,49.0,44.0,58.0,77.0,35.0,42.0,51.0,28.0,63.0,44.0,58.0,571.0
Udalguri,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,60.0,110.0,97.0,124.0,135.0,71.0,97.0,121.0,55.0,120.0,108.0,119.0,1217.0
Udalguri,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,468.0,495.0,434.0,562.0,776.0,539.0,502.0,529.0,573.0,628.0,615.0,517.0,6638.0
Udalguri,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,274.0,326.0,262.0,408.0,430.0,298.0,299.0,299.0,331.0,307.0,293.0,354.0,3881.0
Udalguri,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,194.0,212.0,234.0,300.0,269.0,271.0,242.0,223.0,235.0,223.0,216.0,238.0,2857.0
Udalguri,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,3.0,4.0,0.0,0.0,2.0,3.0,0.0,0.0,1.0,4.0,18.0
Udalguri,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,7.0,2.0,28.0,87.0,47.0,56.0,65.0,52.0,39.0,64.0,68.0,77.0,592.0
Udalguri,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,780.0,805.0,810.0,788.0,780.0,798.0,791.0,785.0,791.0,783.0,785.0,800.0,9496.0
Udalguri,10.4.2,Number of Immunisation sessions held during the month,TOTAL,751.0,779.0,780.0,768.0,743.0,761.0,755.0,760.0,745.0,751.0,731.0,784.0,9108.0
Udalguri,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,751.0,776.0,777.0,767.0,741.0,756.0,749.0,759.0,740.0,750.0,730.0,783.0,9079.0
Udalguri,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,832.0,1099.0,1103.0,1015.0,956.0,171.0,571.0,1076.0,805.0,972.0,946.0,1132.0,10678.0
Udalguri,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,660.0,963.0,896.0,999.0,1329.0,1209.0,1298.0,1312.0,1082.0,1084.0,945.0,1075.0,12852.0
Udalguri,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,161.0,176.0,185.0,275.0,2314.0,378.0,232.0,239.0,237.0,232.0,516.0,269.0,5214.0
Udalguri,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,253.0,258.0,215.0,265.0,2141.0,360.0,280.0,340.0,369.0,380.0,529.0,356.0,5746.0
Udalguri,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,11.0,7.0,26.0,23.0,21.0,30.0,11.0,3.0,3.0,12.0,11.0,12.0,170.0
Udalguri,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,309.0,199.0,311.0,346.0,356.0,216.0,282.0,156.0,89.0,115.0,157.0,157.0,2693.0
Udalguri,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,3.0,10.0,13.0,8.0,11.0,10.0,2.0,8.0,3.0,13.0,17.0,98.0
Udalguri,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,1.0,0.0,0.0,4.0,2.0,5.0,2.0,0.0,3.0,50.0,45.0,14.0,126.0
Udalguri,13.1,Number of Patients operated for cataract,TOTAL,69.0,100.0,24.0,54.0,25.0,29.0,14.0,17.0,47.0,66.0,71.0,46.0,562.0
Udalguri,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,69.0,73.0,13.0,10.0,24.0,10.0,14.0,17.0,47.0,41.0,71.0,48.0,437.0
Udalguri,13.3,Number of School children detected with Refractive errors,TOTAL,7.0,25.0,10.0,9.0,6.0,24.0,13.0,5.0,6.0,8.0,9.0,10.0,132.0
Udalguri,13.4,Number of children provided free glasses,TOTAL,0.0,12.0,36.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0,60.0,0.0,138.0
Udalguri,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,,,,,,,,,,,,-1.0
Udalguri,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,9.0,9.0,9.0,8.0,8.0,8.0,7.0,8.0,9.0,8.0,7.0,7.0,-1.0
Udalguri,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,659.0,718.0,698.0,746.0,709.0,715.0,709.0,729.0,700.0,678.0,682.0,730.0,-1.0
Udalguri,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,2.0,3.0,3.0,3.0,-1.0
Udalguri,14.05,Number of RKS meetings held during the month,TOTAL,12.0,11.0,9.0,13.0,19.0,15.0,11.0,12.0,10.0,10.0,7.0,12.0,141.0
Udalguri,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,34.0,34.0,32.0,30.0,27.0,31.0,32.0,31.0,32.0,30.0,32.0,33.0,-1.0
Udalguri,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,260.0,275.0,245.0,353.0,382.0,259.0,321.0,276.0,218.0,243.0,241.0,283.0,3356.0
Udalguri,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Udalguri,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Udalguri,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,72.0,88.0,166.0,145.0,129.0,78.0,66.0,71.0,37.0,26.0,72.0,108.0,1058.0
Udalguri,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,610.0,512.0,661.0,594.0,509.0,448.0,485.0,358.0,329.0,290.0,210.0,394.0,5400.0
Udalguri,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,89.0,108.0,192.0,153.0,166.0,111.0,81.0,81.0,60.0,38.0,50.0,68.0,1197.0
Udalguri,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,715.0,834.0,1081.0,1073.0,921.0,781.0,730.0,666.0,561.0,476.0,405.0,586.0,8829.0
Udalguri,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,161.0,196.0,358.0,298.0,295.0,189.0,147.0,152.0,97.0,64.0,122.0,176.0,2255.0
Udalguri,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1325.0,1346.0,1742.0,1667.0,1430.0,1229.0,1215.0,1024.0,890.0,766.0,615.0,980.0,14229.0
Udalguri,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,5.0,7.0,7.0,10.0,5.0,3.0,30.0,5.0,7.0,18.0,5.0,105.0
Udalguri,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5.0,3.0,4.0,2.0,3.0,3.0,1.0,64.0,4.0,3.0,51.0,4.0,147.0
Udalguri,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,8.0,8.0,11.0,9.0,13.0,8.0,4.0,94.0,9.0,10.0,69.0,9.0,252.0
Udalguri,14.11,In-Patient Head Count at midnight,TOTAL,949.0,976.0,815.0,895.0,849.0,780.0,646.0,594.0,646.0,494.0,525.0,656.0,8825.0
Udalguri,14.12.1,OPD attendance (All),TOTAL,76382.0,74906.0,90283.0,94382.0,82030.0,73586.0,59260.0,58811.0,53072.0,48738.0,49821.0,67428.0,828699.0
Udalguri,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,1.0,2.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,8.0
Udalguri,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,7.0,5.0,7.0,9.0,11.0,11.0,2.0,10.0,1.0,6.0,3.0,10.0,82.0
Udalguri,14.14.a,Number of patients given AYUSH treatment,TOTAL,1131.0,782.0,817.0,918.0,497.0,570.0,535.0,453.0,335.0,611.0,521.0,592.0,7762.0
Udalguri,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,71.0,105.0,158.0,0.0,64.0,137.0,84.0,83.0,99.0,68.0,121.0,126.0,1116.0
Udalguri,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,4.0,4.0,4.0,5.0,5.0,0.0,0.0,0.0,22.0
Udalguri,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1649.0,2318.0,2137.0,2089.0,2490.0,2281.0,2217.0,2238.0,2194.0,2078.0,2926.0,2566.0,27183.0
Udalguri,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,16.0,26.0,35.0,44.0,25.0,30.0,29.0,45.0,32.0,59.0,25.0,26.0,392.0
Udalguri,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,30.0,25.0,14.0,0.0,16.0,25.0,24.0,21.0,0.0,0.0,20.0,16.0,191.0
Udalguri,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,62.0,30.0,48.0,0.0,44.0,25.0,16.0,12.0,0.0,72.0,40.0,45.0,394.0
Udalguri,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,275.0,322.0,343.0,188.0,242.0,272.0,165.0,226.0,0.0,0.0,192.0,274.0,2499.0
Udalguri,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,367.0,377.0,405.0,188.0,302.0,322.0,205.0,259.0,0.0,72.0,252.0,335.0,3084.0
Udalguri,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,15.2,Number of Widal tests conducted,Number tested,313.0,370.0,769.0,648.0,485.0,188.0,325.0,249.0,162.0,134.0,113.0,244.0,4000.0
Udalguri,15.3.a,Number of VDRL tests conducted on males,Number tested,6.0,2.0,1.0,0.0,1.0,7.0,3.0,9.0,2.0,0.0,0.0,3.0,34.0
Udalguri,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,65.0,21.0,39.0,0.0,85.0,24.0,15.0,7.0,14.0,0.0,32.0,33.0,335.0
Udalguri,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,271.0,315.0,367.0,90.0,254.0,284.0,177.0,253.0,242.0,110.0,236.0,398.0,2997.0
Udalguri,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,342.0,338.0,407.0,90.0,340.0,315.0,195.0,269.0,258.0,110.0,268.0,434.0,3366.0
Udalguri,15.4.1,Number of blood smears examined for Malaria,TOTAL,2760.0,4688.0,7649.0,9285.0,5815.0,4115.0,3352.0,2614.0,2731.0,2555.0,3169.0,3711.0,52444.0
Udalguri,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,30.0,54.0,122.0,153.0,52.0,29.0,76.0,52.0,55.0,43.0,45.0,67.0,778.0
Udalguri,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,37.0,41.0,194.0,96.0,206.0,78.0,63.0,43.0,76.0,25.0,13.0,48.0,920.0
Udalguri,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,49700.0,47200.0,49200.0,51500.0,62500.0,53700.0,62200.0,55700.0,57200.0,56200.0,55200.0,52200.0,652500.0
Udalguri,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,10000.0,10000.0,20000.0,0.0,10000.0,0.0,8000.0,5000.0,0.0,5000.0,0.0,68000.0
Udalguri,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,,,,,0.0,,,,,,0.0
Udalguri,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2500.0,8000.0,7700.0,9000.0,8800.0,1500.0,6500.0,6500.0,6000.0,1000.0,8000.0,3800.0,69300.0
Udalguri,16.1.1,Stock position of DPT vaccines,5. Total Stock,47200.0,49200.0,51500.0,62500.0,53700.0,62200.0,55700.0,57200.0,56200.0,55200.0,52200.0,48400.0,651200.0
Udalguri,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,0.0,,,,,,,,,,2970.0,2970.0
Udalguri,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,0.0,,,,,,,,,9000.0,0.0,9000.0
Udalguri,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Udalguri,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,0.0,,,,,,,,,6030.0,1060.0,7090.0
Udalguri,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2970.0,1910.0,4880.0
Udalguri,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,36300.0,32300.0,27300.0,26800.0,26800.0,32300.0,0.0,0.0,500.0,2000.0,4000.0,11000.0,199300.0
Udalguri,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,16000.0,0.0,15000.0,0.0,0.0,9000.0,8000.0,147000.0,152000.0,0.0,347000.0
Udalguri,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,,,,,0.0,,,,,,0.0
Udalguri,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,4000.0,5000.0,16500.0,0.0,9500.0,32300.0,0.0,8500.0,6500.0,145000.0,145000.0,2250.0,374550.0
Udalguri,16.1.2,Stock position of OPV vaccines,5. Total Stock,32300.0,27300.0,26800.0,26800.0,32300.0,0.0,0.0,500.0,2000.0,4000.0,11000.0,8750.0,171750.0
Udalguri,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,51000.0,46500.0,49000.0,49500.0,55000.0,58000.0,66500.0,60000.0,53000.0,46500.0,45000.0,46000.0,626000.0
Udalguri,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,10000.0,10000.0,16000.0,10000.0,10000.0,0.0,5000.0,0.0,0.0,10000.0,0.0,71000.0
Udalguri,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,,,,,,,0.0,,,,0.0
Udalguri,16.1.3,Stock position of TT vaccines,4. Stock Distributed,4500.0,7500.0,9500.0,10500.0,7000.0,1500.0,6500.0,12000.0,6500.0,1500.0,9000.0,3700.0,79700.0
Udalguri,16.1.3,Stock position of TT vaccines,5. Total Stock,46500.0,49000.0,49500.0,55000.0,58000.0,66500.0,60000.0,53000.0,46500.0,45000.0,46000.0,42300.0,617300.0
Udalguri,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,,,,,,0.0,,,,,0.0
Udalguri,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,,,,,,0.0,,,,,0.0
Udalguri,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Udalguri,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,,,,,,0.0,,,,,0.0
Udalguri,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,10000.0,10000.0,2500.0,8500.0,2500.0,6000.0,4000.0,0.0,6450.0,6950.0,6950.0,4450.0,68300.0
Udalguri,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,8000.0,0.0,7500.0,0.0,0.0,6500.0,4000.0,0.0,6000.0,0.0,32000.0
Udalguri,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Udalguri,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,0.0,7500.0,2000.0,6000.0,4000.0,2000.0,4000.0,50.0,3500.0,0.0,8500.0,4450.0,42000.0
Udalguri,16.1.5,Stock position of BCG vaccines,5. Total Stock,10000.0,2500.0,8500.0,2500.0,6000.0,4000.0,0.0,6450.0,6950.0,6950.0,4450.0,0.0,58300.0
Udalguri,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,16750.0,13750.0,14750.0,14750.0,19250.0,18500.0,17000.0,13000.0,13000.0,20000.0,19500.0,18500.0,198750.0
Udalguri,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,5000.0,5000.0,10000.0,2500.0,0.0,0.0,5000.0,10000.0,0.0,5000.0,0.0,42500.0
Udalguri,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Udalguri,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3000.0,4000.0,5000.0,5500.0,3250.0,1500.0,4000.0,5000.0,3000.0,500.0,6000.0,2250.0,43000.0
Udalguri,16.1.6,Stock position of Measles vaccines,5. Total Stock,13750.0,14750.0,14750.0,19250.0,18500.0,17000.0,13000.0,13000.0,20000.0,19500.0,18500.0,16250.0,198250.0
Udalguri,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,23450.0,21100.0,17850.0,17850.0,23350.0,23900.0,28900.0,26650.0,24050.0,30800.0,30300.0,30300.0,298500.0
Udalguri,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,5000.0,26000.0,1250.0,5000.0,0.0,5000.0,10000.0,0.0,5000.0,0.0,57250.0
Udalguri,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Udalguri,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2350.0,3250.0,5000.0,20500.0,700.0,0.0,2250.0,7600.0,3250.0,500.0,5000.0,3000.0,53400.0
Udalguri,16.1.7,Stock position of JE vaccines,5. Total Stock,21100.0,17850.0,17850.0,23350.0,23900.0,28900.0,26650.0,24050.0,30800.0,30300.0,30300.0,27300.0,302350.0
Udalguri,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1400.0,7400.0,6400.0,5600.0,17600.0,19300.0,17800.0,12300.0,11700.0,5400.0,4400.0,3900.0,113200.0
Udalguri,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,16000.0,8000.0,3000.0,19000.0,7200.0,0.0,0.0,10000.0,0.0,0.0,5000.0,0.0,68200.0
Udalguri,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,,,,,,,0.0,,,,0.0
Udalguri,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,10000.0,9000.0,3800.0,7000.0,5500.0,1500.0,5500.0,10600.0,6300.0,1000.0,5500.0,3500.0,69200.0
Udalguri,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,7400.0,6400.0,5600.0,17600.0,19300.0,17800.0,12300.0,11700.0,5400.0,4400.0,3900.0,400.0,112200.0
Udalguri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,100.0,300.0,300.0,300.0,,0.0,0.0,0.0,1000.0
Udalguri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,1200.0,200.0,,0.0,0.0,,0.0,0.0,0.0,1400.0
Udalguri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Udalguri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,1100.0,0.0,,0.0,300.0,,0.0,0.0,0.0,1400.0
Udalguri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,100.0,300.0,300.0,300.0,0.0,0.0,0.0,0.0,0.0,1000.0
Udalguri,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,5760.0,5760.0,19620.0,19620.0,7380.0,18380.0,18380.0,18380.0,113280.0
Udalguri,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,10800.0,0.0,15120.0,0.0,0.0,11000.0,0.0,0.0,0.0,36920.0
Udalguri,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Udalguri,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,5040.0,0.0,1260.0,0.0,12240.0,0.0,0.0,0.0,0.0,18540.0
Udalguri,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,5760.0,5760.0,19620.0,19620.0,7380.0,18380.0,18380.0,18380.0,18380.0,131660.0
Udalguri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,11000.0,10000.0,9000.0,9000.0,4200.0,4200.0,4200.0,4200.0,55800.0
Udalguri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,17000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17000.0
Udalguri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Udalguri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,6000.0,1000.0,1000.0,0.0,4800.0,0.0,0.0,0.0,0.0,12800.0
Udalguri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,11000.0,10000.0,9000.0,9000.0,4200.0,4200.0,4200.0,4200.0,4200.0,60000.0
Udalguri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,2200.0,2200.0,5200.0,5200.0,2600.0,2600.0,2600.0,2600.0,25200.0
Udalguri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,5400.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,8400.0
Udalguri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Udalguri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,3200.0,0.0,0.0,0.0,2600.0,0.0,0.0,0.0,0.0,5800.0
Udalguri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,2200.0,2200.0,5200.0,5200.0,2600.0,2600.0,2600.0,2600.0,2600.0,27800.0
Udalguri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,900.0,900.0,900.0,900.0,900.0,900.0,900.0,900.0,7200.0
Udalguri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
Udalguri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Udalguri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Udalguri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,900.0,900.0,900.0,900.0,900.0,900.0,900.0,900.0,900.0,8100.0
Udalguri,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Udalguri,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,,,,,,0.0,3400.0,3700.0,3700.0,3700.0,2100.0,16600.0
Udalguri,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,,,,,,3400.0,2700.0,0.0,0.0,0.0,0.0,6100.0
Udalguri,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Udalguri,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,,,,,,0.0,2400.0,0.0,0.0,1600.0,1800.0,5800.0
Udalguri,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,3400.0,3700.0,3700.0,3700.0,2100.0,300.0,16900.0
Udalguri,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Udalguri,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Udalguri,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Udalguri,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Udalguri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,,,,,,,,,,0.0,0.0,0.0
Udalguri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,,,,,,,,,,,,0.0
Udalguri,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Udalguri,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Udalguri,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Udalguri,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Udalguri,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Udalguri,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Udalguri,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Udalguri,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Udalguri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Udalguri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Udalguri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Udalguri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udalguri,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,50.0,50.0,50.0,50.0,50.0,150.0,150.0,70.0,70.0,70.0,20.0,20.0,800.0
Udalguri,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Udalguri,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Udalguri,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,80.0,0.0,0.0,50.0,0.0,0.0,130.0
Udalguri,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,50.0,50.0,50.0,50.0,150.0,150.0,70.0,70.0,70.0,20.0,20.0,20.0,770.0
Udalguri,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,48000.0,32000.0,20000.0,4000.0,2200.0,0.0,,0.0,29200.0,29200.0,16200.0,10600.0,191400.0
Udalguri,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,,0.0,,,36200.0,0.0,0.0,0.0,0.0,36200.0
Udalguri,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Udalguri,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,16000.0,12000.0,16000.0,1800.0,2200.0,,,7000.0,0.0,13000.0,5600.0,7300.0,80900.0
Udalguri,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,32000.0,20000.0,4000.0,2200.0,0.0,0.0,0.0,29200.0,29200.0,16200.0,10600.0,3300.0,146700.0
Udalguri,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4900.0,2000.0,0.0,6000.0,7700.0,6000.0,4300.0,1000.0,200.0,1600.0,1600.0,1000.0,36300.0
Udalguri,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,6600.0,3300.0,3300.0,0.0,0.0,3300.0,3300.0,0.0,2000.0,0.0,21800.0
Udalguri,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Udalguri,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2900.0,2000.0,600.0,1600.0,5000.0,1700.0,3300.0,4100.0,1900.0,0.0,2600.0,1000.0,26700.0
Udalguri,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2000.0,0.0,6000.0,7700.0,6000.0,4300.0,1000.0,200.0,1600.0,1600.0,1000.0,0.0,31400.0
Udalguri,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,124200.0,110200.0,93400.0,75400.0,97800.0,95400.0,157800.0,150600.0,143200.0,157600.0,157600.0,138400.0,1501600.0
Udalguri,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,24000.0,0.0,52800.0,2400.0,62400.0,0.0,24000.0,24000.0,0.0,0.0,0.0,189600.0
Udalguri,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Udalguri,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,14000.0,40800.0,18000.0,30400.0,4800.0,0.0,7200.0,31400.0,9600.0,0.0,19200.0,7200.0,182600.0
Udalguri,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,110200.0,93400.0,75400.0,97800.0,95400.0,157800.0,150600.0,143200.0,157600.0,157600.0,138400.0,131200.0,1508600.0
Udalguri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,8480.0,7280.0,9480.0,9980.0,12780.0,9980.0,11280.0,10380.0,9380.0,10780.0,10780.0,10080.0,120660.0
Udalguri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4000.0,2000.0,6000.0,2000.0,2000.0,0.0,2000.0,2000.0,0.0,2000.0,0.0,22000.0
Udalguri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Udalguri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1200.0,1800.0,1500.0,3200.0,4800.0,700.0,900.0,3000.0,600.0,0.0,2700.0,600.0,21000.0
Udalguri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,7280.0,9480.0,9980.0,12780.0,9980.0,11280.0,10380.0,9380.0,10780.0,10780.0,10080.0,9480.0,121660.0
Udalguri,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,1.0,,2.0,,,,1.0,,,,4.0
Udalguri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,3.0,,,,3.0
Udalguri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Udalguri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,3.0,,,,3.0
Udalguri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,2.0,,1.0,,,1.0,1.0,,,,6.0
Udalguri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Udalguri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,2.0,,1.0,,,1.0,1.0,,,,6.0
Udalguri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,1.0,1.0,2.0,,1.0,2.0,,1.0,,2.0,10.0
Udalguri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,1.0,,,,,,1.0,,,,2.0
Udalguri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,2.0,1.0,2.0,,1.0,2.0,1.0,1.0,,2.0,12.0
Udalguri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,3.0,4.0,1.0,2.0,4.0,2.0,3.0,2.0,1.0,1.0,1.0,25.0
Udalguri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,1.0,1.0,,,3.0
Udalguri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,3.0,4.0,1.0,3.0,4.0,2.0,3.0,3.0,2.0,1.0,1.0,28.0
Udalguri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,2.0,,2.0,3.0,2.0,1.0,3.0,2.0,2.0,1.0,19.0
Udalguri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Udalguri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,2.0,,2.0,3.0,2.0,1.0,3.0,2.0,2.0,1.0,19.0
Udalguri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,,,,1.0,,,,,1.0,,3.0
Udalguri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Udalguri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,,,,1.0,,,,,1.0,,3.0
Udalguri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,1.0,,1.0,2.0,3.0,2.0,2.0,3.0,2.0,1.0,,18.0
Udalguri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,2.0,,1.0,,,1.0,,,,,4.0
Udalguri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,2.0,1.0,3.0,3.0,2.0,3.0,3.0,2.0,1.0,,22.0
Udalguri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,1.0,,,,,,,,,1.0
Udalguri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Udalguri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,1.0,,,,,,,,,1.0
Udalguri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,4.0,2.0,3.0,1.0,6.0,5.0,1.0,10.0,5.0,,6.0,48.0
Udalguri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,,1.0,3.0,3.0,2.0,1.0,1.0,,1.0,,13.0
Udalguri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,4.0,2.0,4.0,4.0,9.0,7.0,2.0,11.0,5.0,1.0,6.0,61.0
Udalguri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,1.0,,,1.0,1.0,1.0,5.0
Udalguri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Udalguri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,,1.0,,,1.0,1.0,1.0,5.0
Udalguri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,1.0,2.0,1.0,,2.0,2.0,1.0,2.0,,,3.0,16.0
Udalguri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,1.0,,,1.0,,,3.0,,,1.0,,8.0
Udalguri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,4.0,2.0,2.0,1.0,1.0,2.0,2.0,4.0,2.0,,1.0,3.0,24.0
Udalguri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,2.0,4.0,3.0,2.0,1.0,7.0,2.0,3.0,1.0,1.0,5.0,32.0
Udalguri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,2.0,3.0,2.0,2.0,4.0,2.0,3.0,1.0,2.0,1.0,1.0,23.0
Udalguri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,4.0,7.0,5.0,4.0,5.0,9.0,5.0,4.0,3.0,2.0,6.0,55.0
Udalguri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Udalguri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Udalguri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,,,,,,,,,1.0
Udalguri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,1.0,1.0,,,,,,,1.0,,3.0
Udalguri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,3.0,3.0,2.0,1.0,3.0,1.0,2.0,2.0,1.0,3.0,,2.0,23.0
Udalguri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,6.0,2.0,5.0,1.0,1.0,1.0,,2.0,,1.0,2.0,4.0,25.0
Udalguri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,9.0,5.0,8.0,3.0,4.0,2.0,2.0,4.0,1.0,4.0,3.0,6.0,51.0
Udalguri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Udalguri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Udalguri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,,,,,,,,,1.0
Udalguri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,10.0,12.0,5.0,6.0,5.0,4.0,5.0,5.0,3.0,8.0,6.0,1.0,70.0
Udalguri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,8.0,11.0,5.0,10.0,7.0,5.0,12.0,12.0,13.0,11.0,11.0,6.0,111.0
Udalguri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,18.0,23.0,10.0,16.0,12.0,9.0,17.0,17.0,16.0,19.0,17.0,7.0,181.0
Udalguri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,,2.0,,2.0,14.0
Udalguri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,2.0,2.0,1.0,3.0,2.0,1.0,1.0,2.0,4.0,,1.0,21.0
Udalguri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,4.0,4.0,3.0,2.0,4.0,3.0,2.0,2.0,2.0,6.0,,3.0,35.0
Udalguri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Udalguri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Udalguri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Udalguri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Udalguri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Udalguri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Udalguri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,1.0,,,,,,2.0,,,3.0
Udalguri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Udalguri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,1.0,,,,,,2.0,,,3.0
Udalguri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,1.0,1.0,,,2.0,,1.0,,6.0
Udalguri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Udalguri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,1.0,1.0,,,2.0,,1.0,,6.0
Udalguri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Udalguri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Udalguri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Udalguri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,1.0,1.0,1.0,,1.0,1.0,1.0,,7.0
Udalguri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Udalguri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,1.0,1.0,1.0,,1.0,1.0,1.0,,7.0
Udalguri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,2.0,2.0,,,1.0,,,,,,5.0
Udalguri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,3.0,5.0,5.0,6.0,7.0,2.0,4.0,3.0,2.0,4.0,1.0,44.0
Udalguri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,2.0,,1.0,,,1.0,,1.0,2.0,1.0,9.0
Udalguri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,3.0,3.0,9.0,7.0,7.0,7.0,3.0,5.0,3.0,3.0,6.0,2.0,58.0
Udalguri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Udalguri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,5.0,3.0,2.0,6.0,4.0,1.0,2.0,3.0,1.0,1.0,2.0,2.0,32.0
Udalguri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,2.0,,,,,1.0,1.0,,,,4.0
Udalguri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,5.0,3.0,4.0,7.0,4.0,1.0,2.0,4.0,2.0,1.0,2.0,2.0,37.0
Udalguri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Udalguri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,1.0,2.0,,,,,,,,,4.0
Udalguri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,,,,,,,1.0,,,,1.0,3.0
Udalguri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,1.0,1.0,2.0,1.0,,,1.0,,,,1.0,8.0
Udalguri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Udalguri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,5.0,3.0,7.0,5.0,4.0,3.0,5.0,11.0,6.0,,3.0,53.0
Udalguri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,4.0,1.0,15.0,4.0,5.0,3.0,6.0,1.0,5.0,6.0,8.0,60.0
Udalguri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,9.0,4.0,22.0,9.0,9.0,6.0,11.0,12.0,11.0,6.0,11.0,113.0
Udalguri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,1.0,2.0,,,,,,,,4.0
Udalguri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,7.0,7.0,4.0,4.0,10.0,3.0,9.0,3.0,8.0,2.0,4.0,4.0,65.0
Udalguri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,7.0,10.0,5.0,6.0,8.0,,8.0,4.0,11.0,5.0,8.0,8.0,80.0
Udalguri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,14.0,18.0,9.0,11.0,20.0,3.0,17.0,7.0,19.0,7.0,12.0,12.0,149.0
Udalguri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,1.0,2.0,2.0,1.0,2.0,,1.0,,,,10.0
Udalguri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,14.0,11.0,26.0,14.0,22.0,16.0,14.0,17.0,9.0,10.0,8.0,12.0,173.0
Udalguri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,18.0,18.0,23.0,27.0,17.0,24.0,11.0,10.0,19.0,22.0,13.0,21.0,223.0
Udalguri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,32.0,30.0,50.0,43.0,41.0,41.0,27.0,27.0,29.0,32.0,21.0,33.0,406.0
